{"meta":{"query_hash":"7c96b6f5b4ee","filters":{"venue":"British Journal of Dermatology"},"cohort_total":688,"direct_labels_cover":4,"predictions_cover":688,"exported":688,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7c96b6f5b4ee","api":"https://metacan.xera.ac/api/v1/cohort?venue=British+Journal+of+Dermatology"},"results":[{"id":"W142975861","doi":"10.1111/j.1365-2133.2012.10935.x","title":"Main Plenary Sessions","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"Action Medical Research","keywords":"Citation; Library science; Plenary session; Medicine; Computer science","score_opus":0.01767040661360554,"score_gpt":0.28041839481695086,"score_spread":0.26274798820334533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W142975861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8107992,0.10603388,0.0012692921,0.012569299,0.0030787073,0.00020606465,0.000007836358,0.000049253926,0.0659865],"genre_scores_gemma":[0.98471797,0.001679978,0.0015115917,0.011140652,0.0005187688,0.00000310955,0.0000042458196,0.000017627131,0.0004060741],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99862736,0.0001312564,0.0005785498,0.000078058016,0.00020340637,0.00038138256],"domain_scores_gemma":[0.9989903,0.00013431293,0.00025974165,0.00011816008,0.00013977003,0.00035771588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018660279,0.00010310976,0.00061644136,0.00017053651,0.00012825467,0.0000034863458,0.000089572226,0.0001449747,0.00016868467],"category_scores_gemma":[0.00025818616,0.00009850379,0.0001531394,0.0001098151,0.00022925006,0.00014843131,0.000041340198,0.0004974035,0.000060701695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009908019,0.0003149014,0.078784175,0.00007445093,0.00018148671,0.021077307,0.00027439516,8.0631196e-8,0.00033267168,0.00014460241,0.89280456,0.0059122955],"study_design_scores_gemma":[0.0018747447,0.00007409731,0.034552608,0.00023537868,0.00018009871,0.7234317,0.0007410568,0.0000024025896,0.00025131085,0.000052777912,0.23851925,0.00008455973],"about_ca_topic_score_codex":0.0000043630907,"about_ca_topic_score_gemma":0.0000023704301,"teacher_disagreement_score":0.70235443,"about_ca_system_score_codex":0.000048354545,"about_ca_system_score_gemma":0.00015977159,"threshold_uncertainty_score":0.4016868},"labels":[],"label_agreement":null},{"id":"W1508752722","doi":"10.1111/bjd.12110","title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":357,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Placebo; Interleukin 17; Internal medicine; Dose; Randomized controlled trial; Gastroenterology; Concomitant; Clinical trial; Plaque psoriasis; Adverse effect; Immunology; Cytokine; Psoriatic arthritis; Pathology","score_opus":0.02137471321531433,"score_gpt":0.28089163570398684,"score_spread":0.25951692248867253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508752722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738658,0.022684796,0.00007318718,0.0002286662,0.00046714384,0.0024760803,0.000034611832,0.000007623573,0.00016208511],"genre_scores_gemma":[0.9976514,0.0019486131,0.00007707418,0.00003149748,0.000059101065,0.00015639476,0.000016492988,0.00001707427,0.00004238261],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99618,0.0017120356,0.0013926177,0.00018970175,0.00009327147,0.0004323663],"domain_scores_gemma":[0.9976708,0.001218495,0.0007301437,0.00019485517,0.00012699173,0.000058660364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009934241,0.000274233,0.0021081187,0.0003548141,0.00019713926,0.000016008433,0.00023552218,0.0002322416,0.0000616924],"category_scores_gemma":[0.000103451785,0.00019813371,0.00033923134,0.00020018185,0.00016636435,0.00015473357,0.00003869944,0.00020058971,0.0000047858266],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94736177,0.009339215,0.001603031,0.00002008684,0.0030909507,0.00043768375,0.014837051,0.000041878116,0.00085256516,0.00011627969,0.00008972289,0.02220975],"study_design_scores_gemma":[0.97060263,0.0018033184,0.0010280756,0.00012517003,0.0014407928,0.018557463,0.002233473,0.0000057533257,0.003710361,0.000026102465,0.00029526805,0.00017159882],"about_ca_topic_score_codex":0.00015211677,"about_ca_topic_score_gemma":0.00012221682,"teacher_disagreement_score":0.023785563,"about_ca_system_score_codex":0.00004722632,"about_ca_system_score_gemma":0.00010221981,"threshold_uncertainty_score":0.8079658},"labels":[],"label_agreement":null},{"id":"W1512287127","doi":"10.1111/j.1365-2133.2010.09972.x","title":"Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment?","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Dehydroepiandrosterone; Immunocytochemistry; Medicine; Dermis; Internal medicine; Endocrinology; Placebo; Androgen receptor; Procollagen peptidase; Androgen; Pathology; Hormone","score_opus":0.017350434410318707,"score_gpt":0.310071384109432,"score_spread":0.29272094969911333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512287127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057336,0.0008319475,0.000057668556,0.017715871,0.0001758535,0.00011739031,0.000003523405,0.0000058250234,0.0005185485],"genre_scores_gemma":[0.99798083,0.00033640576,0.0010672422,0.00021311725,0.00017870443,0.000006349522,9.918853e-7,0.0000068138243,0.0002095713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992572,0.00005254418,0.0003281001,0.00012426056,0.00007233891,0.0001655482],"domain_scores_gemma":[0.99953115,0.000076973,0.000067637244,0.00009801785,0.00011747429,0.000108747154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007400145,0.000068104106,0.000345681,0.00014262012,0.000062516905,0.000012037589,0.00006048823,0.000061141924,0.000023067629],"category_scores_gemma":[0.00032748835,0.000059860893,0.00007509522,0.00011858162,0.00008333173,0.000053314176,0.000025647721,0.00023822027,0.000010059009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005447697,0.00061206653,0.7815218,0.000021423497,0.0001462096,0.012565744,0.0008633678,7.546126e-7,0.061803196,0.0002919533,0.0010838921,0.14054482],"study_design_scores_gemma":[0.0010570268,0.00022254034,0.8426653,0.00005087421,0.000029001669,0.14025457,0.00011021629,7.828965e-7,0.0062628966,0.00014177377,0.009152513,0.000052488027],"about_ca_topic_score_codex":0.000052911648,"about_ca_topic_score_gemma":0.0004339009,"teacher_disagreement_score":0.14049232,"about_ca_system_score_codex":0.00002524307,"about_ca_system_score_gemma":0.00007480701,"threshold_uncertainty_score":0.24410564},"labels":[],"label_agreement":null},{"id":"W1533901323","doi":"10.1111/j.1365-2133.2010.10061.x","title":"Portable video education for informed consent: the shape of things to come?","year":2010,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Music Therapy and Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Informed consent; Comprehension; Medical education; Patient education; General partnership; Medicine; Psychology; Family medicine; Alternative medicine; Computer science; Law; Pathology","score_opus":0.03001527572885988,"score_gpt":0.3457167961922946,"score_spread":0.31570152046343475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533901323","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020569243,0.004551674,0.00047516488,0.9564699,0.009996303,0.001019254,0.00010095024,0.000015528194,0.006801995],"genre_scores_gemma":[0.015218978,0.0005702889,0.0012150824,0.9779124,0.0025902963,0.00007452981,0.00008320398,0.000054993925,0.00228022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976079,0.00022354466,0.0013068545,0.00018054536,0.00022245929,0.00045872244],"domain_scores_gemma":[0.995946,0.0014339725,0.0016726002,0.00030566228,0.0005322003,0.000109556575],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042459098,0.0001894494,0.0008147222,0.00026702686,0.0001563732,0.000049097755,0.00066744146,0.0012687473,0.0017975555],"category_scores_gemma":[0.000371804,0.00017470347,0.00026278742,0.00011893223,0.00018723428,0.00012039258,0.00003284332,0.0028896304,0.000028326986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013102333,0.00007959232,0.00019602511,0.0002939685,0.00016309544,0.00033504702,0.0015269152,6.788949e-8,0.000015535152,0.00066977646,0.96669453,0.029894426],"study_design_scores_gemma":[0.0008815873,0.0001235924,0.0009511778,0.000397924,0.000079717785,0.07538155,0.00027838213,8.5653016e-7,0.000021186192,0.0017017329,0.92003673,0.00014555186],"about_ca_topic_score_codex":0.00048783087,"about_ca_topic_score_gemma":0.00041661988,"teacher_disagreement_score":0.075046495,"about_ca_system_score_codex":0.00003621885,"about_ca_system_score_gemma":0.0018302501,"threshold_uncertainty_score":0.99941075},"labels":[],"label_agreement":null},{"id":"W1539577732","doi":"10.1111/j.1365-2133.2011.10373.x","title":"A case of monilethrix caused by novel compound heterozygous mutations in the desmoglein 4 (DSG4) gene","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Compound heterozygosity; Gene; Genetics; Mutation; Desmoglein 1; Dermatology; Medicine; Biology; Antibody; Autoantibody","score_opus":0.031699793575288994,"score_gpt":0.26691914363208913,"score_spread":0.23521935005680014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539577732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385184,0.002926311,0.0018929137,0.0005555062,0.000080200305,0.00015672746,0.000023281575,0.0000053235913,0.00050791836],"genre_scores_gemma":[0.99814826,0.00014021518,0.001074025,0.0005882739,0.000017710414,0.0000034078175,0.00000879394,0.0000120141785,0.000007298405],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998816,0.00012363702,0.0006157036,0.00009083323,0.00013957423,0.00021424942],"domain_scores_gemma":[0.99926794,0.00011797354,0.00024832037,0.00011413886,0.00014739665,0.00010424385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015212355,0.000090500005,0.00038942927,0.00014336166,0.000057037912,0.000010306556,0.00013016074,0.00010250369,0.000049445393],"category_scores_gemma":[0.00014039868,0.00008303636,0.00010494889,0.0001715156,0.00020491636,0.000085187356,0.000014072998,0.00031229405,0.0000030190902],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007546171,0.0054897997,0.10140144,0.00030936653,0.00054529024,0.8192102,0.018852275,0.000024516086,0.021761816,0.00041382608,0.015133781,0.01610311],"study_design_scores_gemma":[0.004958604,0.00020804023,0.00875634,0.00009299739,0.000102093654,0.9791795,0.0021490587,0.00007176774,0.0037957064,0.0002483571,0.00035050395,0.00008700856],"about_ca_topic_score_codex":0.0006966506,"about_ca_topic_score_gemma":0.00048908475,"teacher_disagreement_score":0.15996936,"about_ca_system_score_codex":0.000016399488,"about_ca_system_score_gemma":0.00011558866,"threshold_uncertainty_score":0.33861244},"labels":[],"label_agreement":null},{"id":"W1549384169","doi":"10.1111/bjd.12018","title":"Functional studies for the<i>TRAF6</i>mutation associated with hypohidrotic ectodermal dysplasia","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"dental development and anomalies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Hypohidrotic ectodermal dysplasia; Mutant; Mutation; Ectodermal dysplasia; Signal transducing adaptor protein; Mutant protein; Wild type; Immunoprecipitation; Biology; Molecular biology; Receptor; Genetics; Gene","score_opus":0.018069687748174964,"score_gpt":0.2455849194724751,"score_spread":0.22751523172430013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1549384169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985709,0.010339684,0.0027232366,0.00045912736,0.00056749565,0.000114367474,0.000008195708,0.0000045661686,0.00007430625],"genre_scores_gemma":[0.99852353,0.00039106337,0.0003173455,0.00024278498,0.00017725748,0.000013878726,0.00004065044,0.00001219505,0.0002813045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992936,0.000052773634,0.000246497,0.00007444669,0.00011514163,0.00021751065],"domain_scores_gemma":[0.99938554,0.00009002614,0.00021034658,0.000040886698,0.00022666367,0.000046527934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012390567,0.000087505956,0.00016711414,0.00002973007,0.0001591649,0.00002416621,0.00008808308,0.00007093635,0.000008084058],"category_scores_gemma":[0.0001898178,0.00007020531,0.00007608836,0.00004734458,0.00011866,0.0000196167,0.000025253497,0.00007993177,0.0000021210058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024627657,0.0014441157,0.5460001,0.00025711133,0.010449805,0.0016702136,0.0013294612,0.00042053644,0.110508606,0.00096040755,0.27745318,0.04704365],"study_design_scores_gemma":[0.005759677,0.0005247235,0.68663967,0.00022978656,0.00045223098,0.18492591,0.0016241233,0.000032642685,0.10245719,0.00030987183,0.016542036,0.00050213415],"about_ca_topic_score_codex":9.491791e-7,"about_ca_topic_score_gemma":0.00003058971,"teacher_disagreement_score":0.26091117,"about_ca_system_score_codex":0.0000136021745,"about_ca_system_score_gemma":0.000056748446,"threshold_uncertainty_score":0.28628892},"labels":[],"label_agreement":null},{"id":"W1572999787","doi":"10.1111/j.1365-2133.2011.10399.x","title":"Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Cilag; Johnson and Johnson; Abbott Laboratories; Abbott Fund","keywords":"Methotrexate; Medicine; Psoriasis; Dosing; Psoriasis Area and Severity Index; Internal medicine; Placebo; Dose; Champion; Gastroenterology; Surgery; Dermatology","score_opus":0.043282077650785816,"score_gpt":0.28162148791945824,"score_spread":0.23833941026867242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572999787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987833,0.00055905554,0.00007595898,0.00011571703,0.00018109729,0.00024250922,0.000018659053,0.0000042686397,0.000019434608],"genre_scores_gemma":[0.9995582,0.00002243076,0.00034282077,0.000026021049,0.00001004155,0.0000037664952,0.000003949626,0.000010660308,0.000022121085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590856,0.0028497092,0.0008189448,0.00017670341,0.000060801525,0.00018526235],"domain_scores_gemma":[0.998413,0.0007039679,0.00051515165,0.00016320689,0.00016700738,0.00003763875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008775926,0.00012053459,0.0005993947,0.00022099588,0.00012206896,0.00000951781,0.00018250852,0.00018014874,0.000015511541],"category_scores_gemma":[0.00046034597,0.00009307538,0.00010919159,0.0002778775,0.00011175684,0.00011164917,0.0000613161,0.00029403504,0.0000034548675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060838386,0.00042049,0.98609495,0.000004200684,0.00047020148,0.00009218228,0.0011548967,0.0000026223327,0.000015499703,0.0000047289845,0.00002438319,0.005631998],"study_design_scores_gemma":[0.0062631285,0.0006102319,0.9905565,0.00008542625,0.00057453365,0.0008972556,0.0003537128,3.5623003e-7,0.00047835128,0.00007535756,0.000010456349,0.00009473596],"about_ca_topic_score_codex":0.00009718076,"about_ca_topic_score_gemma":0.0002127306,"teacher_disagreement_score":0.005537262,"about_ca_system_score_codex":0.000021918035,"about_ca_system_score_gemma":0.0000750393,"threshold_uncertainty_score":0.3795504},"labels":[],"label_agreement":null},{"id":"W1576222573","doi":"10.1046/j.1365-2133.2000.03306.x","title":"Redefining Rowell’s syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Anti-nuclear antibody; Medicine; Erythema multiforme; Rheumatoid factor; Dermatology; Antibody; Pathology; Immunology; Autoantibody","score_opus":0.01616906899157267,"score_gpt":0.2762891581412653,"score_spread":0.26012008914969265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1576222573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733052,0.007477958,0.000051750292,0.0017625212,0.00019854507,0.0001155819,0.00000220381,0.000023259001,0.017062936],"genre_scores_gemma":[0.9951429,0.0014702969,0.00084096415,0.00025918946,0.00009656383,0.0000026937948,0.000002207697,0.000026898137,0.00215828],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99819666,0.00015457609,0.000731905,0.00013443486,0.00042033012,0.00036207685],"domain_scores_gemma":[0.99910057,0.0001149148,0.00017870798,0.00016300664,0.00019906161,0.00024375785],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027753692,0.00009848529,0.0006302156,0.00017960565,0.00007197151,0.000035400273,0.00018663793,0.00014630488,0.002580411],"category_scores_gemma":[0.00021214233,0.000104174746,0.00017202566,0.00018762326,0.000111796886,0.00011351018,0.000022436941,0.00050078635,0.00030238077],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066471257,0.00043201938,0.21575627,0.00065961864,0.0005747098,0.5558422,0.0007193081,0.00000826377,0.00089217984,0.00014348398,0.08899105,0.13531618],"study_design_scores_gemma":[0.002387724,0.00013509007,0.0064428705,0.0012310254,0.000044328575,0.975644,0.0001867916,0.000026181848,0.0002448286,0.00013643081,0.013439829,0.000080935315],"about_ca_topic_score_codex":0.000027058826,"about_ca_topic_score_gemma":0.0000056971517,"teacher_disagreement_score":0.41980177,"about_ca_system_score_codex":0.00006242331,"about_ca_system_score_gemma":0.00021838874,"threshold_uncertainty_score":0.99833137},"labels":[],"label_agreement":null},{"id":"W1580715943","doi":"10.1111/j.1365-2133.2011.10344.x","title":"A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Adapalene; Acne; Medicine; Benzoyl peroxide; Dermatology; Library science; Computer science","score_opus":0.0063267002490228035,"score_gpt":0.2095494778434396,"score_spread":0.20322277759441681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1580715943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926944,0.0029475251,0.000070745395,0.00011049781,0.00012687732,0.0034971633,0.0000144817195,0.000011182696,0.00052717794],"genre_scores_gemma":[0.9968588,0.0017611185,0.0007966569,0.00009556757,0.000047844005,0.00005704329,0.00000946315,0.00003096358,0.00034255194],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974423,0.00044414005,0.0012059417,0.00024770925,0.00033142883,0.0003284489],"domain_scores_gemma":[0.9971775,0.0003894684,0.0015870472,0.00017315947,0.0004669551,0.00020589578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045119386,0.00027020572,0.0027713622,0.00012543787,0.00008445317,0.000022868464,0.00010986114,0.00017435664,0.000015049311],"category_scores_gemma":[0.00042266358,0.00015543231,0.00031875004,0.000086643115,0.00039433007,0.00019882875,0.000023126524,0.00031775446,4.657854e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96790934,0.0019588573,0.01952299,0.000043124503,0.002456608,0.0024228944,0.0008507551,4.489929e-7,0.00005474472,0.000004391607,0.00053309655,0.0042427774],"study_design_scores_gemma":[0.9058756,0.005845724,0.0753861,0.0013381313,0.0010281701,0.0098641,0.00014318037,0.000012951371,0.0002872398,0.000021014466,0.000036496756,0.0001612761],"about_ca_topic_score_codex":0.00020894836,"about_ca_topic_score_gemma":0.000069241156,"teacher_disagreement_score":0.062033698,"about_ca_system_score_codex":0.000020300296,"about_ca_system_score_gemma":0.00015484299,"threshold_uncertainty_score":0.6338346},"labels":[],"label_agreement":null},{"id":"W1582804005","doi":"10.1111/j.1365-2133.2012.10962.x","title":"A novel mutation in the<i>PLCD1</i>gene, which leads to an aberrant splicing event, underlies autosomal recessive leuconychia","year":2012,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"RNA splicing; Event (particle physics); Genetics; Mutation; Gene; Alternative splicing; Computational biology; Content (measure theory); Biology; Computer science; Exon; Physics; Mathematics","score_opus":0.0222667225120318,"score_gpt":0.2971102231618257,"score_spread":0.2748435006497939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1582804005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.695372,0.006030994,0.0008088904,0.2956153,0.0009871532,0.0007102806,0.00010553249,0.00002259695,0.0003472656],"genre_scores_gemma":[0.83678573,0.00030899385,0.001083509,0.15980172,0.0015332444,0.000031815216,0.00028610457,0.00006712184,0.00010177664],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99729824,0.00030809164,0.0009675097,0.00029454278,0.0005358634,0.00059576496],"domain_scores_gemma":[0.9983406,0.00016133739,0.0006954041,0.00026054628,0.00032913563,0.00021299791],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017993669,0.0003204624,0.000951472,0.00040826062,0.000119802906,0.00009267202,0.00031463453,0.0005279168,0.00005945044],"category_scores_gemma":[0.00013680081,0.00028491736,0.00024582428,0.00031584338,0.0000683527,0.0002854838,0.00003728108,0.0015282406,0.000027543098],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010758011,0.0032118033,0.100277096,0.0012018437,0.0016280056,0.24826403,0.0030949716,0.00006874411,0.0014648732,0.000076636024,0.6091663,0.030469846],"study_design_scores_gemma":[0.007177386,0.0006528674,0.18865822,0.0026181987,0.0013083938,0.7735517,0.00043137808,0.000033018805,0.00026477143,0.00025091757,0.024574306,0.00047884442],"about_ca_topic_score_codex":0.00037405797,"about_ca_topic_score_gemma":0.00079148373,"teacher_disagreement_score":0.58459204,"about_ca_system_score_codex":0.00015376111,"about_ca_system_score_gemma":0.00041604368,"threshold_uncertainty_score":0.9999603},"labels":[],"label_agreement":null},{"id":"W1583872719","doi":"10.1111/j.1365-2133.2011.10537.x","title":"Transgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentation","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Dermatology; Keratoderma; Dorsum; Nail (fastener); Etiology; Foot (prosody); Hyperkeratosis; Surgery; Pathology; Anatomy","score_opus":0.022340927888889014,"score_gpt":0.26200998649899976,"score_spread":0.23966905861011073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1583872719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366397,0.0030382178,0.0016613305,0.00016947827,0.00021500241,0.000099624325,0.00002732458,0.0000031707373,0.0011219091],"genre_scores_gemma":[0.9979763,0.00080766133,0.0009156826,0.000035358175,0.00010602675,0.0000041015155,0.000022137203,0.000013778495,0.00011896161],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99875575,0.00026576672,0.0004640085,0.00015567905,0.000113722075,0.00024506007],"domain_scores_gemma":[0.99924284,0.000022513288,0.00020828097,0.00013435,0.00027224593,0.00011977829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016110709,0.000102420745,0.00028117167,0.00006909303,0.00006325708,0.000010356587,0.00020215819,0.00024106455,0.000090485606],"category_scores_gemma":[0.00012114271,0.000108099855,0.00016409656,0.00007130594,0.00043440214,0.000011366344,0.000054592772,0.00021185789,0.0000029858463],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032580623,0.0012718064,0.07666743,0.00021234195,0.0013720696,0.1897974,0.0015871723,0.0000023822347,0.6754571,0.00057185936,0.012075742,0.03772659],"study_design_scores_gemma":[0.0010407909,0.00043988292,0.001484204,0.000019927902,0.000045126977,0.67318624,0.00045757095,0.0000067142364,0.32205883,0.00014895662,0.0010154858,0.00009626854],"about_ca_topic_score_codex":0.000037088674,"about_ca_topic_score_gemma":0.0001863725,"teacher_disagreement_score":0.48338884,"about_ca_system_score_codex":0.0000048939287,"about_ca_system_score_gemma":0.00011865974,"threshold_uncertainty_score":0.44081843},"labels":[],"label_agreement":null},{"id":"W1584376310","doi":"10.1111/j.1365-2133.2010.09851.x","title":"BRG1 expression is increased in human cutaneous melanoma","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Melanoma; SWI/SNF; Gene knockdown; Cancer research; Cell growth; Tissue microarray; Cyclin D1; Chromatin remodeling; Cell cycle; Immunohistochemistry; Cancer; Biology; Medicine; Pathology; Chromatin; Cell culture; Internal medicine; Gene; Genetics","score_opus":0.0048246649421337965,"score_gpt":0.2443027886571357,"score_spread":0.2394781237150019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584376310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997641,0.001256949,0.00016737008,0.00016399904,0.00020653509,0.00003857713,0.0000063886073,0.0000036280871,0.0005155218],"genre_scores_gemma":[0.9984891,0.00023570735,0.0007389336,0.0002831172,0.00017588545,0.0000016910963,0.000010465561,0.000013919814,0.00005117498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991608,0.00006246408,0.00037324982,0.00013430539,0.0000986866,0.00017045274],"domain_scores_gemma":[0.99949974,0.000011014875,0.00018547334,0.00013094937,0.000093388204,0.000079460435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008042071,0.0000829569,0.00020211806,0.000053757085,0.000053674947,0.00002186626,0.00019486189,0.00020863669,0.00009015706],"category_scores_gemma":[0.000073829025,0.000093728275,0.000086397085,0.00003885784,0.000061867024,0.000004581305,0.000044556255,0.00030083876,0.0000025823983],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004304476,0.00006724585,0.007553855,0.000011838076,0.00001442561,0.0015468934,0.000026331252,0.000006121992,0.97915304,0.0000063016882,0.006746163,0.004824724],"study_design_scores_gemma":[0.0016183747,0.0001081797,0.002807903,0.000120601835,0.000013219439,0.21863292,0.000042698888,0.00006715473,0.76473457,0.0003468162,0.0113308765,0.00017665236],"about_ca_topic_score_codex":0.00009602357,"about_ca_topic_score_gemma":0.00031942403,"teacher_disagreement_score":0.21708603,"about_ca_system_score_codex":0.000007808336,"about_ca_system_score_gemma":0.00007723058,"threshold_uncertainty_score":0.38221282},"labels":[],"label_agreement":null},{"id":"W1585166895","doi":"10.1111/j.1365-2133.2011.10489.x","title":"CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; Vancouver General Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Indoleamine 2,3-dioxygenase; Downregulation and upregulation; Basal cell carcinoma; Kynurenine; Biology; Keratinocyte; Cancer research; CXCR3; Carcinogenesis; Western blot; Molecular biology; Immunology; Immune system; In vitro; Biochemistry; Medicine; Pathology; Chemokine; Gene; Basal cell","score_opus":0.02788231292972241,"score_gpt":0.2188410864020706,"score_spread":0.1909587734723482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1585166895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746233,0.0008132366,0.00018163334,0.00006886269,0.00023421206,0.00009472589,0.000010110871,0.000008274974,0.0011265818],"genre_scores_gemma":[0.9991724,0.00009506896,0.00040956237,0.00021099937,0.00004563103,0.0000030135675,0.0000014207831,0.00001499125,0.000046893736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851865,0.000154656,0.0006452327,0.00019149062,0.00023472944,0.0002552272],"domain_scores_gemma":[0.9991988,0.00010865389,0.00040018783,0.00010377638,0.00008741895,0.00010114532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001053962,0.000121020705,0.00034280107,0.00022475285,0.000057656256,0.000017807139,0.00025435232,0.00011886321,0.00019334414],"category_scores_gemma":[0.00026294397,0.00012743018,0.000104578794,0.00020563457,0.00015715924,0.00025360787,0.000062549945,0.00033025813,0.0000074226828],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003544181,0.00070259173,0.012216719,0.00007068279,0.000003300372,0.0049340157,0.0005746427,0.000007349352,0.97697514,0.000059743223,0.0020923482,0.0020090688],"study_design_scores_gemma":[0.002252064,0.00013323317,0.08070497,0.00009009505,0.0000025778952,0.012543492,0.0001267627,0.000037679576,0.9036109,0.0003209569,0.000070820024,0.00010648759],"about_ca_topic_score_codex":0.000026035887,"about_ca_topic_score_gemma":0.000023967777,"teacher_disagreement_score":0.073364265,"about_ca_system_score_codex":0.0000143850175,"about_ca_system_score_gemma":0.000112120506,"threshold_uncertainty_score":0.51964515},"labels":[],"label_agreement":null},{"id":"W1591809044","doi":"10.1111/j.1365-2133.2012.11015.x","title":"A randomized, double‐blind, placebo‐controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer; Amgen","keywords":"Etanercept; Medicine; Psoriasis Area and Severity Index; Psoriasis; Methotrexate; Internal medicine; Placebo; Combination therapy; Adverse effect; Gastroenterology; Randomized controlled trial; Clinical endpoint; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.0201933887183919,"score_gpt":0.26993627326028996,"score_spread":0.24974288454189805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591809044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938502,0.00091817905,0.00036627243,0.00057161076,0.00066122937,0.0033800076,0.00006271151,0.000010414341,0.0001793797],"genre_scores_gemma":[0.99864596,0.000053682517,0.00045023384,0.0002994933,0.000049420647,0.0003313423,0.000026299884,0.00002603422,0.00011751531],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99502987,0.0029291243,0.0011219915,0.00023871765,0.00015879524,0.0005214874],"domain_scores_gemma":[0.99803334,0.00075505464,0.00043959904,0.00022523222,0.0004223966,0.0001243835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016412312,0.0002774674,0.0017157549,0.00043910745,0.00014547908,0.000028450817,0.0003251807,0.00016549186,0.0002477907],"category_scores_gemma":[0.00033664808,0.00019389666,0.00023048981,0.00036400306,0.00007201009,0.00020068556,0.00008374921,0.00029232714,0.00009275458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970087,0.0016080941,0.010442146,0.00000993136,0.0022454823,0.00012260662,0.0048393793,0.00043521644,0.00024096512,0.000030240677,0.0016563268,0.008282622],"study_design_scores_gemma":[0.9656697,0.00096771994,0.02372416,0.00018971151,0.0013399757,0.0036515018,0.001170511,0.00000318566,0.0026818665,0.000036101905,0.00024915423,0.00031644592],"about_ca_topic_score_codex":0.00015305946,"about_ca_topic_score_gemma":0.0004745477,"teacher_disagreement_score":0.013282013,"about_ca_system_score_codex":0.000064596876,"about_ca_system_score_gemma":0.00010196886,"threshold_uncertainty_score":0.7906876},"labels":[],"label_agreement":null},{"id":"W1592628203","doi":"10.1111/j.1365-2133.2010.10139.x","title":"Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Abbott Laboratories","keywords":"Adalimumab; Medicine; Psoriasis; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Dosing; Surgery; Dermatology; Disease","score_opus":0.00973151097607172,"score_gpt":0.23870295296334362,"score_spread":0.2289714419872719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592628203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638609,0.03355246,0.000371715,0.0006443073,0.00090085965,0.00037523388,0.0002700403,0.000010213928,0.000014230713],"genre_scores_gemma":[0.99500513,0.0037156963,0.0010184412,0.000072441,0.000069017515,0.000022096763,0.000053073632,0.000016958367,0.000027142285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988048,0.00016427231,0.00047506258,0.0002489757,0.00004380793,0.00026308847],"domain_scores_gemma":[0.999029,0.0003471544,0.00026358344,0.0001392145,0.000097339034,0.0001237451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001158171,0.00018439267,0.0005767851,0.000086368,0.0001879985,0.000025028681,0.00014000485,0.00020103728,0.00003735959],"category_scores_gemma":[0.00013179048,0.00017647703,0.00013355108,0.000058690355,0.00011366324,0.00012411541,0.00003938163,0.00020426755,0.000002515163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029755563,0.0011234066,0.046633903,0.00010421204,0.0047864346,0.0016486875,0.0017931457,0.000027608985,0.06668496,0.00047126,0.0031292373,0.8438416],"study_design_scores_gemma":[0.20282727,0.0055499175,0.4986866,0.0030881206,0.00390432,0.07170486,0.0007042535,0.00009547748,0.17114994,0.006868514,0.03309479,0.0023259267],"about_ca_topic_score_codex":0.00007146385,"about_ca_topic_score_gemma":0.00017024098,"teacher_disagreement_score":0.84151566,"about_ca_system_score_codex":0.000025061381,"about_ca_system_score_gemma":0.00024004214,"threshold_uncertainty_score":0.7196524},"labels":[],"label_agreement":null},{"id":"W1593834521","doi":"10.1046/j.1365-2133.2000.03341.x","title":"What are some of the lessons learnt from in vitro studies of severe unpredictable drug reactions?","year":2000,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Australasian College of Dermatologists; Canadian Dermatology Foundation","keywords":"Drug; Medicine; In vitro; Intensive care medicine; Pharmacology; Chemistry; Biochemistry","score_opus":0.031451782462730976,"score_gpt":0.2921869687163445,"score_spread":0.26073518625361347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1593834521","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27602306,0.043145537,0.0000016318401,0.6757416,0.0034562119,0.00042171963,0.00038764297,0.000020537074,0.00080206577],"genre_scores_gemma":[0.84009445,0.08919006,0.00031134504,0.06463391,0.0023909372,0.00002243888,0.0001310717,0.00014770223,0.003078083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681455,0.00045079633,0.0015086837,0.00026273512,0.00058494846,0.00037830355],"domain_scores_gemma":[0.99647474,0.0006657774,0.0019270345,0.00040710325,0.00044729997,0.000078026234],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00017356218,0.0002724564,0.001887791,0.00045292123,0.000091702284,0.000026667214,0.00035093562,0.0006074422,0.000036895446],"category_scores_gemma":[0.0004015552,0.00024992612,0.0005222578,0.0003062878,0.0004188627,0.0005351592,0.000095167816,0.0036976456,0.000007686449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019727953,0.0008082645,0.002062561,0.00148113,0.0036345562,0.037605863,0.0013011008,0.00012526604,0.0053522815,0.000009110794,0.9181266,0.029296014],"study_design_scores_gemma":[0.0056170286,0.00003251149,0.019436305,0.025370834,0.0018392237,0.2969605,0.012743342,0.000009932178,0.011758835,0.001646066,0.6240955,0.00048988336],"about_ca_topic_score_codex":0.00062945124,"about_ca_topic_score_gemma":0.00018848809,"teacher_disagreement_score":0.61110765,"about_ca_system_score_codex":0.00025763997,"about_ca_system_score_gemma":0.00052853295,"threshold_uncertainty_score":0.9999953},"labels":[],"label_agreement":null},{"id":"W1596650745","doi":"10.1111/bjd.12212","title":"Small-diameter melanocytic lesions: morphological analysis by means of<i>in vivo</i>confocal microscopy","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermatology; Library science; Computer science","score_opus":0.014314118538661333,"score_gpt":0.24886713085464662,"score_spread":0.2345530123159853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596650745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903917,0.001713411,0.0053666267,0.0013057297,0.00017563198,0.0002307482,0.0000099537865,0.000013255342,0.0007929583],"genre_scores_gemma":[0.9947248,0.00073312974,0.0032187968,0.0008445233,0.00002837599,0.0000080534055,0.000004627805,0.000012141082,0.00042554006],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9983407,0.00016071707,0.0008682334,0.00017334975,0.00019106439,0.00026591492],"domain_scores_gemma":[0.9990609,0.00012297218,0.00032670208,0.00014532682,0.00017686609,0.00016719614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014247537,0.00012518125,0.0008289374,0.0004405545,0.000033232984,0.000028567381,0.00014656848,0.00016014389,0.0015523292],"category_scores_gemma":[0.00015046253,0.0001209312,0.00032579753,0.000389653,0.00013940463,0.0000620452,0.000042206084,0.00032956182,0.000027469681],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011989926,0.0033391253,0.18379812,0.00042901514,0.006179146,0.09869346,0.0005207442,0.00017850101,0.43524078,0.00014032987,0.19685969,0.0734221],"study_design_scores_gemma":[0.009789818,0.0013460994,0.066446595,0.00056736416,0.0034969912,0.7683322,0.0014149124,0.0019748986,0.12150636,0.0003839217,0.024084914,0.0006559678],"about_ca_topic_score_codex":0.00037324475,"about_ca_topic_score_gemma":0.0001730966,"teacher_disagreement_score":0.6696387,"about_ca_system_score_codex":0.000058174766,"about_ca_system_score_gemma":0.00004610325,"threshold_uncertainty_score":0.9993604},"labels":[],"label_agreement":null},{"id":"W1601300544","doi":"10.1111/j.1365-2133.2012.11097.x","title":"Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Melanoma; Incidence (geometry); Epidemiology; Malignancy; Population; Relative risk; Dermatology; Retrospective cohort study; Internal medicine; Confidence interval","score_opus":0.021552750054649013,"score_gpt":0.27512171887440035,"score_spread":0.25356896881975133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601300544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922858,0.005862904,0.00027958237,0.00047741455,0.00017792579,0.000105830055,0.000003683571,0.000005214968,0.00080166373],"genre_scores_gemma":[0.99762255,0.0007606527,0.0012421507,0.00026689327,0.00006506981,0.00000144042,0.0000028251638,0.0000054164825,0.00003300342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905485,0.000101661084,0.0005349138,0.00007303717,0.000091442955,0.00014408653],"domain_scores_gemma":[0.99944955,0.000076210505,0.00023432872,0.000050385424,0.000066934976,0.0001225747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016615032,0.00006109017,0.00040668464,0.00019985277,0.00002765099,0.0000074684403,0.00003052047,0.000097699,0.00005677925],"category_scores_gemma":[0.00012230467,0.00006297071,0.000044427732,0.00009517249,0.000086813234,0.000073943294,0.000043225624,0.000258757,0.0000010452724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010466224,0.00021039887,0.98394483,0.00008002146,0.00001672381,0.0013204265,0.00008342423,5.4868264e-7,0.00007992272,0.00016872172,0.0016420265,0.012348319],"study_design_scores_gemma":[0.0015406138,0.00010041254,0.8050921,0.000039656265,0.000050550567,0.19109942,0.00017268422,0.000033687476,0.000027311182,0.00007473748,0.0017243852,0.00004446775],"about_ca_topic_score_codex":0.000014523682,"about_ca_topic_score_gemma":0.00010131538,"teacher_disagreement_score":0.189779,"about_ca_system_score_codex":0.00001637177,"about_ca_system_score_gemma":0.000021741593,"threshold_uncertainty_score":0.2567871},"labels":[],"label_agreement":null},{"id":"W1606414399","doi":"10.1111/bjd.12074","title":"‘Is it safe?’ Safety is a process, not a question","year":2012,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Process (computing); Computer science; Programming language","score_opus":0.22544266542925703,"score_gpt":0.41292033014990404,"score_spread":0.187477664720647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606414399","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001973158,0.015994944,0.0019511405,0.9723623,0.0023965982,0.00045211503,0.0011181771,0.000019678158,0.00373188],"genre_scores_gemma":[0.021490997,0.0031152214,0.0012376757,0.9666884,0.005160308,0.000033892615,0.00012308922,0.000101002566,0.0020494245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.988482,0.00083353766,0.008993235,0.0005580265,0.00026157396,0.00087164727],"domain_scores_gemma":[0.98751575,0.0008514192,0.010526096,0.00043530445,0.00041102472,0.00026040612],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.006902059,0.0003982608,0.0029054494,0.0006777598,0.0002508849,0.00017946985,0.0007361869,0.0015686714,0.00401658],"category_scores_gemma":[0.0024195076,0.0006008719,0.00051433506,0.00018758557,0.00018067201,0.00089888053,0.000064450345,0.0024447169,0.0033074836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022831635,0.00005664426,0.004219339,0.0010054247,0.00023668738,0.00057788746,0.0009931395,0.0000016477383,1.2021493e-7,0.00040800223,0.9920704,0.00040790206],"study_design_scores_gemma":[0.001066894,0.00004228421,0.0020396302,0.0009202665,0.000057083656,0.04386867,0.00015890016,0.00008047819,0.000007643321,0.0043992517,0.9468259,0.0005329602],"about_ca_topic_score_codex":0.0004089484,"about_ca_topic_score_gemma":0.00005400341,"teacher_disagreement_score":0.045244433,"about_ca_system_score_codex":0.0006192014,"about_ca_system_score_gemma":0.00058283116,"threshold_uncertainty_score":0.9998567},"labels":[],"label_agreement":null},{"id":"W1608707730","doi":"10.1111/j.1365-2133.2010.10095.x","title":"Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Dermatofibrosarcoma protuberans; Medicine; Mohs surgery; Dermatofibrosarcoma; Dermatology; Surgery","score_opus":0.010768728362882419,"score_gpt":0.23991409823919907,"score_spread":0.22914536987631665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608707730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968758,0.0016625586,0.000113690636,0.00044347078,0.00039487402,0.00034331533,0.000017907443,0.000029825096,0.000118525175],"genre_scores_gemma":[0.9965955,0.00028455566,0.0027071903,0.0001937132,0.00013681393,0.000016543148,0.000012108745,0.000042698062,0.000010898666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998309,0.00010647991,0.0007135865,0.00019711257,0.0002757572,0.00039805408],"domain_scores_gemma":[0.9985306,0.00015254226,0.00045412243,0.00016653616,0.00050435547,0.00019179686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091839625,0.00019911073,0.00079480757,0.0003824228,0.00022008995,0.000047868645,0.00010601365,0.00016609824,0.000039649498],"category_scores_gemma":[0.00009129024,0.00019143782,0.00022315353,0.00042181986,0.00031148753,0.00021636566,0.000028267796,0.0006665243,0.0000035277008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002845875,0.00049884396,0.9846659,0.000086992295,0.0003506037,0.006114693,0.00005964459,0.0000012842067,0.0013154395,0.0000031728134,0.0026488418,0.0039700135],"study_design_scores_gemma":[0.00281656,0.00016060022,0.56523603,0.0005406872,0.00024045786,0.42040065,0.00004394999,0.000014645094,0.008067807,0.000017603928,0.0022749705,0.00018604663],"about_ca_topic_score_codex":0.00013192062,"about_ca_topic_score_gemma":0.00037155222,"teacher_disagreement_score":0.41942987,"about_ca_system_score_codex":0.00004156872,"about_ca_system_score_gemma":0.00024766554,"threshold_uncertainty_score":0.78066075},"labels":[],"label_agreement":null},{"id":"W1628071823","doi":"10.1111/j.1365-2133.2012.10824.x","title":"Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PTEN; PI3K/AKT/mTOR pathway; Cadherin; Downregulation and upregulation; Biology; Epithelial–mesenchymal transition; Cancer research; Protein kinase B; Adherens junction; Signal transduction; Cell biology; Cell; Gene","score_opus":0.008879717175272991,"score_gpt":0.24904167469232202,"score_spread":0.24016195751704902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1628071823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732473,0.024283888,0.00026588535,0.0015571167,0.0002681949,0.00012145683,0.000017743598,0.000004424782,0.00023398301],"genre_scores_gemma":[0.99678826,0.0009539497,0.0009018531,0.0008913986,0.0001651093,0.000013627853,0.000026277468,0.00002117458,0.0002383733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878365,0.00012996994,0.00043094,0.00018337063,0.00014747492,0.00032458777],"domain_scores_gemma":[0.9994605,0.000021366943,0.00020094533,0.00012484471,0.000082383674,0.00010991364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018479986,0.00014122677,0.0002611495,0.000026533193,0.0000757053,0.0000431598,0.00024305368,0.00020939556,0.00006594751],"category_scores_gemma":[0.000044054057,0.00012223043,0.000055118566,0.00009774528,0.000093754854,0.000022946468,0.0001203489,0.00020396787,0.0000062060903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045023087,0.00021407826,0.1343319,0.000028857978,0.00024363246,0.00042086415,0.0021246045,0.0000029224166,0.6328838,0.000016652133,0.1562927,0.07298976],"study_design_scores_gemma":[0.0021209342,0.00016583035,0.044603147,0.00026415935,0.000032826152,0.012139705,0.00042403306,0.000007441841,0.6644213,0.00024093244,0.2751836,0.00039610756],"about_ca_topic_score_codex":0.00015897739,"about_ca_topic_score_gemma":0.00006451604,"teacher_disagreement_score":0.11889089,"about_ca_system_score_codex":0.000019864832,"about_ca_system_score_gemma":0.0000756505,"threshold_uncertainty_score":0.49844122},"labels":[],"label_agreement":null},{"id":"W1644093871","doi":"10.1046/j.1365-2133.2000.03287.x","title":"Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Dermis; Keratinocyte; Melanocyte; Melanoma; Human skin; Basement membrane; In vitro; Cell culture; Biology; Epidermis (zoology); Pathology; Cell biology; Medicine; Anatomy; Cancer research; Genetics","score_opus":0.010662076283442144,"score_gpt":0.24214197731450737,"score_spread":0.23147990103106522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1644093871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992899,0.00002883501,0.00025269904,0.000025755893,0.000033864497,0.0000710267,0.000024803254,0.0000014685544,0.00027170443],"genre_scores_gemma":[0.9989018,0.00005727586,0.00060842943,0.00007233609,0.000028221926,0.0000016087814,0.00030481894,0.000009822338,0.000015696614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989648,0.0001656356,0.0005552707,0.00011210492,0.000103372025,0.000098807104],"domain_scores_gemma":[0.99942046,0.0000062569316,0.00034103342,0.00010398328,0.00008739672,0.000040857765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010754025,0.000072234245,0.0002399578,0.00011215442,0.00003154565,0.0000071618115,0.00012227122,0.00013741392,0.00006678262],"category_scores_gemma":[0.0000151585045,0.000087072534,0.0000591127,0.00005603043,0.000059140068,0.000011905752,0.000008179038,0.00008816077,3.5087152e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022620156,0.00016720759,0.0015982721,0.000019114954,0.000010314667,0.00005111006,0.000032891272,0.00016583415,0.9891073,0.00001164749,0.00001954958,0.008590541],"study_design_scores_gemma":[0.0017276199,0.00030792362,0.011454372,0.000083035426,0.0000100366215,0.001425989,0.000018175086,0.0019288932,0.98285806,0.000097038996,0.000012756461,0.0000760884],"about_ca_topic_score_codex":0.000020468296,"about_ca_topic_score_gemma":0.000039805847,"teacher_disagreement_score":0.0098561,"about_ca_system_score_codex":0.0000086516175,"about_ca_system_score_gemma":0.000047791884,"threshold_uncertainty_score":0.35507149},"labels":[],"label_agreement":null},{"id":"W1661616496","doi":"10.1111/bjd.12214","title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":410,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Mace; Adverse effect; Psoriasis; Population; Internal medicine; Dermatology; Disease; Environmental health","score_opus":0.023963248236928882,"score_gpt":0.2498224002245274,"score_spread":0.2258591519875985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1661616496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28500858,0.7119841,0.000018889214,0.000010787475,0.0009504875,0.0005741097,0.0013911775,0.000006488035,0.00005541639],"genre_scores_gemma":[0.11046624,0.8878542,0.00029015134,0.0000149589805,0.000048941736,0.000024893105,0.0010528933,0.000060848386,0.00018685001],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957407,0.000867892,0.0024118037,0.00040160818,0.00013669986,0.00044131186],"domain_scores_gemma":[0.99640137,0.00047967155,0.002313547,0.00035832805,0.00037725142,0.00006984122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018150549,0.00042439188,0.0035130384,0.00050029985,0.000051625153,0.000017123723,0.0006030554,0.00089584425,0.00016846434],"category_scores_gemma":[0.0001772381,0.0004008566,0.0005399043,0.00030274002,0.00016048517,0.00015757878,0.000115131406,0.0005954527,0.000064047585],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048332815,0.0005575969,0.006734433,0.0008403039,0.0023811318,0.0010071165,0.00018901748,0.0000043348527,0.0000033222786,0.000005025147,0.0012476989,0.98219675],"study_design_scores_gemma":[0.1815219,0.0037337118,0.43953976,0.13857387,0.01417061,0.059024032,0.00020450568,7.214443e-7,0.0005944659,0.00011837393,0.15905997,0.003458077],"about_ca_topic_score_codex":0.00025586848,"about_ca_topic_score_gemma":0.00025482354,"teacher_disagreement_score":0.97873867,"about_ca_system_score_codex":0.0000969229,"about_ca_system_score_gemma":0.0005046916,"threshold_uncertainty_score":0.9998443},"labels":[],"label_agreement":null},{"id":"W1774383972","doi":"10.1111/j.1365-2133.2012.10895.x","title":"The quest for psoriasis susceptibility genes in the postgenome-wide association studies era: charting the road ahead","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Wellcome Trust","keywords":"Psoriasis; Association (psychology); Medicine; Dermatology; Genetics; Biology; Psychology","score_opus":0.02616040516835319,"score_gpt":0.280081891607258,"score_spread":0.2539214864389048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1774383972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83803505,0.14816166,0.000017580856,0.0114247445,0.0019470222,0.00031165834,0.000021762986,0.000008465941,0.00007203583],"genre_scores_gemma":[0.9928358,0.006045118,0.000040699942,0.0006036815,0.00027857974,0.000056235684,0.000011581726,0.000011043284,0.00011723116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970456,0.0015041103,0.00070239545,0.00012594741,0.00007264062,0.0005493494],"domain_scores_gemma":[0.99388427,0.004990239,0.000659942,0.0001730647,0.00027354626,0.000018941671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002570707,0.00014698338,0.0004133715,0.000050649684,0.0009081735,0.00004765347,0.00038907924,0.00019636212,0.000012306822],"category_scores_gemma":[0.0024652402,0.00008458444,0.00022460993,0.0001274151,0.00018621917,0.00016970522,0.000047791265,0.00033975387,0.000022267359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003418661,0.00035438838,0.75965375,0.000029669225,0.0015333432,0.00006919257,0.0055916267,0.0000017082032,0.0019036635,0.00037473923,0.021073256,0.20907278],"study_design_scores_gemma":[0.0037221133,0.00018705834,0.88136435,0.000084620784,0.0005976383,0.011466636,0.01137903,0.0000013795243,0.0068712947,0.0008957982,0.08317631,0.00025379288],"about_ca_topic_score_codex":0.000083734776,"about_ca_topic_score_gemma":0.0011268747,"teacher_disagreement_score":0.20881899,"about_ca_system_score_codex":0.00011891263,"about_ca_system_score_gemma":0.00006586437,"threshold_uncertainty_score":0.69850284},"labels":[],"label_agreement":null},{"id":"W1777365448","doi":"10.1111/j.1365-2133.2012.11142.x","title":"The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Pharmaceuticals; IC Design Education Center; Biogen; Amgen","keywords":"Ustekinumab; Medicine; Psoriasis; Discontinuation; Latent tuberculosis; Concomitant; Internal medicine; Adverse effect; Isoniazid; Tuberculosis; Dermatology; Mycobacterium tuberculosis; Adalimumab; Pathology; Disease","score_opus":0.007895784841891467,"score_gpt":0.20746878040034228,"score_spread":0.19957299555845082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1777365448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373424,0.0053052655,0.000025983607,0.00015663404,0.00044217415,0.00022123462,0.000026005442,0.0000049488854,0.00008348776],"genre_scores_gemma":[0.9977181,0.002093707,0.000065422064,0.00002274767,0.000019007062,0.000011976346,0.0000142428835,0.000010730142,0.000044067416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878746,0.0003140633,0.0004552201,0.000103590275,0.000045477307,0.00029421123],"domain_scores_gemma":[0.999341,0.00015095793,0.00024418818,0.00009476212,0.00012354767,0.00004554843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012745221,0.00013647179,0.0004074559,0.00011723615,0.00015485818,0.000012832986,0.000067225,0.00015047488,0.000023512062],"category_scores_gemma":[0.000033233795,0.000096966665,0.00007451344,0.00011780306,0.000084482854,0.00014920106,0.00002645667,0.00011502933,0.0000084415005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020723476,0.00048075165,0.89013565,0.000008688876,0.0005187133,0.000030131012,0.00034959838,0.000017667864,0.00008103047,0.00003908809,0.00014408957,0.10612225],"study_design_scores_gemma":[0.007529616,0.00045348748,0.9808275,0.00008272107,0.00020145021,0.005941209,0.000058895093,7.5584245e-7,0.0030969782,0.000018289853,0.0016780397,0.000111067544],"about_ca_topic_score_codex":0.00024818443,"about_ca_topic_score_gemma":0.00038381814,"teacher_disagreement_score":0.10601118,"about_ca_system_score_codex":0.0000821564,"about_ca_system_score_gemma":0.000046866124,"threshold_uncertainty_score":0.39541858},"labels":[],"label_agreement":null},{"id":"W1781511685","doi":"10.1046/j.1365-2133.2000.03292.x","title":"Refined localization of the gene for Clouston syndrome (hidrotic ectodermal dysplasia) in a large French family","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Pedigree chart; Haplotype; Genetics; Locus (genetics); Ectodermal dysplasia; Lod score; Genetic linkage; Hyperkeratosis; Biology; Gene mapping; Chromosome; Gene; Genotype","score_opus":0.005636440387815742,"score_gpt":0.2177497482849449,"score_spread":0.21211330789712915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781511685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941272,0.002707173,0.002355248,0.000304237,0.00017728533,0.00017004728,0.00004071332,0.0000022262604,0.000115884126],"genre_scores_gemma":[0.9985717,0.00056075153,0.0002460705,0.0004222176,0.00005397647,0.0000073327383,0.00003023474,0.000013944682,0.000093783914],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99880165,0.00016597385,0.00054108,0.00015581089,0.000078272074,0.0002572253],"domain_scores_gemma":[0.99942315,0.000025303012,0.00023039294,0.00015049784,0.00012898847,0.000041645108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001532188,0.00010108332,0.00031594516,0.000059845544,0.000060039914,0.0000086474565,0.00024479025,0.00023157528,0.00004469267],"category_scores_gemma":[0.00009014681,0.000095642434,0.00015226213,0.00010992551,0.000095358184,0.0000057047914,0.00004015591,0.0001397501,0.0000012001839],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024127248,0.0023953794,0.19153568,0.00054654095,0.0008921475,0.0051970882,0.0004991862,0.0043118685,0.6762072,0.00045876563,0.023855437,0.091687985],"study_design_scores_gemma":[0.017550634,0.0020011312,0.35952297,0.00051558245,0.00021934256,0.37632582,0.00021750061,0.0030791273,0.14220405,0.0009230688,0.09659436,0.0008464374],"about_ca_topic_score_codex":0.000043786866,"about_ca_topic_score_gemma":0.00039889253,"teacher_disagreement_score":0.53400314,"about_ca_system_score_codex":0.000012676127,"about_ca_system_score_gemma":0.0001163317,"threshold_uncertainty_score":0.39001852},"labels":[],"label_agreement":null},{"id":"W1804278029","doi":"10.1111/bjd.12099","title":"Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Surgical site infection prevention","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acral lentiginous melanoma; Vascularity; Negative-pressure wound therapy; Surgery; Wound healing; Scars; Melanoma; Foot (prosody); Dermatology; Pathology","score_opus":0.02562243516809961,"score_gpt":0.30012782556553247,"score_spread":0.2745053903974329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1804278029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319094,0.004654987,0.00039523424,0.0010223638,0.00018815692,0.000276799,0.0000032453095,0.0000048897145,0.000263401],"genre_scores_gemma":[0.9991349,0.00048262952,0.00015532387,0.00014420076,0.000035345885,0.000006717657,0.0000018879634,0.000008051254,0.00003095785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986819,0.00027255656,0.0006460119,0.00008988118,0.0001970564,0.00011261672],"domain_scores_gemma":[0.99868757,0.00028330565,0.0005537033,0.000078950485,0.00033795807,0.000058529975],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019344216,0.000079813064,0.00044473767,0.00010307481,0.000043749602,0.00001955071,0.000057300065,0.00010598096,0.0011525808],"category_scores_gemma":[0.00011446346,0.00006146784,0.00013943703,0.00008063385,0.00014664803,0.000153343,0.000022958537,0.0003546771,0.000002696785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025668559,0.0011544301,0.56042945,0.00028144626,0.0008126222,0.00034136878,0.0011608938,0.0000128523925,0.011438232,0.00022272463,0.0022085556,0.4193706],"study_design_scores_gemma":[0.0034192414,0.0008869275,0.949697,0.00083918177,0.000095266216,0.020437736,0.0004719111,0.0001947677,0.021036426,0.0015502431,0.0012932605,0.000077994606],"about_ca_topic_score_codex":0.000117931435,"about_ca_topic_score_gemma":0.000015615351,"teacher_disagreement_score":0.41929257,"about_ca_system_score_codex":0.000012885631,"about_ca_system_score_gemma":0.00002872407,"threshold_uncertainty_score":0.9997605},"labels":[],"label_agreement":null},{"id":"W1809686743","doi":"10.1111/j.1365-2133.2012.10901.x","title":"Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Dermatology Life Quality Index; Randomized controlled trial; Dosing; Placebo; Internal medicine; Clinical trial; Gastroenterology; Dermatology; Surgery; Disease; Adalimumab","score_opus":0.01753720424858743,"score_gpt":0.24308242075807682,"score_spread":0.2255452165094894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1809686743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947939,0.002104291,0.000051582316,0.00020717598,0.002017708,0.0005105363,0.0002371642,0.000008892705,0.000068772744],"genre_scores_gemma":[0.99920154,0.000104224826,0.00018886916,0.0001858902,0.00013534076,0.000012297013,0.000096072516,0.00002163848,0.000054150223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978556,0.0005365781,0.00084412383,0.00020876367,0.00010347152,0.00045144273],"domain_scores_gemma":[0.99863076,0.00044876934,0.00045360022,0.0002488563,0.00015302551,0.000065002554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019684182,0.00018980574,0.0006710422,0.000109885535,0.00008549389,0.000020746678,0.0003759809,0.00025293563,0.00008576181],"category_scores_gemma":[0.000246073,0.00015374536,0.00013828861,0.00021642656,0.000088825276,0.00021345646,0.00007778602,0.0002901032,0.00007460437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40067863,0.0029920058,0.4795474,0.000017630759,0.002143513,0.00073690474,0.013869233,0.000094959294,0.0005091172,0.00004071635,0.014464526,0.08490533],"study_design_scores_gemma":[0.13273044,0.0005641219,0.8596582,0.00026906485,0.00023208588,0.00201032,0.00016889813,8.524602e-8,0.0031417254,0.000015598684,0.0010036736,0.00020582514],"about_ca_topic_score_codex":0.00025212928,"about_ca_topic_score_gemma":0.00022204817,"teacher_disagreement_score":0.38011074,"about_ca_system_score_codex":0.000048938553,"about_ca_system_score_gemma":0.000111178604,"threshold_uncertainty_score":0.6269554},"labels":[],"label_agreement":null},{"id":"W1814149022","doi":"10.1111/bjd.14163","title":"Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16–17 years","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Dermatology; Psoriasis; Quality of life (healthcare); Index (typography); Computer science","score_opus":0.028597857370707472,"score_gpt":0.3066605187112383,"score_spread":0.2780626613405308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1814149022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991703,0.0059031826,0.00013713195,0.0010040256,0.00046021282,0.0005742252,0.000119659955,0.000009268458,0.00008932679],"genre_scores_gemma":[0.9992898,0.0002169675,0.000087139255,0.00029572463,0.000016521339,0.000018845754,0.000047099613,0.00002203925,0.000005879953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98723644,0.008037149,0.0035382116,0.000356178,0.0003138285,0.0005181738],"domain_scores_gemma":[0.9935035,0.0016272829,0.0037481275,0.00050198485,0.0004797125,0.00013935688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016822923,0.0003426212,0.0029895194,0.00035438107,0.00010481757,0.000014682168,0.00073369447,0.0006969927,0.000037775255],"category_scores_gemma":[0.0020793888,0.00026270119,0.00029219317,0.00047020844,0.0016851337,0.00018102677,0.0002690385,0.0009261917,0.0000012777533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003988115,0.0014164308,0.98969644,0.000105804174,0.000905194,0.00002880471,0.0012003244,0.000046058627,0.000056808538,0.0005051325,0.000715821,0.0013350906],"study_design_scores_gemma":[0.032721657,0.00013110961,0.96298796,0.00016270953,0.00016189771,0.0012719107,0.0014383801,0.0000069885937,0.0005748322,0.0002719853,0.000037802358,0.00023274955],"about_ca_topic_score_codex":0.0034210035,"about_ca_topic_score_gemma":0.0043241554,"teacher_disagreement_score":0.02873354,"about_ca_system_score_codex":0.00008352647,"about_ca_system_score_gemma":0.0009694704,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W1824244227","doi":"10.1111/j.1365-2133.2010.09775.x","title":"Type 1 interferon signature in the scalp lesions of alopecia areata","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Child and Family Research Institute; University of British Columbia","funders":"Canadian Dermatology Foundation; Michael Smith Health Research BC; Dermatology Foundation","keywords":"Alopecia areata; Medicine; Alopecia universalis; Scalp; Interferon; Hair follicle; Scarring alopecia; CXCR3; Pathology; Immunology; Chemokine; Dermatology; Immune system; Chemokine receptor; Internal medicine","score_opus":0.010007479761875526,"score_gpt":0.264912808964199,"score_spread":0.25490532920232345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1824244227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059373,0.0023675517,0.000057341695,0.003634794,0.00031068202,0.00008555135,0.0000034079467,0.0000034223124,0.0029435004],"genre_scores_gemma":[0.99865764,0.00029127306,0.00022104812,0.00072617293,0.00006966695,7.430866e-7,0.0000046083132,0.0000070850715,0.000021768157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920607,0.00007441502,0.00036619694,0.00006509778,0.00014191832,0.0001462794],"domain_scores_gemma":[0.99943346,0.00010127642,0.000121668534,0.00011435438,0.00015784003,0.00007137659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013974201,0.00006135169,0.00028937781,0.00011886812,0.000026703874,0.000009454752,0.00019345559,0.00014772035,0.00015334508],"category_scores_gemma":[0.00043306983,0.000048109,0.000076938064,0.00017408788,0.00011729493,0.000059897393,0.000020688889,0.0007783294,0.0000065166873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022445295,0.0023469445,0.43872043,0.00036249126,0.00026790213,0.03692353,0.0032037378,0.000006289268,0.0421536,0.002469772,0.26521465,0.2060861],"study_design_scores_gemma":[0.007453097,0.00084830006,0.49481523,0.00097214687,0.00019423624,0.43578884,0.0031058902,0.000039973293,0.0058815163,0.0020303,0.0486227,0.00024776778],"about_ca_topic_score_codex":0.00003838327,"about_ca_topic_score_gemma":0.0006847062,"teacher_disagreement_score":0.3988653,"about_ca_system_score_codex":0.0000051702004,"about_ca_system_score_gemma":0.0001277167,"threshold_uncertainty_score":0.33814973},"labels":[],"label_agreement":null},{"id":"W1829483440","doi":"10.1046/j.1365-2133.2000.03294.x","title":"In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Malassezia; Ketoconazole; Voriconazole; Itraconazole; Azole; Microbiology; Biology; Minimum inhibitory concentration; Antifungal; Antimicrobial","score_opus":0.006654839223833021,"score_gpt":0.24233686956097036,"score_spread":0.23568203033713733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829483440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288285,0.0020090232,0.0000041614144,0.0037478504,0.000103238795,0.00030609887,0.000042306405,0.0000039922206,0.00090047886],"genre_scores_gemma":[0.9981475,0.00039828924,0.00020148788,0.0005632638,0.000052492873,0.000005391185,0.0000027035305,0.000010915945,0.0006179956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873346,0.000094548544,0.000592667,0.0001459337,0.00020234668,0.00023102007],"domain_scores_gemma":[0.99932915,0.00006620708,0.00016240023,0.0001546314,0.000113169655,0.00017446774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009100119,0.000117328,0.0005253171,0.00009490662,0.00004117889,0.000014777743,0.00012890386,0.00007583891,0.00051544013],"category_scores_gemma":[0.00007636516,0.00009848377,0.00014884715,0.00019027569,0.00013142159,0.00011530568,0.000041759373,0.00021891604,0.000008645345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019189595,0.001353968,0.92487943,0.00018124397,0.00020958102,0.007329212,0.00021048941,0.000007793366,0.012246201,0.00007699134,0.0042599807,0.047326136],"study_design_scores_gemma":[0.0037522651,0.000108711894,0.94288516,0.00020308241,0.00010096133,0.04051274,0.00007212726,0.000009907926,0.008988872,0.00027993822,0.0030067284,0.00007947642],"about_ca_topic_score_codex":0.00010230548,"about_ca_topic_score_gemma":0.0001079803,"teacher_disagreement_score":0.04724666,"about_ca_system_score_codex":0.000048244663,"about_ca_system_score_gemma":0.00011250272,"threshold_uncertainty_score":0.5643708},"labels":[],"label_agreement":null},{"id":"W1845693806","doi":"10.1111/j.1365-2133.2010.10100.x","title":"Dermatological manifestations of inherited cancer syndromes in children","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Xeroderma pigmentosum; Dyskeratosis congenita; Bloom syndrome; Medicine; Dermatology; Family history; Cancer; Ataxia-telangiectasia; Cockayne syndrome; Genetics; DNA repair; DNA damage; Biology; Telomere","score_opus":0.019282632286300134,"score_gpt":0.3096201196731533,"score_spread":0.29033748738685317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1845693806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08356127,0.9156797,0.00005523572,0.000029531606,0.00024645386,0.00027876097,0.00009563973,0.000005143949,0.000048275826],"genre_scores_gemma":[0.014348275,0.984356,0.00095612515,0.00004595411,0.00008183036,0.00003104662,0.000112060276,0.000043763845,0.000024935864],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9976071,0.0003606503,0.0013139775,0.00026299688,0.00016196746,0.00029331463],"domain_scores_gemma":[0.9983232,0.000043237636,0.0011340092,0.00021934295,0.00017704266,0.00010314572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014572944,0.00026202438,0.0015463659,0.00024635458,0.000033043078,0.00002017801,0.0005416875,0.0009261081,0.000052239124],"category_scores_gemma":[0.00018644924,0.00027373817,0.00047950566,0.00018486306,0.00015905708,0.000008078349,0.00013374769,0.00075035635,0.0000034973575],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028682174,0.00047537018,0.0063824817,0.0030394287,0.00086993066,0.010632951,0.000020781607,0.0000027070585,0.000968165,0.00008944666,0.0025894698,0.9749006],"study_design_scores_gemma":[0.0006421237,0.00006376496,0.0012711758,0.0037871636,0.00033933096,0.7456344,0.000010328933,0.0000010199541,0.00053134275,0.000075350144,0.24732785,0.0003161928],"about_ca_topic_score_codex":0.00003764548,"about_ca_topic_score_gemma":0.00013825868,"teacher_disagreement_score":0.9745844,"about_ca_system_score_codex":0.000020337113,"about_ca_system_score_gemma":0.00047813347,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W1869303064","doi":"10.1111/j.1365-2133.2010.10091.x","title":"Risk factors for genital lichen sclerosus in men","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Alopecia areata; Lichen sclerosus; Medicine; Odds ratio; Dermatology; Etiology; Vitiligo; Sex organ; Confidence interval; Family history; Logistic regression; Psoriasis; Internal medicine","score_opus":0.01369721011957613,"score_gpt":0.2826457582701073,"score_spread":0.26894854815053115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1869303064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679536,0.001220327,0.000057706482,0.0006302401,0.00037127006,0.00023024397,0.00003965186,0.0000084647,0.00064671703],"genre_scores_gemma":[0.99856806,0.00006490461,0.0009277908,0.00020505994,0.00015535463,0.0000056100157,0.0000096757585,0.000014332807,0.00004920628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989527,0.00004248518,0.00048551027,0.00009789758,0.00012290047,0.00029850443],"domain_scores_gemma":[0.9989682,0.00014661795,0.00020705789,0.00007962451,0.00017285469,0.00042563985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012798763,0.000081528626,0.0003419892,0.00013926595,0.00005923303,0.000015946252,0.00009027762,0.00014207017,0.000067320434],"category_scores_gemma":[0.00083631446,0.000084206455,0.00013999343,0.00007683348,0.00006329748,0.0000918342,0.000014860647,0.0004986414,0.000007719264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077910034,0.00045918816,0.96582425,0.00017260722,0.000039661336,0.0043099285,0.00027132902,0.0000011439765,0.0011389537,0.00004902757,0.00960824,0.01734657],"study_design_scores_gemma":[0.006778702,0.00023699345,0.9238205,0.000042830514,0.00010978054,0.06465275,0.00038168885,0.000080019185,0.0011938267,0.000805924,0.0017839571,0.00011301724],"about_ca_topic_score_codex":0.00015217066,"about_ca_topic_score_gemma":0.00022924622,"teacher_disagreement_score":0.060342822,"about_ca_system_score_codex":0.00001933865,"about_ca_system_score_gemma":0.00026295375,"threshold_uncertainty_score":0.34338397},"labels":[],"label_agreement":null},{"id":"W1877047792","doi":"10.1111/j.1365-2133.2007.08236.x","title":"Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Adalimumab; Medicine; Psoriasis; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Visual analogue scale; Placebo; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Severity of illness; Psoriatic arthritis; Methotrexate; Dermatology; Physical therapy; Disease; Pathology","score_opus":0.02183459601506674,"score_gpt":0.2774386911100152,"score_spread":0.2556040950949484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1877047792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950758,0.0016186044,0.00003742325,0.00017918453,0.0003742886,0.0021208345,0.0005126993,0.000009115974,0.000072053874],"genre_scores_gemma":[0.9994728,0.00014845726,0.00010292512,0.00010117865,0.0000103779585,0.000028906983,0.00009397063,0.000020280511,0.000021090516],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99345523,0.0020735348,0.003684108,0.00028234426,0.00013484004,0.00036996446],"domain_scores_gemma":[0.9937719,0.0023166274,0.0033283127,0.00020244664,0.00026205266,0.00011863132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009052887,0.00030880223,0.004027262,0.0003712214,0.000066783825,0.000009921539,0.00010604872,0.00031391103,0.000052654388],"category_scores_gemma":[0.0010137453,0.00021513061,0.0005452704,0.00015832983,0.00014351748,0.00007114087,0.000019009074,0.0001938505,0.000002098164],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91938055,0.0030266854,0.062129978,0.0000072694556,0.0062819384,0.00013504864,0.0010866461,0.00004991285,0.000053972915,0.000008507684,0.000095076684,0.007744432],"study_design_scores_gemma":[0.87441933,0.004387446,0.11956543,0.00017443836,0.00029955557,0.00040597154,0.00012839555,0.0000010458336,0.00039124748,0.00005777915,0.000008219714,0.00016111533],"about_ca_topic_score_codex":0.007558094,"about_ca_topic_score_gemma":0.0015217521,"teacher_disagreement_score":0.05743545,"about_ca_system_score_codex":0.00017264223,"about_ca_system_score_gemma":0.0003394407,"threshold_uncertainty_score":0.9990507},"labels":[],"label_agreement":null},{"id":"W1880144017","doi":"10.1111/j.1365-2133.2010.09911.x","title":"A novel fibrotic disorder associated with increased dermal fibroblast proliferation and downregulation of genes of the microfibrillar network","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Cancer Institute; National Institutes of Health","keywords":"Connective Tissue Disorder; Fibrosis; Pathology; Skeletal disorder; Biology; MMP2; Phenotype; Candidate gene; Genetic disorder; ADAMTS; Gene; Medicine; Genetics; Matrix metalloproteinase; Downregulation and upregulation; Metalloproteinase","score_opus":0.004395808283259205,"score_gpt":0.2141999921679469,"score_spread":0.20980418388468772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880144017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963307,0.0015516586,0.0016781766,0.00018019177,0.00003250771,0.00018972367,0.000016034546,0.0000014542318,0.000019565354],"genre_scores_gemma":[0.9991996,0.00008381754,0.00060802227,0.000017865077,0.000048377922,0.000002724594,0.000018572155,0.000012667955,0.000008316911],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99911433,0.00014307686,0.00032492244,0.00011272508,0.00014757292,0.00015735165],"domain_scores_gemma":[0.99894613,0.000054110453,0.00038565983,0.00011177696,0.00046047015,0.00004185803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014508537,0.00008390698,0.00022612224,0.000038590373,0.00007430457,0.000014972878,0.00012916162,0.00014249914,0.000007743706],"category_scores_gemma":[0.0003527771,0.000073328214,0.00006238467,0.00012543763,0.00026244024,0.0000107827755,0.00006993988,0.00014130803,7.452999e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014991971,0.00006878658,0.21867533,0.000033405162,0.00010814197,0.000007436566,0.000021944737,0.00018322191,0.7790863,0.000022049235,0.00013034206,0.0015131377],"study_design_scores_gemma":[0.0020609626,0.00022815782,0.743189,0.00017656527,0.000043134285,0.009353403,0.000046487778,0.00030084833,0.2441928,0.000063714695,0.00023353976,0.00011143837],"about_ca_topic_score_codex":0.000054415705,"about_ca_topic_score_gemma":0.0011835673,"teacher_disagreement_score":0.5348935,"about_ca_system_score_codex":0.000004073598,"about_ca_system_score_gemma":0.00014658745,"threshold_uncertainty_score":0.29902378},"labels":[],"label_agreement":null},{"id":"W1885430784","doi":"10.1111/j.1365-2133.2010.09847.x","title":"Spindle cell liposarcoma of the face: case report and literature review","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Liposarcoma; Forehead; Pathological; Soft tissue; Pathology; Medicine; Soft tissue sarcoma; Sarcoma; Myxoid liposarcoma; Dermatology; Anatomy","score_opus":0.019129675647188808,"score_gpt":0.3153792343696628,"score_spread":0.296249558722474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1885430784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012926483,0.9966826,9.9452e-7,0.0006874353,0.0004077581,0.00069541606,0.000047672875,0.0000040371183,0.00018147877],"genre_scores_gemma":[0.0008177555,0.998407,0.00024560554,0.0002550612,0.00011734811,0.000017448496,0.000021835514,0.000032821234,0.00008511395],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99755806,0.0002659631,0.0015300224,0.0002106368,0.00023787905,0.00019742434],"domain_scores_gemma":[0.9970001,0.00016629968,0.0019629777,0.00040475366,0.00029773734,0.0001681099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023194969,0.00027070774,0.0027981007,0.000114416645,0.00006783203,0.000030370033,0.00017587436,0.00044092935,0.000035224257],"category_scores_gemma":[0.00024093034,0.00017775242,0.00089997007,0.00023288367,0.00014214314,0.000051765113,0.000093565955,0.0012896031,0.0000026163925],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018711089,0.00018311753,0.00020820872,0.025891617,0.00012921558,0.5457278,0.000011199024,8.503923e-10,1.6307631e-7,0.0000023213613,0.0040040878,0.42384043],"study_design_scores_gemma":[0.00031419593,0.00003116176,0.000056190194,0.10518172,0.0018892393,0.5048495,0.0000045345605,2.7410023e-8,0.000006323135,0.0000037225716,0.3876022,0.00006119569],"about_ca_topic_score_codex":0.000011922194,"about_ca_topic_score_gemma":0.00001390104,"teacher_disagreement_score":0.42377922,"about_ca_system_score_codex":0.00002829693,"about_ca_system_score_gemma":0.00037646477,"threshold_uncertainty_score":0.72485334},"labels":[],"label_agreement":null},{"id":"W1892175722","doi":"10.1111/bjd.14018","title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":322,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Janssen Biotech; Allergan; LEO Pharma; Genentech; Celgene; Novartis; Pfizer; ApoPharma; Boehringer Ingelheim; Amgen; AbbVie; Merck; Abbott Laboratories; Eli Lilly and Company","keywords":"Tofacitinib; Janus kinase inhibitor; Placebo; Medicine; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Plaque psoriasis; Gastroenterology; Dermatology; Pathology","score_opus":0.04869677487528288,"score_gpt":0.31686382013012293,"score_spread":0.26816704525484003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1892175722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89344376,0.09621257,0.001090101,0.00077365775,0.004045515,0.002393753,0.0019206567,0.00002791039,0.000092059396],"genre_scores_gemma":[0.99149853,0.006278812,0.00040439895,0.0000533435,0.00075703184,0.00027012618,0.00050983136,0.00003228597,0.00019564209],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9927218,0.0035750112,0.0027529784,0.00034541177,0.000111075424,0.0004937213],"domain_scores_gemma":[0.9909625,0.0059790304,0.002150761,0.00034442337,0.00043401192,0.00012928742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024849556,0.00038005598,0.003613719,0.00019038985,0.00022684856,0.0000517182,0.00038232392,0.00040186304,0.000103397775],"category_scores_gemma":[0.001691588,0.00026314054,0.0012067826,0.000104122475,0.00041693271,0.00021703492,0.000025781079,0.00020322576,0.00001818295],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7638176,0.001957686,0.000030565123,0.0000072366056,0.0055894023,0.0008169835,0.0011670182,0.000045400317,0.00252511,0.000099767676,0.004622989,0.21932022],"study_design_scores_gemma":[0.9044455,0.0022301525,0.000009226125,0.00010207406,0.0037333907,0.008416018,0.0006252618,0.00007546736,0.055107363,0.00045459167,0.024569554,0.00023139674],"about_ca_topic_score_codex":0.0010293572,"about_ca_topic_score_gemma":0.000809523,"teacher_disagreement_score":0.21908882,"about_ca_system_score_codex":0.00014686963,"about_ca_system_score_gemma":0.0006430022,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W1895366991","doi":"10.1111/j.1365-2133.2011.10592.x","title":"Nutritional outcome in children with severe generalized recessive dystrophic epidermolysis bullosa: a short- and long-term evaluation of gastrostomy and enteral feeding","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Enteral administration; Malnutrition; Gastrostomy; Pediatrics; Epidermolysis bullosa; Parenteral nutrition; Head circumference; Internal medicine; Surgery; Dermatology; Birth weight","score_opus":0.026387520134017413,"score_gpt":0.2871117283294626,"score_spread":0.2607242081954452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895366991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925569,0.006994667,0.00015220244,0.000073154755,0.000026441921,0.00015959666,0.00001452541,0.0000011792181,0.000021314521],"genre_scores_gemma":[0.9980371,0.0011393449,0.0006750072,0.000024355388,0.000046366335,0.0000098404125,0.000053078016,0.000009730332,0.0000051570914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870825,0.00031283774,0.00041352434,0.00019163277,0.00017833892,0.00019542224],"domain_scores_gemma":[0.99937016,0.000013109301,0.0001915604,0.00007354893,0.00027132584,0.00008028732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003565864,0.00010598015,0.0003166614,0.0001253802,0.000043786476,0.00001387532,0.000111500296,0.00014381255,0.00003882726],"category_scores_gemma":[0.00007880759,0.00010387722,0.000056730798,0.000063318796,0.00022851767,0.000012925655,0.000066367174,0.00017497537,1.6081712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028637765,0.000092016795,0.97591645,0.000018509374,0.00019306765,0.00075292744,0.00002820389,0.0000012822841,0.019932795,0.00000686517,0.000018800296,0.002752724],"study_design_scores_gemma":[0.002855029,0.0001930451,0.69658184,0.000081030965,0.0000789307,0.2911014,0.000026124919,0.000014744182,0.0089255,0.00005538729,0.0000012807961,0.00008570341],"about_ca_topic_score_codex":0.000018966532,"about_ca_topic_score_gemma":0.00003714421,"teacher_disagreement_score":0.29034847,"about_ca_system_score_codex":0.000011628408,"about_ca_system_score_gemma":0.000068675734,"threshold_uncertainty_score":0.423599},"labels":[],"label_agreement":null},{"id":"W1895525610","doi":"10.1046/j.1365-2133.2002.04561.x","title":"Topical treatment of actinic keratoses with 3·0% diclofenac in 2·5% hyaluronan gel","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University; Centre de Recherche Dermatologique du Québec Métropolitain; Guenther Dermatology Research Centre; Sunnybrook Health Science Centre; Vancouver General Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Diclofenac; Placebo; Actinic keratoses; Adverse effect; Lesion; Randomized controlled trial; Dermatology; Actinic keratosis; Internal medicine; Gastroenterology; Surgery; Basal cell; Anesthesia; Pathology","score_opus":0.02303155757989857,"score_gpt":0.263341211576664,"score_spread":0.24030965399676543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895525610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806399,0.015845789,0.000018953568,0.002007302,0.0000984072,0.00010949974,0.0000033467372,0.0000042332376,0.0012726029],"genre_scores_gemma":[0.9959024,0.0030727512,0.000712173,0.000099576675,0.000086241205,0.000005569396,7.421443e-7,0.0000121821895,0.00010835992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989627,0.000068790025,0.00048414627,0.000109175126,0.00017014836,0.00020506191],"domain_scores_gemma":[0.9993449,0.00014159767,0.00022780384,0.00010284207,0.000098113924,0.00008472926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029064506,0.000108182336,0.00068620837,0.00011612332,0.000027114203,0.0000064826763,0.00006613327,0.00007040525,0.00020681262],"category_scores_gemma":[0.000058280344,0.000088401284,0.00011443294,0.00012017368,0.00015465704,0.00006228668,0.000014846707,0.00015879986,0.0000043949162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003300032,0.0008591901,0.8763171,0.000043901127,0.0002844933,0.02103601,0.00040143766,0.0000024698563,0.000064133055,0.000018279761,0.0017218732,0.09892113],"study_design_scores_gemma":[0.0074991793,0.0028896984,0.6937635,0.00039394427,0.00011843927,0.28741384,0.00019986775,0.00001979275,0.0019942452,0.000033822973,0.005572031,0.000101658006],"about_ca_topic_score_codex":0.00009152121,"about_ca_topic_score_gemma":0.00025375365,"teacher_disagreement_score":0.26637784,"about_ca_system_score_codex":0.00011111219,"about_ca_system_score_gemma":0.000070654954,"threshold_uncertainty_score":0.36048996},"labels":[],"label_agreement":null},{"id":"W1904896785","doi":"10.1111/bjd.14220","title":"Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Legacy Heritage Fund","keywords":"Medicine; Psychiatry; Disease; Mood disorders; Mood; Genodermatosis; Family history; Cohort; Genetic testing; Bipolar disorder; Genotype-phenotype distinction; Genotype; Genetics; Pathology; Internal medicine; Biology; Gene; Anxiety","score_opus":0.011970074457752576,"score_gpt":0.253156087289656,"score_spread":0.2411860128319034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1904896785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704366,0.028631937,0.00015878334,0.00022180479,0.0002214822,0.000112655805,0.0000070549604,0.0000012982141,0.00020839291],"genre_scores_gemma":[0.9988699,0.0006262382,0.0003083341,0.00010314328,0.000062558574,0.0000027145527,0.000009130876,0.000010796178,0.000007179925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886125,0.000261703,0.00038068762,0.00013374089,0.00023211374,0.00013052442],"domain_scores_gemma":[0.9990704,0.0000089294435,0.00021016461,0.00011260336,0.00039575514,0.00020213242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019482829,0.000077643286,0.00018587081,0.00008873253,0.000018207778,0.000012980128,0.000119239085,0.000070818205,0.000007351492],"category_scores_gemma":[0.00039141168,0.00008745362,0.00005462879,0.000091706155,0.00010129258,0.0000047635012,0.000051059254,0.00007683558,7.8427036e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006746337,0.00055080204,0.96277106,0.00007539566,0.000097112,0.0015072983,0.00006315587,0.00085855805,0.002771513,0.000079315956,0.006897371,0.023653792],"study_design_scores_gemma":[0.0052461624,0.00025598492,0.98143876,0.000050221435,0.00016666995,0.008343589,0.00011181583,0.00047741947,0.00090968766,0.0023336157,0.0005195152,0.0001465669],"about_ca_topic_score_codex":0.000028910525,"about_ca_topic_score_gemma":0.000043257976,"teacher_disagreement_score":0.028433314,"about_ca_system_score_codex":0.000009051117,"about_ca_system_score_gemma":0.0004901455,"threshold_uncertainty_score":0.35662553},"labels":[],"label_agreement":null},{"id":"W1937411302","doi":"10.1111/bjd.14221","title":"Review of applications of fluorescence excitation spectroscopy to dermatology","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fluorescence; Fluorescence spectroscopy; Spectroscopy; Excitation; Time-resolved spectroscopy; Ultraviolet; Chemistry; Ultraviolet visible spectroscopy; Endogeny; Materials science; Physics; Optics; Optoelectronics; Biochemistry; Organic chemistry","score_opus":0.03831841648476294,"score_gpt":0.37922530624761375,"score_spread":0.34090688976285083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937411302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067120964,0.9899395,0.007699525,0.00067334477,0.00020044936,0.0010779242,0.000017659735,0.000010431172,0.00037446828],"genre_scores_gemma":[0.00006607008,0.99058247,0.008750735,0.0003657843,0.00009981021,0.00006317333,0.000023893017,0.00002902074,0.000019070549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996948,0.00032836825,0.0020361294,0.00018748028,0.00029235228,0.00020768435],"domain_scores_gemma":[0.99635047,0.0001419032,0.001999619,0.0002474946,0.0010490901,0.00021141981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033122193,0.00019665922,0.0030298396,0.00048696375,0.000030327985,0.0000067483224,0.00027958682,0.00023659413,0.00008286067],"category_scores_gemma":[0.00059939735,0.00019812927,0.0004700529,0.0006507698,0.00013124789,0.000062475636,0.000050759696,0.0005611519,0.000023822939],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016618895,0.000119357275,0.000019088135,0.12619261,0.00017066233,0.000682006,0.000023785058,4.076949e-8,0.000025160045,0.00010173544,0.020617142,0.85203177],"study_design_scores_gemma":[0.00030837828,0.000057017576,0.000008051927,0.14656904,0.00066039345,0.26770833,0.000015824922,4.7365222e-7,0.00011804652,0.00009420221,0.5843726,0.00008763061],"about_ca_topic_score_codex":0.000011445406,"about_ca_topic_score_gemma":0.00000240667,"teacher_disagreement_score":0.85194415,"about_ca_system_score_codex":0.0000804366,"about_ca_system_score_gemma":0.00080644205,"threshold_uncertainty_score":0.8079477},"labels":[],"label_agreement":null},{"id":"W1939041105","doi":"10.1111/j.1365-2133.2011.10205.x","title":"Preventing eczema flares with topical corticosteroids or tacrolimus: which is best?","year":2011,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Tacrolimus; Medicine; Randomized controlled trial; Thursday; Pediatrics; Dermatology; Surgery; Transplantation","score_opus":0.02178413770014885,"score_gpt":0.26944244534259,"score_spread":0.24765830764244112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939041105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3478673,0.028096676,0.0004658928,0.6151766,0.0020850583,0.0009902031,0.000116465424,0.00010674709,0.0050950525],"genre_scores_gemma":[0.38130447,0.003010878,0.0017275672,0.6060535,0.0032254457,0.00003430439,0.00012901456,0.00018820437,0.004326647],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9968386,0.00032425957,0.0012701763,0.00038176292,0.0004913256,0.0006938221],"domain_scores_gemma":[0.9975272,0.00023998646,0.00097404764,0.00035379603,0.00064753834,0.00025742274],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008902111,0.00039325393,0.0016840589,0.00028446782,0.00013937583,0.00007690131,0.00042059305,0.0012837914,0.0015297753],"category_scores_gemma":[0.00032902198,0.0003294885,0.000337336,0.00016615505,0.00032388818,0.00020866876,0.000099252386,0.0028927603,0.00008207288],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059247116,0.00020209566,0.027327802,0.00064280396,0.00066628185,0.2687724,0.00011811392,5.4963273e-8,0.0000032472128,7.8788014e-7,0.6989269,0.0027469848],"study_design_scores_gemma":[0.0028744244,0.00042571407,0.0062583755,0.0029042165,0.0013170963,0.7699309,0.00008602077,0.0000028706481,0.00028003656,0.00011361706,0.21549916,0.00030756966],"about_ca_topic_score_codex":0.000023287088,"about_ca_topic_score_gemma":0.00006120056,"teacher_disagreement_score":0.5011585,"about_ca_system_score_codex":0.00003948148,"about_ca_system_score_gemma":0.0007308794,"threshold_uncertainty_score":0.9999157},"labels":[],"label_agreement":null},{"id":"W1943930704","doi":"10.1111/j.1365-2133.2011.10257.x","title":"Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Ustekinumab; Medicine; Mace; Psoriasis; Placebo; Odds ratio; Internal medicine; Confidence interval; Incidence (geometry); Myocardial infarction; Adverse effect; Stroke (engine); Rate ratio; Clinical trial; Dermatology; Disease; Pathology; Percutaneous coronary intervention","score_opus":0.09309788346243057,"score_gpt":0.3296684587935555,"score_spread":0.2365705753311249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1943930704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755026,0.022264138,0.00013432065,0.000018441442,0.00022604909,0.00017062477,0.0016449101,0.0000035019218,0.00003540396],"genre_scores_gemma":[0.9953559,0.0031574504,0.0011951618,0.000012451392,0.000010312827,0.000001825252,0.00024889637,0.000009963381,0.000008045108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970973,0.00074994937,0.0016080354,0.0002804072,0.000080505866,0.00018381531],"domain_scores_gemma":[0.9979454,0.00024700267,0.0008441476,0.00038673938,0.00053882773,0.000037872313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047198505,0.00016586721,0.0016483106,0.00020310884,0.000051373027,0.0000025895126,0.0003346438,0.00021630236,0.000024111518],"category_scores_gemma":[0.00032411513,0.00013868307,0.00017286527,0.00019944664,0.00030587724,0.0001846722,0.00020006119,0.0002008497,8.189233e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15635116,0.009640298,0.35776007,0.0001911248,0.06289223,0.0018575607,0.0064822854,0.00007676624,0.0020183856,0.00001970875,0.003511092,0.3991993],"study_design_scores_gemma":[0.22936119,0.0076252734,0.67428005,0.0029659264,0.008464505,0.0056156586,0.004781107,0.000019129246,0.06459368,0.00019191594,0.0013345103,0.0007670424],"about_ca_topic_score_codex":0.0009722202,"about_ca_topic_score_gemma":0.00040376972,"teacher_disagreement_score":0.39843228,"about_ca_system_score_codex":0.000015228396,"about_ca_system_score_gemma":0.00012952366,"threshold_uncertainty_score":0.56553316},"labels":[],"label_agreement":null},{"id":"W1948708496","doi":"10.1111/bjd.14222","title":"Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"LEO Pharma","keywords":"Actinic keratosis; Medicine; Dermatology; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.019870865115153423,"score_gpt":0.28194205640140557,"score_spread":0.26207119128625217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948708496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784598,0.01772831,0.00013262845,0.0011405934,0.00021921226,0.0016856584,0.0000063465336,0.000007204201,0.00062026724],"genre_scores_gemma":[0.99579746,0.0034957782,0.00044262435,0.00007153307,0.00005762499,0.00004922438,0.0000011036244,0.000020919935,0.00006374248],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756896,0.00042044075,0.0012774906,0.00017202657,0.0003402462,0.00022082446],"domain_scores_gemma":[0.9969261,0.001206854,0.0010823301,0.00016095542,0.00045219582,0.00017153533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004278777,0.00020272999,0.0035613845,0.0001625927,0.000051125928,0.000012614019,0.00008772026,0.000086997774,0.000015499636],"category_scores_gemma":[0.00075934123,0.00014785398,0.00026804287,0.00010436297,0.00022221314,0.00007376979,0.00003582382,0.0001636427,5.2743843e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8168458,0.0017844682,0.14469035,0.00009071036,0.009409458,0.0057901586,0.006643745,0.0000062846893,0.000066061424,0.000009452083,0.0005854829,0.014078072],"study_design_scores_gemma":[0.9267937,0.0066896453,0.016864123,0.00050369423,0.0032323604,0.041094005,0.002269114,0.000015118734,0.0020954153,0.000024540137,0.0002786542,0.00013962129],"about_ca_topic_score_codex":0.00027818835,"about_ca_topic_score_gemma":0.00042718207,"teacher_disagreement_score":0.12782623,"about_ca_system_score_codex":0.00006749333,"about_ca_system_score_gemma":0.0002846806,"threshold_uncertainty_score":0.602931},"labels":[],"label_agreement":null},{"id":"W1948887633","doi":"10.1111/bjd.14068","title":"Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Pfizer; Merck; Amgen; Abbott Laboratories","keywords":"Medicine; Etanercept; Psoriasis; Adalimumab; Internal medicine; Skin cancer; Population; Cohort; Hazard ratio; Retrospective cohort study; Dermatology; Incidence (geometry); Malignancy; Infliximab; Cumulative incidence; Confidence interval; Cancer; Tumor necrosis factor alpha","score_opus":0.007892005526998097,"score_gpt":0.2158179768008172,"score_spread":0.20792597127381912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948887633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789464,0.0016119998,0.000001095859,0.000033557633,0.00006374543,0.00037418926,0.000011955009,0.0000043695854,0.000004446229],"genre_scores_gemma":[0.9992113,0.0006452532,0.0000100468205,0.000019059462,0.000003141465,0.000012277039,0.0000865113,0.0000067945793,0.000005625989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871314,0.0006003359,0.00037753134,0.00012022557,0.000048323443,0.00014046016],"domain_scores_gemma":[0.9994735,0.00008374234,0.00024225893,0.000055328856,0.00012325874,0.00002188331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015020338,0.000113387985,0.00040382988,0.0002606014,0.000046144618,0.000010004129,0.00004983172,0.000102715116,0.0000018594578],"category_scores_gemma":[0.00005482635,0.00008537379,0.000014087806,0.00022055722,0.00007711626,0.00010017112,0.000020392077,0.00009664892,1.6609201e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004661114,0.0005542868,0.99562746,0.0000085958345,0.00021506412,0.0002468635,0.0016292955,0.0000069459447,0.000021581169,0.0000030974818,0.000026935373,0.0011937306],"study_design_scores_gemma":[0.016505387,0.0007818198,0.9768621,0.00006608946,0.00017292355,0.00467643,0.00071054493,0.0000037347788,0.00007471439,0.00005717792,0.000009546805,0.00007957917],"about_ca_topic_score_codex":0.0048850537,"about_ca_topic_score_gemma":0.0020379084,"teacher_disagreement_score":0.01876544,"about_ca_system_score_codex":0.00001995437,"about_ca_system_score_gemma":0.00001670684,"threshold_uncertainty_score":0.73847723},"labels":[],"label_agreement":null},{"id":"W1953869513","doi":"10.1111/j.1365-2133.2011.10351.x","title":"A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Vitiligo; Placebo; Clobetasol propionate; Tacrolimus; Adverse effect; Randomized controlled trial; Population; Dermatology; Mometasone furoate; Surgery; Internal medicine; Corticosteroid; Transplantation","score_opus":0.013738006213116187,"score_gpt":0.2558783349237193,"score_spread":0.24214032871060312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953869513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521136,0.0010066602,0.00064581964,0.000132975,0.00055785064,0.0012135394,0.000003710893,0.000002979828,0.0012251248],"genre_scores_gemma":[0.99816394,0.000801268,0.0005954997,0.00010715721,0.00017769917,0.00007761255,0.000015475769,0.000012822884,0.000048496968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978829,0.00046962211,0.0010827349,0.0001697537,0.00017565563,0.0002193549],"domain_scores_gemma":[0.9990128,0.000055730194,0.00058877806,0.000120478464,0.0001407665,0.00008143785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044952528,0.00013262793,0.00088221015,0.00011363419,0.000032992386,0.0000147818,0.00019031792,0.0002396268,0.000049929444],"category_scores_gemma":[0.00021887993,0.00012495935,0.00032988627,0.000063915315,0.00014453806,0.000011559431,0.00004518349,0.0002021676,0.0000019550866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99312407,0.00055814965,0.00046462417,0.000018620762,0.00021998186,0.00081388565,0.00024283263,0.0000032112534,0.0026597322,0.00017993306,0.0003316384,0.0013833483],"study_design_scores_gemma":[0.9439112,0.00048853905,0.000487181,0.000056220855,0.00008634426,0.0160686,0.000075446755,0.000014701513,0.038266055,0.00032121094,0.00010745263,0.00011706874],"about_ca_topic_score_codex":0.000057097386,"about_ca_topic_score_gemma":0.00009186037,"teacher_disagreement_score":0.04921286,"about_ca_system_score_codex":0.00001038413,"about_ca_system_score_gemma":0.0001419836,"threshold_uncertainty_score":0.5095694},"labels":[],"label_agreement":null},{"id":"W1957104829","doi":"10.1111/j.1365-2133.2005.06411.x","title":"Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Basal cell carcinoma; Cancer; Medicine; Skin cancer; Basal cell; Dermatology; Agency (philosophy); International agency; Internal medicine; Sociology","score_opus":0.012657992828450247,"score_gpt":0.22208265804553107,"score_spread":0.2094246652170808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957104829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95009804,0.019689552,0.000017976716,0.027591687,0.00069401955,0.00094637467,0.0007824814,0.000010076906,0.00016978905],"genre_scores_gemma":[0.98271203,0.00039351228,0.00057248963,0.01407424,0.0017677826,0.0000389001,0.000025366451,0.00015431733,0.00026135365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583024,0.0002914954,0.0018475356,0.00056905806,0.000654089,0.0008075798],"domain_scores_gemma":[0.9952268,0.0005912342,0.0031304832,0.00048879284,0.0003841457,0.00017854052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021767529,0.0006238084,0.0021708268,0.00023238726,0.00016118046,0.00004149548,0.0005404749,0.000999554,0.000048792495],"category_scores_gemma":[0.00018942074,0.000496474,0.00085582247,0.00012498791,0.0005424817,0.00007989722,0.00019212454,0.0020425387,0.000001335753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032329556,0.00018504515,0.6901509,0.0012389934,0.00021190135,0.0069904006,0.00044339124,6.233765e-7,0.000800514,0.0000010496892,0.29941675,0.00023708833],"study_design_scores_gemma":[0.009913107,0.00076325797,0.6426422,0.00078063505,0.0023670609,0.10153912,0.0005800084,0.0000141874025,0.2029565,0.000085837404,0.037430093,0.00092799345],"about_ca_topic_score_codex":0.00046414247,"about_ca_topic_score_gemma":0.00024680208,"teacher_disagreement_score":0.26198667,"about_ca_system_score_codex":0.00017689209,"about_ca_system_score_gemma":0.00041742608,"threshold_uncertainty_score":0.9997487},"labels":[],"label_agreement":null},{"id":"W1960922507","doi":"10.1111/bjd.14267","title":"Biosimilars for psoriasis: preclinical analytical assessment to determine similarity","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"AbbVie; Wyeth; Cilag; Amgen","keywords":"Biosimilar; Psoriasis; Medicine; Quality (philosophy); Risk analysis (engineering); Product (mathematics); Similarity (geometry); Biological drugs; Pharmacology; Intensive care medicine; Business; Computer science; Immunology; Disease; Artificial intelligence; Internal medicine","score_opus":0.15495882730655608,"score_gpt":0.4507569827974371,"score_spread":0.295798155490881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960922507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012973878,0.990321,0.0032460531,0.0016827581,0.002903483,0.0010228528,0.00050114223,0.00002872046,0.00028106422],"genre_scores_gemma":[0.000049594317,0.9813063,0.01674026,0.0010311696,0.00037530577,0.00006462067,0.00007911727,0.00007659927,0.0002770447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932492,0.0018790524,0.0031766437,0.000651213,0.00016553751,0.00087837677],"domain_scores_gemma":[0.9948943,0.0020745944,0.0013755983,0.0004320562,0.0008599381,0.000363466],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022274514,0.00060229894,0.005572343,0.00045670272,0.0001615141,0.00009341212,0.0011293315,0.0022262365,0.0002909686],"category_scores_gemma":[0.0026335854,0.0005312144,0.0019287415,0.00040586526,0.00042932376,0.0001031286,0.00031377567,0.0020058986,0.000044635857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115479146,0.00037570114,0.000018922945,0.0015194656,0.001329724,0.0008361845,0.0000074906993,1.4157436e-7,0.0000023150806,0.000085119704,0.14103465,0.8546748],"study_design_scores_gemma":[0.0016261657,0.00063433655,0.0000166181,0.0041023213,0.0038540948,0.07254885,0.000019016912,0.0000068232175,0.00001900591,0.0003080683,0.9163666,0.00049810094],"about_ca_topic_score_codex":0.0000039801143,"about_ca_topic_score_gemma":0.00001611481,"teacher_disagreement_score":0.8541767,"about_ca_system_score_codex":0.00019614173,"about_ca_system_score_gemma":0.0012570062,"threshold_uncertainty_score":0.99971396},"labels":[],"label_agreement":null},{"id":"W1964607493","doi":"10.1111/j.1365-2133.2005.06776.x","title":"First case series on the use of imiquimod for morphoea","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Red Deer Regional Hospital; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Library science; Family medicine; Geography","score_opus":0.05295557854268711,"score_gpt":0.2599933048786729,"score_spread":0.20703772633598577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964607493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98333883,0.0059779016,0.00012382356,0.010035245,0.00019345687,0.00021962219,0.000035701003,0.000006859231,0.00006858635],"genre_scores_gemma":[0.99657553,0.0016380167,0.0007141879,0.0008078028,0.00015814784,0.0000068031695,0.000001840424,0.000012965781,0.00008470679],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9990772,0.00005943377,0.00052907615,0.00007233188,0.00012028281,0.00014169133],"domain_scores_gemma":[0.9988721,0.00035816047,0.00032013367,0.000112710964,0.00024371168,0.00009320504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008934006,0.00007430638,0.00035391658,0.00006466541,0.00009207838,0.000019092593,0.00006812827,0.00010039042,0.00006865094],"category_scores_gemma":[0.00041684692,0.00005352121,0.00020421718,0.000060091716,0.000109813765,0.00010535885,0.000012243207,0.00014943116,0.0000035590078],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044384287,0.0023092374,0.021378802,0.0009085993,0.0021307922,0.10094071,0.0012508369,0.001057617,0.004090268,0.0027993773,0.8005335,0.058161836],"study_design_scores_gemma":[0.0020556774,0.00021861415,0.0021543405,0.0015364148,0.0002159251,0.9653001,0.00032099104,0.00019061498,0.004022709,0.000027821587,0.023893949,0.00006286244],"about_ca_topic_score_codex":0.00002832288,"about_ca_topic_score_gemma":0.000042925316,"teacher_disagreement_score":0.8643594,"about_ca_system_score_codex":0.000020935473,"about_ca_system_score_gemma":0.00006869465,"threshold_uncertainty_score":0.21825317},"labels":[],"label_agreement":null},{"id":"W1965953118","doi":"10.1046/j.1365-2133.2002.05006.x","title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dosing; Fluticasone propionate; Atopic dermatitis; Randomized controlled trial; Regimen; Adverse effect; Erythema; Surgery; Internal medicine; Pediatrics; Dermatology; Corticosteroid","score_opus":0.012695804495203565,"score_gpt":0.24653848008606824,"score_spread":0.23384267559086466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965953118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98980623,0.007989545,0.00021531538,0.0011649714,0.0002480765,0.00032245173,0.000023761011,0.000004935499,0.00022471686],"genre_scores_gemma":[0.99742097,0.0015398746,0.00075954734,0.00020368649,0.000027256721,0.000008814395,0.000004752541,0.000012617633,0.000022510083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821013,0.00023250887,0.0010482974,0.00011053203,0.00018073781,0.00021777504],"domain_scores_gemma":[0.99832505,0.00034396542,0.0007693979,0.00014583828,0.0003380625,0.00007771057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015050589,0.000102399725,0.0006153253,0.00017246179,0.00006657214,0.00000795773,0.00015898178,0.00012151335,0.000054101776],"category_scores_gemma":[0.0009994614,0.00008631635,0.00021858414,0.00013499822,0.0002633669,0.00011502961,0.000037506168,0.00031269368,0.000001688954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018746895,0.0015690388,0.9216718,0.0006081364,0.0002976978,0.0016345354,0.0007745848,0.000015807746,0.000074719675,0.000070523165,0.01769481,0.05540089],"study_design_scores_gemma":[0.00742887,0.00027801417,0.92176664,0.0024658297,0.00044641102,0.060814433,0.0003253223,0.0010122908,0.0038106134,0.0007085443,0.00081548165,0.00012757558],"about_ca_topic_score_codex":0.000033966466,"about_ca_topic_score_gemma":0.000013838901,"teacher_disagreement_score":0.0591799,"about_ca_system_score_codex":0.000026937429,"about_ca_system_score_gemma":0.000050061903,"threshold_uncertainty_score":0.35198787},"labels":[],"label_agreement":null},{"id":"W1966064835","doi":"10.1111/j.1365-2133.2005.06895.x","title":"Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Western University","funders":"","keywords":"Rosacea; Medicine; Depression (economics); Ambulatory care; Alcohol abuse; Ambulatory; National Comorbidity Survey; Alcohol dependence; Psychiatry; Odds ratio; Comorbidity; Health care; Dermatology; Internal medicine; Alcohol","score_opus":0.029091906492798077,"score_gpt":0.33531870243699574,"score_spread":0.30622679594419766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966064835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95431983,0.006497275,0.0003119286,0.00082877016,0.00013592113,0.0003874554,0.037507888,0.0000026332043,0.000008316182],"genre_scores_gemma":[0.99276704,0.00028746724,0.0006641823,0.00088846433,0.00007388496,0.0000071215636,0.0052965833,0.000009994978,0.0000052372725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974906,0.0005137392,0.0006282081,0.00021868863,0.0009911397,0.00015766242],"domain_scores_gemma":[0.99696285,0.0006442451,0.00045954948,0.00011266984,0.0016080672,0.00021261763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005862876,0.00012217052,0.00052696565,0.00010359589,0.00021216075,0.000019093568,0.00019413601,0.00011208978,0.000043056392],"category_scores_gemma":[0.00090555573,0.00008695725,0.00006595598,0.00018828934,0.00017002928,0.00009155246,0.00011438716,0.00017010675,1.7031894e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025739908,0.00054075074,0.8488026,0.000049594615,0.00095328136,0.000014335431,0.00063349586,0.000064035485,0.0000057313614,0.000005204872,0.14576006,0.0029135086],"study_design_scores_gemma":[0.0026784304,0.00022934722,0.99224716,0.0000906295,0.00020804303,0.0003530049,0.0001621014,0.002005561,0.00006235957,0.0000050867116,0.0018814395,0.00007685936],"about_ca_topic_score_codex":0.00065559376,"about_ca_topic_score_gemma":0.008996805,"teacher_disagreement_score":0.14387861,"about_ca_system_score_codex":0.00016265381,"about_ca_system_score_gemma":0.0007330958,"threshold_uncertainty_score":0.50204283},"labels":[],"label_agreement":null},{"id":"W1968246079","doi":"10.1111/j.1365-2133.1973.tb07571.x","title":"Recurrent Kaposi's varicelliform eruption in Darier's disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Coxsackievirus; Darier's disease; Medicine; Dermatology; Virology; Enterovirus; Disease; Virus; Pathology","score_opus":0.0033179698617841246,"score_gpt":0.21108203851716276,"score_spread":0.20776406865537864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968246079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773297,0.019432923,0.0017051148,0.0003432361,0.00033364265,0.000088302964,0.000021782798,0.000003610912,0.0007417027],"genre_scores_gemma":[0.9979488,0.0011573096,0.00037781286,0.00012215531,0.00022485526,0.00000415615,0.00007114297,0.000012481905,0.000081249455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989785,0.000084451625,0.0004376321,0.00015440179,0.00012390976,0.0002211039],"domain_scores_gemma":[0.9994492,0.000008498181,0.00019249548,0.0001113979,0.000108786684,0.00012961842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007798989,0.00009833921,0.00017734399,0.000076268756,0.000047229292,0.000031186046,0.00016837954,0.0001069367,0.000036702848],"category_scores_gemma":[0.00005462964,0.00011230977,0.000121138444,0.00007709207,0.00007604359,0.0000067660867,0.000045050267,0.00013042788,0.0000061225414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025526388,0.004366445,0.5634807,0.00034115234,0.00030290475,0.026289336,0.000080989674,0.0016640056,0.03713912,0.0010758437,0.19606492,0.166642],"study_design_scores_gemma":[0.004576029,0.0002662771,0.85565186,0.00025021745,0.00012845323,0.03508294,0.000075098505,0.00014399963,0.009710663,0.0036573594,0.08989895,0.00055817177],"about_ca_topic_score_codex":0.00004029796,"about_ca_topic_score_gemma":0.00014318239,"teacher_disagreement_score":0.29217118,"about_ca_system_score_codex":0.000016517528,"about_ca_system_score_gemma":0.00016402897,"threshold_uncertainty_score":0.45798594},"labels":[],"label_agreement":null},{"id":"W1968731581","doi":"10.1111/j.0366-077x.2004.05949.x","title":"Ciclosporin in psoriasis clinical practice: an international consensus statement","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novartis Pharma; Medical School, University of Michigan; National and Kapodistrian University of Athens; Universiteit Gent; Università degli Studi di Milano; Universitair Ziekenhuis Gent; Saint Louis University","keywords":"Ciclosporin; Psoriasis; Medicine; Statement (logic); Dermatology; Consensus conference; MEDLINE; Intensive care medicine; Internal medicine; Chemotherapy; Political science","score_opus":0.06158428926066879,"score_gpt":0.4470859468103464,"score_spread":0.38550165754967763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968731581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008782297,0.9948085,0.000022108134,0.0011039054,0.0020587326,0.0005121467,0.00005223508,0.000019930454,0.0005441953],"genre_scores_gemma":[0.0010368469,0.99326247,0.004774874,0.00026002552,0.00043627567,0.000013651113,0.00010251512,0.00006393112,0.000049421553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99359393,0.00093533023,0.0041950997,0.00034727243,0.0005686928,0.0003597001],"domain_scores_gemma":[0.9950953,0.00071122585,0.0029717926,0.00030887686,0.000596548,0.0003162476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009713138,0.00030942465,0.0030041786,0.00044278882,0.00003784892,0.000055997414,0.00045592184,0.0005007125,0.00026023402],"category_scores_gemma":[0.004042127,0.00032706527,0.00077130547,0.00019763822,0.00022038636,0.00019501304,0.0001020635,0.0015627738,0.00004656776],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022839957,0.0017517547,0.00077055756,0.0025754534,0.0008779314,0.17457503,0.000026164273,0.0000011387078,2.2423064e-8,0.000077879035,0.004036807,0.81507885],"study_design_scores_gemma":[0.0024713296,0.00015147099,0.0010500067,0.018344715,0.0010894061,0.40470195,0.00007574241,7.823814e-7,1.6753141e-7,0.000060235147,0.57190675,0.00014746947],"about_ca_topic_score_codex":0.0000936117,"about_ca_topic_score_gemma":0.00002036981,"teacher_disagreement_score":0.8149314,"about_ca_system_score_codex":0.0004728992,"about_ca_system_score_gemma":0.0035459243,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W1968932142","doi":"10.1111/j.1365-2133.2006.07389.x","title":"A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. Food and Drug Administration; GlaxoSmithKline","keywords":"Psoriasis; Medicine; Psoriasis Area and Severity Index; Reliability (semiconductor); Index (typography); Dermatology; Severity of illness; Internal medicine; Physics; Computer science","score_opus":0.021414824926412654,"score_gpt":0.2664604296771659,"score_spread":0.2450456047507532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968932142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928071,0.003487302,0.0019994467,0.00006576909,0.0005226259,0.00057179073,0.00031883232,0.000021195834,0.00020592632],"genre_scores_gemma":[0.99831176,0.000119631724,0.0014182696,0.000022052931,0.00006528486,0.000031174855,0.000015925232,0.0000137180195,0.000002192073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731296,0.00066716864,0.0010805618,0.00042654708,0.00013541187,0.000377318],"domain_scores_gemma":[0.99809265,0.00029802794,0.000943926,0.00020945127,0.0003992297,0.000056713485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006257856,0.000320023,0.0013189616,0.00007640974,0.00020179785,0.00004989447,0.00019950875,0.00027599614,0.0000022059603],"category_scores_gemma":[0.000044979683,0.00032342796,0.0001445923,0.0001602571,0.00038754602,0.00030692574,0.00017551998,0.00023243614,2.3588206e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006002979,0.001108598,0.9377816,0.0004197847,0.0010430412,0.00017896014,0.000119574026,0.0000052320015,0.00072072016,0.00026876188,0.00010105136,0.05765242],"study_design_scores_gemma":[0.006575816,0.00057735643,0.98124135,0.00045792165,0.0008509284,0.005762559,0.0020962043,0.00004817569,0.0012186916,0.00089395145,0.000026056265,0.0002509951],"about_ca_topic_score_codex":0.00047721327,"about_ca_topic_score_gemma":0.00070237636,"teacher_disagreement_score":0.057401426,"about_ca_system_score_codex":0.00018527434,"about_ca_system_score_gemma":0.0001500204,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W1969219294","doi":"10.1111/j.1365-2133.2007.08167.x","title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dermatology; Medical school; Family medicine; Library science; Medical education; Computer science","score_opus":0.010677437219917194,"score_gpt":0.25269426996723726,"score_spread":0.24201683274732005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969219294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966766,0.00006572237,0.00011004146,0.0010943642,0.000080545906,0.00012867461,0.0000033234821,0.000007807448,0.0018329085],"genre_scores_gemma":[0.99962676,0.00003450886,0.00019624141,0.00005492896,0.00003507364,5.198448e-7,0.0000020592122,0.0000115882185,0.000038307797],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988655,0.00012131478,0.0004543,0.00009366396,0.0002991719,0.00016604197],"domain_scores_gemma":[0.9982222,0.00028670512,0.0009026077,0.00009752213,0.00041917412,0.00007184616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006471607,0.00008261805,0.00045078382,0.0001423975,0.000091043024,0.000008246693,0.00004689562,0.00011708767,0.0000015489037],"category_scores_gemma":[0.00022304402,0.00007430447,0.000073746734,0.00018038323,0.00008367374,0.00020078548,0.000020057605,0.00045325817,4.7732647e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002256999,0.0008663929,0.23717314,0.00030740336,0.0014577163,0.008774292,0.0016088114,0.0000054402585,0.65505975,0.00021838544,0.00024299572,0.09405995],"study_design_scores_gemma":[0.0014227482,0.00004693896,0.81129307,0.00027119022,0.000223056,0.13339713,0.0011764904,0.000005823841,0.051906306,0.000033002514,0.00016089166,0.00006334409],"about_ca_topic_score_codex":0.00034506933,"about_ca_topic_score_gemma":0.000544059,"teacher_disagreement_score":0.60315347,"about_ca_system_score_codex":0.00012164254,"about_ca_system_score_gemma":0.00008898848,"threshold_uncertainty_score":0.30300486},"labels":[],"label_agreement":null},{"id":"W1971847145","doi":"10.1046/j.1365-2133.2000.03783.x","title":"Topical photodynamic therapy with 5‐aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"DUSA Pharmaceuticals; National Alopecia Areata Foundation","keywords":"Photosensitizer; Lotion; Photodynamic therapy; Erythema; Protoporphyrin IX; Alopecia areata; Dermatology; Phototoxicity; Medicine; Chemistry; Hair follicle; Scalp; Photochemistry; Pharmacology; Internal medicine; Biochemistry; In vitro","score_opus":0.00650929409779413,"score_gpt":0.22243143670518603,"score_spread":0.2159221426073919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971847145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962945,0.00077064964,0.000030808613,0.0015566295,0.00007754468,0.00030417144,0.000009097215,0.00001604617,0.0009405421],"genre_scores_gemma":[0.9966407,0.0007794888,0.0003924496,0.0019909523,0.000057622903,0.00000702849,0.000018123652,0.00002766642,0.000086000146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835944,0.00011387844,0.0005611107,0.00024143781,0.00033967008,0.00038447042],"domain_scores_gemma":[0.9990773,0.000058834103,0.00018571665,0.00018331861,0.00027992562,0.00021486505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006541947,0.00018993882,0.0006742881,0.00017639238,0.00005866918,0.000029319166,0.0001700832,0.0001731559,0.00026664668],"category_scores_gemma":[0.000071012655,0.00013421956,0.00008124234,0.00021312256,0.00019272444,0.0002216855,0.000013045966,0.00058955234,0.000011090461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076921387,0.0010489261,0.86401916,0.00004088633,0.00019563915,0.014410442,0.0003522549,0.0000029274,0.0001373053,0.00001683013,0.0005691002,0.1115144],"study_design_scores_gemma":[0.017968744,0.001272869,0.9481397,0.00045319644,0.000048958274,0.029298278,0.00021256406,0.000007952649,0.0014615867,0.00006374108,0.0008633533,0.00020901792],"about_ca_topic_score_codex":0.00008781564,"about_ca_topic_score_gemma":0.00048390595,"teacher_disagreement_score":0.11130538,"about_ca_system_score_codex":0.000044631164,"about_ca_system_score_gemma":0.0002506149,"threshold_uncertainty_score":0.54733145},"labels":[],"label_agreement":null},{"id":"W1971859790","doi":"10.1111/j.1365-2133.2007.08192.x","title":"A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pimecrolimus; Atopic dermatitis; Medicine; Dermatology; Randomized controlled trial; Head and neck; Tacrolimus; Internal medicine; Surgery","score_opus":0.00779468475392059,"score_gpt":0.26240183618627777,"score_spread":0.2546071514323572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971859790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919799,0.0061748913,0.00013122494,0.0004387024,0.000109130226,0.0010765218,0.0000030096126,0.0000041129356,0.000082485385],"genre_scores_gemma":[0.9976978,0.0016670009,0.00019194328,0.0003874378,0.00002780933,0.000011795696,0.0000011635198,0.0000088512925,0.000006252456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978129,0.00029968502,0.0013104787,0.0001488845,0.00021523933,0.00021279919],"domain_scores_gemma":[0.9985223,0.00050046394,0.000539452,0.00008498918,0.00015663482,0.00019619777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002997731,0.00014533884,0.0020705713,0.0002206166,0.000030266245,0.000012465468,0.00005520721,0.00016173786,0.00001114102],"category_scores_gemma":[0.00064767106,0.000107805005,0.00010254243,0.00006587947,0.00045211831,0.00007557165,0.000028389644,0.00026871866,1.5794292e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7913414,0.0010364748,0.19044513,0.0003575819,0.00021275484,0.010348419,0.00024850457,1.9476781e-7,0.000011540579,0.000024793211,0.00003285673,0.0059403623],"study_design_scores_gemma":[0.6636319,0.00093890197,0.2339631,0.0022838498,0.00023055806,0.0984525,0.00013197227,0.000030443058,0.00019165053,0.00007362173,0.000005294456,0.00006616042],"about_ca_topic_score_codex":0.00006516561,"about_ca_topic_score_gemma":0.00034464156,"teacher_disagreement_score":0.12770946,"about_ca_system_score_codex":0.000010595325,"about_ca_system_score_gemma":0.00010519324,"threshold_uncertainty_score":0.43961602},"labels":[],"label_agreement":null},{"id":"W1971920401","doi":"10.1111/j.1365-2133.2005.06852.x","title":"Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Institute of Innovative Research, Tokyo Institute of Technology","keywords":"Psychosomatics; Prurigo nodularis; Medicine; Dermatology; Family medicine; Psychiatry","score_opus":0.01949863057359436,"score_gpt":0.3113678780365002,"score_spread":0.2918692474629058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971920401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952792,0.0027904694,0.0000854854,0.0009678902,0.000106157444,0.0004436513,0.000026660584,0.000011974074,0.00028853217],"genre_scores_gemma":[0.9991912,0.00007394463,0.00047050996,0.00018683531,0.00004268971,0.000008247825,0.0000036704391,0.000014517628,0.000008378026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969403,0.0005903457,0.0016066976,0.00024981552,0.00026790655,0.00034489474],"domain_scores_gemma":[0.99847436,0.00037151075,0.00060535554,0.00019916173,0.00018165664,0.00016796817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034372153,0.00018249145,0.0013412497,0.00044860697,0.000039692004,0.000013747247,0.00017089705,0.00025317835,0.00005662872],"category_scores_gemma":[0.00055002834,0.00015872649,0.00012827713,0.00031449334,0.0001978324,0.00015555068,0.000021869602,0.00078225386,0.0000032389557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036756713,0.004614657,0.8385893,0.00002831493,0.00017673765,0.14623274,0.00088946923,0.000060659455,0.000012494389,0.000002864593,0.0025090438,0.0032080305],"study_design_scores_gemma":[0.020601816,0.0005114972,0.65855443,0.00021024763,0.000184831,0.31767792,0.0018056313,0.00008142759,0.0001463047,0.000017302644,0.00010883793,0.000099733064],"about_ca_topic_score_codex":0.00018297404,"about_ca_topic_score_gemma":0.0025865736,"teacher_disagreement_score":0.18003488,"about_ca_system_score_codex":0.00004648708,"about_ca_system_score_gemma":0.000096247066,"threshold_uncertainty_score":0.6472678},"labels":[],"label_agreement":null},{"id":"W1972120867","doi":"10.1111/j.1365-2133.2006.07336.x","title":"Topical glycopyrrolate should not be overlooked in treatment of focal hyperhidrosis","year":2006,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glycopyrrolate; Hyperhidrosis; Medicine; Botulinum toxin; Dermatology; Anesthesia; Atropine","score_opus":0.040492355337163055,"score_gpt":0.28929107887351807,"score_spread":0.24879872353635502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972120867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72437876,0.006691157,0.000014274465,0.26700437,0.0005934494,0.00044187464,0.000116115894,0.000019473187,0.0007405408],"genre_scores_gemma":[0.87904537,0.0031186044,0.00097059953,0.114019185,0.0014472837,0.00003439092,0.00022963021,0.00010585108,0.0010291123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967622,0.00023739527,0.0015140005,0.00034462806,0.00059398,0.0005477566],"domain_scores_gemma":[0.99842393,0.00027667033,0.0006948297,0.00028699526,0.00018841236,0.0001291327],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000070657465,0.0004113552,0.0023503406,0.00047787093,0.000048219208,0.00002818876,0.00020383042,0.0013741921,0.00019280161],"category_scores_gemma":[0.000057130077,0.00039409884,0.00077210384,0.00016614034,0.00020115715,0.000100161924,0.000030784573,0.0011900866,0.000010603508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001212817,0.0037579539,0.122499056,0.0004988213,0.0016659717,0.3670477,0.00028566044,0.0000030833808,0.00077425095,0.000019696632,0.47666708,0.025567912],"study_design_scores_gemma":[0.026669921,0.0033008023,0.08307273,0.0020649135,0.0023152148,0.41238123,0.00004049877,0.000035744924,0.009267048,0.00015824942,0.46006134,0.00063230173],"about_ca_topic_score_codex":0.0006599097,"about_ca_topic_score_gemma":0.0001589037,"teacher_disagreement_score":0.1546666,"about_ca_system_score_codex":0.00033611563,"about_ca_system_score_gemma":0.00029972228,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W1972702833","doi":"10.1111/j.1365-2133.2005.06810.x","title":"Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"National Cancer Institute; Foundation Medicine; University of British Columbia; Canadian Dermatology Foundation; Pfizer; Dermatology Foundation","keywords":"Apoptosis; Mutant; Melanoma; Cancer research; Cell culture; Cell growth; Biology; Genetics; Gene","score_opus":0.012303700609848282,"score_gpt":0.25254697020165295,"score_spread":0.24024326959180467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972702833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986075,0.0030322827,0.00068380876,0.008257242,0.0006305185,0.00027153094,0.000016455606,0.000035874094,0.0009972934],"genre_scores_gemma":[0.9947845,0.00048826187,0.0021370295,0.0018264911,0.00048653135,0.000007966983,0.000007060748,0.00005546815,0.0002067207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977552,0.00016242554,0.00093933335,0.00026019636,0.00040602763,0.00047678855],"domain_scores_gemma":[0.998424,0.00008937131,0.0003737161,0.00025398628,0.0003705686,0.00048838044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001429556,0.00021880693,0.00079454086,0.00039919297,0.00008742961,0.000047803267,0.0002476549,0.0002861375,0.00024178866],"category_scores_gemma":[0.00026730218,0.00024040838,0.0002829574,0.00029022997,0.00005329537,0.00011214867,0.00007455347,0.000686597,0.0001330923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013385095,0.00074353156,0.0018799087,0.000110970206,0.00032156994,0.016991543,0.0006331393,0.000029278825,0.8831274,0.000033890265,0.022115031,0.07267525],"study_design_scores_gemma":[0.0055892183,0.0005699505,0.00636397,0.0005632895,0.00028141716,0.24222998,0.00013737682,0.000043978645,0.70869446,0.00003644152,0.035199016,0.00029089968],"about_ca_topic_score_codex":0.000036699155,"about_ca_topic_score_gemma":0.00009308589,"teacher_disagreement_score":0.22523844,"about_ca_system_score_codex":0.00017278861,"about_ca_system_score_gemma":0.0003009501,"threshold_uncertainty_score":0.98035693},"labels":[],"label_agreement":null},{"id":"W1974038474","doi":"10.1111/j.1365-2133.2008.08461.x","title":"Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"Helsingin Yliopisto","keywords":"Medicine; Randomized controlled trial; Prospective cohort study; Surgery; Anesthesia","score_opus":0.01539109098758251,"score_gpt":0.3348134420135868,"score_spread":0.3194223510260043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974038474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98339486,0.008760734,0.00010311847,0.00033480913,0.0005265067,0.00576434,0.000020367175,0.00001038682,0.0010848638],"genre_scores_gemma":[0.99643517,0.002783084,0.00019111419,0.000030605966,0.00008348266,0.00013346777,0.0000026737248,0.000012484086,0.00032794813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940915,0.0036552108,0.0016146094,0.00015502068,0.00022586643,0.00025780953],"domain_scores_gemma":[0.9963355,0.0019009918,0.0013623498,0.00010902995,0.00020979714,0.00008234144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008639571,0.0001529184,0.0022497417,0.00023055698,0.00011947914,0.000004132486,0.00011079526,0.00019477344,0.00012130173],"category_scores_gemma":[0.0009553515,0.0001277733,0.00034690963,0.000083010746,0.00016627635,0.00010730682,0.00004772776,0.00026205633,0.000001300991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9620802,0.00088693545,0.027114969,0.00057437393,0.0013523693,0.000949695,0.003277929,0.000032630574,0.00006562865,0.00017248529,0.0012113829,0.0022814283],"study_design_scores_gemma":[0.9823406,0.00070940546,0.012784547,0.00050313724,0.0007006057,0.0014570572,0.00027797805,0.00009898569,0.00016830384,0.00018353344,0.00067817024,0.00009772881],"about_ca_topic_score_codex":0.00038588792,"about_ca_topic_score_gemma":0.0005092395,"teacher_disagreement_score":0.020260375,"about_ca_system_score_codex":0.00004739893,"about_ca_system_score_gemma":0.00016522677,"threshold_uncertainty_score":0.52104443},"labels":[],"label_agreement":null},{"id":"W1974998967","doi":"10.1111/bjd.13389","title":"When is onychomycosis onychomycosis? A cross-sectional study of fungi in normal-appearing nails","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Tel aviv; Library science; Medicine; History; Sociology; Computer science","score_opus":0.01652345686558986,"score_gpt":0.29457341811871,"score_spread":0.27804996125312015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974998967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960975,0.0024935266,0.0000624402,0.0001707916,0.00023689041,0.00025266918,0.000012392128,0.0000092416685,0.00066453806],"genre_scores_gemma":[0.99899036,0.0002822736,0.00029741094,0.00023805063,0.000091010406,0.000010103877,0.000004516443,0.000020500465,0.0000658017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979671,0.00014283283,0.0010066956,0.0002057678,0.00038738348,0.00029022153],"domain_scores_gemma":[0.99880457,0.00010504407,0.00044390347,0.0001685786,0.00027493952,0.00020295921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020020451,0.00014392617,0.00066304544,0.0003091574,0.00007088853,0.000048244165,0.00015676397,0.00012184479,0.00029372534],"category_scores_gemma":[0.00011500579,0.00015533199,0.0002213742,0.0001653602,0.000067981426,0.00020370609,0.000052289997,0.00032601063,0.000018774615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004266848,0.0023467008,0.97920007,0.000077522,0.00033629066,0.002429691,0.00030237675,0.000004211363,0.00007307093,0.000010921963,0.0008244229,0.013968034],"study_design_scores_gemma":[0.0103241345,0.00061075157,0.95371705,0.0002782004,0.00015165514,0.03357994,0.00015040791,0.000046290817,0.00028137668,0.00030514778,0.00045147553,0.00010356434],"about_ca_topic_score_codex":0.00052027364,"about_ca_topic_score_gemma":0.00019521412,"teacher_disagreement_score":0.031150252,"about_ca_system_score_codex":0.0000751902,"about_ca_system_score_gemma":0.0000972919,"threshold_uncertainty_score":0.6334255},"labels":[],"label_agreement":null},{"id":"W1975297857","doi":"10.1111/j.1365-2133.1946.tb11322.x","title":"PEELIMINARY REPORT OF A DERMATOSIS DUE POSSIBLY TO MEPACRINE.* A DESCRIPTION OF 26 CASES SEEN IN ITALY.","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"","keywords":"Citation; Medicine; General hospital; Library science; Dermatology; Family medicine; Computer science","score_opus":0.014783211876540888,"score_gpt":0.27058817056795664,"score_spread":0.25580495869141573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975297857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923251,0.0058713276,0.0000799946,0.0009317437,0.00008765576,0.00019725412,0.000025051146,0.0000087884655,0.00047302997],"genre_scores_gemma":[0.9983665,0.00015428393,0.0012266242,0.00009385721,0.000038223006,0.0000058058804,0.00001531577,0.000019602423,0.00007980007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981905,0.000077492245,0.0011147222,0.00013447217,0.00027000078,0.00021281956],"domain_scores_gemma":[0.9987669,0.00006602134,0.00053542346,0.0001393897,0.00034833897,0.00014391803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008952486,0.000115671675,0.00071604335,0.0003927335,0.000023763892,0.000009723731,0.00007713121,0.000085467735,0.000029100636],"category_scores_gemma":[0.00022165042,0.0001228638,0.00021422497,0.00027922558,0.0000687826,0.00014499054,0.00003417052,0.00012255202,0.000003145451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004909309,0.0011148826,0.68050665,0.00021145366,0.00012817771,0.3078219,0.0000545366,0.000007539175,0.0018994444,0.000015618834,0.00529038,0.002458498],"study_design_scores_gemma":[0.0017320913,0.00023452482,0.5088485,0.00055104913,0.00017717108,0.485084,0.00011974254,0.00000542666,0.0029841715,0.00010755433,0.00010384816,0.00005194226],"about_ca_topic_score_codex":0.0014102886,"about_ca_topic_score_gemma":0.00042699056,"teacher_disagreement_score":0.1772621,"about_ca_system_score_codex":0.000057602974,"about_ca_system_score_gemma":0.00018735125,"threshold_uncertainty_score":0.501024},"labels":[],"label_agreement":null},{"id":"W1976464484","doi":"10.1046/j.1365-2133.2002.04641.x","title":"The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Library science; Medicine; Computer science","score_opus":0.010441454735486229,"score_gpt":0.22296552862349445,"score_spread":0.21252407388800823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976464484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938527,0.004170164,0.00028001456,0.00056318654,0.00021850748,0.0000921832,0.000018604353,0.000005388503,0.0007993055],"genre_scores_gemma":[0.9969661,0.0013310406,0.0008128608,0.00031991574,0.00017614428,0.0000056788745,0.000006438572,0.000025874651,0.00035590035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986644,0.00011099978,0.00055412896,0.00019186884,0.00015658743,0.0003220183],"domain_scores_gemma":[0.9992273,0.00003316691,0.00031867513,0.00020029266,0.0001361744,0.00008439478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014115384,0.00013492454,0.00026064218,0.00005779127,0.00012949522,0.000063630134,0.00045230353,0.00019500042,0.000056505934],"category_scores_gemma":[0.00009734761,0.00013256689,0.00014231133,0.00006616377,0.00008553184,0.000010368805,0.00011998879,0.0002447964,0.0000058515543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023467603,0.00015843492,0.0007652746,0.000011803088,0.000033858374,0.0005678997,0.000054690987,0.0000076935685,0.9857442,0.000017147606,0.012006122,0.00060943904],"study_design_scores_gemma":[0.0016573309,0.00011886243,0.0011225446,0.00003689422,0.00001557808,0.026278265,0.00006212095,0.00009070612,0.95765805,0.00009550499,0.012715441,0.00014869176],"about_ca_topic_score_codex":0.000027107133,"about_ca_topic_score_gemma":0.00007199838,"teacher_disagreement_score":0.02808611,"about_ca_system_score_codex":0.000011943117,"about_ca_system_score_gemma":0.000028907692,"threshold_uncertainty_score":0.5405921},"labels":[],"label_agreement":null},{"id":"W1977350622","doi":"10.1111/bjd.13469","title":"Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":203,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Dalhousie University","funders":"Janssen Scientific Affairs","keywords":"Dosing; Medicine; Ustekinumab; Psoriasis; Placebo; Psoriasis Area and Severity Index; Population; Discontinuation; Randomized controlled trial; Adverse effect; Internal medicine; Dermatology; Disease; Alternative medicine","score_opus":0.011009835043840488,"score_gpt":0.22599502152068926,"score_spread":0.21498518647684878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977350622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967757,0.002284622,0.00007590456,0.000054571316,0.00021044457,0.00045918574,0.000102569196,0.0000051060874,0.000031884654],"genre_scores_gemma":[0.9993267,0.0002836579,0.00026391915,0.000043127027,0.000018243767,0.000005036483,0.000030443753,0.000017517297,0.000011351303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982297,0.0005367977,0.00066566415,0.0002478418,0.00008935459,0.00023063365],"domain_scores_gemma":[0.9987184,0.00034018556,0.0005642882,0.00019361959,0.00014952366,0.000033979788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018329281,0.00017851462,0.0007327672,0.00008396817,0.000087621396,0.000016282014,0.00017291181,0.00013596202,0.000007523253],"category_scores_gemma":[0.000091063106,0.00013398466,0.000041846033,0.0001292914,0.00020049744,0.00014537192,0.00006537714,0.00020318352,0.0000010243899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024700701,0.0007445806,0.91087043,0.000016616279,0.0010592226,0.00009167467,0.006303363,0.000020969395,0.00020251259,0.000006770927,0.000099812125,0.05588335],"study_design_scores_gemma":[0.051610366,0.00121588,0.94293284,0.0005032594,0.0004017761,0.0017337236,0.0005387814,6.6398854e-7,0.00086455385,0.000015048185,0.000043954144,0.00013916643],"about_ca_topic_score_codex":0.00037208325,"about_ca_topic_score_gemma":0.0008927943,"teacher_disagreement_score":0.055744186,"about_ca_system_score_codex":0.0000184886,"about_ca_system_score_gemma":0.000057887544,"threshold_uncertainty_score":0.5463736},"labels":[],"label_agreement":null},{"id":"W1979000113","doi":"10.1111/j.1365-2133.2007.08205.x","title":"Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Etanercept; Medicine; Psoriasis; Placebo; Internal medicine; Depression (economics); Randomized controlled trial; Clinical trial; Tumor necrosis factor alpha; Dermatology; Pathology; Alternative medicine","score_opus":0.01695004558656602,"score_gpt":0.2591666758012743,"score_spread":0.24221663021470827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979000113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814296,0.008435244,0.0010571362,0.005707284,0.0011465516,0.00178811,0.0003907903,0.000012670367,0.00003265863],"genre_scores_gemma":[0.9791852,0.001448856,0.0006873488,0.017398234,0.0002545597,0.00021400253,0.0003130529,0.00009788108,0.00040086982],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976041,0.00043267076,0.0009758962,0.0003868148,0.00007891643,0.0005216442],"domain_scores_gemma":[0.9972148,0.0015825088,0.0006857714,0.00017451342,0.00028600343,0.00005640246],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002005889,0.00038650993,0.0016035775,0.0007318007,0.000084414314,0.00001442167,0.00028234263,0.0014900219,0.000018473],"category_scores_gemma":[0.00016082161,0.00037248462,0.0003115829,0.00016643052,0.00008371685,0.00006447846,0.000034998222,0.0005180973,0.0000022854583],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037303373,0.0008902661,0.0076382966,0.0020031186,0.0042905686,0.0050103646,0.0023699626,0.000091900205,0.079088375,0.000024885776,0.4572011,0.4040878],"study_design_scores_gemma":[0.04280098,0.005972892,0.014002602,0.004519884,0.0008690649,0.03008841,0.00008351296,0.0000060625794,0.862833,0.00019387435,0.037654717,0.00097497454],"about_ca_topic_score_codex":0.00011671816,"about_ca_topic_score_gemma":0.000091008915,"teacher_disagreement_score":0.78374463,"about_ca_system_score_codex":0.000055267275,"about_ca_system_score_gemma":0.00011225313,"threshold_uncertainty_score":0.9998727},"labels":[],"label_agreement":null},{"id":"W1985189467","doi":"10.1111/j.1365-2133.2009.09217.x","title":"Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Vitiligo; Tacrolimus; Medicine; Dermatology; Depigmentation; Lesion; Cytokine; Pathology; Immunology; Internal medicine; Transplantation","score_opus":0.01202407514816698,"score_gpt":0.27904008044506173,"score_spread":0.26701600529689473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985189467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975495,0.00085446914,0.0012119173,0.000109399945,0.00003406879,0.00004143494,0.000008663549,7.67571e-7,0.00018979823],"genre_scores_gemma":[0.99907404,0.00018943116,0.0006214903,0.000048181588,0.000016688973,8.844153e-7,0.000016911046,0.0000033280241,0.000029055358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99921215,0.00008167827,0.00042402002,0.00009125685,0.00008723117,0.00010366133],"domain_scores_gemma":[0.9995863,0.000018625307,0.00021709711,0.00008035709,0.000059388356,0.000038229067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005743735,0.000065096334,0.00036377064,0.00014282965,0.000014324372,0.0000054646407,0.000086487285,0.00008146783,0.000027048245],"category_scores_gemma":[0.000023216648,0.00006134753,0.00017859334,0.00012643845,0.00003356251,0.000005237198,0.000009637929,0.000047327052,1.8538317e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008805279,0.0013353626,0.27503332,0.000032597145,0.0030701528,0.0045070876,0.000656673,0.00047603808,0.585822,0.00010599669,0.00046617346,0.12761408],"study_design_scores_gemma":[0.0051916535,0.0027071221,0.46168858,0.00018802071,0.00088269496,0.009067892,0.0005469791,0.00015309619,0.5186844,0.000097579614,0.00058855966,0.0002034463],"about_ca_topic_score_codex":0.000031085623,"about_ca_topic_score_gemma":0.00025365746,"teacher_disagreement_score":0.18665524,"about_ca_system_score_codex":0.00001418667,"about_ca_system_score_gemma":0.000055069686,"threshold_uncertainty_score":0.25016797},"labels":[],"label_agreement":null},{"id":"W1986097454","doi":"10.1046/j.1365-2133.2001.03952.x","title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Melanocyte; Vitiligo; Biology; Oxidative stress; Tyrosinase; Calnexin; Melanin; Programmed cell death; Pigmentation disorder; Melanosome; Cell biology; Molecular biology; Calreticulin; Endocrinology; Immunology; Cancer research; Biochemistry; Endoplasmic reticulum; Melanoma; Apoptosis; Enzyme; Genetics","score_opus":0.00562789210959756,"score_gpt":0.23370127897425957,"score_spread":0.22807338686466203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986097454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835235,0.000804607,0.00052669446,0.000054288837,0.00003208949,0.00013209584,0.0000231919,0.000001168882,0.000073519615],"genre_scores_gemma":[0.9988016,0.00023799259,0.00088722445,0.000023439665,0.000015047314,0.0000024873327,0.00002020676,0.000005555434,0.000006481161],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989343,0.0003174524,0.00042843612,0.00010630675,0.000097902244,0.00011556216],"domain_scores_gemma":[0.9994092,0.000033783243,0.00029145836,0.00006508103,0.00013724291,0.0000632582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020157667,0.0000725313,0.00025630734,0.00008777002,0.000019498835,0.000005959013,0.000058352685,0.00011692861,0.000009760291],"category_scores_gemma":[0.00017851609,0.00008022244,0.000039339713,0.00007833485,0.00007620222,0.000011401697,0.00004575585,0.00008541516,2.3069418e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032908513,0.000118657175,0.050922364,0.00003656314,0.000020019155,0.00061647285,0.000094713425,0.000014087921,0.9455081,0.000012538688,0.00007611135,0.0022512926],"study_design_scores_gemma":[0.0012132924,0.00017468208,0.05126452,0.00034111712,0.000009266518,0.007567078,0.0002558208,0.00002278444,0.93901646,0.000039974868,0.000027265807,0.00006772809],"about_ca_topic_score_codex":0.00016160344,"about_ca_topic_score_gemma":0.00022875318,"teacher_disagreement_score":0.006950605,"about_ca_system_score_codex":0.000006210008,"about_ca_system_score_gemma":0.000040447147,"threshold_uncertainty_score":0.32713762},"labels":[],"label_agreement":null},{"id":"W1986974499","doi":"10.1046/j.1365-2133.2001.04292.x","title":"Dissatisfaction with skin appearance among patients with eating disorders and non-clinical controls","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Psychosocial; Bulimia nervosa; Medicine; Eating disorders; Anorexia nervosa; Hyperpigmentation; Dermatology; Psychiatry","score_opus":0.006437944741882827,"score_gpt":0.2711685021682799,"score_spread":0.2647305574263971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986974499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960958,0.0005880428,0.0019964764,0.00015140639,0.00022807626,0.00020806503,0.00000305077,0.000013044939,0.00071604864],"genre_scores_gemma":[0.9992043,0.00019236018,0.00037265295,0.000098263015,0.000047053887,0.0000090857775,0.000003395585,0.000025221767,0.00004766799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985389,0.00019028307,0.0005833109,0.00021433568,0.00018031766,0.00029282566],"domain_scores_gemma":[0.9989561,0.0001072346,0.00058081787,0.00010494757,0.00012892846,0.00012201692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013244044,0.000140634,0.00045339947,0.00007527209,0.00014180507,0.000052415307,0.000107636275,0.00013801905,0.000072507624],"category_scores_gemma":[0.000039612023,0.00012385237,0.00006404267,0.00012114426,0.00032852934,0.00021036819,0.000014774185,0.0004410497,0.0000044102617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035786154,0.00034303946,0.91874987,0.0000073789624,0.00009018688,0.0005741444,0.00017390033,0.000004207704,0.0000013862164,0.000008530513,0.00027620362,0.07941329],"study_design_scores_gemma":[0.006471982,0.0006912424,0.98457336,0.0002694132,0.000075548385,0.007076575,0.00044817952,0.0000130464205,7.000482e-7,0.000039803548,0.00018117069,0.00015894887],"about_ca_topic_score_codex":0.0003640042,"about_ca_topic_score_gemma":0.001320301,"teacher_disagreement_score":0.07925434,"about_ca_system_score_codex":0.000009653421,"about_ca_system_score_gemma":0.00002317541,"threshold_uncertainty_score":0.50505525},"labels":[],"label_agreement":null},{"id":"W1987912342","doi":"10.1111/j.1365-2133.2000.03724.x","title":"Cutaneous<i>Cryptococcus</i>infection due to<i>C. albidus</i>associated with Sézary syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Cryptococcus neoformans; Cryptococcus; Biology; Disease; Cerebrospinal fluid; Cryptococcosis; Yeast; Immunology; Microbiology; Pathology; Medicine; Genetics","score_opus":0.007604452630857988,"score_gpt":0.23067019590327822,"score_spread":0.22306574327242024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987912342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924317,0.00074851944,0.00018821484,0.0017120163,0.00025527074,0.00026365463,0.000012055321,0.00005342591,0.004335151],"genre_scores_gemma":[0.9971767,0.0006110704,0.00026524533,0.0010536952,0.00008650644,0.000012414382,0.0000071165628,0.00002767681,0.0007595653],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986678,0.000103902785,0.00052604143,0.00014325565,0.00023220012,0.00032684297],"domain_scores_gemma":[0.9990571,0.00010472541,0.00017781678,0.00011050486,0.00033143556,0.00021838228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009829076,0.00015664418,0.0006982015,0.00018505854,0.00020265178,0.000038355978,0.000066899105,0.00014008732,0.00079648587],"category_scores_gemma":[0.00014586737,0.00014965184,0.00015203826,0.00038224095,0.000105354615,0.0001324329,0.000016834463,0.00045526953,0.00009236846],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016232167,0.002629447,0.3209835,0.00019869994,0.0030318224,0.42599133,0.0007208252,0.00037363346,0.0012488067,0.00008155249,0.16130088,0.081816286],"study_design_scores_gemma":[0.0015068661,0.0009420824,0.1457731,0.0006006951,0.00018905503,0.8333649,0.000033792767,0.000011504378,0.00025193795,0.000062367035,0.017117672,0.0001460499],"about_ca_topic_score_codex":0.00014873568,"about_ca_topic_score_gemma":0.00026058673,"teacher_disagreement_score":0.40737355,"about_ca_system_score_codex":0.000087691114,"about_ca_system_score_gemma":0.000103747225,"threshold_uncertainty_score":0.8720962},"labels":[],"label_agreement":null},{"id":"W1988320219","doi":"10.1046/j.1365-2133.2000.03679.x","title":"Mycosis fungoides and chronic lymphocytic leukaemia - composite T-cell and B-cell lymphomas presenting in the skin","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Mycosis fungoides; Lymphoproliferative disorders; Lymphoma; Gene rearrangement; Cutaneous lymphoma; Medicine; Immunophenotyping; B cell; Chronic lymphocytic leukemia; Pathology; Antibody; Immunology; Biology; Leukemia; Gene; Antigen","score_opus":0.008322272312694822,"score_gpt":0.2529159958058913,"score_spread":0.24459372349319647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988320219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95445544,0.0413601,0.0000078798785,0.0007825813,0.000024615267,0.00027685624,0.000003803304,0.0000070579736,0.0030816693],"genre_scores_gemma":[0.98627615,0.012778475,0.00014925859,0.00043365962,0.000070068985,0.0000073878787,0.0000039473316,0.000022283042,0.00025877665],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981264,0.00035537648,0.00055751327,0.00021124288,0.00032975746,0.00041974342],"domain_scores_gemma":[0.99911195,0.0003483717,0.00014834713,0.00013508298,0.00011099131,0.00014523626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002654455,0.00015577064,0.0005082723,0.0001863553,0.00015902075,0.0001239297,0.0001799039,0.00012622093,0.00014830522],"category_scores_gemma":[0.00006940738,0.0001417994,0.00008615841,0.00021114876,0.00029639254,0.00013552682,0.000053193686,0.0003465314,0.000010323803],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018015949,0.0014892643,0.6336764,0.0021500094,0.00035601162,0.11042782,0.006468048,0.00017501964,0.033680152,0.000051539737,0.010065173,0.19965896],"study_design_scores_gemma":[0.011312702,0.0002730473,0.04842662,0.00039669295,0.00011225417,0.92315614,0.0008070925,0.0025893254,0.010090605,0.00017863464,0.0024561945,0.00020068539],"about_ca_topic_score_codex":0.00032580574,"about_ca_topic_score_gemma":0.00019206801,"teacher_disagreement_score":0.81272835,"about_ca_system_score_codex":0.0002959311,"about_ca_system_score_gemma":0.00053716,"threshold_uncertainty_score":0.57824117},"labels":[],"label_agreement":null},{"id":"W1993371097","doi":"10.1046/j.1365-2133.2002.04766.x","title":"The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family-based association approach","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Deutsche Forschungsgemeinschaft","keywords":"Genetics; Missense mutation; Male-pattern baldness; Hairless; Biology; Exon; Mutation; Hair loss; Scalp; Single-nucleotide polymorphism; Gene; Internal medicine; Medicine; Genotype; Dermatology","score_opus":0.018226690520261254,"score_gpt":0.2280402590151711,"score_spread":0.20981356849490984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993371097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97264725,0.022139793,0.003434397,0.0009183731,0.000050908347,0.0003294762,0.0000065556333,0.000005345259,0.00046792708],"genre_scores_gemma":[0.9977072,0.0006345033,0.0014812337,0.0001241754,0.00001755732,0.0000073983274,0.000004188303,0.000007908689,0.000015846352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842167,0.00026626332,0.00080810295,0.00008695401,0.00024936025,0.00016766328],"domain_scores_gemma":[0.9988167,0.0002978681,0.00055710616,0.00007190668,0.0001892312,0.000067143206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046196938,0.000068883295,0.0004445043,0.00013977781,0.000060196162,0.000024850759,0.00006516291,0.000102198144,0.0000011353773],"category_scores_gemma":[0.00092865917,0.000060703722,0.00006821919,0.0001852841,0.000053246524,0.000054300774,0.00000864973,0.00017309574,7.809669e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005186559,0.00432233,0.72747135,0.04406764,0.0024699199,0.030319696,0.011295595,0.003799325,0.004476643,0.00024976832,0.016831087,0.14951006],"study_design_scores_gemma":[0.07544122,0.0009635085,0.52040154,0.018859394,0.0011969622,0.23158306,0.009971606,0.13774973,0.0025950847,0.000285595,0.00031897673,0.0006333437],"about_ca_topic_score_codex":0.000035668018,"about_ca_topic_score_gemma":0.00007136312,"teacher_disagreement_score":0.20706986,"about_ca_system_score_codex":0.000034381123,"about_ca_system_score_gemma":0.000045158737,"threshold_uncertainty_score":0.2475426},"labels":[],"label_agreement":null},{"id":"W1993807965","doi":"10.1111/bjd.12815","title":"Psoriatic arthritis screening tools: study design and methodological challenges","year":2014,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Family medicine; CONTEST; Alternative medicine; Arthritis; Dermatology; Internal medicine; Pathology; Political science","score_opus":0.16380652254540934,"score_gpt":0.33965743542428917,"score_spread":0.17585091287887983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993807965","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02477195,0.3896932,0.010787932,0.5709442,0.0013635941,0.0018606557,0.000023410741,0.00007943656,0.00047563383],"genre_scores_gemma":[0.25275683,0.3180923,0.11236698,0.30801067,0.007991697,0.00018213571,0.00007603341,0.0003050767,0.00021828133],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9955521,0.0018844818,0.0011019226,0.00043650088,0.00049038447,0.0005345682],"domain_scores_gemma":[0.9967865,0.0017691007,0.0007529057,0.00022189425,0.00030676433,0.00016286036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076060614,0.00038895098,0.0024628981,0.00024431257,0.000190028,0.00009382306,0.0001797729,0.00072654174,0.00007117399],"category_scores_gemma":[0.0011208222,0.00037803722,0.0002876381,0.000081849175,0.00021143627,0.00011525274,0.00010744032,0.001978091,0.0000093751305],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021131652,0.0002733831,0.0009528085,0.00015948809,0.0016267732,0.28320637,0.00017144003,5.659461e-7,0.000001400384,0.0000054251987,0.2573629,0.45602813],"study_design_scores_gemma":[0.011477264,0.0029739905,0.010396953,0.0020665869,0.0011492561,0.7908547,0.00051785284,0.000008005447,0.000013320317,0.00037144814,0.17980832,0.00036229988],"about_ca_topic_score_codex":0.000024477671,"about_ca_topic_score_gemma":0.00001749631,"teacher_disagreement_score":0.50764835,"about_ca_system_score_codex":0.00003701527,"about_ca_system_score_gemma":0.00007264102,"threshold_uncertainty_score":0.99986714},"labels":[],"label_agreement":null},{"id":"W1994024278","doi":"10.1046/j.1365-2133.2001.04181.x","title":"Rethinking the role of tumour necrosis factor-alpha in ultraviolet (UV) B-induced immunosuppression: altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Immunosuppression; Immune system; Cancer research; Ultraviolet b; Tumor necrosis factor alpha; Mutant; Immunology; Gene; Alpha (finance); Medicine; Biology; Genetics; Dermatology","score_opus":0.016064890542055347,"score_gpt":0.2600533102320043,"score_spread":0.24398841968994894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994024278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897892,0.0072363666,0.000030228246,0.0021352654,0.00039793277,0.0003178527,0.000008328106,0.000020306265,0.00006456019],"genre_scores_gemma":[0.99849653,0.0008483214,0.00021691326,0.00030828532,0.00006584511,0.000009038702,0.0000060247935,0.000032234544,0.000016811668],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965704,0.0009901687,0.0014521836,0.00021752791,0.00033069766,0.00043901324],"domain_scores_gemma":[0.9983436,0.00034663355,0.0007470234,0.00022156541,0.0002252584,0.00011594615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007908427,0.000199092,0.00080824905,0.00048853585,0.000119220946,0.000040089435,0.00032375852,0.000257832,0.0001257722],"category_scores_gemma":[0.0008512469,0.00018154942,0.00020124974,0.0006065937,0.00010468967,0.00018513008,0.000054208656,0.0013041933,0.0000036961483],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003484197,0.0002285044,0.03253725,0.000020745812,0.000074268915,0.007240784,0.0024980872,0.000015562111,0.94552886,0.000002288091,0.00002609447,0.008343367],"study_design_scores_gemma":[0.0042964,0.0001377266,0.5246326,0.0012130763,0.00003076091,0.13175118,0.00077924266,0.00020739708,0.33640856,0.00024652615,0.00016701067,0.00012957517],"about_ca_topic_score_codex":0.0010272993,"about_ca_topic_score_gemma":0.00008398569,"teacher_disagreement_score":0.6091203,"about_ca_system_score_codex":0.00016273715,"about_ca_system_score_gemma":0.0003376893,"threshold_uncertainty_score":0.740337},"labels":[],"label_agreement":null},{"id":"W1997189639","doi":"10.1111/j.1365-2133.2009.09238.x","title":"Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Library science; Art; Art history; Classics; Computer science","score_opus":0.012791580294271805,"score_gpt":0.24806132362284522,"score_spread":0.23526974332857342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997189639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955433,0.0021567706,0.000060790175,0.0012184397,0.0004435725,0.0002965871,0.000052936826,0.000036050642,0.00019153678],"genre_scores_gemma":[0.9975287,0.000523064,0.00093235134,0.00034326312,0.00007240602,0.000008859613,0.000038392023,0.000027764178,0.0005252265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972892,0.00096651196,0.00078417506,0.00036257057,0.00010087086,0.0004966861],"domain_scores_gemma":[0.9985705,0.00024037632,0.00046266033,0.00026124605,0.0003311487,0.00013406319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951549,0.0003114758,0.0009079095,0.00019670755,0.00026318256,0.000041495703,0.0002462177,0.00041006156,0.0001685569],"category_scores_gemma":[0.000088646906,0.00023930249,0.00019485503,0.00019779925,0.0001249823,0.00018397992,0.00002348091,0.00037441088,0.00007591524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23773347,0.0055785473,0.3634108,0.000030306017,0.004735346,0.026580423,0.0018288663,0.00015323241,0.0044441745,0.000027716287,0.007907472,0.34756964],"study_design_scores_gemma":[0.03087308,0.007286347,0.86535037,0.00036503802,0.00066762505,0.08032299,0.00025161906,5.5366394e-7,0.00660433,0.000035145502,0.0077118548,0.0005310699],"about_ca_topic_score_codex":0.000016884243,"about_ca_topic_score_gemma":0.00009564444,"teacher_disagreement_score":0.50193954,"about_ca_system_score_codex":0.00010508499,"about_ca_system_score_gemma":0.00021435771,"threshold_uncertainty_score":0.97584724},"labels":[],"label_agreement":null},{"id":"W1997360117","doi":"10.1111/j.1365-2133.2005.06754.x","title":"Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Kallikrein; Messenger RNA; Medicine; Pathology; Biology; Dermatology; Biochemistry; Enzyme; Gene","score_opus":0.006559460240498487,"score_gpt":0.2401886776562347,"score_spread":0.2336292174157362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997360117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97189516,0.025870573,0.00015924928,0.0016962565,0.00005696664,0.00021587742,0.000007642968,0.000012010224,0.0000862809],"genre_scores_gemma":[0.99639934,0.0009449892,0.002038118,0.00021313407,0.00023227691,0.0000063737493,0.0000075664334,0.00001669405,0.00014148274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988162,0.00008669785,0.0005318916,0.00015701498,0.00016843488,0.00023974742],"domain_scores_gemma":[0.99933493,0.00009037238,0.00020568838,0.00007477237,0.00007418324,0.00022005462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090594374,0.00012161237,0.0004305131,0.00015878855,0.000072516115,0.000037393114,0.0000625466,0.00011637662,0.000071034054],"category_scores_gemma":[0.00017236822,0.00012771871,0.00005300947,0.00008132964,0.00011925022,0.00028501335,0.000045863973,0.00020736252,0.0000029512187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066750776,0.0006004471,0.5272783,0.0002630305,0.000062654384,0.00742839,0.00086291315,0.000019299678,0.011789622,0.00006605448,0.004160753,0.44680104],"study_design_scores_gemma":[0.006655193,0.00015542873,0.8595031,0.0010886808,0.000056801953,0.080303065,0.00015587674,0.0005247212,0.03796292,0.00017560058,0.0132209845,0.00019765702],"about_ca_topic_score_codex":0.00010116584,"about_ca_topic_score_gemma":0.00030988725,"teacher_disagreement_score":0.4466034,"about_ca_system_score_codex":0.000024211891,"about_ca_system_score_gemma":0.000067469446,"threshold_uncertainty_score":0.52082175},"labels":[],"label_agreement":null},{"id":"W1999580944","doi":"10.1046/j.1365-2133.2003.05298.x","title":"A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Dermis; Umbilical vein; Angiogenesis; Chemistry; Dermal fibroblast; In vitro; Basic fibroblast growth factor; Fibroblast; Endothelial stem cell; Cell biology; Biophysics; Biomedical engineering; Growth factor; Anatomy; Biology; Medicine; Biochemistry; Cancer research; Receptor","score_opus":0.012930067276865593,"score_gpt":0.2615254278762025,"score_spread":0.24859536059933687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999580944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859686,0.0015115746,0.009259655,0.00015917726,0.000101788966,0.00030040077,0.000004657959,0.000011956543,0.00005392528],"genre_scores_gemma":[0.99792546,0.00021511759,0.0017845024,0.00003535329,0.000009540792,0.000009606475,0.0000015446951,0.000016459739,0.0000024071433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869543,0.00024471938,0.0005045225,0.0000758127,0.00027103748,0.00020848338],"domain_scores_gemma":[0.99942845,0.00023346233,0.00007397511,0.00009774994,0.00008360669,0.000082770246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003273953,0.0000884539,0.00026336516,0.0002693808,0.000033181022,0.000026376194,0.00013745869,0.000059496535,0.000012925261],"category_scores_gemma":[0.0004771801,0.00008470668,0.00004180816,0.00027055864,0.00003676012,0.00008354646,0.000019668943,0.00019187333,0.0000025581226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039214693,0.0006843762,0.0036304176,0.0004490365,0.00053767645,0.005440249,0.0071308687,0.02277475,0.7557546,0.0002466005,0.0016763293,0.20128293],"study_design_scores_gemma":[0.008395298,0.00055601733,0.06485835,0.00043125256,0.00010804856,0.05269974,0.001642285,0.03195651,0.8365069,0.0012107857,0.0011435929,0.0004912147],"about_ca_topic_score_codex":0.000019643878,"about_ca_topic_score_gemma":0.000021953936,"teacher_disagreement_score":0.20079172,"about_ca_system_score_codex":0.00003724912,"about_ca_system_score_gemma":0.000017577511,"threshold_uncertainty_score":0.3454238},"labels":[],"label_agreement":null},{"id":"W2000094621","doi":"10.1111/j.1365-2133.2009.09621.x","title":"Managing chronic hand eczema","year":2010,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hand eczema; Medicine; Dermatology; Allergy; Immunology; Contact dermatitis","score_opus":0.00907226924250534,"score_gpt":0.23955549016638233,"score_spread":0.230483220923877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000094621","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01566103,0.02755967,0.00027338343,0.95081437,0.0024301095,0.00021445847,0.000019964276,0.000029473571,0.0029975185],"genre_scores_gemma":[0.13727455,0.015755845,0.0008697311,0.8278099,0.014519225,0.000011088431,0.0001513036,0.0001831819,0.0034252226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978973,0.00009540364,0.00092898175,0.00020382486,0.00039884466,0.00047562268],"domain_scores_gemma":[0.99844676,0.00011740232,0.00074302126,0.00024258195,0.00032458396,0.0001256498],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.000088807006,0.00026009287,0.0012273022,0.00034479515,0.00013275047,0.00018200585,0.00029471354,0.0013619983,0.0007925841],"category_scores_gemma":[0.00009712277,0.00028189004,0.0004325353,0.000085080006,0.00022168503,0.00015208896,0.0000703165,0.0068467227,0.00005427594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012142146,0.000019717108,0.00016157432,0.000406132,0.00023218885,0.2157858,0.00002696518,1.6004228e-7,0.00024479523,0.0000037480088,0.7496476,0.033459138],"study_design_scores_gemma":[0.0011404353,0.00005988217,0.00090753176,0.0011867102,0.0001580824,0.4505902,0.000009119839,0.00000873964,0.00029896773,0.00015409445,0.54534847,0.00013777021],"about_ca_topic_score_codex":0.00005179302,"about_ca_topic_score_gemma":0.00012649935,"teacher_disagreement_score":0.2348044,"about_ca_system_score_codex":0.00008629677,"about_ca_system_score_gemma":0.00042340969,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W2002428083","doi":"10.1046/j.1365-2133.2002.04721.x","title":"p53-dependent regulation of heat shock protein 72","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Immunostaining; Heat shock protein; Western blot; Basal (medicine); Biology; Cancer research; Blot; Cellular stress response; Regulator; Immunohistochemistry; Transcription (linguistics); Transcription factor; Pathology; Gene; Immunology; Medicine; Endocrinology; Genetics","score_opus":0.014450711545768576,"score_gpt":0.25698150846663986,"score_spread":0.2425307969208713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002428083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895408,0.0057451255,0.0024036288,0.0007828272,0.000081974475,0.00024686794,0.000009428786,0.000004105269,0.0011852139],"genre_scores_gemma":[0.997785,0.00051695533,0.00086744595,0.000048126167,0.00012858877,0.00000823661,0.000006774616,0.000018732826,0.00062016986],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984301,0.00024353553,0.00057263096,0.00016022651,0.0002981914,0.00029533007],"domain_scores_gemma":[0.99917054,0.000012677955,0.00016018953,0.00019172668,0.0003463455,0.000118528624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021879359,0.00009693827,0.00028044404,0.000102116144,0.00006430573,0.00002117281,0.00026472277,0.0002144981,0.00024649853],"category_scores_gemma":[0.00026456683,0.000111939305,0.00012277115,0.00009163129,0.00011335211,0.00001130072,0.0000983943,0.00023157905,0.000012682161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009805396,0.0001927114,0.0014359162,0.000065398504,0.00008309837,0.00063053874,0.000028889259,0.000057458605,0.9737171,0.00004089388,0.006055287,0.017594663],"study_design_scores_gemma":[0.0013876784,0.00035108902,0.002316663,0.00013041859,0.000013131077,0.048508346,0.000034820387,0.00020954461,0.93860036,0.00014889738,0.008153687,0.0001453556],"about_ca_topic_score_codex":0.00003290688,"about_ca_topic_score_gemma":0.000038636594,"teacher_disagreement_score":0.047877807,"about_ca_system_score_codex":0.000020491616,"about_ca_system_score_gemma":0.00007132258,"threshold_uncertainty_score":0.45647523},"labels":[],"label_agreement":null},{"id":"W2002718216","doi":"10.1111/j.1365-2133.2004.06350.x","title":"Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Keratinocyte; Epidermis (zoology); Biology; Keratinocyte growth factor; Growth factor; Epidermal growth factor; In situ hybridization; Molecular biology; Insulin-like growth factor-binding protein; Messenger RNA; Cell biology; Insulin-like growth factor; Receptor; In vitro; Biochemistry; Anatomy; Gene","score_opus":0.011072059890789247,"score_gpt":0.2526969255039632,"score_spread":0.24162486561317398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002718216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988966,0.0034196123,0.00048603574,0.006255563,0.0000808615,0.0005135323,0.000013369298,0.000020565816,0.00024446423],"genre_scores_gemma":[0.9936317,0.0003386074,0.004507369,0.001279912,0.00012687755,0.000018318538,0.000002678362,0.000024081792,0.00007045787],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981964,0.0001597175,0.0007761639,0.00022213579,0.0002259235,0.00041962042],"domain_scores_gemma":[0.99903286,0.000101403515,0.00019479172,0.000076368946,0.00022927813,0.00036532473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013233825,0.00018953605,0.0006764639,0.00037863164,0.000092508424,0.000062689505,0.000103756975,0.00016131897,0.00008987025],"category_scores_gemma":[0.0006138534,0.00019404737,0.00008515916,0.00023086934,0.00012095393,0.00033217223,0.00004858174,0.0004185321,0.000012452802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031406528,0.0018218937,0.7796482,0.0009646453,0.0005583171,0.026858695,0.006964021,0.00011670786,0.06149984,0.0011860917,0.009860337,0.107380606],"study_design_scores_gemma":[0.03346505,0.0021878257,0.16197382,0.004134673,0.00019807903,0.39247897,0.002985761,0.0026438243,0.38501227,0.0015738298,0.011755214,0.001590684],"about_ca_topic_score_codex":0.000065774366,"about_ca_topic_score_gemma":0.00024968898,"teacher_disagreement_score":0.61767435,"about_ca_system_score_codex":0.00005986888,"about_ca_system_score_gemma":0.00017515548,"threshold_uncertainty_score":0.79130226},"labels":[],"label_agreement":null},{"id":"W2003308576","doi":"10.1111/j.1365-2133.1989.tb07792.x","title":"The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Nifedipine; Medicine; Placebo; Irritation; Open label; Anesthesia; Double blind; Vasodilation; Randomized controlled trial; Surgery; Internal medicine; Pathology; Calcium","score_opus":0.042067926427947974,"score_gpt":0.3274761934050284,"score_spread":0.28540826697708044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003308576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800074,0.0057418775,0.000021676453,0.0035186233,0.00013052326,0.009867089,0.000007813439,0.0000073677716,0.0006976336],"genre_scores_gemma":[0.9978799,0.001360294,0.000026340273,0.0000617852,0.00012207741,0.00037541275,0.0000021807864,0.000012843304,0.00015913308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99616367,0.0010412697,0.0018760221,0.00022317565,0.0004286035,0.00026729054],"domain_scores_gemma":[0.9958273,0.0020702824,0.0014048219,0.00024872358,0.00036753755,0.00008130796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001081501,0.00023818591,0.002780877,0.00009917227,0.0003302416,0.00009029208,0.0003407433,0.000051208808,0.000005814186],"category_scores_gemma":[0.0003422621,0.00010581892,0.00023512256,0.00018255509,0.00068273785,0.000074978685,0.00010659549,0.00021101104,4.582131e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9611727,0.012514317,0.017180542,0.000022149068,0.003017879,0.0038022965,0.0007351695,0.0000017505643,0.0000056639,0.00003558473,0.0002996673,0.0012122679],"study_design_scores_gemma":[0.92958033,0.022473183,0.023812724,0.00013205112,0.002092808,0.020270653,0.0013366923,0.000006496536,0.00004677791,0.00007120648,0.000081568316,0.00009552185],"about_ca_topic_score_codex":0.00070624513,"about_ca_topic_score_gemma":0.0032631347,"teacher_disagreement_score":0.031592395,"about_ca_system_score_codex":0.000026491442,"about_ca_system_score_gemma":0.00016904504,"threshold_uncertainty_score":0.43151703},"labels":[],"label_agreement":null},{"id":"W2005065341","doi":"10.1046/j.1365-2133.2003.05250.x","title":"Atypical exanthem: polymerase chain reaction spots the cause","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Exanthem; Rash; Polymerase chain reaction; Virology; Medicine; Varicella zoster virus; Virus; Herpesviridae; Dermatology; Etiology; Viral disease; Immunology; Pathology; Biology","score_opus":0.02424379290135894,"score_gpt":0.295934575539828,"score_spread":0.2716907826384691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005065341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537886,0.0075474414,0.0003347059,0.0039687487,0.00053136545,0.00022972097,0.000002001576,0.000016690541,0.0019904533],"genre_scores_gemma":[0.9976175,0.0010400782,0.00018945636,0.0003843322,0.00018868099,0.0000057624757,0.00000136635,0.000025363319,0.000547458],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9978884,0.0005265585,0.0006395986,0.00013916637,0.00044506695,0.00036121288],"domain_scores_gemma":[0.99870086,0.00030542567,0.00027713968,0.00022800955,0.0002635166,0.00022505822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055675034,0.000111952715,0.00046878099,0.00015148068,0.00012767359,0.000032378604,0.00016188547,0.00015928171,0.0001817355],"category_scores_gemma":[0.0011638468,0.000088032626,0.00016148195,0.00020831166,0.00018543782,0.000097773016,0.0000229962,0.0006548308,0.00005554209],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033373,0.0019140446,0.4738786,0.00089247455,0.001828073,0.2564106,0.0024025862,0.0000017983031,0.04824744,0.0056805457,0.1477817,0.057624813],"study_design_scores_gemma":[0.0023215779,0.000064129024,0.007402347,0.00041303388,0.00007721267,0.97222203,0.0007045294,0.000011979014,0.00673913,0.00017152596,0.009796496,0.00007599388],"about_ca_topic_score_codex":0.00003003431,"about_ca_topic_score_gemma":0.000020949627,"teacher_disagreement_score":0.71581143,"about_ca_system_score_codex":0.00008642616,"about_ca_system_score_gemma":0.00030486073,"threshold_uncertainty_score":0.35898662},"labels":[],"label_agreement":null},{"id":"W2008928589","doi":"10.1111/j.1365-2133.1975.tb03030.x","title":"Antireticulin antibodies in dermatitis herpetiformis and adult coeliac disease","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Red Cross Society","funders":"","keywords":"Dermatitis herpetiformis; Villous atrophy; Coeliac disease; Antibody; Medicine; Atrophy; Incidence (geometry); Gastroenterology; Pathology; Immunology; Dermatology; Disease","score_opus":0.004524267684815066,"score_gpt":0.24689224930858114,"score_spread":0.24236798162376608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008928589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96845907,0.019550273,0.00012868569,0.010030969,0.00007393424,0.00022013602,0.000017081262,0.000013146669,0.0015067328],"genre_scores_gemma":[0.9870593,0.011854332,0.00031027457,0.0005134481,0.00007762389,0.0000046432583,0.000022160153,0.000012551193,0.0001456455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867034,0.00007881077,0.00051276933,0.00013023084,0.0002867378,0.00032113105],"domain_scores_gemma":[0.99920785,0.00004267292,0.00013275948,0.00008968617,0.00021951213,0.00030754108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080961,0.00010466887,0.00039458802,0.00022785757,0.000054622295,0.00005374785,0.000073251125,0.000049795173,0.00010696602],"category_scores_gemma":[0.00020480434,0.00011031862,0.00010073433,0.00012676143,0.0001791399,0.00016061228,0.000056228728,0.00021219566,0.000010173134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003890838,0.0007258026,0.63773257,0.0008582982,0.00011000279,0.23083779,0.000051233616,0.00000499405,0.00011952188,0.0011928985,0.071815,0.056162816],"study_design_scores_gemma":[0.0042231907,0.000063619525,0.89552504,0.000889821,0.00010491384,0.08313015,0.00016915705,0.00021460623,0.00022330627,0.0009887791,0.014324994,0.0001424537],"about_ca_topic_score_codex":0.00026807532,"about_ca_topic_score_gemma":0.00026647418,"teacher_disagreement_score":0.25779247,"about_ca_system_score_codex":0.000033345088,"about_ca_system_score_gemma":0.00011911576,"threshold_uncertainty_score":0.4498663},"labels":[],"label_agreement":null},{"id":"W2014067251","doi":"10.1046/j.1365-2133.2002.04758.x","title":"Clinical characteristics of pruritus in chronic idiopathic urticaria","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Sensation; Evening; Depression (economics); Itching; McGill Pain Questionnaire; Dermatology; Burning Sensation; Physical therapy; Visual analogue scale","score_opus":0.020718976238766437,"score_gpt":0.2891203630481781,"score_spread":0.26840138680941167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014067251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859524,0.0104575325,0.00018873773,0.0020030404,0.00048728468,0.00010424915,0.0000063624066,0.000008623052,0.0007917642],"genre_scores_gemma":[0.9919845,0.007372551,0.00023691004,0.00013985993,0.0002028772,0.000001551194,0.0000026343366,0.00001226193,0.000046879137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977936,0.00017650184,0.0015426314,0.000103110586,0.00016116613,0.00022294781],"domain_scores_gemma":[0.99898237,0.000100733734,0.00044084768,0.00012104673,0.0002016729,0.00015333714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019645314,0.00007944847,0.00071295997,0.00016469447,0.000028186236,0.000008842665,0.00010520801,0.00028087763,0.0002945135],"category_scores_gemma":[0.00045929797,0.00008373989,0.00019412918,0.00016457078,0.00024148118,0.00006839283,0.000021908532,0.00085479644,0.000027103064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036194385,0.0038578485,0.67928463,0.00029298826,0.0027515877,0.13183731,0.0005865969,0.000005589131,0.0069638686,0.0025147023,0.008635216,0.16290769],"study_design_scores_gemma":[0.0068616443,0.00063101336,0.63772464,0.0016593158,0.001394135,0.34793377,0.00004886851,0.0009036508,0.00045938362,0.00045442712,0.0017818856,0.00014729067],"about_ca_topic_score_codex":0.000008197716,"about_ca_topic_score_gemma":0.000009819602,"teacher_disagreement_score":0.21609646,"about_ca_system_score_codex":0.00005309145,"about_ca_system_score_gemma":0.00019625816,"threshold_uncertainty_score":0.37137127},"labels":[],"label_agreement":null},{"id":"W2018130199","doi":"10.1046/j.1365-2133.2000.03619.x","title":"Efficacy of borage oil in patients with atopic eczema","year":2000,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Agriculture and Agri-Food Canada","funders":"","keywords":"Medicine; Corporation; Dermatology; Library science; Political science; Computer science","score_opus":0.005452804513457715,"score_gpt":0.22207250196905318,"score_spread":0.21661969745559545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018130199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92219925,0.0074040205,0.0000036210745,0.067594,0.0003109767,0.00017049309,0.00005053804,0.000013857326,0.0022532453],"genre_scores_gemma":[0.8813543,0.0012383537,0.00019287734,0.11605731,0.0004336958,0.0000059828417,0.00024025966,0.000070079164,0.00040719996],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.00026717898,0.0011226491,0.00022306411,0.00041997302,0.00040071557],"domain_scores_gemma":[0.9984194,0.00020945017,0.00073934154,0.00024727252,0.00026889623,0.00011560884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000055095665,0.00025213556,0.0015365818,0.00045409822,0.000033315944,0.000014092124,0.00026842984,0.0008157784,0.00036686618],"category_scores_gemma":[0.00014030871,0.00024599503,0.00025581385,0.00019286053,0.00031666973,0.00010413771,0.00002727978,0.0018900731,0.000016029577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068946206,0.000569177,0.24112943,0.0005733425,0.0002977794,0.12628096,0.00003566079,0.0000011245761,2.3564306e-7,9.128838e-7,0.618079,0.012342888],"study_design_scores_gemma":[0.015502824,0.00021089062,0.645833,0.0035564662,0.00049744366,0.16156314,0.0000088614,9.1184717e-7,0.00003698602,0.000050529146,0.17246397,0.00027498553],"about_ca_topic_score_codex":0.000017602817,"about_ca_topic_score_gemma":0.000009200039,"teacher_disagreement_score":0.44561505,"about_ca_system_score_codex":0.00003936731,"about_ca_system_score_gemma":0.00037027788,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W2022190206","doi":"10.1111/j.1365-2133.1971.tb02543.x","title":"THE MECHANISM OF FOLATE DEFICIENCY IN PSORIASIS","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Psoriasis; Mechanism (biology); Medicine; Dermatology","score_opus":0.004366720909134776,"score_gpt":0.22438271057946152,"score_spread":0.22001598967032673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022190206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784497,0.017312367,0.00073216856,0.00030255356,0.0003925757,0.00007477431,0.0000036614265,0.0000015281992,0.002730642],"genre_scores_gemma":[0.9977562,0.0019310833,0.00011902628,0.000029556582,0.00005931041,0.0000013038162,0.000002173165,0.0000072505823,0.000094089904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894065,0.00014610859,0.0005488477,0.00008171428,0.00009362422,0.00018906062],"domain_scores_gemma":[0.99939513,0.000026832164,0.00033336165,0.00007849748,0.00013496079,0.00003123358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002539371,0.000059533093,0.00018831991,0.000047893947,0.00006580478,0.000010877971,0.0001685831,0.00014264455,0.0000024019312],"category_scores_gemma":[0.000058108857,0.00005001576,0.00008309281,0.00008037463,0.00007562451,0.0000034237917,0.000026864645,0.0001264264,0.0000014183296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014178182,0.002412284,0.1604494,0.00067585765,0.0006214852,0.011235605,0.0004822353,0.0006153968,0.4830643,0.14327495,0.051976137,0.14377452],"study_design_scores_gemma":[0.012249662,0.0020552496,0.1396801,0.0011359424,0.0001653614,0.34521216,0.0012606615,0.00010985731,0.39790064,0.050952077,0.048354566,0.00092370366],"about_ca_topic_score_codex":0.00011500886,"about_ca_topic_score_gemma":0.00031569597,"teacher_disagreement_score":0.33397657,"about_ca_system_score_codex":0.000008447943,"about_ca_system_score_gemma":0.00010994216,"threshold_uncertainty_score":0.20395835},"labels":[],"label_agreement":null},{"id":"W2022856743","doi":"10.1111/j.1365-2133.2006.07559.x","title":"Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Mycosis fungoides; Chills; Gastroenterology; Internal medicine; Surgery; myalgia; Alpha interferon; Adjuvant; Interferon; Lymphoma; Immunology","score_opus":0.008973412956973311,"score_gpt":0.26742643371985303,"score_spread":0.25845302076287974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022856743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874855,0.0011642281,0.003293416,0.0053199097,0.00031152557,0.00082745764,0.00005659569,0.00002479987,0.00025351782],"genre_scores_gemma":[0.99656945,0.00008042974,0.0018035223,0.00033207366,0.00020799476,0.000039925806,0.000046846944,0.00004553772,0.000874195],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9979754,0.000111088535,0.000844543,0.00023471788,0.00038378805,0.00045045378],"domain_scores_gemma":[0.9983605,0.00020921239,0.0004109118,0.0001485244,0.00070701394,0.00016379768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017717954,0.00018866947,0.00078420946,0.00023297426,0.000116919866,0.00008181796,0.00014508984,0.00014724079,0.0001177499],"category_scores_gemma":[0.0002243343,0.00014039302,0.00022083428,0.00010237564,0.00014307555,0.00018482866,0.00003257509,0.00031361097,0.000007800968],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027003221,0.003111586,0.7805466,0.0012711594,0.0015519811,0.02305664,0.0009081182,0.00006214754,0.026484014,0.0005834,0.044062614,0.09135854],"study_design_scores_gemma":[0.03840143,0.008236555,0.23654556,0.0006379361,0.0006243416,0.6763691,0.0011029961,0.0023750048,0.028698212,0.002697493,0.0035789444,0.00073245575],"about_ca_topic_score_codex":0.00027511068,"about_ca_topic_score_gemma":0.0007206783,"teacher_disagreement_score":0.65331244,"about_ca_system_score_codex":0.00017805361,"about_ca_system_score_gemma":0.00022710024,"threshold_uncertainty_score":0.5725061},"labels":[],"label_agreement":null},{"id":"W2023505077","doi":"10.1111/j.1365-2133.2005.06788.x","title":"The place of botulinum toxin type A in the treatment of focal hyperhidrosis","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperhidrosis; Medicine; Botulinum toxin; Dermatology; Treatment modality; Surgery","score_opus":0.019658630623304394,"score_gpt":0.2733458037497783,"score_spread":0.2536871731264739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023505077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61007535,0.055326287,0.0000045294096,0.33260357,0.00059635134,0.0006321549,0.000057523102,0.000007057513,0.00069714146],"genre_scores_gemma":[0.9072574,0.039515123,0.00043852854,0.050465442,0.0016244589,0.00003428465,0.000055504846,0.00006901157,0.00054027356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744666,0.00042692022,0.001132654,0.00017220997,0.00046072362,0.0003608579],"domain_scores_gemma":[0.9977698,0.0008023028,0.0008153252,0.00032802176,0.0002331938,0.000051409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018259537,0.00025165363,0.0012561529,0.00018055066,0.00007694415,0.000022208285,0.0003548402,0.0005539377,0.000047768142],"category_scores_gemma":[0.00012254722,0.00015677155,0.00046680696,0.00021026429,0.000277908,0.00005037949,0.000017942028,0.00082474767,0.000007706759],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017038917,0.0042230673,0.033706933,0.0003144205,0.0025106543,0.058485046,0.0026191561,0.000005133584,0.00023975172,0.000027138094,0.82058257,0.07558226],"study_design_scores_gemma":[0.008204634,0.002581263,0.011704629,0.0010938066,0.001239256,0.26315784,0.00041816413,0.000014166576,0.0017130297,0.00007097868,0.7096048,0.0001973978],"about_ca_topic_score_codex":0.00013374249,"about_ca_topic_score_gemma":0.00019061587,"teacher_disagreement_score":0.297182,"about_ca_system_score_codex":0.00013925781,"about_ca_system_score_gemma":0.00031175395,"threshold_uncertainty_score":0.6392958},"labels":[],"label_agreement":null},{"id":"W2025490383","doi":"10.1111/j.1365-2133.2008.08927.x","title":"A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"LEO Pharma","keywords":"Calcipotriol; Betamethasone dipropionate; Scalp; Medicine; Dermatology; Randomized controlled trial; Psoriasis; Betamethasone; Double blind; Surgery; Internal medicine; Placebo","score_opus":0.04040179878295714,"score_gpt":0.2816668870223897,"score_spread":0.24126508823943255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025490383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791402,0.015438521,0.0006422814,0.0003232478,0.00041930954,0.003945368,0.00006066464,0.0000044489007,0.000025914705],"genre_scores_gemma":[0.99703723,0.0023051,0.00022047463,0.000015260091,0.00006200836,0.00026183398,0.000034884226,0.000013198227,0.000050015384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99723643,0.0008586696,0.0013295042,0.00016565618,0.00013648067,0.0002732744],"domain_scores_gemma":[0.9954809,0.0023772786,0.0015634138,0.00016257433,0.000385968,0.000029899878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045185414,0.00020887413,0.0019989228,0.0001835533,0.00014289253,0.0000069278103,0.00027944645,0.00023120726,0.000021407315],"category_scores_gemma":[0.00017665616,0.00012053523,0.0005671523,0.00023176822,0.0002911224,0.000121358906,0.000016223074,0.00015719327,0.0000010255633],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97546846,0.0012416706,0.00063326303,0.000024878838,0.0025297224,0.000069354755,0.0038209294,0.00009293923,0.0011675023,0.00009758481,0.00007659095,0.014777103],"study_design_scores_gemma":[0.9638343,0.0016816182,0.0028691026,0.00015135192,0.0014904549,0.0034588964,0.0005651126,0.00007708536,0.025576964,0.00007083352,0.00012017392,0.00010413111],"about_ca_topic_score_codex":0.00045399863,"about_ca_topic_score_gemma":0.00027763753,"teacher_disagreement_score":0.024409462,"about_ca_system_score_codex":0.000061320185,"about_ca_system_score_gemma":0.0003460657,"threshold_uncertainty_score":0.49152842},"labels":[],"label_agreement":null},{"id":"W2026249831","doi":"10.1111/bjd.13339","title":"Onychomadesis: literature review","year":2014,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Library science; Medicine; Dermatology; Family medicine; Computer science","score_opus":0.019921906923406063,"score_gpt":0.3463844856553183,"score_spread":0.32646257873191226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026249831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013818918,0.9981409,0.000010144736,0.0003574369,0.00036081742,0.0004648197,0.000043803004,0.000013449482,0.0006072936],"genre_scores_gemma":[0.000007545821,0.99795234,0.00022126154,0.0010113072,0.00033336275,0.000017543587,0.000130671,0.000052553638,0.0002734072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753654,0.00034951404,0.0013602527,0.00021091542,0.00027200673,0.00027075535],"domain_scores_gemma":[0.9978041,0.00010656058,0.00119336,0.0002556013,0.000296112,0.0003442757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011953134,0.00031430548,0.004248371,0.0002099471,0.000045725963,0.000048990743,0.00021982421,0.0003763,0.00015605349],"category_scores_gemma":[0.0002986853,0.00025793994,0.0017011925,0.0002859793,0.000053296488,0.00007466354,0.00003359361,0.0008142944,0.00010291149],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007999656,0.0001405955,0.000016209986,0.122890115,0.0006475576,0.05784645,0.0000013398975,6.4152156e-10,4.0911377e-9,0.000010431373,0.06838241,0.75005686],"study_design_scores_gemma":[0.00037301105,0.000038306556,0.000011605672,0.2727386,0.0036021685,0.32954347,2.888974e-7,1.6835282e-8,2.9539544e-8,0.000010447737,0.3936159,0.00006613301],"about_ca_topic_score_codex":0.0000013132596,"about_ca_topic_score_gemma":8.045311e-7,"teacher_disagreement_score":0.74999076,"about_ca_system_score_codex":0.000065503766,"about_ca_system_score_gemma":0.0004212783,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W2028158273","doi":"10.1046/j.1365-2133.2001.04232.x","title":"Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice","year":2001,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hôpital Notre-Dame; Université de Montréal","funders":"Canadian Dermatology Foundation; Dermatology Foundation","keywords":"Hairless; Photodynamic therapy; Skin cancer; Medicine; Skin tumours; In vivo; Intraperitoneal injection; Fluorescence; Pathology; Dermatology; Cancer; Chemistry; Internal medicine; Biology; Biochemistry","score_opus":0.014004208071746476,"score_gpt":0.28150466226595894,"score_spread":0.2675004541942125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028158273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97511446,0.022834249,0.00010005074,0.0011291711,0.00011246369,0.00054206536,0.000006693323,0.000012777031,0.00014805335],"genre_scores_gemma":[0.9807241,0.018803941,0.00006748881,0.0002729381,0.000055048447,0.000022074079,0.0000021399283,0.000032626373,0.000019660883],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99746984,0.00039935505,0.00095295586,0.00021608669,0.00045784013,0.0005039045],"domain_scores_gemma":[0.99846166,0.00020618926,0.00060957833,0.00023485646,0.00037225074,0.000115434945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005259797,0.0002050524,0.0009867727,0.00026208325,0.00008410868,0.00001969933,0.00044289738,0.00013717494,0.000016587166],"category_scores_gemma":[0.00014620226,0.0001516129,0.00017142945,0.00046933873,0.00035850602,0.00012411656,0.000031412867,0.00092897395,0.0000037075745],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066422126,0.0010337713,0.10728172,0.00027688078,0.00093212223,0.028207742,0.0016404729,0.000041450498,0.8180754,0.00002435773,0.00020969946,0.035634127],"study_design_scores_gemma":[0.011019228,0.0010355915,0.30293262,0.0028630926,0.00007428189,0.62225735,0.0021529195,0.00016050575,0.057136115,0.00007013896,0.000075356525,0.00022279352],"about_ca_topic_score_codex":0.00034703402,"about_ca_topic_score_gemma":0.00064505794,"teacher_disagreement_score":0.7609393,"about_ca_system_score_codex":0.000111820744,"about_ca_system_score_gemma":0.00032204553,"threshold_uncertainty_score":0.6182595},"labels":[],"label_agreement":null},{"id":"W2028648418","doi":"10.1111/bjd.13551","title":"Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Plaque psoriasis; Tofacitinib; Medicine; Randomized controlled trial; Dermatology; Psoriasis; Surgery; Internal medicine","score_opus":0.006669906811866754,"score_gpt":0.22138959867279262,"score_spread":0.21471969186092588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028648418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135155,0.013816291,0.0003402139,0.0007861973,0.001433008,0.0016458948,0.000020621103,0.000020695647,0.000585523],"genre_scores_gemma":[0.99740064,0.0015838599,0.00019517005,0.00015424332,0.00013374507,0.00021829511,0.000021605163,0.00002092702,0.00027149302],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99597937,0.0019529983,0.0012597389,0.0002860759,0.00007264471,0.00044915135],"domain_scores_gemma":[0.9981471,0.0009548304,0.0005472702,0.00014331713,0.00012337051,0.000084126696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078686234,0.0002793246,0.0026325847,0.000300405,0.00013940889,0.000049425245,0.00018070058,0.00038187995,0.0001680038],"category_scores_gemma":[0.00056434673,0.00024138876,0.00037789802,0.00011900456,0.00018827748,0.00012896542,0.00004556318,0.00032639076,0.00003957437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9701722,0.00036425903,0.0004852717,0.000017186161,0.0013603672,0.00101308,0.0002783093,0.000023029646,0.00050865236,0.0004341751,0.0008462467,0.02449719],"study_design_scores_gemma":[0.958167,0.00064616953,0.0003279886,0.0001930419,0.00047048024,0.03624046,0.000061078325,0.000029542283,0.0017444241,0.00048372534,0.0014097248,0.00022635749],"about_ca_topic_score_codex":0.00009377204,"about_ca_topic_score_gemma":0.00027427485,"teacher_disagreement_score":0.035227377,"about_ca_system_score_codex":0.00008753797,"about_ca_system_score_gemma":0.00022999992,"threshold_uncertainty_score":0.98435473},"labels":[],"label_agreement":null},{"id":"W2031487819","doi":"10.1111/j.1365-2133.2006.07377.x","title":"Interferon-<i>γ</i>-deficient mice are resistant to the development of alopecia areata","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Alopecia areata; CD8; Hair follicle; Cytokine; Interferon gamma; T cell; Immunology; Immune system; Biology; Interferon; Major histocompatibility complex; Molecular biology; Endocrinology","score_opus":0.009967412245066391,"score_gpt":0.23447625199526398,"score_spread":0.2245088397501976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031487819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428047,0.0048429263,0.0025593487,0.004768232,0.00020585491,0.00016619787,0.000009955428,0.000008103282,0.0031589353],"genre_scores_gemma":[0.9968269,0.000049267925,0.0022685314,0.00066957617,0.00006821179,0.0000034939833,0.000005653659,0.000012338572,0.00009606493],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984924,0.00006614208,0.0008110358,0.00011533141,0.00026932027,0.00024576424],"domain_scores_gemma":[0.9991228,0.00005642051,0.00028721913,0.00012781951,0.00028555244,0.000120214245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018044855,0.00009900505,0.00040910943,0.0001351973,0.0000851839,0.000017910925,0.00020870264,0.00006527418,0.000044816235],"category_scores_gemma":[0.00014469244,0.00008200577,0.00010072016,0.00018043528,0.000073507275,0.000041243427,0.000054944034,0.00019974887,0.000018131692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005737237,0.0032082458,0.15934703,0.0009356896,0.00071607635,0.01980468,0.00519631,0.000165629,0.018515289,0.00088981766,0.6709786,0.1145054],"study_design_scores_gemma":[0.0061512585,0.0005061251,0.4699451,0.0024067813,0.00022973304,0.11770581,0.0060911328,0.000020043743,0.030201618,0.00026002844,0.36607322,0.00040913414],"about_ca_topic_score_codex":0.00005879308,"about_ca_topic_score_gemma":0.0016602093,"teacher_disagreement_score":0.31059808,"about_ca_system_score_codex":0.000045909826,"about_ca_system_score_gemma":0.0002409049,"threshold_uncertainty_score":0.33440983},"labels":[],"label_agreement":null},{"id":"W2032719042","doi":"10.1111/j.1365-2133.2008.08936.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study: reply from authors","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Royal Victoria Hospital","funders":"","keywords":"Medicine; Isotretinoin; Pharmacy; Incidence (geometry); Acne; Dermatology; Family medicine; Library science; Computer science; Mathematics","score_opus":0.014780756564892427,"score_gpt":0.25925935191002686,"score_spread":0.24447859534513444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032719042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793164,0.017104603,0.00008478186,0.0029157568,0.00013288199,0.0003891425,0.000009438979,0.0000075378584,0.000039469138],"genre_scores_gemma":[0.99569297,0.0031579505,0.00020858437,0.00078630383,0.000078805606,0.000005715186,0.0000010967958,0.000011645812,0.000056912708],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99854636,0.00044053342,0.00055084075,0.00012843945,0.00018002102,0.00015379958],"domain_scores_gemma":[0.99871135,0.00047153965,0.00040290135,0.00014922056,0.0001613377,0.000103677594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002775547,0.00011128184,0.00071307004,0.000062476836,0.00017116597,0.000011961197,0.00007935715,0.00008818682,0.000038440197],"category_scores_gemma":[0.00025311558,0.00007180068,0.00012197269,0.000099925666,0.00030366256,0.000086995286,0.000021773736,0.00029962583,0.0000013554591],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041165357,0.0007919434,0.54262346,0.000021436212,0.001184586,0.40801793,0.0053955135,0.000002210687,0.0002711985,0.000017409175,0.005708182,0.031849615],"study_design_scores_gemma":[0.019571397,0.0005680635,0.31433335,0.00013475984,0.00025676625,0.66386664,0.0006884148,0.000060101233,0.00019445967,0.0000662742,0.00020405777,0.00005570934],"about_ca_topic_score_codex":0.0010030285,"about_ca_topic_score_gemma":0.00006542176,"teacher_disagreement_score":0.2558487,"about_ca_system_score_codex":0.000010946234,"about_ca_system_score_gemma":0.00009028548,"threshold_uncertainty_score":0.29279464},"labels":[],"label_agreement":null},{"id":"W2033941563","doi":"10.1111/j.1365-2133.2007.08180.x","title":"A case of do-it-yourself Mohs’ surgery using bloodroot obtained from the internet","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Boulevard; Queen (butterfly); The Internet; Medical library; Library science; Medicine; Computer science; History; World Wide Web","score_opus":0.037210172860954994,"score_gpt":0.29407819728294327,"score_spread":0.25686802442198825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033941563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8835656,0.021875484,0.00015615442,0.09251725,0.0010525336,0.000284387,0.00037734341,0.000013529571,0.00015769948],"genre_scores_gemma":[0.8583394,0.0008301263,0.0004565053,0.13801841,0.0019563353,0.0000022957342,0.00019239681,0.00008018872,0.00012428351],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9972154,0.00031634356,0.0013541906,0.00024676952,0.00041591618,0.00045138807],"domain_scores_gemma":[0.996681,0.0010298027,0.0013793671,0.00030581272,0.00042570318,0.00017832886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019849322,0.00030373246,0.001507595,0.0002952506,0.00006591143,0.000052238564,0.00022262172,0.0006395731,0.00033893666],"category_scores_gemma":[0.00029503554,0.0002546087,0.0008342779,0.00017068356,0.00024101461,0.00008357146,0.00006524343,0.0015075867,0.000008227678],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012902055,0.00015676138,0.023041312,0.00009190627,0.0011863871,0.51555765,0.00005166499,1.8504882e-7,0.0000037930274,7.072084e-7,0.45733365,0.0024469849],"study_design_scores_gemma":[0.0024947894,0.00007260055,0.003073101,0.0023536545,0.0028838161,0.94691586,0.00013492833,0.000018686638,0.00010128102,0.00009297509,0.041668322,0.00018995578],"about_ca_topic_score_codex":0.0017889814,"about_ca_topic_score_gemma":0.000106680396,"teacher_disagreement_score":0.43135828,"about_ca_system_score_codex":0.00009297426,"about_ca_system_score_gemma":0.00048943295,"threshold_uncertainty_score":0.99999064},"labels":[],"label_agreement":null},{"id":"W2037934880","doi":"10.1111/j.1365-2133.2005.06691.x","title":"In vitro evaluation of concurrent use of commercially available insect repellent and sunscreen preparations.","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Insect Pest Control Strategies","field":"Agricultural and Biological Sciences","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"DEET; Lotion; Permeation; Insect repellent; Penetration (warfare); Chemistry; Sun protection factor; Chromatography; Dermatology; Toxicology; Medicine; Organic chemistry; Biology","score_opus":0.06515268946176041,"score_gpt":0.26800500340502403,"score_spread":0.20285231394326364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037934880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549836,0.0030121272,0.0000047810113,0.0010245785,0.000062425344,0.0001436563,0.000020139165,0.0000023454356,0.00023160395],"genre_scores_gemma":[0.9991648,0.0005422074,0.0001442053,0.00007296657,0.00005071107,0.0000027508488,0.0000064085466,5.6266174e-7,0.000015365247],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858135,0.0003498937,0.0006246361,0.000087398475,0.00023523773,0.00012150016],"domain_scores_gemma":[0.998834,0.00022579414,0.00045108504,0.000026682983,0.0004261952,0.00003623629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004539587,0.00006250061,0.00031041855,0.000031927215,0.00003592094,0.00002742439,0.00010067885,0.00007205832,0.00018033895],"category_scores_gemma":[0.00021179668,0.000036869456,0.000056381083,0.00010651139,0.000100888705,0.00035440014,0.000023519458,0.00011470895,0.000001429691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057019974,0.0007342429,0.025500137,0.000041018022,0.00009963326,0.00014475487,0.00050596526,0.00024842957,0.5851958,0.00043274448,0.0064149452,0.38011214],"study_design_scores_gemma":[0.0077579604,0.0010180046,0.7587819,0.0005394367,0.00031727034,0.027955415,0.00057674764,0.007305428,0.16849257,0.00087284,0.02580294,0.0005795115],"about_ca_topic_score_codex":0.0007420729,"about_ca_topic_score_gemma":0.0042343177,"teacher_disagreement_score":0.73328173,"about_ca_system_score_codex":0.000024790648,"about_ca_system_score_gemma":0.00006139967,"threshold_uncertainty_score":0.23628485},"labels":[],"label_agreement":null},{"id":"W2039443641","doi":"10.1111/bjd.12972","title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Venereology; Medicine; Dermatology; Rituximab; Family medicine; Internal medicine; Lymphoma","score_opus":0.021031178401243446,"score_gpt":0.30521073622981026,"score_spread":0.2841795578285668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039443641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962839,0.002547189,0.000021166446,0.00019182371,0.0000791524,0.0008405051,0.0000071669247,0.000008919122,0.00002017486],"genre_scores_gemma":[0.99895173,0.00034567673,0.00056462386,0.000087840825,0.000010174895,0.000012470446,0.0000062671807,0.000013012074,0.000008202972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968568,0.001055845,0.0013770454,0.00022359497,0.0002733427,0.00021335758],"domain_scores_gemma":[0.99795353,0.000805125,0.0006958547,0.00016183588,0.00025417758,0.00012945799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041766986,0.00019284841,0.0027544824,0.00015894951,0.000047811518,0.000019344294,0.000113492315,0.00012802475,0.000018718],"category_scores_gemma":[0.00076671573,0.00014342446,0.0001435074,0.00009619741,0.0007505147,0.00011383968,0.00008358126,0.0003289637,0.0000013836757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050702997,0.0077821407,0.9350982,0.0000333276,0.0008284906,0.0010745014,0.0001719315,5.712576e-7,0.0000010460287,0.00002004573,0.00002535796,0.004261445],"study_design_scores_gemma":[0.35182348,0.0012518007,0.6435457,0.00020816427,0.0003804918,0.0024229235,0.00016876534,0.000012790617,0.0000048527795,0.00010130571,0.000003133804,0.00007659964],"about_ca_topic_score_codex":0.00012072868,"about_ca_topic_score_gemma":0.000039045415,"teacher_disagreement_score":0.3011205,"about_ca_system_score_codex":0.000018708826,"about_ca_system_score_gemma":0.0000771197,"threshold_uncertainty_score":0.58486795},"labels":[],"label_agreement":null},{"id":"W2039479173","doi":"10.1111/j.1365-2133.1989.tb07782.x","title":"Epithelioid cell histiocytoma: a new entity","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Epithelioid cell; Lesion; Pathology; Nodule (geology); Immunohistochemistry; Medicine; CD34; Factor XIIIa; Fibrocyte; Biology; Stem cell","score_opus":0.010809810883076877,"score_gpt":0.26034062528872665,"score_spread":0.24953081440564978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039479173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811082,0.01006081,0.001172551,0.0015996736,0.00017009616,0.00014813279,0.0000100210145,0.000019114112,0.005711412],"genre_scores_gemma":[0.9942565,0.00041996798,0.0029335455,0.00010899528,0.0002523195,0.0000014252972,0.000011269889,0.000013784864,0.002002178],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9988279,0.00007413864,0.00042016883,0.000107862936,0.0002770761,0.00029289545],"domain_scores_gemma":[0.99920654,0.000053250104,0.0001871344,0.00009834832,0.00018477983,0.00026994303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067386674,0.00008939581,0.00037702938,0.00015319654,0.00006403281,0.000031264986,0.00009994034,0.000085734406,0.00032503047],"category_scores_gemma":[0.0000954971,0.00009115722,0.00016428609,0.0001106893,0.00006885061,0.00009841834,0.000025759635,0.00027344152,0.00009366683],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010228311,0.0021926037,0.33661056,0.0002124158,0.00030619864,0.24994919,0.000048687314,0.000004050943,0.009586923,0.0001839181,0.3124706,0.087412074],"study_design_scores_gemma":[0.013411678,0.00029239318,0.37694147,0.0001780234,0.00014570066,0.554361,0.000023003273,0.000038482332,0.022222571,0.0010382233,0.031215023,0.00013241851],"about_ca_topic_score_codex":0.0008439372,"about_ca_topic_score_gemma":0.00015706947,"teacher_disagreement_score":0.30441183,"about_ca_system_score_codex":0.000077765835,"about_ca_system_score_gemma":0.00032927204,"threshold_uncertainty_score":0.37172836},"labels":[],"label_agreement":null},{"id":"W2041128924","doi":"10.1111/j.1365-2133.2007.08249.x","title":"Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Calgary Laboratory Services; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; University of Calgary","keywords":"MSH2; DNA mismatch repair; MSH6; Carcinogenesis; DNA repair; Skin cancer; Biology; Microsatellite instability; Basal cell carcinoma; MLH1; DNA damage; Cancer research; Nucleotide excision repair; PMS2; Genetics; Cancer; Pathology; DNA; Medicine; Basal cell; Microsatellite; Gene","score_opus":0.0370050769851945,"score_gpt":0.3116001870892478,"score_spread":0.2745951101040533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041128924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98483485,0.011870679,0.00017035715,0.0014668037,0.001019631,0.00022345097,0.0000062782283,0.000050882772,0.0003570378],"genre_scores_gemma":[0.9959807,0.0016724946,0.00091765594,0.000775282,0.0003564603,0.0000062945096,0.0000041102535,0.00003914747,0.00024785314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978052,0.000110919296,0.0008683954,0.0002520325,0.00046659182,0.0004968549],"domain_scores_gemma":[0.9982075,0.00018609338,0.0007322454,0.00022245024,0.00036621423,0.00028550863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004051391,0.0001960124,0.0007223976,0.00019898794,0.00011575275,0.000033107135,0.00024160703,0.00027282114,0.00075069186],"category_scores_gemma":[0.00023938755,0.00021024916,0.0002779605,0.00019913926,0.00022440801,0.00017454968,0.000062367275,0.00053844176,0.000014357282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011795205,0.0003195154,0.6943238,0.00036092685,0.0005992642,0.036727156,0.0005922218,0.0000023333844,0.1892041,0.000013985263,0.018404357,0.05827284],"study_design_scores_gemma":[0.0013843955,0.00024130943,0.7002672,0.00150126,0.00014416708,0.17101993,0.00009258085,0.0000075755056,0.12170752,0.000040958137,0.0034198142,0.00017330106],"about_ca_topic_score_codex":0.00018794883,"about_ca_topic_score_gemma":0.00052958954,"teacher_disagreement_score":0.13429277,"about_ca_system_score_codex":0.00020095381,"about_ca_system_score_gemma":0.00022805898,"threshold_uncertainty_score":0.85737115},"labels":[],"label_agreement":null},{"id":"W2045034709","doi":"10.1111/bjd.13379","title":"Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Propranolol; Medicine; Adverse effect; Psychomotor learning; Pediatrics; Intensive care medicine; Mood; Cognition; Anesthesia; Internal medicine; Psychiatry","score_opus":0.003564067646307629,"score_gpt":0.19110914229658488,"score_spread":0.18754507465027725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045034709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9421701,0.0010923989,0.054829866,0.0010690328,0.00018211511,0.000472182,0.000016354785,0.000027155844,0.00014081625],"genre_scores_gemma":[0.9972417,0.00003879561,0.002357833,0.00009172287,0.00018708919,0.000018747434,0.000036086116,0.000016024713,0.0000120501045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909896,0.000039266954,0.00040781827,0.00010529026,0.00012467161,0.00022397285],"domain_scores_gemma":[0.9989989,0.0000271192,0.0002731587,0.00010447415,0.0004558077,0.00014057064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006838998,0.000089208246,0.00033575192,0.0001589843,0.00017023295,0.00003983395,0.00005758168,0.000091053305,0.000006320657],"category_scores_gemma":[0.00004243689,0.00007988675,0.00012706031,0.00012201952,0.00005494159,0.00016780154,0.000017069973,0.00010839434,0.0000019855888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013691318,0.00091994513,0.78075117,0.0021538727,0.0011954498,0.00066551735,0.00027800733,0.00006836726,0.00024568298,0.0076131155,0.016638732,0.18810102],"study_design_scores_gemma":[0.0052218502,0.0004517163,0.8799628,0.00014491407,0.0005815567,0.10883221,0.00006632862,0.00029390075,0.000035546396,0.000086745924,0.004219514,0.00010293918],"about_ca_topic_score_codex":0.000006336228,"about_ca_topic_score_gemma":0.000007205639,"teacher_disagreement_score":0.18799809,"about_ca_system_score_codex":0.000023339811,"about_ca_system_score_gemma":0.00006514023,"threshold_uncertainty_score":0.3257687},"labels":[],"label_agreement":null},{"id":"W2047011925","doi":"10.1111/bjd.13235","title":"Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12–17 years of age","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Astellas Pharma; LEO Pharma; Galderma; Dermira; Celgene; Amgen; Pfizer; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Medicine; Dermatology; Calcipotriol; Scalp; Psoriasis","score_opus":0.013583323941817375,"score_gpt":0.24151719145665604,"score_spread":0.22793386751483866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047011925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869287,0.0124347145,0.00003235152,0.00008970928,0.0002045888,0.00020928742,0.000038136848,0.0000023126609,0.00006022714],"genre_scores_gemma":[0.99469423,0.0051261205,0.000094253206,0.000020456602,0.000016635857,0.000003863629,0.000013747882,0.000009022066,0.000021650596],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979053,0.0007681879,0.0008902639,0.0001447561,0.00006551535,0.00022593483],"domain_scores_gemma":[0.99881816,0.00040189124,0.0005446458,0.0001535445,0.000058916,0.000022852895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029074174,0.0001338009,0.00089853286,0.00023308363,0.000029592817,0.000003963514,0.00020846825,0.0002282188,0.00001703161],"category_scores_gemma":[0.00012497473,0.000114729206,0.00016700475,0.00014683626,0.00029040733,0.000048632344,0.000026857238,0.00015485084,0.0000018138263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043706233,0.0038994905,0.31862456,0.0001826001,0.0007392058,0.0016116777,0.0048411335,0.000047494414,0.01624218,0.00017369461,0.00018345528,0.6490839],"study_design_scores_gemma":[0.017786259,0.00062111346,0.9643336,0.00047681012,0.00021364912,0.0046539116,0.00022829654,0.000003160483,0.010529481,0.00008075551,0.0009687822,0.000104176324],"about_ca_topic_score_codex":0.00041207552,"about_ca_topic_score_gemma":0.0004821203,"teacher_disagreement_score":0.6489797,"about_ca_system_score_codex":0.000040075087,"about_ca_system_score_gemma":0.00006185684,"threshold_uncertainty_score":0.46785212},"labels":[],"label_agreement":null},{"id":"W2047454818","doi":"10.1111/bjd.12385","title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Rosacea; Medicine; Dermatology; Epidemiology; Cross-sectional study; Itching; Demographics; Internal medicine; Pathology; Demography","score_opus":0.11508349845175621,"score_gpt":0.4295678299170698,"score_spread":0.3144843314653136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047454818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983001,0.00096961966,0.00008057727,0.0002924027,0.0001440854,0.0001258339,0.000045385663,0.000006056987,0.00003594953],"genre_scores_gemma":[0.99845564,0.00019631944,0.00095094775,0.00008291971,0.00014256216,0.000002305996,0.00012956109,0.000007705419,0.000032033968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986642,0.0002435605,0.00066906493,0.00010398006,0.00019363457,0.0001255709],"domain_scores_gemma":[0.9983126,0.00037218694,0.0004277217,0.000056810222,0.0006837243,0.00014697043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044050533,0.0000662205,0.00041996394,0.000052590003,0.000105182495,0.00003913808,0.0000523703,0.00018044177,0.000063212974],"category_scores_gemma":[0.000440355,0.000056972447,0.000080970916,0.00007701183,0.00014138519,0.00024161013,0.000016884835,0.00021672154,0.0000040387176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041215026,0.00026094096,0.9889061,0.000014594636,0.00015345549,0.00010380485,0.000011941061,8.699203e-7,0.000045942943,0.0000094844645,0.0010450843,0.009406561],"study_design_scores_gemma":[0.0017304139,0.00035065392,0.99327934,0.000055455497,0.000045232617,0.004164582,0.000005933219,0.00005024518,0.000089747155,0.000103417035,0.0000775504,0.00004741551],"about_ca_topic_score_codex":0.00019716407,"about_ca_topic_score_gemma":0.000025693455,"teacher_disagreement_score":0.009359146,"about_ca_system_score_codex":0.000015147576,"about_ca_system_score_gemma":0.00014760501,"threshold_uncertainty_score":0.2323269},"labels":[],"label_agreement":null},{"id":"W2049388747","doi":"10.1046/j.1365-2133.2002.04800.x","title":"Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Systemic administration; Penetration (warfare); Immune system; Tacrolimus; Liposome; Pharmacology; Immunology; Chemistry; Surgery; Transplantation; In vivo; Biology","score_opus":0.1599082507375588,"score_gpt":0.44483770198040484,"score_spread":0.2849294512428461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049388747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95504886,0.03934169,0.0031043491,0.00086310145,0.0008938952,0.00052915164,0.000086013526,0.000013415773,0.0001195009],"genre_scores_gemma":[0.9822928,0.015801826,0.0013279327,0.00026230898,0.000103135535,0.00007707676,0.000013220241,0.000021502927,0.000100249454],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980283,0.00019073668,0.0010374556,0.00020039934,0.00014884575,0.00039430888],"domain_scores_gemma":[0.999004,0.0002941703,0.00038800773,0.00008709351,0.00012999658,0.00009675108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113900984,0.00020371434,0.0006903569,0.0001770784,0.00009643059,0.0000069062494,0.00019149535,0.00022762272,0.00017459282],"category_scores_gemma":[0.00008989339,0.00022337177,0.00024179225,0.000108308646,0.00028248507,0.00017601746,0.000039542676,0.0002491581,0.000008592924],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016610444,0.09416666,0.022027943,0.0017084143,0.009586437,0.017140802,0.04788975,0.10698057,0.18346293,0.0017907841,0.007545728,0.49108955],"study_design_scores_gemma":[0.15227008,0.010008178,0.0040876763,0.0009638277,0.0014310672,0.08792231,0.008126527,0.3270694,0.34867692,0.0019351043,0.055497114,0.0020117853],"about_ca_topic_score_codex":0.000024279336,"about_ca_topic_score_gemma":0.00008210281,"teacher_disagreement_score":0.48907775,"about_ca_system_score_codex":0.00017663685,"about_ca_system_score_gemma":0.000040426658,"threshold_uncertainty_score":0.9108836},"labels":[],"label_agreement":null},{"id":"W2049798709","doi":"10.1111/j.0366-077x.2004.05950.x","title":"The use of ciclosporin in psoriasis: a clinical review","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ciclosporin; Psoriasis; Skin cancer; Dermatology; Adverse effect; Quality of life (healthcare); Population; Disease; Malignancy; Clinical trial; PUVA therapy; Intensive care medicine; Internal medicine; Cancer; Transplantation","score_opus":0.09772538025185368,"score_gpt":0.35004147090312127,"score_spread":0.2523160906512676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049798709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016145803,0.9967041,0.0000055748624,0.00015588653,0.0023476395,0.00051402225,0.000068620335,0.0000081520875,0.00003453994],"genre_scores_gemma":[0.000070211354,0.9993755,0.0001238879,0.00007490932,0.000078224955,0.000028957436,0.00005322954,0.000035127567,0.00015993892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99270105,0.0026415484,0.0038613754,0.00027832648,0.00007890345,0.00043878428],"domain_scores_gemma":[0.9945919,0.0018404694,0.00292745,0.000375649,0.00021568169,0.00004888486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094489154,0.00035850808,0.004133549,0.00020374215,0.00010217465,0.000022698308,0.00071526226,0.00091780437,0.00007954053],"category_scores_gemma":[0.001112013,0.00026761164,0.0015768791,0.0003542643,0.00040053265,0.000119511446,0.00010207029,0.001179844,0.000082830215],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053305703,0.00024981855,0.0001631169,0.006371678,0.0011248586,0.0027611998,0.000008460137,8.8509054e-8,1.5040612e-7,0.00007918216,0.0083568925,0.98083127],"study_design_scores_gemma":[0.001353878,0.000084040694,0.00016339599,0.08438222,0.0018917937,0.11140718,0.000005694158,7.2346844e-9,0.0000032602316,0.000037796046,0.8005023,0.00016841205],"about_ca_topic_score_codex":0.00007261182,"about_ca_topic_score_gemma":0.0001217748,"teacher_disagreement_score":0.9806628,"about_ca_system_score_codex":0.00008082201,"about_ca_system_score_gemma":0.0010940026,"threshold_uncertainty_score":0.9999776},"labels":[],"label_agreement":null},{"id":"W2050002232","doi":"10.1111/j.1365-2133.2007.08110.x","title":"Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Trichophyton rubrum; Microbiology; Polymerase chain reaction; Biology; Nail (fastener); Molecular biology; DNA extraction; Agarose; DNA; Gene; Antifungal; Biochemistry","score_opus":0.0059319939154741505,"score_gpt":0.2181120213315096,"score_spread":0.21218002741603545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050002232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957061,0.0019339909,0.0015576545,0.00024898894,0.0000890391,0.00021121162,0.00021363638,0.000004840357,0.000034555782],"genre_scores_gemma":[0.99944806,0.00014992947,0.00014099255,0.00014730036,0.0000351924,0.0000020822076,0.000056598197,0.000014217266,0.000005614348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988655,0.000105807514,0.00046884638,0.00012621425,0.00027152392,0.00016213302],"domain_scores_gemma":[0.99845445,0.00040061792,0.0006056068,0.00009660422,0.0003157849,0.00012693898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011588262,0.0001155325,0.0004231322,0.00010883708,0.00007509695,0.00001168903,0.000041495456,0.00008454801,0.0000075407625],"category_scores_gemma":[0.000074061325,0.000090416135,0.00009979886,0.00015994372,0.000139693,0.000087705965,0.000009110787,0.0001597515,3.58916e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012609364,0.0017347638,0.8444986,0.00006947903,0.0009915255,0.0011892566,0.00016237207,0.0000010439475,0.01264848,0.0000038561934,0.00031734258,0.12577392],"study_design_scores_gemma":[0.015282512,0.0005521369,0.90078443,0.00035018282,0.00057413493,0.0024249332,0.00033479708,0.000010339578,0.07948206,0.00001530458,0.000102638354,0.00008650662],"about_ca_topic_score_codex":0.0015418705,"about_ca_topic_score_gemma":0.0003860048,"teacher_disagreement_score":0.1256874,"about_ca_system_score_codex":0.00004808096,"about_ca_system_score_gemma":0.0000810663,"threshold_uncertainty_score":0.3687063},"labels":[],"label_agreement":null},{"id":"W2050106566","doi":"10.1111/j.1365-2133.2008.08680.x","title":"A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"U.S. Food and Drug Administration","keywords":"Psoriasis; Medicine; Index (typography); Library science; Family medicine; Dermatology; Computer science","score_opus":0.043202111919481895,"score_gpt":0.28073312112201226,"score_spread":0.23753100920253037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050106566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563026,0.0016060915,0.00115418,0.0001630923,0.0006949152,0.00057575334,0.000080904436,0.000006783588,0.00008803347],"genre_scores_gemma":[0.9984973,0.0003387201,0.00095145823,0.000046911962,0.000032012653,0.000048563346,0.000009981058,0.000014378803,0.000060685983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782956,0.0004922552,0.0010949344,0.00023547845,0.00008063501,0.00026712794],"domain_scores_gemma":[0.99823433,0.0003981799,0.0007729376,0.00022626821,0.00033425682,0.000034034652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006058568,0.00019308602,0.00085205055,0.00012012779,0.00018302727,0.000014099678,0.00029298698,0.00020765042,0.00010091429],"category_scores_gemma":[0.0001427008,0.0001527955,0.00015329331,0.00011648163,0.00037436222,0.00016307623,0.00012043361,0.0002549608,0.0000016436612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021811943,0.005036149,0.9124631,0.0001797109,0.003386646,0.0005288737,0.0062999246,0.000012715655,0.013894285,0.00004849859,0.003579503,0.052389394],"study_design_scores_gemma":[0.015313811,0.0015278409,0.9194692,0.00016947709,0.0005914336,0.035810016,0.003253035,0.000015993848,0.022459649,0.00004865494,0.0011101268,0.00023075861],"about_ca_topic_score_codex":0.00012581325,"about_ca_topic_score_gemma":0.00007261277,"teacher_disagreement_score":0.052158635,"about_ca_system_score_codex":0.000037664282,"about_ca_system_score_gemma":0.00019900154,"threshold_uncertainty_score":0.623082},"labels":[],"label_agreement":null},{"id":"W2050243251","doi":"10.1111/j.1365-2133.2005.06674.x","title":"Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Pimecrolimus; Medicine; Tolerability; Atopic dermatitis; Eczema Area and Severity Index; Randomized controlled trial; Placebo; Dermatology Life Quality Index; Calcineurin; Dermatology; Adverse effect; SCORAD; Internal medicine; Psoriasis; Transplantation","score_opus":0.015374750972260636,"score_gpt":0.2785592612875164,"score_spread":0.26318451031525575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050243251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859126,0.009214784,0.000119229,0.0024153737,0.00009979954,0.0021157924,0.0000126080195,0.000003979532,0.00010579886],"genre_scores_gemma":[0.998174,0.0012405502,0.0002465682,0.00022646559,0.000034592773,0.00006256241,0.0000028325169,0.000007459828,0.000004953339],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99682313,0.00085771654,0.001764291,0.00012843027,0.00023161406,0.00019481221],"domain_scores_gemma":[0.9975353,0.0012847871,0.00070423784,0.00017206612,0.00019884005,0.000104795334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003049866,0.00016744103,0.003219942,0.00017223235,0.000033910805,0.000009897654,0.00013061865,0.00012661649,0.0000449826],"category_scores_gemma":[0.00054743385,0.00011029066,0.00043896414,0.00009206395,0.0003406573,0.00006921718,0.000018207598,0.00013825408,4.5621655e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.950209,0.005316114,0.029039575,0.00018692466,0.0010676414,0.0010910667,0.0015663498,0.000054048945,0.000092174334,0.0001184612,0.0003979774,0.010860641],"study_design_scores_gemma":[0.90705633,0.00064991205,0.06924049,0.00031386723,0.0008039223,0.01922742,0.00011761064,0.00022395517,0.0014967241,0.0007436605,0.000042736974,0.00008339833],"about_ca_topic_score_codex":0.00006319181,"about_ca_topic_score_gemma":0.00023986821,"teacher_disagreement_score":0.043152723,"about_ca_system_score_codex":0.000024752542,"about_ca_system_score_gemma":0.00012901954,"threshold_uncertainty_score":0.44975227},"labels":[],"label_agreement":null},{"id":"W2051641690","doi":"10.1111/j.1365-2133.2007.08025.x","title":"Inhibition of tumour necrosis factor-? secretion from EpiDerm<sup>TM</sup>tissues by a novel small molecule, UTL-5d","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Psoriasis; Lotion; Tumor necrosis factor alpha; Epidermis (zoology); Secretion; Necrosis; Cell; Medicine; Cancer research; In vitro; Pharmacology; Chemistry; Immunology; Pathology; Internal medicine; Biochemistry","score_opus":0.017621404559757834,"score_gpt":0.22872303095357402,"score_spread":0.2111016263938162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051641690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738723,0.018602137,0.005888065,0.00024573336,0.00043388622,0.00016161577,0.00055874535,0.000030934047,0.00020660463],"genre_scores_gemma":[0.9971979,0.0012355748,0.00076014665,0.00016299411,0.00007235344,0.000004650272,0.00041642095,0.000031844047,0.0001180631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765646,0.0003102318,0.0011607677,0.0002850115,0.00009034525,0.00049715926],"domain_scores_gemma":[0.9982696,0.00036660585,0.00084459735,0.00015973418,0.0002761293,0.00008332634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002413654,0.00026886782,0.0008385234,0.00024555018,0.00014823972,0.000026317466,0.00023373998,0.00057444343,0.000379987],"category_scores_gemma":[0.00016975786,0.00030077633,0.00027161028,0.00018186422,0.00021760544,0.00019738368,0.000060055027,0.0003890155,0.000050779592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050889613,0.0005901782,0.009516451,0.00003177871,0.00063386036,0.0015243504,0.0006324191,0.0000039916113,0.9613907,0.00003895967,0.004130841,0.020997588],"study_design_scores_gemma":[0.0061669042,0.00029170746,0.03875149,0.00034956922,0.0003308451,0.0332969,0.0005054063,0.0000061602827,0.91640157,0.00025871024,0.0032843626,0.00035635525],"about_ca_topic_score_codex":0.0008375536,"about_ca_topic_score_gemma":0.0002195751,"teacher_disagreement_score":0.044989098,"about_ca_system_score_codex":0.000062983454,"about_ca_system_score_gemma":0.000090121335,"threshold_uncertainty_score":0.99994445},"labels":[],"label_agreement":null},{"id":"W2053248776","doi":"10.1111/bjd.13237","title":"Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)","year":2014,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Programme Grants for Applied Research; National Institute for Health and Care Research","keywords":"Medicine; Atopic dermatitis; Clinical trial; Quality of life (healthcare); Pediatrics; Scale (ratio); Randomized controlled trial; Erythema; MEDLINE; Family medicine; Physical therapy; Dermatology; Surgery; Pathology; Nursing","score_opus":0.2840139127202188,"score_gpt":0.48605393439295247,"score_spread":0.20204002167273366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053248776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095824053,0.97796416,0.0007443604,0.011872828,0.0059063155,0.0017102512,0.00038769993,0.000043935834,0.0004122129],"genre_scores_gemma":[0.004226269,0.9858544,0.002565589,0.0042822454,0.0023143608,0.00012299052,0.00032736058,0.00008561786,0.00022116647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.988004,0.0027309838,0.0077025383,0.00050245936,0.0006003244,0.00045966325],"domain_scores_gemma":[0.9802085,0.012573076,0.0052486975,0.000522069,0.0009687691,0.00047887975],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00470056,0.00047346533,0.007097884,0.00024553272,0.00023464736,0.00012838215,0.00083066884,0.0008867567,0.00009928997],"category_scores_gemma":[0.04312346,0.00035758084,0.0029473593,0.00013867751,0.00036955436,0.00006430293,0.00016359898,0.0013345997,0.00005394473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015272385,0.00016774007,0.022766601,0.0019255922,0.0025559496,0.03204634,0.000029393173,2.6166666e-7,1.0826038e-7,0.000038174614,0.53916913,0.401148],"study_design_scores_gemma":[0.0019334973,0.000034374785,0.0022806968,0.009873882,0.0032737942,0.33474308,0.00002779953,0.000004148106,0.0000011568525,0.0003312607,0.6472864,0.00020987891],"about_ca_topic_score_codex":0.000036494308,"about_ca_topic_score_gemma":0.000060658516,"teacher_disagreement_score":0.40093812,"about_ca_system_score_codex":0.0000888866,"about_ca_system_score_gemma":0.001125542,"threshold_uncertainty_score":0.99988765},"labels":[],"label_agreement":null},{"id":"W2053952900","doi":"10.1046/j.1365-2133.148.s63.1.x","title":"International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies","year":2003,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Technische Universität München; University of California, San Diego; Université de Genève; School of Medicine, University of California, San Diego; Instituto Nacional de Pediatria","keywords":"Atopic dermatitis; Medicine; Dermatology; Library science; Family medicine; Computer science","score_opus":0.08834798399718323,"score_gpt":0.40612397775430337,"score_spread":0.3177759937571201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053952900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028757849,0.99074674,0.000022468252,0.0016145866,0.0020637927,0.00040020372,0.00010585902,0.000020899817,0.0021496871],"genre_scores_gemma":[0.010331612,0.9886071,0.00024580277,0.00035749385,0.00021450754,0.000018910692,0.00010000526,0.000029415069,0.00009512258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639344,0.0006836145,0.0019669926,0.00035567945,0.00026404907,0.0003361939],"domain_scores_gemma":[0.9976218,0.00031378728,0.0011929454,0.00021563137,0.00030104507,0.00035481315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014496154,0.00042069936,0.0028912472,0.0002787098,0.00021709672,0.00007913973,0.00023592844,0.0005095951,0.00028753895],"category_scores_gemma":[0.00019924129,0.00037621686,0.0006935742,0.00008579476,0.0005497742,0.000097295975,0.00009086962,0.00095959095,0.00003097287],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003683353,0.00079580094,0.00061289663,0.0016120026,0.001037768,0.021140471,0.00002304917,7.3661376e-8,1.7302881e-8,0.0015732693,0.031475335,0.9416925],"study_design_scores_gemma":[0.0020456095,0.00020260396,0.0003655091,0.007309555,0.0011191417,0.34085166,0.000028720617,0.0000027130045,5.970928e-7,0.00042528016,0.64747405,0.00017452602],"about_ca_topic_score_codex":0.0000039978804,"about_ca_topic_score_gemma":0.000009878728,"teacher_disagreement_score":0.94151795,"about_ca_system_score_codex":0.00008700831,"about_ca_system_score_gemma":0.001354711,"threshold_uncertainty_score":0.999869},"labels":[],"label_agreement":null},{"id":"W2054669733","doi":"10.1111/j.1365-2133.2009.09312.x","title":"Optimizing technique in elliptical excisional surgery: some pearls for practice","year":2009,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Magnification; Trunk; Fibrous joint; Surgery; Lesion; Computer science","score_opus":0.02247801261517803,"score_gpt":0.301356126454342,"score_spread":0.278878113839164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054669733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018310766,0.022979934,0.0018637431,0.97154826,0.0006456949,0.0006104531,0.000022652674,0.000023615543,0.00047457693],"genre_scores_gemma":[0.0094385175,0.0107584,0.0421258,0.9275659,0.009336157,0.000056314162,0.00014521468,0.00012511486,0.00044861474],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713457,0.0003216595,0.0012453818,0.00027583574,0.0004705955,0.0005519666],"domain_scores_gemma":[0.99485326,0.0037417216,0.00070337974,0.00013729144,0.00040477532,0.00015955174],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00055475207,0.00024621974,0.0015515261,0.00043367234,0.000057961402,0.000064912914,0.0001944006,0.0012040624,0.00009914238],"category_scores_gemma":[0.002651274,0.00024676547,0.0007216536,0.00013918664,0.000119018085,0.00025289797,0.000033145312,0.0031075543,0.000005916242],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003898169,0.00018693318,0.0000658735,0.00016495291,0.000105781386,0.19303636,0.000011898939,0.0000016417533,0.000046384863,0.00005203441,0.79704034,0.008897953],"study_design_scores_gemma":[0.0008414928,0.00011115972,0.00031598008,0.001409606,0.00012940646,0.40736392,0.000018519266,0.000006917041,0.00014794941,0.00084826956,0.5886454,0.00016136376],"about_ca_topic_score_codex":0.00001216783,"about_ca_topic_score_gemma":0.000001233909,"teacher_disagreement_score":0.21432756,"about_ca_system_score_codex":0.00008695404,"about_ca_system_score_gemma":0.00041532546,"threshold_uncertainty_score":0.99999845},"labels":[],"label_agreement":null},{"id":"W2054717635","doi":"10.1111/bjd.12266","title":"A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Université de Montréal; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Adverse effect; Tolerability; Discontinuation; Erythema; Dermatology; Psoriasis; Plaque psoriasis; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacology; Rheumatoid arthritis","score_opus":0.013713880296584411,"score_gpt":0.24996373882449766,"score_spread":0.23624985852791325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054717635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795782,0.017567575,0.000017923037,0.0006009454,0.00082855346,0.0011795985,0.000060822855,0.000004725782,0.00016164318],"genre_scores_gemma":[0.99418324,0.005453621,0.000033078322,0.000051849493,0.00011753355,0.000067509965,0.000015668971,0.000009320973,0.00006818815],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99664974,0.0017395285,0.0010861538,0.00016268341,0.00007518381,0.00028670198],"domain_scores_gemma":[0.99681586,0.0022077337,0.00064460543,0.00019939382,0.00009917362,0.000033242948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031726848,0.0001911611,0.0011484736,0.000112301335,0.00010667755,0.00001740091,0.00025730339,0.0002820897,0.00006890875],"category_scores_gemma":[0.00042556963,0.00011839041,0.0003986624,0.000137482,0.000523259,0.00008471482,0.000031671792,0.00021067882,0.000005767252],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3373156,0.017377045,0.0025988277,0.00015446387,0.0041276375,0.0017620015,0.0075460426,0.000007828573,0.024177188,0.0009779556,0.0063831317,0.59757227],"study_design_scores_gemma":[0.93334913,0.0017572059,0.003027251,0.00015818718,0.0005463238,0.011973143,0.00042766478,0.0000033311508,0.04040528,0.00018385107,0.008094735,0.000073902185],"about_ca_topic_score_codex":0.00016393285,"about_ca_topic_score_gemma":0.00007105982,"teacher_disagreement_score":0.59749836,"about_ca_system_score_codex":0.00004598302,"about_ca_system_score_gemma":0.00016364933,"threshold_uncertainty_score":0.48278207},"labels":[],"label_agreement":null},{"id":"W2056006467","doi":"10.1111/j.1365-2133.2008.08895.x","title":"Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Retinoic acid; Retinoid; Downregulation and upregulation; Tretinoin; Retinol; Biology; Epidermis (zoology); Proinflammatory cytokine; Molecular biology; Inflammation; Cancer research; Chemistry; Biochemistry; Immunology; Vitamin; Gene","score_opus":0.009414241412423512,"score_gpt":0.2320890324613776,"score_spread":0.2226747910489541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056006467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929658,0.006261987,0.00019645778,0.00019201523,0.000083567465,0.000118968186,0.000004133391,0.0000034966088,0.00017352919],"genre_scores_gemma":[0.9972168,0.0020386705,0.00037218147,0.00006590336,0.00014438157,0.000008115699,0.000019177874,0.000017050916,0.00011771748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854565,0.00022176083,0.0005940563,0.00019362327,0.00019211021,0.0002528032],"domain_scores_gemma":[0.9991919,0.000026238054,0.00036864675,0.00018497629,0.00014749575,0.00008077543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010017121,0.00015568329,0.0003505613,0.00006038655,0.00012990531,0.000014352528,0.00026080862,0.00019696272,0.000023024912],"category_scores_gemma":[0.00003632514,0.00011795145,0.00012773313,0.00008565589,0.00030586656,0.000014904474,0.000063175816,0.00018129275,8.735932e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046660195,0.00034683925,0.086266436,0.00005448157,0.000095365824,0.004584181,0.00024980155,0.00013975703,0.9020198,0.000008974067,0.0009147061,0.0048530707],"study_design_scores_gemma":[0.0024688686,0.00056366355,0.010166079,0.000117785006,0.000028444267,0.062373854,0.00015212281,0.0000084466,0.9223934,0.00002147731,0.0015682809,0.00013759822],"about_ca_topic_score_codex":0.00007769662,"about_ca_topic_score_gemma":0.000098859935,"teacher_disagreement_score":0.07610036,"about_ca_system_score_codex":0.000028879722,"about_ca_system_score_gemma":0.00018545883,"threshold_uncertainty_score":0.48099205},"labels":[],"label_agreement":null},{"id":"W2056787110","doi":"10.1111/j.1365-2133.2004.06099.x","title":"Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Canadian Dermatology Foundation; Dermatology Foundation","keywords":"Photodynamic therapy; Irradiance; Medicine; Pathology; Dermatology; Chemistry; Optics; Physics","score_opus":0.011832456445917095,"score_gpt":0.2748666580562967,"score_spread":0.2630342016103796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056787110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98215103,0.015757224,0.00041203602,0.0012029392,0.000045801942,0.0003215661,0.000010357576,0.000016622345,0.00008243604],"genre_scores_gemma":[0.987393,0.011679795,0.00030995117,0.00055477564,0.00001565231,0.000010352374,0.000005098492,0.000020614209,0.000010714564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998395,0.00012817235,0.0006216415,0.00020992354,0.00033222698,0.00031298242],"domain_scores_gemma":[0.9987462,0.00007626896,0.00046514857,0.00015192226,0.00037307263,0.00018735358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016112656,0.00017141744,0.0007429459,0.0001670569,0.00009411771,0.000019755702,0.00018181046,0.00016725794,0.000019798625],"category_scores_gemma":[0.00020521102,0.00014750205,0.00007419071,0.00026115723,0.00048240242,0.0002016275,0.000033684435,0.00050600304,0.0000012382911],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022565315,0.0006941443,0.00787306,0.00013621389,0.0004260582,0.005689355,0.0006165541,0.000021963386,0.97319466,0.000027310589,0.00029929003,0.008764833],"study_design_scores_gemma":[0.034387354,0.005909217,0.19951732,0.0020812873,0.0001694765,0.26698077,0.0005368861,0.00013837882,0.48695222,0.0008825843,0.0018518255,0.00059269654],"about_ca_topic_score_codex":0.00012802592,"about_ca_topic_score_gemma":0.00009931878,"teacher_disagreement_score":0.48624247,"about_ca_system_score_codex":0.00011386368,"about_ca_system_score_gemma":0.00028518218,"threshold_uncertainty_score":0.6014959},"labels":[],"label_agreement":null},{"id":"W2057417368","doi":"10.1111/j.1365-2133.2006.07736.x","title":"Itch Severity Scale: a self-report instrument for the measurement of pruritus severity","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Canada Research Chairs","keywords":"Construct validity; Quality of life (healthcare); Reliability (semiconductor); Medicine; Dermatology Life Quality Index; Exploratory factor analysis; Psychometrics; Internal consistency; Severity of illness; Clinical psychology; Scale (ratio); Physical therapy; Psoriasis; Psychiatry; Dermatology","score_opus":0.017663357402825992,"score_gpt":0.27396279125558193,"score_spread":0.25629943385275594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057417368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98180413,0.0075564473,0.004711227,0.0035399175,0.00078609755,0.00062442076,0.000017105946,0.000028088236,0.000932541],"genre_scores_gemma":[0.9957592,0.00052084756,0.0029852926,0.00056803867,0.000116192656,0.0000107674805,0.00000473993,0.000015103454,0.000019817619],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9975589,0.000090118636,0.0012550037,0.00016429953,0.0005581795,0.0003735081],"domain_scores_gemma":[0.9975893,0.00023211297,0.0007250036,0.00022736227,0.0010114328,0.00021477485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012343576,0.00014694186,0.00068624376,0.00010911946,0.00015437782,0.000014793243,0.00021575215,0.00018808093,0.000045689878],"category_scores_gemma":[0.0005544139,0.00012753002,0.0003332046,0.00013945361,0.00023982288,0.00010965495,0.000049068305,0.00035179092,0.000002138828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031831823,0.0031471066,0.7710514,0.001099366,0.0023754234,0.044093292,0.0005129785,0.000002903235,0.00069684576,0.00008786987,0.09595888,0.07779073],"study_design_scores_gemma":[0.003453158,0.000070038855,0.3917313,0.0002879525,0.00063403364,0.5715228,0.00031036112,0.00004520694,0.009929046,0.00042965016,0.021462774,0.00012372801],"about_ca_topic_score_codex":0.00003571028,"about_ca_topic_score_gemma":0.00015067907,"teacher_disagreement_score":0.52742946,"about_ca_system_score_codex":0.000087355635,"about_ca_system_score_gemma":0.00050168537,"threshold_uncertainty_score":0.5200523},"labels":[],"label_agreement":null},{"id":"W2057877473","doi":"10.1046/j.1365-2133.2003.05418.x","title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Terbinafine; Ketoconazole; Microbiology; In vitro; Broth microdilution; Antifungal; Dermatophyte; Griseofulvin; Pharmacology; Minimum inhibitory concentration; Biology; Chemistry; Medicine; Dermatology; Antimicrobial; Biochemistry","score_opus":0.019732299801595677,"score_gpt":0.28459500914168157,"score_spread":0.2648627093400859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057877473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933292,0.005884152,0.000012420075,0.00015170485,0.000048502014,0.0004092357,0.000022015618,0.0000032209368,0.00013954117],"genre_scores_gemma":[0.99879915,0.00036763932,0.0007473213,0.000053232478,0.0000071900295,0.0000075678804,0.000006393317,0.000010012263,0.0000014995451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984047,0.00031862166,0.0006474815,0.00018091708,0.00026300736,0.00018526787],"domain_scores_gemma":[0.99880344,0.00024221366,0.00044030423,0.0000865488,0.0003240514,0.00010343128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004170837,0.0001321102,0.0006325304,0.00023852721,0.000035906534,0.000014527112,0.00003540643,0.00010328789,0.000006183818],"category_scores_gemma":[0.0005669974,0.00014735213,0.000048181944,0.00019138565,0.00017358777,0.00030282023,0.00002586998,0.00020372117,1.2502761e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048023247,0.0009051602,0.7507135,0.0004452622,0.000052225176,0.00069080666,0.000075230084,0.0000023588689,0.21894374,0.000013974159,0.000012327501,0.027665127],"study_design_scores_gemma":[0.009553416,0.00006586388,0.76004934,0.0003214212,0.00011753845,0.012011176,0.000094700124,0.0010550543,0.21606737,0.00057218736,0.0000042828383,0.00008763921],"about_ca_topic_score_codex":0.00006945896,"about_ca_topic_score_gemma":0.00003349993,"teacher_disagreement_score":0.027577488,"about_ca_system_score_codex":0.000053740052,"about_ca_system_score_gemma":0.00018908552,"threshold_uncertainty_score":0.60088456},"labels":[],"label_agreement":null},{"id":"W2059576098","doi":"10.1111/j.1365-2133.1976.tb07918.x","title":"(30) Benign hyperglobulinaemic purpura of Waldenstrom","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Citation; Medicine; Library science; Classics; History; Computer science","score_opus":0.004409450661732599,"score_gpt":0.21081282209350716,"score_spread":0.20640337143177456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059576098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859257,0.007420358,0.00019778704,0.001022127,0.00020329571,0.000089431385,0.0000044682147,0.000014341027,0.00512251],"genre_scores_gemma":[0.9981999,0.00056921877,0.0007817703,0.00019438844,0.0000977164,0.0000012148463,0.0000071543877,0.000017818145,0.00013081021],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99846464,0.000050110186,0.0009340157,0.00009919972,0.00022092271,0.00023110762],"domain_scores_gemma":[0.9989728,0.00003795889,0.00051366334,0.00012777562,0.00028045266,0.000067383706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009083506,0.000106115396,0.0006367423,0.00013474439,0.000046995516,0.000010902739,0.00014161532,0.00014537056,0.000301315],"category_scores_gemma":[0.00007039733,0.000116305004,0.00021889324,0.00010995888,0.00017502811,0.00011773777,0.000025400044,0.00030845345,0.000022392427],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014656257,0.0021997362,0.42762864,0.0009220144,0.0011037461,0.0959416,0.00048569814,0.00016639047,0.058944263,0.00452453,0.2683938,0.13822395],"study_design_scores_gemma":[0.008481225,0.0004419041,0.2773433,0.0008026362,0.0003716928,0.6401782,0.0006447984,0.00008214861,0.019964114,0.0024559724,0.04892306,0.00031094937],"about_ca_topic_score_codex":0.000080535865,"about_ca_topic_score_gemma":0.00001179037,"teacher_disagreement_score":0.5442366,"about_ca_system_score_codex":0.000024872641,"about_ca_system_score_gemma":0.00018468562,"threshold_uncertainty_score":0.47427803},"labels":[],"label_agreement":null},{"id":"W2060268129","doi":"10.1111/bjd.13163","title":"The Hidradenitis Suppurativa Priority Setting Partnership","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Medicine; General partnership; Library science; Political science; Law; Computer science","score_opus":0.010793316099065309,"score_gpt":0.2707435683111784,"score_spread":0.2599502522121131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060268129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7816574,0.0062717036,0.00107943,0.1932407,0.0011958135,0.000541361,0.000011849024,0.00008406306,0.015917696],"genre_scores_gemma":[0.99816465,0.0003629288,0.00063273445,0.000050406266,0.00030515957,0.0000047914273,0.000006801964,0.000020560658,0.00045197151],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980771,0.00044061095,0.00064467464,0.0001369672,0.00031587825,0.00038477025],"domain_scores_gemma":[0.99845755,0.0005447584,0.00035219218,0.00016294197,0.0002512257,0.00023130428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002816317,0.00014073408,0.00046066835,0.00006714124,0.00038334238,0.000104880135,0.000159351,0.00012432803,0.00007110516],"category_scores_gemma":[0.0008149592,0.0001117112,0.00019148385,0.00011988247,0.00022724752,0.00019985951,0.000033418957,0.00050535594,0.00004300906],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030033087,0.00035502153,0.16841528,0.00008423249,0.00048145294,0.521759,0.000759977,1.0861723e-7,0.0004704779,0.0022395372,0.023257207,0.28187737],"study_design_scores_gemma":[0.0022237848,0.000183358,0.015732238,0.00018060136,0.0001158734,0.95084184,0.00024228933,0.00003337473,0.0011458244,0.0009714538,0.028232459,0.00009689307],"about_ca_topic_score_codex":0.000017745773,"about_ca_topic_score_gemma":0.000053856955,"teacher_disagreement_score":0.42908284,"about_ca_system_score_codex":0.000047734884,"about_ca_system_score_gemma":0.0001754389,"threshold_uncertainty_score":0.45554504},"labels":[],"label_agreement":null},{"id":"W2062348457","doi":"10.1111/bjd.12583","title":"The interpretation of long-term trials of biologic treatments for psoriasis: trial designs and the choices of statistical analyses affect ability to compare outcomes across trials","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Adalimumab; Psoriasis; Clinical trial; Infliximab; Clinical study design; Research design; Intensive care medicine; Disease; Medical physics; Internal medicine; Dermatology; Rheumatoid arthritis","score_opus":0.2213100421307294,"score_gpt":0.46960002834956105,"score_spread":0.24828998621883164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062348457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.111579135,0.87962496,0.0012481112,0.000041921867,0.0012358478,0.0040812967,0.0021799167,0.0000053488816,0.0000034702264],"genre_scores_gemma":[0.23188138,0.7672058,0.00023107183,0.00000783692,0.0000620893,0.0003703156,0.00020416392,0.000019273644,0.000018123294],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98077583,0.013320046,0.0051526623,0.00030019673,0.00009963571,0.00035159697],"domain_scores_gemma":[0.9500136,0.04230669,0.0069275023,0.00029832032,0.00040696305,0.000046963836],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0057349266,0.00043150724,0.009481273,0.00018024436,0.00020037933,0.000045294455,0.00058184715,0.00043048122,0.000041850893],"category_scores_gemma":[0.012072404,0.0002141501,0.0021538737,0.00015948186,0.0009842012,0.0000795023,0.00009205704,0.00022956416,0.000002517099],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022522025,0.0004354637,0.0023629915,0.0018538624,0.013455334,0.000022067226,0.00019908848,8.473967e-7,0.00009130757,0.00006584072,0.00026470303,0.95872647],"study_design_scores_gemma":[0.6105787,0.014783228,0.07266954,0.032364126,0.2088752,0.026018888,0.0017811388,0.0000072784824,0.010778186,0.002009672,0.017537458,0.0025965818],"about_ca_topic_score_codex":0.00013802103,"about_ca_topic_score_gemma":0.00016982296,"teacher_disagreement_score":0.9561299,"about_ca_system_score_codex":0.00004182888,"about_ca_system_score_gemma":0.00025743202,"threshold_uncertainty_score":0.9962493},"labels":[],"label_agreement":null},{"id":"W2066048636","doi":"10.1111/j.1365-2133.2009.09374.x","title":"Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Melanoma; Basal cell carcinoma; Referral; Biopsy; Dermatology; Primary care; Psychological intervention; Skin cancer; Radiology; Surgery; Basal cell; Pathology; Cancer; Internal medicine","score_opus":0.015618427519693827,"score_gpt":0.3092356060656229,"score_spread":0.29361717854592906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066048636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861784,0.002380628,0.009700608,0.00025909225,0.0003317139,0.0009194145,0.000021603935,0.000008895252,0.00019963305],"genre_scores_gemma":[0.998525,0.00061402144,0.00069360225,0.00004132032,0.000060388644,0.000010200481,0.00002580598,0.000012362266,0.000017300881],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985076,0.00006178455,0.00088445575,0.00014620324,0.00019129814,0.00020865309],"domain_scores_gemma":[0.999238,0.000048860868,0.0003670582,0.000117466254,0.00015322119,0.000075405216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001393914,0.00012788363,0.00048447712,0.00023070622,0.000056268742,0.000045391993,0.000114215545,0.000058022382,0.000018449804],"category_scores_gemma":[0.000020939813,0.000114642506,0.00035262978,0.00012501121,0.00010371709,0.00014665994,0.00005421574,0.00017115197,1.9871993e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04240887,0.0018966829,0.018752804,0.0014280056,0.0018578889,0.0089836875,0.0005362732,0.00003665845,0.010901557,0.00014841625,0.0009670676,0.9120821],"study_design_scores_gemma":[0.20855291,0.008778824,0.4911934,0.0071649044,0.003525633,0.26463845,0.0038328469,0.0010969981,0.009186637,0.000773737,0.00057027047,0.0006853485],"about_ca_topic_score_codex":0.00003429946,"about_ca_topic_score_gemma":0.000017852475,"teacher_disagreement_score":0.91139674,"about_ca_system_score_codex":0.00014944616,"about_ca_system_score_gemma":0.00007471831,"threshold_uncertainty_score":0.46749857},"labels":[],"label_agreement":null},{"id":"W2066966639","doi":"10.1111/j.1365-2133.2009.09572.x","title":"Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Innovaderm (Canada)","funders":"Division of Chemistry; Basilea Pharmaceutica","keywords":"Medicine; Placebo; Randomized controlled trial; Adverse effect; Dermatology; Physical therapy; Surgery; Internal medicine; Alternative medicine","score_opus":0.002944624182156752,"score_gpt":0.21106614131133408,"score_spread":0.20812151712917734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066966639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995468,0.0023279034,0.000045760517,0.0014212739,0.000046037283,0.00025684654,0.0000032763676,0.0000074991626,0.0004233688],"genre_scores_gemma":[0.99887943,0.0002584904,0.00037990187,0.00033382178,0.00004581506,0.0000025060585,0.000019009694,0.000013212738,0.000067834786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989174,0.000067560664,0.00035329693,0.00014939926,0.00022945841,0.0002829082],"domain_scores_gemma":[0.99935174,0.000027559447,0.00022942782,0.0001087164,0.00014026956,0.00014228858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051090483,0.00014752803,0.00054563495,0.00012332515,0.00007606553,0.000029910676,0.000059313294,0.000099447585,0.00004447708],"category_scores_gemma":[0.000015605487,0.00010034293,0.00006186062,0.00015207854,0.000086593005,0.00013087303,0.0000071829627,0.00023372479,0.0000042698907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020054553,0.0011913695,0.9426119,0.00004070731,0.00021165682,0.029242788,0.00011823329,0.000008413633,0.000022231241,0.000009679092,0.0016566457,0.022880927],"study_design_scores_gemma":[0.025771048,0.006288608,0.9193617,0.0012232852,0.00021529564,0.045520008,0.00004105971,0.000008317774,0.0008768091,0.000026351494,0.00053703133,0.00013049337],"about_ca_topic_score_codex":0.000047888432,"about_ca_topic_score_gemma":0.000094002244,"teacher_disagreement_score":0.023765592,"about_ca_system_score_codex":0.00012902752,"about_ca_system_score_gemma":0.00015256529,"threshold_uncertainty_score":0.40918657},"labels":[],"label_agreement":null},{"id":"W2067033715","doi":"10.1111/j.1365-2133.2006.07466.x","title":"Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dysplasia; Dermatology; Odds ratio; Melanoma; Risk factor; Dysplastic nevus; Nevus; Confidence interval; Family history; Grading (engineering); Pathology; Internal medicine","score_opus":0.009083285836853385,"score_gpt":0.22601710826591484,"score_spread":0.21693382242906145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067033715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93895525,0.0006801241,0.056390025,0.001798188,0.0003805083,0.0005357234,0.000054505566,0.00004356418,0.0011620868],"genre_scores_gemma":[0.9926453,0.000063779495,0.0058673834,0.00041372576,0.00015982974,0.000017314462,0.0000042276833,0.000024183772,0.000804243],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99870133,0.00007103702,0.0005105964,0.00019837255,0.00020766344,0.0003110244],"domain_scores_gemma":[0.9990062,0.00013600914,0.0003098722,0.00010212185,0.00025352888,0.00019226832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066561486,0.00015210285,0.00057571003,0.00017988746,0.00012946225,0.000043165834,0.000096461205,0.00012281789,0.00015899864],"category_scores_gemma":[0.00015442612,0.00013563952,0.00013129694,0.000113572954,0.000057787558,0.000059339618,0.000024413916,0.00028679022,0.000019818874],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04381361,0.0035409287,0.07409799,0.0012524694,0.003375866,0.34261325,0.00063111057,0.0037521466,0.0049972166,0.0021081264,0.21035281,0.30946448],"study_design_scores_gemma":[0.0063274205,0.001990666,0.033189412,0.00021627895,0.00042746976,0.90778387,0.000092335744,0.00062674866,0.0009306225,0.00033052967,0.047828145,0.00025652134],"about_ca_topic_score_codex":0.00005031866,"about_ca_topic_score_gemma":0.0003242104,"teacher_disagreement_score":0.5651706,"about_ca_system_score_codex":0.000102456004,"about_ca_system_score_gemma":0.00008836497,"threshold_uncertainty_score":0.5531219},"labels":[],"label_agreement":null},{"id":"W2067243972","doi":"10.1111/bjd.13462","title":"A global perspective on the epidemiology of acne","year":2015,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":748,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"Les Laboratories Pierre Fabre","keywords":"Acne; Epidemiology; Disease; Medicine; Population; Perspective (graphical); Environmental health; Dermatology; Pathology; Computer science","score_opus":0.09316110181563922,"score_gpt":0.41973472231953557,"score_spread":0.3265736205038964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067243972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021361747,0.9943742,0.000024783876,0.0016183879,0.00034688498,0.00035112508,0.0000480262,0.0000049667574,0.003017996],"genre_scores_gemma":[0.001730086,0.9973959,0.00011260317,0.00040865713,0.00023507248,0.000007445158,0.000010710395,0.000017306102,0.0000822584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975535,0.0008750495,0.00096744316,0.00016770298,0.00016962244,0.0002666254],"domain_scores_gemma":[0.9972845,0.00073316216,0.0012219117,0.00019025135,0.00040229983,0.0001679206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005029841,0.00023147049,0.0034169292,0.000093182876,0.000054063898,0.000003974337,0.0002058126,0.00040427374,0.000050981827],"category_scores_gemma":[0.0012147992,0.0001325161,0.00082696776,0.0001841945,0.00023890584,0.000027875036,0.00004785,0.0005458416,0.000022501665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016235671,0.000508326,0.00073961995,0.0025887163,0.0026356133,0.017021146,0.00006441471,3.7140114e-7,2.1739206e-8,0.0046082768,0.0999664,0.87170476],"study_design_scores_gemma":[0.0009735151,0.000590308,0.00019296072,0.0122624,0.0019560894,0.43022075,0.00012986032,6.5427815e-7,2.6512834e-7,0.0010285185,0.552551,0.0000937131],"about_ca_topic_score_codex":0.00007197299,"about_ca_topic_score_gemma":0.000009052234,"teacher_disagreement_score":0.871611,"about_ca_system_score_codex":0.00028307395,"about_ca_system_score_gemma":0.0007259126,"threshold_uncertainty_score":0.54038495},"labels":[],"label_agreement":null},{"id":"W2067426415","doi":"10.1111/j.1365-2133.1973.tb07562.x","title":"Skin lesions in tyrosinosis: response to dietary treatment","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Tyrosine; Medicine; Abnormality; Hyperkeratosis; Concomitant; Skin lesion; Phenylalanine; Internal medicine; Physiology; Dermatology; Biology; Biochemistry","score_opus":0.009675249115818563,"score_gpt":0.25975792247437973,"score_spread":0.25008267335856116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067426415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962045,0.0021919755,0.00031325532,0.0008608822,0.00014466587,0.00007750349,0.000008567511,0.0000019864744,0.0001966823],"genre_scores_gemma":[0.99817014,0.00038268568,0.00092109345,0.00021764988,0.00010353856,0.0000066431503,0.000020098458,0.000008642875,0.00016951888],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99913335,0.00019813763,0.0003347881,0.00011084902,0.000072166484,0.00015071857],"domain_scores_gemma":[0.99969876,0.00002244458,0.00009434194,0.00007700827,0.000049347505,0.000058104928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010084876,0.00007250606,0.00016378597,0.00009013577,0.000037913924,0.000017314724,0.000088053566,0.00008741211,0.000013931103],"category_scores_gemma":[0.000047124377,0.000079419064,0.000071843606,0.00006712334,0.000024567478,0.0000042178594,0.000019924211,0.00005238401,0.00000654286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002541571,0.00091745163,0.05258658,0.0000132900905,0.00008536173,0.00630929,0.00018528423,0.00035712335,0.83769846,0.000045806097,0.043106847,0.056152962],"study_design_scores_gemma":[0.0032596432,0.000860315,0.56288725,0.00010145323,0.000029080664,0.039717298,0.0001936728,0.000011194357,0.3626515,0.00015904767,0.02991176,0.00021780818],"about_ca_topic_score_codex":0.00013856382,"about_ca_topic_score_gemma":0.00051474874,"teacher_disagreement_score":0.51030064,"about_ca_system_score_codex":0.000028984772,"about_ca_system_score_gemma":0.0000640771,"threshold_uncertainty_score":0.32386154},"labels":[],"label_agreement":null},{"id":"W2069236338","doi":"10.1111/bjd.13745","title":"A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"U.S. Food and Drug Administration; Astellas Pharma","keywords":"Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Dosing; Adverse effect; Body surface area; Internal medicine; Clinical endpoint; Dermatology Life Quality Index; Clinical trial; Gastroenterology; Randomized controlled trial; Janus kinase; Urology; Cytokine; Dermatology; Pathology","score_opus":0.026855971073515394,"score_gpt":0.28088120055266036,"score_spread":0.25402522947914496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069236338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935749,0.0012638522,0.00047928243,0.00028601766,0.00062281726,0.0036454184,0.000048940587,0.000009812541,0.00006893949],"genre_scores_gemma":[0.99947387,0.00003752519,0.0001683893,0.00006750356,0.000048850583,0.000116347255,0.00003354308,0.000022352027,0.00003160795],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964709,0.0014462838,0.0012330381,0.00030016352,0.00019129478,0.0003582927],"domain_scores_gemma":[0.99806195,0.0005264151,0.0005095358,0.00019376593,0.00058525056,0.00012306812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013477303,0.0002803851,0.001513604,0.00035785243,0.00014942796,0.000047470265,0.00023086015,0.00018823367,0.000023702929],"category_scores_gemma":[0.00039884786,0.00020345513,0.0001545792,0.00028821113,0.00015713897,0.00018946751,0.0000931701,0.0003035726,0.000012998179],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9746612,0.0048656194,0.0063219015,0.000008928287,0.0014264449,0.00022677529,0.0023526598,0.00041888285,0.00035059973,0.00001947589,0.00018435834,0.009163186],"study_design_scores_gemma":[0.9853927,0.002118518,0.0062675574,0.00015237421,0.0010386733,0.0030682292,0.00051878125,0.000024312789,0.0011251826,0.000023321341,0.000050203238,0.00022015549],"about_ca_topic_score_codex":0.00023251775,"about_ca_topic_score_gemma":0.00034690232,"teacher_disagreement_score":0.010731523,"about_ca_system_score_codex":0.00007678141,"about_ca_system_score_gemma":0.0002606599,"threshold_uncertainty_score":0.82966596},"labels":[],"label_agreement":null},{"id":"W2069588504","doi":"10.1111/j.1365-2133.2005.06877.x","title":"Pathogenetic mechanisms of vitiligo in a patient with Sezary syndrome","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Vitiligo; Medicine; Dermatology","score_opus":0.0032796574327813408,"score_gpt":0.20010785059721187,"score_spread":0.19682819316443054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069588504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940919,0.0016961391,0.003818235,0.000114972085,0.00005643373,0.000072173854,0.000006961758,0.0000012196735,0.00014192663],"genre_scores_gemma":[0.9954107,0.00028732553,0.0040854276,0.00016314656,0.000019765313,0.000003208596,0.0000110528645,0.000009785643,0.000009632631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991671,0.000089981804,0.00039055897,0.00009965145,0.00012073606,0.00013198229],"domain_scores_gemma":[0.9995555,0.000008448833,0.00023032425,0.00007524116,0.00008156054,0.000048869722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007093516,0.00006958685,0.00020121585,0.000067656525,0.000015880732,0.000006640113,0.00009558235,0.000088446366,0.00002252992],"category_scores_gemma":[0.000019723993,0.000072966024,0.000048326023,0.00005596535,0.000039324455,0.00000571229,0.000023565315,0.00008157521,0.000001277658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051920343,0.0006876011,0.010491402,0.00009331931,0.00017369607,0.018426776,0.00027750366,0.00048371157,0.8870336,0.00018613544,0.0015190826,0.08010797],"study_design_scores_gemma":[0.0021540115,0.0008022339,0.010375224,0.00018245589,0.000026376369,0.4438267,0.00029709813,0.000061397346,0.5411753,0.00030468596,0.0006390403,0.00015549434],"about_ca_topic_score_codex":0.000008912722,"about_ca_topic_score_gemma":0.000096739925,"teacher_disagreement_score":0.4253999,"about_ca_system_score_codex":0.000009119426,"about_ca_system_score_gemma":0.000059822458,"threshold_uncertainty_score":0.2975468},"labels":[],"label_agreement":null},{"id":"W2074314525","doi":"10.1111/j.1365-2133.2009.09145.x","title":"Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Pimecrolimus; Medicine; Atopic dermatitis; Randomized controlled trial; Dermatology; Staphylococcus aureus; Tacrolimus; Clinical trial; Superantigen; Internal medicine; Allergy; Erythema; Immunology; Transplantation","score_opus":0.007860142340897273,"score_gpt":0.27181637742829534,"score_spread":0.2639562350873981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074314525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993539,0.0017262776,0.000096847994,0.0016140176,0.00017012397,0.0027779993,0.0000059564554,0.0000056116783,0.00006417937],"genre_scores_gemma":[0.99805313,0.00060519914,0.00018436777,0.0010533924,0.000057432913,0.00003141027,0.0000037881196,0.0000073460883,0.00000392879],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959708,0.0016839905,0.0016301457,0.00016082708,0.0002914108,0.0002628168],"domain_scores_gemma":[0.99617445,0.0025101586,0.00071062084,0.0001608672,0.00026621853,0.00017768539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025052179,0.0001767954,0.0024271226,0.0001489455,0.000039400275,0.000013675438,0.0001231149,0.00017930371,0.000007795495],"category_scores_gemma":[0.0012352997,0.00011829645,0.00048837764,0.00013859425,0.00028869553,0.000080358506,0.000009878055,0.00024017232,0.000001346733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6768309,0.01638938,0.2623921,0.000100605925,0.0006205008,0.014511328,0.00064705685,0.0000024045669,0.000010744615,0.000020365187,0.00033446448,0.028140124],"study_design_scores_gemma":[0.5250156,0.0025126792,0.46607423,0.00031437774,0.00059454667,0.005056561,0.000032303546,0.00003455425,0.00022658586,0.000058722886,0.000021884765,0.00005798936],"about_ca_topic_score_codex":0.000027846387,"about_ca_topic_score_gemma":0.000059238533,"teacher_disagreement_score":0.2036821,"about_ca_system_score_codex":0.000026103058,"about_ca_system_score_gemma":0.00016716798,"threshold_uncertainty_score":0.48239893},"labels":[],"label_agreement":null},{"id":"W2074749048","doi":"10.1111/j.1365-2133.2004.05696.x","title":"Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Novartis Pharma; Novartis","keywords":"Eczema Area and Severity Index; Pimecrolimus; Atopic dermatitis; Medicine; SCORAD; Dermatology; Placebo; Dermatology Life Quality Index; Population; Randomized controlled trial; Clinical endpoint; Severity of illness; Calcineurin; Internal medicine; Psoriasis; Pathology","score_opus":0.029370789385876794,"score_gpt":0.32502904911414104,"score_spread":0.29565825972826426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074749048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014753,0.0033862942,0.00051046064,0.0027624744,0.00030957087,0.0027859658,0.00005404158,0.000004668452,0.00003896609],"genre_scores_gemma":[0.998146,0.000873399,0.00022080817,0.00060034596,0.000044935874,0.000081772065,0.000020758103,0.0000092642495,0.0000027152191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941794,0.0023602638,0.002879508,0.00013674282,0.00025157517,0.00019247997],"domain_scores_gemma":[0.9918874,0.005333816,0.0020665755,0.00016344801,0.0004523771,0.0000963768],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002524421,0.00013149138,0.0030494716,0.00007757493,0.00006536534,0.00001732872,0.00017512332,0.00024326732,0.000018217846],"category_scores_gemma":[0.016364189,0.000081773804,0.00077866326,0.00010123657,0.0005991356,0.00009196906,0.000041409057,0.00030049492,2.4507358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036191195,0.0010327095,0.95733696,0.00007812417,0.00093091646,0.00016178661,0.00015302235,0.0000045403194,0.0000044788094,0.000051238483,0.00078663416,0.0032683937],"study_design_scores_gemma":[0.3644657,0.000089790585,0.6235475,0.00054508843,0.0010245932,0.0040628547,0.00007343748,0.00006249698,0.00043085674,0.005589288,0.00004971068,0.000058658185],"about_ca_topic_score_codex":0.0002054632,"about_ca_topic_score_gemma":0.00010274806,"teacher_disagreement_score":0.33378944,"about_ca_system_score_codex":0.000022135157,"about_ca_system_score_gemma":0.00032181496,"threshold_uncertainty_score":0.99192137},"labels":[],"label_agreement":null},{"id":"W2078226469","doi":"10.1111/bjd.12517","title":"Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Placebo; Internal medicine; Gastroenterology; Ruxolitinib; Hematology; Pharmacology; Immunology; Myelofibrosis; Bone marrow; Pathology; Rheumatoid arthritis","score_opus":0.011939957086453021,"score_gpt":0.2302836348210307,"score_spread":0.2183436777345777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078226469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374014,0.0045559243,0.000009677275,0.00015017,0.00078755,0.0003768523,0.00007977103,0.000018635574,0.00028130476],"genre_scores_gemma":[0.99889344,0.00073067617,0.0001491212,0.00002151412,0.000028963777,0.000041701616,0.000025998925,0.000019156665,0.00008940192],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721384,0.0009762974,0.0010485755,0.00024657857,0.00008682569,0.0004279038],"domain_scores_gemma":[0.99799824,0.00076870224,0.0008033275,0.00021751037,0.00013853634,0.00007366821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016424041,0.00029903906,0.0013979711,0.0002633672,0.00010545466,0.000014331819,0.00024042338,0.00043720967,0.00038743883],"category_scores_gemma":[0.0002191738,0.00024795267,0.000532602,0.000117102005,0.000320474,0.00012411285,0.00004535522,0.00024235435,0.000078306635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008749991,0.004225218,0.16961624,0.00064380234,0.0058457684,0.012234636,0.0009659757,0.00003251017,0.2640868,0.00019877026,0.0032054568,0.5301948],"study_design_scores_gemma":[0.011271937,0.003654425,0.02483693,0.00035803928,0.00044827157,0.055176653,0.00011040648,8.7713175e-7,0.9034882,0.000061012423,0.0003861954,0.0002070267],"about_ca_topic_score_codex":0.00018537998,"about_ca_topic_score_gemma":0.00001762435,"teacher_disagreement_score":0.63940144,"about_ca_system_score_codex":0.000056232093,"about_ca_system_score_gemma":0.00006096682,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W2079101710","doi":"10.1111/j.1365-2133.2009.09116.x","title":"Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"LEO Pharma","keywords":"Calcipotriol; Scalp; Medicine; Betamethasone; Betamethasone dipropionate; Dermatology; Adverse effect; Randomized controlled trial; Psoriasis; Randomization; Surgery; Internal medicine","score_opus":0.014460332997114416,"score_gpt":0.25436953819956776,"score_spread":0.23990920520245335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079101710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741073,0.021176336,0.0006560565,0.00051362626,0.00032493993,0.003105537,0.000031690826,0.000010548353,0.00007393025],"genre_scores_gemma":[0.9958484,0.0036443705,0.00024999963,0.00003140347,0.00005551815,0.000080703794,0.000055061497,0.0000112789485,0.000023234443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952731,0.0021596197,0.0018373372,0.0002317838,0.00014472965,0.00035343596],"domain_scores_gemma":[0.99630004,0.0018191801,0.0014096156,0.00018049,0.0002461574,0.000044492703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008310759,0.00028537196,0.002973653,0.00031835496,0.00015605036,0.000018091183,0.00019644904,0.00033563864,0.000026808077],"category_scores_gemma":[0.0002904189,0.00018372638,0.0004952486,0.00024314696,0.00036581114,0.00013739931,0.000012904943,0.0002095008,0.0000017952209],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93851185,0.0018689777,0.00038471314,0.000018848043,0.0012748427,0.00020306773,0.0013486884,0.00005826886,0.002296017,0.00018150646,0.00005026886,0.053802926],"study_design_scores_gemma":[0.9702832,0.0026847597,0.014372439,0.00025794748,0.0016824603,0.006638624,0.00019517375,0.000112057256,0.003293,0.00017945285,0.00012873737,0.00017211722],"about_ca_topic_score_codex":0.00016441486,"about_ca_topic_score_gemma":0.000118376905,"teacher_disagreement_score":0.05363081,"about_ca_system_score_codex":0.00009021144,"about_ca_system_score_gemma":0.00019092031,"threshold_uncertainty_score":0.7492144},"labels":[],"label_agreement":null},{"id":"W2079960625","doi":"10.1111/j.1365-2133.2007.08227.x","title":"Usefulness of the QuantiFERON<sup>®</sup>test in the confirmation of latent tuberculosis in association with erythema induratum","year":2007,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Histopathology; Medicine; Dermatology; Queen (butterfly); Pathology; Biology","score_opus":0.012837998284444572,"score_gpt":0.23521678231300897,"score_spread":0.2223787840285644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079960625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8810299,0.0005896828,0.000016734612,0.11749812,0.00016361021,0.0004261837,0.000047928123,0.000004026151,0.00022380645],"genre_scores_gemma":[0.9638311,0.00028016022,0.000016442935,0.035537858,0.00023259249,0.000011566087,0.000041945634,0.000028951488,0.00001936571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680895,0.0005534252,0.0013455108,0.00015698944,0.0007912492,0.00034386996],"domain_scores_gemma":[0.9968282,0.0007019859,0.0015976633,0.00023283626,0.0006016464,0.000037688387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006400064,0.00021260562,0.0009816524,0.0004127277,0.00005170523,0.00002885469,0.00026744473,0.00073375186,0.000040778283],"category_scores_gemma":[0.00049232296,0.00014881254,0.0003115636,0.0005382569,0.0001418561,0.00012186966,0.000030360483,0.002102996,0.0000018357462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001051236,0.00049909146,0.8998935,0.00062534446,0.0003062401,0.0036363953,0.0006002073,0.000056652218,0.000015193605,0.00001634838,0.09383161,0.0004142906],"study_design_scores_gemma":[0.0042695655,0.00029828402,0.89972454,0.0042765383,0.00090446486,0.08512631,0.00048465747,0.00012729249,0.00088066206,0.0000975734,0.0035668926,0.0002431889],"about_ca_topic_score_codex":0.00061612384,"about_ca_topic_score_gemma":0.00036267014,"teacher_disagreement_score":0.09026472,"about_ca_system_score_codex":0.00022012915,"about_ca_system_score_gemma":0.00029283634,"threshold_uncertainty_score":0.91365874},"labels":[],"label_agreement":null},{"id":"W2080237150","doi":"10.1111/bjd.13814","title":"Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Novartis Pharma","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Dosing; Randomized controlled trial; Interleukin 17; Internal medicine; Dermatology; Cytokine; Psoriatic arthritis","score_opus":0.01857271942566301,"score_gpt":0.2995247510734746,"score_spread":0.2809520316478116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080237150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219603,0.008200681,0.0001798582,0.0033727784,0.003935269,0.0019198545,0.000059720838,0.000016484433,0.00011932333],"genre_scores_gemma":[0.9987035,0.00031366138,0.000121516365,0.00016543832,0.00020082157,0.0001990613,0.000028073408,0.000022850347,0.00024510827],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98767424,0.009109713,0.0021087164,0.00035081897,0.00014196453,0.00061457884],"domain_scores_gemma":[0.996177,0.002338327,0.0009104038,0.00025280277,0.00020821829,0.00011325566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004428375,0.00031882472,0.0022379872,0.00057222164,0.00013833266,0.00011138695,0.0003299927,0.0004422373,0.000029018096],"category_scores_gemma":[0.004150757,0.00023065764,0.00057462096,0.00030926144,0.0002293701,0.00022940725,0.00005082356,0.00048176755,0.000028809996],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9636871,0.0010894039,0.000029679606,0.000002326483,0.00070135423,0.0076218285,0.0016224318,0.00007562303,0.003769846,0.000017068418,0.0011478766,0.020235466],"study_design_scores_gemma":[0.9704822,0.0017520977,0.00022422538,0.00010489027,0.00047198447,0.018297533,0.0016051459,0.000028881715,0.004534053,0.00015786766,0.0021261664,0.00021498486],"about_ca_topic_score_codex":0.0002861259,"about_ca_topic_score_gemma":0.00029631273,"teacher_disagreement_score":0.020020481,"about_ca_system_score_codex":0.0002900097,"about_ca_system_score_gemma":0.0010200525,"threshold_uncertainty_score":0.94059455},"labels":[],"label_agreement":null},{"id":"W2081479967","doi":"10.1111/j.1365-2133.2008.08962.x","title":"Economic evaluation of systemic therapies for moderate to severe psoriasis","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Abbott Laboratories","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Efalizumab; Ciclosporin; Psoriasis; Psoriasis Area and Severity Index; Confidence interval; Quality-adjusted life year; Methotrexate; Internal medicine; Cost effectiveness; Transplantation; Dermatology; Rheumatoid arthritis; Tumor necrosis factor alpha","score_opus":0.030662793363812158,"score_gpt":0.26129945777624486,"score_spread":0.2306366644124327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081479967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97591734,0.021791903,0.00043797313,0.00020312222,0.0011163907,0.00031506614,0.00008637976,0.00000878263,0.00012301972],"genre_scores_gemma":[0.99771637,0.0016498701,0.00036141416,0.00004559161,0.000059778165,0.00003363591,0.000020467278,0.000014056537,0.0000988082],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9986364,0.00037390448,0.00060040347,0.00013509094,0.000048307804,0.0002058479],"domain_scores_gemma":[0.998911,0.00016348869,0.0004116526,0.00010621385,0.00038024609,0.000027402028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033674724,0.00011592723,0.0005356963,0.00015113696,0.00013937062,0.000007121218,0.00016831221,0.00018597287,0.00013264202],"category_scores_gemma":[0.00007922359,0.00012255952,0.00018819637,0.00004658923,0.000069552385,0.0001285786,0.000016793101,0.00008059174,0.000041098465],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009609562,0.0012143163,0.048669003,0.0003472484,0.011263975,0.0010265227,0.013768843,0.004023078,0.15000263,0.0014856324,0.077629924,0.6809593],"study_design_scores_gemma":[0.03346061,0.00090369117,0.03477404,0.0006908839,0.0019109123,0.7404744,0.0020477485,0.000113122194,0.17764182,0.0015438569,0.005717867,0.00072106585],"about_ca_topic_score_codex":0.000037141985,"about_ca_topic_score_gemma":0.00004839187,"teacher_disagreement_score":0.73944783,"about_ca_system_score_codex":0.00007073365,"about_ca_system_score_gemma":0.00030034274,"threshold_uncertainty_score":0.4997832},"labels":[],"label_agreement":null},{"id":"W2082530084","doi":"10.1111/bjd.12343","title":"Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Imiquimod; Actinic keratosis; Medicine; Cryotherapy; Placebo; Psychological intervention; Meta-analysis; Dermatology; Randomized controlled trial; Internal medicine; Surgery; Pathology; Alternative medicine; Psychiatry","score_opus":0.4646027338780947,"score_gpt":0.4694573342131769,"score_spread":0.0048546003350822264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082530084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037350834,0.99588114,0.000038813694,0.0009455748,0.00048512674,0.001971083,0.0002678836,0.0000036291603,0.00003325518],"genre_scores_gemma":[0.02536871,0.9732774,0.00024388748,0.00035773744,0.000051817733,0.0005670343,0.00002191312,0.000047412632,0.00006408825],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9921577,0.0010323249,0.005444502,0.00032017488,0.0004751814,0.0005701462],"domain_scores_gemma":[0.9921221,0.0014568198,0.0051054433,0.00065023877,0.0005524546,0.00011293902],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011107918,0.00041566737,0.015390816,0.00038996225,0.00008776233,0.000017351169,0.0006104527,0.00022779717,0.00033229165],"category_scores_gemma":[0.0011984867,0.00028800275,0.0098878965,0.0011608567,0.00027187035,0.00007187086,0.00014692142,0.0007815976,0.000005480141],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059665577,0.0014187319,0.0017957366,0.2846068,0.6208088,0.00078998663,0.00026798475,0.000033221302,0.0000019888162,0.000097299504,0.018216353,0.07136645],"study_design_scores_gemma":[0.002335273,0.00031558497,0.00310045,0.1671185,0.73408484,0.0044424846,0.00003225214,0.000010944225,0.0000069751177,0.000030641055,0.08824637,0.000275698],"about_ca_topic_score_codex":0.000057204994,"about_ca_topic_score_gemma":0.00032775494,"teacher_disagreement_score":0.11748832,"about_ca_system_score_codex":0.000080613965,"about_ca_system_score_gemma":0.00027805462,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W2082814239","doi":"10.1046/j.1365-2133.2003.05160.x","title":"Computerized morphometry and three-dimensional image reconstruction in the evaluation of scalp biopsy from patients with non-cicatricial alopecias","year":2003,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia; St. Thomas Hospital; Vancouver General Hospital; Western University","funders":"","keywords":"Scalp; Medicine; Biopsy; Dermatology; Pathology","score_opus":0.010561696971454405,"score_gpt":0.2411759458217928,"score_spread":0.2306142488503384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082814239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975893,0.0007264967,0.00088607357,0.00021958126,0.00014330674,0.00021089047,0.00000825862,0.0000018332429,0.00021425336],"genre_scores_gemma":[0.99248874,0.000028136907,0.007314155,0.00012040973,0.00002808971,0.0000019317422,0.000012400924,0.000005908918,2.5399126e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987724,0.00021923085,0.00041819928,0.00009870738,0.00037808003,0.000113421665],"domain_scores_gemma":[0.9991315,0.00010314621,0.00025964133,0.00006478462,0.00038605346,0.000054890494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031226926,0.000071709415,0.00031926285,0.0001759402,0.000038151284,0.000012781766,0.000052196185,0.00007442275,0.000057725098],"category_scores_gemma":[0.00022226338,0.000057254336,0.00004302818,0.00022639774,0.00014563193,0.00011211459,0.000008328248,0.00018186212,0.0000010877301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006222127,0.0004305419,0.9119047,0.000025340207,0.0000902892,0.0004978189,0.00014980376,0.000006553311,0.00050599984,0.00001343314,0.00040815354,0.08534518],"study_design_scores_gemma":[0.012060361,0.00013169885,0.95597535,0.00016915807,0.00014424007,0.03004122,0.00014134111,0.00043064044,0.0002820212,0.0005410092,0.000019226141,0.000063737214],"about_ca_topic_score_codex":0.00009367438,"about_ca_topic_score_gemma":0.00008370718,"teacher_disagreement_score":0.08528145,"about_ca_system_score_codex":0.000018648196,"about_ca_system_score_gemma":0.00014521305,"threshold_uncertainty_score":0.23347642},"labels":[],"label_agreement":null},{"id":"W2083054661","doi":"10.1046/j.1365-2133.149.s65.5.x","title":"Onychomycosis in clinical practice: factors contributing to recurrence","year":2003,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Galderma","keywords":"Medicine; Disease; Psoriasis; Dermatology; Population; Nail disease; Diabetes mellitus; Nail (fastener); Intensive care medicine; Internal medicine","score_opus":0.07794931063022224,"score_gpt":0.4641900335995579,"score_spread":0.38624072296933565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083054661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012711994,0.9965877,0.000036125755,0.00021067524,0.0008683414,0.00057063706,0.000060678532,0.000006567774,0.00038808002],"genre_scores_gemma":[0.0017753489,0.99686784,0.000794146,0.0003428999,0.000113013215,0.0000107469505,0.000035672067,0.000032857653,0.000027503183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955994,0.0008667681,0.0024371436,0.0002901306,0.00029992798,0.00050663325],"domain_scores_gemma":[0.9962022,0.0012317366,0.0015003755,0.00018281612,0.0003681868,0.0005147017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005814602,0.00027515175,0.0032727693,0.00030412053,0.000057577483,0.000044083503,0.00018554066,0.0004278777,0.00006733006],"category_scores_gemma":[0.0067107165,0.0002538518,0.0009033806,0.00038440194,0.00005379379,0.00012318684,0.00005585829,0.0011881298,0.00004712719],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005701403,0.0007602089,0.018879471,0.0014045456,0.00051777635,0.043379087,0.000008440435,2.1788004e-8,4.0490007e-9,0.00001138626,0.0035186324,0.9314634],"study_design_scores_gemma":[0.0016290717,0.00018087201,0.0036181058,0.024233999,0.0019892077,0.20349808,0.000033995926,7.976211e-8,1.4944415e-7,0.000010168467,0.7646571,0.00014917104],"about_ca_topic_score_codex":0.000027100557,"about_ca_topic_score_gemma":0.000010246938,"teacher_disagreement_score":0.93131423,"about_ca_system_score_codex":0.00019624834,"about_ca_system_score_gemma":0.0009721735,"threshold_uncertainty_score":0.99999136},"labels":[],"label_agreement":null},{"id":"W2083117221","doi":"10.1111/j.1365-2133.1978.tb06543.x","title":"Erythema gyratum repens with pulmonary tuberculosis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Clearance; Pathology; Lung; Erythema multiforme; Repens; Dermatology; Internal medicine; Biology","score_opus":0.004004797568197451,"score_gpt":0.20833120747884123,"score_spread":0.2043264099106438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083117221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977226,0.010213877,0.000045880864,0.0023452418,0.00012528195,0.000084490246,0.0000072156577,0.00002027648,0.009931708],"genre_scores_gemma":[0.9980015,0.00025050744,0.00078882766,0.00048114033,0.0002420321,0.000002727971,0.000011057649,0.000021063122,0.00020109984],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99895513,0.000044837972,0.00041020432,0.00012300414,0.00021637553,0.00025045656],"domain_scores_gemma":[0.9992171,0.000070530914,0.00020645454,0.00012178885,0.0002289978,0.00015516097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054073542,0.00010087616,0.000417587,0.00010355424,0.000058115947,0.000029357165,0.00007929171,0.000085308086,0.00017785901],"category_scores_gemma":[0.00007062666,0.00009214265,0.00015549088,0.000126969,0.000108462125,0.00011018705,0.000018442533,0.0002104785,0.000012836898],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000478391,0.0009416532,0.7603568,0.00014322097,0.00026214603,0.14501895,0.00001497887,0.0000076276574,0.0011687336,0.00030101658,0.0803803,0.010926179],"study_design_scores_gemma":[0.0015722449,0.00014315205,0.3526214,0.00042358894,0.00024829153,0.6388631,0.00008106408,0.000023288869,0.0018509967,0.0007468847,0.0033149512,0.00011102564],"about_ca_topic_score_codex":0.000066707486,"about_ca_topic_score_gemma":0.000020545627,"teacher_disagreement_score":0.49384415,"about_ca_system_score_codex":0.000021948023,"about_ca_system_score_gemma":0.00011321317,"threshold_uncertainty_score":0.37574682},"labels":[],"label_agreement":null},{"id":"W2083481300","doi":"10.1111/j.1365-2133.2010.10013.x","title":"Induction of p38, tumour necrosis factor-α and RANTES by mechanical stretching of keratinocytes expressing mutant keratin 10R156H","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Keratin; Mutant; Keratinocyte; Tumor necrosis factor alpha; Necrosis; Molecular biology; Medicine; Cancer research; Dermatology; Chemistry; Immunology; Pathology; Biology; Cell culture; Genetics; Gene","score_opus":0.008619020893956176,"score_gpt":0.2523322071968302,"score_spread":0.24371318630287403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083481300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961871,0.0027670101,0.0006273833,0.00012539489,0.00016617854,0.00006444502,0.000032143078,0.0000021880153,0.000028150562],"genre_scores_gemma":[0.99807656,0.00068367546,0.001093164,0.000022864024,0.00007649456,0.0000014355369,0.00002237828,0.000012398802,0.000011032682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877304,0.00019926303,0.0005341587,0.00016913004,0.00013108118,0.0001933399],"domain_scores_gemma":[0.99917954,0.000052056897,0.00036488264,0.00010516303,0.00021344476,0.0000849117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020215663,0.00010861136,0.0003530853,0.00007476527,0.0000739067,0.000026964375,0.00017748048,0.00028420956,0.000029983352],"category_scores_gemma":[0.000291861,0.00010997016,0.00009770263,0.000055428773,0.00025814032,0.000013004385,0.000090057125,0.00039635174,1.8846355e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000812301,0.00007386938,0.0071752598,0.000023684828,0.00006394703,0.000100575664,0.000043631553,4.7476195e-7,0.9846579,0.000024311825,0.00031546838,0.007439637],"study_design_scores_gemma":[0.0009116659,0.00017846614,0.0015861556,0.000060236835,0.00001729872,0.02565295,0.00016402146,0.00004359452,0.9709807,0.0001090873,0.00020251403,0.00009329804],"about_ca_topic_score_codex":0.000044665867,"about_ca_topic_score_gemma":0.000033465047,"teacher_disagreement_score":0.025552375,"about_ca_system_score_codex":0.0000031805196,"about_ca_system_score_gemma":0.00009083074,"threshold_uncertainty_score":0.4484453},"labels":[],"label_agreement":null},{"id":"W2084768692","doi":"10.1111/j.1365-2133.1975.tb03119.x","title":"The effect of the activity of psoriasis on the response to autologous ground skin extract","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Psoriasis; Stimulant; Medicine; Inhibitory postsynaptic potential; DNA synthesis; Dermatology; Pharmacology; DNA; Internal medicine; Chemistry; Biochemistry","score_opus":0.007098427813098961,"score_gpt":0.2267103106540354,"score_spread":0.21961188284093644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084768692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917855,0.0037848423,0.000029572433,0.0026807606,0.0011220383,0.0002775954,0.000031498956,0.000007265188,0.00028088473],"genre_scores_gemma":[0.99943745,0.00013188805,0.000015103267,0.000056401364,0.000043339474,0.000013179154,0.0000013825851,0.000012859222,0.00028840356],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99548346,0.0034196586,0.0005574363,0.00013956502,0.000094374285,0.00030549482],"domain_scores_gemma":[0.9942966,0.0045643076,0.0006854609,0.00032543266,0.000108857304,0.00001934824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010103495,0.00016932467,0.00053920207,0.00008594275,0.00037332866,0.000018275885,0.00058428146,0.00023637532,0.000043302887],"category_scores_gemma":[0.0006732515,0.00009059065,0.00037498528,0.00020405046,0.00041088153,0.000052717704,0.000072622,0.00036182988,0.000019951483],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032424215,0.00091818965,0.031864025,0.000058949292,0.002145325,0.0011215471,0.00055004563,0.000054558423,0.40016887,0.0010055664,0.036994763,0.49269396],"study_design_scores_gemma":[0.0023337256,0.00080315524,0.4201086,0.00011747545,0.0002450988,0.024911214,0.00006207813,5.9159555e-7,0.54109085,0.00016729695,0.010052971,0.00010694347],"about_ca_topic_score_codex":0.00021824607,"about_ca_topic_score_gemma":0.00019935859,"teacher_disagreement_score":0.492587,"about_ca_system_score_codex":0.000038631737,"about_ca_system_score_gemma":0.00010064455,"threshold_uncertainty_score":0.36941794},"labels":[],"label_agreement":null},{"id":"W2085238780","doi":"10.1111/bjd.13191","title":"A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; SKiN Health; University of British Columbia; Occupational Cancer Research Centre; Dermatrials Research; Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Medicine; Adapalene; Acne; Benzoyl peroxide; Adverse effect; Randomized controlled trial; Doxycycline; Fixed-dose combination; Population; Isotretinoin; Papulopustular; Dermatology; Confidence interval; Internal medicine; Surgery; Gastroenterology","score_opus":0.029301897707804354,"score_gpt":0.30113028524355123,"score_spread":0.2718283875357469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085238780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506314,0.0037319248,0.0025036563,0.004396487,0.0008262652,0.0030977696,0.000021711543,0.000038552105,0.00032049645],"genre_scores_gemma":[0.993241,0.00093741564,0.0035185374,0.001007056,0.0007379178,0.00014623423,0.000044705503,0.00004851505,0.0003185934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99640536,0.00077219895,0.0015466198,0.00035063984,0.00033581836,0.00058936543],"domain_scores_gemma":[0.99682087,0.0010407541,0.00092481455,0.0002471637,0.00034312878,0.0006232611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073858694,0.0004222333,0.004305833,0.00020166668,0.00026302895,0.000094576215,0.00016920411,0.00033963137,0.0000601918],"category_scores_gemma":[0.0017652959,0.00032486726,0.0012549962,0.00011598064,0.00027718645,0.00017172661,0.00004597295,0.00038649936,0.000014066076],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9725969,0.0012047325,0.0046893945,0.00016075862,0.002187398,0.0038055782,0.00024060167,0.00005982188,0.00019014878,0.00012644903,0.0070570665,0.0076811956],"study_design_scores_gemma":[0.92274916,0.0025861799,0.0005364013,0.00043157602,0.002166822,0.057859156,0.00007119269,0.0053717257,0.00062491605,0.00019159648,0.0071251,0.00028614723],"about_ca_topic_score_codex":0.0001900865,"about_ca_topic_score_gemma":0.00013221108,"teacher_disagreement_score":0.05405358,"about_ca_system_score_codex":0.00018157325,"about_ca_system_score_gemma":0.0006239229,"threshold_uncertainty_score":0.99992037},"labels":[],"label_agreement":null},{"id":"W2085929759","doi":"10.1111/j.1365-2133.2009.09626.x","title":"Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval","keywords":"Epidermolysis bullosa simplex; Keratin 5; Keratin 14; Intermediate filament; Keratin; Epidermolysis bullosa; Genetics; Biology; Mutation; Gene; Molecular biology; Cytoskeleton; Cell; Transgene; Genetically modified mouse","score_opus":0.004352177017664982,"score_gpt":0.23194460173512743,"score_spread":0.22759242471746244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085929759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971531,0.0009858604,0.0014474231,0.00018240917,0.000028332435,0.00011276677,0.00006476426,0.0000013772135,0.000023949635],"genre_scores_gemma":[0.9989941,0.000087643115,0.0006400855,0.0000437946,0.000023478078,0.000001254785,0.0001969272,0.0000065853997,0.000006100069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990149,0.0001690066,0.00038157505,0.00015010018,0.00011432435,0.00017008834],"domain_scores_gemma":[0.99939114,0.000031578104,0.00022468802,0.0001013816,0.00018213283,0.00006907443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007314453,0.00009463324,0.00027813372,0.000072499424,0.00004755796,0.000013105361,0.0001232223,0.000134841,0.000012938436],"category_scores_gemma":[0.00013527162,0.00009393281,0.000047954625,0.00010026576,0.00016793604,0.0000082171655,0.000034994886,0.00020456956,2.480013e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000299411,0.00025785548,0.95237917,0.000029765051,0.00023277801,0.0015012058,0.00012207085,0.00009843702,0.012565323,0.000061246756,0.0002987625,0.032153975],"study_design_scores_gemma":[0.0018212156,0.00036408822,0.9788746,0.00005569943,0.000044171542,0.003581292,0.0000381269,0.000023025728,0.014487331,0.0005189129,0.00006719083,0.00012434626],"about_ca_topic_score_codex":0.000009924777,"about_ca_topic_score_gemma":0.000024965879,"teacher_disagreement_score":0.03202963,"about_ca_system_score_codex":0.000010623323,"about_ca_system_score_gemma":0.0000634893,"threshold_uncertainty_score":0.3830469},"labels":[],"label_agreement":null},{"id":"W2086043494","doi":"10.1111/j.1365-2133.2004.06336.x","title":"Henna tattoos for children: a potential source of para-phenylenediamine and thiuram sensitization","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Dermatology; Medicine; Citation; Library science; Computer science","score_opus":0.0064250238686300205,"score_gpt":0.23093993707256572,"score_spread":0.22451491320393568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086043494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423721,0.004217981,0.04769247,0.005300107,0.00012666636,0.00022474128,0.0000143418465,0.0000096317435,0.000041955573],"genre_scores_gemma":[0.9921849,0.002102425,0.005100033,0.0003905252,0.00016290716,0.0000021388914,0.000019318828,0.000015541606,0.000022253576],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99903995,0.00003171656,0.00052816566,0.000095010466,0.00014039416,0.00016474814],"domain_scores_gemma":[0.9991823,0.0000551164,0.00033743752,0.00006460401,0.00026478284,0.000095757765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006536082,0.00009268059,0.00047063615,0.00016288806,0.000059726484,0.00002231569,0.000048754962,0.00009322906,0.000014601147],"category_scores_gemma":[0.0001323684,0.00009929057,0.00012391333,0.00008568505,0.00010181752,0.00012785943,0.000020332132,0.00013577528,7.373635e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004009847,0.0034377477,0.13986191,0.003086863,0.0043528117,0.02645836,0.0039839447,0.0007217913,0.19503663,0.0036915091,0.015754255,0.5996043],"study_design_scores_gemma":[0.012982278,0.00050243066,0.31672397,0.0008480391,0.00030300074,0.6516947,0.00022615201,0.0001663544,0.014359364,0.0012919393,0.000712213,0.000189539],"about_ca_topic_score_codex":0.000051277155,"about_ca_topic_score_gemma":0.000033060573,"teacher_disagreement_score":0.6252364,"about_ca_system_score_codex":0.000011912656,"about_ca_system_score_gemma":0.00008255358,"threshold_uncertainty_score":0.4048952},"labels":[],"label_agreement":null},{"id":"W2086861262","doi":"10.1111/j.1365-2133.2006.07237.x","title":"Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology Life Quality Index; Infliximab; Psoriasis; Medicine; Maintenance therapy; Placebo; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Regimen; Psoriasis Area and Severity Index; Physical therapy; Surgery; Dermatology; Chemotherapy; Pathology; Tumor necrosis factor alpha","score_opus":0.007955155368587987,"score_gpt":0.21694139133958537,"score_spread":0.20898623597099739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086861262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523026,0.0024686574,0.000086043794,0.00017108109,0.00024370145,0.0017324408,0.00001243026,0.0000050426756,0.000050357117],"genre_scores_gemma":[0.9992472,0.00033076497,0.00014512554,0.00007426462,0.000021440348,0.00013053487,0.000013470106,0.000011255519,0.000025955143],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972589,0.0009595858,0.0012625753,0.00018493632,0.000080902646,0.00025309395],"domain_scores_gemma":[0.99851096,0.00027267842,0.0008648622,0.00008874017,0.00023450897,0.00002822412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057929644,0.000177141,0.0018657489,0.00025421297,0.000042992273,0.000015191679,0.00009322704,0.000187722,0.000016486947],"category_scores_gemma":[0.00016143826,0.00012722812,0.00011358611,0.0001487704,0.00015355689,0.00013619146,0.00001515484,0.00020469955,7.859424e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94924706,0.00097096135,0.041090365,0.0000115760495,0.00050068024,0.000059093672,0.00014815187,0.000039413455,0.0004002348,0.00005972073,0.000049653077,0.0074230726],"study_design_scores_gemma":[0.907151,0.0010366219,0.08993243,0.00013150927,0.00007100626,0.000499439,0.000099039156,0.0000015452035,0.00079230923,0.0001373838,0.000012687186,0.00013505029],"about_ca_topic_score_codex":0.0006323143,"about_ca_topic_score_gemma":0.0007304081,"teacher_disagreement_score":0.04884206,"about_ca_system_score_codex":0.000039402727,"about_ca_system_score_gemma":0.00016145821,"threshold_uncertainty_score":0.51882124},"labels":[],"label_agreement":null},{"id":"W2086898224","doi":"10.1111/j.1365-2133.1983.tb06814.x","title":"Leukotrienes as mediators of skin inflammation","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Guinea pig; Vascular permeability; Leukotriene; Leukotriene B4; Leukotriene D4; Chemistry; Arachidonic acid; Chemotaxis; Frog Skin; Immunology; Histamine; Inflammation; Biology; Endocrinology; Biochemistry; Enzyme; Receptor","score_opus":0.004166143960058501,"score_gpt":0.23694931201149394,"score_spread":0.23278316805143545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086898224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254715,0.0052994867,0.00013970879,0.00052010483,0.00016719375,0.00006228724,0.0000032033415,0.00000816263,0.0012527106],"genre_scores_gemma":[0.99916846,0.00019832204,0.00016787785,0.000094834715,0.00030086504,0.0000010253767,0.000005333169,0.00000940205,0.000053894208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893224,0.00006503195,0.0005942567,0.00006148948,0.00022236425,0.00012463493],"domain_scores_gemma":[0.9991266,0.000052489908,0.00039964463,0.000061662955,0.00026479393,0.00009480411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065482185,0.000065667766,0.0003494017,0.00014941313,0.000032387867,0.000008043955,0.00006696465,0.0000944765,0.00010304223],"category_scores_gemma":[0.00016029419,0.00006501789,0.0001393697,0.00010598233,0.00012102844,0.00010351688,0.000012539997,0.00012312959,0.000010672987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010317168,0.00094884576,0.5845787,0.0007099088,0.0002944281,0.048016723,0.00027101615,0.000074907846,0.020934552,0.0019935365,0.046622332,0.29452336],"study_design_scores_gemma":[0.006488969,0.00040595702,0.45876405,0.00069296814,0.000290943,0.31681788,0.0005536097,0.000027940237,0.16962728,0.0016838148,0.04443099,0.00021559677],"about_ca_topic_score_codex":0.0000396147,"about_ca_topic_score_gemma":0.00001898506,"teacher_disagreement_score":0.29430777,"about_ca_system_score_codex":0.000016313985,"about_ca_system_score_gemma":0.00023308724,"threshold_uncertainty_score":0.2651353},"labels":[],"label_agreement":null},{"id":"W2088155036","doi":"10.1111/j.1365-2133.2008.08771.x","title":"Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Placebo; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Gastroenterology; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.013127596193070683,"score_gpt":0.23315935662622386,"score_spread":0.22003176043315317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088155036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946431,0.002139728,0.00016847352,0.00034749391,0.00026466078,0.0022750685,0.000026890528,0.000009923596,0.00012469568],"genre_scores_gemma":[0.9984063,0.00054972013,0.00057608925,0.00015899492,0.000017710097,0.00007756274,0.000043185522,0.000021101285,0.00014935418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99706775,0.0010619155,0.0011617987,0.00030110547,0.000109612076,0.0002977912],"domain_scores_gemma":[0.9980918,0.00041175948,0.000867093,0.00014437322,0.0004172109,0.0000677355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031644147,0.0002639407,0.002295126,0.00021939808,0.0001665483,0.000034083692,0.00020927699,0.0003093834,0.00006508763],"category_scores_gemma":[0.00013665832,0.00020225495,0.00009635645,0.0001745543,0.00024180875,0.00022427892,0.000040101986,0.0002750588,0.000008098889],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99132526,0.0015787648,0.0017348462,0.000012523859,0.00082493963,0.0011892449,0.000453738,0.0000235039,0.0005806786,0.000011038626,0.000557214,0.0017082394],"study_design_scores_gemma":[0.9650125,0.002778389,0.004997657,0.00032736023,0.00042568025,0.023832573,0.00009295811,0.000019395244,0.0022000745,0.000016196615,0.00006487856,0.00023233466],"about_ca_topic_score_codex":0.00007909977,"about_ca_topic_score_gemma":0.00014229298,"teacher_disagreement_score":0.026312765,"about_ca_system_score_codex":0.00002998852,"about_ca_system_score_gemma":0.00035665676,"threshold_uncertainty_score":0.8247717},"labels":[],"label_agreement":null},{"id":"W2091162745","doi":"10.1111/j.1365-2133.2008.08678.x","title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Unit (ring theory); Medicine; Identification (biology); Vitiligo; Library science; Psychology; Dermatology; Computer science; Mathematics education; Biology","score_opus":0.007790009760276121,"score_gpt":0.2405824887110398,"score_spread":0.23279247895076366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091162745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773145,0.00039566006,0.0015513827,0.000030700576,0.00008775843,0.00013695203,0.000059560556,7.113977e-7,0.0000058218225],"genre_scores_gemma":[0.9991715,0.0003376629,0.00035709798,0.00001849869,0.000018163288,0.000005001318,0.00007558051,0.000005894871,0.000010588379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892324,0.00012106889,0.0006633324,0.00008601635,0.000119580895,0.00008673016],"domain_scores_gemma":[0.9987787,0.000024915804,0.0008113155,0.00007759116,0.0002737349,0.000033737433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001582375,0.000053411484,0.00023060481,0.000043460062,0.00003546951,0.0000026854095,0.000077703786,0.000070695634,0.000004735698],"category_scores_gemma":[0.00013651566,0.000055204047,0.00005136434,0.000039461764,0.00009120487,0.0000070800893,0.000017392915,0.000040558985,1.8930703e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010765544,0.0002898997,0.970408,0.00007081822,0.00007291585,0.000010712319,0.00012206471,0.000028572542,0.026579378,0.00003261258,0.00085311057,0.0004553589],"study_design_scores_gemma":[0.0030276026,0.00029226107,0.79926175,0.000016723803,0.000014298579,0.00034475926,0.00007357828,0.0000027989392,0.19679932,0.00009000765,0.00002412858,0.00005276757],"about_ca_topic_score_codex":0.000084706306,"about_ca_topic_score_gemma":0.00012678071,"teacher_disagreement_score":0.17114626,"about_ca_system_score_codex":0.000013163561,"about_ca_system_score_gemma":0.00006481371,"threshold_uncertainty_score":0.22511557},"labels":[],"label_agreement":null},{"id":"W2091320760","doi":"10.1111/j.1365-2133.2007.07681.x","title":"The antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves a vacuolar cytopathology","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Centre hospitalier universitaire de Québec","funders":"Health Canada","keywords":"Library science; Humanities; Cytopathology; Art; Medicine; Computer science; Cytology","score_opus":0.006906920331438601,"score_gpt":0.27463349319129104,"score_spread":0.26772657285985246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091320760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067765,0.0047229785,0.0027617724,0.00070917484,0.0004698079,0.00016067468,7.122849e-7,0.00001376816,0.00048345455],"genre_scores_gemma":[0.99912035,0.0003104938,0.00024609218,0.00014899836,0.00010737799,0.0000013073721,7.865359e-7,0.000009156347,0.000055424982],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857,0.00030139,0.0006058878,0.00009112385,0.00017019911,0.000261379],"domain_scores_gemma":[0.99879503,0.0005009517,0.0003157397,0.00009557549,0.00019147762,0.00010124115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069609314,0.000085900436,0.00045290563,0.00008570637,0.00010148562,0.000014102048,0.00012247922,0.00014337365,0.000026687721],"category_scores_gemma":[0.0006557013,0.00006565517,0.0001481101,0.00015235685,0.00028264304,0.000049802125,0.000028625765,0.00047896392,0.0000033335261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017568249,0.00021355653,0.5448887,0.00020762834,0.00032056536,0.047640827,0.00047911674,9.1055847e-7,0.19453822,0.0004897259,0.0011694311,0.20829451],"study_design_scores_gemma":[0.0030754898,0.00054353836,0.14488517,0.00021262778,0.00008608608,0.3692317,0.00018146411,0.000016025924,0.47930312,0.000114744886,0.0022852004,0.00006484301],"about_ca_topic_score_codex":0.000016314529,"about_ca_topic_score_gemma":0.0000192461,"teacher_disagreement_score":0.40000352,"about_ca_system_score_codex":0.000024749283,"about_ca_system_score_gemma":0.00006588317,"threshold_uncertainty_score":0.26773402},"labels":[],"label_agreement":null},{"id":"W2091824266","doi":"10.1111/bjd.12687","title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Critical appraisal; Family medicine; Library science; General hospital; Alternative medicine; Pathology","score_opus":0.12013446466045938,"score_gpt":0.4242890843564514,"score_spread":0.304154619695992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091824266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052541855,0.994284,0.000009158001,0.0042438903,0.00037578293,0.00047980057,0.000011133559,0.0000030271526,0.000067796296],"genre_scores_gemma":[0.00040800526,0.99823576,0.00034589,0.0006662736,0.00012691648,0.000006229972,0.000008842218,0.00001740928,0.00018468009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972422,0.00042901622,0.0016637385,0.00017301021,0.00028407027,0.00020795806],"domain_scores_gemma":[0.99799114,0.0006606884,0.0006415496,0.00014296894,0.00037670098,0.0001869379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016339066,0.00022156027,0.002547063,0.00013597583,0.000031272288,0.000030845655,0.00016583156,0.00013274315,0.0000711033],"category_scores_gemma":[0.0009630453,0.00016680318,0.00013150916,0.00017983934,0.00013492443,0.00003643374,0.000064906344,0.0006257974,0.0000024469819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012249709,0.00004159671,0.00019693852,0.020257812,0.00014308751,0.0072345086,0.000021016876,4.1732523e-8,3.625618e-7,0.000039595285,0.46875507,0.50329775],"study_design_scores_gemma":[0.0003258039,0.00008425697,0.0002821785,0.022741571,0.0007371454,0.33135465,0.00003948203,0.000001675357,2.6318028e-7,0.000003346342,0.64434904,0.000080557766],"about_ca_topic_score_codex":0.04221164,"about_ca_topic_score_gemma":0.02247035,"teacher_disagreement_score":0.50321716,"about_ca_system_score_codex":0.000024816118,"about_ca_system_score_gemma":0.00044995185,"threshold_uncertainty_score":0.995367},"labels":[],"label_agreement":null},{"id":"W2095370280","doi":"10.1046/j.1365-2133.2003.05728.x","title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Western University; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Terbinafine; Medicine; Fluconazole; Dermatophyte; Meta-analysis; Internal medicine; Griseofulvin; Randomized controlled trial; Confidence interval; Regimen; Dermatology; Surgery; Antifungal","score_opus":0.16510020542580864,"score_gpt":0.41439880283074104,"score_spread":0.2492985974049324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095370280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006542111,0.9965596,0.0001713133,0.000045371737,0.00014807767,0.0012473122,0.0011492752,0.0000033513431,0.000021494943],"genre_scores_gemma":[0.03275349,0.9666619,0.00018398903,0.0000132348705,0.000036735375,0.000081816775,0.0001256725,0.000032683274,0.000110514244],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969763,0.00026049468,0.001973629,0.00022089228,0.00034314775,0.00022549777],"domain_scores_gemma":[0.9955186,0.0007064007,0.0028387974,0.00031823746,0.00047913572,0.00013882066],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.000115830255,0.0003330066,0.008012508,0.0005141973,0.0000589397,0.000013463591,0.0002049613,0.00022038352,0.0001601314],"category_scores_gemma":[0.0000798206,0.00020235359,0.009960842,0.000507892,0.000118159915,0.000042895583,0.000015739732,0.0001324282,0.000002224437],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001229785,0.0017581729,0.0003979366,0.009494205,0.80126184,0.0025583615,0.000079199504,0.000020481853,2.133775e-7,0.000036785652,0.00026440798,0.18400541],"study_design_scores_gemma":[0.0024641512,0.00050892925,0.00032376777,0.004687584,0.92127,0.030062065,0.000044423323,0.0000075003813,0.000007105716,0.000017289316,0.040492572,0.000114607705],"about_ca_topic_score_codex":0.00013348347,"about_ca_topic_score_gemma":0.000016308328,"teacher_disagreement_score":0.1838908,"about_ca_system_score_codex":0.0002063748,"about_ca_system_score_gemma":0.00051682553,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W2096882452","doi":"10.1111/j.1365-2133.2010.09755.x","title":"British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Aberdeen","keywords":"Acitretin; Dermatology; Medicine; Dermatologic agents; Association (psychology); MEDLINE; Family medicine; Psoriasis; Psychology; Biology","score_opus":0.056650671493028666,"score_gpt":0.3478676417949854,"score_spread":0.29121697030195676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096882452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08624016,0.91122574,0.000009384455,0.0015412926,0.00029878708,0.00056642405,0.000040700255,0.0000071556938,0.0000703559],"genre_scores_gemma":[0.015634878,0.9834813,0.00039774008,0.0002694709,0.00007065727,0.000011291743,0.000030162279,0.000034194905,0.00007029846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643487,0.0005902854,0.0021235489,0.0002230985,0.00029560676,0.00033258548],"domain_scores_gemma":[0.99492365,0.0018370962,0.0024411867,0.00020999077,0.00047844127,0.00010962696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034576992,0.0002875256,0.0032893524,0.00029439444,0.0000537213,0.00003639956,0.00020073846,0.000931811,0.000050910494],"category_scores_gemma":[0.00318174,0.0002249854,0.0004549661,0.00023962831,0.00024503228,0.0000946446,0.00007289207,0.0010952232,0.0000028393274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119194774,0.00071789813,0.014801892,0.006276914,0.00088478666,0.018276477,0.00006810118,6.2142755e-7,0.00000839529,0.00009392651,0.032892045,0.92585975],"study_design_scores_gemma":[0.0029122522,0.00017869489,0.004242228,0.029367777,0.0014058816,0.4403128,0.000021904305,0.0000070139936,0.00006691965,0.000038900518,0.5212373,0.00020831607],"about_ca_topic_score_codex":0.000162842,"about_ca_topic_score_gemma":0.00021682825,"teacher_disagreement_score":0.92565143,"about_ca_system_score_codex":0.00005454,"about_ca_system_score_gemma":0.000311601,"threshold_uncertainty_score":0.91746384},"labels":[],"label_agreement":null},{"id":"W2096935199","doi":"10.1111/j.1365-2133.1995.tb08705.x","title":"U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies?","year":2006,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Antibody; Lupus erythematosus; Immunology; Systemic lupus erythematosus; Association (psychology); Dermatology; Internal medicine; Disease; Psychology","score_opus":0.017190050764987076,"score_gpt":0.3126523946781687,"score_spread":0.2954623439131816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096935199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033245655,0.9912706,0.0002333309,0.00022439846,0.0006427428,0.00094624603,0.00012336315,0.00004409339,0.0031906618],"genre_scores_gemma":[0.001150658,0.9959022,0.00078672165,0.000041869807,0.00047867774,0.000022052718,0.00015856799,0.0001647328,0.0012945551],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99398226,0.001192894,0.0021711532,0.0004536839,0.0013736094,0.00082639785],"domain_scores_gemma":[0.99356705,0.001396816,0.003135852,0.0003390953,0.0012447776,0.00031642508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085007417,0.0005748257,0.005320025,0.00080620026,0.00015030915,0.00017885004,0.00045987614,0.0011174515,0.00006600783],"category_scores_gemma":[0.0007075537,0.00049495033,0.0009895051,0.0005868534,0.0002512892,0.00025060336,0.00012072217,0.0021287273,0.00007484733],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002175952,0.0006336107,0.044020187,0.05940114,0.0057681315,0.29138592,0.00029269423,5.1767904e-7,0.0000037175541,0.00013492662,0.10179184,0.49634972],"study_design_scores_gemma":[0.0020258802,0.00010759903,0.000068138994,0.060311057,0.0013861782,0.647249,0.00009206977,0.0000014662725,0.000008904397,0.000018527155,0.28847057,0.00026058604],"about_ca_topic_score_codex":0.000046240366,"about_ca_topic_score_gemma":0.000028323226,"teacher_disagreement_score":0.49608913,"about_ca_system_score_codex":0.0008005521,"about_ca_system_score_gemma":0.001762452,"threshold_uncertainty_score":0.9997502},"labels":[],"label_agreement":null},{"id":"W2098835966","doi":"10.1111/j.1365-2133.2005.06948.x","title":"Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Etanercept; Dermatology Life Quality Index; Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Physical therapy; Surgery; Dermatology; Tumor necrosis factor alpha; Pathology; Nursing","score_opus":0.01380888393346637,"score_gpt":0.25708492088982243,"score_spread":0.24327603695635605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098835966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040926,0.007157025,0.00012175561,0.00044852993,0.0007275071,0.0007683143,0.000085683,0.000013311395,0.0002686461],"genre_scores_gemma":[0.99722934,0.0018835666,0.0005065727,0.00009556563,0.000047036443,0.000029973227,0.00004786178,0.000017869503,0.00014224535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963092,0.0006746572,0.0023876417,0.00020431902,0.00012662489,0.00029752747],"domain_scores_gemma":[0.9960075,0.00051446684,0.0028025992,0.00022541563,0.00040609698,0.000043898544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005251244,0.00023081986,0.0021128128,0.0002358793,0.000073816416,0.000009164939,0.00019789017,0.00026155202,0.00018587291],"category_scores_gemma":[0.0002811492,0.00017556881,0.0005771256,0.0001376512,0.0003539777,0.00012710433,0.000028943734,0.00020934873,0.0000041728304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7146586,0.0022108627,0.00027254276,0.0000098421,0.0056011574,0.00055913144,0.00078557275,0.0000037237182,0.017819792,0.00001778624,0.0011791325,0.25688183],"study_design_scores_gemma":[0.8571948,0.0018951084,0.00027586427,0.000078713354,0.00085415755,0.012843803,0.00022541138,0.0000012117299,0.12436951,0.000026482934,0.0020803774,0.00015459451],"about_ca_topic_score_codex":0.00015624489,"about_ca_topic_score_gemma":0.00005280273,"teacher_disagreement_score":0.25672725,"about_ca_system_score_codex":0.000025416686,"about_ca_system_score_gemma":0.00019589317,"threshold_uncertainty_score":0.7159489},"labels":[],"label_agreement":null},{"id":"W2099237146","doi":"10.1111/bjd.12751","title":"Skin cancer: more than skin deep?","year":2014,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada; University of British Columbia; SKiN Health","funders":"","keywords":"Medicine; Dermatology; Cancer; Skin cancer; Internal medicine","score_opus":0.012944552021130557,"score_gpt":0.27685709269329345,"score_spread":0.2639125406721629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099237146","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01333681,0.060871355,0.00037209637,0.9196954,0.0029008212,0.00035550355,0.000056399273,0.000034444056,0.0023771704],"genre_scores_gemma":[0.09791155,0.01801117,0.0015415637,0.86128855,0.019386493,0.000063409745,0.00009608419,0.00026041587,0.0014407692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966727,0.00025045237,0.0012215887,0.0003951397,0.0007150086,0.0007451147],"domain_scores_gemma":[0.9974141,0.00024820917,0.0012671514,0.00035619125,0.00053288316,0.00018143002],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00014740766,0.00044134195,0.0022161875,0.00037432648,0.00013202342,0.00005732511,0.00049801,0.0010815475,0.00031034695],"category_scores_gemma":[0.00015094223,0.00047398877,0.0006194111,0.0001760197,0.00042384068,0.00009564168,0.00012263372,0.0035726565,0.000055843397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006554648,0.000038169568,0.012318398,0.00047772948,0.0008419009,0.09893151,0.00013429752,8.5225906e-7,0.0000028039756,0.0000016827279,0.8686818,0.018505318],"study_design_scores_gemma":[0.0016356745,0.00008696263,0.013749572,0.0012698405,0.00045445203,0.40017,0.000039533043,0.000004186685,0.00016692266,0.00006399825,0.58210725,0.00025163364],"about_ca_topic_score_codex":0.00038733694,"about_ca_topic_score_gemma":0.00031635413,"teacher_disagreement_score":0.30123848,"about_ca_system_score_codex":0.00027100652,"about_ca_system_score_gemma":0.00045338413,"threshold_uncertainty_score":0.9997712},"labels":[],"label_agreement":null},{"id":"W2106026283","doi":"10.1111/j.1365-2133.2006.07741.x","title":"Idiopathic facial aseptic granuloma: a multicentre prospective study of 30 cases","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Bartonella species infections research","field":"Immunology and Microbiology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Dermatology; Granuloma; Lesion; Bartonella; Etiology; Prospective cohort study; Nodule (geology); Surgery; Outpatient clinic; Pathology; Internal medicine","score_opus":0.013307541731414293,"score_gpt":0.2823753806552936,"score_spread":0.2690678389238793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106026283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919489,0.0059055425,0.00023724501,0.000053338943,0.0008010853,0.00041078884,0.000013092348,0.000019091201,0.00061091216],"genre_scores_gemma":[0.9995964,0.00014869425,0.000042518255,0.000019698306,0.00005784798,0.000005008079,0.0000022147267,0.00001666084,0.00011091144],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99772114,0.00050676346,0.000979282,0.00019657616,0.000116401265,0.00047983762],"domain_scores_gemma":[0.9983277,0.00034489296,0.0004743465,0.0001682593,0.00062852364,0.000056301265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049386977,0.00014811747,0.00064080924,0.00036296682,0.000244831,0.000018514864,0.00029391452,0.00025801593,0.00060815486],"category_scores_gemma":[0.00081383984,0.0001613084,0.00015495544,0.00028264563,0.0004965082,0.00012779329,0.00010713248,0.00087578513,0.000113827286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039782533,0.016548272,0.6271879,0.00024497986,0.0032843002,0.09738329,0.010633342,0.000030110874,0.13980323,0.0005146779,0.009021354,0.09137028],"study_design_scores_gemma":[0.014063865,0.002305373,0.2874039,0.00021472349,0.00023843716,0.62311757,0.012664796,0.0000022695128,0.05651229,0.00013703018,0.0030188295,0.00032089034],"about_ca_topic_score_codex":0.00028867027,"about_ca_topic_score_gemma":0.001071227,"teacher_disagreement_score":0.5257343,"about_ca_system_score_codex":0.00008549924,"about_ca_system_score_gemma":0.00013223801,"threshold_uncertainty_score":0.66588694},"labels":[],"label_agreement":null},{"id":"W2106171751","doi":"10.1111/j.1365-2133.2004.05986.x","title":"Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris","year":2004,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Calcipotriol; Medicine; Betamethasone dipropionate; Psoriasis; Betamethasone; Dermatology; Psoriasis Area and Severity Index; Internal medicine","score_opus":0.013239316774461081,"score_gpt":0.23853204966403918,"score_spread":0.2252927328895781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106171751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741768,0.023909228,0.000112405876,0.0007391433,0.0003838965,0.00045622006,0.000052106814,0.000018462371,0.00015171566],"genre_scores_gemma":[0.9919695,0.0065952893,0.0011183193,0.000036834466,0.000036365105,0.000035134926,0.000035886813,0.00002973057,0.00014288504],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975085,0.000424022,0.0010453196,0.00037872136,0.00011399852,0.0005294331],"domain_scores_gemma":[0.998479,0.0003064992,0.0007117744,0.00023902397,0.00016443928,0.000099279845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019504548,0.00035513428,0.0012178418,0.0003634332,0.00013646748,0.000020565967,0.00020343314,0.00033892778,0.00008797312],"category_scores_gemma":[0.000081597675,0.0002989165,0.00022421229,0.00025511225,0.00037354598,0.00014165633,0.00005773789,0.00030580332,0.000020718286],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00950146,0.007855401,0.031066636,0.00014405586,0.006409494,0.017695688,0.0046557686,0.00029965542,0.033409625,0.0009855173,0.0005971772,0.8873795],"study_design_scores_gemma":[0.16434418,0.01684744,0.16234086,0.00216598,0.002859961,0.2138185,0.0019416618,0.000004011999,0.4214345,0.0007950261,0.012100261,0.0013476337],"about_ca_topic_score_codex":0.0009126027,"about_ca_topic_score_gemma":0.00056502747,"teacher_disagreement_score":0.88603187,"about_ca_system_score_codex":0.0003133407,"about_ca_system_score_gemma":0.00035094813,"threshold_uncertainty_score":0.9999463},"labels":[],"label_agreement":null},{"id":"W2106886047","doi":"10.1111/j.1365-2133.2012.10994.x","title":"Homeopathy for eczema: a systematic review of controlled clinical trials","year":2012,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park","funders":"","keywords":"Homeopathy; Alternative medicine; Medicine; Clinical trial; Family medicine; Classics; History; Internal medicine; Pathology","score_opus":0.337114868072886,"score_gpt":0.540665372948514,"score_spread":0.20355050487562804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106886047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008114294,0.9908508,0.00040368002,0.00024017648,0.001538724,0.0067489827,0.00011311491,0.000006126175,0.00009025437],"genre_scores_gemma":[0.00008911547,0.99756145,0.0003275728,0.00033882816,0.001275734,0.00026153526,0.000046125515,0.000035451165,0.00006417749],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9834948,0.004593106,0.010994864,0.00019621207,0.00039962246,0.000321358],"domain_scores_gemma":[0.97695214,0.011067624,0.010629229,0.00024769641,0.00087356893,0.00022973986],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011056716,0.000362441,0.029726524,0.0002703508,0.000052243122,0.00000817577,0.000309503,0.000113076974,0.00016829836],"category_scores_gemma":[0.028677614,0.00024284142,0.0051483144,0.00015225979,0.00019284732,0.000058389553,0.0000725202,0.00065596076,0.000008300204],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014981568,0.00025815016,0.000023883458,0.7940303,0.0051204497,0.0009324747,0.0000095385185,5.164446e-10,2.5712508e-8,0.000030201216,0.0039081387,0.19553703],"study_design_scores_gemma":[0.0076902774,0.0004666307,0.000002997383,0.6169817,0.05003889,0.10491468,0.00003415646,2.0247617e-7,1.8731134e-7,0.000015726406,0.21974961,0.00010497713],"about_ca_topic_score_codex":0.0000021558685,"about_ca_topic_score_gemma":0.000001913103,"teacher_disagreement_score":0.21584147,"about_ca_system_score_codex":0.00004727716,"about_ca_system_score_gemma":0.00044427582,"threshold_uncertainty_score":0.99027854},"labels":[],"label_agreement":null},{"id":"W2110447511","doi":"10.1111/j.1365-2133.1989.tb07783.x","title":"Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma)","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Histogenesis; Pathology; Vimentin; Population; Connective tissue; S100 protein; Biology; Dermis; Immunohistochemistry; Monoclonal antibody; Antibody; Medicine; Immunology","score_opus":0.009447492113769034,"score_gpt":0.244238658606278,"score_spread":0.23479116649250897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110447511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666164,0.030511212,0.00021816145,0.0011112997,0.00023296213,0.00016480245,0.00001948658,0.000026627938,0.0010990397],"genre_scores_gemma":[0.996364,0.0005428071,0.0025304358,0.0002263151,0.0002272369,0.00000979726,0.0000145967915,0.00003257874,0.000052254683],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9977241,0.00011778335,0.0011213548,0.00019894131,0.00041959868,0.00041821186],"domain_scores_gemma":[0.9984436,0.00016600429,0.00066183746,0.00015622261,0.0003811142,0.00019119821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009371911,0.00020895885,0.00096637517,0.00028254694,0.000093934745,0.00003124481,0.00018195665,0.00017274507,0.00015351338],"category_scores_gemma":[0.00010531846,0.00022077988,0.0003986811,0.0001834224,0.00019403955,0.00016703016,0.00005069042,0.00030902337,0.00002171207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005960854,0.002776573,0.71018785,0.00023759308,0.0006077021,0.23278326,0.0000658426,0.000015909656,0.005069893,0.00075354165,0.026387475,0.02051825],"study_design_scores_gemma":[0.0042979047,0.00018231863,0.3988757,0.00036824908,0.00034228896,0.5376799,0.000055776454,0.000029510717,0.056283068,0.00017092763,0.0015933183,0.00012098844],"about_ca_topic_score_codex":0.00024368674,"about_ca_topic_score_gemma":0.00013233136,"teacher_disagreement_score":0.31131217,"about_ca_system_score_codex":0.000118097414,"about_ca_system_score_gemma":0.00026588055,"threshold_uncertainty_score":0.9003142},"labels":[],"label_agreement":null},{"id":"W2111537744","doi":"10.1111/j.1365-2133.1976.tb07921.x","title":"(33) Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Pyoderma gangrenosum; Carboxylesterase; Isozyme; Immunology; Globulin; Biology; Medicine; Enzyme; Biochemistry; Pathology; Disease","score_opus":0.004122588779252667,"score_gpt":0.18627306750658615,"score_spread":0.18215047872733348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111537744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851523,0.012675202,0.0006109038,0.0004909987,0.000030019295,0.00022997688,0.0000147006585,0.0000448836,0.0007510154],"genre_scores_gemma":[0.9976434,0.0011788916,0.00082262175,0.00009896589,0.000042619027,0.0000048824354,0.000033907625,0.0000501689,0.00012453858],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9983404,0.00015352824,0.0005747028,0.00019917414,0.00036230695,0.00036988076],"domain_scores_gemma":[0.9988687,0.00009702846,0.00033970966,0.00018731359,0.00033269133,0.00017455427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008674031,0.00023144948,0.00075017515,0.0002458444,0.00020036296,0.000054048713,0.00013346871,0.00015672704,0.0000757072],"category_scores_gemma":[0.000032962413,0.00019861128,0.00010847774,0.00024371552,0.00035749393,0.0001513507,0.00002459164,0.0004289913,0.000003911205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00781446,0.0016308686,0.7959514,0.0004488693,0.0007749191,0.1570072,0.000229064,0.000074800206,0.021805331,0.000087304135,0.004660901,0.0095148245],"study_design_scores_gemma":[0.009438906,0.0007077138,0.41701812,0.000986454,0.0008157064,0.5259033,0.00028259394,0.000054545126,0.043368522,0.000053486725,0.0010944421,0.0002762189],"about_ca_topic_score_codex":0.0010496526,"about_ca_topic_score_gemma":0.00040238723,"teacher_disagreement_score":0.37893334,"about_ca_system_score_codex":0.00005409416,"about_ca_system_score_gemma":0.00023090828,"threshold_uncertainty_score":0.8099133},"labels":[],"label_agreement":null},{"id":"W2116561250","doi":"10.1111/j.1365-2133.2007.08092.x","title":"Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liposuction; Surgery; Curettage; Scars; Hyperhidrosis; Cannula; Patient satisfaction","score_opus":0.008366073237409722,"score_gpt":0.26609275320390535,"score_spread":0.2577266799664956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116561250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788512,0.018965255,0.000100479396,0.00057962426,0.00022323837,0.00026269606,0.000013771872,0.000010547065,0.0009931605],"genre_scores_gemma":[0.9923658,0.0061225076,0.0010534299,0.00022242854,0.00012034008,0.0000045054285,0.000004015281,0.000018028562,0.00008895602],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99868673,0.00007256294,0.00059356325,0.00016989275,0.00024309,0.00023418381],"domain_scores_gemma":[0.99888474,0.00018964651,0.00033182206,0.00013243,0.00027606342,0.00018531394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014936234,0.00015431993,0.000749868,0.00020310754,0.00008632296,0.00001274571,0.000048157748,0.0001726455,0.00006764322],"category_scores_gemma":[0.00009132042,0.0001424999,0.00022650899,0.00012816387,0.00015703616,0.00011333615,0.000014486757,0.00013031156,0.00000523284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001285147,0.0018601642,0.6248227,0.00013133252,0.0015337877,0.022615379,0.0016030354,3.2107667e-7,0.00792016,0.000041908777,0.001363547,0.33682257],"study_design_scores_gemma":[0.0082512805,0.0021253114,0.390685,0.00038688566,0.00078956434,0.4861456,0.0003095385,0.0000046308905,0.10450339,0.00009429206,0.0065678703,0.00013666159],"about_ca_topic_score_codex":0.000089653506,"about_ca_topic_score_gemma":0.000022196995,"teacher_disagreement_score":0.4635302,"about_ca_system_score_codex":0.00012794157,"about_ca_system_score_gemma":0.00006524556,"threshold_uncertainty_score":0.5810977},"labels":[],"label_agreement":null},{"id":"W2117159275","doi":"10.1111/j.1365-2133.2011.10775.x","title":"Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Welichem Biotech (Canada); University of British Columbia; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Randomized controlled trial; Randomization; Clinical endpoint; Confidence interval; Double blind; Gastroenterology; Dermatology; Pathology","score_opus":0.020735843188581012,"score_gpt":0.253027453172948,"score_spread":0.232291609984367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117159275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944014,0.0010602395,0.00008875762,0.00058233447,0.00025926207,0.0024983047,0.000038258655,0.000011372037,0.0010600964],"genre_scores_gemma":[0.9981195,0.00020892234,0.0011116549,0.00038787277,0.00006327182,0.000030866253,0.000029976372,0.000016477681,0.00003147232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968069,0.00056204223,0.0017484303,0.0002574707,0.00030180177,0.00032334463],"domain_scores_gemma":[0.9976312,0.00094238645,0.00067148474,0.00019557396,0.00023724545,0.0003220962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025660818,0.00021372337,0.0020352902,0.00024281058,0.00005804473,0.000017362714,0.00017255073,0.00025656057,0.0000941886],"category_scores_gemma":[0.0010332066,0.00018168306,0.00020616408,0.00011638093,0.00027137148,0.00016057515,0.000057617646,0.00039396365,0.0000049254522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9084746,0.0015029362,0.08363154,0.000043742046,0.00054813223,0.0027680849,0.0009837268,0.0000023233727,6.7873856e-7,0.000021135262,0.00087018654,0.0011528991],"study_design_scores_gemma":[0.70649093,0.00028582907,0.28766724,0.0006055333,0.00044799998,0.004087973,0.00010152165,0.0000133740605,0.00006608983,0.000056110366,0.000054616197,0.00012278906],"about_ca_topic_score_codex":0.0002534219,"about_ca_topic_score_gemma":0.00035348526,"teacher_disagreement_score":0.20403571,"about_ca_system_score_codex":0.000031004016,"about_ca_system_score_gemma":0.00016494411,"threshold_uncertainty_score":0.74088204},"labels":[],"label_agreement":null},{"id":"W2117252673","doi":"10.1111/bjd.12042","title":"U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Bexarotene; Medicine; Dosing; Pharmacology; Retinoid X receptor; Internal medicine; Chemistry; Biochemistry; Nuclear receptor","score_opus":0.027984189372815126,"score_gpt":0.32428958093910853,"score_spread":0.29630539156629343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117252673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961658,0.0011613283,0.00042438696,0.0005656126,0.00022664796,0.0008198172,0.00005947871,0.000007442241,0.00056948885],"genre_scores_gemma":[0.9962945,0.00023886473,0.0029077015,0.0002918155,0.00009711566,0.000009674017,0.000019869298,0.000037426602,0.000103062914],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99728227,0.00026297584,0.0012330844,0.00017111999,0.0005362226,0.0005143044],"domain_scores_gemma":[0.9970594,0.0006982334,0.00065789075,0.00016486734,0.0010825525,0.00033705257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033761305,0.00015901032,0.0008122814,0.00016230987,0.000080470214,0.000015065092,0.00013333092,0.00014052833,0.000058281006],"category_scores_gemma":[0.00079468655,0.00014581923,0.00019884715,0.00009642745,0.00026708518,0.000056755962,0.000038054695,0.00022420604,0.0000070023893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0131447185,0.008596839,0.9099736,0.00040348322,0.00060303224,0.004800199,0.00023980012,0.000012957117,0.00039540976,0.00004029094,0.013858123,0.04793152],"study_design_scores_gemma":[0.08974142,0.018960603,0.17050044,0.00205126,0.00081960624,0.678793,0.0010383762,0.00031117757,0.020841831,0.0001709657,0.016038403,0.00073288946],"about_ca_topic_score_codex":0.000022622406,"about_ca_topic_score_gemma":0.000010336185,"teacher_disagreement_score":0.73947316,"about_ca_system_score_codex":0.000114136026,"about_ca_system_score_gemma":0.0004172435,"threshold_uncertainty_score":0.5946335},"labels":[],"label_agreement":null},{"id":"W2118533896","doi":"10.1111/bjd.12190","title":"Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham; National Institute for Health and Care Research; Pfizer","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Receiver operating characteristic; Dermatology; Internal medicine; Epidemiology; Gold standard (test); Arthritis; Physical therapy","score_opus":0.02475089544807674,"score_gpt":0.27740036532054674,"score_spread":0.25264946987247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118533896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954201,0.0027908043,0.0002974251,0.0002550725,0.00016538143,0.00096015114,0.000010141786,0.000008650735,0.0000923005],"genre_scores_gemma":[0.9965536,0.00009424787,0.0031658795,0.00007986751,0.000040029772,0.000035892586,0.000004033869,0.000022664073,0.0000037815714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979998,0.00008864953,0.001028387,0.00018105138,0.00037554838,0.00032658578],"domain_scores_gemma":[0.9986016,0.00013415645,0.00043816576,0.00015079303,0.00050583127,0.00016945059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091369104,0.00016665789,0.0012032043,0.00024351232,0.00007018676,0.000037502195,0.0001213267,0.000071349146,0.00008473862],"category_scores_gemma":[0.00029866686,0.0001589094,0.00009883916,0.00028007943,0.000064029715,0.00021218904,0.000053994372,0.00026174934,0.000012429216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033841122,0.0008118259,0.7332647,0.000015618605,0.00024189068,0.0011151314,0.00020028418,0.00000460535,0.0000062835734,0.0000014919507,0.0003404733,0.26365933],"study_design_scores_gemma":[0.01983272,0.0034445,0.970767,0.0011103498,0.00012207248,0.0035765644,0.0007747368,0.0000068158597,0.00015008128,0.000029084931,0.00006107369,0.00012497984],"about_ca_topic_score_codex":0.0006092812,"about_ca_topic_score_gemma":0.0032335054,"teacher_disagreement_score":0.26353434,"about_ca_system_score_codex":0.00004399595,"about_ca_system_score_gemma":0.00004743569,"threshold_uncertainty_score":0.6480137},"labels":[],"label_agreement":null},{"id":"W2119766232","doi":"10.1111/j.1365-2133.1995.tb02506.x","title":"A case of necrotizing fasciitis due to Streptococcus pnewnoniae","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital; University of Manitoba","funders":"","keywords":"Fasciitis; Streptococcus pneumoniae; Medicine; Streptococcus; Pathogenesis; STREPTOCOCCAL INFECTIONS; Dermatology; Pathology; Microbiology; Surgery; Immunology; Biology; Bacteria; Antibiotics; Genetics","score_opus":0.011799329379802964,"score_gpt":0.2742067164965582,"score_spread":0.26240738711675526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119766232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579453,0.0006706191,0.0010898303,0.00042802584,0.00025718263,0.0003027477,0.000021646934,0.000014203925,0.0014212234],"genre_scores_gemma":[0.9977289,0.000024494151,0.0019094183,0.00009671624,0.00011097653,0.000012346297,0.000003998232,0.000015562982,0.000097583536],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987976,0.000057138004,0.00067082106,0.00012653208,0.000119212826,0.0002286879],"domain_scores_gemma":[0.9990376,0.000077801255,0.00028007157,0.00012223622,0.0003140739,0.00016818798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060490882,0.00010861972,0.0005614912,0.00023013374,0.000080820275,0.00002221965,0.000045278928,0.000096750955,0.00015806756],"category_scores_gemma":[0.000088597335,0.00011471743,0.00020243855,0.00023630375,0.000073050105,0.00008509349,0.000028146525,0.00018982278,0.000012895075],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008417042,0.0007829482,0.21669048,0.0000706145,0.00025368074,0.70870984,0.00006704293,0.00002203524,0.0020039538,0.00017131798,0.009010173,0.062133767],"study_design_scores_gemma":[0.0023789732,0.00029689816,0.07339366,0.00026923293,0.00014040744,0.91496587,0.00009851553,0.000012179547,0.0066871634,0.00021511051,0.0014631063,0.00007890977],"about_ca_topic_score_codex":0.0013114846,"about_ca_topic_score_gemma":0.0004876807,"teacher_disagreement_score":0.20625603,"about_ca_system_score_codex":0.00005100248,"about_ca_system_score_gemma":0.00010137338,"threshold_uncertainty_score":0.4678041},"labels":[],"label_agreement":null},{"id":"W2120155938","doi":"10.1046/j.1365-2133.2002.04975.x","title":"Differential expression of collagen integrin receptor on fetal vs. adult skin fibroblasts: implication in wound contraction during healing","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"Medical Research Council; Fondation des pompiers du Québec pour les grands brûlés","keywords":"Contraction (grammar); Medicine; Wound healing; Humanities; Art; Surgery; Internal medicine","score_opus":0.011227314788184905,"score_gpt":0.26008299129265794,"score_spread":0.24885567650447304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120155938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804217,0.0004217966,0.0001142744,0.000848378,0.00023115428,0.00017971404,0.0000084083695,0.000010190746,0.00014391213],"genre_scores_gemma":[0.99857813,0.000785746,0.00037716236,0.000044637836,0.00012405192,0.0000062354275,0.000012323085,0.000014731584,0.000056992325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986322,0.000112959424,0.0007055862,0.00013773989,0.00021640433,0.00019513369],"domain_scores_gemma":[0.99909717,0.00008163469,0.00043110928,0.00009144172,0.00019815593,0.00010050548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000053864365,0.0001048565,0.00046090066,0.0002044995,0.00006798136,0.000017203218,0.00005851596,0.00017068943,0.00015980331],"category_scores_gemma":[0.0001278221,0.000106281834,0.0001019456,0.00010030641,0.00004065176,0.00010218501,0.000012322264,0.0003053422,0.000010347719],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013238557,0.009363039,0.22539647,0.0017903401,0.00069738773,0.008201874,0.00379797,0.00016758002,0.6437204,0.0001792095,0.00900761,0.08443959],"study_design_scores_gemma":[0.022343984,0.0011417308,0.36079064,0.007413079,0.0001502025,0.088780895,0.0006047326,0.0004319213,0.51758647,0.00011684582,0.00036467297,0.00027481175],"about_ca_topic_score_codex":0.00014497094,"about_ca_topic_score_gemma":0.000058402064,"teacher_disagreement_score":0.13539416,"about_ca_system_score_codex":0.00015804658,"about_ca_system_score_gemma":0.000032447002,"threshold_uncertainty_score":0.43340474},"labels":[],"label_agreement":null},{"id":"W2121157956","doi":"10.1046/j.1365-2133.2000.03479.x","title":"Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; St. Michael's Hospital; Ministry of Health and Long Term Care; Toronto Western Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Tinea capitis; Microsporum canis; Medicine; Microsporum; Trichophyton tonsurans; Fluconazole; Trichophyton; Mycosis; Griseofulvin; Dermatology; Dermatophyte; Dosing; Antifungal; Surgery; Internal medicine","score_opus":0.004481592176194673,"score_gpt":0.2612122906321673,"score_spread":0.25673069845597263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121157956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073714,0.0071058054,5.994797e-7,0.0003967833,0.000025777435,0.0014547574,0.000025389052,0.0000038130895,0.0002499171],"genre_scores_gemma":[0.99827814,0.0014202452,0.0000382091,0.00012538026,0.000032809683,0.00004881651,0.000004804397,0.000010699018,0.000040915787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987316,0.00022435021,0.00048081492,0.00015545226,0.0001956624,0.00021211685],"domain_scores_gemma":[0.99949104,0.00008998479,0.00015854128,0.00011901022,0.0000715623,0.000069840484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057711222,0.00012823367,0.0005517022,0.000115907635,0.000033549022,0.000012439905,0.0000929539,0.000052382136,0.00014779599],"category_scores_gemma":[0.000024230372,0.00010036452,0.0001362117,0.00018744326,0.00005730917,0.00007619315,0.000006316528,0.00014917763,0.000010477859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057636556,0.009127633,0.92027736,0.000011681865,0.00033287675,0.010910314,0.0027976409,0.0000031924505,0.00000770338,0.0000018202905,0.00009772538,0.055855673],"study_design_scores_gemma":[0.020868609,0.0015307984,0.94476616,0.00020051857,0.00025539292,0.030853312,0.0010865909,0.000014951781,0.00026091738,0.00003599901,0.00006247856,0.00006429471],"about_ca_topic_score_codex":0.0010996893,"about_ca_topic_score_gemma":0.00044434838,"teacher_disagreement_score":0.05579138,"about_ca_system_score_codex":0.00012437064,"about_ca_system_score_gemma":0.000072408526,"threshold_uncertainty_score":0.40927464},"labels":[],"label_agreement":null},{"id":"W2121994209","doi":"10.1111/bjd.13980","title":"Prioritizing the global research agenda in psoriasis: an International Psoriasis Council Delphi consensus exercise","year":2015,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; AbbVie; Celgene; Novartis; Amgen; Pfizer; Eli Lilly and Company","keywords":"Psoriasis; Delphi method; Delphi; Medicine; Consensus conference; MEDLINE; Dermatology; Political science; Family medicine; Internal medicine; Computer science; Law","score_opus":0.3033537745233487,"score_gpt":0.468302712239089,"score_spread":0.16494893771574026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121994209","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026849382,0.00947147,0.00002638874,0.9295926,0.0055001914,0.0011371988,0.00022486453,0.00009133953,0.027106574],"genre_scores_gemma":[0.6972679,0.06364744,0.008397913,0.18314287,0.043220405,0.0005023991,0.00017103857,0.0004759336,0.0031741122],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855846,0.00547906,0.0014990114,0.00050421956,0.005555456,0.0013776434],"domain_scores_gemma":[0.9893343,0.0014271718,0.00073057064,0.0004675267,0.007743161,0.0002972877],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.014901466,0.00027877878,0.00086871657,0.00054324715,0.0006264592,0.0008670545,0.0038478035,0.0015635246,0.000121938516],"category_scores_gemma":[0.009975617,0.00029483583,0.0002540541,0.001100641,0.0020681166,0.00047060734,0.00040115564,0.00629534,0.000042636777],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010733527,0.00008179779,0.0007875878,0.000030050263,0.00007323699,0.062077563,0.0018135338,0.0000010363098,0.0000013213288,0.0002941345,0.90766585,0.027066559],"study_design_scores_gemma":[0.0010083035,0.00005661601,0.00038589103,0.000765811,0.000032372067,0.038010847,0.005818974,0.000013801947,0.000004331986,0.015536735,0.9380851,0.0002812147],"about_ca_topic_score_codex":0.011839395,"about_ca_topic_score_gemma":0.017902907,"teacher_disagreement_score":0.7464497,"about_ca_system_score_codex":0.0039365804,"about_ca_system_score_gemma":0.010003783,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W2124603351","doi":"10.1111/j.1365-2133.2006.07343.x","title":"Update on the use of ciclosporin in immune-mediated dermatoses","year":2006,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novartis Pharma; Novartis","keywords":"Ciclosporin; Medicine; Atopic dermatitis; Psoriasis; Pyoderma gangrenosum; Dermatology; Adverse effect; Immunology; Population; Disease; Chemotherapy; Internal medicine","score_opus":0.05653462639228964,"score_gpt":0.30541151866331423,"score_spread":0.24887689227102458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124603351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005113233,0.9932292,0.0000075786998,0.00049808715,0.00027747362,0.00063224224,0.00010030709,0.000018409475,0.0001234683],"genre_scores_gemma":[0.006918871,0.9922661,0.00012303141,0.0003137388,0.00007514648,0.000019177778,0.0001363809,0.00008543073,0.00006212176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517256,0.00073389034,0.0029524558,0.0002328766,0.000465165,0.00044303134],"domain_scores_gemma":[0.9952954,0.0012965892,0.0025471915,0.00046923035,0.00027673438,0.00011483794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024257104,0.00040803425,0.0037819429,0.00059833005,0.00005587816,0.000040862942,0.00051628693,0.00045954113,0.00015445052],"category_scores_gemma":[0.0013639675,0.00032144156,0.001023076,0.00051616656,0.0003296327,0.00012224342,0.00010790937,0.0013231036,0.000050623526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030466137,0.0021718163,0.0026648701,0.01650437,0.0014681909,0.123040654,0.000043462183,0.000009755563,0.000004259527,0.0002815445,0.10377207,0.74973434],"study_design_scores_gemma":[0.0010381102,0.000057168945,0.0023984055,0.034751505,0.00084529154,0.21303666,0.000012562703,0.0000028080663,0.000015315383,0.000027991613,0.74761313,0.00020106962],"about_ca_topic_score_codex":0.00016222744,"about_ca_topic_score_gemma":0.000024403404,"teacher_disagreement_score":0.7495333,"about_ca_system_score_codex":0.00012118052,"about_ca_system_score_gemma":0.0009275518,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2126457303","doi":"10.1111/j.1365-2133.2010.09707.x","title":"Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis","year":2010,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Abbott Laboratories","keywords":"Psoriasis; Medicine; Risk factor; Necrosis; Oncology; Dermatology; Internal medicine","score_opus":0.027893241891942245,"score_gpt":0.3084209535246435,"score_spread":0.28052771163270124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126457303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06741128,0.92943215,0.000008039446,0.00004699296,0.001453272,0.00051615055,0.0010040718,0.000006086531,0.00012196035],"genre_scores_gemma":[0.043646432,0.9557381,0.00025173975,0.0000081134,0.00007594264,0.000046491205,0.00014781099,0.000036094323,0.00004922569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956818,0.0013163075,0.0021557843,0.00029754467,0.00011767989,0.00043084862],"domain_scores_gemma":[0.99524444,0.0009679471,0.0031546254,0.00037993558,0.00021220672,0.00004082229],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002930854,0.00048375435,0.0036916821,0.00045032063,0.00012269219,0.000026108006,0.000722504,0.0010024002,0.00016972481],"category_scores_gemma":[0.00007983459,0.00034980557,0.0013900489,0.00029824182,0.00028425682,0.000088116765,0.00004071026,0.0007529658,0.000011909392],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051460887,0.0014973156,0.0031704647,0.0007413387,0.0015054927,0.0008748709,0.0002615615,2.4132342e-7,0.00016372447,0.000051929102,0.00023230456,0.9914493],"study_design_scores_gemma":[0.005762702,0.0012887461,0.018599499,0.0046780226,0.005942503,0.08945236,0.0001788421,2.2451509e-7,0.0017506134,0.0001096356,0.8717194,0.00051740184],"about_ca_topic_score_codex":0.000315541,"about_ca_topic_score_gemma":0.00037519124,"teacher_disagreement_score":0.99093187,"about_ca_system_score_codex":0.00011012102,"about_ca_system_score_gemma":0.0005466208,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2129350137","doi":"10.1111/j.1365-2133.2010.10093.x","title":"Assessing peristomal skin changes in ostomy patients: validation of the Ostomy Skin Tool","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Stoma care and complications","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; London Health Sciences Centre","funders":"","keywords":"Medicine; Health professionals; Scale (ratio); Categorical variable; Nursing assessment; Nursing; Nurse practitioners; Health care; MEDLINE; Family medicine; Physical therapy","score_opus":0.010410828228777065,"score_gpt":0.2750689416190242,"score_spread":0.2646581133902471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129350137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960337,0.0001840964,0.0000966359,0.002270524,0.0004021051,0.0001568547,0.0000057807765,0.000006233747,0.00084401784],"genre_scores_gemma":[0.9988263,0.000027999313,0.0006319981,0.00036610055,0.00009821056,0.000007756787,0.000006349566,0.0000114017885,0.000023867276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989526,0.00010201101,0.00047257252,0.00009764171,0.00022331838,0.00015182006],"domain_scores_gemma":[0.9988654,0.0000872819,0.0004087248,0.00016533284,0.0004251473,0.000048087768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012511472,0.00007654971,0.0003027053,0.00015630633,0.00006856073,0.00003170569,0.00017347733,0.00011518194,0.000102423255],"category_scores_gemma":[0.00028864498,0.00007084557,0.00010656275,0.00022571707,0.0001137538,0.00017087057,0.000041715015,0.0004457786,0.000003005006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007673412,0.00067566126,0.8166453,0.00011250858,0.00007040723,0.00047285878,0.0007121476,0.0000016634943,0.012137132,0.0002886084,0.00363533,0.16517162],"study_design_scores_gemma":[0.0016107945,0.00005589824,0.9342963,0.0002048414,0.00004611173,0.030447988,0.00026516162,0.000012951666,0.02613735,0.000106811,0.0067416555,0.00007411359],"about_ca_topic_score_codex":0.00005245864,"about_ca_topic_score_gemma":0.00021858489,"teacher_disagreement_score":0.1650975,"about_ca_system_score_codex":0.000031602878,"about_ca_system_score_gemma":0.00015644664,"threshold_uncertainty_score":0.28889984},"labels":[],"label_agreement":null},{"id":"W2130843061","doi":"10.1111/j.1365-2133.2008.08747.x","title":"A 4-year follow-up study of atopic dermatitis therapy with 0·1% tacrolimus ointment in children and adult patients","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Tacrolimus; Medicine; Tolerability; Atopic dermatitis; Population; Surgery; Clinical trial; Pediatrics; Adverse effect; Dermatology; Internal medicine; Transplantation","score_opus":0.006434480742738847,"score_gpt":0.22380721295109574,"score_spread":0.2173727322083569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130843061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966638,0.0025283613,0.0000064294795,0.00021748872,0.00006513624,0.0004176058,0.000008425002,0.0000074547183,0.000085283995],"genre_scores_gemma":[0.99739486,0.002103757,0.00011785344,0.00032602364,0.000017007682,0.000008441643,0.000008418415,0.000014207964,0.000009432454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986374,0.000164952,0.0006080542,0.00014186371,0.00024079924,0.00020695942],"domain_scores_gemma":[0.99913406,0.000044645458,0.0003072275,0.000116729294,0.00027084092,0.00012651329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000038876547,0.00012946303,0.00065734354,0.00018943596,0.00006664488,0.0000072257158,0.0000972558,0.000092194394,0.000027274238],"category_scores_gemma":[0.00006755128,0.00011765663,0.0000675913,0.00013148814,0.00017964498,0.00012364406,0.00002584191,0.00023272472,0.0000017255063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043609887,0.0018069559,0.98438,0.00002327743,0.0002740859,0.00649841,0.0007196476,6.979075e-7,0.0000021414687,0.0000044945905,0.0022804388,0.003573727],"study_design_scores_gemma":[0.025425922,0.0009468207,0.81681395,0.00015442088,0.00006409901,0.15604767,0.0002814704,0.0000016005885,0.0001294205,0.000028388675,0.000025816875,0.000080422426],"about_ca_topic_score_codex":0.00011804637,"about_ca_topic_score_gemma":0.00013347542,"teacher_disagreement_score":0.16756609,"about_ca_system_score_codex":0.000016675109,"about_ca_system_score_gemma":0.000096395444,"threshold_uncertainty_score":0.4797898},"labels":[],"label_agreement":null},{"id":"W2131020062","doi":"10.1111/j.1365-2133.2006.07585.x","title":"Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with psoriasis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Etanercept; Psoriasis; Medicine; Pharmacokinetics; Internal medicine; Dermatology; Pharmacology; Tumor necrosis factor alpha","score_opus":0.018106902793602615,"score_gpt":0.29266588155561674,"score_spread":0.2745589787620141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131020062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859644,0.01314696,0.000025618632,0.00015069282,0.00030887892,0.00017351062,0.000053414446,0.000005641187,0.00017087483],"genre_scores_gemma":[0.99855334,0.0007612534,0.00054330134,0.000023150269,0.000031153933,0.0000033722404,0.000027037828,0.000012947597,0.000044449513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976721,0.0005231163,0.0012854596,0.00020250988,0.00007252345,0.00024432005],"domain_scores_gemma":[0.9984824,0.0003184512,0.00088387995,0.00009239087,0.00018605003,0.000036802998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020841809,0.00016403274,0.0010643284,0.00016803051,0.000056337623,0.000008440159,0.00014498032,0.0002578884,0.000049141054],"category_scores_gemma":[0.00006070761,0.00015376593,0.0000880099,0.00011915636,0.0005069081,0.00011473624,0.000046607118,0.0003040657,0.0000022551587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001235618,0.00087083987,0.9519946,0.00006639999,0.0002508018,0.00011787007,0.000114758885,0.0000027390747,0.0032512725,0.000032262305,0.0010776682,0.04098517],"study_design_scores_gemma":[0.012210085,0.00070710666,0.97578156,0.00024289609,0.00030445826,0.0031878161,0.00017138083,0.000004154636,0.006311755,0.000039399685,0.00089940795,0.0001399758],"about_ca_topic_score_codex":0.00019141939,"about_ca_topic_score_gemma":0.00013253735,"teacher_disagreement_score":0.040845193,"about_ca_system_score_codex":0.000008787807,"about_ca_system_score_gemma":0.00007468681,"threshold_uncertainty_score":0.62703925},"labels":[],"label_agreement":null},{"id":"W2131727392","doi":"10.1111/bjd.14164","title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","year":2015,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":479,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; SKiN Health","funders":"Celgene","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Internal medicine; Dermatology Life Quality Index; Nausea; Randomized controlled trial; Population; Tolerability; Dermatology; Psoriatic arthritis; Pathology; Alternative medicine","score_opus":0.007377866692009705,"score_gpt":0.2451757533723236,"score_spread":0.2377978866803139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131727392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959988,0.0006541855,0.0013247654,0.000096338576,0.00045828265,0.0014000788,0.000019218403,0.0000047030267,0.00004364537],"genre_scores_gemma":[0.99900675,0.00013019818,0.00043147846,0.00016406525,0.000106788975,0.000031952462,0.00007763426,0.000019287858,0.000031854615],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976704,0.0005518323,0.001091245,0.00023559692,0.00023772064,0.0002132091],"domain_scores_gemma":[0.9985053,0.00008562837,0.0006056218,0.00013766137,0.00041864227,0.00024717022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049954274,0.00019927407,0.0013204636,0.00013327674,0.000050343308,0.000041654162,0.00010564715,0.0002100284,0.000010918954],"category_scores_gemma":[0.00036433933,0.00016912271,0.0001332778,0.00009597718,0.00014757323,0.000042776963,0.000047460842,0.00016550641,3.262753e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9937942,0.0010552005,0.001381421,0.000010231242,0.00023460729,0.00009258122,0.00020334177,0.00030995472,0.0005577902,0.000007287934,0.00071393704,0.001639442],"study_design_scores_gemma":[0.99165523,0.0019416842,0.0010494688,0.00012773326,0.00012364327,0.0012069031,0.00007500467,0.00019489128,0.0030383891,0.000028372737,0.00035762964,0.00020102413],"about_ca_topic_score_codex":0.000046142308,"about_ca_topic_score_gemma":0.00012516287,"teacher_disagreement_score":0.0030079577,"about_ca_system_score_codex":0.00002700463,"about_ca_system_score_gemma":0.00022094583,"threshold_uncertainty_score":0.6896624},"labels":[],"label_agreement":null},{"id":"W2132923004","doi":"10.1111/bjd.13013","title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR)","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Janssen Biotech; Janssen Scientific Affairs","keywords":"Medicine; Psoriasis; Disease; Patient registry; Prospective cohort study; Baseline (sea); Longitudinal study; Internal medicine; Physical therapy; Pediatrics; Dermatology; Pathology","score_opus":0.00590134978092694,"score_gpt":0.188536144276712,"score_spread":0.18263479449578507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132923004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989102,0.009586213,0.00018087689,0.000106755244,0.00040347475,0.00032636177,0.00025252148,0.000011986784,0.000029779243],"genre_scores_gemma":[0.9986068,0.0007087121,0.00027450974,0.00006217419,0.000028269207,0.000024711113,0.00018803657,0.000020303885,0.00008648297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982365,0.0005362422,0.00062554097,0.00024962347,0.000071924456,0.00028016831],"domain_scores_gemma":[0.9985852,0.00025793482,0.0006196098,0.0001873747,0.00021849536,0.00013138822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011758752,0.00022575165,0.00071205763,0.00024753995,0.00005847758,0.00000893932,0.00012788741,0.00013224185,0.00006216015],"category_scores_gemma":[0.00024452712,0.00020375717,0.0001574302,0.0000990818,0.0002648395,0.00009764152,0.000020125699,0.00015009516,0.0000026769846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006377344,0.0017667551,0.9643161,0.00006270682,0.00032880995,0.0006632049,0.00008972541,0.000002291521,0.00008620028,0.000014708144,0.00033416066,0.025957959],"study_design_scores_gemma":[0.020046266,0.00032878574,0.9741634,0.00023684157,0.00058276486,0.0003325815,0.00002115395,0.00003238773,0.0001776559,0.000018166316,0.0038703342,0.0001896217],"about_ca_topic_score_codex":0.000041782536,"about_ca_topic_score_gemma":0.000087865534,"teacher_disagreement_score":0.025768336,"about_ca_system_score_codex":0.00014688392,"about_ca_system_score_gemma":0.0003013182,"threshold_uncertainty_score":0.83089757},"labels":[],"label_agreement":null},{"id":"W2135480474","doi":"10.1111/j.1365-2133.2004.05708.x","title":"Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma","year":2004,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":569,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Melanoma; Incidence (geometry); Epidemiology; Medicine; Etiology; Dermatology; Pathology; Cancer research","score_opus":0.03889809445399199,"score_gpt":0.3269901848030527,"score_spread":0.2880920903490607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135480474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067304017,0.99330825,0.00019542848,0.00023441558,0.00042394554,0.0003062799,0.000099681805,0.00001904116,0.0047398936],"genre_scores_gemma":[0.07473689,0.92429006,0.00056059426,0.00004224907,0.00011777385,0.0000050434596,0.000020111469,0.00002652732,0.00020073267],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9960207,0.0005153414,0.0025225398,0.00030560434,0.00033887487,0.0002969723],"domain_scores_gemma":[0.9962716,0.00023817591,0.0026995414,0.00024543362,0.00032855838,0.00021668259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025907665,0.00035220696,0.004915327,0.0004576934,0.000036085716,0.000009954779,0.0002999325,0.00052625564,0.000253555],"category_scores_gemma":[0.00045049743,0.00030173908,0.0015533252,0.00041403592,0.00038793756,0.00004257339,0.000096187185,0.00052930857,0.0000057527045],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003087884,0.00071760616,0.00025157354,0.012001237,0.001939022,0.11599239,0.00007090044,0.0000019896302,0.0000019050917,0.00094219856,0.004660547,0.86311185],"study_design_scores_gemma":[0.0009604394,0.00074023963,0.000097841,0.015138473,0.0011143438,0.7134535,0.00027299233,9.1207284e-7,0.000004189747,0.00014499752,0.26791117,0.00016092401],"about_ca_topic_score_codex":0.00009724417,"about_ca_topic_score_gemma":0.000015796188,"teacher_disagreement_score":0.8629509,"about_ca_system_score_codex":0.00026774537,"about_ca_system_score_gemma":0.00069078564,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W2138315687","doi":"10.1111/j.1365-2133.2009.09436.x","title":"A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0·02% tretinoin product regimen","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Moisturizer; Niacinamide; Medicine; Wrinkle; Dermatology; Regimen; Tretinoin; Sensitive skin; Erythema; Tolerability; Surgery; Pharmacology; Adverse effect; Nicotinamide; Chemistry; Retinoic acid","score_opus":0.018211022899139253,"score_gpt":0.2702476302366969,"score_spread":0.25203660733755767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138315687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825733,0.005377902,0.000048982853,0.0055956673,0.0004301487,0.005408791,0.0000023846526,0.000024781415,0.0005380454],"genre_scores_gemma":[0.9985039,0.00029620645,0.0003424409,0.00007072329,0.00017986384,0.00008761305,0.0000022815188,0.000016801585,0.00050014484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953544,0.0015919458,0.001861414,0.0003287479,0.00059439306,0.0002690757],"domain_scores_gemma":[0.99590534,0.00013944226,0.0024020744,0.00032972614,0.0011307417,0.00009266742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001276296,0.00023398116,0.0024437893,0.00032594346,0.00014182345,0.00002293162,0.00021579626,0.00008369174,0.000024589974],"category_scores_gemma":[0.001289182,0.00017202116,0.00042952996,0.00043919805,0.0003029313,0.00018623061,0.000039718496,0.00058372197,0.0000013950897],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83803314,0.0137211345,0.012594715,0.00095991994,0.0057081236,0.0011678155,0.02728789,0.0011082068,0.04927549,0.0008190478,0.014551024,0.03477352],"study_design_scores_gemma":[0.67879975,0.0029705395,0.051568493,0.0042823404,0.003028203,0.17592,0.0052220593,0.0004852057,0.0760781,0.0010057362,0.00021359876,0.0004259783],"about_ca_topic_score_codex":0.000083641426,"about_ca_topic_score_gemma":0.000014816134,"teacher_disagreement_score":0.17475219,"about_ca_system_score_codex":0.000064949425,"about_ca_system_score_gemma":0.00021122642,"threshold_uncertainty_score":0.70148194},"labels":[],"label_agreement":null},{"id":"W2140579099","doi":"10.1111/j.1365-2133.2006.07743.x","title":"Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Psoriasis; Editorial board; Medical school; Family medicine; Dermatology; Library science; Medical education","score_opus":0.017322771621634578,"score_gpt":0.26841306818914656,"score_spread":0.251090296567512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140579099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953462,0.0037858766,0.000055625223,0.00039473953,0.00007845227,0.00018633532,0.000009686521,0.0000040276773,0.00013905542],"genre_scores_gemma":[0.9990141,0.00042461793,0.00013333342,0.0003554295,0.000045679255,8.2991494e-7,0.000003256915,0.0000100944,0.000012656369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989067,0.00008307762,0.00044796168,0.00012309646,0.00024916846,0.00019001671],"domain_scores_gemma":[0.9992887,0.0001212924,0.0002702395,0.00008902087,0.00015495456,0.00007578547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002797552,0.000106150714,0.0003641334,0.00009007247,0.00007095828,0.000020024123,0.00008611657,0.00009135382,0.000021372125],"category_scores_gemma":[0.00003917009,0.00008255697,0.000028671991,0.00010207863,0.00015026954,0.000108755354,0.000011472592,0.00024292896,2.9093155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480344,0.00042445978,0.92410123,0.00006236781,0.00007871409,0.0014896018,0.0009326719,0.0000012034888,0.00031932566,0.0003249283,0.00022815853,0.071389295],"study_design_scores_gemma":[0.003952743,0.0005446169,0.9847179,0.0002771575,0.00003286609,0.0077993204,0.00021563658,0.0000045401134,0.001721106,0.0004503,0.00020245569,0.00008136819],"about_ca_topic_score_codex":0.00012707202,"about_ca_topic_score_gemma":0.0005188175,"teacher_disagreement_score":0.07130793,"about_ca_system_score_codex":0.000010320912,"about_ca_system_score_gemma":0.000051504816,"threshold_uncertainty_score":0.33665755},"labels":[],"label_agreement":null},{"id":"W2141045409","doi":"10.1111/j.1365-2133.2009.09491.x","title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Psoriasis; Medicine; Quality of life (healthcare); Phoenix; Dermatology; Dermatologic agents; Physical therapy; Internal medicine; Disease; Pathology; Nursing","score_opus":0.0183358813007874,"score_gpt":0.24431816057660868,"score_spread":0.2259822792758213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141045409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913857,0.0049907444,0.000017448336,0.0019398881,0.00078310276,0.0004915482,0.00030089694,0.000012670001,0.000078006444],"genre_scores_gemma":[0.99892473,0.00019484186,0.00013745273,0.0005180733,0.000044165175,0.0000056169583,0.00013136657,0.000012323771,0.000031414595],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9960065,0.0013481773,0.0018953991,0.00025845476,0.000108592845,0.00038288397],"domain_scores_gemma":[0.9976234,0.00048434568,0.0013475784,0.00024261263,0.00022998563,0.00007208518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048529,0.00020156274,0.0011006721,0.00012584534,0.00014103822,0.00002128442,0.00034752922,0.0003018833,0.00003591774],"category_scores_gemma":[0.00053738814,0.00015638427,0.00016170702,0.00022828883,0.00010321738,0.00014188951,0.00003194986,0.00040966697,0.000013492373],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.683747,0.0042008534,0.058090493,0.000029616169,0.0022895618,0.00041271822,0.0047983704,0.00010826975,0.0012812916,0.0001333229,0.015304582,0.22960392],"study_design_scores_gemma":[0.2318222,0.0019652026,0.7623614,0.00028371825,0.000116296644,0.00112924,0.00033523,0.0000010813604,0.0010427277,0.00031746607,0.00036511334,0.00026031473],"about_ca_topic_score_codex":0.0014913348,"about_ca_topic_score_gemma":0.00070292887,"teacher_disagreement_score":0.7042709,"about_ca_system_score_codex":0.000055933688,"about_ca_system_score_gemma":0.0003852959,"threshold_uncertainty_score":0.63771653},"labels":[],"label_agreement":null},{"id":"W2142329760","doi":"10.1111/bjd.12632","title":"Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from <scp>PHOENIX</scp> 1","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Moncton Hospital","funders":"Celgene; Janssen Research and Development; Pfizer; Amgen","keywords":"Ustekinumab; Medicine; Psoriasis; Dermatology; Nail (fastener); Placebo; Dosing; Psoriasis Area and Severity Index; Randomized controlled trial; Nail disease; Surgery; Internal medicine; Disease; Pathology","score_opus":0.006298647247534306,"score_gpt":0.18957286171401702,"score_spread":0.1832742144664827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142329760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942711,0.0035201316,0.000031501982,0.0002996133,0.0008534668,0.00042548636,0.00037273916,0.000026644608,0.00019931702],"genre_scores_gemma":[0.99847174,0.00018956658,0.00036334214,0.00025670996,0.000062493746,0.000038683585,0.00024922812,0.000034584922,0.00033365586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976128,0.000406357,0.00090347114,0.00038875703,0.00010703351,0.0005815933],"domain_scores_gemma":[0.99834347,0.0003560012,0.00049505115,0.00027068472,0.00036075877,0.00017404534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000094318624,0.00029321466,0.00071773276,0.00025742888,0.0001486041,0.000078401674,0.0003777835,0.00030490325,0.00009127174],"category_scores_gemma":[0.00039572603,0.00027297297,0.00014347993,0.00020406893,0.00011382564,0.0004171625,0.00008173229,0.00038784268,0.00029710022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01117532,0.003893855,0.50737077,0.00007155186,0.0029171028,0.006186083,0.003399361,0.00018824638,0.0040424345,0.000042858675,0.103938416,0.35677397],"study_design_scores_gemma":[0.02463073,0.0003547147,0.9647808,0.00032953423,0.00023674531,0.0021982759,0.00030161534,0.0000055913356,0.0034062357,0.0003074294,0.0032301666,0.00021817144],"about_ca_topic_score_codex":0.00076027185,"about_ca_topic_score_gemma":0.00024703197,"teacher_disagreement_score":0.45741,"about_ca_system_score_codex":0.00007045359,"about_ca_system_score_gemma":0.00020189006,"threshold_uncertainty_score":0.9999722},"labels":[],"label_agreement":null},{"id":"W2143097167","doi":"10.1111/j.1365-2133.2005.06847.x","title":"Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen α receptors in mouse sebaceous glands","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"","keywords":"Internal medicine; Endocrinology; Dihydrotestosterone; Dehydroepiandrosterone; Sebaceous gland; Androgen receptor; Androgen; Testosterone (patch); Estrogen; Intracrine; Basal (medicine); Biology; Hormone; Estrogen receptor; Sex steroid; Receptor; Steroid; Medicine; Paracrine signalling; Cancer; Breast cancer; Insulin","score_opus":0.008078751776596957,"score_gpt":0.23196927840746448,"score_spread":0.22389052663086753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143097167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796589,0.019811211,0.000010769136,0.0002577368,0.000047641104,0.00015706627,0.0000042277893,0.0000043340106,0.000048103266],"genre_scores_gemma":[0.9900855,0.009414489,0.00020514587,0.00018425059,0.000040988456,0.0000024444628,0.0000022886609,0.000011102424,0.000053791086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991546,0.00009374327,0.00031726412,0.0001403187,0.00011003532,0.00018401709],"domain_scores_gemma":[0.9995031,0.00012001877,0.00013933456,0.000056345336,0.000027116703,0.00015410072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007038795,0.00012784159,0.0005629319,0.00012430426,0.000045388893,0.00001896561,0.000032169268,0.00012041062,0.0000058485048],"category_scores_gemma":[0.000027708438,0.00010501662,0.000035514793,0.000042469957,0.00012239207,0.00008401624,0.00002995484,0.00016749256,4.2411622e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003697305,0.00033243187,0.8947357,0.0003225298,0.00024933336,0.0038495774,0.00095441693,9.4394045e-7,0.0017551155,0.000006386036,0.00037272394,0.09705114],"study_design_scores_gemma":[0.03619978,0.005269701,0.47768942,0.0018102059,0.0005846062,0.40211084,0.0006608631,0.00020122931,0.07335505,0.00014676465,0.0014745898,0.0004969611],"about_ca_topic_score_codex":0.00002061033,"about_ca_topic_score_gemma":0.00003140124,"teacher_disagreement_score":0.41704625,"about_ca_system_score_codex":0.000014237361,"about_ca_system_score_gemma":0.00002371732,"threshold_uncertainty_score":0.42824534},"labels":[],"label_agreement":null},{"id":"W2144445655","doi":"10.1046/j.1365-2133.2002.04894.x","title":"Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Atopic dermatitis; Hydrocortisone; Medicine; Randomized controlled trial; Dermatology; Phosphodiesterase; Internal medicine; Gastroenterology; Chemistry; Enzyme; Biochemistry","score_opus":0.0232340344813625,"score_gpt":0.28565288522299986,"score_spread":0.26241885074163734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144445655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139484,0.081066735,0.00015914332,0.0034968087,0.00032822147,0.0007735321,0.00004110594,0.000009560167,0.00017645062],"genre_scores_gemma":[0.9878931,0.011019554,0.00023476926,0.000426545,0.00008536193,0.000034219036,0.000006521531,0.000018117831,0.00028178637],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99786115,0.00028821625,0.001245526,0.00014626223,0.00020654232,0.0002523336],"domain_scores_gemma":[0.99713135,0.0012575212,0.0009008606,0.00023021275,0.00034847774,0.00013158288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013572,0.00018721346,0.0014939837,0.00007872729,0.00017500926,0.000019480043,0.00016453509,0.00015551891,0.00013217525],"category_scores_gemma":[0.0004445905,0.0001233684,0.00040641593,0.00013508394,0.00074646604,0.00009180614,0.000031018975,0.00017844727,0.0000020349007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055080518,0.026373042,0.6355988,0.001744778,0.006609176,0.003886574,0.007025294,0.00011550541,0.001670949,0.00040411353,0.17612936,0.08536192],"study_design_scores_gemma":[0.54760915,0.004466469,0.121924154,0.0024821744,0.007703231,0.14344673,0.0015302458,0.016798805,0.11508141,0.0012953543,0.036952566,0.0007097375],"about_ca_topic_score_codex":0.00006382105,"about_ca_topic_score_gemma":0.000056092053,"teacher_disagreement_score":0.5136746,"about_ca_system_score_codex":0.000024420335,"about_ca_system_score_gemma":0.00007181402,"threshold_uncertainty_score":0.50308174},"labels":[],"label_agreement":null},{"id":"W2145156771","doi":"10.1111/j.1365-2133.2010.09809.x","title":"Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007","year":2010,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Skin cancer; Incidence (geometry); Basal cell carcinoma; Head and neck; Malignancy; Basal cell; Cancer registry; Epidemiology; Retrospective cohort study; Dermatology; Cancer; Internal medicine; Surgery","score_opus":0.0056091210494941595,"score_gpt":0.24907783798402006,"score_spread":0.2434687169345259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145156771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909183,0.002089791,0.000005646002,0.002429612,0.0008231626,0.00007210238,0.000010023786,0.000001560512,0.0036498155],"genre_scores_gemma":[0.99856395,0.00033796098,0.0004491457,0.00034436217,0.00011988305,0.0000053329254,0.0000024699007,0.000016473785,0.00016044258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819225,0.00006713546,0.0009133598,0.00016424127,0.00030291086,0.0003600863],"domain_scores_gemma":[0.998951,0.00021176625,0.00041977683,0.00015042843,0.00013307232,0.00013392001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001644821,0.000136132,0.00082007714,0.00042343893,0.000025005627,0.0000060986586,0.00021040469,0.00014026077,0.00025566042],"category_scores_gemma":[0.0002470402,0.00015674639,0.000087344786,0.00038171184,0.00018796556,0.000101747595,0.000049224916,0.0007775995,0.0000014553701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015800136,0.000072455194,0.95162034,0.00004634351,0.000058293987,0.015809506,0.00026558887,0.000008364246,0.00016563805,0.00003542094,0.0100535415,0.02170648],"study_design_scores_gemma":[0.0024248867,0.00007025083,0.90001446,0.00035179884,0.000026388088,0.090179496,0.00015445819,0.00002167766,0.0014932664,0.000036315756,0.0051113567,0.00011564774],"about_ca_topic_score_codex":0.8030677,"about_ca_topic_score_gemma":0.9937782,"teacher_disagreement_score":0.19071054,"about_ca_system_score_codex":0.0003402824,"about_ca_system_score_gemma":0.0013636877,"threshold_uncertainty_score":0.63919324},"labels":[],"label_agreement":null},{"id":"W2146675394","doi":"10.1111/j.1365-2133.2007.08250.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case–control study","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Isotretinoin; Center (category theory); Pharmacy; Library science; Art; Art history; Family medicine; Acne; Dermatology","score_opus":0.009676895545310954,"score_gpt":0.2734383505836538,"score_spread":0.2637614550383428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146675394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820666,0.01579512,0.00026333818,0.001269526,0.00009874764,0.0003973335,0.000002295709,0.0000046580108,0.00010241019],"genre_scores_gemma":[0.9981134,0.001209712,0.00012460185,0.0004414622,0.000063890024,0.0000022819565,3.0755507e-7,0.000008479768,0.000035844318],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99887425,0.00022545777,0.00049875025,0.00008533088,0.0001503742,0.00016581295],"domain_scores_gemma":[0.9988807,0.00045262443,0.00031928992,0.0000977781,0.0001607291,0.000088865214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063429604,0.00008914232,0.0005464229,0.00007335759,0.00009990169,0.00001272634,0.00006136601,0.00007531066,0.000022667167],"category_scores_gemma":[0.0001601395,0.000055671913,0.00009427298,0.00010266421,0.00020083757,0.00006532301,0.000016857806,0.00023349428,8.399962e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005464841,0.0011115281,0.47046965,0.000047832556,0.0010676131,0.3669109,0.0026972955,0.0000012089062,0.00040421763,0.00008222768,0.0012976568,0.15044503],"study_design_scores_gemma":[0.02137247,0.0007503842,0.26042733,0.00011716576,0.00024948834,0.71530193,0.0012347931,0.000020672229,0.00030399815,0.000044375658,0.00013202163,0.000045355227],"about_ca_topic_score_codex":0.00018400143,"about_ca_topic_score_gemma":0.000108394044,"teacher_disagreement_score":0.34839106,"about_ca_system_score_codex":0.0000098944265,"about_ca_system_score_gemma":0.00004961626,"threshold_uncertainty_score":0.22702347},"labels":[],"label_agreement":null},{"id":"W2146843653","doi":"10.1111/j.1365-2133.2005.06688.x","title":"A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":692,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"SAINT; Medicine; Library science; Family medicine; Art history; Art","score_opus":0.006313327572443979,"score_gpt":0.26180500052152084,"score_spread":0.2554916729490769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146843653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97352046,0.023470629,0.000038261136,0.00025607285,0.0010554485,0.0013667721,0.000026281074,0.000008244384,0.0002578361],"genre_scores_gemma":[0.9957143,0.0039962656,0.00009002224,0.00000955438,0.0000924994,0.000033794782,0.000016371816,0.00000857884,0.000038630238],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951937,0.0024792955,0.001839481,0.0001702144,0.00007016003,0.0002471165],"domain_scores_gemma":[0.997555,0.00095055904,0.0012287952,0.000111308735,0.00011675672,0.000037577156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011974509,0.00019847517,0.0031177711,0.00021983853,0.000053910313,0.000007834468,0.00014811703,0.00035389044,0.000103926395],"category_scores_gemma":[0.00058263086,0.00016851984,0.00049182656,0.00015842979,0.0003820897,0.000114516,0.000030313768,0.00018983212,0.000003495604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88214004,0.0009221508,0.0001338852,0.00002401169,0.0012848933,0.00019853874,0.00015720911,0.0000093908675,0.0050641433,0.00006511379,0.00022608726,0.10977452],"study_design_scores_gemma":[0.95561403,0.0011417477,0.00041981807,0.00017430983,0.0012122893,0.03271232,0.000051398787,0.000005045636,0.008331115,0.000043262837,0.00018468972,0.000109972425],"about_ca_topic_score_codex":0.000083833365,"about_ca_topic_score_gemma":0.000052234354,"teacher_disagreement_score":0.10966455,"about_ca_system_score_codex":0.0000419588,"about_ca_system_score_gemma":0.00012069766,"threshold_uncertainty_score":0.68720394},"labels":[],"label_agreement":null},{"id":"W2149076399","doi":"10.1046/j.1365-2133.2000.03299.x","title":"Descriptive epidemiology of hand dermatitis at the St John’s contact dermatitis clinic 1983-97","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hand eczema; Medicine; Contact dermatitis; Epidemiology; Dermatology; Hand dermatitis; Irritant contact dermatitis; Population; Quarter (Canadian coin); Environmental health; Allergy; Internal medicine","score_opus":0.030696837710295133,"score_gpt":0.2862535420040539,"score_spread":0.25555670429375876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149076399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485352,0.030985663,0.000264766,0.014824766,0.00053236313,0.00038226112,0.00012316264,0.000023311504,0.0043284846],"genre_scores_gemma":[0.97554326,0.01667077,0.00049261824,0.00560021,0.00017767485,0.000013255159,0.000035526165,0.000037869806,0.0014288175],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.995515,0.00088667386,0.0024035852,0.00025097845,0.0003468052,0.00059695484],"domain_scores_gemma":[0.9963162,0.0013487069,0.0012164979,0.00034811936,0.00048649684,0.0002839815],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055814226,0.00029170263,0.0017767675,0.00018718178,0.00033027452,0.00003636314,0.00037427008,0.0002946691,0.008763105],"category_scores_gemma":[0.000823696,0.0002475726,0.0005923694,0.00020305556,0.00069867243,0.00032853874,0.00008821572,0.00075215136,0.00021234741],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057712494,0.00067973917,0.33407322,0.0005435623,0.0019651626,0.024460206,0.0027574368,0.000017947963,0.00072355644,0.00037648276,0.39130253,0.24252304],"study_design_scores_gemma":[0.0043501137,0.0003386826,0.5223335,0.0010318072,0.00029305997,0.35023978,0.00054193736,0.0000633609,0.0016180922,0.0005248177,0.11843239,0.00023245678],"about_ca_topic_score_codex":0.00046938346,"about_ca_topic_score_gemma":0.0012726793,"teacher_disagreement_score":0.3257796,"about_ca_system_score_codex":0.00012699651,"about_ca_system_score_gemma":0.00030212928,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W2149530115","doi":"10.1111/j.1365-2133.2005.06529.x","title":"Surgery for basal cell carcinoma: study biases","year":2005,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Citation; SAINT; Library science; Medicine; History; Computer science; Art history","score_opus":0.040379261375525874,"score_gpt":0.28613934357973647,"score_spread":0.24576008220421058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149530115","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34267482,0.053455934,0.00013114752,0.5967849,0.004330876,0.0015108165,0.00022139195,0.0000327562,0.00085734547],"genre_scores_gemma":[0.7411495,0.0011393646,0.0008307114,0.24206397,0.013489588,0.00007960539,0.00008799822,0.00016623063,0.0009930346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968363,0.00024414874,0.0014107934,0.000360001,0.00050654454,0.0006422324],"domain_scores_gemma":[0.9960965,0.0018365661,0.0010880845,0.0002708893,0.0005806239,0.00012731594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024957102,0.00037114686,0.0023055412,0.0004956184,0.00013469809,0.00004920307,0.00026315075,0.0005917709,0.00013320518],"category_scores_gemma":[0.00049341517,0.0004086342,0.00074178615,0.00013499417,0.0001677828,0.00010132053,0.00007947835,0.0018577713,0.000014505554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014207346,0.00031284548,0.08757134,0.00038604482,0.00033659884,0.117978305,0.00006486512,2.2744649e-7,0.0000016992036,6.414103e-8,0.7907838,0.0024221456],"study_design_scores_gemma":[0.0046611223,0.00052263617,0.065035775,0.0006728448,0.0012110912,0.32134476,0.00023117018,0.0000020048815,0.00028152144,0.00001851909,0.60561305,0.00040546787],"about_ca_topic_score_codex":0.000071977476,"about_ca_topic_score_gemma":0.00007185749,"teacher_disagreement_score":0.39847466,"about_ca_system_score_codex":0.00017159885,"about_ca_system_score_gemma":0.0006919046,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W2151105422","doi":"10.1111/bjd.12292","title":"No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia","year":2013,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"German; Library science; Medicine; History; Computer science","score_opus":0.008106671396456655,"score_gpt":0.2421247788481602,"score_spread":0.23401810745170354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151105422","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.385466,0.016065743,0.0093221385,0.5788556,0.0024254888,0.0057750144,0.0009667078,0.000021768634,0.0011015752],"genre_scores_gemma":[0.7594092,0.002010457,0.0024634576,0.23206675,0.0023502198,0.00016532872,0.00064391806,0.000098015065,0.00079267594],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997795,0.00016629661,0.0011934998,0.00017693345,0.00025334585,0.00041492961],"domain_scores_gemma":[0.9973032,0.00020744691,0.0008405084,0.00019903612,0.0013291346,0.00012066822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016010278,0.00018347663,0.0011949352,0.0002383586,0.000044192228,0.000011109744,0.00026044308,0.00060394517,0.00021862258],"category_scores_gemma":[0.0006536709,0.00015356031,0.0003412338,0.00011736936,0.00022162698,0.000028746806,0.00003768815,0.00060454267,0.000027605753],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028997372,0.00008206449,0.012067901,0.00046488259,0.00028837094,0.0016695176,0.000054703367,0.000002050226,0.0003015511,0.000009304132,0.9822818,0.0024878627],"study_design_scores_gemma":[0.004366402,0.0015333421,0.015298246,0.00042889136,0.00049486884,0.12473072,0.000029106846,0.000015862548,0.00080499327,0.00015885492,0.8519737,0.00016501946],"about_ca_topic_score_codex":0.000043494285,"about_ca_topic_score_gemma":0.000049147897,"teacher_disagreement_score":0.37394318,"about_ca_system_score_codex":0.000029538145,"about_ca_system_score_gemma":0.0004913192,"threshold_uncertainty_score":0.6262008},"labels":[],"label_agreement":null},{"id":"W2152124559","doi":"10.1111/bjd.12694","title":"Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009","year":2013,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Confidence interval; Cancer; Cancer registry; Melanoma; Oncology; Internal medicine; Cancer research","score_opus":0.005183936699703287,"score_gpt":0.21043968080961953,"score_spread":0.20525574410991623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152124559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949095,0.0022683707,0.000031070056,0.0011355808,0.00058046664,0.00046810365,0.0001438698,0.000004725079,0.00045829563],"genre_scores_gemma":[0.996831,0.0009426096,0.0006307788,0.0007577182,0.00006278397,0.00004278912,0.000005694189,0.000026569829,0.0007000291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977367,0.00013889272,0.001188331,0.00021923316,0.00036463136,0.00035221502],"domain_scores_gemma":[0.99834245,0.00039322948,0.00066287746,0.00019091979,0.00018310847,0.00022741048],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000089287896,0.00018692757,0.0010729039,0.00026939795,0.000040379975,0.00001783088,0.00020278033,0.00012339087,0.0019220788],"category_scores_gemma":[0.00022152229,0.00018087542,0.00019936102,0.00024371629,0.000048865306,0.00008953627,0.0000738376,0.00025984598,0.000006854701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001025665,0.00055493927,0.791325,0.00045083254,0.0015367189,0.07710922,0.0008949883,0.000106643565,0.006027905,0.000008133888,0.05001129,0.07094866],"study_design_scores_gemma":[0.005053963,0.00083376776,0.78676116,0.0026803592,0.00067439757,0.1469574,0.001223258,0.00007930182,0.03484382,0.000088399436,0.020319806,0.0004843516],"about_ca_topic_score_codex":0.75295115,"about_ca_topic_score_gemma":0.9107811,"teacher_disagreement_score":0.15782996,"about_ca_system_score_codex":0.00022791013,"about_ca_system_score_gemma":0.0006180346,"threshold_uncertainty_score":0.9989903},"labels":[],"label_agreement":null},{"id":"W2154234582","doi":"10.1046/j.1365-2133.2002.04967.x","title":"Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial","year":2002,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Calcipotriol; Betamethasone dipropionate; Medicine; Psoriasis; Psoriasis Area and Severity Index; Betamethasone; Randomized controlled trial; Adverse effect; Dermatology; Corticosteroid; Surgery; Internal medicine","score_opus":0.06992348893430708,"score_gpt":0.32695770503985633,"score_spread":0.2570342161055492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154234582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971141,0.02484285,0.00013771713,0.00077158085,0.00045557736,0.0025449882,0.000040943127,0.0000070738834,0.000058283353],"genre_scores_gemma":[0.98726535,0.012123496,0.0002991915,0.000055201872,0.00006335717,0.000068872745,0.000018704799,0.000015614865,0.000090223926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99392605,0.0025668151,0.0027206263,0.00031685602,0.00014465516,0.0003250168],"domain_scores_gemma":[0.9926531,0.00515414,0.0016066424,0.0002395317,0.00025568297,0.000090913905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012278423,0.0002854966,0.003087417,0.00034721315,0.00010683307,0.000019357778,0.0002974582,0.00041129568,0.00007687531],"category_scores_gemma":[0.0008888481,0.00020197245,0.00043700275,0.00035951732,0.000487758,0.00012274948,0.000048349324,0.00028654886,0.0000032653832],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9155763,0.0032947282,0.0016667705,0.000039571245,0.0019499653,0.00021295607,0.003148668,0.000007155491,0.0009881905,0.00009250869,0.00021656966,0.07280664],"study_design_scores_gemma":[0.9818488,0.0036618242,0.0051837172,0.00024757558,0.0017512543,0.0032003256,0.0004024373,0.00004166258,0.0026499154,0.000052177744,0.0007826557,0.00017767432],"about_ca_topic_score_codex":0.00059333147,"about_ca_topic_score_gemma":0.00024297075,"teacher_disagreement_score":0.07262897,"about_ca_system_score_codex":0.00003908996,"about_ca_system_score_gemma":0.0001365302,"threshold_uncertainty_score":0.8236198},"labels":[],"label_agreement":null},{"id":"W2156475253","doi":"10.1111/bjd.13004","title":"Long‐term efficacy and safety of infliximab maintenance therapy in patients with plaque‐type psoriasis in real‐world practice","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Schering-Plough","keywords":"Art history; Art; Medicine; Humanities","score_opus":0.008659925112616014,"score_gpt":0.23623426742092551,"score_spread":0.2275743423083095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156475253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99537635,0.0033861948,0.000020998421,0.00027200062,0.0003001161,0.00020003671,0.0000100128755,0.0000062551203,0.0004280566],"genre_scores_gemma":[0.9938764,0.0056938026,0.00022651331,0.00010850556,0.000015647329,0.0000033726403,0.000020528274,0.000014994982,0.00004021271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817026,0.0006247696,0.0006789569,0.00017961166,0.000056789835,0.00028964045],"domain_scores_gemma":[0.99850136,0.0005292816,0.00058228,0.00013228784,0.00022417823,0.00003062557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028057507,0.00015567256,0.00062588364,0.00027354877,0.00004770692,0.00001108206,0.00016536798,0.00018042827,0.00003591983],"category_scores_gemma":[0.00022332596,0.00014111893,0.000045603836,0.0002484486,0.00017523335,0.00022053866,0.000031148156,0.00030201004,0.0000050107415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010316207,0.0008156755,0.8570729,0.000019668045,0.00026168156,0.0004494142,0.00029729493,0.0000043863856,0.00023710694,0.00012406525,0.00020702634,0.13019457],"study_design_scores_gemma":[0.025366701,0.00064945023,0.9658239,0.00032581066,0.000059742328,0.0045893155,0.000036490666,3.585367e-7,0.001197785,0.000029264565,0.0017844323,0.00013676363],"about_ca_topic_score_codex":0.00018578685,"about_ca_topic_score_gemma":0.00078907947,"teacher_disagreement_score":0.13005781,"about_ca_system_score_codex":0.000039388553,"about_ca_system_score_gemma":0.00008175981,"threshold_uncertainty_score":0.5754663},"labels":[],"label_agreement":null},{"id":"W2161654538","doi":"10.1046/j.1365-2133.2000.03293.x","title":"Sequential assessment of an antidrug antibody response in a patient with a systemic delayed-onset sulphonamide hypersensitivity syndrome reaction","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Prince Edward Island","funders":"","keywords":"Medicine; Methylprednisolone; Antibody; Rash; Prednisone; Immunology; Gastroenterology; Serum sickness; Eosinophilia; Internal medicine","score_opus":0.009053523655366682,"score_gpt":0.2892527244367183,"score_spread":0.28019920078135163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161654538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985082,0.00013442044,0.00010450242,0.00027331695,0.00015702266,0.00029532833,0.00004951051,0.000020284835,0.00045741754],"genre_scores_gemma":[0.9987311,0.0001964555,0.00091221306,0.00006089126,0.00001998424,0.0000040694754,0.00003097636,0.000027697404,0.000016650753],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9974597,0.00076559454,0.0008520827,0.00021814668,0.0004088238,0.0002956234],"domain_scores_gemma":[0.9986735,0.000154538,0.00050737296,0.0002130303,0.000261074,0.00019047529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004375757,0.00015874632,0.0007676776,0.00042685887,0.00006342083,0.000017943614,0.00007506025,0.00015202025,0.000013763308],"category_scores_gemma":[0.00008115185,0.00016793166,0.00012562083,0.00032326486,0.00013104043,0.00041243216,0.000014737297,0.000597848,0.0000050902986],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061093406,0.0034810677,0.024315218,0.00025557386,0.0006968147,0.6073826,0.0007133036,0.00072240183,0.30547085,0.000012528198,0.00004336461,0.050796967],"study_design_scores_gemma":[0.0024047703,0.000395004,0.3219221,0.00090489286,0.00012410551,0.6715662,0.00077389344,0.00039423545,0.0013424231,0.000004249316,0.00006830951,0.0000998396],"about_ca_topic_score_codex":0.00068633986,"about_ca_topic_score_gemma":0.00021000886,"teacher_disagreement_score":0.30412844,"about_ca_system_score_codex":0.0002963634,"about_ca_system_score_gemma":0.0007049787,"threshold_uncertainty_score":0.68480545},"labels":[],"label_agreement":null},{"id":"W2161955658","doi":"10.1111/j.1365-2133.1994.tb08556.x","title":"Local steroid therapy and bacterial skin flora in atopic dermatitis","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Atopic dermatitis; Staphylococcus aureus; Medicine; Clinical trial; Randomized controlled trial; Colonization; Dermatology; Skin flora; Micrococcaceae; Corticosteroid; Internal medicine; Surgery; Bacteria; Microbiology; Biology","score_opus":0.007875800932189042,"score_gpt":0.2322505170404579,"score_spread":0.22437471610826887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161955658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829678,0.014232742,0.0002814235,0.0016204849,0.00029717627,0.000115814546,0.0000060820535,0.000011913067,0.00046657474],"genre_scores_gemma":[0.99730676,0.0014938863,0.00030377225,0.00069820584,0.0001374978,0.0000037574966,0.0000127281655,0.000013816663,0.000029569332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867254,0.00017302617,0.0006349594,0.00012796567,0.00013620892,0.0002553092],"domain_scores_gemma":[0.9994466,0.00008210187,0.00018242378,0.000087050386,0.00008809525,0.00011375903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072807,0.000121102836,0.000557118,0.00017658855,0.000050348506,0.00003379724,0.000088608744,0.00017779219,0.00015949302],"category_scores_gemma":[0.00003758888,0.00012877723,0.00009456908,0.00009501398,0.0002569327,0.00017800083,0.00002452016,0.00027989972,0.000008214978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072919443,0.0008808578,0.7147076,0.00019857744,0.00016469584,0.10322543,0.00019761887,0.0000050071963,0.00055174454,0.0002407607,0.06375547,0.11534306],"study_design_scores_gemma":[0.0050051394,0.00004605687,0.65529335,0.00016890973,0.000024826195,0.3297965,0.00005992878,0.000024055294,0.0017655296,0.0005782693,0.007148974,0.000088456734],"about_ca_topic_score_codex":0.00009307327,"about_ca_topic_score_gemma":0.00019695557,"teacher_disagreement_score":0.22657105,"about_ca_system_score_codex":0.000023073897,"about_ca_system_score_gemma":0.000107122985,"threshold_uncertainty_score":0.5251383},"labels":[],"label_agreement":null},{"id":"W2163232748","doi":"10.1111/j.1365-2133.2007.08315.x","title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":722,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Champion; SAINT; Medicine; Nice; Humanities; Library science; Art; Political science; Art history; Law","score_opus":0.011530061312799737,"score_gpt":0.2450423416198201,"score_spread":0.23351228030702037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163232748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933129,0.004087202,0.00009668258,0.00019364353,0.00040664306,0.0016592045,0.00008829239,0.000008132154,0.00014733204],"genre_scores_gemma":[0.99922484,0.00041744031,0.00017239893,0.000052632153,0.000023582734,0.00001611763,0.000054703854,0.000012136807,0.000026165717],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943991,0.0032229386,0.0017133438,0.0002454362,0.00011200336,0.0003072101],"domain_scores_gemma":[0.99081886,0.0073022526,0.0013855394,0.00017688816,0.00027609986,0.000040368763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001638291,0.00023905859,0.0025307622,0.00017808539,0.00015817882,0.000017713573,0.00023367493,0.00019921482,0.00003682058],"category_scores_gemma":[0.0006437183,0.00015630647,0.00017687882,0.0001724863,0.00034509005,0.00010298362,0.00005107426,0.00036170817,0.0000044111835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9453474,0.0015188551,0.03739752,0.0000035364328,0.003468962,0.00035527657,0.004623429,0.000012706552,0.00005827999,0.000017799202,0.00024514156,0.0069510443],"study_design_scores_gemma":[0.67430085,0.00059025,0.32139874,0.00012386643,0.0007423407,0.00080802257,0.0012320795,0.0000014181641,0.00055065856,0.000022678461,0.00011028746,0.0001188297],"about_ca_topic_score_codex":0.0005064841,"about_ca_topic_score_gemma":0.0012480041,"teacher_disagreement_score":0.2840012,"about_ca_system_score_codex":0.000029654806,"about_ca_system_score_gemma":0.00007121718,"threshold_uncertainty_score":0.6373993},"labels":[],"label_agreement":null},{"id":"W2163901561","doi":"10.1111/j.1365-2133.2008.08487.x","title":"Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial","year":2008,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada); Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Placebo; Refractory (planetary science); Adverse effect; Randomized controlled trial; Internal medicine; Placebo-controlled study; Clinical trial; Dermatology; Surgery; Double blind","score_opus":0.013525113201406801,"score_gpt":0.25456753004195853,"score_spread":0.24104241684055172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163901561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941091,0.0022771044,0.00004492816,0.00084052474,0.0001631413,0.0024082053,0.00002242384,0.000006078648,0.00012849577],"genre_scores_gemma":[0.9984119,0.00094835175,0.00038601737,0.0000925299,0.00006803855,0.000019249392,0.00001631574,0.000018433757,0.00003918067],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962996,0.00044772448,0.0022657542,0.00022425264,0.00045247716,0.00031015108],"domain_scores_gemma":[0.99742717,0.0006023228,0.0011238576,0.00018616806,0.00044979373,0.00021069738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038167715,0.00021046164,0.0024809716,0.0002665319,0.00006154522,0.000020705937,0.00012950378,0.00018269167,0.00004139191],"category_scores_gemma":[0.0009813631,0.0001750302,0.00023546058,0.00014920806,0.00033100732,0.0001533438,0.000058405985,0.00040444414,0.0000011741862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9814229,0.00074134674,0.009000954,0.00011535449,0.00040499985,0.0017410824,0.00082012574,0.000009376572,0.0000984892,0.00000423404,0.00032014406,0.005321014],"study_design_scores_gemma":[0.9367612,0.0019388066,0.048041318,0.0013823461,0.0002860258,0.01039213,0.000092415925,0.000028199072,0.0006488363,0.0000028633594,0.00027318133,0.00015265873],"about_ca_topic_score_codex":0.00013762158,"about_ca_topic_score_gemma":0.00037657196,"teacher_disagreement_score":0.04466166,"about_ca_system_score_codex":0.000076735625,"about_ca_system_score_gemma":0.00027440247,"threshold_uncertainty_score":0.71375245},"labels":[],"label_agreement":null},{"id":"W2166018121","doi":"10.1046/j.1365-2133.2003.05241.x","title":"The British Association of Dermatologists therapeutic guidelines: can we AGREE?","year":2003,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality (philosophy); Family medicine; Alternative medicine; Randomized controlled trial; MEDLINE; Medical education; Political science; Law; Pathology","score_opus":0.08183156640259864,"score_gpt":0.4236325965968229,"score_spread":0.34180103019422425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166018121","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003860965,0.0672664,0.0009416722,0.0688773,0.85706073,0.0010118218,0.00036519213,0.00004978818,0.0005661111],"genre_scores_gemma":[0.04433141,0.3600781,0.0052287513,0.00661,0.5778422,0.000057219342,0.00082481,0.00038506146,0.0046425145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904664,0.0012015412,0.005646055,0.00032949148,0.0017686185,0.00058789883],"domain_scores_gemma":[0.97612566,0.009004396,0.0074012917,0.00036070953,0.0068936488,0.00021427289],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0026988292,0.0003223151,0.0017779095,0.00014350632,0.0003773989,0.0003253491,0.0005463517,0.0014155613,0.00010645985],"category_scores_gemma":[0.065844655,0.00033143038,0.00064689404,0.00029645863,0.00025700603,0.00019655078,0.000084059895,0.002461067,0.0000110532355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016422727,0.00015215915,0.002479242,0.000191332,0.00080021354,0.0030956876,0.000023714709,0.0000016768721,0.000014373478,0.000008187631,0.9340367,0.059032485],"study_design_scores_gemma":[0.004412084,0.00018737164,0.0004859701,0.0013419515,0.0012797052,0.08525128,0.00030786888,0.000016754371,0.00007034046,0.0010121617,0.9053907,0.00024384107],"about_ca_topic_score_codex":0.0011859657,"about_ca_topic_score_gemma":0.006838441,"teacher_disagreement_score":0.2928117,"about_ca_system_score_codex":0.00045201366,"about_ca_system_score_gemma":0.0028644996,"threshold_uncertainty_score":0.99991375},"labels":[],"label_agreement":null},{"id":"W2167141300","doi":"10.1111/bjd.12129","title":"Skin tumours in the West of Scotland renal transplant population","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Renal transplant; Medicine; Population; Dermatology; Transplantation; Pathology; Surgery; Environmental health","score_opus":0.012648881811785214,"score_gpt":0.2659796348748114,"score_spread":0.2533307530630262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167141300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891079,0.008402556,0.000079977224,0.0016071463,0.00020505837,0.00008895925,0.000005795725,0.0000018203899,0.00050075224],"genre_scores_gemma":[0.9987212,0.00066536013,0.00025826404,0.0001557632,0.00018097964,0.0000020468415,0.0000044980784,0.000007210113,0.0000046793784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989555,0.00013035313,0.00047231655,0.000049744605,0.00020042376,0.00019169453],"domain_scores_gemma":[0.9994944,0.000101013735,0.00023718394,0.00006452789,0.000054008808,0.000048871716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025427024,0.000064564345,0.00036743417,0.000104433886,0.000030393525,0.000005453365,0.000090352834,0.000056260367,0.000027949915],"category_scores_gemma":[0.00004969986,0.000052479867,0.00007858301,0.00010536446,0.00007369129,0.00010249499,0.000008200177,0.00024297324,0.0000019087106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011586213,0.00012884838,0.99282384,0.00004123452,0.000038947306,0.0018355157,0.0008154715,0.0000015104794,0.000085354724,0.000058667632,0.0011778205,0.0028769288],"study_design_scores_gemma":[0.001138561,0.00005027823,0.77282625,0.00032083935,0.000063531705,0.22446209,0.00015727719,0.0000015668068,0.00059845473,0.00004960475,0.00029576503,0.00003576491],"about_ca_topic_score_codex":0.00020882367,"about_ca_topic_score_gemma":0.00038794286,"teacher_disagreement_score":0.22262657,"about_ca_system_score_codex":0.000025680161,"about_ca_system_score_gemma":0.00003408738,"threshold_uncertainty_score":0.21400669},"labels":[],"label_agreement":null},{"id":"W2167305078","doi":"10.1111/j.1365-2133.2012.11168.x","title":"Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study","year":2012,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":336,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Placebo; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Dose-ranging study; Internal medicine; Gastroenterology; Randomized controlled trial; Clinical endpoint; Dermatology; Double blind; Pathology","score_opus":0.01880262927208139,"score_gpt":0.28178375465673705,"score_spread":0.2629811253846557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167305078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96964025,0.028108673,0.000025024758,0.00008263102,0.0005624724,0.0014478796,0.000056014138,0.0000076018405,0.00006944862],"genre_scores_gemma":[0.9980169,0.0016837635,0.00008854909,0.000021030666,0.00006165983,0.00007027048,0.000027393384,0.000013818213,0.000016632406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99483234,0.003192,0.001339614,0.0001655388,0.00008247451,0.00038801716],"domain_scores_gemma":[0.9976089,0.001284548,0.0007646217,0.00018296688,0.000104209204,0.000054773685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012122432,0.0002425595,0.0019740646,0.00027145102,0.00011906469,0.000014895763,0.0001877996,0.00019864655,0.00006895574],"category_scores_gemma":[0.00022037102,0.00017461936,0.00033138884,0.0001514118,0.0002765612,0.00019536243,0.000019960453,0.00016959196,0.0000026549408],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71243215,0.026125781,0.022401344,0.000037826012,0.0040075253,0.0016496099,0.019498805,0.000005336264,0.007326217,0.00012200839,0.00008861818,0.2063048],"study_design_scores_gemma":[0.95557064,0.0020854182,0.010978653,0.000112226786,0.0017404838,0.015605697,0.0037695551,0.0000038836524,0.009412089,0.000026338652,0.00051731366,0.00017768602],"about_ca_topic_score_codex":0.00016034723,"about_ca_topic_score_gemma":0.00009771683,"teacher_disagreement_score":0.24313852,"about_ca_system_score_codex":0.000031168438,"about_ca_system_score_gemma":0.0000832758,"threshold_uncertainty_score":0.7120771},"labels":[],"label_agreement":null},{"id":"W2169005742","doi":"10.1111/j.1365-2133.2011.10280.x","title":"Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute for Health and Care Research","keywords":"Life course approach; Psoriasis; Medicine; Course (navigation); Disease; Perception; Gerontology; Psychology; Dermatology; Internal medicine; Developmental psychology; Neuroscience","score_opus":0.01610294237770836,"score_gpt":0.2565166595212557,"score_spread":0.2404137171435473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169005742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97130275,0.025778031,0.000025547959,0.00076551037,0.0013320989,0.0004701093,0.000086529566,0.00001983599,0.0002196085],"genre_scores_gemma":[0.9976588,0.0018521885,0.00008719476,0.00022614928,0.00003766623,0.0000317535,0.000041098203,0.000024084009,0.000041079067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682766,0.0010287239,0.0013180755,0.00024333574,0.00012713445,0.00045508778],"domain_scores_gemma":[0.9982289,0.00015563158,0.000989804,0.00024553636,0.00024497308,0.00013514109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033444725,0.0002614436,0.0007278698,0.00013657763,0.0001644075,0.000012507941,0.0003273774,0.00028808785,0.000707163],"category_scores_gemma":[0.00011388399,0.00021578562,0.00035748226,0.00019303142,0.00039263052,0.00019564846,0.00007875409,0.000407904,0.00006729769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014185952,0.024262046,0.6980264,0.00023686596,0.013969096,0.0075675356,0.056344096,0.000215432,0.003168574,0.0011055187,0.034682307,0.14623617],"study_design_scores_gemma":[0.0079824515,0.0010186231,0.97118014,0.000326242,0.001567109,0.007821251,0.007758833,0.000014701829,0.0010693028,0.0005030194,0.00045654632,0.0003017797],"about_ca_topic_score_codex":0.00026191547,"about_ca_topic_score_gemma":0.00006722464,"teacher_disagreement_score":0.27315372,"about_ca_system_score_codex":0.000060618513,"about_ca_system_score_gemma":0.0004883294,"threshold_uncertainty_score":0.8799482},"labels":[],"label_agreement":null},{"id":"W2169708276","doi":"10.1111/j.1365-2133.2009.09094.x","title":"Nonlinear spectral imaging of human hypertrophic scar based on two-photon excited fluorescence and second-harmonic generation","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Elastin; Hypertrophic scar; Human skin; Ex vivo; Biomedical engineering; Supercontinuum; Pathology; Scars; Materials science; Microscopy; In vivo; Medicine; Biology; Optoelectronics; Wavelength","score_opus":0.020514164401071882,"score_gpt":0.3010947509442552,"score_spread":0.2805805865431833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169708276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951367,0.0018807288,0.000053044307,0.0022696813,0.000076482385,0.0001594916,0.0000069677108,0.000011646446,0.00040525306],"genre_scores_gemma":[0.9974276,0.00029390486,0.0015441513,0.00057639845,0.00010078334,0.0000012199116,0.000016549417,0.000011216178,0.000028170274],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9986485,0.00012805052,0.000517931,0.00016885836,0.00027172608,0.0002649252],"domain_scores_gemma":[0.9992465,0.000040082534,0.00023144412,0.00012402027,0.0002043504,0.00015359701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119541124,0.00012473813,0.0004933992,0.00026206093,0.00010701191,0.000033943103,0.00009468464,0.0000736804,0.00010975625],"category_scores_gemma":[0.000055217573,0.00011155089,0.000110692854,0.00012298723,0.00015947812,0.000098517885,0.000012284185,0.00035359955,0.000002230612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008261919,0.002463179,0.12331163,0.00022675851,0.00023356338,0.07432601,0.00014729923,0.000025443805,0.7446829,0.00015084473,0.004878167,0.048727993],"study_design_scores_gemma":[0.017566452,0.0020165446,0.25680363,0.0009130008,0.00021149994,0.40196806,0.00009009227,0.0286858,0.29085496,0.00031330704,0.00026041706,0.0003162362],"about_ca_topic_score_codex":0.000021280779,"about_ca_topic_score_gemma":0.000008733687,"teacher_disagreement_score":0.45382795,"about_ca_system_score_codex":0.000040090443,"about_ca_system_score_gemma":0.00011360399,"threshold_uncertainty_score":0.45489135},"labels":[],"label_agreement":null},{"id":"W2169732146","doi":"10.1111/j.1365-2133.2005.07056.x","title":"Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in <i>PTCH</i> heterozygous mice","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Université de Montréal","funders":"","keywords":"Photosensitizer; Photodynamic therapy; Protoporphyrin IX; Basal cell carcinoma; Histopathology; Medicine; Skin cancer; Significant difference; Pathology; Dermatology; Basal cell; Cancer; Chemistry; Internal medicine","score_opus":0.012635211864949604,"score_gpt":0.2952521041559337,"score_spread":0.28261689229098413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169732146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865792,0.0087698875,0.00033283338,0.0036356316,0.00009824042,0.0003528366,0.000019346004,0.000026150617,0.00018591923],"genre_scores_gemma":[0.99044895,0.0063923327,0.0020503695,0.0008638222,0.00007508887,0.000009337925,0.000006398481,0.000032781696,0.00012089986],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99782604,0.00029427256,0.0006554376,0.00023133302,0.00037970816,0.0006131984],"domain_scores_gemma":[0.99884385,0.0003187195,0.00023268587,0.00017205706,0.0002256808,0.00020700906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028718842,0.00019674486,0.00080543413,0.00017721405,0.00011329993,0.000030251038,0.00024248273,0.00015390878,0.00008339098],"category_scores_gemma":[0.00014301148,0.00017002712,0.00014485331,0.00022535106,0.00017407144,0.00020383539,0.0000638451,0.0009511003,0.000009525841],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010395104,0.0068483404,0.30619115,0.00028928998,0.0019453263,0.10254377,0.0030312804,0.00042964524,0.45402864,0.000060568826,0.0036592477,0.110577635],"study_design_scores_gemma":[0.055402026,0.0018269974,0.30946085,0.0014396887,0.00011463323,0.49748316,0.0011767863,0.0039640274,0.09854869,0.00015291588,0.029643882,0.0007863247],"about_ca_topic_score_codex":0.00013242883,"about_ca_topic_score_gemma":0.0020627652,"teacher_disagreement_score":0.39493942,"about_ca_system_score_codex":0.00014692657,"about_ca_system_score_gemma":0.00020344392,"threshold_uncertainty_score":0.6933505},"labels":[],"label_agreement":null},{"id":"W2169787227","doi":"10.1111/j.1365-2133.2006.07344.x","title":"CLinical experience acquired with the efalizumab (Raptiva<sup>®</sup>) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":143,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Plaque psoriasis; Psoriasis; Placebo; Medicine; Randomized controlled trial; Clinical trial; Internal medicine; Dermatology; Alternative medicine; Pathology","score_opus":0.011873326462174835,"score_gpt":0.25914505403540095,"score_spread":0.2472717275732261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169787227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311477,0.0006670333,0.00037920813,0.0007965499,0.00152963,0.0030169564,0.00021371112,0.000025421012,0.00025673688],"genre_scores_gemma":[0.99821204,0.0001246837,0.0002594554,0.0001792753,0.00042440818,0.00032207463,0.000253251,0.000031283707,0.00019351309],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99387777,0.0026485396,0.0022498341,0.00050226256,0.00023241267,0.0004891969],"domain_scores_gemma":[0.9958913,0.0021480746,0.0012732367,0.00027642515,0.00033319765,0.00007780072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008591064,0.00036939853,0.0020926138,0.00024102932,0.00023418921,0.00010073268,0.0006088612,0.00044637593,0.00016633084],"category_scores_gemma":[0.00056270114,0.00024705785,0.00042938828,0.00018811734,0.00045677478,0.00029493144,0.00007118979,0.00045858807,0.000023984825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9850542,0.0023847169,0.00049892074,0.0000013304622,0.0015909398,0.0008684023,0.0008828568,0.00025045782,0.0000094698435,0.000029667599,0.0027509844,0.005678038],"study_design_scores_gemma":[0.9929559,0.0020418644,0.0005784842,0.00014840715,0.00045552786,0.0018947349,0.00041655972,0.00006773863,0.00013186107,0.000057161764,0.00095697655,0.00029475777],"about_ca_topic_score_codex":0.00042335145,"about_ca_topic_score_gemma":0.00029648526,"teacher_disagreement_score":0.00790171,"about_ca_system_score_codex":0.00007614113,"about_ca_system_score_gemma":0.0003129631,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W2170428123","doi":"10.1111/j.1365-2133.2009.09209.x","title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","year":2009,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Initiatives Ontario North","funders":"","keywords":"Adapalene; Acne; Benzoyl peroxide; Dermatology; Medicine; Double blind; Randomized controlled trial; Internal medicine; Chemistry; Pathology; Organic chemistry; Placebo","score_opus":0.020477828992286742,"score_gpt":0.3020965266291488,"score_spread":0.2816186976368621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170428123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846936,0.0037637765,0.0005240311,0.002709972,0.0001536873,0.0042993412,0.0000052616706,0.000005488989,0.00006908141],"genre_scores_gemma":[0.9970499,0.0023888717,0.00012275673,0.00016499998,0.000054635886,0.0001125904,0.000013015879,0.000009940103,0.00008326182],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981785,0.0002975167,0.0009480864,0.00014037947,0.00020967312,0.00022586924],"domain_scores_gemma":[0.99853545,0.0006224852,0.00038193417,0.00011469913,0.00025803427,0.00008738102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002768159,0.00016945455,0.0015487504,0.00014579533,0.00008177456,0.000021125506,0.00009044244,0.00013430408,0.00001962841],"category_scores_gemma":[0.00008991777,0.00010492565,0.00042936293,0.00009782887,0.000071105555,0.00007785221,0.0000044740973,0.00015012592,8.6162567e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8725795,0.028798139,0.042188108,0.00007218647,0.0020628748,0.002682733,0.0024851,0.000018809904,0.00009174369,0.00024482422,0.000704301,0.04807167],"study_design_scores_gemma":[0.94168913,0.006445745,0.045928054,0.00018944453,0.0012936002,0.0029448087,0.0003154768,0.0002897658,0.00048598342,0.00010857228,0.00021556935,0.000093866656],"about_ca_topic_score_codex":0.000115595925,"about_ca_topic_score_gemma":0.00015601821,"teacher_disagreement_score":0.069109604,"about_ca_system_score_codex":0.00006135272,"about_ca_system_score_gemma":0.0000983355,"threshold_uncertainty_score":0.4278744},"labels":[],"label_agreement":null},{"id":"W2171278825","doi":"10.1111/j.1365-2133.2008.08976.x","title":"Kindler syndrome: a focal adhesion genodermatosis","year":2008,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Wellcome Trust","keywords":"Genodermatosis; Poikiloderma; Epidermolysis bullosa; Filamin; Focal adhesion; Keratinocyte; Extracellular matrix; Biology; Cell biology; Pathology; Medicine; Cytoskeleton; Genetics; Gene; Signal transduction","score_opus":0.02537034770262849,"score_gpt":0.3013689773690643,"score_spread":0.27599862966643585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171278825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024865943,0.9963146,0.00015309028,0.000038390433,0.00045376323,0.0002602766,0.00003389335,0.00000738675,0.00025200256],"genre_scores_gemma":[0.0018322301,0.99704385,0.00021910241,0.00007096562,0.0002822301,0.000020443626,0.00020715543,0.000081566024,0.00024243334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966814,0.0008190124,0.0012105095,0.00042646972,0.00029039526,0.00057221734],"domain_scores_gemma":[0.9982984,0.00006936431,0.00077429874,0.0003553303,0.00024739798,0.00025522595],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00017635328,0.00039678856,0.0018842181,0.00026241803,0.00016564422,0.000043607663,0.00084573374,0.0013497181,0.00008348186],"category_scores_gemma":[0.00021109056,0.0003929207,0.0011656582,0.00019588442,0.00034400786,0.0000067913984,0.00029122608,0.00094707083,0.000085203865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046075103,0.00021811257,0.00006701851,0.001727667,0.00094814075,0.06700787,0.000009468291,3.138621e-7,0.00013357223,0.0000051348575,0.043748282,0.8860884],"study_design_scores_gemma":[0.00030164942,0.00010874599,0.0000074640775,0.0012861708,0.000109431276,0.49738058,0.0000045223846,3.6993112e-7,0.000107885375,0.0000049811174,0.50049746,0.00019074186],"about_ca_topic_score_codex":0.0000065835443,"about_ca_topic_score_gemma":0.0000051216275,"teacher_disagreement_score":0.8858976,"about_ca_system_score_codex":0.000034730554,"about_ca_system_score_gemma":0.0007506749,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W2286365142","doi":"10.1111/bjd.14495","title":"Dermoscopy, a useful tool for general practitioners in melanoma screening: a nationwide survey","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hospices Civils de Lyon","keywords":"Medicine; Family medicine; Dermatology; Melanoma; MEDLINE; Political science","score_opus":0.023843283588133007,"score_gpt":0.2850041089268297,"score_spread":0.26116082533869667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286365142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493111,0.0002777581,0.044204727,0.00521166,0.00037761586,0.00033752437,0.000019979676,0.000017368071,0.00024229045],"genre_scores_gemma":[0.9918768,0.00022895803,0.006358239,0.0006672815,0.00012027037,0.000017589819,0.000010233173,0.000018650202,0.00070202636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872077,0.00016362204,0.00057141157,0.0001396086,0.00018116586,0.00022345196],"domain_scores_gemma":[0.9989206,0.0002992425,0.00030502133,0.00008011364,0.00030125375,0.000093751354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003598668,0.00009039436,0.00034916296,0.0002790487,0.000052070598,0.000029162627,0.00007928972,0.00009482551,0.00010454408],"category_scores_gemma":[0.0009300526,0.000082981365,0.00011031147,0.00013492559,0.000048490892,0.00016153062,0.00002067024,0.00013027746,0.000007694767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055188937,0.00095280545,0.6476132,0.00021454255,0.00084312505,0.03479858,0.00018829385,0.000018679244,0.011782148,0.0008901781,0.094715185,0.20246433],"study_design_scores_gemma":[0.01048216,0.0004095866,0.53105676,0.00044854908,0.00009679316,0.40639165,0.0000829825,0.00013690874,0.0037809613,0.00036836969,0.046529315,0.0002159735],"about_ca_topic_score_codex":0.00008815809,"about_ca_topic_score_gemma":0.000711633,"teacher_disagreement_score":0.37159306,"about_ca_system_score_codex":0.00007102169,"about_ca_system_score_gemma":0.0001174013,"threshold_uncertainty_score":0.3383882},"labels":[],"label_agreement":null},{"id":"W2300677989","doi":"10.1111/bjd.14433","title":"The need to improve reporting of routinely collected dermatology data for patient benefit","year":2016,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute for Health and Care Research; National Institute on Handicapped Research","keywords":"Dermatology; Medicine; MEDLINE; Family medicine","score_opus":0.014835097528781727,"score_gpt":0.28730478234090695,"score_spread":0.27246968481212525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300677989","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016046599,0.0033558162,0.0034960946,0.010145082,0.9625565,0.0024646418,0.0010632451,0.000057814064,0.0008142423],"genre_scores_gemma":[0.23959313,0.0064234748,0.008408395,0.001704991,0.7326538,0.00032068798,0.0012774817,0.00055526185,0.009062788],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943774,0.000121875426,0.004025307,0.0003939308,0.0005875966,0.00049392076],"domain_scores_gemma":[0.9889518,0.0014084077,0.006704965,0.000729854,0.0019789364,0.00022601192],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00057278393,0.00025889458,0.0016265793,0.00028811517,0.0002183503,0.00006085651,0.0006365067,0.0005726581,0.00002547128],"category_scores_gemma":[0.0172424,0.00020602295,0.00030603417,0.00018978473,0.000119219825,0.00006709956,0.00040669632,0.00064158096,0.0000043487103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012790912,0.00009107766,0.000045717014,0.000252245,0.00058701786,0.0059397295,0.000039241877,5.317239e-7,0.00041702465,0.000018176868,0.94948,0.041850124],"study_design_scores_gemma":[0.0026097544,0.0005432251,0.000054562403,0.0007166717,0.00045836216,0.13522355,0.00015312705,0.000031401745,0.0009399712,0.00009710995,0.85900074,0.00017154696],"about_ca_topic_score_codex":0.00008638897,"about_ca_topic_score_gemma":0.0004058987,"teacher_disagreement_score":0.22990268,"about_ca_system_score_codex":0.00013410674,"about_ca_system_score_gemma":0.00074125483,"threshold_uncertainty_score":0.99103576},"labels":[],"label_agreement":null},{"id":"W2416237154","doi":"10.1111/bjd.14799","title":"Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis","year":2016,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; University of New Brunswick; Canada Research Chairs; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Medicine; Quality of life (healthcare); Dermatology; Nursing","score_opus":0.03790143397671786,"score_gpt":0.3160734435432042,"score_spread":0.27817200956648636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416237154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7618207,0.0033327981,0.0001732157,0.23342906,0.00020830927,0.00037053833,0.00023038851,0.00001930642,0.0004157232],"genre_scores_gemma":[0.97294945,0.0019298778,0.0005460916,0.02428209,0.000110505214,0.000009599883,0.00007589847,0.000045480458,0.00005102456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487895,0.0011599797,0.0026969954,0.00038915407,0.00042323876,0.00045167285],"domain_scores_gemma":[0.99443096,0.0011237108,0.0031683384,0.00036573285,0.00045309332,0.0004581894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006468447,0.0002934233,0.0025471228,0.00054280035,0.00011529633,0.000015968539,0.0002007587,0.00093453226,0.00004350491],"category_scores_gemma":[0.000924386,0.00028212392,0.00036181393,0.0002456621,0.0008600433,0.00015738224,0.00006633445,0.0016433288,0.0000035633798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006617029,0.0038202032,0.41365558,0.009124483,0.011903101,0.045369565,0.0006236159,0.0000036877152,0.0059894407,0.00030931094,0.37592834,0.13261099],"study_design_scores_gemma":[0.0032310898,0.000111842935,0.76588285,0.0014411418,0.00033223105,0.22387846,0.000072266055,0.000005311311,0.000029139397,0.0001873803,0.0046249283,0.0002033674],"about_ca_topic_score_codex":0.0013899058,"about_ca_topic_score_gemma":0.00018709582,"teacher_disagreement_score":0.3713034,"about_ca_system_score_codex":0.00007823267,"about_ca_system_score_gemma":0.00030606257,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W2465799764","doi":"10.1111/bjd.14871","title":"Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research; Innovaderm (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Eczema Area and Severity Index; Tolerability; Medicine; Janus kinase inhibitor; Atopic dermatitis; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Pharmacodynamics; Dermatology; Pharmacokinetics; Onset of action; Rheumatoid arthritis","score_opus":0.01635605518526289,"score_gpt":0.30022126625121304,"score_spread":0.28386521106595014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465799764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713897,0.0064458526,0.009666777,0.009321663,0.0010100064,0.001193084,0.00006856734,0.000046866997,0.00085747376],"genre_scores_gemma":[0.99473524,0.0008753837,0.0011349835,0.0020058427,0.00044757925,0.00012137503,0.00001467951,0.000024504421,0.000640398],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974054,0.00039207013,0.0012870533,0.00021135702,0.00024707578,0.0004570506],"domain_scores_gemma":[0.9964821,0.002089331,0.00054437615,0.00017207883,0.00036154548,0.00035059548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030018477,0.00019523111,0.0015958297,0.00018561503,0.00017989287,0.000030063176,0.00020383415,0.0002996481,0.00011970163],"category_scores_gemma":[0.0058415835,0.00015173302,0.0007932162,0.000086803884,0.00045403597,0.00021878294,0.000047751546,0.00024393642,0.00001798137],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33458546,0.0037069526,0.00448599,0.00047308192,0.0020551311,0.037165973,0.0004534785,1.4450411e-7,0.0004043368,0.0038578557,0.516909,0.09590261],"study_design_scores_gemma":[0.733708,0.00033479385,0.0003941745,0.0004122136,0.0004553757,0.2005355,0.000057315065,0.000011786882,0.0025384717,0.0037577632,0.057726964,0.000067592155],"about_ca_topic_score_codex":0.0000031451004,"about_ca_topic_score_gemma":0.0000047725034,"teacher_disagreement_score":0.45918202,"about_ca_system_score_codex":0.000034851975,"about_ca_system_score_gemma":0.00032376952,"threshold_uncertainty_score":0.6993343},"labels":[],"label_agreement":null},{"id":"W2472098090","doi":"10.1111/bjd.14873","title":"Mosaicism for a <i>SPRED1</i> deletion revealed in a patient with clinically suspected mosaic neurofibromatosis","year":2016,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"Children's Tumor Foundation","keywords":"Neurofibromatosis; Medicine; Neurofibromatoses; Dermatology; Pathology","score_opus":0.013350272614719095,"score_gpt":0.24949402239279803,"score_spread":0.23614374977807892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472098090","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64663804,0.0015339697,0.0003927857,0.34900394,0.00060826546,0.0012915821,0.00029931217,0.000056325203,0.00017580381],"genre_scores_gemma":[0.46054786,0.0022365386,0.007351119,0.52495164,0.0032324735,0.00027063384,0.000525898,0.0005005435,0.00038329887],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9949269,0.000516044,0.002578514,0.00057460833,0.0006239581,0.0007799217],"domain_scores_gemma":[0.99577284,0.00097077264,0.0019064455,0.00039372352,0.00073354563,0.00022265402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021312402,0.00046422688,0.0021685322,0.0005211592,0.00008589323,0.000078853365,0.0003075144,0.00096299534,0.00005391913],"category_scores_gemma":[0.00052524987,0.0003952694,0.00057384104,0.00028315157,0.00020827359,0.00017906599,0.00006397669,0.001901091,0.00000924599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019142373,0.00017575495,0.004663822,0.0005449043,0.00019226772,0.22793347,0.000028443737,3.8186252e-7,0.00074754114,0.000004564693,0.7599912,0.0038034085],"study_design_scores_gemma":[0.008679244,0.0032510778,0.0017725556,0.0056761494,0.0004149683,0.73635525,0.00001930251,0.000013048919,0.0008082295,0.0001642937,0.24241443,0.0004314382],"about_ca_topic_score_codex":0.000024992642,"about_ca_topic_score_gemma":0.000013139822,"teacher_disagreement_score":0.51757675,"about_ca_system_score_codex":0.00010821755,"about_ca_system_score_gemma":0.0005251898,"threshold_uncertainty_score":0.9998499},"labels":[],"label_agreement":null},{"id":"W2472169523","doi":"10.1111/j.1365-2133.1976.tb07881.x","title":"Measurement of dermal atrophy induced by topical steroids using a radiographic technique","year":2006,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Library science; Computer science","score_opus":0.015341087338458842,"score_gpt":0.25253337134620873,"score_spread":0.2371922840077499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472169523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801646,0.012730422,0.005951716,0.00050854485,0.00016581522,0.00020453574,0.0000067421247,0.00001644764,0.00025118177],"genre_scores_gemma":[0.9977862,0.000097858916,0.0018058519,0.00019739228,0.000083435276,0.000005104081,0.000003823167,0.000016245907,0.0000040812897],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981212,0.00021420498,0.0008660878,0.00013692185,0.00038687867,0.00027472345],"domain_scores_gemma":[0.99890417,0.000028681667,0.00040183513,0.00013066265,0.00039663908,0.00013803807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015005587,0.00013675164,0.00069181086,0.0002687448,0.00006612513,0.0000133141375,0.00014531311,0.00024449648,0.00003473063],"category_scores_gemma":[0.000089228335,0.00014769255,0.00028906393,0.00020118374,0.00020964559,0.00010809083,0.000028579574,0.00037467227,9.700155e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001040673,0.002172683,0.5573459,0.00059386314,0.0007320078,0.028814094,0.00003743927,0.0000053949884,0.3625823,0.00019184483,0.040914666,0.0055691083],"study_design_scores_gemma":[0.0058392272,0.0002968037,0.17267625,0.0011005194,0.0005977103,0.6835354,0.00004909961,0.00004979102,0.13348258,0.0007112814,0.0013822982,0.00027903676],"about_ca_topic_score_codex":0.00007775356,"about_ca_topic_score_gemma":0.000012614113,"teacher_disagreement_score":0.6547213,"about_ca_system_score_codex":0.00004236793,"about_ca_system_score_gemma":0.00020248756,"threshold_uncertainty_score":0.6022728},"labels":[],"label_agreement":null},{"id":"W2512873140","doi":"10.1111/bjd.14965","title":"Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharma","keywords":"Secukinumab; Medicine; Immunogenicity; Psoriasis; Psoriasis Area and Severity Index; Monoclonal antibody; Immunology; Cytokine; Interleukin 17; Antibody; Internal medicine; Psoriatic arthritis","score_opus":0.007734141049989083,"score_gpt":0.22355477557271214,"score_spread":0.21582063452272304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512873140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967801,0.0013620225,0.00020395746,0.00035199607,0.0006223932,0.00030016154,0.00018338866,0.000027731921,0.00016827851],"genre_scores_gemma":[0.9990973,0.00015970749,0.00026639327,0.0001293128,0.000057117544,0.0000139912345,0.00007012706,0.000042171996,0.00016388996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997187,0.00049735315,0.0010320935,0.00042926063,0.00012835072,0.0007259247],"domain_scores_gemma":[0.9985798,0.00017247634,0.0005403728,0.00024290869,0.0003622271,0.00010220541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018289416,0.00036821043,0.0010172442,0.00041271944,0.00022970828,0.00004552678,0.00048781722,0.000422345,0.00037320566],"category_scores_gemma":[0.00007169034,0.00030035974,0.00023029675,0.00021979032,0.00020371846,0.000357664,0.00012394848,0.00036233015,0.00011434819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010354821,0.0018475364,0.86396426,0.000039098217,0.0017065152,0.0052831913,0.0005733753,0.000011350454,0.07538267,0.00014417301,0.0034638143,0.03722922],"study_design_scores_gemma":[0.03196553,0.0011663311,0.8684695,0.00082346285,0.00021265881,0.0391778,0.00009355805,6.002936e-7,0.055873655,0.00012901038,0.0014403309,0.0006475711],"about_ca_topic_score_codex":0.00013546257,"about_ca_topic_score_gemma":0.00037518534,"teacher_disagreement_score":0.03658165,"about_ca_system_score_codex":0.00015170555,"about_ca_system_score_gemma":0.00021081962,"threshold_uncertainty_score":0.99994487},"labels":[],"label_agreement":null},{"id":"W2513381104","doi":"10.1111/bjd.14958","title":"Pre‐eclampsia and risk of infantile haemangioma","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Université de Sherbrooke; Université de Montréal; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Eclampsia; Medicine; Obstetrics; Pregnancy; Pediatrics; Biology; Genetics","score_opus":0.005931832682211824,"score_gpt":0.2333034888667877,"score_spread":0.2273716561845759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513381104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149674,0.0047292113,0.0024419462,0.00075204385,0.00006845106,0.00007708997,0.000009122609,0.000006740767,0.00041862874],"genre_scores_gemma":[0.9945279,0.0034395037,0.0018780896,0.00003709597,0.00004277404,0.0000011660477,9.5357797e-7,0.000008491114,0.000064062784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991507,0.000056142642,0.00046734128,0.00006175251,0.00013482732,0.00012923441],"domain_scores_gemma":[0.99920344,0.000064532025,0.0003443098,0.000098741184,0.00019570247,0.000093271505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013741407,0.00006080337,0.00037348754,0.00014803279,0.000041772022,0.000008285167,0.000058657333,0.00008258927,0.00008696673],"category_scores_gemma":[0.00017356039,0.00004697295,0.00015006804,0.00007338125,0.00012528368,0.0001561319,0.000028342589,0.000095748954,0.000004990355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023933052,0.00024234221,0.8360601,0.00026838403,0.0008423719,0.004719186,0.00046710018,6.071315e-7,0.0039783367,0.000985932,0.0110629415,0.14113338],"study_design_scores_gemma":[0.0033448413,0.0001399359,0.58549696,0.00057710486,0.00029714202,0.3983623,0.00006327355,0.000018019597,0.0053109727,0.0005471756,0.005770382,0.00007187938],"about_ca_topic_score_codex":0.000024894576,"about_ca_topic_score_gemma":0.000020100351,"teacher_disagreement_score":0.39364314,"about_ca_system_score_codex":0.000008815114,"about_ca_system_score_gemma":0.00005257662,"threshold_uncertainty_score":0.19155012},"labels":[],"label_agreement":null},{"id":"W2519779602","doi":"10.1111/bjd.15067","title":"Biosimilars for psoriasis: clinical studies to determine similarity","year":2016,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Cilag; Galderma; Dermira; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Biosimilar; Psoriasis; Similarity (geometry); Medicine; Dermatology; MEDLINE; Intensive care medicine; Computer science; Internal medicine; Artificial intelligence; Chemistry","score_opus":0.19206551971016245,"score_gpt":0.46453267096096384,"score_spread":0.2724671512508014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519779602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013306492,0.98944986,0.0012460452,0.0021168212,0.0059426036,0.0007236671,0.0004321314,0.000024914587,0.000050645547],"genre_scores_gemma":[0.000016664173,0.9922893,0.0052975505,0.0013568021,0.0005303408,0.000048063437,0.0000128216,0.000061672734,0.00038675178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311644,0.0019770938,0.0034872093,0.00057557644,0.000080903555,0.0007627507],"domain_scores_gemma":[0.9925782,0.0044145156,0.0017303064,0.0003605115,0.00074174185,0.00017469199],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017852244,0.000542914,0.005930086,0.0003749675,0.0001989144,0.000040184997,0.00095456676,0.0018356479,0.0001699777],"category_scores_gemma":[0.0055169957,0.0004005306,0.0023056043,0.0002386245,0.00067856855,0.00009251699,0.0002934646,0.0011778878,0.00008420829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092498514,0.00014054523,0.000011710451,0.0018627475,0.002489409,0.00066365686,0.0000075462317,4.1485317e-9,0.000004373452,0.000037165246,0.15259922,0.84209114],"study_design_scores_gemma":[0.0014537418,0.0004413165,0.000007988324,0.014377168,0.0023987181,0.06731814,0.000022452341,5.910818e-8,0.000078760466,0.00040507465,0.91307247,0.00042409357],"about_ca_topic_score_codex":0.0000010335697,"about_ca_topic_score_gemma":0.000013973825,"teacher_disagreement_score":0.84166706,"about_ca_system_score_codex":0.00008576896,"about_ca_system_score_gemma":0.0003998191,"threshold_uncertainty_score":0.9998447},"labels":[],"label_agreement":null},{"id":"W2530767409","doi":"10.1111/bjd.15122","title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Galderma","keywords":"Rosacea; Chemistry; Dermatology; Medicine","score_opus":0.03693367658517458,"score_gpt":0.32251941785432947,"score_spread":0.28558574126915487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530767409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978028,0.00693739,0.0008324937,0.010848936,0.0005918154,0.0005236383,0.000371338,0.00003185761,0.0018345532],"genre_scores_gemma":[0.98605365,0.010827115,0.0014472015,0.0009523737,0.00033743566,0.00004442461,0.00009209544,0.00003549223,0.00021022465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969692,0.00061902596,0.0010506071,0.00035783378,0.00045932346,0.0005439935],"domain_scores_gemma":[0.99280137,0.0050194715,0.0011794183,0.00037822308,0.00035323383,0.00026825772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054601097,0.00030770473,0.0007976877,0.000078842866,0.0005541117,0.000132838,0.00033130223,0.00029180394,0.00001812923],"category_scores_gemma":[0.002159886,0.00018288453,0.00025259668,0.00025318578,0.00042161648,0.0002717402,0.00012729336,0.0005356177,0.000014797411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008352242,0.00060995296,0.76482373,0.000059236532,0.00085732265,0.0007699355,0.00060070364,0.0000029955286,0.0020008993,0.0006341885,0.19212776,0.037504923],"study_design_scores_gemma":[0.0048689106,0.00034519288,0.8789817,0.00096599496,0.0007607576,0.01674365,0.0055726743,0.00015456816,0.003287035,0.0007279244,0.08754304,0.000048529553],"about_ca_topic_score_codex":0.00017646505,"about_ca_topic_score_gemma":0.00010162508,"teacher_disagreement_score":0.114158,"about_ca_system_score_codex":0.00014414912,"about_ca_system_score_gemma":0.00028519717,"threshold_uncertainty_score":0.7457815},"labels":[],"label_agreement":null},{"id":"W2552053986","doi":"10.1111/bjd.15186","title":"Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cellulitis; Odds ratio; Meta-analysis; Confidence interval; Observational study; Risk factor; Surgery; Abscess; Internal medicine; Body mass index; Dermatology","score_opus":0.06759241568192687,"score_gpt":0.36118000587718574,"score_spread":0.2935875901952589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552053986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000058791607,0.99568087,0.00064886647,0.00013136269,0.00008395671,0.0028189823,0.0005773866,0.00001105654,0.00004161839],"genre_scores_gemma":[0.00011212842,0.99877775,0.00021345964,0.000082091494,0.000032573134,0.00039422975,0.000047395384,0.000036999907,0.00030335344],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965545,0.00056051154,0.0021444745,0.00028758723,0.00018744261,0.00026551416],"domain_scores_gemma":[0.9956343,0.0008675798,0.0026062117,0.000294227,0.00034913202,0.00024855035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028361066,0.0003900018,0.012953681,0.0004357293,0.0001046121,0.000043706033,0.00012899499,0.00026910327,0.00032390814],"category_scores_gemma":[0.00063686765,0.00023208321,0.006334512,0.00030959275,0.000078413126,0.00007563936,0.00003270495,0.0003321388,0.00001462744],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002390196,0.0001251372,0.000054614244,0.5896433,0.39976385,0.0011639295,0.0000046266496,9.832273e-9,5.510867e-9,0.000010716223,0.0008346246,0.008396768],"study_design_scores_gemma":[0.00040600475,0.000087221495,0.000007346249,0.07449776,0.78665596,0.092508584,0.0000053998288,1.6605243e-7,3.4211698e-7,0.000019251156,0.045670625,0.00014134338],"about_ca_topic_score_codex":0.000033953278,"about_ca_topic_score_gemma":0.000011142629,"teacher_disagreement_score":0.51514554,"about_ca_system_score_codex":0.000082277984,"about_ca_system_score_gemma":0.0001430613,"threshold_uncertainty_score":0.94640785},"labels":[],"label_agreement":null},{"id":"W2556344553","doi":"10.1111/bjd.15173","title":"Rosacea treatment update: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Galderma; Dermira","keywords":"Chemistry","score_opus":0.02276731997857802,"score_gpt":0.2835938768255624,"score_spread":0.2608265568469844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556344553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96976113,0.013193742,0.0007231577,0.009610384,0.0016557734,0.00071923196,0.0011501733,0.000113319904,0.0030730555],"genre_scores_gemma":[0.97564375,0.015259149,0.0013391722,0.0027436598,0.0010994106,0.000053092175,0.00034817908,0.00010403319,0.003409521],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956884,0.00059714005,0.0013146014,0.0006221095,0.0005819832,0.0011957833],"domain_scores_gemma":[0.9943804,0.0028789644,0.0009894333,0.00061149144,0.00038648595,0.0007532279],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003030704,0.000641246,0.0014538865,0.00014832443,0.0006972771,0.00020639988,0.0004959741,0.0005599368,0.000079950645],"category_scores_gemma":[0.0012632541,0.00041119862,0.00068042683,0.00036209743,0.0004218705,0.0003863165,0.00014042176,0.0005445679,0.0004040298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005248143,0.0020004688,0.1813286,0.000049605096,0.003322663,0.018343898,0.00097571115,0.0000066694465,0.0016953188,0.00023726883,0.7315539,0.06043343],"study_design_scores_gemma":[0.018705232,0.0013314191,0.119065665,0.0010949002,0.0021923129,0.119919784,0.0030953996,0.000042438453,0.0130849965,0.0013325012,0.7200077,0.0001276232],"about_ca_topic_score_codex":0.00034831985,"about_ca_topic_score_gemma":0.0002329828,"teacher_disagreement_score":0.10157588,"about_ca_system_score_codex":0.0004727894,"about_ca_system_score_gemma":0.00047766752,"threshold_uncertainty_score":0.999834},"labels":[],"label_agreement":null},{"id":"W2571703912","doi":"10.1111/bjd.14819","title":"Shortcomings in rosacea diagnosis and classification","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Rosacea; Dermatology; Medicine","score_opus":0.02743460161754105,"score_gpt":0.3085512398547808,"score_spread":0.28111663823723976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571703912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907525,0.002959824,0.000025402509,0.005356797,0.000106293206,0.00007668425,0.0000013186785,0.000002701496,0.00071848853],"genre_scores_gemma":[0.9959026,0.0035334022,0.00023936771,0.00021096268,0.000044775024,0.0000041384874,0.000001401593,0.0000056204635,0.00005773407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995069,0.000025607555,0.00022067806,0.000071960276,0.00006572943,0.00010914814],"domain_scores_gemma":[0.9995571,0.000038207196,0.00019600587,0.00008678598,0.000045379504,0.00007656795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074164695,0.00005152687,0.00027126426,0.000059243663,0.000119723954,0.000047638947,0.000056559973,0.00007748211,0.000015069216],"category_scores_gemma":[0.00014087494,0.000047130427,0.00004364659,0.000016001757,0.00007890356,0.00014491369,0.000020515889,0.00014296314,0.0000026532664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004784843,0.000121260404,0.89267886,0.000025466652,0.000035469187,0.007777193,0.000057785932,8.27995e-8,0.0001149448,0.00003571258,0.0036683618,0.09543701],"study_design_scores_gemma":[0.002038727,0.000070731694,0.9333704,0.00028799,0.000056292705,0.060425617,0.00004727328,0.00004721808,0.0004836093,0.00008886094,0.003041076,0.000042193144],"about_ca_topic_score_codex":0.00004966778,"about_ca_topic_score_gemma":0.00004798151,"teacher_disagreement_score":0.09539482,"about_ca_system_score_codex":0.000015739048,"about_ca_system_score_gemma":0.000029643634,"threshold_uncertainty_score":0.19219232},"labels":[],"label_agreement":null},{"id":"W2581695738","doi":"10.1111/bjd.15319","title":"Cross-sectional evaluation of acute adverse reactions during ultraviolet A1 phototherapy","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Cross-sectional study; Dermatology; Adverse effect; Internal medicine; Pathology","score_opus":0.034587363990815294,"score_gpt":0.3472183744248262,"score_spread":0.3126310104340109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581695738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393202,0.0012545645,0.00027872922,0.053791203,0.002861165,0.0006031149,0.00009935875,0.000033907832,0.0017577437],"genre_scores_gemma":[0.9647842,0.001502966,0.00045504997,0.026578214,0.004115174,0.000038236423,0.00013490526,0.00009162504,0.0022996238],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9974014,0.00024050171,0.001024703,0.00022962812,0.0008464799,0.00025726753],"domain_scores_gemma":[0.9963792,0.00006685032,0.0018346008,0.00025832086,0.0013825127,0.00007849046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004849274,0.00018619158,0.00068538944,0.0004165206,0.00027005622,0.000057387384,0.00021039844,0.00069259905,0.00115324],"category_scores_gemma":[0.000286328,0.00021384656,0.00045378713,0.00007546643,0.0002271802,0.00022342874,0.00001871428,0.0022007676,0.000012506906],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019038006,0.0007532357,0.17904858,0.0018431696,0.009608707,0.12966834,0.00035001707,0.00008308875,0.06720756,0.0000075582875,0.5873896,0.022136327],"study_design_scores_gemma":[0.0053191083,0.00005991423,0.2523112,0.0010962933,0.0006130731,0.6879062,0.000014193113,0.000032756267,0.006801393,0.000110741414,0.045566507,0.00016861972],"about_ca_topic_score_codex":0.000088886016,"about_ca_topic_score_gemma":0.0000053362314,"teacher_disagreement_score":0.55823785,"about_ca_system_score_codex":0.00018101245,"about_ca_system_score_gemma":0.0004719053,"threshold_uncertainty_score":0.99975985},"labels":[],"label_agreement":null},{"id":"W2588014405","doi":"10.1111/bjd.15381","title":"Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Dermatology Life Quality Index; Internal medicine; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Confidence interval; Quality of life (healthcare); Visual analogue scale; Severity of illness; Surgery; Gastroenterology; Physical therapy; Randomized controlled trial; Dermatology; Tumor necrosis factor alpha","score_opus":0.024319528757040982,"score_gpt":0.27268119109163624,"score_spread":0.24836166233459525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588014405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974287,0.00040685153,0.000012260901,0.00036577997,0.00039758196,0.0010572895,0.00016448366,0.000006234462,0.00016079904],"genre_scores_gemma":[0.99912506,0.00008401713,0.00021961216,0.00008628315,0.000014475321,0.000041811003,0.000013227447,0.000030318868,0.0003851875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997409,0.00094332866,0.0007835137,0.00035035808,0.00010413669,0.00040965696],"domain_scores_gemma":[0.9982627,0.00021382108,0.0006524507,0.00048857025,0.00027690688,0.00010556497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020985291,0.000284758,0.0011383455,0.00032761844,0.00031054392,0.00009500594,0.00079889235,0.0002389143,0.00012463047],"category_scores_gemma":[0.00017331172,0.00025822214,0.00006616034,0.00011508613,0.00010002865,0.00031732657,0.00022573427,0.00020832058,0.000060034694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089937456,0.010652632,0.8060078,0.00001803082,0.0019145035,0.0041463207,0.0050098705,0.000048564718,0.0015624462,0.000012720444,0.0020659491,0.0786237],"study_design_scores_gemma":[0.06872578,0.006808145,0.9156739,0.0002848919,0.00024835538,0.0038726686,0.0007039325,5.4576486e-7,0.0026581176,0.000014277064,0.00070653815,0.00030282658],"about_ca_topic_score_codex":0.0013406127,"about_ca_topic_score_gemma":0.005736723,"teacher_disagreement_score":0.10966611,"about_ca_system_score_codex":0.00016854302,"about_ca_system_score_gemma":0.00031735018,"threshold_uncertainty_score":0.999987},"labels":[],"label_agreement":null},{"id":"W2591192302","doi":"10.1111/bjd.15403","title":"Cross-sectional comparisons of patient-reported disease control, disease severity and symptom frequency in children with atopic dermatitis","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Valeant Pharmaceuticals International","keywords":"Atopic dermatitis; Medicine; Disease; Patient-reported outcome; MEDLINE; Pediatrics; Dermatology; Quality of life (healthcare); Internal medicine","score_opus":0.009048142398290965,"score_gpt":0.2661719888662231,"score_spread":0.2571238464679322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591192302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306756,0.0052971644,0.00013060731,0.00088567333,0.0001247555,0.00026727605,0.000109845954,0.000011361059,0.00010577343],"genre_scores_gemma":[0.9991382,0.00027902584,0.00016097253,0.00032858457,0.000035479632,0.000009564596,0.000027096532,0.000013497544,0.000007620258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982931,0.00013644775,0.0008414226,0.00020361372,0.00027134063,0.00025406008],"domain_scores_gemma":[0.9979533,0.00007588676,0.00090327096,0.00028273228,0.00029667717,0.0004881259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075480486,0.00015511122,0.00066690054,0.00014442888,0.0002405995,0.00007124967,0.00017566804,0.00010745107,0.00006973848],"category_scores_gemma":[0.0005262402,0.00015586677,0.00013353254,0.000049743885,0.00082390703,0.00038044737,0.000047024976,0.00032772185,0.0000014262857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003686688,0.00045028125,0.9829432,0.0001036543,0.00032627888,0.01467617,0.000020040286,0.0000064895025,0.0000034325947,0.00005017856,0.0006107108,0.00044092772],"study_design_scores_gemma":[0.006173,0.000039509545,0.8854841,0.00032951662,0.0002543846,0.10701537,0.000010229836,0.00005827592,0.000020572665,0.00045408556,0.000038322916,0.00012260482],"about_ca_topic_score_codex":0.0001361952,"about_ca_topic_score_gemma":0.0000675306,"teacher_disagreement_score":0.09745905,"about_ca_system_score_codex":0.000025272375,"about_ca_system_score_gemma":0.0004002969,"threshold_uncertainty_score":0.6356062},"labels":[],"label_agreement":null},{"id":"W2592400639","doi":"10.1111/bjd.15252","title":"Taking steps to improve the assessment and management of rosacea","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Rosacea; Dermatology; Medicine","score_opus":0.017116407933621933,"score_gpt":0.31500771569186253,"score_spread":0.2978913077582406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592400639","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09646294,0.01114386,0.00059102435,0.8830805,0.0017658483,0.0012991473,0.000056361532,0.000011882912,0.005588457],"genre_scores_gemma":[0.785852,0.008257048,0.004458984,0.19631827,0.0021291443,0.000041099513,0.000043169952,0.00009277752,0.0028075147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987055,0.00008961576,0.00048200306,0.00017089643,0.00028992502,0.00026205298],"domain_scores_gemma":[0.9985073,0.00007144252,0.0009387377,0.0002672675,0.00013301877,0.000082204446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001551155,0.00017542116,0.00078769156,0.00009513299,0.00016865172,0.00006712275,0.0002170934,0.0002808214,0.000030185709],"category_scores_gemma":[0.000019367899,0.00012310629,0.00017665853,0.00003189091,0.00011678543,0.000057343528,0.00012708348,0.0008485149,0.000002426595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004557792,0.000077666606,0.0026144302,0.0009658775,0.0013843883,0.1032193,0.000053079468,4.637771e-7,0.000032992233,0.00001597905,0.81272495,0.07886529],"study_design_scores_gemma":[0.0050413543,0.00080008764,0.07583863,0.005959035,0.0024051478,0.26147008,0.00015328068,0.000015970078,0.00025083814,0.00008906186,0.64768434,0.00029219326],"about_ca_topic_score_codex":0.000045446286,"about_ca_topic_score_gemma":0.000004778791,"teacher_disagreement_score":0.68938905,"about_ca_system_score_codex":0.000043806318,"about_ca_system_score_gemma":0.00008762294,"threshold_uncertainty_score":0.5020129},"labels":[],"label_agreement":null},{"id":"W2597329772","doi":"10.1111/bjd.15463","title":"Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; Dermira; Valeant Pharmaceuticals International; Genentech; Celgene; Eli Lilly and Company; GlaxoSmithKline; Amgen","keywords":"Psoriasis; Medicine; Dermatology; Resolution (logic); Computer science; Artificial intelligence","score_opus":0.037536062191523216,"score_gpt":0.2521970647376623,"score_spread":0.21466100254613907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597329772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6493619,0.15968436,0.00061701983,0.16851294,0.010745526,0.0013073825,0.007889393,0.00012198644,0.0017594931],"genre_scores_gemma":[0.90496385,0.042657513,0.008982155,0.03477436,0.00308886,0.00006672301,0.0022738858,0.00028522906,0.0029074093],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690217,0.0009459887,0.0012275726,0.00034913182,0.00009830562,0.00047682654],"domain_scores_gemma":[0.99566686,0.0009772342,0.0025635827,0.00039502335,0.00035532724,0.00004198233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031761115,0.00035268138,0.0014872184,0.0002542873,0.0009997899,0.0001239586,0.00036780955,0.0012861313,0.00026180677],"category_scores_gemma":[0.0006185632,0.00034950674,0.00033101861,0.00005029089,0.0007178444,0.00020773613,0.0001131559,0.0018071239,0.00003262122],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005612634,0.00013774454,0.0037653577,0.00021962206,0.00416068,0.017531626,0.00048433457,0.0000053192493,0.0014050583,0.0001379583,0.94061875,0.030972272],"study_design_scores_gemma":[0.0057869377,0.0003241495,0.011418718,0.0009800673,0.0022636775,0.42469,0.00006627279,0.0000076876795,0.0005430554,0.0016323557,0.55179185,0.0004952554],"about_ca_topic_score_codex":0.0007915334,"about_ca_topic_score_gemma":0.0005095844,"teacher_disagreement_score":0.40715837,"about_ca_system_score_codex":0.000047262176,"about_ca_system_score_gemma":0.00029334924,"threshold_uncertainty_score":0.9998957},"labels":[],"label_agreement":null},{"id":"W2604462359","doi":"10.1111/bjd.15549","title":"Burnout in dermatology residents: a Canadian perspective","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Calgary","funders":"Canadian Dermatology Foundation","keywords":"Burnout; Perspective (graphical); Dermatology; Medicine; MEDLINE; Family medicine; Clinical psychology; Political science; Art","score_opus":0.040502429943785265,"score_gpt":0.3996074951409514,"score_spread":0.3591050651971661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604462359","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0061298916,0.03950367,0.000014893226,0.93624735,0.0059117014,0.00080000545,0.0002680222,0.000025679768,0.011098813],"genre_scores_gemma":[0.27723166,0.010926197,0.00029329394,0.7011015,0.007178751,0.00013891397,0.0001495094,0.00020481941,0.0027753757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98972267,0.0040248223,0.0027906678,0.00058410206,0.00064754736,0.0022301849],"domain_scores_gemma":[0.9925046,0.0012106668,0.0030457415,0.00062724936,0.001962259,0.00064950256],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007123171,0.00050515775,0.0023731266,0.0015414162,0.0016250529,0.0000774933,0.0016270906,0.0036621636,0.0010187237],"category_scores_gemma":[0.002660178,0.0005519124,0.00037319527,0.00018794996,0.00037320674,0.00038232023,0.00025136129,0.016581388,0.00029380314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037860264,0.000027193706,0.033606563,0.00045596145,0.00009990301,0.23791046,0.00085719913,1.1788393e-7,6.972805e-7,0.00010798978,0.72531664,0.0015794239],"study_design_scores_gemma":[0.0028321291,0.000043828084,0.028641036,0.022519352,0.00009214131,0.1727375,0.002827552,0.0000059010736,0.000003736324,0.0062209447,0.76344573,0.00063015794],"about_ca_topic_score_codex":0.53067183,"about_ca_topic_score_gemma":0.6125493,"teacher_disagreement_score":0.27110177,"about_ca_system_score_codex":0.0016441214,"about_ca_system_score_gemma":0.012451988,"threshold_uncertainty_score":0.9998945},"labels":[],"label_agreement":null},{"id":"W2607887215","doi":"10.1111/bjd.15604","title":"Dermoscopy use by Canadian dermatologists and dermatology residents: a cross‐sectional nationwide study","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Canadian Dermatology Foundation","keywords":"Cross-sectional study; Medicine; Dermatology; Family medicine; Pathology","score_opus":0.021038590490452855,"score_gpt":0.29262979643376136,"score_spread":0.2715912059433085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607887215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68349946,0.0058348486,0.00022120732,0.3037213,0.0036307056,0.001567056,0.00021497684,0.00009215692,0.0012182816],"genre_scores_gemma":[0.8644857,0.000956666,0.00023500879,0.13086794,0.00070252456,0.000033328357,0.00016019668,0.00009355884,0.0024650705],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996076,0.00047500708,0.0014566528,0.00057243905,0.00065733836,0.0007625964],"domain_scores_gemma":[0.9966513,0.0002868708,0.0013244371,0.0004709428,0.0007855464,0.00048089857],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000201871,0.00044600113,0.0013706124,0.0009805936,0.0007063561,0.00076492724,0.00047705756,0.0010378595,0.00022607675],"category_scores_gemma":[0.0010247391,0.00052510586,0.00025581048,0.000110424466,0.00048714134,0.00039699263,0.000103582686,0.0027159497,0.000030077477],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053811964,0.00007823681,0.27407795,0.00011803285,0.0004302618,0.22258373,0.000024210945,2.6198384e-7,0.000008008586,0.000002188193,0.5023288,0.00029452116],"study_design_scores_gemma":[0.0021218976,0.00009645809,0.17700624,0.00014889435,0.00023482263,0.55032176,0.00002778514,0.000009831083,0.000040499614,0.000033175784,0.26972282,0.0002358058],"about_ca_topic_score_codex":0.032053143,"about_ca_topic_score_gemma":0.044635393,"teacher_disagreement_score":0.32773805,"about_ca_system_score_codex":0.00029259687,"about_ca_system_score_gemma":0.00086036464,"threshold_uncertainty_score":0.99972004},"labels":[],"label_agreement":null},{"id":"W2624322160","doi":"10.1111/bjd.15723","title":"Infections from seven clinical trials of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriasis","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Psoriasis; Medicine; Interleukin 17; Monoclonal antibody; Immunology; Clinical trial; Dermatology; Monoclonal; Interleukin; Plaque psoriasis; Antibody; Internal medicine; Cytokine; Secukinumab; Psoriatic arthritis","score_opus":0.09830212884903328,"score_gpt":0.39601046185283323,"score_spread":0.29770833300379995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624322160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2948952,0.7002832,0.00007535076,0.0000255067,0.0024131374,0.000718397,0.0015044074,0.000014870525,0.000069875634],"genre_scores_gemma":[0.10948202,0.8884464,0.00031985377,0.000027306563,0.00022050894,0.000030092606,0.0013386202,0.000072148665,0.00006304822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891777,0.0053354534,0.0042895228,0.00056942593,0.00012349115,0.0005044244],"domain_scores_gemma":[0.9927028,0.0014780574,0.004677823,0.0005539755,0.00044648955,0.00014086536],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013695299,0.00056692056,0.0074346396,0.00066189346,0.0002141324,0.00007551805,0.000874263,0.0014190621,0.00024382173],"category_scores_gemma":[0.0011636654,0.0004902586,0.0012938931,0.00018886274,0.000284857,0.00033837458,0.00014795864,0.001105855,0.00006248613],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001148838,0.0017366601,0.036856517,0.00034559632,0.0039049538,0.0010422502,0.000079185105,0.000002651784,0.0000024444903,0.000007629061,0.0008326951,0.9540406],"study_design_scores_gemma":[0.04675267,0.003927008,0.2005248,0.040255286,0.013814561,0.05715105,0.00010344861,0.0000016636457,0.00011407394,0.00022662591,0.63483965,0.0022891439],"about_ca_topic_score_codex":0.00041211356,"about_ca_topic_score_gemma":0.00043750482,"teacher_disagreement_score":0.9517514,"about_ca_system_score_codex":0.00009624632,"about_ca_system_score_gemma":0.00095396326,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W2666466176","doi":"10.1111/bjd.15734","title":"Letter to the Editor re: ‘Long‐term complications of Stevens–Johnson syndrome/toxic epidermal necrolysis ( <scp>SJS</scp> / <scp>TEN</scp> ): the spectrum of chronic problems in patients who survive an episode of <scp>SJS</scp> / <scp>TEN</scp> necessitates multidisciplinary follow‐up’","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Alberta","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Erythroderma; Broad spectrum","score_opus":0.017180805148251467,"score_gpt":0.26822676363083975,"score_spread":0.25104595848258826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2666466176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92721516,0.004922634,0.00045193837,0.05323015,0.006753257,0.0042140796,0.001749507,0.00010402586,0.0013592187],"genre_scores_gemma":[0.9751734,0.0020719168,0.0005005604,0.0107978545,0.0070962952,0.00042958977,0.001281358,0.00058904744,0.0020599465],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9857512,0.0023320795,0.005232387,0.0016198119,0.002493477,0.0025710277],"domain_scores_gemma":[0.9774262,0.00819191,0.008581371,0.0029678135,0.0020537078,0.0007790038],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0016726066,0.0016091088,0.0052509187,0.0021168801,0.0009629892,0.0002579392,0.0036532586,0.002219905,0.000010684109],"category_scores_gemma":[0.006040561,0.0014118354,0.0018473589,0.0014424704,0.0017228668,0.001297397,0.0009985183,0.0067214705,0.00007120827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016809918,0.002641737,0.11122967,0.0023021584,0.0031850452,0.006780846,0.0039843954,0.00052596984,0.0011042303,0.000010730593,0.865835,0.0023833828],"study_design_scores_gemma":[0.01002046,0.0014303043,0.77338314,0.008412056,0.0030645765,0.05108388,0.0023862696,0.0003589959,0.0034558622,0.00033605986,0.1457354,0.00033301895],"about_ca_topic_score_codex":0.0010506518,"about_ca_topic_score_gemma":0.0023654883,"teacher_disagreement_score":0.7200996,"about_ca_system_score_codex":0.0007974247,"about_ca_system_score_gemma":0.0013061161,"threshold_uncertainty_score":0.9996657},"labels":[],"label_agreement":null},{"id":"W2684473450","doi":"10.1111/bjd.15756","title":"Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"AbbVie; Wyeth; Cilag; Amgen","keywords":"Psoriasis; Biosimilar; Medicine; Dermatology; Clinical Practice; Family medicine; Internal medicine","score_opus":0.2872613720546832,"score_gpt":0.5035942397088006,"score_spread":0.21633286765411736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2684473450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000636479,0.9857035,0.0022391423,0.00808128,0.0019770588,0.0011105322,0.0007836617,0.000014596235,0.000083852],"genre_scores_gemma":[0.000019348357,0.9561291,0.042135134,0.001121975,0.00023297995,0.00009069647,0.00007202156,0.0000620492,0.00013672505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924779,0.0013473807,0.0049715834,0.0005612398,0.00006351557,0.0005784025],"domain_scores_gemma":[0.98590785,0.0055140965,0.00600933,0.0006461405,0.001793835,0.00012875882],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023472672,0.00047164457,0.005206329,0.0003179947,0.00033977896,0.000054836673,0.0009950772,0.0020387284,0.000028268416],"category_scores_gemma":[0.012885429,0.00043509566,0.0018044333,0.00013660596,0.0010716184,0.00019542624,0.00020394252,0.00096855895,0.0000031097074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013337226,0.00018024577,0.000026334332,0.0044127707,0.0018627088,0.000076603894,0.000003953795,1.3487849e-8,0.0000062085833,0.0014546631,0.12957904,0.8622641],"study_design_scores_gemma":[0.0017965604,0.00016169716,0.00015731048,0.005758405,0.005321839,0.1474739,0.000016382335,5.436e-7,0.000025750487,0.0012330079,0.8377468,0.00030781998],"about_ca_topic_score_codex":0.0000056802774,"about_ca_topic_score_gemma":0.00001687739,"teacher_disagreement_score":0.8619563,"about_ca_system_score_codex":0.000036410544,"about_ca_system_score_gemma":0.0008686036,"threshold_uncertainty_score":0.9998101},"labels":[],"label_agreement":null},{"id":"W2697574135","doi":"10.1111/bjd.15750","title":"Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase <scp>III NAVIGATE</scp> trial","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis; Double blind; Dermatology; Randomized controlled trial; Randomization; Internal medicine; Alternative medicine; Disease; Pathology; Placebo","score_opus":0.01798615141328034,"score_gpt":0.2754203383737347,"score_spread":0.25743418696045434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2697574135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996523,0.0009675059,0.000017690078,0.0002671234,0.0006196022,0.001313124,0.00017130791,0.0000054245725,0.00011521327],"genre_scores_gemma":[0.9993812,0.0002844869,0.000067185174,0.000027263899,0.000033877775,0.000020350693,0.00002806033,0.000021285388,0.00013628282],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957522,0.0019543825,0.0014983054,0.00029029025,0.00013452162,0.00037028774],"domain_scores_gemma":[0.9958613,0.0011997836,0.001988359,0.0005068669,0.00036123852,0.00008244854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013346126,0.00024837052,0.0015371313,0.000249471,0.00030568728,0.000043629912,0.0006267794,0.00035869452,0.0000070462015],"category_scores_gemma":[0.0016950831,0.00018854988,0.00021387766,0.00012032786,0.0006738748,0.0002669844,0.0001419337,0.00036941224,0.0000025259862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9725189,0.0011597573,0.003658433,0.00001588505,0.0006645664,0.00022590396,0.0014402053,0.000008222095,0.0005298173,0.00001968674,0.00028058988,0.019478004],"study_design_scores_gemma":[0.9260177,0.0016289646,0.051325943,0.0004848672,0.00042219984,0.0020685445,0.00020228571,0.0000011702368,0.01722045,0.000027753053,0.00049989234,0.00010024373],"about_ca_topic_score_codex":0.0003627648,"about_ca_topic_score_gemma":0.0003485457,"teacher_disagreement_score":0.04766751,"about_ca_system_score_codex":0.00003840208,"about_ca_system_score_gemma":0.0002163327,"threshold_uncertainty_score":0.76888406},"labels":[],"label_agreement":null},{"id":"W2749695403","doi":"10.1111/bjd.15611","title":"Alopecia in Cronkhite-Canada syndrome","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology; Medicine","score_opus":0.01314099627497874,"score_gpt":0.2466695192643888,"score_spread":0.23352852298941004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749695403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30191523,0.015245581,0.000012279062,0.6719497,0.005961591,0.0004033823,0.00007508348,0.000011435059,0.0044257543],"genre_scores_gemma":[0.68440187,0.0010420162,0.0004947289,0.309755,0.001983979,0.000011900783,0.000049073886,0.00010829016,0.0021531435],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99740285,0.00015476174,0.0009905511,0.00026690643,0.0006413904,0.0005435639],"domain_scores_gemma":[0.99813884,0.0001594669,0.0009060295,0.00036274144,0.0002907475,0.00014215238],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00011631904,0.00026668672,0.0014640478,0.00026582056,0.00007012015,0.00006004367,0.0005923432,0.0009060951,0.0005826102],"category_scores_gemma":[0.000477029,0.00031014372,0.00020737264,0.000077746336,0.00019521468,0.000069918555,0.00008868664,0.0037345085,0.000013846218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025809108,0.000014543494,0.0070051625,0.00013868234,0.00008518591,0.39579928,0.000007051343,5.941076e-7,0.0000053886115,1.2165741e-7,0.59488255,0.0020356188],"study_design_scores_gemma":[0.0009819779,0.0000700636,0.03525837,0.00092665816,0.000071735325,0.5004197,0.0000052370783,9.732863e-7,0.000045659595,0.000036699334,0.4620394,0.00014352074],"about_ca_topic_score_codex":0.043655917,"about_ca_topic_score_gemma":0.18726389,"teacher_disagreement_score":0.38248667,"about_ca_system_score_codex":0.0005202867,"about_ca_system_score_gemma":0.0031809323,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W2751469248","doi":"10.1111/bjd.15928","title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Chugai Pharmaceutical; LEO Pharma; LEO Fondet; Eli Lilly and Company; AstraZeneca; Galderma; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Celgene","keywords":"Atopic dermatitis; Medicine; Statement (logic); Dermatology; Dermatologic agents; Political science; Antibiotics","score_opus":0.06914032686386164,"score_gpt":0.309942794932204,"score_spread":0.24080246806834238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751469248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827225,0.0045981845,0.00086313323,0.004257005,0.0012692328,0.00032275947,0.00012448445,0.000011445783,0.00028152007],"genre_scores_gemma":[0.99692804,0.0010617385,0.0011617271,0.00056466874,0.00007383053,0.0000116513365,0.000012538413,0.000014784008,0.00017104177],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99811256,0.00008449498,0.00109589,0.0001263837,0.00036299278,0.00021768379],"domain_scores_gemma":[0.9966182,0.00024106132,0.0012868824,0.0002498479,0.0014563754,0.00014762582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017965242,0.0001169281,0.00065406185,0.000085099804,0.00015959717,0.00007710786,0.00026070024,0.00012860532,0.00005156338],"category_scores_gemma":[0.0017380542,0.00012516031,0.00020865383,0.000018629018,0.0003241148,0.00021361372,0.000056637495,0.00016335084,0.0000052969317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008589293,0.0006830532,0.65957046,0.0012809648,0.0016935408,0.030959396,0.00032924564,0.00001136171,0.0009934404,0.0004510014,0.2867583,0.016410291],"study_design_scores_gemma":[0.00849596,0.00014404897,0.2693719,0.0023969703,0.00050160516,0.6886113,0.00028173337,0.00028469978,0.0027436032,0.00049276836,0.026493737,0.00018165835],"about_ca_topic_score_codex":0.000040824045,"about_ca_topic_score_gemma":0.00004993881,"teacher_disagreement_score":0.6576519,"about_ca_system_score_codex":0.00012043542,"about_ca_system_score_gemma":0.00061782164,"threshold_uncertainty_score":0.5103889},"labels":[],"label_agreement":null},{"id":"W2755068232","doi":"10.1111/bjd.15993","title":"Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vital capacity; Diffusing capacity; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Cohort; Pulmonary function testing; Randomized controlled trial; Surgery; Lung; Lung function","score_opus":0.030916953434419307,"score_gpt":0.29006118937910613,"score_spread":0.25914423594468683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755068232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002168471,0.9947981,0.000004211381,0.00006014377,0.00031453607,0.0025176343,0.00008635618,0.00000577841,0.00004473222],"genre_scores_gemma":[0.052548543,0.94727916,0.00001177115,0.00003546238,0.000024900666,0.0000333092,0.000013565986,0.00003123274,0.000022084208],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99383634,0.0014337627,0.0039068265,0.00022222623,0.00039203517,0.00020879123],"domain_scores_gemma":[0.9929686,0.00043718694,0.005661526,0.00047914294,0.00033604592,0.000117464304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006893476,0.00031320087,0.006458874,0.00026790446,0.000065659864,0.000030017103,0.00045726742,0.0005755778,0.0000043388045],"category_scores_gemma":[0.0002959126,0.00020326319,0.000911795,0.00028191588,0.00018507583,0.00007658995,0.000041377578,0.00070149475,0.0000014466622],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042311127,0.0001127687,0.000035181387,0.9748058,0.0003646367,0.0015044516,0.00020226043,1.6226083e-7,0.000006573015,0.0000062361682,0.00011683377,0.022802813],"study_design_scores_gemma":[0.0013115805,0.000036666526,0.0002217983,0.6754896,0.0069254776,0.31573433,0.000053647585,4.877747e-7,0.000009042035,0.0000011188744,0.000121824196,0.000094451025],"about_ca_topic_score_codex":0.0000074675686,"about_ca_topic_score_gemma":0.0000017381756,"teacher_disagreement_score":0.31422988,"about_ca_system_score_codex":0.00006636826,"about_ca_system_score_gemma":0.0005034154,"threshold_uncertainty_score":0.82888323},"labels":[],"label_agreement":null},{"id":"W2760959372","doi":"10.1111/bjd.16018","title":"Systemic retinoids and psychiatric disorders in patients with skin diseases: a multifactorial relationship","year":2017,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Psychiatry; Dermatology","score_opus":0.008063970809050745,"score_gpt":0.22409785839275548,"score_spread":0.21603388758370473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760959372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511069,0.0019170472,0.00004110249,0.04327513,0.0024945934,0.0006774179,0.00015439872,0.000028184402,0.00030523396],"genre_scores_gemma":[0.9894874,0.00035425363,0.000053530097,0.009366696,0.0006107266,0.0000095707255,0.000023189728,0.000051294006,0.00004333459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997412,0.00057545496,0.0007218014,0.00041332017,0.00046011372,0.00041727035],"domain_scores_gemma":[0.9978747,0.00051034085,0.0011743836,0.00025820825,0.00007800528,0.00010436805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000697589,0.0002750969,0.00067554583,0.00044216472,0.00024383786,0.00020508483,0.00056454795,0.00057900255,0.000012049142],"category_scores_gemma":[0.0011374749,0.00027769763,0.00013382187,0.00016083643,0.00035247844,0.00034085754,0.00006217503,0.0019055736,0.0000063185257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036946606,0.00027396035,0.7743036,0.00045163097,0.000032890177,0.0048018247,0.00014881534,0.0000031876393,0.000003571586,0.00002437703,0.21516363,0.00442304],"study_design_scores_gemma":[0.013353192,0.0002664944,0.92861,0.001235904,0.00011592686,0.023760358,0.000043522738,0.000008719928,0.000010668733,0.0010426231,0.030790795,0.00076174474],"about_ca_topic_score_codex":0.00004295214,"about_ca_topic_score_gemma":0.00008326558,"teacher_disagreement_score":0.18437283,"about_ca_system_score_codex":0.00005175771,"about_ca_system_score_gemma":0.00017621787,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2764109025","doi":"10.1111/bjd.16050","title":"Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Etanercept; Medicine; Placebo; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Post-hoc analysis; Dosing; Dermatology; Secukinumab; Tumor necrosis factor alpha; Psoriatic arthritis; Pathology","score_opus":0.0660134355339033,"score_gpt":0.3257095382569747,"score_spread":0.25969610272307136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764109025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955327,0.038843818,0.00070343935,0.00057296624,0.0028331033,0.00090806745,0.00046890264,0.000030469135,0.00031223803],"genre_scores_gemma":[0.9936848,0.005019035,0.00031096948,0.000052278177,0.00011424593,0.00009617327,0.00014966089,0.00003531913,0.0005374617],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99677116,0.0003711208,0.0016542968,0.00044836153,0.00013833614,0.00061674335],"domain_scores_gemma":[0.9944032,0.0011224173,0.0026600095,0.0006410721,0.0010916323,0.00008170297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043998528,0.00048830296,0.0034605286,0.00066901935,0.0007117775,0.00010357351,0.00075217284,0.0005423175,0.00013852485],"category_scores_gemma":[0.00071146514,0.00041198664,0.0017866312,0.00031583518,0.00050442526,0.00034552664,0.00010414146,0.00026574163,0.000023249386],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11048892,0.005322663,0.049392514,0.0001528561,0.3113245,0.003177389,0.0014098368,0.00043076777,0.0052692173,0.0012375845,0.009991752,0.501802],"study_design_scores_gemma":[0.6363007,0.0058892625,0.10756699,0.0009760024,0.098912,0.022197835,0.002725862,0.00008279525,0.08968754,0.0020511393,0.03172667,0.0018832288],"about_ca_topic_score_codex":0.00058615213,"about_ca_topic_score_gemma":0.0033639069,"teacher_disagreement_score":0.52581173,"about_ca_system_score_codex":0.00023836613,"about_ca_system_score_gemma":0.00047342145,"threshold_uncertainty_score":0.9998332},"labels":[],"label_agreement":null},{"id":"W2767163492","doi":"10.1111/bjd.16101","title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"UCB Pharma; Health and Care Research Wales","keywords":"Hidradenitis suppurativa; Medicine; Population; Algorithm; Dermatology; Computer science; Internal medicine; Disease; Environmental health","score_opus":0.19675901393901296,"score_gpt":0.511889246454113,"score_spread":0.3151302325151001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767163492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602275,0.00057485304,0.009508133,0.02771339,0.0007518924,0.0009701982,0.000060547525,0.000009920353,0.00018358737],"genre_scores_gemma":[0.9828035,0.00010898944,0.0165266,0.000019478493,0.00043012804,0.000007914721,0.000021093923,0.000032211712,0.000050073577],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99536246,0.0015025226,0.0014941305,0.00028720684,0.0009755547,0.00037813876],"domain_scores_gemma":[0.9953537,0.0013521974,0.0010069392,0.0006494018,0.0013702239,0.0002675618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022048462,0.00016151521,0.0008533587,0.00025421078,0.00082749117,0.00025492793,0.00060601474,0.00016736488,0.000056185458],"category_scores_gemma":[0.003376023,0.0001399959,0.00020479015,0.00018393314,0.00028266315,0.00072322413,0.00015719436,0.0009546472,0.0000140805005],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087431166,0.0025585508,0.18367147,0.00007491813,0.0011739272,0.7425451,0.0017659415,0.00013081146,0.00018309322,0.00004771901,0.0013341395,0.06563998],"study_design_scores_gemma":[0.0054581123,0.0007949192,0.037439194,0.00066415156,0.000595086,0.9400955,0.0032773328,0.01046934,0.00026694906,0.00020726952,0.0005730371,0.00015912644],"about_ca_topic_score_codex":0.0035914148,"about_ca_topic_score_gemma":0.00009739644,"teacher_disagreement_score":0.19755036,"about_ca_system_score_codex":0.00008564055,"about_ca_system_score_gemma":0.00045249384,"threshold_uncertainty_score":0.63644767},"labels":[],"label_agreement":null},{"id":"W2767470025","doi":"10.1111/bjd.15524","title":"British Society for Paediatric Dermatology and British Society for Allergy &amp; Clinical Immunology joint session","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Session (web analytics); Medicine; Clinical immunology; Dermatology; Allergy; Family medicine; Immunology","score_opus":0.023433065312754166,"score_gpt":0.2850984189599192,"score_spread":0.26166535364716503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767470025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7219871,0.25834587,0.0107112955,0.0032132843,0.0045338143,0.0007927995,0.00019678142,0.00007464054,0.00014439835],"genre_scores_gemma":[0.9422747,0.05195781,0.0032993327,0.0011502532,0.00011844687,0.00009074413,0.0002266261,0.00008725229,0.000794823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99547404,0.00035613685,0.0022164115,0.0006694792,0.00009314292,0.001190776],"domain_scores_gemma":[0.99589986,0.00076642976,0.0020696977,0.00048822668,0.00071614736,0.00005965545],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009937495,0.000373476,0.001729331,0.00008694915,0.0022613478,0.00036709805,0.0010312983,0.001559302,0.00022140144],"category_scores_gemma":[0.0013057191,0.0005115896,0.0022973805,0.000084973675,0.0021848085,0.00054356956,0.0004326169,0.0012408472,0.000017509012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009306199,0.0019416767,0.0099322945,0.0005587592,0.00688329,0.0009714329,0.0009732805,0.0000064700243,0.01475034,0.000751777,0.37023383,0.5920662],"study_design_scores_gemma":[0.024707252,0.00046272218,0.06478916,0.00061724556,0.0006814878,0.3881736,0.0013424653,0.000079598765,0.0012639764,0.0037677172,0.5130222,0.0010926105],"about_ca_topic_score_codex":0.00059493206,"about_ca_topic_score_gemma":0.00043522625,"teacher_disagreement_score":0.5909736,"about_ca_system_score_codex":0.000047089623,"about_ca_system_score_gemma":0.0003812494,"threshold_uncertainty_score":0.9997369},"labels":[],"label_agreement":null},{"id":"W2768998510","doi":"10.1111/bjd.16140","title":"Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab","year":2017,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"U.S. Food and Drug Administration; Gemeinsame Bundesausschuss; Eli Lilly and Company","keywords":"Secukinumab; Ixekizumab; Medicine; Plaque psoriasis; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis","score_opus":0.03443892017663107,"score_gpt":0.28688891720687554,"score_spread":0.25244999703024446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768998510","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3260085,0.67218846,0.000015199481,0.000018885934,0.00038640827,0.0009032985,0.00031219982,0.000023941273,0.00014314291],"genre_scores_gemma":[0.50196004,0.4968478,0.00019446384,0.000015035077,0.000038320355,0.00004765644,0.0006721281,0.00011177863,0.00011274605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99561244,0.0011522372,0.0018855265,0.0005245262,0.00016650138,0.0006587455],"domain_scores_gemma":[0.9955799,0.0003754673,0.0030514828,0.0004910263,0.00039669892,0.00010541085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017967043,0.0007321567,0.005914996,0.00086647115,0.00024997664,0.000065191656,0.0008462503,0.0010887499,0.00008334508],"category_scores_gemma":[0.00007578982,0.0005922511,0.00044747264,0.0003675177,0.00023251602,0.00020466605,0.00010456635,0.0010643128,0.000048616228],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006324379,0.0020290283,0.012555836,0.0016802393,0.0043413253,0.002420313,0.0005063901,0.000024446808,9.0737836e-7,0.000008438236,0.0008834346,0.9692253],"study_design_scores_gemma":[0.1258456,0.00886936,0.12914951,0.13480115,0.0202503,0.19759592,0.00043834516,0.0000017578035,0.0009148633,0.000037668116,0.37729272,0.004802793],"about_ca_topic_score_codex":0.0002800252,"about_ca_topic_score_gemma":0.00066231133,"teacher_disagreement_score":0.96442246,"about_ca_system_score_codex":0.00018465014,"about_ca_system_score_gemma":0.0006758371,"threshold_uncertainty_score":0.99965286},"labels":[],"label_agreement":null},{"id":"W2774562674","doi":"10.1111/bjd.16217","title":"Chronic pain in pachyonychia congenita: evidence for neuropathic origin","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Neuropathic pain; Nail disease; Anesthesia; Psoriasis","score_opus":0.03969304816606819,"score_gpt":0.33561014422087254,"score_spread":0.2959170960548044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774562674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95863944,0.034160707,0.0047038435,0.0017279002,0.00043831792,0.00020484619,0.000007645801,0.0000026285798,0.00011467489],"genre_scores_gemma":[0.995238,0.003770256,0.0002875434,0.00010644551,0.0004247657,0.000014130652,0.000008287146,0.000016207192,0.00013432855],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9983596,0.0006152667,0.00037774004,0.00021188495,0.000093964845,0.00034153953],"domain_scores_gemma":[0.9990219,0.0001266925,0.00029081528,0.00028139137,0.00018734377,0.00009188473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014652625,0.00010332874,0.00026777457,0.00006172604,0.0001824362,0.00007425792,0.00062276307,0.00022226159,0.000014549059],"category_scores_gemma":[0.0031341584,0.00011410272,0.00014235673,0.000028028278,0.00026903907,0.000013500541,0.000112329064,0.00028404905,0.000003935721],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006584155,0.00018730914,0.25614792,0.00020869513,0.00020316604,0.011917099,0.000034201006,0.0000104383225,0.3939517,0.00013659276,0.0110034,0.32554105],"study_design_scores_gemma":[0.015083186,0.005267042,0.15137962,0.0016782718,0.00014323203,0.39043292,0.00018702036,0.0008074496,0.25131506,0.0019279635,0.18044814,0.0013300789],"about_ca_topic_score_codex":0.000028162049,"about_ca_topic_score_gemma":0.00032849715,"teacher_disagreement_score":0.37851584,"about_ca_system_score_codex":0.000019927213,"about_ca_system_score_gemma":0.00032324344,"threshold_uncertainty_score":0.46529737},"labels":[],"label_agreement":null},{"id":"W2789298639","doi":"10.1111/bjd.16398","title":"Initial validation of the Burden of Disease in Atopic Eczema instrument, a quality-of-life measure for adult atopic dermatitis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Eczema Society of Canada","keywords":"Atopic dermatitis; Medicine; Measure (data warehouse); Quality of life (healthcare); Dermatology; Atopy; Allergy; Immunology; Computer science","score_opus":0.03346211099179377,"score_gpt":0.3074571514843458,"score_spread":0.2739950404925521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789298639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83808535,0.002902898,0.00015968658,0.15679474,0.000834263,0.00070000865,0.00035790916,0.000007487551,0.00015762898],"genre_scores_gemma":[0.9691097,0.0002458903,0.00017234238,0.029470515,0.00078906055,0.000025175324,0.00012262093,0.00003255912,0.000032100772],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9956744,0.00085699843,0.0023417121,0.00021826974,0.0005859588,0.00032270033],"domain_scores_gemma":[0.99512285,0.00047129003,0.0024778133,0.00036726496,0.0014197745,0.00014100906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023962757,0.0002491899,0.0016656471,0.00033983908,0.000060389648,0.000012053721,0.00046333493,0.0006968035,0.00008722241],"category_scores_gemma":[0.0029177496,0.00023428678,0.00066284585,0.00020387769,0.0006544967,0.00014514546,0.00008196423,0.00083161425,0.0000017528731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007126258,0.00043302384,0.28198403,0.010658951,0.0009934079,0.0028143844,0.000608467,0.000006593918,0.000038471575,0.00012451081,0.6996154,0.0020100956],"study_design_scores_gemma":[0.051233895,0.0007727014,0.7082729,0.039022695,0.0053277416,0.07615614,0.0009789679,0.00014933574,0.01752028,0.014650329,0.084266976,0.0016480582],"about_ca_topic_score_codex":0.00018218577,"about_ca_topic_score_gemma":0.000041337717,"teacher_disagreement_score":0.61534846,"about_ca_system_score_codex":0.00004565382,"about_ca_system_score_gemma":0.0010864028,"threshold_uncertainty_score":0.9553938},"labels":[],"label_agreement":null},{"id":"W2789403302","doi":"10.1111/bjd.16224","title":"Survival of the fittest","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dermatrials Research","funders":"","keywords":"Survival of the fittest; Survival analysis; Medicine; Biology; Internal medicine; Genetics","score_opus":0.012995572759145311,"score_gpt":0.24644456402048684,"score_spread":0.23344899126134153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789403302","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08119614,0.017550962,0.00004616954,0.89290726,0.004371784,0.00039702564,0.00011569866,0.000026361442,0.0033886065],"genre_scores_gemma":[0.44075507,0.0015054393,0.0004715974,0.5435298,0.009006358,0.0000077261375,0.00008419019,0.00021939627,0.004420401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975491,0.0003186829,0.0010447507,0.00015839135,0.00059288356,0.00033617768],"domain_scores_gemma":[0.99715596,0.00026373524,0.0014138599,0.00040809053,0.0006907737,0.000067554654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013067128,0.00020321243,0.0011732084,0.0001390299,0.00007326891,0.0000197416,0.00060331606,0.0006446238,0.00050861906],"category_scores_gemma":[0.0008460983,0.00017162696,0.0006217176,0.0001410497,0.0006604539,0.00004521653,0.00013935166,0.00185198,0.000027369213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042411495,0.00007931702,0.011374679,0.00027340054,0.0002912551,0.027308827,0.000021812211,8.9411245e-8,0.000039789047,0.0000024486546,0.9598976,0.0006683746],"study_design_scores_gemma":[0.0011046111,0.00008550166,0.030010087,0.0016618648,0.0005074978,0.40424407,0.00001958955,9.60522e-7,0.00040996142,0.00014182192,0.56169343,0.0001206279],"about_ca_topic_score_codex":0.000042068124,"about_ca_topic_score_gemma":0.000009814741,"teacher_disagreement_score":0.39820418,"about_ca_system_score_codex":0.000048990634,"about_ca_system_score_gemma":0.00068695314,"threshold_uncertainty_score":0.80460346},"labels":[],"label_agreement":null},{"id":"W2790811276","doi":"10.1111/bjd.16571","title":"Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Aspirin; Medicine; Folic acid; Colorectal cancer; Randomized controlled trial; Internal medicine; Oncology; Gastroenterology; Cancer","score_opus":0.03206373877466592,"score_gpt":0.3573981421682029,"score_spread":0.32533440339353703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790811276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497694,0.003289963,0.0003213843,0.00024072091,0.00017676293,0.0008733035,0.00001269558,9.213723e-7,0.00010730156],"genre_scores_gemma":[0.9979496,0.0013259163,0.0005431495,0.000015111019,0.0001254133,0.000010727809,0.0000018857434,0.000008433337,0.00001978627],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972756,0.00085555494,0.0014124456,0.00009684434,0.00020126074,0.00015832785],"domain_scores_gemma":[0.996978,0.0016079972,0.0008639747,0.000090246285,0.0003958544,0.0000639672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002408749,0.00006839784,0.0011592146,0.0001664344,0.000026483474,0.000004714256,0.000120166515,0.00015759983,0.000022712224],"category_scores_gemma":[0.002039735,0.00005235448,0.00038586344,0.00011446912,0.0006869269,0.000049609564,0.00004199188,0.00028817475,3.610521e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8693659,0.001360462,0.09526602,0.0003676766,0.00051038334,0.00031788403,0.0003554509,4.1641533e-7,0.0039460766,0.000029271956,0.0009193921,0.02756108],"study_design_scores_gemma":[0.808633,0.0065951096,0.13158317,0.00028007664,0.0005753046,0.0061003217,0.000197169,0.0007363741,0.044739,0.00041583212,0.000082225386,0.00006240461],"about_ca_topic_score_codex":0.00013990403,"about_ca_topic_score_gemma":0.00016798943,"teacher_disagreement_score":0.060732868,"about_ca_system_score_codex":0.000009554003,"about_ca_system_score_gemma":0.00026024462,"threshold_uncertainty_score":0.25310105},"labels":[],"label_agreement":null},{"id":"W2791629745","doi":"10.1111/bjd.16350","title":"Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Center for Advancing Translational Sciences; National Institutes of Health; Dystrophic Epidermolysis Bullosa Research Association; Hospital for Sick Children; Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Epidermolysis bullosa; Medicine; Intraclass correlation; Cronbach's alpha; Construct validity; Quality of life (healthcare); Observational study; Reliability (semiconductor); Dermatology; Physical therapy; Patient satisfaction; Psychometrics; Surgery; Internal medicine; Clinical psychology","score_opus":0.09219870509020982,"score_gpt":0.40402842750019236,"score_spread":0.3118297224099825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791629745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960951,0.00076855795,0.0016579772,0.00076931424,0.00030666968,0.00033151504,0.000035415025,9.668936e-7,0.000034454886],"genre_scores_gemma":[0.9969456,0.0006743804,0.0021065352,0.000031861404,0.00017125746,0.000012491119,0.0000054633597,0.000009347012,0.000043043507],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789363,0.0006771462,0.000780418,0.00021340798,0.0001701313,0.00026527292],"domain_scores_gemma":[0.99764097,0.00065068924,0.00034687936,0.00026129163,0.0010254482,0.000074725926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002811164,0.000077401106,0.00043733962,0.000056661636,0.00013512731,0.000009573391,0.00036100886,0.00022557582,0.00000616359],"category_scores_gemma":[0.0049190857,0.000061583494,0.00032501886,0.00008050538,0.0014277108,0.0000047282133,0.00022828091,0.00020781034,1.9592969e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009071647,0.00039586864,0.9094047,0.00023679362,0.00042014298,0.00005935743,0.000043611122,8.414598e-7,0.0681364,0.00020488036,0.0042742323,0.015916003],"study_design_scores_gemma":[0.004417041,0.0023635603,0.26478875,0.00018266874,0.00012291825,0.019676415,0.0002496659,0.00006519315,0.6983442,0.0045340247,0.005074312,0.00018126964],"about_ca_topic_score_codex":0.00002440181,"about_ca_topic_score_gemma":0.000033210446,"teacher_disagreement_score":0.64461595,"about_ca_system_score_codex":0.000008035108,"about_ca_system_score_gemma":0.0001871125,"threshold_uncertainty_score":0.58889604},"labels":[],"label_agreement":null},{"id":"W2792200490","doi":"10.1111/bjd.16426","title":"Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; Dalhousie University","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Dosing; Psoriasis; Plaque psoriasis; Adverse effect; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Dermatology","score_opus":0.008463195056420257,"score_gpt":0.23560179499714487,"score_spread":0.2271385999407246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792200490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962781,0.0018679334,0.0001781877,0.000061040315,0.0005057416,0.000932735,0.000075330914,0.0000060119005,0.0000948965],"genre_scores_gemma":[0.9993114,0.00028200794,0.00024494558,0.00004089622,0.000033880708,0.000014206286,0.00003114591,0.000019244766,0.000022284989],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99682343,0.0009851741,0.0014967576,0.0002478194,0.00009000154,0.0003567934],"domain_scores_gemma":[0.99803734,0.0006096142,0.0008930447,0.00014046124,0.0002666685,0.000052883872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004685813,0.00022868694,0.0020400963,0.0004381239,0.00007418732,0.000014269266,0.00017830756,0.0003312031,0.00009924249],"category_scores_gemma":[0.00030751937,0.00021003872,0.00015581786,0.00024503714,0.00041470394,0.00017689433,0.000054151085,0.00026781502,0.0000030692004],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9582141,0.0021579398,0.0075582536,0.000025974901,0.00071650406,0.0003244096,0.0009558077,0.000008642638,0.0006075268,0.000029070878,0.00021738229,0.029184375],"study_design_scores_gemma":[0.9621144,0.0020522177,0.026047317,0.0005477589,0.00030031198,0.002815415,0.000102019185,0.0000062148047,0.0056458944,0.00006124874,0.000093548544,0.00021367965],"about_ca_topic_score_codex":0.00029588406,"about_ca_topic_score_gemma":0.00027172512,"teacher_disagreement_score":0.028970696,"about_ca_system_score_codex":0.000046049245,"about_ca_system_score_gemma":0.00017634213,"threshold_uncertainty_score":0.856513},"labels":[],"label_agreement":null},{"id":"W2792723400","doi":"10.1111/bjd.16099","title":"Risk of depression among patients with acne in the U.K.: a population-based cohort study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Mach-Gaensslen Foundation of Canada","keywords":"Depression (economics); Acne; Medicine; Cohort; Cohort study; Population; Psychiatry; Internal medicine; Dermatology; Environmental health","score_opus":0.004598128683009221,"score_gpt":0.23339578804816635,"score_spread":0.22879765936515714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792723400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272925,0.0003146672,0.00002168029,0.0058373734,0.00014561911,0.0008712604,0.000021778706,0.000003644186,0.00005473724],"genre_scores_gemma":[0.98686016,0.00004536226,0.0000733088,0.012533283,0.00028079632,0.0000151425465,0.00015038573,0.00002355179,0.000018012368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980262,0.00049972825,0.00060185284,0.0001668543,0.0005030321,0.00020235743],"domain_scores_gemma":[0.9983428,0.0002045606,0.00094629696,0.00020646416,0.00025951173,0.00004035983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020317249,0.00017277569,0.00082321884,0.00019051143,0.0000831049,0.00001796251,0.00015349362,0.00032249253,0.000032419066],"category_scores_gemma":[0.00010463906,0.000102806014,0.0001280685,0.00012797145,0.00008842603,0.00006404163,0.000016788152,0.0009880506,0.0000013800055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018512156,0.0006580341,0.88369036,0.0000624207,0.00033558183,0.010634923,0.00006868763,0.0000024665665,7.3045314e-8,1.5764385e-8,0.10369805,0.00066428044],"study_design_scores_gemma":[0.0059720785,0.00085978373,0.98560166,0.0010081105,0.0009916422,0.0045353123,0.000032436903,0.0000093279505,0.0000053018694,0.000005190274,0.0008860518,0.000093088835],"about_ca_topic_score_codex":0.00094940304,"about_ca_topic_score_gemma":0.00023509916,"teacher_disagreement_score":0.102812,"about_ca_system_score_codex":0.000035286805,"about_ca_system_score_gemma":0.000081640654,"threshold_uncertainty_score":0.4292643},"labels":[],"label_agreement":null},{"id":"W2792844945","doi":"10.1111/bjd.16109","title":"Advances in the diagnosis of pigmented skin lesions","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Advanced Chemical Sensor Technologies","field":"Engineering","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatoscopy; Melanoma; Skin cancer; Medicine; Dermatology; Teledermatology; Basal cell carcinoma; Cancer; Pathology; Basal cell; Internal medicine","score_opus":0.0059406965671506065,"score_gpt":0.2468536857086351,"score_spread":0.2409129891414845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792844945","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09101845,0.13695902,0.0011055851,0.00051426276,0.76792914,0.00042150318,0.00029346853,0.00022415194,0.0015343913],"genre_scores_gemma":[0.50477666,0.31434685,0.002209265,0.000033939024,0.17838775,0.000059213817,0.000048410086,0.00012663641,0.000011264776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982999,0.00007128882,0.000836661,0.000120579054,0.00036226356,0.00030933495],"domain_scores_gemma":[0.9980017,0.0011991395,0.000385588,0.00018389616,0.00019489336,0.000034811248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007957713,0.00018366754,0.0006845903,0.00018505806,0.000029717019,0.000017028566,0.00081317645,0.00066979416,0.00002100078],"category_scores_gemma":[0.0016186922,0.00017060612,0.00014381825,0.00023732135,0.00028236967,0.00016299309,0.00005409979,0.0012937066,0.000003267584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012378573,0.000055654695,0.000098597855,0.00016299926,0.000038486094,0.0012394674,0.00004146067,0.0001908499,0.00012710184,0.0000076721435,0.96991426,0.02811108],"study_design_scores_gemma":[0.0007191778,0.000060471386,0.000052104308,0.0011542331,0.000051949657,0.00492984,0.00022248103,0.000022987299,0.022107184,0.0014876932,0.9689661,0.00022573277],"about_ca_topic_score_codex":0.000008456714,"about_ca_topic_score_gemma":0.000110240406,"teacher_disagreement_score":0.58954144,"about_ca_system_score_codex":0.000072335984,"about_ca_system_score_gemma":0.000021012867,"threshold_uncertainty_score":0.69571155},"labels":[],"label_agreement":null},{"id":"W2792999790","doi":"10.1111/bjd.16449","title":"Children with facial morphoea managing everyday life: a qualitative study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Psychosocial; Thematic analysis; Psychology; Qualitative research; Focus group; Quality of life (healthcare); Developmental psychology; Medicine; Psychiatry; Psychotherapist; Sociology","score_opus":0.016523858459272126,"score_gpt":0.29739996276983915,"score_spread":0.28087610431056703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792999790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938189,0.0044931117,0.00017059885,0.0006084263,0.00026467067,0.00029954585,0.000008134755,0.000019948831,0.00031669915],"genre_scores_gemma":[0.9986874,0.00024001366,0.0001692938,0.00037855806,0.00045025887,0.000004370827,0.0000033574659,0.000019925415,0.00004685103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983964,0.0003156978,0.0005725744,0.0001606055,0.00032401294,0.00023069436],"domain_scores_gemma":[0.99882084,0.000060666032,0.0003785668,0.000113362665,0.00037610615,0.0002504275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021258935,0.00012171183,0.000552755,0.00011198216,0.00012549652,0.000036468613,0.0001227702,0.00008585862,0.00010489997],"category_scores_gemma":[0.00016529736,0.00010099615,0.000107226144,0.00018140227,0.00021087452,0.00011304325,0.000028655893,0.00026755707,0.000029738598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025848441,0.0028125567,0.85567266,0.00008606468,0.00605355,0.017536746,0.038973667,0.0000038959506,0.00041601458,0.000027890857,0.04096482,0.03486728],"study_design_scores_gemma":[0.011863801,0.0016873168,0.6171433,0.0017183494,0.00091791427,0.31986007,0.046033572,0.0000133768735,0.0002747558,0.000049782135,0.00020486167,0.00023293054],"about_ca_topic_score_codex":0.0001355832,"about_ca_topic_score_gemma":0.0000317925,"teacher_disagreement_score":0.30232334,"about_ca_system_score_codex":0.000029346142,"about_ca_system_score_gemma":0.00016138762,"threshold_uncertainty_score":0.41185033},"labels":[],"label_agreement":null},{"id":"W2800609435","doi":"10.1111/bjd.16737","title":"Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriasis; Medicine; Cross-sectional study; Socioeconomic status; Correlation; Internal medicine; Dermatology; Environmental health; Pathology; Population","score_opus":0.014122502836669474,"score_gpt":0.2676546408851366,"score_spread":0.2535321380484671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800609435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479014,0.0015855216,0.0001612121,0.0016772592,0.00082712603,0.00024529747,0.0006175674,0.0000048509773,0.00009102346],"genre_scores_gemma":[0.9972827,0.00080607017,0.00013011268,0.0008847551,0.00016733095,0.000017072562,0.0006323574,0.00002233562,0.000057263544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672323,0.0011162573,0.0012237921,0.00037163135,0.00017436262,0.00039074113],"domain_scores_gemma":[0.9956277,0.0008061306,0.0027716176,0.0002769229,0.0004927362,0.000024915862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004833076,0.00031271947,0.0015130359,0.00069562986,0.00016806964,0.000046927857,0.00035208248,0.0011038623,0.0002611743],"category_scores_gemma":[0.00007608304,0.00026750445,0.0004543021,0.00029987574,0.0006700616,0.0002137017,0.0000569775,0.0011500398,0.0000034652724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009461293,0.00034712028,0.97447824,0.000074451294,0.006964397,0.00031515775,0.00019613522,0.000026961916,0.00003283385,0.000003513729,0.014305759,0.0023093203],"study_design_scores_gemma":[0.0054898853,0.0003747587,0.98538405,0.00008137179,0.0028215612,0.0031909859,0.000070803544,0.00001068048,0.00013264736,0.000024533321,0.0022094257,0.00020932732],"about_ca_topic_score_codex":0.00026260215,"about_ca_topic_score_gemma":0.000333627,"teacher_disagreement_score":0.012096333,"about_ca_system_score_codex":0.0001602341,"about_ca_system_score_gemma":0.0003758858,"threshold_uncertainty_score":0.9999777},"labels":[],"label_agreement":null},{"id":"W2801085776","doi":"10.1111/bjd.16724","title":"Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Medicine; Placebo; Adverse effect; Tolerability; Internal medicine; Etanercept; Psoriasis; Gastroenterology; Dermatology; Tumor necrosis factor alpha","score_opus":0.019734505675629236,"score_gpt":0.27073648183936555,"score_spread":0.2510019761637363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801085776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952534,0.019477936,0.022389382,0.0006340108,0.0017243521,0.002140534,0.000671064,0.000019880315,0.00040883286],"genre_scores_gemma":[0.99744743,0.0007978264,0.0012355993,0.000094169176,0.0001044702,0.000082537736,0.00008055248,0.000021448777,0.00013596092],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930546,0.0025031636,0.003695977,0.00025748138,0.00010332845,0.00038543178],"domain_scores_gemma":[0.9904863,0.0049538957,0.0030851758,0.00024240752,0.0011685656,0.00006365442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031006988,0.00028106192,0.008952769,0.00085824454,0.00015543748,0.000018071936,0.000384449,0.0004753566,0.0005507606],"category_scores_gemma":[0.0038302578,0.00022813096,0.0028952572,0.00044139044,0.000378451,0.0001069049,0.000045973145,0.0001638045,0.00001224056],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8473964,0.00053606543,0.0006641715,0.000047528403,0.10321146,0.00011885798,0.00042090306,0.0001151505,0.012173931,0.00094950094,0.0028936109,0.031472415],"study_design_scores_gemma":[0.8494012,0.00069784984,0.001981644,0.0003047904,0.059369896,0.006658809,0.00018416671,0.00017369125,0.07862711,0.001519587,0.0007057241,0.00037556692],"about_ca_topic_score_codex":0.00009502426,"about_ca_topic_score_gemma":0.00036468523,"teacher_disagreement_score":0.066453174,"about_ca_system_score_codex":0.000034078217,"about_ca_system_score_gemma":0.00028716918,"threshold_uncertainty_score":0.930291},"labels":[],"label_agreement":null},{"id":"W2802931074","doi":"10.1111/bjd.16736","title":"Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Placebo; Psoriasis; Clinical endpoint; Adverse effect; Internal medicine; Randomized controlled trial; Dermatology; Secukinumab; Pathology; Psoriatic arthritis","score_opus":0.012094035804152687,"score_gpt":0.2528384543173931,"score_spread":0.2407444185132404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802931074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529,0.00211039,0.000120911856,0.000044410415,0.00033928346,0.0018894803,0.000056039364,0.0000073142387,0.00014217371],"genre_scores_gemma":[0.99954444,0.00014895957,0.00014772319,0.000019322664,0.000027466433,0.000043503438,0.000017735874,0.000019443727,0.00003138731],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99698234,0.0009197131,0.0014163782,0.00025133102,0.00010609585,0.00032412767],"domain_scores_gemma":[0.99783325,0.0005613726,0.00087705045,0.00016606598,0.00050084264,0.000061445884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043738715,0.00024293356,0.0021992084,0.00042564332,0.000116735886,0.000014954795,0.00021674042,0.00023194324,0.00009858483],"category_scores_gemma":[0.00018995533,0.00020344814,0.00016944949,0.00022311049,0.00032891505,0.00014852578,0.00006510103,0.000224359,0.000006293742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9615956,0.0042580264,0.008766706,0.000019160352,0.0023463876,0.00032598956,0.0017566698,0.000015953496,0.00020916079,0.000018659772,0.00009383186,0.020593854],"study_design_scores_gemma":[0.976483,0.0024621657,0.012514741,0.0001503422,0.00085179735,0.004493492,0.0004996541,0.0000054513357,0.0022890556,0.000023162895,0.00003553081,0.00019160469],"about_ca_topic_score_codex":0.00013729498,"about_ca_topic_score_gemma":0.00034735634,"teacher_disagreement_score":0.02040225,"about_ca_system_score_codex":0.000027802507,"about_ca_system_score_gemma":0.00013838153,"threshold_uncertainty_score":0.82963747},"labels":[],"label_agreement":null},{"id":"W2803308785","doi":"10.1111/bjd.16815","title":"Applying the phenotype approach for rosacea to practice and research","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Windsor","funders":"Galderma","keywords":"Rosacea; Subtyping; Medicine; Clinical phenotype; Phenotype; Computer science; Dermatology; Biology","score_opus":0.09634705907690584,"score_gpt":0.4344209756318519,"score_spread":0.33807391655494606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803308785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015591468,0.99456626,0.00095514255,0.00072100485,0.00023338309,0.0026578617,0.000011715391,0.0000053832537,0.00083364197],"genre_scores_gemma":[0.00007204002,0.98973954,0.0083633615,0.00037912693,0.00067309535,0.00042498411,0.000018270272,0.00004058106,0.00028899123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998106,0.0004798352,0.0005482515,0.00022178795,0.00028228472,0.0003618135],"domain_scores_gemma":[0.99755955,0.0011311917,0.0003633072,0.00017508703,0.0005708439,0.000200004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010805303,0.00017474993,0.0013282624,0.00018152643,0.00035332554,0.00009379743,0.00018572736,0.00027621817,0.000006265742],"category_scores_gemma":[0.0012163804,0.000109690656,0.00025677678,0.00023455296,0.00016556437,0.000081915,0.00009716121,0.0007265812,0.000011427745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010429148,0.00014555984,0.0000034380691,0.0046896716,0.0005132416,0.0013134866,0.000083577754,6.924632e-8,2.3178222e-7,0.00002901129,0.072035916,0.9210815],"study_design_scores_gemma":[0.00060307386,0.00034307403,0.000002414259,0.004454031,0.0011911506,0.20026407,0.00015635241,0.000004812415,8.9302483e-7,0.000019107352,0.7928834,0.00007763688],"about_ca_topic_score_codex":0.00001682384,"about_ca_topic_score_gemma":0.000002018081,"teacher_disagreement_score":0.9210039,"about_ca_system_score_codex":0.000051979143,"about_ca_system_score_gemma":0.00035551612,"threshold_uncertainty_score":0.44730553},"labels":[],"label_agreement":null},{"id":"W2803431177","doi":"10.1111/bjd.16671","title":"FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health; National Cancer Institute; Skin Cancer Foundation","keywords":"Medicine; Cancer; Skin cancer; Surgery; Dermatology; Internal medicine","score_opus":0.03715408956041201,"score_gpt":0.31067981324824845,"score_spread":0.27352572368783645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803431177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97756517,0.014310121,0.001026889,0.0023967822,0.0040662363,0.00039471532,0.000045380646,0.00002663655,0.00016806682],"genre_scores_gemma":[0.99671656,0.0009686198,0.0007290096,0.000675328,0.00064943626,0.00010045166,0.000004238095,0.000054875356,0.000101500045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973542,0.00008642823,0.0011912772,0.00029619408,0.00047715177,0.0005947561],"domain_scores_gemma":[0.9979546,0.00025777982,0.00080916396,0.0001720293,0.0006112757,0.00019512295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023009274,0.00024461342,0.0013334956,0.00024142767,0.00026736245,0.000040093702,0.00014593113,0.0001695932,0.000107809],"category_scores_gemma":[0.0005016478,0.00025366215,0.00063932076,0.00018781734,0.00017892364,0.00021219805,0.00006993093,0.00029867658,0.00000408198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023799467,0.000106886706,0.8364726,0.00009937817,0.0015516886,0.0031678139,0.00049553835,0.0000072667344,0.00013825412,0.0000020920252,0.016344553,0.14137594],"study_design_scores_gemma":[0.0056810663,0.00016127765,0.91436577,0.001429531,0.0008271207,0.029642647,0.0004547876,0.000049409922,0.02027873,0.00012076618,0.026494576,0.00049434573],"about_ca_topic_score_codex":0.0008608726,"about_ca_topic_score_gemma":0.0016260066,"teacher_disagreement_score":0.1408816,"about_ca_system_score_codex":0.00025792504,"about_ca_system_score_gemma":0.0005353569,"threshold_uncertainty_score":0.99999154},"labels":[],"label_agreement":null},{"id":"W2803716254","doi":"10.1111/bjd.16673","title":"Is depression screening in patients with acne critical?: reply from authors","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions; Mach-Gaensslen Foundation of Canada","keywords":"Acne; Depression (economics); Medicine; Dermatology; Psychiatry; Economics","score_opus":0.014269364124786276,"score_gpt":0.2723595729106663,"score_spread":0.25809020878588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803716254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58235776,0.005352505,0.0006826369,0.40917122,0.0012371895,0.00056574267,0.00018595837,0.000057563513,0.0003894142],"genre_scores_gemma":[0.52457416,0.00029373364,0.01969124,0.4508677,0.0032794215,0.00001774236,0.0006398532,0.00025651528,0.00037963883],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99652207,0.000347122,0.0011118958,0.00051353313,0.0009550325,0.0005503421],"domain_scores_gemma":[0.9976206,0.00038637858,0.00076916494,0.00042042977,0.00058487727,0.00021856838],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00011944615,0.00036467277,0.0013343849,0.00045021586,0.00009469802,0.000070040944,0.00030979465,0.0010627058,0.00050873583],"category_scores_gemma":[0.00060957373,0.00032617312,0.00021577947,0.00015518541,0.00026200252,0.00027163245,0.000117552954,0.0028556238,0.000027414339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005258057,0.00018701251,0.36187434,0.00007231731,0.00017436834,0.047836576,0.000046327437,6.963873e-8,0.0000034787984,9.589897e-8,0.58369344,0.0055861482],"study_design_scores_gemma":[0.013327689,0.0006710308,0.7558421,0.015528878,0.0008492343,0.05654596,0.000021751439,0.000011666674,0.00057741534,0.00015342749,0.15601781,0.00045307248],"about_ca_topic_score_codex":0.0001883406,"about_ca_topic_score_gemma":0.000015929849,"teacher_disagreement_score":0.42767563,"about_ca_system_score_codex":0.00008408432,"about_ca_system_score_gemma":0.00015189422,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W2804131537","doi":"10.1111/bjd.16798","title":"Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Plaque psoriasis; Psoriasis; Open label; Dermatology; Term (time); Extension (predicate logic); Internal medicine; Adverse effect; Computer science","score_opus":0.019806568419189007,"score_gpt":0.27153936439104526,"score_spread":0.25173279597185627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804131537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691087,0.0017465247,0.00003007427,0.00009552632,0.00036452085,0.0007706535,0.00003744809,0.000010714589,0.00003364261],"genre_scores_gemma":[0.99946445,0.00018390088,0.000098733144,0.00010029668,0.00003564768,0.0000139927815,0.000052836836,0.000024389965,0.000025775424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775964,0.0006541376,0.0007107479,0.00038389247,0.000065020904,0.00042654722],"domain_scores_gemma":[0.99913657,0.000093518036,0.0002678279,0.00020616363,0.00021819478,0.00007774584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023384712,0.00022581415,0.0007520859,0.00027799944,0.00017614433,0.00006670159,0.00036940165,0.00023684549,0.00008709103],"category_scores_gemma":[0.00005067897,0.00021586157,0.00002279697,0.00021676032,0.00014121927,0.00042076033,0.00015526364,0.00031623596,0.000025847221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012613263,0.005327946,0.88171905,0.0000134255015,0.00024232393,0.0024326802,0.00085087155,0.000009025273,0.00048162753,0.000010297124,0.00012891128,0.09617055],"study_design_scores_gemma":[0.053914137,0.0038860396,0.93266606,0.00033056294,0.000080558864,0.008112288,0.00011293228,0.0000022705121,0.00058402336,0.000010553286,0.000060691873,0.00023986535],"about_ca_topic_score_codex":0.000106477106,"about_ca_topic_score_gemma":0.004158133,"teacher_disagreement_score":0.09593068,"about_ca_system_score_codex":0.00009405522,"about_ca_system_score_gemma":0.00016404015,"threshold_uncertainty_score":0.8802579},"labels":[],"label_agreement":null},{"id":"W2808308077","doi":"10.1111/bjd.16597","title":"Atopic dermatitis and cardiovascular disease: have we seen enough to refute a causal link?","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Link (geometry); Disease; Medicine; Dermatology; Internal medicine; Computer science","score_opus":0.014007600460468006,"score_gpt":0.25077546460503947,"score_spread":0.23676786414457146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808308077","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018263213,0.17248748,0.0003169635,0.80630463,0.0012797321,0.00056313013,0.00021437326,0.000058648016,0.0005118462],"genre_scores_gemma":[0.19469301,0.031124713,0.0022039074,0.7577592,0.0115654925,0.000068926376,0.0003558765,0.00024318733,0.0019856633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962672,0.00055755395,0.0011599982,0.0005506139,0.0007258455,0.0007388014],"domain_scores_gemma":[0.99743366,0.00020560974,0.00043367027,0.0006235013,0.00057009823,0.00073343073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017335788,0.00047151657,0.002127777,0.00046355714,0.00020829747,0.00010909212,0.00038326762,0.0011205962,0.0002306632],"category_scores_gemma":[0.00047778417,0.0005186863,0.0008559897,0.00015207077,0.0005137556,0.00019036458,0.00018682369,0.0020703862,0.000096941374],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051823372,0.00003839211,0.0056096553,0.0007271886,0.0018205906,0.2706197,0.00008129089,6.081251e-7,6.8746186e-7,0.000004475596,0.7160604,0.004985198],"study_design_scores_gemma":[0.0013622327,0.000060259445,0.016454732,0.0015276957,0.0017186078,0.37908283,0.000022173586,0.000006354511,0.000024185665,0.0002493756,0.5992115,0.00028001098],"about_ca_topic_score_codex":0.000042764346,"about_ca_topic_score_gemma":0.000013900353,"teacher_disagreement_score":0.17642981,"about_ca_system_score_codex":0.0000661381,"about_ca_system_score_gemma":0.00055557286,"threshold_uncertainty_score":0.9997265},"labels":[],"label_agreement":null},{"id":"W2808777671","doi":"10.1111/bjd.16891","title":"Revisiting atopic dermatitis and cardiovascular disease","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine; Disease; Internal medicine","score_opus":0.011519969796532463,"score_gpt":0.2384410021728599,"score_spread":0.22692103237632744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808777671","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05281989,0.3462827,0.0003277147,0.5971333,0.0012623745,0.00042312476,0.00009143052,0.00006541238,0.0015940787],"genre_scores_gemma":[0.31670016,0.019902308,0.00084513536,0.65229577,0.009459642,0.000017179427,0.00019507614,0.0001350257,0.00044969874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972756,0.0004486767,0.0009577205,0.000347433,0.00049794675,0.0004726052],"domain_scores_gemma":[0.9980976,0.00019401831,0.0004879901,0.00040329245,0.00046261703,0.00035448465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016644267,0.00030632346,0.0016248907,0.00027676148,0.00017178299,0.00008345002,0.00022926283,0.000725399,0.00023551224],"category_scores_gemma":[0.00063556747,0.00034002156,0.0008272184,0.00010748194,0.0005336366,0.00017066378,0.00009759447,0.0017257287,0.000038940012],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016321203,0.000017371989,0.016044727,0.0010237499,0.001129005,0.28423122,0.000014556447,1.12989966e-7,2.382776e-7,0.000002316163,0.68968207,0.007838361],"study_design_scores_gemma":[0.0010329988,0.000014522622,0.024064852,0.0017644953,0.0016869708,0.4635368,0.000012247099,0.000006708316,0.000009403665,0.00022734117,0.50746745,0.00017620776],"about_ca_topic_score_codex":0.000012657621,"about_ca_topic_score_gemma":7.456907e-7,"teacher_disagreement_score":0.3263804,"about_ca_system_score_codex":0.000030645715,"about_ca_system_score_gemma":0.00034787445,"threshold_uncertainty_score":0.99990517},"labels":[],"label_agreement":null},{"id":"W2810315811","doi":"10.1111/bjd.16929","title":"Genotype-phenotype data from a case series of patients with mosaic neurofibromatosis type 1","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurofibromatosis; Mosaic; Series (stratigraphy); Genotype; Phenotype; Medicine; Type (biology); Genetics; Biology; Paleontology; Gene; Geography","score_opus":0.026954495917726078,"score_gpt":0.24805931601224543,"score_spread":0.22110482009451934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810315811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96195847,0.0029995423,0.000018051735,0.03082715,0.001006297,0.00033166114,0.0026811552,0.000029633717,0.00014807128],"genre_scores_gemma":[0.86097896,0.0011591807,0.009993959,0.1133608,0.0046844096,0.000007989871,0.008949457,0.00053960766,0.0003256488],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9967967,0.00031336414,0.0013021661,0.0005096195,0.00064731133,0.00043078515],"domain_scores_gemma":[0.9959294,0.00024696905,0.0014925827,0.001009434,0.0011439373,0.00017763335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000079661055,0.00039558712,0.0016921535,0.00026482518,0.00010573464,0.000072738105,0.00062944007,0.00061788975,0.00041214563],"category_scores_gemma":[0.00032016728,0.00036784873,0.00017209403,0.00027462648,0.00042731466,0.00037917166,0.00028807743,0.0013456203,0.000035777186],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007765465,0.00015766821,0.015126109,0.0003139438,0.0004540999,0.29960257,0.000024601866,7.0471e-8,0.000050867693,8.23453e-7,0.6831163,0.00037637012],"study_design_scores_gemma":[0.00275891,0.0017821983,0.0075395876,0.0012454082,0.0013416769,0.77795047,0.000023037974,0.000004500526,0.0004355015,0.0000606383,0.20649463,0.00036343464],"about_ca_topic_score_codex":0.00020452967,"about_ca_topic_score_gemma":0.000057403726,"teacher_disagreement_score":0.4783479,"about_ca_system_score_codex":0.000026926366,"about_ca_system_score_gemma":0.00045597742,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W2885233185","doi":"10.1111/bjd.17080","title":"The frequency of specific contact allergies is reduced in patients with psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psoriasis; Medicine; Allergy; Dermatology; Atopic dermatitis; Odds ratio; Contact dermatitis; Immunology; Allergic contact dermatitis; Sensitization; Nickel allergy; Confidence interval; Internal medicine","score_opus":0.008830557283445051,"score_gpt":0.23064724120972216,"score_spread":0.2218166839262771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885233185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310315,0.002871042,0.000018225115,0.0022519815,0.0003307286,0.00014295107,0.0000072229873,0.0000053279323,0.0012693541],"genre_scores_gemma":[0.9975865,0.0017086929,0.0003451019,0.000209855,0.000101832506,0.0000019394147,0.0000023150412,0.000013788867,0.000029967106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985905,0.00008317237,0.0007204895,0.00010158083,0.0002785033,0.00022571158],"domain_scores_gemma":[0.9986205,0.00011113675,0.0004466206,0.00015797061,0.0005926183,0.000071134804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102920705,0.000105502644,0.000495606,0.00011923779,0.0000835863,0.000032301985,0.00016884533,0.00007428098,0.0001511925],"category_scores_gemma":[0.00009758011,0.00007888352,0.000096073556,0.00014514754,0.00021081684,0.0001509487,0.000023907793,0.00023712894,0.000005813414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017041569,0.00069146807,0.8698144,0.0000956981,0.00070051977,0.0038563476,0.0019681987,4.061649e-7,0.0017014341,0.0008381873,0.047568318,0.07106088],"study_design_scores_gemma":[0.005379745,0.0005375624,0.97225666,0.00062655285,0.00003285625,0.010747017,0.00041257232,0.0000021934895,0.0030378299,0.00024878848,0.0066221924,0.00009600132],"about_ca_topic_score_codex":0.0000768319,"about_ca_topic_score_gemma":0.00025646886,"teacher_disagreement_score":0.1024423,"about_ca_system_score_codex":0.00003327477,"about_ca_system_score_gemma":0.00012694018,"threshold_uncertainty_score":0.32167765},"labels":[],"label_agreement":null},{"id":"W2885657058","doi":"10.1111/bjd.17076","title":"Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Wound healing; Randomized controlled trial; Surgery; Laser; Dermatology; Optics","score_opus":0.013604813698110256,"score_gpt":0.29901435174939794,"score_spread":0.2854095380512877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885657058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936397,0.0014833546,0.00025646572,0.0014566034,0.0003639887,0.0017881434,0.000027695722,0.000022142063,0.00096190965],"genre_scores_gemma":[0.99764216,0.00039006572,0.0006253787,0.00033221228,0.0003375423,0.00009687656,0.000018284023,0.000033587363,0.00052392186],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99666667,0.00069416995,0.0011112402,0.00034028562,0.00058904546,0.00059860136],"domain_scores_gemma":[0.99780715,0.0004788019,0.0006079997,0.00017042049,0.0006620219,0.0002735829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045541557,0.00029000195,0.0018247432,0.00035468937,0.00019873303,0.000116191375,0.0001405966,0.00028658923,0.0001594919],"category_scores_gemma":[0.00029566593,0.0002087808,0.0002928949,0.00027816082,0.00077424117,0.00031713568,0.00003110664,0.0006142616,0.000034067125],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.903743,0.0020985738,0.046815097,0.000058451616,0.003110184,0.036628008,0.00044606195,0.000011878252,0.00013005934,0.00004634346,0.0008111216,0.006101189],"study_design_scores_gemma":[0.8935667,0.0030765391,0.030134646,0.0006850527,0.00051084976,0.06912155,0.00020980947,0.00023310856,0.0014637368,0.00030905547,0.00046163728,0.00022727335],"about_ca_topic_score_codex":0.00059652014,"about_ca_topic_score_gemma":0.00017288004,"teacher_disagreement_score":0.03249354,"about_ca_system_score_codex":0.00017696846,"about_ca_system_score_gemma":0.000474426,"threshold_uncertainty_score":0.8513834},"labels":[],"label_agreement":null},{"id":"W2886710556","doi":"10.1111/bjd.17099","title":"Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Apremilast; Psoriasis; Medicine; Retrospective cohort study; Clinical Practice; Term (time); Series (stratigraphy); Pediatrics; Intensive care medicine; Dermatology; Family medicine; Surgery; Psoriatic arthritis","score_opus":0.030738576802847452,"score_gpt":0.3218042530086166,"score_spread":0.2910656762057691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886710556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8817831,0.02683225,0.00008508693,0.07652199,0.009810197,0.0015872518,0.002773132,0.000044259315,0.00056271604],"genre_scores_gemma":[0.9349688,0.02877521,0.004807654,0.0193215,0.0033618012,0.0003097868,0.0026458774,0.00033540724,0.005473924],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9940283,0.0015972363,0.002917144,0.000584729,0.00011042606,0.0007621665],"domain_scores_gemma":[0.9947879,0.0019598668,0.0023353936,0.0003658346,0.00049626525,0.000054763503],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00048069368,0.00056196435,0.0030333356,0.00084103143,0.00012695434,0.000029755984,0.00034209611,0.002138286,0.00022830798],"category_scores_gemma":[0.0008277383,0.0005452494,0.0009882698,0.0002880061,0.0005153306,0.00031840123,0.00006436678,0.00091616943,0.0000172252],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007973903,0.0044006216,0.4114343,0.00017205239,0.0054369057,0.28445467,0.0013119633,8.361542e-7,0.000031447496,0.000010904968,0.1269655,0.15780689],"study_design_scores_gemma":[0.032047283,0.0027914902,0.25791752,0.00050025835,0.0020090158,0.60338926,0.00038901012,6.4523704e-7,0.00047849253,0.00004303343,0.09986147,0.0005725015],"about_ca_topic_score_codex":0.0003160126,"about_ca_topic_score_gemma":0.0036540006,"teacher_disagreement_score":0.3189346,"about_ca_system_score_codex":0.00042071677,"about_ca_system_score_gemma":0.00029212527,"threshold_uncertainty_score":0.9996999},"labels":[],"label_agreement":null},{"id":"W2889338440","doi":"10.1111/bjd.17084","title":"Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma; Mylan; Astellas Pharma; University of Connecticut; Valeant Pharmaceuticals International; National Cancer Institute; AbbVie; Celgene; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Adalimumab; Medicine; Psoriasis; Plaque psoriasis; Dermatology; Clinical trial; Term (time); Internal medicine; Disease","score_opus":0.04027400225608697,"score_gpt":0.31018953441184344,"score_spread":0.2699155321557565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889338440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950658,0.0017960132,0.00040509715,0.00021849615,0.0015505605,0.00038351168,0.00045684562,0.000011845763,0.0001117925],"genre_scores_gemma":[0.99779916,0.0008833796,0.0006551077,0.00030197098,0.0001457016,0.000008159992,0.00015252344,0.000024981113,0.000029046716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99399924,0.0027950723,0.0023909104,0.00032514022,0.0001000583,0.00038960195],"domain_scores_gemma":[0.99589515,0.0015299903,0.0013112876,0.00022962719,0.0009426219,0.00009134991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051217293,0.0002539469,0.0020110083,0.00023187512,0.00011329354,0.000019508814,0.0003474357,0.0005279768,0.0005007687],"category_scores_gemma":[0.0006583265,0.00022885286,0.00031789465,0.0001835917,0.00034870717,0.00016116361,0.00007831591,0.00040049347,0.000072732866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034500964,0.0015515261,0.8188318,0.000035512712,0.0026172185,0.0013878974,0.0005692822,0.000009081074,0.0007704493,0.000034179833,0.0071951523,0.13249695],"study_design_scores_gemma":[0.039257225,0.001227525,0.9429474,0.00068750035,0.00046601778,0.0058214455,0.00014438054,0.0000017589863,0.008024622,0.0001086597,0.0009936508,0.00031982773],"about_ca_topic_score_codex":0.00023533675,"about_ca_topic_score_gemma":0.0007917105,"teacher_disagreement_score":0.13217713,"about_ca_system_score_codex":0.000047133584,"about_ca_system_score_gemma":0.00022508671,"threshold_uncertainty_score":0.9332349},"labels":[],"label_agreement":null},{"id":"W2890430426","doi":"10.1111/bjd.17189","title":"Diagnostic accuracy of content‐based dermatoscopic image retrieval with deep classification features","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MetaOptima Technology (Canada); Simon Fraser University","funders":"MetaOptima Technology","keywords":"Softmax function; Convolutional neural network; Diagnostic accuracy; Medical diagnosis; Pattern recognition (psychology); Classifier (UML)","score_opus":0.01942943451022958,"score_gpt":0.2689061410456525,"score_spread":0.24947670653542295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890430426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422503,0.0010693015,0.010332651,0.002780356,0.0003476758,0.00031513325,0.0000039621355,0.000024744739,0.0009011502],"genre_scores_gemma":[0.9957947,0.0002062659,0.0031474584,0.00063168054,0.00012487438,0.0000024700068,0.0000059284907,0.000016601736,0.00006998734],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9988146,0.000095681055,0.00051909767,0.0001233051,0.0002661733,0.00018115652],"domain_scores_gemma":[0.9981872,0.00030167686,0.000556023,0.00015089051,0.0006802856,0.00012396224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008634792,0.000103137725,0.000406408,0.0001864609,0.00006986205,0.000030224524,0.00011122808,0.00008917351,0.00014524885],"category_scores_gemma":[0.0011221075,0.000096336495,0.000090071306,0.00017555607,0.00027804755,0.000104973085,0.000017527984,0.00023323919,0.000013358113],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018076992,0.0041214796,0.23505442,0.0029601995,0.0026775654,0.1331216,0.0012820736,0.000008702781,0.3962962,0.0011847413,0.0608106,0.14440545],"study_design_scores_gemma":[0.0074969577,0.0013758966,0.28620955,0.001054188,0.00048488178,0.5138062,0.00089416263,0.00017460473,0.18414964,0.00005184555,0.0041093193,0.00019273646],"about_ca_topic_score_codex":0.000020961024,"about_ca_topic_score_gemma":0.0000720699,"teacher_disagreement_score":0.3806846,"about_ca_system_score_codex":0.000040990315,"about_ca_system_score_gemma":0.00012675443,"threshold_uncertainty_score":0.39284885},"labels":[],"label_agreement":null},{"id":"W2891620699","doi":"10.1111/bjd.17149","title":"Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Plaque psoriasis; Medicine; Psoriasis; Dermatology; Clinical trial; Internal medicine; Rheumatoid arthritis","score_opus":0.023656340273300085,"score_gpt":0.3111337158610936,"score_spread":0.2874773755877935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891620699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946179,0.0025898102,0.00032965984,0.00010918006,0.0007470537,0.00044313484,0.0010870623,0.0000145446365,0.00006170141],"genre_scores_gemma":[0.9985891,0.00048117852,0.00044135546,0.000069740956,0.00012284533,0.00002149665,0.00018050101,0.000024049112,0.00006973316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99454004,0.0019651428,0.0024097401,0.0003892488,0.00011658201,0.000579245],"domain_scores_gemma":[0.9965245,0.0006981271,0.001729001,0.00028212383,0.000667356,0.00009885661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015290942,0.00027335863,0.002262016,0.00038519446,0.0001768342,0.00003081049,0.00038621284,0.00057225453,0.00056329835],"category_scores_gemma":[0.00073020736,0.0002433167,0.0005614784,0.000650334,0.00032242888,0.00018536799,0.000078705314,0.00046430458,0.00006550539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009432824,0.001167148,0.8444022,0.000027286815,0.009238523,0.00030946737,0.00047955895,0.00008709144,0.0002738961,0.000024917264,0.0014328916,0.1331242],"study_design_scores_gemma":[0.035739098,0.0024789202,0.93656725,0.00033199147,0.0041608787,0.0028332942,0.00026781618,0.000018403296,0.015666848,0.00009746654,0.0013638948,0.00047413955],"about_ca_topic_score_codex":0.00016689891,"about_ca_topic_score_gemma":0.0018587006,"teacher_disagreement_score":0.13265006,"about_ca_system_score_codex":0.00006959613,"about_ca_system_score_gemma":0.00027553152,"threshold_uncertainty_score":0.99221665},"labels":[],"label_agreement":null},{"id":"W2891836054","doi":"10.1111/bjd.17195","title":"Granulocyte–macrophage colony‐stimulating factor ( <scp>GM</scp> ‐ <scp>CSF</scp> ) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐ <scp>GM</scp> ‐ <scp>CSF</scp> monoclonal antibody","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Dermatrials Research; Probity Medical Research","funders":"Department of Medicine, University of Toronto; University of Toronto; Gentofte Hospital; Takeda Pharmaceutical Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Internal medicine; Granulocyte macrophage colony-stimulating factor; Immunology; Population; Granulocyte colony-stimulating factor; Clinical trial; Monoclonal antibody; Gastroenterology; Randomized controlled trial; Antibody; Pharmacology; Cytokine; Pathology; Chemotherapy","score_opus":0.020038037774897877,"score_gpt":0.27071297728936855,"score_spread":0.2506749395144707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891836054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438727,0.04634135,0.0010969085,0.00008730882,0.0038994108,0.0026633246,0.00025929278,0.00021176315,0.0015679536],"genre_scores_gemma":[0.991538,0.0031963652,0.0015412099,0.0006194828,0.0009286877,0.00015833203,0.00047326184,0.00024952198,0.0012951378],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98498046,0.005717851,0.0045917565,0.0014796908,0.0006238962,0.0026063384],"domain_scores_gemma":[0.9833394,0.009987307,0.0041098585,0.00074986945,0.0013400282,0.00047353303],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0024658667,0.0015771837,0.006182,0.0017257846,0.0016768598,0.00054590957,0.0013620326,0.0020093876,0.0001235026],"category_scores_gemma":[0.00665652,0.0015998669,0.0018105186,0.0011924002,0.0020975268,0.0011707062,0.00030674264,0.002099611,0.00036970468],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045080082,0.0033400436,0.18045948,0.0004453625,0.01371798,0.014993473,0.014987664,0.0004606556,0.74239695,0.00113443,0.018335942,0.005220006],"study_design_scores_gemma":[0.5987388,0.0022582738,0.10500674,0.0024722486,0.004426136,0.09140514,0.0068863346,0.0016743244,0.15532593,0.006927441,0.024203494,0.0006751363],"about_ca_topic_score_codex":0.0005179343,"about_ca_topic_score_gemma":0.00022527797,"teacher_disagreement_score":0.5942308,"about_ca_system_score_codex":0.0004193021,"about_ca_system_score_gemma":0.0008663824,"threshold_uncertainty_score":0.9996976},"labels":[],"label_agreement":null},{"id":"W2891941421","doi":"10.1111/bjd.17201","title":"The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Optical coherence tomography; Concordance; Medicine; Histopathology; Basal cell carcinoma; Pathology; Basal cell; Nuclear medicine; Radiology; Internal medicine","score_opus":0.04004082900953006,"score_gpt":0.3119928536075381,"score_spread":0.27195202459800805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891941421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017145215,0.995735,0.0018978358,0.0000512764,0.00020221938,0.001087266,0.0002834209,0.00001216815,0.0005593763],"genre_scores_gemma":[0.010306308,0.98428094,0.0049993405,0.000010563202,0.000034791592,0.00031739956,0.000011305054,0.000037825193,0.0000015252015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968474,0.00025418933,0.0021060533,0.00019994387,0.00024990566,0.00034251594],"domain_scores_gemma":[0.99492466,0.0027570063,0.001031882,0.0003539146,0.00079461955,0.00013791671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083009,0.00028393365,0.0022900195,0.00016749797,0.00007760277,0.000022944723,0.00084793026,0.00028140223,0.00004437009],"category_scores_gemma":[0.0004794133,0.00024467584,0.001269005,0.000677132,0.0008036419,0.00008482599,0.00005693378,0.0005510311,0.0000035332737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003158216,0.00046739526,0.0007296395,0.19701007,0.0009704415,0.00014924078,0.00004380627,7.882489e-7,0.0000013613746,0.0015893296,0.07147236,0.727534],"study_design_scores_gemma":[0.0010565972,0.0007116652,0.0008443848,0.10017717,0.005862771,0.009150543,0.00008400642,0.00017277658,0.00048246313,0.0022382634,0.8782535,0.0009658522],"about_ca_topic_score_codex":0.000007050229,"about_ca_topic_score_gemma":0.000019892486,"teacher_disagreement_score":0.8067812,"about_ca_system_score_codex":0.00001765558,"about_ca_system_score_gemma":0.0001986344,"threshold_uncertainty_score":0.9977591},"labels":[],"label_agreement":null},{"id":"W2897043380","doi":"10.1111/bjd.17318","title":"Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase <scp>III</scp> trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Ortho Dermatologics","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Psoriatic arthritis; Subgroup analysis; Body surface area; Dermatology; Adalimumab; Meta-analysis; Disease","score_opus":0.016526440334536593,"score_gpt":0.2833830834402225,"score_spread":0.2668566431056859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897043380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99433434,0.003843151,0.00049860054,0.000071333096,0.00032116176,0.00065529725,0.00020018387,0.000008186406,0.00006776924],"genre_scores_gemma":[0.998679,0.00070677686,0.00036395807,0.00004973692,0.000029928402,0.000013850883,0.000057244622,0.000018968773,0.00008055397],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99347264,0.003516314,0.0021968326,0.00029774432,0.00012644615,0.0003900553],"domain_scores_gemma":[0.9934349,0.003939583,0.0017643295,0.00023495845,0.0005465538,0.00007967226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018604026,0.0002626413,0.0036112727,0.0012397557,0.00010753153,0.000018708948,0.0002699348,0.00026537705,0.000056246623],"category_scores_gemma":[0.0027886715,0.0002269551,0.0004201878,0.0008683607,0.0006120186,0.00015304083,0.00006846595,0.00020651938,0.0000047801936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6532732,0.0034201415,0.18216874,0.00007534459,0.025135629,0.00062895514,0.003910601,0.000026379505,0.005778865,0.00023912363,0.0012146354,0.12412839],"study_design_scores_gemma":[0.6902877,0.0018398907,0.26479137,0.00045064348,0.007798893,0.0017793819,0.0002577393,0.0000074225545,0.032071516,0.000059815156,0.0004735267,0.00018212345],"about_ca_topic_score_codex":0.00037663392,"about_ca_topic_score_gemma":0.0004938055,"teacher_disagreement_score":0.12394626,"about_ca_system_score_codex":0.000039721854,"about_ca_system_score_gemma":0.00015082052,"threshold_uncertainty_score":0.92549604},"labels":[],"label_agreement":null},{"id":"W2897116385","doi":"10.1111/bjd.17038","title":"Ixekizumab in genital psoriasis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Ixekizumab; Psoriasis; Dermatology; Medicine; Sex organ; Biology; Psoriatic arthritis; Secukinumab","score_opus":0.013219328369075627,"score_gpt":0.22586833331081116,"score_spread":0.21264900494173553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897116385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54804176,0.13635406,0.00010285798,0.2799861,0.027798982,0.0007902601,0.00073542667,0.00011965114,0.0060708956],"genre_scores_gemma":[0.6697612,0.012855515,0.0011623695,0.28497228,0.01367162,0.00010161216,0.0023531353,0.00047070064,0.014651624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967224,0.0008571208,0.0012147924,0.00036103567,0.000099235185,0.00074539066],"domain_scores_gemma":[0.9982635,0.0002996447,0.00087219966,0.0002620076,0.00026926387,0.000033407927],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018830768,0.00039289688,0.0013412657,0.0006130846,0.00012973341,0.000046740366,0.00066957937,0.00239774,0.0012014054],"category_scores_gemma":[0.00015975357,0.0004348848,0.00048257664,0.00020425257,0.00035463876,0.00016091502,0.00009413757,0.0021877992,0.0007280924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015449719,0.00010955175,0.00083579274,0.000043021588,0.00073595176,0.053461924,0.00010687686,9.080504e-8,0.00013538111,0.000003709975,0.8996521,0.044761065],"study_design_scores_gemma":[0.0036204357,0.00015290697,0.0018709652,0.0002626396,0.00031613663,0.3291815,0.000041423253,1.07848116e-7,0.0017762155,0.00017738302,0.6622721,0.00032819554],"about_ca_topic_score_codex":0.000115371935,"about_ca_topic_score_gemma":0.0001368236,"teacher_disagreement_score":0.27571958,"about_ca_system_score_codex":0.000114628754,"about_ca_system_score_gemma":0.00034068822,"threshold_uncertainty_score":0.9998103},"labels":[],"label_agreement":null},{"id":"W2897199008","doi":"10.1111/bjd.17335","title":"Network meta‐analyses of systemic treatments for psoriasis: a critical appraisal","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Critical appraisal; Psoriasis; Systemic risk; Systemic therapy; Medicine; Psychology; Dermatology; Internal medicine; Alternative medicine; Economics; Pathology","score_opus":0.07494401286254536,"score_gpt":0.3382779030980835,"score_spread":0.2633338902355381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897199008","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025179038,0.8468709,0.0045810193,0.08423341,0.03395318,0.0015622644,0.0029886072,0.00012106724,0.00051052624],"genre_scores_gemma":[0.82176054,0.024633426,0.014243256,0.09767157,0.030005226,0.001232227,0.0049579046,0.0008748527,0.0046210266],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99528253,0.0014110578,0.0018672339,0.00044843135,0.00013372059,0.00085704227],"domain_scores_gemma":[0.9935671,0.003607919,0.0016378885,0.00034932894,0.0007850798,0.000052668634],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00032355168,0.00055869477,0.003378081,0.00033248487,0.00022586282,0.000038428967,0.00064397743,0.0020851041,0.00037993895],"category_scores_gemma":[0.00071009167,0.0005057761,0.0017987867,0.00017871449,0.0005666396,0.00013511619,0.000072571456,0.00087281695,0.00006565126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046157482,0.00021696977,0.0001388498,0.00037488982,0.05467257,0.004264709,0.0000730292,0.000001792711,0.0007922632,0.000034255096,0.9362814,0.0026877192],"study_design_scores_gemma":[0.009907758,0.0014206535,0.00017649376,0.0018844317,0.14350054,0.4938338,0.00015415883,0.0000014417041,0.010678699,0.0009812838,0.33652335,0.0009373866],"about_ca_topic_score_codex":0.00006796312,"about_ca_topic_score_gemma":0.000012091344,"teacher_disagreement_score":0.82223743,"about_ca_system_score_codex":0.000055237375,"about_ca_system_score_gemma":0.00034497783,"threshold_uncertainty_score":0.9997394},"labels":[],"label_agreement":null},{"id":"W2897668014","doi":"10.1111/bjd.16943","title":"Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; MEDLINE; Pediatrics","score_opus":0.04033806836309275,"score_gpt":0.31859535119345556,"score_spread":0.27825728283036283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897668014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040577047,0.087688945,0.00074280845,0.8672421,0.0021733055,0.0013795557,0.000032893786,0.000026663278,0.00013668976],"genre_scores_gemma":[0.057927456,0.016523346,0.0032823405,0.88974196,0.029858526,0.00026088397,0.00021703639,0.000117035466,0.0020714274],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996624,0.00058139546,0.001577977,0.00029447628,0.0004255173,0.0004966532],"domain_scores_gemma":[0.9957113,0.002372922,0.0010565424,0.00033647454,0.0003607378,0.00016198133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003456964,0.00027277952,0.0011578519,0.00038324812,0.00019605957,0.0000786375,0.00053255336,0.00095347164,0.00020911291],"category_scores_gemma":[0.0032585685,0.0002344009,0.0004417157,0.00026335634,0.00032145236,0.00021256146,0.000057306694,0.0016628118,0.000022845821],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005175532,0.00006244432,0.0036679448,0.00031792896,0.00017120907,0.014116322,0.00009845904,7.2176005e-7,0.0000010806611,0.0000048443435,0.97462946,0.0064120446],"study_design_scores_gemma":[0.048445858,0.00031397093,0.0051596584,0.0034083598,0.0019645866,0.46983862,0.00007051686,0.00013247653,0.00006518013,0.0014972051,0.46869326,0.00041029477],"about_ca_topic_score_codex":0.00007515091,"about_ca_topic_score_gemma":0.000082630926,"teacher_disagreement_score":0.5059362,"about_ca_system_score_codex":0.00008964478,"about_ca_system_score_gemma":0.0013688932,"threshold_uncertainty_score":0.9558591},"labels":[],"label_agreement":null},{"id":"W2898564948","doi":"10.1111/bjd.17347","title":"Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study","year":2018,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Dermatology; Quality of life (healthcare); Prospective cohort study; Pyoderma; Intensive care medicine; Surgery; Internal medicine; Disease","score_opus":0.01818263959690763,"score_gpt":0.31744323645646466,"score_spread":0.299260596859557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898564948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9572966,0.007973365,0.0000059845474,0.032953214,0.00035144523,0.0008864003,0.00005132345,0.000018104887,0.00046356276],"genre_scores_gemma":[0.960026,0.0006313071,0.000027080121,0.038405918,0.0006671644,0.000008009424,0.00002066684,0.000058390044,0.00015542623],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9966126,0.0005434143,0.0015852656,0.00029866173,0.00054928573,0.0004107769],"domain_scores_gemma":[0.9967669,0.00023851122,0.001779527,0.00025333572,0.0008081196,0.00015358621],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028849233,0.0003484221,0.0020157064,0.0003183615,0.000083956955,0.000032118256,0.00022248854,0.0006150421,0.00020433422],"category_scores_gemma":[0.00078997156,0.00032096964,0.00037497585,0.00013187615,0.0002400856,0.00015180884,0.00007191493,0.0019175358,0.000018834018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001906239,0.0012834643,0.21945733,0.00094199413,0.002751331,0.024228094,0.001356925,7.770283e-7,0.00007311461,0.0000043125765,0.7464713,0.0015251517],"study_design_scores_gemma":[0.019406639,0.0032280402,0.8794059,0.0018221616,0.0010071525,0.076046415,0.0013173745,0.000025201132,0.00032027587,0.00009297146,0.016736094,0.00059178605],"about_ca_topic_score_codex":0.00008830839,"about_ca_topic_score_gemma":0.000022555389,"teacher_disagreement_score":0.7297352,"about_ca_system_score_codex":0.00008035616,"about_ca_system_score_gemma":0.0004977323,"threshold_uncertainty_score":0.99992424},"labels":[],"label_agreement":null},{"id":"W2902260894","doi":"10.1111/bjd.17462","title":"Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"Allergan","keywords":"Erythema; Oxymetazoline; Medicine; Rosacea; Clinical trial; Randomized controlled trial; Dermatology; Surgery; Internal medicine","score_opus":0.09987158512007305,"score_gpt":0.45240620816703725,"score_spread":0.3525346230469642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902260894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488586,0.0003452797,0.0008545418,0.00010039466,0.00004643932,0.0036831212,0.00008222133,0.0000015135902,6.454158e-7],"genre_scores_gemma":[0.9939515,0.00004508574,0.0058426135,0.00002863062,0.000021563355,0.00008629306,0.000007962067,0.000014349225,0.000001989151],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99469596,0.003072106,0.0014607868,0.00023937071,0.00034696984,0.00018481321],"domain_scores_gemma":[0.9953104,0.0026866605,0.00085652975,0.00016124039,0.0008759503,0.00010920653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008416289,0.00015086742,0.0015495232,0.00047395146,0.000018941957,0.000005149286,0.000083458384,0.00010283321,0.000004614372],"category_scores_gemma":[0.0033682892,0.000115715666,0.00020124333,0.00028729314,0.00016172911,0.00010250458,0.000028011757,0.00013938599,2.2223155e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76985866,0.01648916,0.12605889,0.00034588433,0.0006893913,0.00031545185,0.0028341438,0.000084004605,0.011291894,9.217411e-7,0.000012551359,0.07201907],"study_design_scores_gemma":[0.4420968,0.16970351,0.26499206,0.0023352671,0.0022217245,0.0028182766,0.0011846609,0.059639778,0.054749854,0.00007407036,0.0000034782427,0.00018052547],"about_ca_topic_score_codex":0.00035342338,"about_ca_topic_score_gemma":0.0007011413,"teacher_disagreement_score":0.32776186,"about_ca_system_score_codex":0.0000351344,"about_ca_system_score_gemma":0.00020573693,"threshold_uncertainty_score":0.4718748},"labels":[],"label_agreement":null},{"id":"W2902697340","doi":"10.1111/bjd.17454","title":"Safety of guselkumab in patients with moderate‐to‐severe psoriasis treated through 100 weeks: a pooled analysis from the randomized <scp>VOYAGE</scp> 1 and <scp>VOYAGE</scp> 2 studies","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Adalimumab; Adverse effect; Randomized controlled trial; Placebo; Clinical trial; Psoriasis; Internal medicine; Dermatology; Pathology; Alternative medicine; Disease","score_opus":0.010887670862251838,"score_gpt":0.23301051871707845,"score_spread":0.2221228478548266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902697340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97534984,0.022537174,0.00026023664,0.00019652268,0.00039256032,0.00066455494,0.00028502278,0.000026022237,0.00028804992],"genre_scores_gemma":[0.9947446,0.003949462,0.00052570575,0.00025086966,0.00006938523,0.0000404643,0.00014009421,0.000037488353,0.00024195912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99514776,0.0020573183,0.0015041665,0.0004973149,0.00017209393,0.00062132603],"domain_scores_gemma":[0.9942826,0.0033633537,0.0011264924,0.00036659976,0.0007825343,0.00007841346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005305239,0.0004648362,0.00279118,0.00041220488,0.00039999618,0.000054639473,0.00045867756,0.0004476337,0.000061256476],"category_scores_gemma":[0.0012975207,0.0003383901,0.00044461002,0.0009164551,0.00090591697,0.00029654513,0.0001556418,0.00041091017,0.000026228054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06584829,0.0032920146,0.7065166,0.00011056838,0.13593757,0.0018622167,0.03312994,0.00019673059,0.0018172811,0.0002084007,0.026557697,0.024522666],"study_design_scores_gemma":[0.42593092,0.0016055834,0.5087288,0.0009394871,0.02342532,0.0045132986,0.00812553,0.000028067083,0.022361854,0.0013734985,0.0025725402,0.0003950928],"about_ca_topic_score_codex":0.0009135108,"about_ca_topic_score_gemma":0.0015115432,"teacher_disagreement_score":0.36008263,"about_ca_system_score_codex":0.00007932816,"about_ca_system_score_gemma":0.00013948802,"threshold_uncertainty_score":0.99990684},"labels":[],"label_agreement":null},{"id":"W2902753829","doi":"10.1111/bjd.16230","title":"Dermatomyositis: a slow path towards targeted therapies or will conventional therapies prevail?","year":2018,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dermatomyositis; Medicine; Intensive care medicine; Dermatology","score_opus":0.00807862611607661,"score_gpt":0.26085924316389303,"score_spread":0.2527806170478164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902753829","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034852464,0.096851245,0.0015280391,0.0042308155,0.8583259,0.0014265305,0.0012853523,0.00030779478,0.0011918638],"genre_scores_gemma":[0.07470383,0.0424901,0.006452185,0.0022876211,0.86935085,0.00013375175,0.001134269,0.00053423626,0.0029131644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99298745,0.0007400149,0.002628227,0.0006186245,0.0019193477,0.0011063458],"domain_scores_gemma":[0.9928636,0.00058541266,0.0022700492,0.0005203015,0.0032587873,0.0005018326],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006622994,0.00083296036,0.0028764145,0.00058682926,0.0004689136,0.00038108433,0.00075109483,0.0020679848,0.0020214184],"category_scores_gemma":[0.0010273808,0.00076246355,0.0011022124,0.00032994166,0.00089948374,0.00077608926,0.0002019678,0.00242922,0.00009508581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001694999,0.00027742813,0.00041234467,0.0010293368,0.0018327405,0.05808641,0.00065567717,1.5465807e-7,0.00007711115,0.000045400433,0.93104064,0.00484778],"study_design_scores_gemma":[0.0059876167,0.0005599975,0.0010041645,0.0035607102,0.00060895324,0.27635953,0.00036809332,0.000012763885,0.00035048855,0.00036719284,0.710241,0.0005794459],"about_ca_topic_score_codex":0.000070723014,"about_ca_topic_score_gemma":0.000047659803,"teacher_disagreement_score":0.22079958,"about_ca_system_score_codex":0.00024004493,"about_ca_system_score_gemma":0.0031936073,"threshold_uncertainty_score":0.9998722},"labels":[],"label_agreement":null},{"id":"W2906008486","doi":"10.1111/bjd.17590","title":"Interventions for rosacea based on the phenotype approach: an updated systematic review including<scp>GRADE</scp>assessments","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Southwest Hospital; Army Medical University; Universiteit Leiden","keywords":"Rosacea; Brimonidine; Medicine; Dermatology; Minocycline; Isotretinoin; Metronidazole; Tolerability; Randomized controlled trial; Erythema; Acne; Surgery; Adverse effect; Internal medicine; Antibiotics","score_opus":0.12109585316626695,"score_gpt":0.4087974071537314,"score_spread":0.28770155398746444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906008486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031393516,0.9936542,0.001301816,0.00022219642,0.00039282028,0.0039413,0.00009253025,0.000024977486,0.00033876929],"genre_scores_gemma":[0.00041127656,0.99603057,0.00093197776,0.0010322985,0.00021815054,0.00031938532,0.0006997576,0.000084492116,0.0002721036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995867,0.0011661624,0.0018817233,0.00032763716,0.0003571115,0.00040034836],"domain_scores_gemma":[0.99606496,0.0006392509,0.0021943536,0.00047515033,0.00039259766,0.00023366214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009292157,0.00044439183,0.004276235,0.00024338214,0.00031432285,0.00009140358,0.00046863136,0.0003603234,0.000037688274],"category_scores_gemma":[0.0007190534,0.00027026015,0.0018363362,0.00031058092,0.00012309596,0.00011055348,0.000057910336,0.00064442353,0.00002691966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011600625,0.001173825,0.0000043238356,0.89958715,0.0015654953,0.000949175,0.00001620356,2.3506932e-7,9.961434e-8,0.000045393175,0.08551775,0.011128753],"study_design_scores_gemma":[0.0015511742,0.00097462966,0.0000033723627,0.83910286,0.017951062,0.041169006,0.000050190698,0.00013218971,0.0000013626611,0.00002561445,0.098905645,0.00013286246],"about_ca_topic_score_codex":0.0000040917275,"about_ca_topic_score_gemma":0.0000024605902,"teacher_disagreement_score":0.06048426,"about_ca_system_score_codex":0.00012725066,"about_ca_system_score_gemma":0.00038474522,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W2907063679","doi":"10.1111/bjd.17323","title":"Tofacitinib: a new oral Janus kinase inhibitor for psoriasis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Tofacitinib; Janus kinase inhibitor; Psoriasis; Janus kinase; Dermatology; Medicine; Janus; Plaque psoriasis; Internal medicine; Materials science","score_opus":0.03670535944546116,"score_gpt":0.31420712493776765,"score_spread":0.2775017654923065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907063679","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030979212,0.011378489,0.0003563795,0.9514949,0.0030156146,0.0009136767,0.0005378712,0.00002684349,0.001297033],"genre_scores_gemma":[0.007556048,0.0042542443,0.009370528,0.89053714,0.032142717,0.00003854893,0.0010905603,0.00028232532,0.05472786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674654,0.00018303098,0.0011726551,0.00035045194,0.0007343944,0.0008129258],"domain_scores_gemma":[0.99757075,0.0005689566,0.00062435,0.00023203465,0.00070114894,0.0003027373],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00020249297,0.00035311622,0.0017146897,0.00039906634,0.000100663325,0.0000958554,0.00039458377,0.0010801373,0.00061398325],"category_scores_gemma":[0.00054000714,0.0003497254,0.00092955393,0.00014654551,0.00017715477,0.00012539687,0.00009852388,0.002917057,0.00012998024],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075129006,0.000072225,0.00081935985,0.00081905694,0.00046628856,0.05784882,0.000029378067,1.7901814e-7,0.00010182762,0.000011993984,0.906458,0.032621536],"study_design_scores_gemma":[0.0037410783,0.0004264429,0.000263893,0.00085795915,0.0002495245,0.26877356,0.000014274243,0.000007815716,0.00080540084,0.00025576074,0.7243745,0.0002298579],"about_ca_topic_score_codex":0.00021406177,"about_ca_topic_score_gemma":0.000024367742,"teacher_disagreement_score":0.21092473,"about_ca_system_score_codex":0.00008384709,"about_ca_system_score_gemma":0.0012312074,"threshold_uncertainty_score":0.99989545},"labels":[],"label_agreement":null},{"id":"W2909090268","doi":"10.1111/bjd.17624","title":"Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"LEO Pharma; Sun Pharma; National Institute for Health and Care Research; Celgene; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Adverse effect; Dermatology Life Quality Index; Randomized controlled trial; Plaque psoriasis; Physical therapy; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","score_opus":0.011956762107803524,"score_gpt":0.26709302827115905,"score_spread":0.25513626616335555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909090268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687555,0.016013531,0.0016079086,0.001733431,0.0103305625,0.00037752345,0.00015978939,0.00005299606,0.0009688034],"genre_scores_gemma":[0.9977875,0.0004034245,0.0010136956,0.00017645016,0.00019272324,0.000028047798,0.000049779766,0.000034675224,0.0003136993],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99794674,0.00035636194,0.0007811451,0.00027813777,0.000068718444,0.00056887657],"domain_scores_gemma":[0.99750316,0.0016406999,0.00033248117,0.00019343701,0.00026386592,0.00006638309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021614115,0.00022546708,0.00083971885,0.00018356522,0.00016826969,0.000044645723,0.000369564,0.0005116935,0.0008431372],"category_scores_gemma":[0.0006043796,0.00023946117,0.00040410092,0.000106059575,0.00018876289,0.00023041494,0.00005280382,0.0003800762,0.00035643025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020704163,0.0042251097,0.04934589,0.0009665553,0.007895562,0.011797638,0.0023101124,0.000024450783,0.04132341,0.023333834,0.4507653,0.38730794],"study_design_scores_gemma":[0.035236944,0.0017656416,0.014004141,0.00055507396,0.0011700072,0.5604632,0.0010376389,0.000016741216,0.04531488,0.0016166535,0.33790138,0.00091769616],"about_ca_topic_score_codex":0.000026387868,"about_ca_topic_score_gemma":0.000022895283,"teacher_disagreement_score":0.5486656,"about_ca_system_score_codex":0.000043136723,"about_ca_system_score_gemma":0.00021727924,"threshold_uncertainty_score":0.97649425},"labels":[],"label_agreement":null},{"id":"W2909378861","doi":"10.1111/bjd.16952","title":"Pyoderma gangrenosum and systemic treatment","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pyoderma gangrenosum; Regimen; Quality of life (healthcare); Systemic therapy; Intensive care medicine; Dermatology; Disease; Surgery; Internal medicine; Cancer","score_opus":0.009232885061978497,"score_gpt":0.24759179167958095,"score_spread":0.23835890661760245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909378861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818974,0.014789863,0.00015279626,0.0009996139,0.00023899775,0.000100618534,0.0000017154133,0.000015543232,0.0018034664],"genre_scores_gemma":[0.9966672,0.002432902,0.00017841463,0.00034875955,0.00014316455,0.0000018341015,0.0000017184914,0.000013280791,0.00021273356],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9991455,0.0000546879,0.0004371925,0.00008859125,0.000097548334,0.00017648649],"domain_scores_gemma":[0.9994017,0.000024900406,0.00021361951,0.00008811237,0.00016975706,0.000101908205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005332164,0.00008978198,0.000426772,0.00009312375,0.00008031895,0.00001939034,0.00005242938,0.00009100273,0.00009375314],"category_scores_gemma":[0.000043379765,0.00008532742,0.00008369128,0.00005454165,0.00020236663,0.00009993531,0.000015775602,0.00011104606,0.000029652041],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010543038,0.0008143232,0.31495327,0.0005137681,0.0015158537,0.062359054,0.0029646435,9.56518e-7,0.012537373,0.0006110678,0.051663317,0.5510121],"study_design_scores_gemma":[0.004363801,0.0006622047,0.045560405,0.00045957323,0.000176079,0.9151027,0.0005649067,0.00003619513,0.0034006813,0.00010608145,0.029459136,0.000108191874],"about_ca_topic_score_codex":0.000021876946,"about_ca_topic_score_gemma":0.000014111067,"teacher_disagreement_score":0.8527437,"about_ca_system_score_codex":0.000034091252,"about_ca_system_score_gemma":0.00013117866,"threshold_uncertainty_score":0.3479551},"labels":[],"label_agreement":null},{"id":"W2911434758","doi":"10.1111/bjd.17628","title":"Efficacy and safety of mirikizumab ( <scp>LY</scp> 3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase <scp>II</scp> study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Internal medicine; Clinical endpoint; Gastroenterology; Plaque psoriasis; Randomized controlled trial; Surgery; Immunology; Pathology","score_opus":0.013537018109192079,"score_gpt":0.251430133745222,"score_spread":0.2378931156360299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911434758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792091,0.017205518,0.000028023202,0.00019746466,0.0006398617,0.0018327411,0.0005234356,0.0000130706,0.00035078972],"genre_scores_gemma":[0.9946442,0.0046430756,0.00015791714,0.000059445803,0.000048999063,0.00005378628,0.00011687289,0.00002645228,0.000249236],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99469054,0.0023709037,0.0018876105,0.00043122718,0.00014254756,0.000477151],"domain_scores_gemma":[0.99280554,0.0053863777,0.0011241175,0.0003952149,0.00021547299,0.0000732663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007090449,0.00038173754,0.0023539402,0.00033981728,0.00016223585,0.000027844311,0.00043333767,0.00039688117,0.000018629362],"category_scores_gemma":[0.0008035417,0.00029702144,0.00036894652,0.00026708425,0.00024058142,0.00014508018,0.000072609364,0.00030661147,0.000023807985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53257644,0.06019588,0.022063607,0.00019681727,0.025723107,0.010170646,0.17076594,0.0004015397,0.031777386,0.00035907564,0.015244441,0.13052513],"study_design_scores_gemma":[0.8994484,0.0049806386,0.027098289,0.00044505682,0.0017362987,0.015664404,0.009681265,0.000016884056,0.035350006,0.00026721694,0.0051639373,0.00014759971],"about_ca_topic_score_codex":0.00053753,"about_ca_topic_score_gemma":0.00029313835,"teacher_disagreement_score":0.36687198,"about_ca_system_score_codex":0.000058233065,"about_ca_system_score_gemma":0.00018731217,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W2914540870","doi":"10.1111/bjd.17397","title":"<i> <scp>BJD</scp> </i> Medical Student Editors: reaching out to undergraduates in a rapidly evolving world of digital dermatology publishing","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cardiff University; University of Birmingham","keywords":"Publishing; Dermatology; Medical education; Medicine; Art; Literature","score_opus":0.012374547424337837,"score_gpt":0.29027664196031044,"score_spread":0.2779020945359726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914540870","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013096325,0.044693746,0.0005438893,0.014274159,0.9073774,0.001016544,0.00011341256,0.00009483056,0.018789645],"genre_scores_gemma":[0.15122737,0.007877761,0.0010861859,0.009000285,0.82724386,0.00008114195,0.00056607043,0.00047449404,0.0024428],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.989387,0.00073477725,0.0043711876,0.0008498769,0.0033214202,0.0013357858],"domain_scores_gemma":[0.9852483,0.008560873,0.002665098,0.00062464183,0.0018757656,0.0010253008],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013999726,0.00078517525,0.0051502367,0.0022608805,0.00015900366,0.00023253834,0.0014536168,0.0022948883,0.000029482746],"category_scores_gemma":[0.036193665,0.0008372503,0.00069601904,0.0007436657,0.0006875865,0.0011023266,0.00071860186,0.006723899,0.00005239381],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001235614,0.00057557167,0.017934615,0.0010809524,0.0008582299,0.04406863,0.0012094271,0.000001762112,0.0000133962485,0.000015097397,0.93284523,0.0012734933],"study_design_scores_gemma":[0.007737232,0.0003635761,0.00057313364,0.008189008,0.0005551653,0.07101752,0.0022535713,0.000018333229,0.000048307167,0.00012006773,0.90881217,0.00031192068],"about_ca_topic_score_codex":0.00010393587,"about_ca_topic_score_gemma":0.00056401547,"teacher_disagreement_score":0.13813105,"about_ca_system_score_codex":0.00065325364,"about_ca_system_score_gemma":0.0037066676,"threshold_uncertainty_score":0.9994078},"labels":[],"label_agreement":null},{"id":"W2914630598","doi":"10.1111/bjd.17738","title":"Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta‐analysis","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Psoriasis; Discontinuation; Meta-analysis; Persistence (discontinuity); Medicine; Drug; Systematic review; Intensive care medicine; Internal medicine; MEDLINE; Pharmacology; Immunology; Biology","score_opus":0.07836011503659017,"score_gpt":0.296998066237931,"score_spread":0.21863795120134083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914630598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009266502,0.9975627,0.0000042061956,0.000024399902,0.0002563237,0.00096798746,0.00021637164,0.000010000752,0.000031371037],"genre_scores_gemma":[0.0076394756,0.9920146,0.000027536465,0.000029469482,0.0000074357476,0.00005568591,0.00009065371,0.000022655795,0.00011249399],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938197,0.0026531883,0.0027011214,0.0003779119,0.000076498975,0.00037159392],"domain_scores_gemma":[0.9947289,0.0012184462,0.0035172973,0.00031578247,0.00017603984,0.00004350377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007164457,0.0004944428,0.013689699,0.00079664245,0.000065884895,0.000017442031,0.00054207264,0.0007280378,0.00014559453],"category_scores_gemma":[0.00042854922,0.00035580905,0.0031942711,0.0007283466,0.00017932912,0.0001119657,0.000104307925,0.0005689331,0.0000142980625],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001048776,0.00014719465,0.0007349885,0.70105696,0.29088402,0.0002818056,0.00018042553,2.3388364e-7,9.586473e-7,0.000011344893,0.00006875314,0.00662282],"study_design_scores_gemma":[0.0004922209,0.00008314505,0.000081017824,0.07118052,0.9044533,0.021513477,0.0002270347,9.121807e-8,0.000006626635,0.0000042728125,0.001665422,0.0002929129],"about_ca_topic_score_codex":0.00005693832,"about_ca_topic_score_gemma":0.00005094205,"teacher_disagreement_score":0.62987643,"about_ca_system_score_codex":0.00005114776,"about_ca_system_score_gemma":0.0002081802,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W2920674058","doi":"10.1111/bjd.17853","title":"Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Atopic dermatitis; Medicine; Environmental health; Dermatology","score_opus":0.0449560202204928,"score_gpt":0.3308570608658106,"score_spread":0.28590104064531785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920674058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1296374,0.8689774,0.000012342065,0.000032373468,0.00023650701,0.00036215375,0.0005876571,0.000016877188,0.0001372519],"genre_scores_gemma":[0.24457173,0.7552023,0.000030309726,0.000032124623,0.000019141398,0.000006681872,0.00009742505,0.000029637942,0.000010657137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722064,0.00055068044,0.0013915737,0.0002295077,0.0002748644,0.00033276],"domain_scores_gemma":[0.9957169,0.0015943638,0.0020029123,0.00022324531,0.00021379298,0.0002487268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009202182,0.0004083242,0.003587856,0.00037973523,0.00009527205,0.000030697192,0.0002156815,0.00055671856,0.00014689086],"category_scores_gemma":[0.0012504137,0.00032133955,0.000962152,0.00014320182,0.0002767368,0.00010441622,0.00005793459,0.0009449003,0.000013763974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007494733,0.0021526513,0.6835649,0.07282173,0.0075947735,0.012170977,0.00016034914,0.0000027405417,3.853866e-7,0.0001357153,0.02058592,0.20073493],"study_design_scores_gemma":[0.002547397,0.00044221204,0.5731322,0.09642658,0.0143449325,0.3051633,0.000041211373,0.000015140185,0.000017892115,0.0007875478,0.0065676793,0.0005139349],"about_ca_topic_score_codex":0.000018355193,"about_ca_topic_score_gemma":0.0000048692436,"teacher_disagreement_score":0.2929923,"about_ca_system_score_codex":0.000081833736,"about_ca_system_score_gemma":0.00037852785,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W2924174256","doi":"10.1111/bjd.17929","title":"Regardless of how risks are framed, patients seem hesitant to use topical steroids for atopic dermatitis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.2573558088244633,"score_gpt":0.37580356111300917,"score_spread":0.11844775228854587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924174256","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2793091,0.002623148,0.009336407,0.7016136,0.003156702,0.0013475537,0.0025295245,0.000014558816,0.00006941376],"genre_scores_gemma":[0.26804832,0.0005275374,0.007740151,0.72036755,0.0019979905,0.000090690926,0.00022335805,0.00013844275,0.0008659766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926016,0.0006034776,0.0054676966,0.00049482967,0.00021725553,0.00061517867],"domain_scores_gemma":[0.98900396,0.0018114533,0.007916707,0.0004915275,0.00059660524,0.00017973052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016101497,0.00032108693,0.0031219039,0.0005803169,0.00011459739,0.00021012942,0.0006884636,0.0011227702,0.00008550333],"category_scores_gemma":[0.0048583,0.0004532873,0.0005058287,0.00011509779,0.00009018067,0.00054614275,0.00009823828,0.0011209435,0.00012702968],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012891661,0.00006297024,0.13852829,0.001402453,0.00020291016,0.0002073769,0.00019169212,0.0000036490142,9.418739e-8,0.00028023348,0.85870075,0.00040668136],"study_design_scores_gemma":[0.0024831502,0.00025027248,0.13568713,0.0014341215,0.000053582426,0.0030321558,0.00015302308,0.00008063258,0.000009357752,0.0014168469,0.85487,0.0005296879],"about_ca_topic_score_codex":0.00029802613,"about_ca_topic_score_gemma":0.00014751332,"teacher_disagreement_score":0.018753957,"about_ca_system_score_codex":0.00045546485,"about_ca_system_score_gemma":0.0002147835,"threshold_uncertainty_score":0.99979186},"labels":[],"label_agreement":null},{"id":"W2924781650","doi":"10.1111/bjd.17919","title":"Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"LEO Pharma; Eli Lilly and Company; AstraZeneca; Galderma; Medac; AbbVie; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Celgene; Biogen; Gilead Sciences; Amgen; Pfizer","keywords":"Adalimumab; Medicine; Placebo; Dosing; Adverse effect; Hidradenitis suppurativa; Randomized controlled trial; Post-hoc analysis; Internal medicine; Clinical trial; Post hoc; Tumor necrosis factor alpha","score_opus":0.025221703626630166,"score_gpt":0.3089418987806154,"score_spread":0.2837201951539852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924781650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96962076,0.0021648705,0.0008781598,0.021437794,0.00069521135,0.003905919,0.0004223171,0.000035213867,0.00083976757],"genre_scores_gemma":[0.99792576,0.00045519738,0.00032506758,0.000112748145,0.00020452587,0.00008797134,0.0003930985,0.000044980956,0.00045063673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9910622,0.0035845754,0.0037133507,0.0004445044,0.00062084745,0.00057451753],"domain_scores_gemma":[0.9915894,0.005880967,0.0013925913,0.0003334387,0.0004554205,0.00034816956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003073488,0.00043879275,0.0054267733,0.00050586107,0.00014728695,0.0002281839,0.0003315457,0.0003629384,0.00087623345],"category_scores_gemma":[0.0033987472,0.00030247506,0.00090007775,0.0005862533,0.0001831897,0.00045494866,0.000050116254,0.000988548,0.000060288417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.770777,0.00077908585,0.00080186396,0.00001587377,0.0042126714,0.21352802,0.001855145,0.000043358934,0.0010897804,0.000042475283,0.0019799746,0.0048747845],"study_design_scores_gemma":[0.66097575,0.00027822453,0.00041064265,0.0006924109,0.0016217333,0.33263105,0.00078629004,0.0010817919,0.0010408093,0.00020739113,0.000058480982,0.00021543376],"about_ca_topic_score_codex":0.0008304046,"about_ca_topic_score_gemma":0.0005873971,"teacher_disagreement_score":0.11910303,"about_ca_system_score_codex":0.00017417695,"about_ca_system_score_gemma":0.00072217657,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W2925250388","doi":"10.1111/bjd.17918","title":"Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Merck","keywords":"Medicine; Pharmacokinetics; Immunogenicity; Monoclonal; Interleukin 23; Monoclonal antibody; Clinical trial; Internal medicine; Pharmacology; Antibody; Interleukin 17; Immunology; Cytokine","score_opus":0.00609147270162685,"score_gpt":0.2360848474658084,"score_spread":0.22999337476418155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925250388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874614,0.01073233,0.000011372812,0.00023506631,0.00085712055,0.00028479833,0.000030338777,0.0000023492817,0.00038521056],"genre_scores_gemma":[0.9979702,0.001849488,0.000032725296,0.00005434215,0.000010562906,0.0000018319744,0.0000029771636,0.000008053072,0.00006981049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847555,0.00062303833,0.00058077025,0.000099100405,0.00006726242,0.0001542882],"domain_scores_gemma":[0.99791753,0.0009979927,0.0007462967,0.00019340293,0.00013162398,0.000013125106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019408541,0.00011244899,0.00053230196,0.000057213034,0.00006388623,0.0000033935576,0.0003096072,0.00013448279,0.00010813972],"category_scores_gemma":[0.000116534924,0.0000748765,0.00018838035,0.00008754424,0.00029104497,0.00003109642,0.00008287252,0.00024943563,0.000003288524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013063992,0.0010168614,0.08375239,0.00031049663,0.0026807024,0.0001051696,0.00032091668,0.000013573941,0.8623073,0.0013316921,0.001470123,0.04538434],"study_design_scores_gemma":[0.006321726,0.00037673957,0.4802816,0.00038922715,0.0003314404,0.005853846,0.0000476948,0.0000014729973,0.50557154,0.00004707325,0.0007096906,0.00006796733],"about_ca_topic_score_codex":0.000026155281,"about_ca_topic_score_gemma":0.0000040337636,"teacher_disagreement_score":0.3965292,"about_ca_system_score_codex":0.000015072624,"about_ca_system_score_gemma":0.000094258954,"threshold_uncertainty_score":0.30533752},"labels":[],"label_agreement":null},{"id":"W2926521451","doi":"10.1111/bjd.17935","title":"Pain perception in patients with hidradenitis suppurativa","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"InflaRx; LEO Pharma; Galderma; Cilag; Region Sjælland; Pfizer; Coloplast; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Sanofi","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Perception; MEDLINE; Psychology; Internal medicine; Neuroscience; Disease; Biology","score_opus":0.0037115843970377334,"score_gpt":0.2085867444786881,"score_spread":0.20487516008165038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2926521451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945647,0.00015425248,0.000069698224,0.00406749,0.00012152881,0.00030148,0.000007395943,0.0000094877905,0.00070392614],"genre_scores_gemma":[0.99910426,0.00005329971,0.00055901875,0.00003695295,0.000033775214,0.0000034410537,0.00003920742,0.000020715086,0.00014931367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986358,0.00024175593,0.00045992478,0.00013888496,0.0002810108,0.00024257158],"domain_scores_gemma":[0.9993178,0.00007540082,0.0001958328,0.000097114076,0.0001931237,0.0001206858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000010195051,0.00012331943,0.00049297535,0.00019867027,0.000032537755,0.000025142966,0.000073702264,0.000110805326,0.0006796823],"category_scores_gemma":[0.00007223466,0.00011221392,0.00007931729,0.00015524484,0.000059807615,0.00030930675,0.000012617258,0.00032193793,0.00007641143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031905493,0.00040177483,0.8764825,0.00003120649,0.000057965746,0.10643352,0.00018302348,1.0989846e-7,0.000072559764,0.0000061935634,0.0004485833,0.01556353],"study_design_scores_gemma":[0.006352188,0.00060767785,0.5322638,0.0003380279,0.000030028395,0.45993185,0.00018004638,0.000008385559,0.000035136414,0.000023809805,0.00015540939,0.00007362356],"about_ca_topic_score_codex":0.000034061784,"about_ca_topic_score_gemma":0.000044871176,"teacher_disagreement_score":0.35349834,"about_ca_system_score_codex":0.00009438421,"about_ca_system_score_gemma":0.00010354297,"threshold_uncertainty_score":0.74420446},"labels":[],"label_agreement":null},{"id":"W2928021446","doi":"10.1111/bjd.17927","title":"Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross‐sectional study among 2465 patients","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York Central Hospital","funders":"LEO Pharma; Cilag; Galderma; Regeneron Pharmaceuticals; Sanofi","keywords":"Hidradenitis suppurativa; Medicine; Acne; Dermatology; Cross-sectional study; Disease; Internal medicine; Pathology","score_opus":0.009877143291401335,"score_gpt":0.27083539868066986,"score_spread":0.26095825538926853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928021446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976517,0.00020228169,0.00021842646,0.0004026632,0.00062873797,0.0006197268,0.00007852637,0.000019919356,0.0001780197],"genre_scores_gemma":[0.99940836,0.000032935917,0.00008592041,0.000014064475,0.000097698954,0.000009171476,0.0001727493,0.000034979952,0.0001441344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732953,0.000350051,0.0011084295,0.00028320146,0.00063047843,0.00029832104],"domain_scores_gemma":[0.9980059,0.00007773753,0.00061428826,0.00019664723,0.0007296913,0.00037573202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000138168625,0.00021286904,0.0006830908,0.00027766213,0.000117963194,0.00007374775,0.0001809907,0.00014382157,0.000522188],"category_scores_gemma":[0.00017116759,0.0002224316,0.00019340533,0.00021392973,0.0002405232,0.00084451586,0.000060593004,0.00035333168,0.000027814047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008104433,0.0029505221,0.8999136,0.00006833555,0.00028272512,0.09434981,0.0004425328,0.000004165247,0.000037014925,0.000011401833,0.00026444046,0.00086498604],"study_design_scores_gemma":[0.0077432594,0.0015134615,0.70644844,0.00018226575,0.00014248492,0.28321216,0.00022996953,0.00015102093,0.00016713388,0.00004883867,0.000037618713,0.00012335225],"about_ca_topic_score_codex":0.00019344068,"about_ca_topic_score_gemma":0.00016440297,"teacher_disagreement_score":0.19346519,"about_ca_system_score_codex":0.00013489669,"about_ca_system_score_gemma":0.00025575462,"threshold_uncertainty_score":0.9070497},"labels":[],"label_agreement":null},{"id":"W2932169608","doi":"10.1111/bjd.17932","title":"The oral Janus kinase/spleen tyrosine kinase inhibitor<scp>ASN</scp>002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Asana Biosciences","keywords":"Placebo; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Gastroenterology; Internal medicine; Adverse effect; Biomarker; Randomized controlled trial; Systemic inflammation; Pharmacokinetics; Inflammation; Immunology; Pharmacology; Pathology","score_opus":0.006940791390641539,"score_gpt":0.2301773568234335,"score_spread":0.22323656543279194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932169608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909032,0.0031575116,0.000017108941,0.0006204333,0.00029854744,0.004809703,0.00004737097,0.000034864617,0.0001112754],"genre_scores_gemma":[0.9992405,0.00017944127,0.00007068274,0.000154045,0.000057011417,0.00011051467,0.000093496106,0.00003372862,0.000060562932],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99531317,0.0013560534,0.0019682047,0.00037936916,0.00048607588,0.00049710396],"domain_scores_gemma":[0.9950382,0.002569335,0.0012146414,0.00026424747,0.0006324021,0.00028116212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007589912,0.0003564282,0.0022049034,0.00030775677,0.00022896349,0.00022651623,0.00022680833,0.000294738,0.0000050024687],"category_scores_gemma":[0.002564792,0.00026717014,0.00016449003,0.00028759902,0.00021409865,0.000392846,0.00007925205,0.000609555,0.000013179203],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4822978,0.0015030329,0.5044115,0.0001279551,0.0021562437,0.0043133083,0.0014915231,0.0001414769,0.00014012495,0.000015678588,0.0018881295,0.0015131716],"study_design_scores_gemma":[0.685864,0.000337369,0.30621633,0.0012330374,0.00064878375,0.003911423,0.0007464208,0.00052095024,0.00029890885,0.00006779724,0.000014486473,0.0001405219],"about_ca_topic_score_codex":0.00015271919,"about_ca_topic_score_gemma":0.00033420484,"teacher_disagreement_score":0.20356615,"about_ca_system_score_codex":0.0000874065,"about_ca_system_score_gemma":0.00027659,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W2933704068","doi":"10.1111/bjd.17941","title":"Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Quality-adjusted life year; Population; Health Utilities Index; SF-36; Gerontology; Demography; Physical therapy; Health related quality of life; Cost effectiveness; Internal medicine; Environmental health; Disease","score_opus":0.01913976649523259,"score_gpt":0.31173505991366884,"score_spread":0.29259529341843626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933704068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503923,0.00931255,0.00003144301,0.0039935885,0.00007012705,0.00029040163,0.000043300246,0.00000551147,0.0012138649],"genre_scores_gemma":[0.9972697,0.0021431225,0.00023024365,0.00021508957,0.000012571567,0.0000016738596,0.000007947152,0.0000163193,0.00010332249],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99785453,0.0002449069,0.0013615082,0.00014752087,0.00016506275,0.00022645759],"domain_scores_gemma":[0.9980503,0.00029495073,0.0009218657,0.00017892584,0.00033023785,0.0002237612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022488921,0.000093349096,0.0010096205,0.00018093197,0.000038945367,0.00000899013,0.00013070286,0.0001195991,0.00019291311],"category_scores_gemma":[0.00023348811,0.00010693131,0.00013620751,0.000094932766,0.0002222209,0.000057621444,0.000046418303,0.00016043322,0.000014648126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009918099,0.0008432442,0.96159667,0.0010943521,0.00036824268,0.0006515596,0.0005102694,0.000021981654,0.008296774,0.0006583564,0.0029613008,0.02200543],"study_design_scores_gemma":[0.0091638295,0.0007170082,0.30088454,0.00023505816,0.000040059018,0.68419456,0.00063728285,0.00016544863,0.002542829,0.00087570597,0.0003949239,0.0001487428],"about_ca_topic_score_codex":0.0006969078,"about_ca_topic_score_gemma":0.00019452353,"teacher_disagreement_score":0.683543,"about_ca_system_score_codex":0.000095815274,"about_ca_system_score_gemma":0.0011220948,"threshold_uncertainty_score":0.43605322},"labels":[],"label_agreement":null},{"id":"W2936420507","doi":"10.1111/bjd.18005","title":"Development of a new patient‐reported outcome measure to evaluate treatments for acne and acne scarring: the <scp>ACNE</scp> ‐Q","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Plastic Surgery Foundation","keywords":"Acne; Dermatology; Medicine; Measure (data warehouse); Patient-reported outcome; Computer science; Quality of life (healthcare); Data mining","score_opus":0.04120438314623499,"score_gpt":0.3063394034541947,"score_spread":0.2651350203079597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936420507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994744,0.0029069178,0.0002443527,0.00070682046,0.00029422806,0.0008806127,0.000006270594,0.000008701763,0.0002081029],"genre_scores_gemma":[0.99445534,0.00011927409,0.0042436314,0.00042497483,0.000049950257,0.000017234808,0.000008839248,0.000023734341,0.0006570083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828035,0.00006220413,0.0008251421,0.00018726203,0.00033309477,0.0003119648],"domain_scores_gemma":[0.9986502,0.00014364056,0.00049392035,0.00015766811,0.00028504367,0.00026953995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022469663,0.00017957864,0.00074036827,0.00011213964,0.00012111281,0.00002516519,0.00009912991,0.000116828574,0.000016565264],"category_scores_gemma":[0.00027147066,0.00012339522,0.00016456035,0.00011534367,0.000037247388,0.00008614201,0.000055086966,0.0001457165,0.000008349774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000585209,0.0009642801,0.61058897,0.00036946253,0.0049637104,0.0033256824,0.006644029,0.000015308091,0.009157812,0.000019162455,0.017286198,0.34608015],"study_design_scores_gemma":[0.034191366,0.0030345945,0.71180314,0.0022781233,0.002952662,0.16286106,0.002791851,0.000078121026,0.03563035,0.0001737981,0.0439546,0.00025032574],"about_ca_topic_score_codex":0.000026291285,"about_ca_topic_score_gemma":0.000019542083,"teacher_disagreement_score":0.3458298,"about_ca_system_score_codex":0.00005793559,"about_ca_system_score_gemma":0.0003137715,"threshold_uncertainty_score":0.5031911},"labels":[],"label_agreement":null},{"id":"W2940378003","doi":"10.1111/bjd.18008","title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Versus Arthritis; Medical Research Scotland; Alopecia UK; AstraZeneca","keywords":"Alopecia areata; Medicine; Immune dysregulation; Hospital Anxiety and Depression Scale; Depression (economics); Alopecia universalis; Immunology; Pathogenesis; Cytokine; Anxiety; Internal medicine; Cohort; Immune system; Psychiatry","score_opus":0.014190539026619573,"score_gpt":0.28469670553236553,"score_spread":0.27050616650574594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940378003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891803,0.00635478,0.000023903278,0.003326317,0.00039618125,0.0004385866,0.00011619039,0.000020263593,0.00014346935],"genre_scores_gemma":[0.9966786,0.0011031383,0.000025376545,0.001701101,0.000056199147,0.00000619672,0.00017260657,0.000015781827,0.00024103864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983293,0.00026013065,0.0006432264,0.0002540191,0.00020825012,0.0003050998],"domain_scores_gemma":[0.9986393,0.00011494647,0.0002888414,0.0001635774,0.0004744863,0.00031883843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017571461,0.00015565757,0.000810162,0.00014904607,0.00004603925,0.000034398166,0.00013688472,0.00025301758,0.00027967882],"category_scores_gemma":[0.00052714604,0.00015733574,0.00006627134,0.0003278654,0.000059713075,0.00014863293,0.000044518703,0.0003166818,0.00005799824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019783014,0.00032018553,0.9036861,0.0000943521,0.00010779925,0.004182688,0.000027349373,0.0000010179665,0.0012243561,0.000008935493,0.08760205,0.00076684996],"study_design_scores_gemma":[0.004584021,0.0001265056,0.9406024,0.00066024926,0.00012270112,0.04776199,0.000021850385,0.00004295176,0.00013780464,0.0000656068,0.00572012,0.00015377362],"about_ca_topic_score_codex":0.000011309479,"about_ca_topic_score_gemma":0.000020405849,"teacher_disagreement_score":0.08188193,"about_ca_system_score_codex":0.000057116613,"about_ca_system_score_gemma":0.00011151246,"threshold_uncertainty_score":0.64159656},"labels":[],"label_agreement":null},{"id":"W2942732521","doi":"10.1111/bjd.18096","title":"Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"U.S. Department of Veterans Affairs","keywords":"Dermatomyositis; Delphi; Dermatology; Medicine; Computer science; Delphi method; Process (computing); Artificial intelligence; Programming language","score_opus":0.022202479835067693,"score_gpt":0.3165257924529844,"score_spread":0.2943233126179167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942732521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97256416,0.0024574606,0.012724773,0.010028844,0.0008265147,0.00084691145,0.000015170813,0.000032606553,0.0005035541],"genre_scores_gemma":[0.99394244,0.00036592092,0.0033909704,0.0018714254,0.0002823053,0.00004616585,0.00001663885,0.00003892292,0.000045194804],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99795103,0.00013298362,0.0010152878,0.00019981193,0.00029673162,0.00040416306],"domain_scores_gemma":[0.9979368,0.00019424869,0.0006325138,0.0002154857,0.000900482,0.000120457895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033583614,0.00017831825,0.00064198277,0.00014516474,0.00023334763,0.000109833636,0.0002823754,0.00019263037,0.00009518881],"category_scores_gemma":[0.00016515261,0.00015302082,0.00025275684,0.00017065302,0.00012545007,0.00029629638,0.00003744371,0.00034246602,0.000040544415],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010409814,0.0017508727,0.21910714,0.017134707,0.0038449827,0.053750377,0.018828975,0.00006752782,0.039313685,0.056200236,0.29532295,0.28426874],"study_design_scores_gemma":[0.006384335,0.00018465791,0.06053938,0.0017140462,0.0002772237,0.86426955,0.0034435373,0.0018616403,0.017545464,0.002003996,0.04138451,0.00039162868],"about_ca_topic_score_codex":0.0000066578596,"about_ca_topic_score_gemma":0.0000074590885,"teacher_disagreement_score":0.8105192,"about_ca_system_score_codex":0.00008069739,"about_ca_system_score_gemma":0.0004376718,"threshold_uncertainty_score":0.62400085},"labels":[],"label_agreement":null},{"id":"W2944340031","doi":"10.1111/bjd.17992","title":"Sunscreen photoprotection and vitamin D status","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"Symrise; Galderma; L'Oreal USA","keywords":"Photoprotection; Sun exposure; Vitamin D and neurology; Vitamin; Sunlight; Medicine; Dermatology; Environmental health; Chemistry; Physics; Internal medicine; Optics; Biochemistry","score_opus":0.036576843923994226,"score_gpt":0.32316383523312575,"score_spread":0.2865869913091315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944340031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002546017,0.99767774,0.0004045248,0.00009783904,0.000505149,0.0005316063,0.000007824664,0.000016704162,0.000503989],"genre_scores_gemma":[0.0007886858,0.99832517,0.00034485292,0.000096344855,0.00019106378,0.000010439819,0.000008887995,0.000036644244,0.00019793166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984317,0.00019689325,0.00076971744,0.00017692163,0.00017421208,0.00025054894],"domain_scores_gemma":[0.9988217,0.00008976153,0.0007092592,0.000109836416,0.00010175972,0.00016771816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013119342,0.00018274412,0.0017450417,0.0003426705,0.000058890924,0.0000455694,0.00007056809,0.00033975806,0.00009533413],"category_scores_gemma":[0.00018192502,0.00017840219,0.00033228812,0.00015985494,0.000066430155,0.00008687347,0.00003590369,0.0010381306,0.000019360132],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018465795,0.000028298053,0.000046483616,0.0065262057,0.0001829358,0.003741543,0.00001293987,1.6501005e-8,0.0000046477066,0.0000049134683,0.0006538486,0.9887797],"study_design_scores_gemma":[0.00065044477,0.000062249484,0.000058973354,0.012282098,0.00048118248,0.45385504,0.000023362993,0.000001521571,0.000011866808,0.0000067388874,0.5324807,0.00008581324],"about_ca_topic_score_codex":0.000054390475,"about_ca_topic_score_gemma":0.0000051504862,"teacher_disagreement_score":0.9886939,"about_ca_system_score_codex":0.000057589346,"about_ca_system_score_gemma":0.00028885968,"threshold_uncertainty_score":0.727503},"labels":[],"label_agreement":null},{"id":"W2946933084","doi":"10.1111/bjd.18165","title":"Electron microscopy in the diagnosis of Ehlers–Danlos syndromes: correlation with clinical and genetic investigations","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"North-West University","keywords":"Ehlers–Danlos syndrome; Medicine; Pathology; Dermatology","score_opus":0.017423616335589493,"score_gpt":0.32275276986576057,"score_spread":0.3053291535301711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946933084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935275,0.0053662146,0.00025618498,0.0005816463,0.000036074554,0.00018518258,0.000003481702,7.345801e-7,0.000043005617],"genre_scores_gemma":[0.99722654,0.0022203773,0.00040570123,0.00009890665,0.000015667703,0.0000078740495,0.0000066403054,0.000007834988,0.000010460627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989657,0.00031878107,0.00034911247,0.00012314222,0.00010811398,0.00013515551],"domain_scores_gemma":[0.9994303,0.00012361354,0.00017469669,0.000103410515,0.00013067618,0.00003728668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017508943,0.000060444938,0.00019981591,0.0000648685,0.000022763174,0.000013756758,0.00015176559,0.000099833,0.0000112621165],"category_scores_gemma":[0.00024018927,0.000054283857,0.000042706415,0.00010910354,0.00023094095,0.0000070895576,0.000028330489,0.00021778222,0.0000017002228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006616119,0.000089016205,0.9905313,0.000023699942,0.000048570317,0.00014689432,0.00007853215,0.00002459702,0.006796629,0.000021036287,0.00046693953,0.001706584],"study_design_scores_gemma":[0.002114935,0.0008062457,0.9510629,0.00014575176,0.00003196825,0.031285603,0.00033061273,0.000062677915,0.012730702,0.0002483933,0.0010722183,0.00010797399],"about_ca_topic_score_codex":0.000036600333,"about_ca_topic_score_gemma":0.00024139548,"teacher_disagreement_score":0.03946842,"about_ca_system_score_codex":0.000004956827,"about_ca_system_score_gemma":0.00012304011,"threshold_uncertainty_score":0.22136314},"labels":[],"label_agreement":null},{"id":"W2948326073","doi":"10.1111/bjd.17946","title":"Anti‐GM‐CSF therapy in psoriasis","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Medicine; Itching; Disease; Rheumatoid arthritis; Placebo; Inflammation; Internal medicine; Dermatology; Psoriatic arthritis; Immunology; Pathology; Alternative medicine","score_opus":0.011001263949879712,"score_gpt":0.22774501016155635,"score_spread":0.21674374621167664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948326073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97182447,0.024270268,0.000011952936,0.00039315884,0.001984919,0.00013459912,0.000011885113,0.000014437901,0.0013543201],"genre_scores_gemma":[0.99368,0.005529416,0.0000838966,0.00019840094,0.000046221023,0.0000039147008,0.000014439548,0.000016604621,0.00042709283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984924,0.0003675697,0.0005736622,0.00017151098,0.000044020802,0.00035081455],"domain_scores_gemma":[0.99927425,0.0001518668,0.0002976233,0.00014214678,0.00010643512,0.000027648131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001742873,0.00014668555,0.00063593313,0.00023271375,0.00005593661,0.000020778944,0.00027154913,0.00030771687,0.0010060803],"category_scores_gemma":[0.00004532029,0.00014819943,0.00018566225,0.00016650178,0.00007763917,0.0001779219,0.000029544255,0.00031606978,0.0004800055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007251212,0.0007510657,0.5073131,0.000025060606,0.0008161209,0.005154478,0.0004427024,0.000006915777,0.05332314,0.00027410925,0.009854951,0.4213133],"study_design_scores_gemma":[0.022575922,0.00054916233,0.58450097,0.0002808635,0.00010654752,0.21956286,0.0004399014,0.000001637977,0.09797735,0.0005285104,0.07297987,0.0004964086],"about_ca_topic_score_codex":0.00008459769,"about_ca_topic_score_gemma":0.00005592668,"teacher_disagreement_score":0.4208169,"about_ca_system_score_codex":0.000028324748,"about_ca_system_score_gemma":0.00010423059,"threshold_uncertainty_score":0.99990714},"labels":[],"label_agreement":null},{"id":"W2948733093","doi":"10.1111/bjd.17916","title":"How does the International League of Dermatological Societies promote skin health for the world?","year":2019,"lang":"en","type":"editorial","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"League; Dermatology; Dermatological diseases; Medicine; Political science","score_opus":0.015056354565532776,"score_gpt":0.2950096010108635,"score_spread":0.2799532464453307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948733093","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000762394,0.07212669,0.00084095536,0.23174635,0.6919247,0.0013519466,0.0002452017,0.00002487709,0.0009769173],"genre_scores_gemma":[0.02070254,0.06622885,0.0026921364,0.038243398,0.8482203,0.00025882226,0.0005124167,0.00026040585,0.022881163],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996452,0.00029951837,0.0014435431,0.0002997115,0.0010204513,0.00048482412],"domain_scores_gemma":[0.99172187,0.004018701,0.0024162238,0.00036123281,0.0013544861,0.00012747139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008131673,0.00033293708,0.0020807472,0.00022732234,0.00032724038,0.00005378651,0.00093754544,0.0006260885,0.000026322217],"category_scores_gemma":[0.0023351028,0.00018165635,0.0007750154,0.00014105185,0.0012113139,0.00009803687,0.00017498902,0.002079772,0.0000034613117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030298947,0.0001233641,0.0002969948,0.0007890358,0.001202599,0.0007037713,0.00029228983,4.8349295e-7,0.0000053010463,0.00006391019,0.99214303,0.004076254],"study_design_scores_gemma":[0.0031502098,0.0002086203,0.00015980277,0.0009881535,0.00047301542,0.030724937,0.0013658128,0.000024951087,0.00009912452,0.00015838642,0.96249586,0.00015114051],"about_ca_topic_score_codex":0.000016860704,"about_ca_topic_score_gemma":0.00013182077,"teacher_disagreement_score":0.19350295,"about_ca_system_score_codex":0.00016730928,"about_ca_system_score_gemma":0.0016324406,"threshold_uncertainty_score":0.90356904},"labels":[],"label_agreement":null},{"id":"W2952089805","doi":"10.1111/bjd.18220","title":"<scp>AURIEL</scp> ‐PsO: a randomized, double‐blind phase <scp>III</scp> equivalence trial to demonstrate the clinical similarity of the proposed biosimilar <scp>MSB</scp> 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Fresenius Kabi; Merck","keywords":"Biosimilar; Equivalence (formal languages); Medicine; Double blind; Similarity (geometry); Adalimumab; Mathematics; Computer science; Internal medicine; Artificial intelligence; Discrete mathematics; Disease; Pathology","score_opus":0.03661824537907298,"score_gpt":0.32251316386995915,"score_spread":0.28589491849088616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876345,0.0019893283,0.0005187858,0.0016659494,0.0021133586,0.004294319,0.00018222026,0.00002878109,0.00044382134],"genre_scores_gemma":[0.99546444,0.0005729523,0.0011899368,0.0021249123,0.00014395277,0.00005859232,0.000020787611,0.000056576228,0.0003678414],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9903391,0.0039749625,0.0029828178,0.00091636425,0.00047211966,0.0013146519],"domain_scores_gemma":[0.9908943,0.0052558426,0.0015539288,0.00084191316,0.0010975106,0.0003564671],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033470362,0.00064242026,0.002808069,0.0003741717,0.00035079703,0.00014230111,0.0018608348,0.0011767541,0.00006221641],"category_scores_gemma":[0.005390784,0.00042838368,0.0006344426,0.0011742311,0.001050786,0.00028217828,0.00057689537,0.002468423,0.000057895515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8164873,0.011305099,0.038081255,0.00055859674,0.0064002792,0.0011249566,0.0032451411,0.00071940967,0.013901809,0.0012911105,0.08654119,0.020343829],"study_design_scores_gemma":[0.91097915,0.0073959576,0.007944192,0.0012606705,0.0011012589,0.0038942015,0.0009032013,0.00009819673,0.05236165,0.00061542273,0.013165389,0.00028072632],"about_ca_topic_score_codex":0.000106385625,"about_ca_topic_score_gemma":0.0003441524,"teacher_disagreement_score":0.09449181,"about_ca_system_score_codex":0.00014491893,"about_ca_system_score_gemma":0.0012454287,"threshold_uncertainty_score":0.9998329},"labels":[],"label_agreement":null},{"id":"W2953512757","doi":"10.1111/bjd.18064","title":"Evidence‐based treatments for rosacea based on phenotype approach","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosacea; Medicine; Isotretinoin; Minocycline; Doxycycline; Dermatology; Ivermectin; Metronidazole; Acne; Antibiotics","score_opus":0.03568559269790506,"score_gpt":0.29206318542559967,"score_spread":0.2563775927276946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953512757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820994,0.0056135408,0.0059429025,0.0027384027,0.0005568748,0.0010817789,0.000021050735,0.000026623093,0.0019194287],"genre_scores_gemma":[0.9929682,0.00013493633,0.0047262027,0.0016624938,0.00010127339,0.000017235507,0.000028011418,0.00002417589,0.00033747958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989381,0.000078969,0.0003336349,0.00017679452,0.00020985481,0.0002626551],"domain_scores_gemma":[0.9990588,0.00025680725,0.00022341122,0.0001523906,0.00015864857,0.00014995426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011221413,0.0001448617,0.00056206493,0.00012276902,0.0000776739,0.000025331023,0.00008664307,0.00013826152,0.00010154592],"category_scores_gemma":[0.00010287818,0.000117779215,0.00026915985,0.000088962704,0.000038175294,0.000109228764,0.0000073542337,0.0001634475,0.000029966244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025241923,0.016018124,0.52133125,0.0027221162,0.0039723986,0.023780504,0.00033131262,0.0037834246,0.0052951635,0.0003501529,0.10597176,0.2912019],"study_design_scores_gemma":[0.2167146,0.03858003,0.34197345,0.021180594,0.008542727,0.14097854,0.00056734507,0.1581703,0.03876834,0.00049535744,0.031823132,0.002205577],"about_ca_topic_score_codex":0.000011899913,"about_ca_topic_score_gemma":9.299509e-7,"teacher_disagreement_score":0.2889963,"about_ca_system_score_codex":0.00006606375,"about_ca_system_score_gemma":0.00021369528,"threshold_uncertainty_score":0.4802897},"labels":[],"label_agreement":null},{"id":"W2953973901","doi":"10.1111/bjd.17863","title":"International and multidisciplinary scientific collaborations and networks are advancing knowledge about Stevens–Johnson syndrome and toxic epidermal necrolysis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council","keywords":"Toxic epidermal necrolysis; Carr; Multidisciplinary approach; Dermatology; Medicine; Sociology; Social science; Biology","score_opus":0.01379527853086929,"score_gpt":0.27243921820337413,"score_spread":0.2586439396725048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953973901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7175772,0.036760785,0.0006396699,0.23739025,0.005386158,0.0008164516,0.0002817373,0.000052703454,0.0010950164],"genre_scores_gemma":[0.9733052,0.008708821,0.0016207983,0.012632692,0.0015545954,0.00001851675,0.0002512462,0.00011386836,0.0017942477],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9977317,0.00021262172,0.00084480725,0.00047168296,0.00030072895,0.00043844918],"domain_scores_gemma":[0.9975918,0.00048157354,0.0008557945,0.00020563476,0.00065614504,0.00020906329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027142794,0.00029369097,0.0010841792,0.00074379507,0.00036976405,0.00026146809,0.0001474146,0.00065420166,0.000015744543],"category_scores_gemma":[0.00031725378,0.0003386759,0.00013443976,0.0002997211,0.00042817323,0.00047581425,0.00020250925,0.0019671915,0.0000071056484],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106413914,0.00061581936,0.047770392,0.0020767916,0.002955433,0.18780312,0.0010741894,0.00021425875,0.0011668364,0.000019659148,0.66308343,0.09311365],"study_design_scores_gemma":[0.0021918917,0.000038929924,0.07327078,0.002358031,0.0005783657,0.66498244,0.0004800451,0.0016954244,0.000014683741,0.000022455031,0.25405887,0.00030809562],"about_ca_topic_score_codex":0.00001724867,"about_ca_topic_score_gemma":0.00011298569,"teacher_disagreement_score":0.47717932,"about_ca_system_score_codex":0.00015371732,"about_ca_system_score_gemma":0.0003620679,"threshold_uncertainty_score":0.99990654},"labels":[],"label_agreement":null},{"id":"W2954357071","doi":"10.1111/bjd.18309","title":"Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Clinical trial; Translational research; Surgery; Pathology; Disease","score_opus":0.3585862039857243,"score_gpt":0.538722044539774,"score_spread":0.1801358405540497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954357071","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03514849,0.02739478,0.00004881499,0.93454486,0.0006374128,0.0016737655,0.0004911688,0.000010549584,0.00005015019],"genre_scores_gemma":[0.93373775,0.039440412,0.012450388,0.00861202,0.0022615262,0.00017860555,0.002352595,0.00015451584,0.00081216893],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9920781,0.0040438217,0.0023680853,0.00046427525,0.0005835503,0.00046215832],"domain_scores_gemma":[0.9828302,0.015286813,0.0007404141,0.00011854122,0.0008936831,0.00013034188],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00045996928,0.00029735395,0.002481321,0.000742576,0.00026567816,0.000091001115,0.000122082,0.00090119307,0.00010853919],"category_scores_gemma":[0.0055010677,0.00027463565,0.000337322,0.00020483023,0.00059256353,0.00024982734,0.000057919457,0.0027304932,0.000005946392],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007752781,0.00031078444,0.019658899,0.00071293814,0.0011842886,0.14060877,0.0005068718,2.8338032e-8,0.000020790007,0.00016003451,0.811215,0.024846327],"study_design_scores_gemma":[0.013419903,0.0008235391,0.009344993,0.0035414612,0.00044234854,0.8928055,0.00051141786,0.000034054,0.00004326564,0.0014910761,0.077278525,0.0002638736],"about_ca_topic_score_codex":0.000019540044,"about_ca_topic_score_gemma":0.00005662234,"teacher_disagreement_score":0.9259328,"about_ca_system_score_codex":0.00007239554,"about_ca_system_score_gemma":0.00092721573,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2956723919","doi":"10.1111/bjd.18335","title":"Hidradenitis Suppurativa Area and Severity Index ( <scp>HASI</scp> ): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences","keywords":"Hidradenitis suppurativa; Measure (data warehouse); Medicine; Index (typography); Content (measure theory); Severity of illness; Dermatology; Computer science; World Wide Web; Data mining; Pathology; Internal medicine; Mathematics; Disease","score_opus":0.03722694733378218,"score_gpt":0.26658319016762916,"score_spread":0.22935624283384698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956723919","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47180614,0.0003942816,0.0005502119,0.5219073,0.0006595111,0.003613761,0.0006635785,0.000040157414,0.00036505522],"genre_scores_gemma":[0.9924881,0.000091000096,0.0005775118,0.0047775838,0.0010156813,0.00013689513,0.00013479992,0.00016885638,0.0006095875],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9930178,0.0010023533,0.0020316632,0.0009129923,0.0018973851,0.0011378129],"domain_scores_gemma":[0.99440235,0.0014924901,0.00119974,0.00068455347,0.001647449,0.000573428],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000026133961,0.0010218568,0.0033117062,0.0007705694,0.00032534287,0.00025108398,0.0008536714,0.0005488822,0.00006664301],"category_scores_gemma":[0.001676836,0.0008717273,0.00035310708,0.0010883535,0.00041717637,0.00045667114,0.00046518425,0.0034451212,0.000057476303],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043994767,0.0037110138,0.03285272,0.00037880806,0.0024131741,0.691458,0.0078124697,3.473016e-7,0.0011780269,0.000008613984,0.25566775,0.00407914],"study_design_scores_gemma":[0.0074363155,0.0073997444,0.01637084,0.0016327631,0.0009861508,0.94549966,0.0025163565,0.000007986561,0.000840449,0.000062732564,0.016836049,0.0004109551],"about_ca_topic_score_codex":0.0003847784,"about_ca_topic_score_gemma":0.0002634935,"teacher_disagreement_score":0.520682,"about_ca_system_score_codex":0.00034633165,"about_ca_system_score_gemma":0.0014243622,"threshold_uncertainty_score":0.9993733},"labels":[],"label_agreement":null},{"id":"W2960529495","doi":"10.1111/bjd.18333","title":"Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, <scp>BADBIR</scp> )","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Manchester Biomedical Research Centre; NIHR Newcastle Biomedical Research Centre; Medical Research Council; National Institute for Health and Care Research; Psoriasis Association","keywords":"Interquartile range; Medicine; Psoriasis; Concordance; Psoriasis Area and Severity Index; Cohort; Internal medicine; Rank correlation; Severity of illness; Population; Dermatology; Statistics","score_opus":0.02617875109033765,"score_gpt":0.27468237432130155,"score_spread":0.2485036232309639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960529495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224025,0.0051467014,0.000061024435,0.00015044694,0.0011324761,0.0007294971,0.00042095833,0.000027054675,0.000091572554],"genre_scores_gemma":[0.9976956,0.00057036587,0.00094027043,0.00011268804,0.00002894433,0.000017205191,0.00041600005,0.000033475633,0.00018540572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958306,0.001413147,0.0015220811,0.00054340705,0.00016852286,0.00052224577],"domain_scores_gemma":[0.9958547,0.0017553328,0.0015205464,0.0005904673,0.0002207947,0.00005820206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088577386,0.0003139461,0.001548171,0.00037568307,0.00031126503,0.00013708048,0.00071880646,0.00042033187,0.00004904473],"category_scores_gemma":[0.00094680197,0.0003132027,0.00018449662,0.00047138592,0.00009338872,0.00032066117,0.000259993,0.00039184096,0.000023538329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009512416,0.0004400821,0.99212176,0.000016410097,0.0010316173,0.00047519573,0.00021156833,0.00004791536,0.0007103459,0.0000086824075,0.0007229969,0.0041183247],"study_design_scores_gemma":[0.005349056,0.00013221185,0.98824096,0.00016748237,0.0005750726,0.0034446588,0.00061726366,0.000057110672,0.0007559769,0.00009659952,0.00039915266,0.00016445757],"about_ca_topic_score_codex":0.01655088,"about_ca_topic_score_gemma":0.008559837,"teacher_disagreement_score":0.007991043,"about_ca_system_score_codex":0.00021165461,"about_ca_system_score_gemma":0.00015361568,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W2962832397","doi":"10.1111/bjd.18252","title":"Depression and anxiety in atopic dermatitis: increasing recognition and opportunities to intervene","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Anxiety; Depression (economics); Medicine; Dermatology; Psychology; Clinical psychology; Psychiatry","score_opus":0.032573844451728375,"score_gpt":0.2645143230528485,"score_spread":0.23194047860112013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962832397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78578746,0.025407843,0.000041738764,0.1877059,0.00032473743,0.00027484976,0.00005024415,0.000014752657,0.00039246175],"genre_scores_gemma":[0.667302,0.011439958,0.00037287647,0.32032746,0.00030551045,0.000010059226,0.00013088422,0.000034991423,0.00007627837],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9979868,0.00048475715,0.00079839723,0.00024260084,0.00018760358,0.0002998284],"domain_scores_gemma":[0.9988827,0.00028569612,0.0003837428,0.00012426444,0.0001734824,0.00015011933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017415032,0.00021634925,0.0009775516,0.000497019,0.00005447572,0.000061840154,0.00010278605,0.000692212,0.000062907406],"category_scores_gemma":[0.00033994843,0.00024226881,0.00010957933,0.000053478,0.0001577922,0.00022805478,0.00010593195,0.0013038297,0.000009012711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011835284,0.00005937605,0.16577354,0.0014135885,0.00013010246,0.076761305,0.00015807153,9.3318796e-8,0.000013213889,5.8821695e-7,0.6745345,0.08103729],"study_design_scores_gemma":[0.0021006935,0.000057838814,0.1585655,0.006978941,0.00022113313,0.7044782,0.00011985671,0.000007784211,0.00009935187,0.00028600454,0.12685476,0.00022994002],"about_ca_topic_score_codex":0.000074693984,"about_ca_topic_score_gemma":0.00003315246,"teacher_disagreement_score":0.6277169,"about_ca_system_score_codex":0.000040074745,"about_ca_system_score_gemma":0.00015632145,"threshold_uncertainty_score":0.98794353},"labels":[],"label_agreement":null},{"id":"W2967093367","doi":"10.1111/bjd.18420","title":"Recommendations for rosacea diagnosis, classification and management: update from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus 2019 panel","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Rosacea; Medicine; Dermatology","score_opus":0.025511764923736906,"score_gpt":0.28558465721288434,"score_spread":0.26007289228914743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967093367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97239166,0.011406003,0.00055442104,0.012180412,0.0008546359,0.0009511358,0.0004566949,0.000028485814,0.0011765589],"genre_scores_gemma":[0.96898204,0.02483948,0.002039271,0.002516731,0.00026034293,0.00005669597,0.00051353173,0.00003376472,0.00075811596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984918,0.00014682491,0.00053225266,0.00026729386,0.00019227008,0.00036953425],"domain_scores_gemma":[0.9980987,0.000898948,0.00044741365,0.00022291185,0.00015338905,0.00017868097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001848583,0.00019338948,0.0005102645,0.000062805855,0.00025458998,0.00011097095,0.0001732669,0.00018829739,0.000019636984],"category_scores_gemma":[0.00020862542,0.00015567572,0.0001748413,0.00013221437,0.00009804479,0.0001835607,0.00005742432,0.00024194008,0.00006685297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032288353,0.00033789713,0.29505944,0.00009872107,0.00079919794,0.0007298713,0.00017456053,0.000002752163,0.00006357171,0.00060942676,0.6742834,0.027808886],"study_design_scores_gemma":[0.0071237846,0.0002442274,0.45923802,0.00048749542,0.00080350763,0.015060833,0.0014922314,0.00018211508,0.00042822302,0.0010131135,0.513866,0.00006042887],"about_ca_topic_score_codex":0.0000614845,"about_ca_topic_score_gemma":0.000032249878,"teacher_disagreement_score":0.16417857,"about_ca_system_score_codex":0.0000652895,"about_ca_system_score_gemma":0.00005533688,"threshold_uncertainty_score":0.6348272},"labels":[],"label_agreement":null},{"id":"W2967936177","doi":"10.1111/bjd.18321","title":"How I learned to stop worrying about antidrug antibodies","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Antibody; Immunology","score_opus":0.033651841188627934,"score_gpt":0.31008294319086827,"score_spread":0.2764311020022403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967936177","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08179672,0.015804565,0.00013883218,0.8983232,0.0013934582,0.00042315293,0.00007599779,0.000027570717,0.0020165478],"genre_scores_gemma":[0.06837168,0.015828982,0.0028567829,0.8209816,0.00986525,0.0000112564585,0.0002489949,0.00023387549,0.08160157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962387,0.0003283183,0.00090438954,0.00044094867,0.0010981981,0.0009894398],"domain_scores_gemma":[0.9975358,0.00042857582,0.000616297,0.000326384,0.0008142346,0.00027869962],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00024369701,0.0004171025,0.0019797906,0.00072552933,0.00017111102,0.0002945241,0.0005932737,0.00087828195,0.00022872622],"category_scores_gemma":[0.0005647028,0.00040643648,0.000659743,0.00026499073,0.00025484987,0.00020592066,0.00023627754,0.004758425,0.00022671027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024334554,0.00005126966,0.0052103237,0.0008570867,0.00043284975,0.12100266,0.00009575558,8.417604e-7,0.00039946614,0.000009365577,0.8545161,0.01718092],"study_design_scores_gemma":[0.0009687094,0.0001986624,0.0034576033,0.001925632,0.00013191039,0.28373605,0.00006730954,0.0000063642083,0.0004267165,0.00004867984,0.7087504,0.00028194685],"about_ca_topic_score_codex":0.00011062494,"about_ca_topic_score_gemma":0.000014475536,"teacher_disagreement_score":0.16273339,"about_ca_system_score_codex":0.00008735541,"about_ca_system_score_gemma":0.0004841435,"threshold_uncertainty_score":0.99983877},"labels":[],"label_agreement":null},{"id":"W2969152870","doi":"10.1111/bjd.18323","title":"The pain of hidradenitis suppurativa: ‘We only see what we know’","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine; Disease","score_opus":0.012593371322565503,"score_gpt":0.2514064585942939,"score_spread":0.2388130872717284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969152870","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009412131,0.098123156,0.00005737286,0.8979635,0.0017301693,0.0005363482,0.00009277949,0.000019385416,0.0005360497],"genre_scores_gemma":[0.5005891,0.42356476,0.0008193395,0.047040157,0.005544407,0.000044549062,0.00057613273,0.00040107773,0.021420501],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99482507,0.0014217512,0.0017680179,0.0003560943,0.00088166987,0.0007474211],"domain_scores_gemma":[0.9947103,0.0022313427,0.0015867895,0.00048696995,0.00082409894,0.00016050092],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000035712346,0.00050234277,0.0020108703,0.0003412076,0.00021257497,0.00023614214,0.00059059536,0.0011512968,0.00044942074],"category_scores_gemma":[0.00062377803,0.00040735616,0.0008060057,0.00023251785,0.00052875996,0.00055963686,0.00009281888,0.0031529663,0.00014411786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006766397,0.00008371925,0.0005028184,0.00028902624,0.00060533796,0.41542476,0.00017484135,1.2027283e-8,0.00002309516,0.0000066410153,0.5047272,0.07809492],"study_design_scores_gemma":[0.0016908407,0.0003044112,0.00005294719,0.003954147,0.00032385622,0.53805715,0.00035431696,0.0000025802758,0.00016255694,0.0001892211,0.45474082,0.00016716952],"about_ca_topic_score_codex":0.000041717285,"about_ca_topic_score_gemma":0.000059714857,"teacher_disagreement_score":0.85092336,"about_ca_system_score_codex":0.00014912899,"about_ca_system_score_gemma":0.0009429408,"threshold_uncertainty_score":0.9998378},"labels":[],"label_agreement":null},{"id":"W2970810260","doi":"10.1111/bjd.18431","title":"Classifying primary paediatric cutaneous mucinoses","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dermatology; Primary (astronomy); Pediatrics","score_opus":0.01140086464533488,"score_gpt":0.2334006468511879,"score_spread":0.221999782205853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970810260","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13647091,0.18680409,0.000045905068,0.6586122,0.005780279,0.0007475173,0.00017015007,0.00010886763,0.01126006],"genre_scores_gemma":[0.09072476,0.008268125,0.0006883841,0.8888678,0.009797774,0.000005869385,0.00026565764,0.00015184177,0.0012297932],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9973984,0.00017527194,0.000994744,0.00028538267,0.00057056354,0.00057564204],"domain_scores_gemma":[0.9975631,0.00069671357,0.00092927436,0.00026885563,0.00037796123,0.00016404362],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00006873749,0.0002972573,0.0015079479,0.000441539,0.00006428422,0.00008070879,0.00030481096,0.00100287,0.00037279827],"category_scores_gemma":[0.00045272693,0.00031643547,0.0006915223,0.00016353105,0.00012355237,0.000110484,0.00008406379,0.002586537,0.00012185737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049329683,0.000064573454,0.016371632,0.0009237984,0.0002384009,0.22916472,0.000006821022,4.370609e-7,0.000015098607,8.222474e-7,0.74545306,0.007711311],"study_design_scores_gemma":[0.0013850027,0.00012755561,0.0045992774,0.00088734244,0.0007039798,0.54850495,0.000015633737,0.000003537711,0.000027426493,0.00006935652,0.44346344,0.00021252382],"about_ca_topic_score_codex":0.000013568249,"about_ca_topic_score_gemma":9.5094873e-7,"teacher_disagreement_score":0.3193402,"about_ca_system_score_codex":0.00012247195,"about_ca_system_score_gemma":0.00076631166,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2970820653","doi":"10.1111/bjd.18469","title":"Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double‐blind, vehicle‐controlled phase <scp>II</scp> a study","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"LEO Pharma; LEO Pharma Research Foundation","keywords":"Medicine; Discontinuation; Adverse effect; Randomized controlled trial; Confidence interval; Clinical endpoint; Internal medicine; Odds ratio; Statistical significance; Incidence (geometry); Clinical trial; Severity of illness; Surgery","score_opus":0.015410334198645768,"score_gpt":0.27861650333811117,"score_spread":0.2632061691394654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970820653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932884,0.003996686,0.0000789952,0.00024160705,0.00013269634,0.0020854278,0.000045729525,0.000006525048,0.00012393197],"genre_scores_gemma":[0.9991448,0.00045671058,0.00012300351,0.00008349172,0.00007300013,0.000013006622,0.00005949676,0.000018470095,0.000028004673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99747777,0.00030273013,0.0013195769,0.00026981314,0.00036268297,0.0002674557],"domain_scores_gemma":[0.9977428,0.0009070295,0.0006623871,0.0003158986,0.00022740086,0.00014453543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033704747,0.00018724464,0.0022123847,0.0001754731,0.00006862806,0.000051764313,0.00025305265,0.000119467215,0.000051369676],"category_scores_gemma":[0.00041106174,0.00015333478,0.000116576244,0.00011809983,0.00018298019,0.00026653396,0.00017607851,0.00042484901,0.0000027456977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5325446,0.0060831285,0.44149885,0.00015330715,0.002437268,0.004680969,0.0018932266,0.000008684886,0.00027301128,0.000027119444,0.00042787782,0.0099719325],"study_design_scores_gemma":[0.76498306,0.0011880168,0.22940315,0.00063289504,0.00040592722,0.002462459,0.00031625316,0.00026049672,0.00009952483,0.000013493767,0.00017285137,0.000061859326],"about_ca_topic_score_codex":0.00025349762,"about_ca_topic_score_gemma":0.00072868215,"teacher_disagreement_score":0.23243846,"about_ca_system_score_codex":0.00003732487,"about_ca_system_score_gemma":0.00020746191,"threshold_uncertainty_score":0.6252811},"labels":[],"label_agreement":null},{"id":"W2971816470","doi":"10.1111/bjd.18484","title":"Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Dosing; Etanercept; Medicine; Plaque psoriasis; Psoriasis; Pharmacology; Dermatology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.02410772837681473,"score_gpt":0.2871277570869232,"score_spread":0.26302002871010843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971816470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963687,0.034112222,0.00013698157,0.00019506115,0.0005623397,0.00048811964,0.0007757439,0.000013209724,0.000029303606],"genre_scores_gemma":[0.9910905,0.0076695555,0.0007811476,0.00003998368,0.000052056886,0.000012198889,0.0002502358,0.000019920135,0.000084428284],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982743,0.00024241692,0.000853932,0.00032576767,0.00004872398,0.00025481603],"domain_scores_gemma":[0.9979986,0.0008439984,0.0007842852,0.00015626576,0.00016863398,0.00004820423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011456613,0.00025042414,0.0011059911,0.00011535868,0.00014624425,0.000023093437,0.000114811395,0.00022294828,0.000040084884],"category_scores_gemma":[0.00007790023,0.00020832379,0.00010903884,0.00004993716,0.00016449513,0.00015657069,0.000046414385,0.00014211934,0.0000045611623],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099534,0.0021370891,0.015044612,0.00007759706,0.015265382,0.0013995791,0.012972511,0.000007783305,0.060545165,0.00005285207,0.0011826435,0.79178077],"study_design_scores_gemma":[0.69497657,0.010747732,0.10040578,0.0039059923,0.0072366963,0.055424314,0.011643842,0.000026604845,0.101244934,0.0005321326,0.012638388,0.0012170081],"about_ca_topic_score_codex":0.00045247466,"about_ca_topic_score_gemma":0.00024407676,"teacher_disagreement_score":0.79056376,"about_ca_system_score_codex":0.000059593956,"about_ca_system_score_gemma":0.00006910248,"threshold_uncertainty_score":0.8495198},"labels":[],"label_agreement":null},{"id":"W2971827843","doi":"10.1111/bjd.18483","title":"Weight change in patients with psoriasis using tumour necrosis factor‐α inhibitors","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto; Memorial University of Newfoundland; McGill University","funders":"","keywords":"Psoriasis; Medicine; Necrosis; Tumor necrosis factor alpha; Dermatology; Internal medicine","score_opus":0.013307073982252402,"score_gpt":0.21876449199317632,"score_spread":0.20545741801092393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971827843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941791,0.0036812855,0.000007341869,0.000090878784,0.0016509732,0.0002465797,0.000044204906,0.000012585202,0.00008701219],"genre_scores_gemma":[0.99939114,0.00020743441,0.0001451606,0.00008790142,0.00006164276,0.0000051842285,0.000027660375,0.000025844616,0.0000480119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984739,0.00027309012,0.00055440876,0.00020900833,0.000075196345,0.00041442591],"domain_scores_gemma":[0.9991557,0.00007945643,0.00044302706,0.00012068286,0.00015806091,0.00004309783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007578322,0.00019967204,0.00062989176,0.00029629876,0.000080769016,0.000023325549,0.000202756,0.0002914845,0.00039333792],"category_scores_gemma":[0.000024228213,0.00018765643,0.00013439392,0.00021397385,0.000077762255,0.00033808575,0.00004558377,0.00030947654,0.00008919642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000433618,0.00032806155,0.9708304,0.000018441528,0.00023826318,0.00044844218,0.00029398475,0.0000013033069,0.0024446268,0.000008640204,0.00023698017,0.024717258],"study_design_scores_gemma":[0.010812929,0.0002945645,0.9632912,0.00034485653,0.00012765288,0.008675241,0.00006950413,0.0000013485453,0.014635296,0.000019227633,0.0014509755,0.00027717577],"about_ca_topic_score_codex":0.00024402105,"about_ca_topic_score_gemma":0.00011351581,"teacher_disagreement_score":0.024440082,"about_ca_system_score_codex":0.000077362805,"about_ca_system_score_gemma":0.00008377987,"threshold_uncertainty_score":0.7652407},"labels":[],"label_agreement":null},{"id":"W2971900016","doi":"10.1111/bjd.18482","title":"Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"Genentech; Agence Nationale de la Recherche","keywords":"Pemphigus vulgaris; Rituximab; Medicine; Dermatology; Pemphigus; Steroid; Internal medicine; Lymphoma","score_opus":0.0030958986819212865,"score_gpt":0.21886601093164418,"score_spread":0.2157701122497229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971900016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956086,0.003344726,0.000011393221,0.00010287724,0.000069192596,0.00073840783,0.0000071140394,0.000013134244,0.0001045103],"genre_scores_gemma":[0.9995553,0.000105038096,0.00016339969,0.00009823869,0.000016544802,0.000014080129,0.000008213867,0.000025042977,0.000014145223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987461,0.00021498161,0.00037715543,0.00020881176,0.00018433873,0.00026862574],"domain_scores_gemma":[0.9991968,0.00015851538,0.00023970245,0.00013808206,0.000116685806,0.00015020043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081164355,0.00017833292,0.0008401819,0.00017546404,0.000044219752,0.000038310696,0.00007121691,0.000102133694,0.000040691237],"category_scores_gemma":[0.00005205711,0.0001539533,0.00007284596,0.00009183462,0.000096347874,0.00019967587,0.000026357708,0.00022131827,0.000009905379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015286744,0.000944722,0.95447373,0.00009477685,0.00019472752,0.0034012112,0.00022673445,0.0000017207199,0.00004986999,0.0000013722317,0.000035557434,0.039046925],"study_design_scores_gemma":[0.024462743,0.0045402227,0.9348458,0.0006921437,0.00021938086,0.03379532,0.000081489285,0.000041720803,0.0011363883,0.000017695027,0.000036742906,0.00013035217],"about_ca_topic_score_codex":0.0001872637,"about_ca_topic_score_gemma":0.000059435257,"teacher_disagreement_score":0.038916573,"about_ca_system_score_codex":0.00010739461,"about_ca_system_score_gemma":0.00008726575,"threshold_uncertainty_score":0.6278033},"labels":[],"label_agreement":null},{"id":"W2973074546","doi":"10.1111/bjd.18515","title":"Musculoskeletal ultrasound can improve referrals from dermatology to rheumatology for patients with psoriasis","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Rheumatology; Psoriasis; Medicine; Dermatology; Ultrasound; Internal medicine; Medical physics; Radiology","score_opus":0.008778593186146955,"score_gpt":0.22375239530891752,"score_spread":0.21497380212277056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973074546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86898535,0.009019347,0.0004647792,0.09952508,0.013034633,0.002318464,0.006361222,0.00009814728,0.00019296464],"genre_scores_gemma":[0.79834205,0.002789638,0.004378275,0.16777812,0.0021006118,0.00063667377,0.020471128,0.0007687158,0.0027347982],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944853,0.0010257389,0.0018710574,0.00096836395,0.00019180085,0.001457719],"domain_scores_gemma":[0.9939018,0.0024710798,0.0019107299,0.00065536203,0.0009480773,0.00011296332],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00014105796,0.00090889854,0.0032074733,0.00063277234,0.00030238455,0.00008182362,0.0011204459,0.003290529,0.00040270574],"category_scores_gemma":[0.00057054334,0.0008810243,0.00080046465,0.00023899053,0.00035578723,0.00019393592,0.0001365948,0.0020391701,0.00030044554],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013472275,0.00036358854,0.022990342,0.00029109462,0.004963053,0.0031185262,0.00021110209,0.0000010061896,0.0005312264,0.000018373123,0.9498725,0.016291995],"study_design_scores_gemma":[0.020644682,0.0016993723,0.008539402,0.00071422826,0.0027907775,0.10482419,0.00013518558,2.2586592e-7,0.0032436454,0.00030506548,0.855498,0.0016051834],"about_ca_topic_score_codex":0.000493462,"about_ca_topic_score_gemma":0.00041344218,"teacher_disagreement_score":0.10170566,"about_ca_system_score_codex":0.00017777545,"about_ca_system_score_gemma":0.0006088392,"threshold_uncertainty_score":0.999364},"labels":[],"label_agreement":null},{"id":"W2974374499","doi":"10.1111/bjd.18528","title":"Quality of reporting in systematic reviews published in dermatology journals","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dermatology; Quality (philosophy); Medicine; Philosophy; Epistemology","score_opus":0.6679723516129221,"score_gpt":0.5441044734489416,"score_spread":0.12386787816398048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974374499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94629675,0.0469123,0.0013520278,0.0014268262,0.00064799207,0.0012840396,0.0000026505115,0.0000016541508,0.0020757786],"genre_scores_gemma":[0.99669135,0.0010363363,0.0017826281,0.00022564326,0.000026151281,0.000017002825,0.0000010126836,0.000012322802,0.00020754972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8151681,0.06355678,0.11540421,0.00079063117,0.0044545485,0.0006257529],"domain_scores_gemma":[0.87254506,0.009445149,0.113449246,0.0019144589,0.0024502752,0.0001957849],"candidate_categories":["metaresearch","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2525059,0.00028982648,0.01748739,0.0017930662,0.000039527476,0.00051803753,0.002275516,0.0002717668,0.003875929],"category_scores_gemma":[0.37447414,0.0001837849,0.0026328547,0.002276076,0.00008640145,0.0009513261,0.0001583775,0.00079696835,0.00031014177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016649776,0.00015130719,0.9768246,0.008162307,0.00013602877,0.0025987264,0.00039464858,0.000027195962,0.00029246477,0.0003696123,0.008521827,0.0025046745],"study_design_scores_gemma":[0.0033029122,0.000064056454,0.5221427,0.029865569,0.00025365007,0.4182257,0.003858259,0.0010177424,0.00026171483,0.015686784,0.0046888245,0.00063209416],"about_ca_topic_score_codex":0.00007246798,"about_ca_topic_score_gemma":0.0005668519,"teacher_disagreement_score":0.45468184,"about_ca_system_score_codex":0.00006824623,"about_ca_system_score_gemma":0.00023362729,"threshold_uncertainty_score":0.99709904},"labels":[],"label_agreement":null},{"id":"W2978721186","doi":"10.1111/bjd.18396","title":"Practice‐based differences in paediatric DLE","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hydroxychloroquine; Discoid lupus erythematosus; Dermatology; Lupus nephritis; Systemic lupus erythematosus; Lupus erythematosus; Disease; Pediatrics; Internal medicine; Immunology; Antibody","score_opus":0.01957930935059316,"score_gpt":0.2969754048982307,"score_spread":0.27739609554763756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978721186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540664,0.0075892243,0.00009679176,0.00340155,0.000386526,0.00025539417,0.000001665324,0.000009535366,0.002852689],"genre_scores_gemma":[0.9978673,0.0006709346,0.0007893677,0.0003661811,0.00010403623,0.0000040325845,0.0000015187717,0.00001572042,0.00018094042],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9980408,0.00035258467,0.0006854747,0.00013694869,0.0004734615,0.00031076057],"domain_scores_gemma":[0.99828106,0.0007288266,0.0003572388,0.00014414218,0.00034186358,0.00014686049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046818706,0.00009020767,0.00063612964,0.00040827502,0.000020986672,0.000030941734,0.00018058978,0.00014308674,0.00027387842],"category_scores_gemma":[0.0012247037,0.000087395216,0.0001144073,0.00032344979,0.00005660691,0.00017895942,0.000033489465,0.00057581643,0.00012016194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000261873,0.00026108633,0.9760065,0.00030256578,0.00004953116,0.016902154,0.00012960403,0.0000014751553,0.00022693875,0.000031243228,0.0029449041,0.0028821079],"study_design_scores_gemma":[0.0061063254,0.00021493486,0.05650176,0.00092568464,0.00004442724,0.9319762,0.0009803241,0.00028901963,0.00029737726,0.00006592929,0.002499058,0.00009893004],"about_ca_topic_score_codex":0.000050444294,"about_ca_topic_score_gemma":0.000019335659,"teacher_disagreement_score":0.91950476,"about_ca_system_score_codex":0.000082904575,"about_ca_system_score_gemma":0.0004624059,"threshold_uncertainty_score":0.35638735},"labels":[],"label_agreement":null},{"id":"W2979570796","doi":"10.1111/bjd.18604","title":"Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Western University; SKiN Health","funders":"","keywords":"Tears; Reliability (semiconductor); Medicine; Optometry; Dermatology; Ophthalmology; Surgery","score_opus":0.06360944030853781,"score_gpt":0.3388807698418896,"score_spread":0.27527132953335176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979570796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924497,0.00026175642,0.0007884691,0.0018828885,0.00074791146,0.000602061,0.0000271492,0.000009296812,0.003230772],"genre_scores_gemma":[0.9993393,0.00014024516,0.0002899732,0.000090125744,0.000040019706,0.000012581064,0.0000017370022,0.0000072286766,0.000078816505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699306,0.0013034797,0.0010859283,0.00012765377,0.0003449939,0.00014487676],"domain_scores_gemma":[0.9970962,0.00078906,0.0013985615,0.00020648891,0.00048223592,0.000027454935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023314238,0.000070591326,0.0003016958,0.00009211383,0.00014567854,0.000014741267,0.00034061164,0.000110648754,0.00003063942],"category_scores_gemma":[0.00076873874,0.00005493348,0.000067941764,0.00013232592,0.00014140102,0.00016893176,0.00014693932,0.00045968776,0.0000027689823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015151384,0.00014735914,0.9761804,0.001600592,0.00007726322,0.000012238664,0.0019771983,0.000082220766,0.0019504139,0.00851358,0.003968887,0.005338347],"study_design_scores_gemma":[0.0010572302,0.000019490819,0.9759867,0.001245063,0.0000401796,0.00040379653,0.008656396,0.0014207489,0.00021130002,0.00043506798,0.01046744,0.000056581957],"about_ca_topic_score_codex":0.0002732329,"about_ca_topic_score_gemma":0.00013685964,"teacher_disagreement_score":0.008078513,"about_ca_system_score_codex":0.00016302735,"about_ca_system_score_gemma":0.00021210425,"threshold_uncertainty_score":0.22401223},"labels":[],"label_agreement":null},{"id":"W2980603063","doi":"10.1111/bjd.18623","title":"Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE)","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Novartis Pharmaceuticals UK Limited","keywords":"Secukinumab; Medicine; Randomized controlled trial; Oncology; Open label; Tumor necrosis factor alpha; Signature (topology); Internal medicine; Necrosis","score_opus":0.018624505448480617,"score_gpt":0.264304644580543,"score_spread":0.24568013913206235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980603063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843494,0.010709807,0.0000367757,0.00010385168,0.0016615052,0.0027494652,0.00026495027,0.000014158991,0.00011002671],"genre_scores_gemma":[0.9984819,0.000749852,0.00023385129,0.00007202655,0.000037728016,0.00006477612,0.00008569103,0.00003169944,0.00024242014],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965689,0.0011091514,0.0015367173,0.0003143636,0.00009470686,0.00037613508],"domain_scores_gemma":[0.99670506,0.0009679625,0.0014822449,0.00020879712,0.00059318764,0.000042775162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005911868,0.0002616066,0.00188221,0.00019041779,0.00013858646,0.0000579296,0.00058618747,0.0003403655,0.000072778865],"category_scores_gemma":[0.00048475858,0.0002314899,0.00037706472,0.0001337807,0.00011227802,0.00024278926,0.00011712855,0.00030715717,0.000019614372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6030298,0.022870526,0.056874316,0.0002349633,0.0116986735,0.0006960963,0.00789445,0.000006094906,0.083247125,0.00006578915,0.013040017,0.20034215],"study_design_scores_gemma":[0.9273414,0.00264474,0.0071883453,0.0003306165,0.00059386593,0.0030016426,0.0004871822,0.00000375881,0.055406127,0.00021467889,0.0023955754,0.00039206588],"about_ca_topic_score_codex":0.000133138,"about_ca_topic_score_gemma":0.000042859447,"teacher_disagreement_score":0.3243116,"about_ca_system_score_codex":0.00003675483,"about_ca_system_score_gemma":0.00016404518,"threshold_uncertainty_score":0.9439884},"labels":[],"label_agreement":null},{"id":"W2983911779","doi":"10.1111/bjd.18643","title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","year":2019,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; LEO Pharma; King's College London; Sanofi Genzyme; Incyte; Dermira; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company","keywords":"Skin infection; Atopic dermatitis; Staphylococcus aureus; Medicine; Dermatology; Immunology; Microbiome; Colonization; Erythema; Virulence; Microbiology; Biology; Bacteria; Bioinformatics","score_opus":0.02783365788754095,"score_gpt":0.3048529346464201,"score_spread":0.27701927675887916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983911779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002387853,0.99436015,0.000014820667,0.0009438767,0.0012500029,0.0006635292,0.00007306754,0.0000071415566,0.00029955374],"genre_scores_gemma":[0.0044195578,0.99454886,0.000028418326,0.00056428585,0.00022728968,0.00006528724,0.00010875093,0.000021885984,0.00001566756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672896,0.00070838607,0.0017357144,0.00019346665,0.00041755103,0.0002159144],"domain_scores_gemma":[0.9971914,0.0008771326,0.0012724007,0.00023499319,0.00034258864,0.00008144226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048972666,0.00023762969,0.0016312373,0.00010365241,0.00011122112,0.000060296883,0.00028425988,0.00025511548,0.00018175853],"category_scores_gemma":[0.0006714304,0.0001664709,0.0004239147,0.00014929198,0.0002248415,0.00017049868,0.00011512874,0.0006275229,0.000012543945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031387794,0.000307869,0.0068517877,0.005158862,0.0009769959,0.0007726215,0.00013743027,1.186906e-7,6.560555e-7,0.000076351695,0.06694987,0.91873604],"study_design_scores_gemma":[0.0010093403,0.00003411927,0.0046989922,0.033949576,0.00071861374,0.07627397,0.000048940175,0.0000027398555,0.0000025011955,0.00017189002,0.8829745,0.00011482248],"about_ca_topic_score_codex":0.00042146226,"about_ca_topic_score_gemma":0.0011310767,"teacher_disagreement_score":0.91862124,"about_ca_system_score_codex":0.00023135691,"about_ca_system_score_gemma":0.00091348705,"threshold_uncertainty_score":0.6788486},"labels":[],"label_agreement":null},{"id":"W2989929492","doi":"10.1111/bjd.18627","title":"Dupilumab in adolescent atopic dermatitis: interpreting the data","year":2019,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dupilumab; Atopic dermatitis; Dermatology; Medicine","score_opus":0.026013691756835954,"score_gpt":0.28616456313947697,"score_spread":0.26015087138264104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989929492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017307118,0.044216216,0.00014604576,0.9338113,0.002173547,0.00056278176,0.00010941504,0.000028378068,0.0016451644],"genre_scores_gemma":[0.39621803,0.0020846755,0.0001158862,0.60012466,0.00092866126,0.000006068162,0.00027039967,0.000051380084,0.00020025198],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965477,0.0007053125,0.0014061902,0.00035947052,0.00043125273,0.0005500514],"domain_scores_gemma":[0.9973996,0.0005712722,0.0008827295,0.00086314627,0.00020359203,0.00007960447],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00026623352,0.0002945769,0.0013245574,0.0003060992,0.000082755054,0.00008157764,0.0013441555,0.0008756117,0.00019935449],"category_scores_gemma":[0.00084189884,0.00026058411,0.000268228,0.00015903346,0.00030827182,0.00024080758,0.00040245618,0.004572155,0.000097740296],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003018758,0.00008430733,0.04275193,0.0006176072,0.00018721186,0.12727654,0.000051983574,4.7091686e-7,6.2420787e-7,0.0000019618124,0.8255523,0.003444892],"study_design_scores_gemma":[0.0015765245,0.000017942639,0.031540267,0.0039745984,0.00024763675,0.47083387,0.00007302648,0.0000728777,0.000010118263,0.00008115571,0.49140754,0.0001644546],"about_ca_topic_score_codex":0.000036440113,"about_ca_topic_score_gemma":0.00004891703,"teacher_disagreement_score":0.37891093,"about_ca_system_score_codex":0.00008241519,"about_ca_system_score_gemma":0.0005920611,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W2993854221","doi":"10.1111/bjd.18573","title":"The ACNE‐Q","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acne; Medicine; Dermatology; Acne scars; Distress; Quality of life (healthcare); Clinical psychology","score_opus":0.004165917996818942,"score_gpt":0.23669656340663028,"score_spread":0.23253064540981133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993854221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837412,0.007576034,0.000030006071,0.003964426,0.00047293055,0.000088863424,6.330128e-7,0.000004964777,0.004120912],"genre_scores_gemma":[0.99656063,0.0015049377,0.00009023374,0.00046271726,0.00008291519,6.6715097e-7,8.810735e-7,0.0000061581745,0.0012908444],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99948376,0.0000373021,0.00019715475,0.0000450659,0.000098672135,0.00013802267],"domain_scores_gemma":[0.9995947,0.00008263344,0.0001082466,0.00007092721,0.000077658435,0.00006583318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006818469,0.000044825178,0.00020938026,0.00002221659,0.00008239552,0.000021121583,0.000061313796,0.000051009778,0.00007554697],"category_scores_gemma":[0.00003885103,0.000028257378,0.00010005728,0.00003952748,0.00003972323,0.00004775425,0.000013962657,0.00016123003,0.00008198611],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078449247,0.00050633657,0.3717861,0.00012498237,0.0010524871,0.04689648,0.00023726093,0.000003136253,0.001993595,0.0009873881,0.22447014,0.3511576],"study_design_scores_gemma":[0.0042209006,0.00038528067,0.08640976,0.00024109863,0.00012099661,0.71374375,0.00019746748,0.000025961423,0.0016236034,0.00026880132,0.19268884,0.00007356913],"about_ca_topic_score_codex":0.0000069796192,"about_ca_topic_score_gemma":0.000003937333,"teacher_disagreement_score":0.6668472,"about_ca_system_score_codex":0.000010999656,"about_ca_system_score_gemma":0.00005737592,"threshold_uncertainty_score":0.11523024},"labels":[],"label_agreement":null},{"id":"W2994439256","doi":"10.1111/bjd.18746","title":"The psychological impact of Stevens–Johnson syndrome and toxic epidermal necrolysis on patients’ lives: a Critically Appraised Topic*","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Limerick","keywords":"Toxic epidermal necrolysis; Anxiety; Medicine; Skin biopsy; Depression (economics); Inclusion (mineral); Psychiatry; Dermatology; Biopsy; Psychology; Pathology","score_opus":0.011611264403932117,"score_gpt":0.3012481988346902,"score_spread":0.28963693443075805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994439256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995026,0.00047501363,0.000026779693,0.001282245,0.000274582,0.00023360639,0.00001149665,0.000010541886,0.0026597304],"genre_scores_gemma":[0.9989774,0.0003878048,0.00019968078,0.00032571927,0.000036662277,0.0000029100565,0.0000027966112,0.000015272899,0.00005171111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983566,0.00021393476,0.0006665161,0.00017754505,0.00027215498,0.00031326275],"domain_scores_gemma":[0.998284,0.00064173876,0.0003180553,0.00020246995,0.0003380272,0.00021573277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016539937,0.00013893838,0.0006505262,0.00014339194,0.000087084685,0.000028452347,0.00013642902,0.00014762391,0.00005400657],"category_scores_gemma":[0.0008536005,0.00010483848,0.00031591117,0.00013709198,0.00019199603,0.00012283926,0.000035082805,0.000550356,0.000020177802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014486648,0.0065931715,0.55172294,0.0004193989,0.0025093686,0.028945256,0.0006098469,0.000039582817,0.0074510486,0.00096515275,0.0033614563,0.39593408],"study_design_scores_gemma":[0.003006784,0.0007630664,0.80598396,0.00023121941,0.00011911214,0.18892615,0.00019545287,0.000031167456,0.00010942968,0.000106915606,0.00043608638,0.00009068111],"about_ca_topic_score_codex":0.000018991204,"about_ca_topic_score_gemma":0.0000055878463,"teacher_disagreement_score":0.39584342,"about_ca_system_score_codex":0.00005924589,"about_ca_system_score_gemma":0.00008662069,"threshold_uncertainty_score":0.4275189},"labels":[],"label_agreement":null},{"id":"W2997184801","doi":"10.1111/bjd.18648","title":"How cutaneous T-cell lymphoma affects quality of life, and its cost to individual patients and the U.S. healthcare system","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Embarrassment; Health care; Rash; Dermatology Life Quality Index; Quality-adjusted life year; Population; Disease; Mycosis fungoides; Gerontology; Family medicine; Cost effectiveness; Lymphoma; Dermatology; Psychology; Environmental health; Internal medicine; Nursing","score_opus":0.029249451368623426,"score_gpt":0.2859054147810646,"score_spread":0.2566559634124412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997184801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96320146,0.011839672,0.00004695531,0.023771094,0.00006934067,0.0009015831,0.000084303,0.000009732805,0.00007584569],"genre_scores_gemma":[0.99683434,0.00079651416,0.000063612926,0.002203112,0.000053445066,0.000009261098,0.000007412924,0.000020395624,0.000011926755],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9976383,0.0007420712,0.000563184,0.00020240608,0.00056208135,0.00029194937],"domain_scores_gemma":[0.9978388,0.0004417471,0.00040255862,0.000088346846,0.00064311136,0.00058547064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025140157,0.00014232945,0.0009302538,0.000098367804,0.00011668019,0.00007601172,0.00016762086,0.00012351044,0.000003889919],"category_scores_gemma":[0.0017431184,0.00012106132,0.00008965041,0.00018915339,0.00021055875,0.0000714571,0.00013967649,0.00024269983,0.0000018829594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017111905,0.001036639,0.8485251,0.010601034,0.00096428645,0.018435076,0.008019634,0.000004840479,0.0013381953,0.00087104127,0.011412849,0.08167941],"study_design_scores_gemma":[0.07774862,0.003638801,0.16299176,0.0014182815,0.0003311959,0.7350527,0.011365258,0.000679208,0.004629351,0.000050618753,0.0015128921,0.0005813072],"about_ca_topic_score_codex":0.00006961335,"about_ca_topic_score_gemma":0.0000627693,"teacher_disagreement_score":0.71661764,"about_ca_system_score_codex":0.00005090432,"about_ca_system_score_gemma":0.00031719534,"threshold_uncertainty_score":0.49367374},"labels":[],"label_agreement":null},{"id":"W2997875868","doi":"10.1111/bjd.18851","title":"A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Dalhousie University; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Double blinded; Plaque psoriasis; Psoriasis; Randomized controlled trial; Dermatology; Head start; Internal medicine; Placebo; Secukinumab; Pathology","score_opus":0.019551203705524007,"score_gpt":0.26708486217334143,"score_spread":0.2475336584678174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997875868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493074,0.0018635801,0.000086613945,0.00033863776,0.0007480026,0.0017711116,0.00019986604,0.000011787163,0.000049651615],"genre_scores_gemma":[0.9990929,0.00013627957,0.0005199411,0.00006451967,0.00002607935,0.000013785199,0.000067924324,0.000029884313,0.000048680944],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954565,0.0017527031,0.0018389948,0.000369711,0.00015798699,0.0004241036],"domain_scores_gemma":[0.996918,0.0013720004,0.0010158616,0.00027234157,0.00031818944,0.00010360533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061431003,0.00031454122,0.002874032,0.00051527837,0.000076376804,0.000023070888,0.00032054618,0.00045181674,0.000108124295],"category_scores_gemma":[0.00029840917,0.00028925997,0.00024325453,0.00024802116,0.00019540393,0.00015564589,0.00009060144,0.00040118414,0.000027370554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9611276,0.0018371182,0.025571574,0.000029312896,0.0011623289,0.00016260425,0.0015235818,0.00015083872,0.0007775465,0.000017633387,0.00028561955,0.0073542385],"study_design_scores_gemma":[0.86134356,0.0029212798,0.12590921,0.00066085317,0.0003960471,0.0016251145,0.00022197764,0.000010586621,0.0063455617,0.000032947442,0.00024641503,0.0002864185],"about_ca_topic_score_codex":0.00057589455,"about_ca_topic_score_gemma":0.0006243638,"teacher_disagreement_score":0.10033763,"about_ca_system_score_codex":0.000069095746,"about_ca_system_score_gemma":0.00031535863,"threshold_uncertainty_score":0.99995595},"labels":[],"label_agreement":null},{"id":"W2997936799","doi":"10.1111/bjd.18605","title":"British Association of Dermatologists centenary year: standing on the shoulders of giants","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology; Medicine; Family medicine","score_opus":0.029911043589218488,"score_gpt":0.2599010878940676,"score_spread":0.2299900443048491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997936799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346903,0.009627232,0.0003955788,0.043263428,0.0006291841,0.00031133092,0.000029485525,0.000024959161,0.011028481],"genre_scores_gemma":[0.98837656,0.0023898466,0.0001730432,0.008901787,0.00008614991,0.0000019942763,0.0000046232817,0.00001730246,0.000048694368],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99781,0.00025173565,0.0010365065,0.00014313142,0.0004846023,0.00027400776],"domain_scores_gemma":[0.99772316,0.00043248187,0.0011183765,0.00011701237,0.0004578889,0.00015107615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002611028,0.00012114172,0.0009827549,0.00010423453,0.00007541573,0.000006893383,0.00019442858,0.00019343098,0.00013486824],"category_scores_gemma":[0.0016647099,0.00011605677,0.00023285764,0.00020872326,0.0003268277,0.000074561554,0.00004974398,0.00057752465,0.000006181437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042227661,0.0002353199,0.19128864,0.00039701196,0.0006520336,0.010691928,0.0006057783,0.00000255619,0.00059200614,0.00016470328,0.79289937,0.0020483716],"study_design_scores_gemma":[0.03485497,0.0032635226,0.30217776,0.008879725,0.0026915306,0.48709,0.022364603,0.00036209516,0.022679653,0.0006851176,0.11386934,0.0010817017],"about_ca_topic_score_codex":0.000023401364,"about_ca_topic_score_gemma":0.000017432045,"teacher_disagreement_score":0.67903006,"about_ca_system_score_codex":0.000080316866,"about_ca_system_score_gemma":0.00017719272,"threshold_uncertainty_score":0.4732658},"labels":[],"label_agreement":null},{"id":"W2998173673","doi":"10.1111/bjd.18661","title":"A study of dupilumab in the treatment of adolescents with eczema","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Medicine; Itching; Atopic dermatitis; Dermatology; Quality of life (healthcare); Dermatology Life Quality Index; Young adult; Internal medicine; Psoriasis","score_opus":0.02077555368915389,"score_gpt":0.27324640356432106,"score_spread":0.25247084987516716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998173673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947162,0.0033597415,0.000011573529,0.0014521957,0.000032158157,0.00028912938,0.000003478405,0.0000029176692,0.00013254867],"genre_scores_gemma":[0.99921316,0.00035795083,0.000038759536,0.00035330863,0.000022504202,0.0000044194094,0.000001062871,0.000006967635,0.00000185566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988155,0.00022284349,0.00055095874,0.00008635552,0.00019934296,0.00012502586],"domain_scores_gemma":[0.9993368,0.000053109612,0.00031726973,0.00009799856,0.00011645729,0.00007837917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004181348,0.000084094056,0.0006295694,0.00007908208,0.000020155694,0.0000040178857,0.00012941756,0.0000516991,0.000014857023],"category_scores_gemma":[0.00005964012,0.000058987738,0.00008963918,0.00016491095,0.00011602393,0.000043620334,0.000008838763,0.00013094542,0.0000013757999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017084759,0.0059713786,0.937765,0.00014189744,0.0001939628,0.047303677,0.003658702,0.000004271326,0.000027954968,0.0000040222044,0.0011127725,0.002107868],"study_design_scores_gemma":[0.015201168,0.0031665089,0.8203627,0.0005265212,0.0003570421,0.15372457,0.0057317223,0.000008788038,0.000639616,0.00001840572,0.00020447987,0.000058492504],"about_ca_topic_score_codex":0.000028209794,"about_ca_topic_score_gemma":0.000078628334,"teacher_disagreement_score":0.11740232,"about_ca_system_score_codex":0.000010777188,"about_ca_system_score_gemma":0.00010365003,"threshold_uncertainty_score":0.24054502},"labels":[],"label_agreement":null},{"id":"W2998576867","doi":"10.1111/bjd.18662","title":"How many people develop anti-drug antibodies to the biologic drug tildrakizumab, and what impact does this have on the effectiveness of their treatment","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Clinical trial; Adverse effect; Antibody; Pharmacokinetics; Incidence (geometry); Internal medicine; Psoriasis; Pharmacology; Immunology","score_opus":0.016572192714455206,"score_gpt":0.2646796761144864,"score_spread":0.2481074834000312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998576867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384313,0.018182334,0.00012221352,0.042507734,0.00033988777,0.00030745103,0.000059964816,0.000009400196,0.00003972127],"genre_scores_gemma":[0.99041766,0.008279265,0.00011915946,0.0010732707,0.000036519654,0.000005919182,0.0000043137024,0.000011155772,0.000052740008],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99689156,0.0021364172,0.0003804502,0.00022695673,0.00004883267,0.00031576172],"domain_scores_gemma":[0.99722004,0.002095628,0.00028740277,0.00015360629,0.00018347523,0.0000598467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061918533,0.00023071512,0.00082633295,0.00006515547,0.0002327721,0.00012943064,0.00036291027,0.00016580144,0.00007561622],"category_scores_gemma":[0.0004797501,0.00009865976,0.0002298983,0.00017060454,0.00042519261,0.00014453166,0.00012473087,0.00037071988,0.0000062573286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008433749,0.001702764,0.28705347,0.0006082179,0.010516905,0.0023840745,0.017366752,0.000021033931,0.22583452,0.0030953751,0.045763694,0.39721945],"study_design_scores_gemma":[0.0030933109,0.0014390944,0.2955636,0.00081557577,0.00036458453,0.026328571,0.009413654,0.000020302718,0.64154613,0.0009688678,0.01996597,0.0004803129],"about_ca_topic_score_codex":0.000071256705,"about_ca_topic_score_gemma":0.0001022497,"teacher_disagreement_score":0.4157116,"about_ca_system_score_codex":0.000029799834,"about_ca_system_score_gemma":0.00007006548,"threshold_uncertainty_score":0.40232283},"labels":[],"label_agreement":null},{"id":"W3003334583","doi":"10.1111/bjd.18898","title":"Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Lundbeckfonden; Eli Lilly and Company","keywords":"Medicine; Placebo; Atopic dermatitis; Concomitant; Adverse effect; Randomized controlled trial; Internal medicine; Gastroenterology; Clinical endpoint; Erythema; Phases of clinical research; Clinical trial; Dermatology","score_opus":0.019513080547020206,"score_gpt":0.2875085191582279,"score_spread":0.26799543861120767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003334583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98106927,0.0016302579,0.0021168627,0.013762358,0.00014017544,0.0010618718,0.00013373238,0.00002391357,0.000061585655],"genre_scores_gemma":[0.986567,0.00024267376,0.0014388069,0.011546531,0.00009563726,0.000024787676,0.000040868923,0.000027097904,0.000016605232],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995254,0.0018334485,0.0018425126,0.00035333526,0.00033218157,0.00038456236],"domain_scores_gemma":[0.99523467,0.0030939865,0.0005481492,0.00016537141,0.00027822782,0.00067959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050416624,0.00024882003,0.0022307227,0.00023978096,0.00007991786,0.0000825548,0.00017643234,0.00018307606,0.00002245071],"category_scores_gemma":[0.0077119768,0.0002255592,0.00016850118,0.00023947022,0.00015627644,0.00020120361,0.000059622245,0.00043818593,0.000012684019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7579674,0.001066615,0.13463002,0.00009956547,0.0011286485,0.031080881,0.0062724072,0.00011600499,0.00020149189,0.00003171621,0.028736489,0.038668722],"study_design_scores_gemma":[0.7434934,0.00088779937,0.23724873,0.00084998563,0.00037990193,0.012038623,0.00030611816,0.00043404286,0.0015343976,0.00040382976,0.00220671,0.00021645275],"about_ca_topic_score_codex":0.00008331295,"about_ca_topic_score_gemma":0.000046610003,"teacher_disagreement_score":0.10261871,"about_ca_system_score_codex":0.000037537968,"about_ca_system_score_gemma":0.00020438789,"threshold_uncertainty_score":0.92325133},"labels":[],"label_agreement":null},{"id":"W3004695540","doi":"10.1111/bjd.18922","title":"Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Scleroderma (fungus); Patient-reported outcome; Scale (ratio); Systemic scleroderma; Measure (data warehouse); Outcome (game theory); Medicine; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Psychology; Quality of life (healthcare); Internal medicine; Psychiatry; Computer science; Geography; Pathology; Cartography; Data mining; Nursing; Economics","score_opus":0.07790764148776234,"score_gpt":0.27151966259031857,"score_spread":0.1936120211025562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004695540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927446,0.004122148,0.0009872317,0.0016515191,0.00010755075,0.00034055172,0.000003775543,0.000011964031,0.000030630734],"genre_scores_gemma":[0.99876374,0.00012441489,0.000499303,0.00052088103,0.00004546356,0.000018420511,0.000003993189,0.000014974165,0.000008807333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800026,0.00014610152,0.001069648,0.00016007014,0.00044053534,0.00018340074],"domain_scores_gemma":[0.9987576,0.00011029587,0.000561123,0.00008392255,0.00021611303,0.00027093774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017732284,0.00012425172,0.0005978047,0.00010758151,0.00007970458,0.00003278602,0.00007093226,0.00009301108,0.000017918486],"category_scores_gemma":[0.00021602261,0.00009285445,0.000066598026,0.0002807486,0.000052109255,0.00012536235,0.000033509874,0.00022718916,0.0000011255757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092172716,0.00022837728,0.9566051,0.00027525116,0.00034753265,0.00029807028,0.0072900862,0.0001758877,0.014031353,0.000003728566,0.002100921,0.017722012],"study_design_scores_gemma":[0.0029420496,0.0001284005,0.9604171,0.0049390933,0.00020272279,0.022124989,0.0057016513,0.00009407645,0.003298253,0.0000014941328,0.000041282845,0.000108883825],"about_ca_topic_score_codex":0.000042742315,"about_ca_topic_score_gemma":0.00018963538,"teacher_disagreement_score":0.02182692,"about_ca_system_score_codex":0.000054847595,"about_ca_system_score_gemma":0.00046262116,"threshold_uncertainty_score":0.37864944},"labels":[],"label_agreement":null},{"id":"W3004975025","doi":"10.1111/bjd.18755","title":"People with non‐blanchable erythema are at higher risk of pressure ulcers","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erythema; Medicine; Dermatology; Pressure sores; Blanching; Surgery","score_opus":0.01821117619453831,"score_gpt":0.2931042001561561,"score_spread":0.2748930239616178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004975025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90951395,0.010242929,0.014011371,0.032206774,0.0022733193,0.0021288164,0.00024183626,0.00013693866,0.029244084],"genre_scores_gemma":[0.9944484,0.0006014821,0.00065299944,0.0014519941,0.00014452303,0.000015258279,0.0000041768126,0.000024709205,0.0026564333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794525,0.000573062,0.00072814117,0.00016244622,0.000267815,0.00032327144],"domain_scores_gemma":[0.99776363,0.0001732428,0.0014270993,0.00014643464,0.00028343048,0.00020613999],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022563225,0.000120839504,0.00062407483,0.00006926465,0.00024050642,0.000008067886,0.00027509674,0.00014574859,0.0020349484],"category_scores_gemma":[0.00011606645,0.00011477881,0.00012539305,0.00015436874,0.00006046556,0.0001470747,0.00018380355,0.0005230654,0.00004854918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048800677,0.00014289306,0.3381925,0.001283859,0.0008872007,0.0011429613,0.002227468,0.0001545968,0.00011022055,0.00017568702,0.65446365,0.0007309962],"study_design_scores_gemma":[0.009115258,0.00027283636,0.39301735,0.001270878,0.000992365,0.0039261403,0.0029723397,0.00021093238,0.00043404862,0.00034766778,0.5870901,0.00035008832],"about_ca_topic_score_codex":0.00011686304,"about_ca_topic_score_gemma":0.0007227073,"teacher_disagreement_score":0.084934495,"about_ca_system_score_codex":0.00002395887,"about_ca_system_score_gemma":0.00009548908,"threshold_uncertainty_score":0.99887735},"labels":[],"label_agreement":null},{"id":"W3005031357","doi":"10.1111/bjd.18943","title":"The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Health and Medical Research Council; Medical Research Council; Pfizer","keywords":"Scabies; Medicine; Delphi method; Standardization; Intensive care medicine; Dermatology; Computer science; Artificial intelligence","score_opus":0.05561759819834139,"score_gpt":0.37920051202005417,"score_spread":0.3235829138217128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005031357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035783818,0.9590431,0.0020839302,0.035122346,0.00087160245,0.0014749959,0.0013113687,0.000005920454,0.000050937633],"genre_scores_gemma":[0.0087421145,0.9894272,0.00038068934,0.0006889327,0.00029099782,0.00037860693,0.000029672274,0.000024851084,0.000036948655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975277,0.00022849807,0.0016094842,0.00015035908,0.00025764754,0.0002262976],"domain_scores_gemma":[0.9864127,0.010641573,0.0016925327,0.00018876448,0.0009713251,0.00009312913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027221025,0.00020508411,0.001660566,0.00003743973,0.00023556921,0.00006716594,0.00063433184,0.00015453757,0.00006217932],"category_scores_gemma":[0.0045058713,0.00010783775,0.0012305421,0.00012166845,0.0008127181,0.00004625438,0.00005694103,0.00031858814,0.0000021018398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039187804,0.00016658295,0.00033938972,0.0051558386,0.002906244,0.00037441665,0.00004452748,0.0000026373757,0.000001247851,0.0019393979,0.18160251,0.8070753],"study_design_scores_gemma":[0.0015641053,0.00013441891,0.0004948911,0.0043441816,0.0030123019,0.025546566,0.00020965317,0.00027425901,0.0000057627244,0.00049271225,0.96382445,0.00009667531],"about_ca_topic_score_codex":0.000007940889,"about_ca_topic_score_gemma":0.000011233012,"teacher_disagreement_score":0.80697864,"about_ca_system_score_codex":0.000023131663,"about_ca_system_score_gemma":0.0004043272,"threshold_uncertainty_score":0.5394274},"labels":[],"label_agreement":null},{"id":"W3005494339","doi":"10.1111/bjd.18757","title":"Which treatments for fungal nail infections work better, those taken by mouth work or those applied to the nail?","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Terbinafine; Itraconazole; Dermatology; Adverse effect; Nail (fastener); Clinical trial; Randomized controlled trial; Surgery; Dentistry; Antifungal; Internal medicine","score_opus":0.028958720128343822,"score_gpt":0.28919440659339024,"score_spread":0.2602356864650464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005494339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604385,0.0057734135,0.0013674812,0.029698865,0.00045070442,0.0014508172,0.00019916173,0.000057772675,0.0005632717],"genre_scores_gemma":[0.99291617,0.0004606158,0.001022817,0.0047468743,0.0003388045,0.00013460573,0.000055757995,0.00004570193,0.00027865526],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984374,0.00008804865,0.00056005194,0.00025615437,0.0002532829,0.00040505274],"domain_scores_gemma":[0.99864185,0.00018319646,0.00026344787,0.00017513512,0.00020425716,0.0005320919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066695815,0.00021940125,0.0006125631,0.00007117148,0.00025719666,0.00008144458,0.00018883686,0.00013183155,0.00011881993],"category_scores_gemma":[0.00023641296,0.00016194906,0.00024499197,0.0005566097,0.000049764265,0.000083359635,0.000052475232,0.00029520382,0.0000668953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005184715,0.002242025,0.18578908,0.000091899994,0.0030384003,0.0047274763,0.0009516636,0.000016234602,0.00008764516,0.00002488049,0.55625767,0.2415883],"study_design_scores_gemma":[0.071027696,0.0049248524,0.50679636,0.0025594907,0.01031442,0.09012577,0.0020107538,0.000039853236,0.002119207,0.00041396165,0.30823663,0.0014309871],"about_ca_topic_score_codex":0.000017419341,"about_ca_topic_score_gemma":0.00004043068,"teacher_disagreement_score":0.32100728,"about_ca_system_score_codex":0.0000719709,"about_ca_system_score_gemma":0.00018547062,"threshold_uncertainty_score":0.6604091},"labels":[],"label_agreement":null},{"id":"W3011453881","doi":"10.1111/bjd.19018","title":"Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to &lt; 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label <scp>CADMUS</scp> Jr study","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexus Clinical Research (Canada); Memorial University of Newfoundland","funders":"Janssen Research and Development","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Dermatology Life Quality Index; Dosing; Internal medicine; Discontinuation; Gastroenterology; Dermatology; Infliximab; Disease","score_opus":0.03612339614048511,"score_gpt":0.273350417063129,"score_spread":0.23722702092264392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011453881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928493,0.0064557884,0.000047910595,0.0009079695,0.00049436395,0.0017811027,0.0009825868,0.0000056567933,0.000039690254],"genre_scores_gemma":[0.996547,0.0027898666,0.00019143465,0.00022693981,0.000053424403,0.000055868255,0.00007308349,0.000022741931,0.00003967421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975975,0.0006674138,0.0010229409,0.00031315023,0.00008760595,0.00031136535],"domain_scores_gemma":[0.99622875,0.0028452014,0.000503665,0.00019671857,0.0001473079,0.00007834997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023053147,0.00021733757,0.0008086388,0.00012701673,0.00012795808,0.00003353795,0.0005691755,0.00016384223,0.00001541215],"category_scores_gemma":[0.00050437864,0.00016501054,0.00012611494,0.00029410698,0.00009263008,0.000079124424,0.00017124582,0.0001388267,0.0000075621797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025591018,0.010150943,0.08706635,0.000054889533,0.006003275,0.0014453144,0.0289514,0.00034390253,0.005981589,0.000019055968,0.039599683,0.7947926],"study_design_scores_gemma":[0.11208627,0.0046567055,0.8511607,0.00016169676,0.0016112572,0.0010694949,0.0020316697,0.000033470733,0.006433595,0.000050008613,0.020490242,0.00021487719],"about_ca_topic_score_codex":0.0004331137,"about_ca_topic_score_gemma":0.0005455077,"teacher_disagreement_score":0.7945777,"about_ca_system_score_codex":0.000042516836,"about_ca_system_score_gemma":0.00010975989,"threshold_uncertainty_score":0.6728934},"labels":[],"label_agreement":null},{"id":"W3014954599","doi":"10.1111/bjd.19089","title":"Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Tongji Medical College, Huazhong University of Science and Technology; Department of Medicine, University of Toronto; Zhongnan Hospital of Wuhan University; Hubei University of Medicine; Tongji University; Wuhan University; University of Toronto; Peking University; Huazhong University of Science and Technology; Hubei University; Renmin Hospital of Wuhan University; Peking University First Hospital","keywords":"Outbreak; Disease; Health care; Coronavirus disease 2019 (COVID-19); Coronavirus; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Environmental health; Virology; Infectious disease (medical specialty); Pathology; Economic growth","score_opus":0.03942157222490661,"score_gpt":0.30232677924604273,"score_spread":0.2629052070211361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014954599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821926,0.0030278994,0.00022809455,0.008032629,0.00023792272,0.00020364908,0.000014130534,0.0000128073725,0.00002360279],"genre_scores_gemma":[0.9987484,0.00066756405,0.000008082816,0.00036800554,0.000117185795,0.000004263384,0.000009512657,0.00001159875,0.00006535899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998767,0.00033525488,0.00046397772,0.00011886832,0.00013212173,0.00018277907],"domain_scores_gemma":[0.9991042,0.0001437323,0.00027822482,0.00005795887,0.00016147422,0.00025440965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002292439,0.000079359495,0.00027744155,0.00010476691,0.00017463858,0.000022968516,0.000049694227,0.000069049405,0.0000152050125],"category_scores_gemma":[0.00044896523,0.00007694406,0.000087606495,0.00020487135,0.00005725084,0.00021153636,0.000021947415,0.0004373813,0.0000038939725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046882537,0.000041736115,0.9960163,0.00007969506,0.000040186376,0.0020552203,0.00016099404,0.000035563826,0.00003789427,0.000029355559,0.00029725375,0.0007369453],"study_design_scores_gemma":[0.0019411356,0.000032330474,0.9792065,0.00040209782,0.000047097306,0.017241066,0.00024177118,0.00039696318,0.00001717547,0.000015222103,0.0003963445,0.000062268395],"about_ca_topic_score_codex":0.0010525859,"about_ca_topic_score_gemma":0.0024250052,"teacher_disagreement_score":0.016809803,"about_ca_system_score_codex":0.000060689334,"about_ca_system_score_gemma":0.00012358869,"threshold_uncertainty_score":0.31376877},"labels":[],"label_agreement":null},{"id":"W3015243915","doi":"10.1111/bjd.19132","title":"Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE-1)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Bausch Health; Ortho Dermatologics","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Psoriasis; Dermatology; Pathology","score_opus":0.01067272546066037,"score_gpt":0.2536275253746416,"score_spread":0.24295479991398125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015243915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95976406,0.03886595,0.00017792893,0.00037652548,0.0001724539,0.00049833657,0.00010274921,0.000006794433,0.000035181944],"genre_scores_gemma":[0.9881844,0.011457957,0.00017129343,0.000060467875,0.000030577696,0.000014813085,0.000054898726,0.00001345955,0.000012168161],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99718827,0.0008453856,0.0013524479,0.00029323122,0.000069896625,0.00025074184],"domain_scores_gemma":[0.9982941,0.0006155051,0.0007916091,0.00012205848,0.00010882677,0.000067903246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002990704,0.00023622214,0.0024437997,0.0003034481,0.00006251337,0.000018725064,0.00011443156,0.00027448818,0.00011145268],"category_scores_gemma":[0.00021001542,0.00021952113,0.00030904537,0.00035750328,0.00061480846,0.00017835222,0.00007222246,0.00022501292,6.3992496e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.861652,0.0010840072,0.08348046,0.00011586777,0.011916597,0.0022337975,0.0031130603,0.0000016808334,0.00239599,0.00007345306,0.000058107627,0.03387495],"study_design_scores_gemma":[0.87492794,0.00090307684,0.10565089,0.00018761538,0.007861928,0.007183887,0.00014726716,0.000013254823,0.002837214,0.000040627838,0.00004131533,0.00020497697],"about_ca_topic_score_codex":0.00015516407,"about_ca_topic_score_gemma":0.00018329297,"teacher_disagreement_score":0.033669975,"about_ca_system_score_codex":0.000016371856,"about_ca_system_score_gemma":0.00006550463,"threshold_uncertainty_score":0.8951812},"labels":[],"label_agreement":null},{"id":"W3015607706","doi":"10.1111/bjd.19135","title":"High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enthesitis; Medicine; Hidradenitis suppurativa; Spondyloarthropathy; Dermatology; Internal medicine; Psoriatic arthritis; Physical therapy; Arthritis; Psoriasis; Disease","score_opus":0.014241447572193752,"score_gpt":0.26236534689952123,"score_spread":0.24812389932732748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015607706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932326,0.0015058975,0.000024177874,0.008820997,0.000053271055,0.00020483612,0.00003153023,0.000004394455,0.000031616055],"genre_scores_gemma":[0.9970479,0.0017927643,0.0010731734,0.00002446879,0.000036020017,0.0000023478735,0.000007817641,0.000011590055,0.000003919567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984142,0.00021399785,0.00082646246,0.00017120613,0.00021097367,0.00016314199],"domain_scores_gemma":[0.9990963,0.00015108318,0.0003592173,0.00005382933,0.000110519424,0.0002290623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000009832161,0.00011976459,0.0008205219,0.000102718084,0.00003429315,0.000019174537,0.00006097682,0.000071654606,0.000039561328],"category_scores_gemma":[0.00015272356,0.00010040395,0.00006687298,0.00013376586,0.00042496357,0.00023426423,0.000029631077,0.00027810747,6.381279e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054600165,0.00027201633,0.9051746,0.00010345746,0.00012907681,0.073583335,0.0002461409,1.6514267e-8,0.000008299731,0.00003163116,0.000055787877,0.019849611],"study_design_scores_gemma":[0.0066295867,0.0012228293,0.69276506,0.00049426086,0.00011926803,0.29832634,0.00016313403,0.0000051581505,0.00013137366,0.000055440218,0.00001943011,0.00006809186],"about_ca_topic_score_codex":0.00004388361,"about_ca_topic_score_gemma":0.00004295374,"teacher_disagreement_score":0.22474302,"about_ca_system_score_codex":0.000004686251,"about_ca_system_score_gemma":0.00006609545,"threshold_uncertainty_score":0.40943542},"labels":[],"label_agreement":null},{"id":"W3016397458","doi":"10.1111/bjd.19147","title":"Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; UCB Pharma; Sanofi Genzyme; Genentech; Ortho Dermatologics; Gilead Sciences; LEO Pharma; Bausch Health; Astellas Pharma; Sanofi; Kyowa Hakko Kirin; Coherus Biosciences; Sun Pharma; Dermira; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Medac; Baxalta; Celgene; Pfizer; Biogen; Amgen; Meiji Seika Pharma; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; Astellas Pharma US","keywords":"Ixekizumab; Placebo; Medicine; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Secukinumab; Internal medicine; Dermatology; Pathology","score_opus":0.012410969481534086,"score_gpt":0.23847296329299128,"score_spread":0.2260619938114572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016397458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98161525,0.012632763,0.0001995482,0.00015539837,0.00054472033,0.004327543,0.00015513215,0.000041357012,0.00032827305],"genre_scores_gemma":[0.99677044,0.0021691176,0.0001939779,0.0001998551,0.00010542127,0.00024988738,0.00011241038,0.00007583179,0.00012308056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99253786,0.0025685534,0.0027776617,0.0007913931,0.00028143992,0.0010430941],"domain_scores_gemma":[0.9914804,0.0058136703,0.0016359391,0.00030246453,0.00046440182,0.00030311817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010175897,0.0007290609,0.0042245993,0.0010474336,0.00023536931,0.00008925174,0.0005961776,0.00071893353,0.000015264819],"category_scores_gemma":[0.002761035,0.0006709135,0.00042167367,0.0010115049,0.00030566685,0.00042058877,0.00020795815,0.0010617936,0.000033163393],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8070915,0.014350142,0.10825268,0.0002675968,0.008642781,0.0086352145,0.024212763,0.0010999155,0.0006354129,0.00007957647,0.008266839,0.018465577],"study_design_scores_gemma":[0.9724145,0.0019321153,0.012742717,0.00024402041,0.0013781473,0.0047936765,0.003793664,0.0000476603,0.0017946949,0.000046452467,0.0006727017,0.00013968346],"about_ca_topic_score_codex":0.00015904669,"about_ca_topic_score_gemma":0.00039289636,"teacher_disagreement_score":0.16532296,"about_ca_system_score_codex":0.00010545557,"about_ca_system_score_gemma":0.00044084666,"threshold_uncertainty_score":0.9995742},"labels":[],"label_agreement":null},{"id":"W3017296821","doi":"10.1111/bjd.19152","title":"Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Sun exposure; Keratinocyte; Systematic review; Occupational exposure; Medicine; Dermatology; Oncology; Environmental health; MEDLINE; Biology; Genetics","score_opus":0.058881188850304654,"score_gpt":0.3719527484577637,"score_spread":0.3130715596074591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017296821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009124037,0.9968869,0.000037734502,0.0011085366,0.00036882065,0.0013680941,0.00008114481,0.00001180349,0.00012784413],"genre_scores_gemma":[0.0002244104,0.99746126,0.0003275914,0.0015252583,0.00030447444,0.000098417724,0.000011109159,0.000029688577,0.000017788356],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962359,0.0006181944,0.002004659,0.00033448503,0.00054431247,0.0002624494],"domain_scores_gemma":[0.99674517,0.0005659229,0.0018802182,0.00022341356,0.00034175755,0.0002435306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026543136,0.0003848699,0.0059841103,0.000092174945,0.00008667345,0.000051612045,0.0002646366,0.00022269931,0.000043199834],"category_scores_gemma":[0.0021175568,0.00033467612,0.00057336275,0.00031693777,0.00014334223,0.000116643794,0.00009448566,0.00062534516,0.000022354963],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004495467,0.00002272279,0.00033128177,0.8587781,0.0010058163,0.019051375,0.000013380259,3.3172313e-8,7.108398e-9,0.000023730945,0.017175814,0.10355275],"study_design_scores_gemma":[0.00031344086,0.00017163037,0.0001412232,0.57537025,0.003912051,0.35353586,0.0000071485724,3.0100625e-7,7.971702e-8,0.000005700811,0.066407904,0.00013437876],"about_ca_topic_score_codex":0.00002159814,"about_ca_topic_score_gemma":0.00003942362,"teacher_disagreement_score":0.3344845,"about_ca_system_score_codex":0.00059767225,"about_ca_system_score_gemma":0.0017186748,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W3022063920","doi":"10.1111/bjd.19044","title":"Topical condyloma treatment: comparative evidence for a common problem","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Dermatology; Medicine","score_opus":0.18485903225365494,"score_gpt":0.42316269157641656,"score_spread":0.23830365932276162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022063920","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017086219,0.023868758,0.00023565772,0.97026086,0.00020688279,0.0009891482,0.000095366944,0.000019039891,0.0026156632],"genre_scores_gemma":[0.20800366,0.006773361,0.0030174174,0.77243924,0.007284491,0.00019438846,0.00026916093,0.000095813295,0.0019224696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796134,0.00023194255,0.00075975637,0.00025330402,0.00039130886,0.00040233426],"domain_scores_gemma":[0.99778587,0.0009365538,0.0003386299,0.00013188367,0.00058049755,0.00022658444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058479858,0.00021175935,0.0015790552,0.00011219747,0.00009284091,0.00007215949,0.00023601386,0.00044350678,0.0008448835],"category_scores_gemma":[0.00016880731,0.000197899,0.0004723649,0.00010105369,0.00024052276,0.00009118562,0.000045413606,0.0017291029,0.000020371006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095803145,0.00008003805,0.0006403191,0.0007937615,0.00040217146,0.04862599,0.00014640813,1.1906285e-7,0.000009398608,0.000020263775,0.9259303,0.022393206],"study_design_scores_gemma":[0.004838571,0.0019212973,0.0010956485,0.0008069549,0.00045382537,0.16703354,0.000035974634,0.000030393581,0.00036217805,0.0009806058,0.8222656,0.00017538777],"about_ca_topic_score_codex":0.000073876676,"about_ca_topic_score_gemma":0.000080650236,"teacher_disagreement_score":0.20629503,"about_ca_system_score_codex":0.00019575605,"about_ca_system_score_gemma":0.0006015475,"threshold_uncertainty_score":0.92508817},"labels":[],"label_agreement":null},{"id":"W3022245210","doi":"10.1111/bjd.17239","title":"CONSORT 2010 statement: extension checklist for reporting within person randomised trials","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"Medical Research Council; Cancer Research UK","keywords":"Consolidated Standards of Reporting Trials; Checklist; Clinical trial; Medicine; Transparency (behavior); Psychological intervention; Randomized controlled trial; Quality (philosophy); Systematic review; Reliability (semiconductor); MEDLINE; Medical physics; Family medicine; Psychology; Computer science; Nursing; Surgery","score_opus":0.6750508357817939,"score_gpt":0.5191783007553237,"score_spread":0.15587253502647025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022245210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95948786,0.0049936306,0.026950572,0.0020202124,0.002744134,0.0019898943,0.000021228154,0.000004161246,0.0017883371],"genre_scores_gemma":[0.982427,0.00010827941,0.0096703945,0.00042811251,0.00013878662,0.00002146557,0.000006969828,0.000018240618,0.007180727],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.94653,0.011832344,0.038075157,0.00058687845,0.0026521755,0.00032344268],"domain_scores_gemma":[0.9156586,0.0092070615,0.07093047,0.00096369896,0.0030479624,0.00019221148],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24675663,0.00021327146,0.008262954,0.0003436962,0.00014989426,0.0007247253,0.00083782064,0.0001440711,0.0042905593],"category_scores_gemma":[0.2750755,0.00012783965,0.0033516388,0.00032528877,0.00006658633,0.00035103824,0.00004051345,0.00027053157,0.00026766394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018203973,0.00021211052,0.045481578,0.0003259523,0.0018899941,0.0029122324,0.001155999,0.00015711747,0.0049130544,0.0007955394,0.90035254,0.03998348],"study_design_scores_gemma":[0.10298307,0.0006434335,0.033028036,0.0022985155,0.004856987,0.45152843,0.015093561,0.01799075,0.006228637,0.020649213,0.34303382,0.0016655175],"about_ca_topic_score_codex":0.000014054253,"about_ca_topic_score_gemma":0.00001763055,"teacher_disagreement_score":0.5573187,"about_ca_system_score_codex":0.00002697368,"about_ca_system_score_gemma":0.00021389948,"threshold_uncertainty_score":0.99661964},"labels":[],"label_agreement":null},{"id":"W3032957745","doi":"10.1111/bjd.19075","title":"A study of the drug tildrakizumab for plaque psoriasis","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Medicine; Dermatology; Plaque psoriasis; Drug; Dermatologic agents; Pharmacology; Antibiotics; Microbiology","score_opus":0.019651180493657584,"score_gpt":0.23760066452775977,"score_spread":0.2179494840341022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032957745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914191,0.0049461015,0.000073394556,0.002025335,0.001003257,0.00037157364,0.000054770746,0.0000105436475,0.00009594539],"genre_scores_gemma":[0.9993491,0.00016094501,0.00008583622,0.00021068155,0.00007048942,0.000014739004,0.00000521711,0.000014265272,0.00008868122],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986033,0.00039189908,0.0006020624,0.00014264365,0.000048149628,0.00021195637],"domain_scores_gemma":[0.9989433,0.0002306661,0.00050882896,0.00012246946,0.00016299014,0.000031687297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010185016,0.00012206294,0.00053347694,0.00005068628,0.0001528468,0.000010629094,0.00040525256,0.00013378436,0.00006942712],"category_scores_gemma":[0.00017330688,0.000100845806,0.00025510456,0.00013384376,0.00009610718,0.00006951329,0.00006519305,0.00020891654,0.000012494616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010690922,0.008680309,0.18209524,0.00041380568,0.013519401,0.0054229493,0.040700696,0.00007062742,0.042834386,0.0012209713,0.3566025,0.3377482],"study_design_scores_gemma":[0.10516629,0.004635177,0.13576831,0.00056271284,0.0049502235,0.23731327,0.025972119,0.0000120251625,0.3604596,0.0009995563,0.122950815,0.0012099115],"about_ca_topic_score_codex":0.00004156555,"about_ca_topic_score_gemma":0.00010337661,"teacher_disagreement_score":0.33653829,"about_ca_system_score_codex":0.000013873238,"about_ca_system_score_gemma":0.00011521513,"threshold_uncertainty_score":0.41123727},"labels":[],"label_agreement":null},{"id":"W3034109117","doi":"10.1111/bjd.19072","title":"A study comparing the biologic drugs ixekizumab and guselkumab for the treatment of moderate‐to‐severe plaque psoriasis","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ixekizumab; Psoriasis; Medicine; Dermatology; Secukinumab; Psoriatic arthritis","score_opus":0.0377995545386855,"score_gpt":0.2587733163398282,"score_spread":0.2209737618011427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034109117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755369,0.0197053,0.00024799613,0.003227782,0.00041455982,0.0007629287,0.00005793995,0.000013147629,0.000033485343],"genre_scores_gemma":[0.9973621,0.0021221158,0.000111573456,0.00021335213,0.00007189184,0.00006716722,0.000008850158,0.000013774359,0.000029182787],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851274,0.0004086708,0.0005635242,0.00020300804,0.00004229006,0.00026976335],"domain_scores_gemma":[0.9986109,0.00073421607,0.0003303906,0.00014433125,0.00013477754,0.000045370278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013874118,0.00018762071,0.0007058893,0.000043848187,0.00035435782,0.000031494983,0.00030785182,0.00013390974,0.000023651584],"category_scores_gemma":[0.00007698178,0.000115508745,0.00018898933,0.000118670054,0.00015350865,0.000055539487,0.00005133936,0.00013429111,0.000008948026],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01910474,0.0048475857,0.0778958,0.00011368707,0.015235029,0.0016539724,0.062670656,0.00046454,0.0049449215,0.0005618487,0.01635151,0.7961557],"study_design_scores_gemma":[0.16615988,0.035409622,0.22953184,0.000488259,0.011574185,0.21086444,0.0957965,0.00048136522,0.11504292,0.0011854665,0.13117549,0.0022900163],"about_ca_topic_score_codex":0.00010027307,"about_ca_topic_score_gemma":0.000119845135,"teacher_disagreement_score":0.7938657,"about_ca_system_score_codex":0.00002822427,"about_ca_system_score_gemma":0.00006454514,"threshold_uncertainty_score":0.471031},"labels":[],"label_agreement":null},{"id":"W3034204123","doi":"10.1111/bjd.19314","title":"Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Dermira","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriasis; Randomized controlled trial; Plaque psoriasis; Internal medicine; Term (time); Pooled analysis; Gastroenterology; Dermatology; Meta-analysis; Pathology; Alternative medicine; Disease; Adalimumab","score_opus":0.016365935629782575,"score_gpt":0.26628293293723104,"score_spread":0.24991699730744846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034204123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9202676,0.07652856,0.0008408962,0.0009265306,0.0005990393,0.0005829059,0.00016850038,0.000019253486,0.00006672333],"genre_scores_gemma":[0.9921883,0.0073215505,0.000113654736,0.000105948544,0.000087678636,0.00003658368,0.00009412382,0.00002108851,0.000031077307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957768,0.0013363493,0.0020369967,0.00033472033,0.00011324506,0.00040192023],"domain_scores_gemma":[0.99681526,0.0013991185,0.001315911,0.00019126161,0.00019923753,0.000079231184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002474939,0.00030704137,0.0041580726,0.00043896257,0.0000867104,0.000020682632,0.00038607858,0.0003806767,0.00068675895],"category_scores_gemma":[0.0005687058,0.00029212257,0.001149803,0.00044245485,0.00034814765,0.0001741838,0.00009367641,0.00041794154,0.000021293035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81800985,0.0010068992,0.032352015,0.000056410892,0.081062675,0.021549284,0.003151194,0.000054594388,0.00348273,0.00007455392,0.0015603718,0.037639413],"study_design_scores_gemma":[0.94271314,0.00020635666,0.028592357,0.00022403034,0.014832742,0.009503231,0.00050043233,0.0000624188,0.002715523,0.00020319884,0.00010063898,0.00034595898],"about_ca_topic_score_codex":0.00023330028,"about_ca_topic_score_gemma":0.0013259596,"teacher_disagreement_score":0.12470326,"about_ca_system_score_codex":0.00006059132,"about_ca_system_score_gemma":0.00016152968,"threshold_uncertainty_score":0.9999531},"labels":[],"label_agreement":null},{"id":"W3037060742","doi":"10.1111/bjd.19341","title":"Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label, efficacy–assessor‐blinded clinical trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"AbbVie","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Interleukin 17; Internal medicine; Randomized controlled trial; Clinical endpoint; Confidence interval; Clinical trial; Dermatology; Psoriatic arthritis; Cytokine","score_opus":0.04242110571347812,"score_gpt":0.3147352210618506,"score_spread":0.27231411534837247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037060742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992528,0.0021242232,0.00023464512,0.0013753646,0.00080908043,0.0021358093,0.000671209,0.000018443761,0.000103227205],"genre_scores_gemma":[0.99706423,0.0011581415,0.00086425076,0.00036706452,0.00009351207,0.000031490286,0.00036452888,0.000038383147,0.000018421455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99280447,0.0024872231,0.0034328299,0.00063814555,0.00015366783,0.00048365],"domain_scores_gemma":[0.9947666,0.0026227485,0.0018007276,0.00028929565,0.0003191877,0.00020146286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008677997,0.00039648224,0.003399917,0.00021641927,0.00016521412,0.000070434144,0.0006657612,0.00062429206,0.00014052892],"category_scores_gemma":[0.0018174329,0.00035761565,0.00023867263,0.00035659468,0.00035163158,0.00029595415,0.00024560533,0.0007537473,0.000017725808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9387372,0.0043780054,0.001401783,0.0000133326885,0.0019801178,0.0006785578,0.00090926973,0.000022409837,0.00007364639,0.000021151456,0.0028235796,0.048960954],"study_design_scores_gemma":[0.9838293,0.0032001748,0.007947286,0.00036623937,0.0007602341,0.001038974,0.00010700958,0.000018390821,0.00116796,0.000043131626,0.0011536762,0.00036761188],"about_ca_topic_score_codex":0.00026709572,"about_ca_topic_score_gemma":0.0001342383,"teacher_disagreement_score":0.048593342,"about_ca_system_score_codex":0.00004382219,"about_ca_system_score_gemma":0.000383516,"threshold_uncertainty_score":0.9998876},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3037583352","doi":"10.1111/bjd.19338","title":"COVID‐19 chilblain‐like lesion: immunohistochemical demonstration of SARS‐CoV‐2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction‐negative patient","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Calgary","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Lesion; Pathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Dermatology; Endothelium; Emergency department; 2019-20 coronavirus outbreak; Internal medicine; Outbreak; Disease","score_opus":0.021736448261101878,"score_gpt":0.26817749021407594,"score_spread":0.24644104195297406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037583352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.593871,0.011703199,0.0000651364,0.39293772,0.00018984253,0.00092568184,0.00009053093,0.000021975213,0.00019491209],"genre_scores_gemma":[0.84879786,0.00230744,0.00040520707,0.14800599,0.000271277,0.00007583594,0.00006565548,0.00004086787,0.000029839272],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99627495,0.00055782794,0.001779212,0.00045774135,0.0004794267,0.00045084473],"domain_scores_gemma":[0.9978955,0.0003781564,0.0011534627,0.00017443555,0.00019391066,0.00020457593],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00014978444,0.00040567722,0.0018481323,0.00045519363,0.0000950059,0.000026963326,0.00019904005,0.00071142893,0.000018980913],"category_scores_gemma":[0.0009812457,0.00039316763,0.00023913142,0.00031605308,0.0005626418,0.00012923863,0.00012012068,0.0024464445,0.0000024612548],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004790135,0.00247242,0.02728411,0.005874823,0.0013379119,0.45272765,0.0035765283,0.000001462602,0.2482511,0.00007863069,0.24544813,0.0081571005],"study_design_scores_gemma":[0.029356753,0.0022527755,0.009458451,0.0077894223,0.001002365,0.7527397,0.001423025,0.000047103797,0.12849718,0.0034121398,0.06254415,0.0014768988],"about_ca_topic_score_codex":0.0005376712,"about_ca_topic_score_gemma":0.000113229915,"teacher_disagreement_score":0.30001208,"about_ca_system_score_codex":0.00016416302,"about_ca_system_score_gemma":0.00062916934,"threshold_uncertainty_score":0.9998549},"labels":[],"label_agreement":null},{"id":"W3042003151","doi":"10.1111/bjd.19393","title":"Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2)","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Randomized controlled trial; Internal medicine; Dermatology; Adalimumab; Disease","score_opus":0.043120984841270325,"score_gpt":0.30675068317116083,"score_spread":0.2636296983298905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042003151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453619,0.047649927,0.00086873205,0.00255863,0.00083766296,0.0013273838,0.0013451104,0.00001579934,0.000034847544],"genre_scores_gemma":[0.9830454,0.0161204,0.00026961332,0.000038266127,0.0002455265,0.000043865646,0.00017956519,0.000024936757,0.000032452117],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955188,0.0015091395,0.0022647213,0.00029641663,0.00008049607,0.0003304396],"domain_scores_gemma":[0.99041253,0.0070372666,0.0020137166,0.00022489815,0.00022337135,0.00008819018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036850365,0.00029599748,0.0028803875,0.000120596895,0.00015139583,0.000025672987,0.00030686427,0.0002898196,0.00012663026],"category_scores_gemma":[0.0013606354,0.000212758,0.0009327285,0.0001116279,0.0004366082,0.000096837786,0.000035067802,0.00015937629,0.0000060579073],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7717557,0.0015968605,0.00067424786,0.00005328403,0.010060292,0.0012968958,0.0041256086,0.0000059081,0.010841883,0.000114163944,0.0025914833,0.19688368],"study_design_scores_gemma":[0.9056902,0.0015828675,0.0013826606,0.00017639718,0.0047284914,0.013533295,0.0003674463,0.000015638858,0.07033874,0.00012936995,0.001840886,0.00021404258],"about_ca_topic_score_codex":0.0002894659,"about_ca_topic_score_gemma":0.00006885928,"teacher_disagreement_score":0.19666964,"about_ca_system_score_codex":0.000028628874,"about_ca_system_score_gemma":0.00018659519,"threshold_uncertainty_score":0.86760193},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W3047954696","doi":"10.1111/bjd.19461","title":"Exploring the human hair follicle microbiome*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institute for Advanced Research; University of Miami","keywords":"Microbiome; Human Microbiome Project; Dysbiosis; Human microbiome; Human skin; Hair follicle; Alopecia areata; Biology; Cathelicidin; Immunology; Microbiology; Medicine; Dermatology; Antimicrobial peptides; Antimicrobial; Bioinformatics; Cell biology; Genetics","score_opus":0.10481497034995306,"score_gpt":0.3367475182305985,"score_spread":0.23193254788064543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047954696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006925466,0.9962957,0.000016119806,0.0014343652,0.0006723049,0.0003269388,0.000025233938,0.000031967957,0.0005048237],"genre_scores_gemma":[0.0030967533,0.99574155,0.00007860942,0.0005097049,0.00037966066,0.00002826688,0.000029941157,0.000057528432,0.00007799797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744934,0.00043997477,0.0013273779,0.00022799497,0.0001992229,0.0003561069],"domain_scores_gemma":[0.9982509,0.0002514519,0.0008365524,0.00024686765,0.00014603733,0.0002682067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012466396,0.00029895446,0.0027139136,0.00021580563,0.00022914314,0.000057166813,0.000506075,0.00024324506,0.00009671062],"category_scores_gemma":[0.00024064364,0.00023520764,0.0011841478,0.00031364665,0.00028821643,0.00016026679,0.000116003466,0.0012221423,0.000115141775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002006117,0.00014785203,0.000121659956,0.0062065176,0.0009971709,0.09151132,0.00005742556,2.6811065e-8,0.0000027135372,0.000046873603,0.10313758,0.79775083],"study_design_scores_gemma":[0.00043667707,0.000019765353,0.00009286048,0.007005661,0.0012234753,0.43509817,0.00002627456,1.1673659e-7,0.000008457803,0.000025389414,0.5559578,0.00010535838],"about_ca_topic_score_codex":0.000006496657,"about_ca_topic_score_gemma":0.0000043507425,"teacher_disagreement_score":0.79764545,"about_ca_system_score_codex":0.00005255764,"about_ca_system_score_gemma":0.00045819767,"threshold_uncertainty_score":0.95914894},"labels":[],"label_agreement":null},{"id":"W3049615455","doi":"10.1111/bjd.19490","title":"Intralesional rituximab in the treatment of indolent primary cutaneous B‐cell lymphoma","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; McGill University","funders":"","keywords":"Rituximab; Medicine; Dermatology; Lymphoma; Primary (astronomy); Oncology; Internal medicine","score_opus":0.02096061679933361,"score_gpt":0.2733077475475117,"score_spread":0.2523471307481781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049615455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808942,0.010089338,0.00005797343,0.0075586913,0.000050107414,0.00034560196,0.00001499544,0.000005228179,0.0009838325],"genre_scores_gemma":[0.99257976,0.005447981,0.00035481888,0.0014662924,0.00009524711,0.0000069435528,0.0000110236715,0.000016036629,0.000021894293],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981001,0.00028244234,0.0006991078,0.00015075659,0.00049075286,0.00027686617],"domain_scores_gemma":[0.9990423,0.00025167307,0.00022760268,0.000109073044,0.0002167193,0.00015266637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007866666,0.00013114241,0.00069788686,0.00012904206,0.000043442175,0.00001921754,0.00021567121,0.00010267752,0.00010603757],"category_scores_gemma":[0.00012994958,0.00010639973,0.00020329794,0.00018525115,0.00019577402,0.00004883884,0.000024321187,0.00018724585,0.000013854349],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008728263,0.029698258,0.14569122,0.0008646736,0.00049948343,0.50087035,0.014302763,0.000032009273,0.009805931,0.00007521835,0.013063122,0.27636874],"study_design_scores_gemma":[0.02083502,0.0027724039,0.017231815,0.00018684464,0.00008969689,0.94359654,0.000951498,0.00017334674,0.006992176,0.000092578484,0.0069528744,0.00012520625],"about_ca_topic_score_codex":0.000059614715,"about_ca_topic_score_gemma":0.000047670652,"teacher_disagreement_score":0.4427262,"about_ca_system_score_codex":0.00015694344,"about_ca_system_score_gemma":0.0005667445,"threshold_uncertainty_score":0.4338855},"labels":[],"label_agreement":null},{"id":"W3084270130","doi":"10.1111/bjd.19538","title":"Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Conceptualization; Library science; Townsend; Hidradenitis suppurativa; Medicine; Computer science; Psychology; Artificial intelligence; Internal medicine; Disease","score_opus":0.041185504932253564,"score_gpt":0.3043674350963584,"score_spread":0.26318193016410485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084270130","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005508646,0.9919213,0.000013426183,0.0013493327,0.00023560827,0.0008247579,0.00006685255,0.00001235024,0.00006769202],"genre_scores_gemma":[0.52368927,0.4761063,0.000078933954,0.000004098114,0.000040721712,0.0000115285375,0.00002218796,0.00004054035,0.000006465834],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9965178,0.0009575078,0.0014763437,0.00030119906,0.00043447677,0.00031271658],"domain_scores_gemma":[0.99795157,0.00017586905,0.0012898943,0.0002533603,0.00013254152,0.00019673792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000012867956,0.00040265537,0.0031763816,0.00030493562,0.0001160042,0.000058617985,0.0003188172,0.00027663755,0.000018728628],"category_scores_gemma":[0.00003567571,0.00028116486,0.00038833337,0.00034831848,0.00022716807,0.00015878971,0.000062978965,0.00090290944,0.000004896151],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028018703,0.0004936071,0.0014937642,0.009611471,0.0013426017,0.6418559,0.0005459193,4.225943e-8,0.000037469057,0.0001458089,0.000011734782,0.3441815],"study_design_scores_gemma":[0.002817044,0.00053724385,0.0014461916,0.044641227,0.0013824701,0.94065726,0.00023728177,0.000004930892,0.000065605855,0.000014336635,0.008005663,0.00019072527],"about_ca_topic_score_codex":0.00006184524,"about_ca_topic_score_gemma":0.00002897847,"teacher_disagreement_score":0.5181806,"about_ca_system_score_codex":0.00016029419,"about_ca_system_score_gemma":0.00032010957,"threshold_uncertainty_score":0.99996406},"labels":[],"label_agreement":null},{"id":"W3087522660","doi":"10.1111/bjd.19561","title":"The global burden of chronic urticaria for the patient and society*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Chronic urticaria; Dermatology; Intensive care medicine","score_opus":0.015063105415696382,"score_gpt":0.2944130739982385,"score_spread":0.27934996858254213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087522660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016978887,0.9935772,0.00030572564,0.0049687843,0.00041012556,0.0005211682,0.00008319956,0.0000045466104,0.00011227209],"genre_scores_gemma":[0.00093689654,0.99852484,0.00012032188,0.00008204117,0.00028174385,0.0000190932,0.000007662569,0.0000151623935,0.000012229177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860454,0.00010293214,0.00083703815,0.00010552456,0.00015391345,0.00019604828],"domain_scores_gemma":[0.998374,0.0005982745,0.00060736487,0.000119756216,0.00019181294,0.000108790424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007776268,0.00013353939,0.0010489684,0.00001542763,0.00019226423,0.000031889977,0.00018156151,0.00026407637,0.000014807659],"category_scores_gemma":[0.00019179961,0.000077002216,0.0007379032,0.00012538856,0.00035806978,0.000022305985,0.00005823673,0.00054839643,0.0000020030275],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001390233,0.00002695692,0.0000021411324,0.0008639642,0.004941595,0.00052389124,0.00007273995,3.4312976e-7,3.8114183e-7,0.0010496269,0.012069751,0.9804347],"study_design_scores_gemma":[0.00065878767,0.0001906067,0.000012233004,0.0035960027,0.013484107,0.180782,0.00012873963,0.00007101149,7.2746667e-7,0.0003139628,0.8007027,0.000059140857],"about_ca_topic_score_codex":0.000008565522,"about_ca_topic_score_gemma":0.000003346509,"teacher_disagreement_score":0.9803756,"about_ca_system_score_codex":0.000082271166,"about_ca_system_score_gemma":0.0008011427,"threshold_uncertainty_score":0.3140059},"labels":[],"label_agreement":null},{"id":"W3090227268","doi":"10.1111/bjd.19573","title":"Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Placebo; Atopic dermatitis; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.03726144453849478,"score_gpt":0.31077395832284244,"score_spread":0.27351251378434766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090227268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9266635,0.0142758945,0.004372388,0.046856236,0.0007056376,0.006742788,0.00021075222,0.000025007168,0.00014780187],"genre_scores_gemma":[0.99315864,0.0020000194,0.00038471963,0.0035506221,0.00045263726,0.0002953097,0.00005606428,0.000022634018,0.000079341065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99640363,0.00059226836,0.002054879,0.00027062636,0.00030759655,0.00037096677],"domain_scores_gemma":[0.9937769,0.00445471,0.0008298167,0.00027596328,0.000318011,0.00034459226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022084672,0.00026895903,0.0023761438,0.00006115766,0.0002178874,0.00007011274,0.00032716905,0.00021157035,0.00008321685],"category_scores_gemma":[0.0013389448,0.0001658134,0.00092205865,0.00011549615,0.00029902422,0.00011615001,0.000028300921,0.00028721313,0.000007166065],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9714919,0.0009771221,0.00009350967,0.000037813257,0.0020375277,0.0022009658,0.0023717822,0.00010327106,0.000013945638,0.000048164326,0.013756543,0.0068675005],"study_design_scores_gemma":[0.9751604,0.00073750137,0.00022815487,0.00017616799,0.002677931,0.010644347,0.0006067785,0.0050909133,0.00062028825,0.00013465708,0.00377585,0.00014699704],"about_ca_topic_score_codex":0.000094443174,"about_ca_topic_score_gemma":0.00009475412,"teacher_disagreement_score":0.06649516,"about_ca_system_score_codex":0.00005583829,"about_ca_system_score_gemma":0.00036798138,"threshold_uncertainty_score":0.6761674},"labels":[],"label_agreement":null},{"id":"W3091046625","doi":"10.1111/bjd.19574","title":"Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":595,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research; Lynde Centre for Dermatology; University of Toronto","funders":"LEO Pharma","keywords":"Placebo; Atopic dermatitis; Double blind; Medicine; Randomized controlled trial; Physical therapy; Dermatology; Internal medicine; Alternative medicine","score_opus":0.04667870606626964,"score_gpt":0.33081951389425385,"score_spread":0.28414080782798423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091046625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93357575,0.019139986,0.008231684,0.031273816,0.00074317947,0.0057754302,0.00064008066,0.000085993204,0.00053410465],"genre_scores_gemma":[0.988566,0.0015039872,0.0032054544,0.0056262277,0.0006201754,0.00016728355,0.00017908365,0.000050600156,0.00008119091],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936933,0.0012628702,0.0035258117,0.0005274112,0.00037502774,0.00061556365],"domain_scores_gemma":[0.9924256,0.0044038584,0.0014300875,0.00022665219,0.00049812876,0.0010156468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009143237,0.00043308028,0.005122462,0.0002441644,0.00024310547,0.00016730202,0.00029224,0.00036802382,0.00016471231],"category_scores_gemma":[0.006047627,0.00040478597,0.0010012917,0.0001680816,0.00027952195,0.0003713375,0.00005838529,0.0006024631,0.000019463429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9381767,0.00060875947,0.00017886216,0.00016636404,0.0024368851,0.009440915,0.0012909592,0.00008130003,0.00010306633,0.000095622185,0.04135537,0.0060652276],"study_design_scores_gemma":[0.94229066,0.00021852991,0.00012709519,0.00053769,0.0029558304,0.043706685,0.00040778815,0.0046779085,0.001419254,0.00072661065,0.002570315,0.00036163034],"about_ca_topic_score_codex":0.000079173624,"about_ca_topic_score_gemma":0.00006624615,"teacher_disagreement_score":0.05499027,"about_ca_system_score_codex":0.000036085185,"about_ca_system_score_gemma":0.00035137014,"threshold_uncertainty_score":0.9998404},"labels":[],"label_agreement":null},{"id":"W3094557022","doi":"10.1111/bjd.19626","title":"Hidradenitis suppurativa and perceived stigmatization in a diverse Canadian clinic population: a pilot study","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Queen's University","funders":"LEO Fondet","keywords":"Hidradenitis suppurativa; Medicine; Population; Family medicine; Gerontology; Dermatology; Psychiatry; Environmental health; Pathology; Disease","score_opus":0.040006498285056966,"score_gpt":0.28687886405824575,"score_spread":0.24687236577318877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094557022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97819734,0.00042458007,0.000016103748,0.020606479,0.00008672993,0.00041008156,0.000018136328,0.000009896085,0.00023065053],"genre_scores_gemma":[0.9993474,0.00020868315,0.0002146006,0.000087986635,0.00006747191,0.0000049155765,0.000028736791,0.000014967546,0.000025222795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862254,0.00023741931,0.00059722085,0.00016024025,0.00017663701,0.00020596496],"domain_scores_gemma":[0.9991693,0.00006286331,0.00017089288,0.000055620505,0.000112834976,0.00042847023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000074281465,0.00011687366,0.0005039309,0.00020655394,0.00010069046,0.000043722775,0.000064974265,0.000059644182,0.00038108835],"category_scores_gemma":[0.0002673703,0.00012872498,0.00004022668,0.00021384137,0.000052370433,0.00027282292,0.000019058945,0.0002876583,0.000019811065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014146327,0.00024957937,0.68508095,0.000022854112,0.00006275127,0.3102151,0.0016080586,1.257381e-7,0.000031680618,0.0000049774144,0.00033644377,0.002246024],"study_design_scores_gemma":[0.004056781,0.0009552466,0.5469342,0.00011823457,0.00007732575,0.44598195,0.0017045666,0.00004086391,0.000003849666,0.000025935333,0.000035710753,0.00006535894],"about_ca_topic_score_codex":0.013956145,"about_ca_topic_score_gemma":0.07315574,"teacher_disagreement_score":0.13814677,"about_ca_system_score_codex":0.00008534119,"about_ca_system_score_gemma":0.00020779727,"threshold_uncertainty_score":0.99261},"labels":[],"label_agreement":null},{"id":"W3098806773","doi":"10.1111/bjd.19613","title":"Long‐term safety of dupilumab in children","year":2020,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Dupilumab; Dermatology; Term (time); Medicine; Atopic dermatitis; Physics; Astronomy","score_opus":0.00839095991920796,"score_gpt":0.24382186479428533,"score_spread":0.23543090487507737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098806773","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22460358,0.037690073,0.000104246414,0.7344386,0.0008310357,0.0006383546,0.00021341516,0.000036560697,0.0014441459],"genre_scores_gemma":[0.6849614,0.0038499122,0.00017313678,0.30946982,0.0010302268,0.000004879038,0.00033746124,0.00006859793,0.000104613755],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996924,0.00036045848,0.0016368711,0.0002668031,0.00038926335,0.00042261012],"domain_scores_gemma":[0.99815375,0.00018106977,0.0010315506,0.00023033521,0.00023235744,0.00017095622],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00007574936,0.0002788956,0.0019922487,0.00042486712,0.000041477004,0.000016289516,0.0004106473,0.0009258152,0.00036070577],"category_scores_gemma":[0.00034759214,0.0003166592,0.00051167264,0.00020972354,0.00038052766,0.00011023089,0.00008619997,0.0029941187,0.0000271787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002509588,0.00010508611,0.3186071,0.00032117264,0.0003511441,0.16504078,0.00002018767,1.8294513e-7,0.0000029683783,0.0000012260647,0.5137778,0.0015214069],"study_design_scores_gemma":[0.003596571,0.000063478394,0.42106643,0.0013279846,0.00037986183,0.5581238,0.0000054721477,0.0000011266955,0.00008706168,0.00009925399,0.015082354,0.00016661642],"about_ca_topic_score_codex":0.000020400552,"about_ca_topic_score_gemma":0.000011347823,"teacher_disagreement_score":0.49869546,"about_ca_system_score_codex":0.00005135934,"about_ca_system_score_gemma":0.0005229943,"threshold_uncertainty_score":0.99992853},"labels":[],"label_agreement":null},{"id":"W3103797363","doi":"10.1111/bjd.19675","title":"Identifying and appraising patient‐reported outcome measures on treatment satisfaction in acne: a systematic review*","year":2020,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Windsor Clinical Research","funders":"","keywords":"Acne; Patient satisfaction; Patient-reported outcome; Outcome (game theory); Systematic review; Medicine; Psychology; MEDLINE; Dermatology; Surgery; Quality of life (healthcare); Nursing; Political science; Mathematics","score_opus":0.09559344214986257,"score_gpt":0.37524820642767187,"score_spread":0.27965476427780933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103797363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095990783,0.9969607,0.00002088835,0.00017558702,0.00024831074,0.0015753839,0.0000062665936,0.000011962331,0.00004097231],"genre_scores_gemma":[0.0072593032,0.9922887,0.00007542168,0.00020814042,0.000049479728,0.000053335098,0.000016835324,0.00003505592,0.00001374266],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966528,0.00051665027,0.0020722984,0.00024924785,0.0002916862,0.00021733044],"domain_scores_gemma":[0.99770063,0.00021653388,0.0016789513,0.0001495712,0.0000799498,0.00017434782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017626143,0.0003474657,0.00499973,0.0002677263,0.00007199816,0.000047532656,0.000051954445,0.00022998152,0.0000070526653],"category_scores_gemma":[0.0005305418,0.00024128941,0.00056674285,0.00019682838,0.000032203385,0.00009011844,0.000022701059,0.00045155146,0.000008293963],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018210681,0.00012951465,0.0006715007,0.38890478,0.00093257875,0.04383676,0.00006698218,2.870427e-8,2.1740493e-7,0.0000011688423,0.00019202169,0.5652462],"study_design_scores_gemma":[0.0012620558,0.00032590018,0.00021446112,0.60351014,0.0070849443,0.3698011,0.000040162762,7.257994e-7,0.0000010295753,0.0000031773818,0.017613184,0.00014311411],"about_ca_topic_score_codex":0.000050487106,"about_ca_topic_score_gemma":0.000022380014,"teacher_disagreement_score":0.5651031,"about_ca_system_score_codex":0.0002639722,"about_ca_system_score_gemma":0.00017918063,"threshold_uncertainty_score":0.98394966},"labels":[],"label_agreement":null},{"id":"W3105897515","doi":"10.1111/bjd.19686","title":"Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Conceptualization; Medicine; Dermatology; Library science; Computer science; Artificial intelligence; Pathology","score_opus":0.033529507752379124,"score_gpt":0.2972846565370426,"score_spread":0.2637551487846635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105897515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8725069,0.0019692087,0.01871752,0.1025757,0.00020610062,0.0026426918,0.00042080056,0.00006624476,0.00089483365],"genre_scores_gemma":[0.95151675,0.00006407544,0.04790731,0.00010519513,0.00013085177,0.000046318135,0.00008350499,0.00008476103,0.00006122545],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9965768,0.00043785997,0.0011742999,0.0005746421,0.0005666941,0.0006697301],"domain_scores_gemma":[0.9975076,0.00061945274,0.00061715266,0.00015967945,0.00049465743,0.000601469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000026314008,0.00044818615,0.0014646947,0.00031472012,0.00026881075,0.0001816448,0.00018267651,0.00027323625,0.00008004358],"category_scores_gemma":[0.0008493584,0.00043251767,0.00015914305,0.00038706945,0.00029239865,0.0007916058,0.00010727523,0.00071223173,0.0000032455268],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059067896,0.0019766027,0.2758359,0.0014255177,0.0012190213,0.5812295,0.011358513,0.0000012299839,0.005346835,0.0008714611,0.001393268,0.11343534],"study_design_scores_gemma":[0.029020099,0.0027325796,0.065817244,0.00090093917,0.00045113417,0.8969942,0.0013460736,0.00077668665,0.0006794787,0.00065151596,0.00020693736,0.0004231389],"about_ca_topic_score_codex":0.00007459687,"about_ca_topic_score_gemma":0.00010619637,"teacher_disagreement_score":0.31576464,"about_ca_system_score_codex":0.00009910234,"about_ca_system_score_gemma":0.00026818446,"threshold_uncertainty_score":0.99981266},"labels":[],"label_agreement":null},{"id":"W3121257303","doi":"10.1111/bjd.19808","title":"Inducible skin‐associated lymphoid tissue (iSALT) in a patient with Schnitzler syndrome who manifested wheals on recurrent localized erythema","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Erythema; Kyoto Protocol; Library science; Medicine; Medical education; Psychology; Computer science; Dermatology; Greenhouse gas","score_opus":0.007333987465562128,"score_gpt":0.22212702708737989,"score_spread":0.21479303962181776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121257303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567456,0.015269985,0.000043038683,0.02614307,0.0006864991,0.00046683804,0.00007155247,0.000011674604,0.0005616916],"genre_scores_gemma":[0.8434823,0.008572812,0.0002585567,0.14315751,0.00063222996,0.00010630315,0.002545065,0.0003052739,0.0009399681],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.996392,0.0007117247,0.0012072299,0.00052964705,0.0004441379,0.00071526505],"domain_scores_gemma":[0.99794656,0.000050694693,0.0010563125,0.0003839072,0.00046896984,0.000093557646],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00018379327,0.00045140795,0.0012017625,0.00033998524,0.00009996113,0.0000938149,0.000424297,0.0013960758,0.000094787385],"category_scores_gemma":[0.00020606452,0.00048767313,0.00025306345,0.00028741092,0.00014497715,0.000015765227,0.00012562939,0.0015902378,0.000013156796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005920554,0.0006805181,0.0011280206,0.00028921492,0.0010218093,0.19993901,0.0001800564,0.000032778116,0.001415336,0.0000038944204,0.7831637,0.011553589],"study_design_scores_gemma":[0.0063034235,0.002154334,0.0010538008,0.003984345,0.00015036123,0.5051447,0.00024198272,0.0000044512867,0.025605978,0.0000438015,0.45437983,0.0009329809],"about_ca_topic_score_codex":0.00008602876,"about_ca_topic_score_gemma":0.00026910598,"teacher_disagreement_score":0.32878387,"about_ca_system_score_codex":0.000116495336,"about_ca_system_score_gemma":0.0005850601,"threshold_uncertainty_score":0.99990034},"labels":[],"label_agreement":null},{"id":"W3127741312","doi":"10.1111/bjd.19874","title":"Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of California, San Francisco; Medical Research Council; National Institute for Health and Care Research; Wellcome Trust","keywords":"Atopic dermatitis; Dermatology; Consensus conference; Medicine; MEDLINE; Family medicine; Political science; Internal medicine; Law","score_opus":0.23209595287328302,"score_gpt":0.4617653728410365,"score_spread":0.2296694199677535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127741312","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031502586,0.00419386,0.000078617944,0.94311893,0.0024447322,0.0005275255,0.00009738236,0.000067973655,0.017968416],"genre_scores_gemma":[0.710359,0.041608088,0.0110410955,0.21311219,0.01760219,0.00023727972,0.00026675357,0.0002704832,0.0055029267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98696417,0.006313741,0.0013594774,0.00043707955,0.0038839949,0.0010415645],"domain_scores_gemma":[0.99044865,0.0016890939,0.0005397214,0.00036996242,0.0067056892,0.00024687516],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0056712586,0.00021083474,0.0007827912,0.0008268678,0.0005289975,0.00066708185,0.0019458671,0.0015873376,0.0006417268],"category_scores_gemma":[0.008904578,0.000290898,0.00020758426,0.0007559627,0.0016106818,0.000472079,0.00027107797,0.0075105857,0.000031083608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005980273,0.00012785169,0.0027755348,0.000063429135,0.00006038807,0.12858418,0.0010221138,0.0000010676274,0.0000049904675,0.0007196556,0.86189616,0.0047386354],"study_design_scores_gemma":[0.0005351125,0.00003568991,0.0031514787,0.000976976,0.00001546324,0.059867322,0.0015286345,0.000016548447,0.000019026458,0.0066412436,0.9269604,0.00025208667],"about_ca_topic_score_codex":0.010480629,"about_ca_topic_score_gemma":0.032077674,"teacher_disagreement_score":0.7300067,"about_ca_system_score_codex":0.0021426452,"about_ca_system_score_gemma":0.009750764,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W3129022701","doi":"10.1111/bjd.19866","title":"Five‐year efficacy and safety of tildrakizumab in patients with moderate‐to‐severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Mediprobe Research (Canada); University of Toronto","funders":"Manchester Biomedical Research Centre; Merck Sharp and Dohme; Almirall; National Institute for Health and Care Research","keywords":"Medicine; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Etanercept; Adverse effect; Placebo; Psoriasis; Gastroenterology; Surgery; Dermatology; Rheumatoid arthritis; Pathology","score_opus":0.038113802512536245,"score_gpt":0.34746219059349354,"score_spread":0.30934838808095727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129022701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841092,0.014437159,0.00009200882,0.0002399572,0.00025133122,0.00054869015,0.00025794347,0.000005947022,0.000057711888],"genre_scores_gemma":[0.9955576,0.0032447828,0.0008358851,0.000046655638,0.000016316495,0.000005184913,0.000060896265,0.000019673947,0.00021302792],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99042225,0.0062101334,0.0025629483,0.00037426464,0.00011858914,0.0003118397],"domain_scores_gemma":[0.9939816,0.0037283532,0.0014671966,0.00022166227,0.0005009219,0.00010025647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020863255,0.00025463593,0.003432671,0.00025447796,0.00011199327,0.00001902981,0.0001630118,0.00033505884,0.0001250852],"category_scores_gemma":[0.002548303,0.00022114276,0.0002994266,0.00027703983,0.0004277612,0.00012975548,0.00012796921,0.00031102062,0.0000030883205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92338705,0.0020402863,0.03555509,0.00006857568,0.0052730227,0.0010583948,0.0008696148,0.00015583095,0.0068885298,0.000038780225,0.0013967688,0.023268081],"study_design_scores_gemma":[0.88064593,0.0010025712,0.07346814,0.0007029428,0.0021701187,0.0045453063,0.00024109158,0.000012119095,0.03666042,0.00006870313,0.00017567888,0.00030695088],"about_ca_topic_score_codex":0.00010747004,"about_ca_topic_score_gemma":0.00013427493,"teacher_disagreement_score":0.04274107,"about_ca_system_score_codex":0.000031094816,"about_ca_system_score_gemma":0.00024419688,"threshold_uncertainty_score":0.901794},"labels":[],"label_agreement":null},{"id":"W3134902410","doi":"10.1111/bjd.20048","title":"Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mycosis fungoides; Conceptualization; Library science; Medicine; Computer science; Pathology","score_opus":0.01704176493645321,"score_gpt":0.2796455711869432,"score_spread":0.26260380625049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134902410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71521807,0.054468036,0.000011075109,0.22987802,0.00003985505,0.00021389904,0.000039183346,0.0000023890198,0.00012946955],"genre_scores_gemma":[0.92685425,0.018153053,0.00014652922,0.054243434,0.00035060407,0.000008540896,0.000054569176,0.00003644333,0.0001525472],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99746823,0.0006602615,0.0007912261,0.0002306352,0.00052107486,0.00032855984],"domain_scores_gemma":[0.99813366,0.00096846634,0.0003619483,0.00016794054,0.00028511652,0.00008288771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003528894,0.00018792688,0.0011876238,0.00026615988,0.0000554034,0.000060834114,0.0002415405,0.0005082062,0.00009456229],"category_scores_gemma":[0.00045689594,0.00016663753,0.00011793374,0.00025945963,0.00040981336,0.00007792272,0.00010140933,0.0019962399,0.0000012052996],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007008046,0.00005046756,0.44653347,0.00075998536,0.00029516642,0.2942589,0.00052523887,1.7853063e-7,0.00005742154,7.9797474e-7,0.25058508,0.0068632257],"study_design_scores_gemma":[0.0011713239,0.00022842713,0.14212364,0.0014138905,0.00015411073,0.84475344,0.00030808002,0.0000059387894,0.000053608455,0.0001517787,0.00951645,0.0001192842],"about_ca_topic_score_codex":0.00018847302,"about_ca_topic_score_gemma":0.00011582476,"teacher_disagreement_score":0.5504946,"about_ca_system_score_codex":0.000045454024,"about_ca_system_score_gemma":0.0004933554,"threshold_uncertainty_score":0.86727804},"labels":[],"label_agreement":null},{"id":"W3165137789","doi":"10.1111/bjd.20527","title":"Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Psoriasis; Eczematous dermatitis; Ustekinumab; Ixekizumab; Adverse effect; Population; Atopy; Etanercept; Allergy; Internal medicine; Secukinumab; Disease; Adalimumab; Immunology; Psoriatic arthritis","score_opus":0.010541554469904646,"score_gpt":0.20993748670632478,"score_spread":0.19939593223642013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165137789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898505,0.0034346003,0.000075530865,0.0040998873,0.0003069969,0.00051896105,0.0015404293,0.0000225921,0.00015046442],"genre_scores_gemma":[0.98401266,0.0032741588,0.0005260558,0.0029402215,0.00008423874,0.00006462028,0.0076885456,0.00011885181,0.001290638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629176,0.0009781002,0.001421667,0.00058883545,0.00014367595,0.00057598],"domain_scores_gemma":[0.9974579,0.0002446675,0.0010964794,0.0003721135,0.0007494439,0.000079348065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000086896165,0.0006153028,0.0027284957,0.0014725275,0.00016717323,0.000043486318,0.00024431795,0.0011073804,0.0005257032],"category_scores_gemma":[0.00004645829,0.00050206116,0.00038609523,0.0013491249,0.0002089332,0.00015353801,0.000044847657,0.00092154014,0.00000676242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029169748,0.005177348,0.43039078,0.0005107538,0.15689364,0.056539636,0.0024719955,0.0017550007,0.0005201155,0.000016505632,0.1268068,0.18974769],"study_design_scores_gemma":[0.08546284,0.008681407,0.43137154,0.004617096,0.06751574,0.15510419,0.0024196897,0.000051842162,0.004875544,0.000022852597,0.23607883,0.0037984354],"about_ca_topic_score_codex":0.0014627161,"about_ca_topic_score_gemma":0.0026978229,"teacher_disagreement_score":0.18594925,"about_ca_system_score_codex":0.0003823111,"about_ca_system_score_gemma":0.00044801366,"threshold_uncertainty_score":0.9997431},"labels":[],"label_agreement":null},{"id":"W3167211705","doi":"10.1111/bjd.20571","title":"COVID‐19 outcomes in patients with autoimmune blistering disease","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Galderma; Regeneron Pharmaceuticals; Celgene; Sanofi; Valeant Pharmaceuticals International; Pfizer","keywords":"Coronavirus disease 2019 (COVID-19); Rituximab; Medicine; Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Hydroxychloroquine; Population; Disease; Autoimmune disease; Immunology; Intensive care medicine; Infectious disease (medical specialty); Internal medicine; Virology; Antibody; Environmental health","score_opus":0.012355053018266282,"score_gpt":0.2501066067087263,"score_spread":0.23775155369046003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167211705","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.395558,0.023191605,0.00011468822,0.57872975,0.0010846701,0.0008079777,0.00021227541,0.000076393764,0.00022465856],"genre_scores_gemma":[0.4467351,0.00052366353,0.00049791776,0.5496109,0.0004243465,0.000027626425,0.00095416326,0.00020132145,0.0010249635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996506,0.0003397469,0.0013740463,0.00037844272,0.0007944732,0.0006073204],"domain_scores_gemma":[0.99731874,0.00022923602,0.0010410346,0.00047022355,0.00044274007,0.0004980158],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000099537014,0.00040545277,0.0019814197,0.00054179085,0.0000896169,0.00009805214,0.00038877458,0.0004976496,0.0005899547],"category_scores_gemma":[0.0016888151,0.00040766457,0.0004312111,0.00023145947,0.00024923295,0.00016915833,0.00016510006,0.0023722725,0.000011435748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033127383,0.0003796949,0.45591685,0.0006637946,0.00030569834,0.3002079,0.000028886367,0.000004095553,5.080902e-7,6.990183e-7,0.24152434,0.0006362502],"study_design_scores_gemma":[0.007821863,0.000114567316,0.761588,0.0023344718,0.00054314715,0.06731334,0.000024800009,0.00000244065,0.0000014171125,0.000031472522,0.15987436,0.00035014437],"about_ca_topic_score_codex":0.00009759844,"about_ca_topic_score_gemma":0.00001950991,"teacher_disagreement_score":0.30567113,"about_ca_system_score_codex":0.00037711833,"about_ca_system_score_gemma":0.0025931569,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W3173878348","doi":"10.1111/bjd.20595","title":"Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Psoriasis Area and Severity Index; Medicine; Dermatology Life Quality Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Dermatology; Surgery","score_opus":0.03393482954166807,"score_gpt":0.2914853224965989,"score_spread":0.2575504929549308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173878348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804001,0.01724858,0.00025502016,0.00021944035,0.00090174866,0.0005786125,0.0003731069,0.0000020489695,0.000021341268],"genre_scores_gemma":[0.9951794,0.004378894,0.00019627917,0.000027072618,0.00002199724,0.000017608274,0.000043585394,0.000013383517,0.00012174571],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99796945,0.00050194195,0.0010510688,0.00020870735,0.000074077565,0.000194772],"domain_scores_gemma":[0.99749964,0.0008302384,0.0009415904,0.00032364397,0.0003749414,0.000029970413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020927894,0.00016115887,0.001307222,0.00016598799,0.00010505231,0.000013750629,0.00038300743,0.0002278622,0.00006092806],"category_scores_gemma":[0.00015643405,0.000119718316,0.00044715696,0.00033306621,0.00022578401,0.00006778471,0.0001230908,0.00010171658,5.6389126e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23444583,0.008663705,0.016660776,0.0002202747,0.048073307,0.0005663924,0.0060140137,0.00023884466,0.09956407,0.00041956326,0.002031388,0.58310187],"study_design_scores_gemma":[0.27710214,0.0047235307,0.26189318,0.0008567767,0.01970441,0.010894897,0.0013725501,0.00003528668,0.4216505,0.00020774145,0.0011340716,0.00042492797],"about_ca_topic_score_codex":0.000121418874,"about_ca_topic_score_gemma":0.0004636182,"teacher_disagreement_score":0.58267695,"about_ca_system_score_codex":0.000032706223,"about_ca_system_score_gemma":0.00021678583,"threshold_uncertainty_score":0.48819712},"labels":[],"label_agreement":null},{"id":"W3184945293","doi":"10.1111/bjd.20656","title":"The WHO ICD-11 Classification of Dermatological Diseases: a new comprehensive online skin disease taxonomy designed by and for dermatologists","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"World Health Organization","keywords":"Dermatology; Medicine; Dermatological diseases; Taxonomy (biology); Disease; Pathology; Biology","score_opus":0.03488992226106373,"score_gpt":0.292297492517278,"score_spread":0.25740757025621425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184945293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8418039,0.13017674,0.011855698,0.014675938,0.00019013413,0.00087858585,0.00036330562,0.000034827415,0.000020837744],"genre_scores_gemma":[0.99175006,0.004255385,0.002627376,0.00091031706,0.000069540234,0.000046256006,0.0002099969,0.00003179538,0.00009928154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748796,0.00036250518,0.0011708704,0.0002919751,0.00028990826,0.0003967835],"domain_scores_gemma":[0.9963226,0.0010968599,0.0008654018,0.0003015506,0.0008642271,0.00054939324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068457615,0.00023020816,0.0009994161,0.00008377132,0.00023899652,0.00006983371,0.00025878017,0.00016471205,0.000027221115],"category_scores_gemma":[0.0016170847,0.00020317026,0.0003461958,0.00017708576,0.00063045195,0.00013927405,0.000101628255,0.00023908146,0.0000013182553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039185546,0.0031686737,0.4805776,0.0014523249,0.0011284015,0.019350942,0.00013046048,0.000010485,0.004169406,0.0015386825,0.41643178,0.06812269],"study_design_scores_gemma":[0.009370139,0.00015157435,0.7412438,0.0008418973,0.0012025523,0.15439688,0.0010485926,0.00041522316,0.0031961335,0.001288517,0.086487375,0.0003573171],"about_ca_topic_score_codex":0.000020765377,"about_ca_topic_score_gemma":0.000031111962,"teacher_disagreement_score":0.3299444,"about_ca_system_score_codex":0.000047573147,"about_ca_system_score_gemma":0.001075614,"threshold_uncertainty_score":0.82850426},"labels":[],"label_agreement":null},{"id":"W3186609223","doi":"10.1111/bjd.20661","title":"Association between atopic dermatitis and hypertension: a systematic review and meta‐analysis*","year":2021,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Lundbeckfonden","keywords":"Atopic dermatitis; Meta-analysis; Medicine; Dermatology; Association (psychology); MEDLINE; Internal medicine; Psychology; Biology","score_opus":0.043756712871461004,"score_gpt":0.3184358567561177,"score_spread":0.2746791438846567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186609223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001946351,0.99703234,0.000024081057,0.0020317067,0.00005890741,0.00071162474,0.000059874455,0.000013333898,0.00004866061],"genre_scores_gemma":[0.00036633137,0.99732774,0.00013457781,0.0017864108,0.000043396103,0.000042126943,0.00008856359,0.000025889705,0.00018494086],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955737,0.0015048154,0.0020639827,0.00027906144,0.00031297578,0.00026543837],"domain_scores_gemma":[0.99587935,0.001062895,0.0020683028,0.00024113426,0.00046518148,0.0002831615],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00040382895,0.000339588,0.014867719,0.00035070846,0.000103398714,0.000067899164,0.00013624076,0.00053185644,0.00013471993],"category_scores_gemma":[0.0012763806,0.00028600515,0.0020350553,0.00045955632,0.000091259535,0.00012488266,0.000085188905,0.00067808956,0.0000075351027],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.8802864e-7,0.000039800532,0.00054146146,0.7129039,0.25713772,0.016034992,0.000006329611,3.498088e-9,1.8781927e-9,0.000006431143,0.010542062,0.0027869113],"study_design_scores_gemma":[0.00019988879,0.0000074659515,0.0002148571,0.07684406,0.57426244,0.32382095,0.0000060716748,2.0906045e-7,7.1443e-8,0.000011264642,0.024510128,0.00012258296],"about_ca_topic_score_codex":0.000005621272,"about_ca_topic_score_gemma":0.0000075250077,"teacher_disagreement_score":0.6360599,"about_ca_system_score_codex":0.000050433504,"about_ca_system_score_gemma":0.00026812448,"threshold_uncertainty_score":0.99995923},"labels":[],"label_agreement":null},{"id":"W3190527361","doi":"10.1111/bjd.14773","title":"Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Medicine; Clinical trial; Outcome (game theory); Family medicine; Dermatology; Pediatrics; Pathology","score_opus":0.24330472887355384,"score_gpt":0.43757963074610623,"score_spread":0.1942749018725524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190527361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8480371,0.0037652128,0.0071094655,0.13541286,0.003844457,0.0008562598,0.00034841886,0.000046741585,0.00057948736],"genre_scores_gemma":[0.987434,0.00051858876,0.0036689122,0.007324505,0.00083222846,0.000032638338,0.000026282773,0.000027135366,0.00013569584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947567,0.0010763243,0.0031467213,0.00028207264,0.0004075097,0.00033066902],"domain_scores_gemma":[0.9880123,0.008805275,0.001652729,0.00025300865,0.00095857296,0.00031808118],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023346932,0.00019298501,0.0014632259,0.00012173324,0.00016845934,0.00005179027,0.00036714913,0.00025021573,0.00018538658],"category_scores_gemma":[0.038930926,0.00012973165,0.0006641857,0.00008127723,0.00033269936,0.00011352386,0.00008679022,0.00035864583,0.000026846043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053115387,0.0001438226,0.66814655,0.000022356196,0.0008519885,0.021811323,0.000078323734,4.0165105e-7,0.000063773514,0.00006319589,0.28554899,0.022738133],"study_design_scores_gemma":[0.010305779,0.00009632225,0.5742442,0.0011462739,0.0006476409,0.3205117,0.00023767193,0.000017639664,0.00060327025,0.0037968725,0.0881617,0.00023093459],"about_ca_topic_score_codex":0.000024076793,"about_ca_topic_score_gemma":0.000075233904,"teacher_disagreement_score":0.29870036,"about_ca_system_score_codex":0.00005329365,"about_ca_system_score_gemma":0.00041197412,"threshold_uncertainty_score":0.96916455},"labels":[],"label_agreement":null},{"id":"W3200981700","doi":"10.1111/bjd.20760","title":"Transcriptomic changes during stage progression of mycosis fungoides","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta","funders":"Faculty of Graduate Studies and Research, University of Alberta; Canadian Institutes of Health Research; Bispebjerg Hospital; Alberta Innovates; Kræftens Bekæmpelse; Canadian Dermatology Foundation","keywords":"Mycosis fungoides; Transcriptome; Laser capture microdissection; Biology; KEGG; Pathology; Cancer research; Lymphoma; Medicine; Gene expression; Gene; Immunology; Genetics","score_opus":0.017150419950369054,"score_gpt":0.31197931245031735,"score_spread":0.2948288924999483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200981700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754943,0.021103118,0.00007866328,0.002722273,0.00009876309,0.00014452667,0.000017301692,0.000009711688,0.0003313403],"genre_scores_gemma":[0.99346256,0.005381269,0.00060181133,0.00011910649,0.00005465837,0.000004777699,0.0000066188272,0.000021819842,0.00034739196],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.998513,0.00018903181,0.00049219886,0.00014313309,0.0003826641,0.00027998682],"domain_scores_gemma":[0.99875295,0.000069795526,0.00023016636,0.00011763466,0.0006831248,0.00014633982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110212946,0.00009975473,0.00058771623,0.00019041676,0.00007018936,0.000023007568,0.00010623227,0.000111071124,0.00041981548],"category_scores_gemma":[0.0003183938,0.000106949454,0.00016186382,0.00021025365,0.0001453806,0.00007366795,0.000037395876,0.00030414297,0.0000032845655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011755247,0.0008274469,0.16368352,0.0014948391,0.00046038837,0.09439674,0.000870248,0.00000303071,0.68892294,0.000040140505,0.0011312194,0.046993963],"study_design_scores_gemma":[0.0027775804,0.00018496341,0.024990557,0.00085482077,0.00006030519,0.50487614,0.00081138615,0.000021261616,0.4644641,0.000029109557,0.0008518519,0.00007792047],"about_ca_topic_score_codex":0.000017001326,"about_ca_topic_score_gemma":0.00018314322,"teacher_disagreement_score":0.4104794,"about_ca_system_score_codex":0.00005362017,"about_ca_system_score_gemma":0.00034661673,"threshold_uncertainty_score":0.4596685},"labels":[],"label_agreement":null},{"id":"W3203661707","doi":"10.1111/bjd.20769","title":"Targeting the opioid pathway for the treatment of chronic kidney disease‐associated pruritus: a systematic review and meta‐analysis of randomized controlled trials","year":2021,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba; Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"","keywords":"Conceptualization; Medicine; Biostatistics; Randomized controlled trial; Library science; Meta-analysis; Family medicine; Psychology; Public health; Internal medicine; Computer science; Artificial intelligence; Pathology","score_opus":0.042610205215862236,"score_gpt":0.346742159712007,"score_spread":0.3041319544961448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203661707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033206493,0.9851343,0.00013890273,0.0012140926,0.0001460766,0.012600072,0.0007506714,0.000006402059,0.000006170262],"genre_scores_gemma":[0.0004280116,0.9963758,0.000028865936,0.00035542794,0.00005302423,0.0024038537,0.00025150308,0.00003156783,0.00007193964],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.978989,0.011994132,0.008087634,0.00025371785,0.0003827132,0.0002927915],"domain_scores_gemma":[0.95668936,0.0294782,0.012256769,0.00041465907,0.0009208945,0.00024010181],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.006239607,0.00048510177,0.063515194,0.00032633558,0.00014475106,0.000037700647,0.0003147377,0.00027102273,0.00016672329],"category_scores_gemma":[0.04430186,0.00021232101,0.021829503,0.00047567216,0.0004400826,0.000044149492,0.00003338488,0.00026213285,3.986976e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018826644,0.00047383134,0.0000029139549,0.387537,0.60634977,0.0007118789,0.000031043895,6.795755e-7,5.07833e-8,0.00003053446,0.0019228845,0.0010567652],"study_design_scores_gemma":[0.057505846,0.00005377185,6.1875755e-7,0.10752476,0.8187282,0.0065507265,0.00002898945,0.00004745474,7.54411e-7,0.000021968808,0.009416901,0.000119986835],"about_ca_topic_score_codex":0.000007734985,"about_ca_topic_score_gemma":0.0000055553396,"teacher_disagreement_score":0.28001225,"about_ca_system_score_codex":0.00007617741,"about_ca_system_score_gemma":0.001936259,"threshold_uncertainty_score":0.98796666},"labels":[],"label_agreement":null},{"id":"W3207194448","doi":"10.1111/bjd.20818","title":"Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"AbbVie","keywords":"Psoriasis; Medicine; Plaque psoriasis; Term (time); Clinical trial; Dermatology; Pediatrics; Internal medicine","score_opus":0.02992038853060693,"score_gpt":0.2943077013034289,"score_spread":0.264387312772822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207194448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915959,0.005684704,0.0003740784,0.0003040778,0.0012722239,0.00024192907,0.0003670719,0.000009156098,0.00015086055],"genre_scores_gemma":[0.997556,0.0011679995,0.0006321269,0.00017690883,0.000079272264,0.000006427283,0.00026076942,0.000021872816,0.000098640965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99366844,0.003184637,0.002378134,0.00031910464,0.00009528611,0.0003543999],"domain_scores_gemma":[0.9967463,0.0014471461,0.0011032932,0.00023918643,0.00038145244,0.0000826315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008316404,0.00022003365,0.0020152729,0.0001698361,0.00008415032,0.000023244784,0.00027676538,0.0005258051,0.0006298947],"category_scores_gemma":[0.0009017866,0.0002068498,0.00036963733,0.00019274911,0.00013659045,0.00015122179,0.00008047641,0.0004796224,0.000033205655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014785622,0.0016226788,0.8669562,0.00002170877,0.0019753007,0.0040905047,0.00023423311,0.000023424083,0.00036802405,0.00002788603,0.0052398792,0.10465459],"study_design_scores_gemma":[0.03141611,0.00039027387,0.94951856,0.00048954884,0.0004348138,0.008644215,0.00007697649,5.259257e-7,0.0077192793,0.00012091178,0.0009434602,0.00024532803],"about_ca_topic_score_codex":0.000074280666,"about_ca_topic_score_gemma":0.00055417314,"teacher_disagreement_score":0.10440926,"about_ca_system_score_codex":0.00004913095,"about_ca_system_score_gemma":0.0004119961,"threshold_uncertainty_score":0.843509},"labels":[],"label_agreement":null},{"id":"W3209037189","doi":"10.1111/bjd.20813","title":"Risankizumab vs. fumaric acid esters: a direct comparison","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fumaric acid; Medicine; Dermatology; Chemistry; Organic chemistry","score_opus":0.018649059170808356,"score_gpt":0.23844152917481465,"score_spread":0.21979247000400629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209037189","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08191435,0.61664593,0.0002811481,0.26645702,0.024700044,0.0007002085,0.0007230097,0.00020153204,0.008376753],"genre_scores_gemma":[0.66351837,0.01919006,0.001139756,0.29500264,0.00513714,0.00009158685,0.0052159606,0.00039940438,0.010305098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956191,0.0015359387,0.0014284744,0.00047749656,0.00013537737,0.00080359087],"domain_scores_gemma":[0.9973998,0.0004553549,0.0014165457,0.00037357296,0.0003033124,0.00005138165],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00016453907,0.0005153498,0.0023181993,0.00040141,0.0002490182,0.00011534123,0.00069884286,0.0023588915,0.0012679652],"category_scores_gemma":[0.00015226859,0.00056881964,0.00080643466,0.0002289066,0.00028855194,0.00016408815,0.00014719633,0.002864304,0.00033618486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017200744,0.00020067766,0.001847657,0.00010640992,0.002251068,0.055169478,0.00013378027,4.2123597e-7,0.00043452802,0.0000019976826,0.90059984,0.03908215],"study_design_scores_gemma":[0.0028378635,0.0001559231,0.0009725881,0.00047582327,0.0009512514,0.29392537,0.00006519103,2.8013102e-7,0.006174089,0.000023873414,0.6940229,0.00039486357],"about_ca_topic_score_codex":0.00009908556,"about_ca_topic_score_gemma":0.000080695434,"teacher_disagreement_score":0.59745586,"about_ca_system_score_codex":0.0001233364,"about_ca_system_score_gemma":0.00045343235,"threshold_uncertainty_score":0.99967635},"labels":[],"label_agreement":null},{"id":"W3210606024","doi":"10.1111/bjd.20803","title":"The expected missing heritability of hidradenitis suppurativa in perspective","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Hidradenitis suppurativa; Missing heritability problem; Perspective (graphical); Heritability; Medicine; Dermatology; Biology; Computer science; Evolutionary biology; Genetics; Pathology; Artificial intelligence; Disease; Genotype; Genetic variants","score_opus":0.017800628307202998,"score_gpt":0.2801699338886474,"score_spread":0.26236930558144445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210606024","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024530847,0.022799514,0.000027365546,0.9504108,0.00054136774,0.00035094382,0.000057853707,0.000011609708,0.0012696896],"genre_scores_gemma":[0.99489725,0.0016265409,0.0005295506,0.0018622766,0.000631887,0.000012510319,0.00007431086,0.000056628043,0.0003090784],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9962299,0.001008824,0.00142364,0.00031209423,0.00054491614,0.0004806266],"domain_scores_gemma":[0.9967967,0.00087111944,0.00086573197,0.00030415304,0.0010525623,0.00010970773],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000013853809,0.00030038602,0.0015506964,0.00023123535,0.00014628345,0.000080657665,0.00026621763,0.00069299765,0.00024541633],"category_scores_gemma":[0.0011477823,0.00026575243,0.00047497844,0.0003424776,0.000534266,0.00017407695,0.000059544545,0.0026754283,0.000003751752],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111097535,0.00022978835,0.00614941,0.00014809251,0.0004282824,0.8942406,0.00082042784,1.1571757e-8,0.00013768431,0.000014402962,0.09434829,0.0033719009],"study_design_scores_gemma":[0.0025188846,0.00015658299,0.0037482032,0.0015982314,0.00022534981,0.97209823,0.0024750917,0.0000022263216,0.0009397377,0.00064558734,0.015413262,0.00017862472],"about_ca_topic_score_codex":0.00031117714,"about_ca_topic_score_gemma":0.00025591406,"teacher_disagreement_score":0.97036636,"about_ca_system_score_codex":0.00037809167,"about_ca_system_score_gemma":0.0009750805,"threshold_uncertainty_score":0.9999795},"labels":[],"label_agreement":null},{"id":"W3211175351","doi":"10.1111/bjd.20872","title":"IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis*","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; SCORAD; Dupilumab; Medicine; Clinical trial; Post-hoc analysis; Placebo; Randomized controlled trial; Severity of illness; Disease; Dermatology; Internal medicine; Alternative medicine; Dermatology Life Quality Index; Pathology","score_opus":0.007535835295399717,"score_gpt":0.2585358083281043,"score_spread":0.2509999730327046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211175351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224097,0.0042947093,0.0004123367,0.002715188,0.00010312855,0.0001573808,0.000025644702,0.000008616547,0.000042024792],"genre_scores_gemma":[0.99682456,0.00011121779,0.0016503686,0.0013308412,0.00001928759,0.000005511505,0.000029672961,0.000012929276,0.0000156017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987889,0.00028369308,0.00042438818,0.00014519837,0.00014436571,0.00021348266],"domain_scores_gemma":[0.9988766,0.00027124156,0.00018028893,0.00009823874,0.00033462825,0.00023903012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093316616,0.0001024353,0.00046904891,0.00010910774,0.000093000264,0.000051119874,0.000054695334,0.000085249085,0.000018066865],"category_scores_gemma":[0.00043749326,0.00010834424,0.000074334974,0.00010458835,0.00014472452,0.00025055336,0.000029804978,0.00021356747,8.2395644e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014658807,0.0003850592,0.9694596,0.00019746402,0.00006712203,0.024391385,0.00004814596,0.0000012453271,0.000011637941,0.000011573301,0.0015712142,0.0023896513],"study_design_scores_gemma":[0.006614026,0.00003797611,0.93117416,0.0006963252,0.00013765691,0.060067628,0.00006391042,0.000032401687,0.00012586122,0.0002477231,0.0007021202,0.00010018385],"about_ca_topic_score_codex":0.0000023211546,"about_ca_topic_score_gemma":0.00001069805,"teacher_disagreement_score":0.038285434,"about_ca_system_score_codex":0.00003084167,"about_ca_system_score_gemma":0.0003779312,"threshold_uncertainty_score":0.441815},"labels":[],"label_agreement":null},{"id":"W3212200002","doi":"10.1111/bjd.20890","title":"Bullous pemphigoid after SARS‐CoV‐2 vaccination: spike‐protein‐directed immunofluorescence confocal microscopy and T‐cell‐receptor studies","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Dermatologic surgery; Dermatology; Computer science","score_opus":0.012643619235316888,"score_gpt":0.27296883556902196,"score_spread":0.2603252163337051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212200002","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3316719,0.47559044,0.00005022917,0.18989217,0.0016766486,0.0007606714,0.00011870712,0.000105874205,0.00013337744],"genre_scores_gemma":[0.5638655,0.06977738,0.008582918,0.3472689,0.0050808573,0.00023395305,0.00067027664,0.00055539055,0.0039647934],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99573064,0.0005442339,0.0016701296,0.0006083619,0.00070025906,0.0007463473],"domain_scores_gemma":[0.99609,0.00027317848,0.0012654162,0.00044006287,0.0017831044,0.00014824556],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00016607398,0.00062754686,0.0023754004,0.00039621117,0.00020005087,0.00017752073,0.0003785759,0.0011108618,0.000562085],"category_scores_gemma":[0.0007481063,0.0007020909,0.00050125737,0.00025212433,0.00049349456,0.00018139413,0.00027479624,0.0028676414,0.000047795515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004831554,0.00022829248,0.0011760658,0.0017908736,0.00089593034,0.1559525,0.0001898865,5.6726197e-8,0.018631915,9.3563585e-7,0.8183672,0.0022831897],"study_design_scores_gemma":[0.0062688054,0.0004582903,0.008888435,0.0077836877,0.0013959174,0.5050417,0.00033399236,0.000003821476,0.0761584,0.000068168316,0.3926478,0.00095095864],"about_ca_topic_score_codex":0.000068123045,"about_ca_topic_score_gemma":0.0000132098385,"teacher_disagreement_score":0.4257194,"about_ca_system_score_codex":0.00024196872,"about_ca_system_score_gemma":0.0008580994,"threshold_uncertainty_score":0.999543},"labels":[],"label_agreement":null},{"id":"W3214576279","doi":"10.1111/bjd.20885","title":"Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; ABB (Canada); Surrey Memorial Hospital; SKiN Health; University of British Columbia; Queen's University; Probity Medical Research","funders":"AbbVie Canada","keywords":"Adalimumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Methotrexate; Dermatology Life Quality Index; Clinical endpoint; Internal medicine; Quality of life (healthcare); Patient satisfaction; Physical therapy; Clinical trial; Surgery; Dermatology; Disease","score_opus":0.010135586516618247,"score_gpt":0.24391609904802913,"score_spread":0.23378051253141088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214576279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902876,0.002565469,0.00007560337,0.00507106,0.0006869624,0.00082324515,0.0003519058,0.000015728852,0.00012242116],"genre_scores_gemma":[0.99281824,0.001030708,0.0026656247,0.002529846,0.00012152202,0.00007989671,0.0004772849,0.00010271456,0.00017416872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939809,0.003175969,0.0013978776,0.00061231415,0.00015086845,0.00068206666],"domain_scores_gemma":[0.9968223,0.0016572871,0.0008528589,0.00026021426,0.00033417606,0.000073149386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005827903,0.0005063147,0.0020804529,0.0019532773,0.00013324399,0.000042082556,0.00022295199,0.00070782274,0.000059262533],"category_scores_gemma":[0.00024036205,0.000513345,0.00020123083,0.0009149275,0.00008647981,0.000174123,0.000109441935,0.0008768829,0.0000057896145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019689947,0.0005010339,0.83547527,0.0005450424,0.0030094185,0.020940294,0.0013202508,0.0001732156,0.0019421235,0.000027971655,0.004217241,0.112158194],"study_design_scores_gemma":[0.018928515,0.0012610401,0.946418,0.004923925,0.0006407872,0.010503447,0.000173482,6.0543647e-7,0.0039421343,0.00001643987,0.012553773,0.0006378517],"about_ca_topic_score_codex":0.0014438959,"about_ca_topic_score_gemma":0.003646211,"teacher_disagreement_score":0.11152034,"about_ca_system_score_codex":0.0006627475,"about_ca_system_score_gemma":0.00036999525,"threshold_uncertainty_score":0.99973184},"labels":[],"label_agreement":null},{"id":"W4206317343","doi":"10.1111/bjd.20969","title":"Janus kinase 1 inhibitor <scp>INCB054707</scp> for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase <scp>II</scp> studies*","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York Central Hospital","funders":"Incyte","keywords":"Hidradenitis suppurativa; Medicine; Tolerability; Internal medicine; Adverse effect; Clinical endpoint; Placebo; Gastroenterology; Clinical trial; Surgery; Disease; Pathology","score_opus":0.018912326871015076,"score_gpt":0.28713409122451755,"score_spread":0.2682217643535025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206317343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839948,0.003037504,0.00018522037,0.005343639,0.0010219275,0.0016594414,0.004376703,0.00006494854,0.0003158441],"genre_scores_gemma":[0.99392164,0.00022689115,0.0027780083,0.00019377857,0.0004900397,0.00021477946,0.0011327484,0.0001217112,0.0009204202],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9951077,0.00049239997,0.0016585346,0.00073756214,0.0010339026,0.00096986856],"domain_scores_gemma":[0.9949723,0.0016913586,0.0010087367,0.00038949685,0.0011921314,0.00074599264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00003845525,0.0005678577,0.0016990097,0.00045558985,0.0011544911,0.00011774284,0.00039447244,0.00017864961,0.00003814486],"category_scores_gemma":[0.0022901874,0.0005639548,0.00035776015,0.0005143317,0.00022459336,0.0005944973,0.00030420648,0.0009462409,0.00002406845],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052263923,0.009149512,0.02867729,0.00018844212,0.004385296,0.70840186,0.014912777,0.000043886525,0.0008513579,0.00006669693,0.2103227,0.017773809],"study_design_scores_gemma":[0.123085976,0.009627941,0.0031733192,0.0008451896,0.0011863455,0.8131204,0.008386614,0.00012137952,0.00827651,0.0007374956,0.031165674,0.00027314888],"about_ca_topic_score_codex":0.00011633127,"about_ca_topic_score_gemma":0.00013513118,"teacher_disagreement_score":0.17915702,"about_ca_system_score_codex":0.00044414305,"about_ca_system_score_gemma":0.0005518804,"threshold_uncertainty_score":0.9996812},"labels":[],"label_agreement":null},{"id":"W4206535562","doi":"10.1111/bjd.21015","title":"The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase <scp>III</scp> trials","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Conceptualization; Miami; Atopic dermatitis; Medicine; Dermatology; Library science; Psychology; Computer science; Artificial intelligence","score_opus":0.014567766244598716,"score_gpt":0.2948778005423152,"score_spread":0.2803100342977165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206535562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8853457,0.0051981513,0.000119034834,0.10697719,0.00052019267,0.0015410165,0.00022789587,0.000010517018,0.000060329967],"genre_scores_gemma":[0.8994758,0.00069783686,0.000023020091,0.09926088,0.00014899671,0.000112423695,0.00023004388,0.000032658143,0.000018352152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99104804,0.003885342,0.003176009,0.00038862394,0.0007619827,0.00074002],"domain_scores_gemma":[0.9928743,0.003647159,0.0023332036,0.00038831538,0.00054569496,0.00021131641],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001403862,0.00039236882,0.002683529,0.00047497227,0.0002697151,0.0000629953,0.0005423107,0.0007358778,0.000041100004],"category_scores_gemma":[0.005579754,0.00029722045,0.00027727292,0.0004598107,0.00048220585,0.00017921595,0.00022652393,0.0026896105,0.0000021711892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070594717,0.0006762594,0.6088391,0.00029827774,0.0005661542,0.009708894,0.00034746891,0.0000024200335,0.0000013975521,0.000024129513,0.37392092,0.004909036],"study_design_scores_gemma":[0.029208869,0.00025698234,0.81581885,0.00053789455,0.00038186694,0.030477969,0.00052813237,0.000021470267,0.00013382605,0.00031262633,0.122129865,0.00019164584],"about_ca_topic_score_codex":0.0003480821,"about_ca_topic_score_gemma":0.00061256107,"teacher_disagreement_score":0.25179106,"about_ca_system_score_codex":0.00013799313,"about_ca_system_score_gemma":0.00069395604,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W4213146943","doi":"10.1111/bjd.16515","title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"UCB Pharma; Health and Care Research Wales","keywords":"Hidradenitis suppurativa; Medicine; Acne; Population; Polycystic ovary; Dermatology; Acanthosis nigricans; Disease; Ulcerative colitis; Scars; Depression (economics); Pediatrics; Obesity; Internal medicine; Algorithm; Surgery; Insulin resistance","score_opus":0.1610779611514354,"score_gpt":0.4961405342960012,"score_spread":0.3350625731445658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213146943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619023,0.000535928,0.019068336,0.016582677,0.0007478873,0.00094314147,0.000050334904,0.000013279541,0.00015608393],"genre_scores_gemma":[0.97526675,0.000063448984,0.02379909,0.000035297868,0.0007310296,0.0000069916996,0.000024136507,0.000033537617,0.00003969195],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9947774,0.0019422744,0.0016044412,0.00029192911,0.0009872091,0.00039677488],"domain_scores_gemma":[0.9952245,0.0015462725,0.0005950729,0.00037612152,0.0019928676,0.00026516893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002103212,0.00016079219,0.00078874367,0.00033700644,0.0003883422,0.00010369883,0.00035844723,0.00016547457,0.00010965766],"category_scores_gemma":[0.0019333672,0.00013876811,0.00017708163,0.00054836954,0.00032422057,0.00046836832,0.00010263041,0.0008250355,0.000026977079],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019472945,0.004858851,0.13489269,0.00010567553,0.0019906056,0.75547713,0.0053932527,0.00011429868,0.0005159472,0.00007679373,0.00421752,0.090409964],"study_design_scores_gemma":[0.0045365817,0.0016249822,0.00975503,0.00054422504,0.00054231216,0.9646248,0.0046491455,0.011953036,0.0005137385,0.00018320663,0.0009197041,0.00015319066],"about_ca_topic_score_codex":0.0020638418,"about_ca_topic_score_gemma":0.00008788437,"teacher_disagreement_score":0.20914774,"about_ca_system_score_codex":0.000095295225,"about_ca_system_score_gemma":0.00047619778,"threshold_uncertainty_score":0.56587994},"labels":[],"label_agreement":null},{"id":"W4214654857","doi":"10.1111/bjd.20952","title":"From <scp> <i>FOS</i> </scp> fusions to somatic mutations in the <scp>MAPK</scp> pathway, heterogeneous genetic abnormalities cause distinct pathophysiology among subsets of epithelioid haemangiomas","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Toronto; Stanford Bio-X; National Institute for Health and Care Research","keywords":"Pathophysiology; Somatic cell; Mutation; MAPK/ERK pathway; Genetics; Biology; Cancer research; Medicine; Signal transduction; Gene; Endocrinology","score_opus":0.012392616143037582,"score_gpt":0.22996201578552644,"score_spread":0.21756939964248886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214654857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719395,0.011401636,0.00015656337,0.0138932755,0.00070088496,0.00082010694,0.0009385684,0.000032510885,0.000116941344],"genre_scores_gemma":[0.9361307,0.0010169401,0.00072663045,0.058747537,0.0016188024,0.00019450314,0.0011639722,0.00018834851,0.00021254909],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9936404,0.0016917846,0.0021824995,0.0005419674,0.00095786765,0.0009854358],"domain_scores_gemma":[0.9950014,0.0022649872,0.0014419692,0.00072863983,0.0003011875,0.00026181398],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00034751507,0.00058605603,0.002161497,0.0008113526,0.00031205895,0.00008801504,0.0010055264,0.00062474306,0.00011684288],"category_scores_gemma":[0.000995342,0.0005421266,0.0011529699,0.0005271046,0.00046577764,0.000116981406,0.00032311116,0.0024199362,0.0000288417],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001670505,0.00071173947,0.023640368,0.0008076975,0.001282152,0.50098497,0.007458204,0.0001733583,0.0017009309,0.000009636155,0.4621474,0.0010668245],"study_design_scores_gemma":[0.0052365707,0.0012472818,0.20062391,0.0027108665,0.0026504498,0.65690327,0.0065066554,0.00013199559,0.0021028407,0.005193956,0.1162998,0.00039237752],"about_ca_topic_score_codex":0.0009125344,"about_ca_topic_score_gemma":0.0005191749,"teacher_disagreement_score":0.3458476,"about_ca_system_score_codex":0.00010528389,"about_ca_system_score_gemma":0.00041204563,"threshold_uncertainty_score":0.9998815},"labels":[],"label_agreement":null},{"id":"W4224237183","doi":"10.1111/bjd.21615","title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"National Center for Advancing Translational Sciences; Eli Lilly and Company","keywords":"Atopic dermatitis; Medicine; Dermatology; Skin barrier","score_opus":0.04372437995746584,"score_gpt":0.3598911613908305,"score_spread":0.31616678143336463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224237183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8593939,0.024954781,0.01381039,0.09425553,0.00373384,0.0026430588,0.0009211898,0.000063511136,0.0002237966],"genre_scores_gemma":[0.9903584,0.00055998086,0.0020640686,0.006575901,0.000114725335,0.00020579417,0.00004097432,0.000024118921,0.000056029283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586135,0.0009100876,0.0020101916,0.00023193988,0.0005208,0.00046563888],"domain_scores_gemma":[0.99553,0.0020210112,0.0011358624,0.00036873392,0.0006278067,0.00031659077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010616819,0.00021342153,0.0010615268,0.000058474216,0.0009834159,0.000057518344,0.00064236973,0.00019179353,0.00006866787],"category_scores_gemma":[0.0023892748,0.00016885104,0.00078955234,0.00022478969,0.00065078324,0.00013630216,0.00017426339,0.00067828223,0.0000016792203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015884134,0.00044308527,0.73065233,0.00036985782,0.0011224769,0.0015605713,0.00007691251,0.000008519707,0.0000051569236,0.0012391438,0.23700449,0.027358627],"study_design_scores_gemma":[0.007048192,0.00023330052,0.6903233,0.000149083,0.0009654987,0.1657292,0.00054119393,0.00051373465,0.00014872669,0.0050285812,0.12912202,0.00019719066],"about_ca_topic_score_codex":0.000027855333,"about_ca_topic_score_gemma":0.00008200009,"teacher_disagreement_score":0.16416863,"about_ca_system_score_codex":0.00013418306,"about_ca_system_score_gemma":0.0011671748,"threshold_uncertainty_score":0.75637394},"labels":[],"label_agreement":null},{"id":"W4225001772","doi":"10.1111/bjd.21628","title":"Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Université de Toulouse","keywords":"Dupilumab; Medicine; Dosing; Atopic dermatitis; Retrospective cohort study; Cohort; Young adult; Cohort study; Dermatology; Pediatrics; Internal medicine","score_opus":0.006241071681612049,"score_gpt":0.2392440382122407,"score_spread":0.23300296653062863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225001772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781651,0.002321815,0.00002088235,0.017136164,0.0007723598,0.0012275535,0.00014974765,0.00003146776,0.00017494337],"genre_scores_gemma":[0.9293767,0.00019077025,0.0001922013,0.06942844,0.00027360168,0.0001119698,0.00030462485,0.00006598795,0.00005566861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953583,0.00089209387,0.001519472,0.00060783233,0.0010136111,0.00060869096],"domain_scores_gemma":[0.9972638,0.00027927224,0.001174365,0.00040062662,0.00071245985,0.00016948971],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000095240044,0.00044679514,0.0020501052,0.00046205107,0.00017433058,0.00008517472,0.0004907659,0.00053815247,0.0014190926],"category_scores_gemma":[0.00042530618,0.00046408243,0.0002607665,0.0002996621,0.0002888962,0.00033588594,0.00017658378,0.0034108323,0.000013047465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109683526,0.0008584713,0.667619,0.000082152685,0.0005335892,0.13696091,0.0017314157,5.191629e-7,1.3296918e-7,1.546325e-7,0.19177975,0.00032425695],"study_design_scores_gemma":[0.009946495,0.00026583884,0.9393629,0.0015630639,0.0006659315,0.042520236,0.0012188172,0.000009620096,0.000008508374,0.00002987283,0.0040269108,0.00038180812],"about_ca_topic_score_codex":0.0008149888,"about_ca_topic_score_gemma":0.00058815273,"teacher_disagreement_score":0.27174392,"about_ca_system_score_codex":0.0004054521,"about_ca_system_score_gemma":0.0002840509,"threshold_uncertainty_score":0.9997811},"labels":[],"label_agreement":null},{"id":"W4225128715","doi":"10.1111/bjd.21605","title":"Clinical practice guidelines for psoriasis: which ones are the best?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Psoriasis; Medicine; Dermatology; Clinical Practice; MEDLINE; Intensive care medicine; Family medicine; Biology","score_opus":0.299294172863615,"score_gpt":0.5236842696513468,"score_spread":0.22439009678773186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225128715","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069780933,0.010289498,0.0012706234,0.9793738,0.006960035,0.000988532,0.00015813242,0.00002519297,0.00023636794],"genre_scores_gemma":[0.00060097454,0.011671632,0.028290462,0.9366626,0.021878501,0.00008680661,0.00031236693,0.000120025514,0.00037664454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891398,0.0018531316,0.006840334,0.00047053266,0.0011717317,0.00052447786],"domain_scores_gemma":[0.96174234,0.017738847,0.007407628,0.00053564477,0.012417485,0.00015806498],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0050858785,0.00033826905,0.001778769,0.00020178073,0.00034041854,0.00013352941,0.0006923813,0.000946823,0.00051272614],"category_scores_gemma":[0.22129585,0.000299074,0.0009220695,0.00030723328,0.00018475541,0.00040812255,0.00021259343,0.0064743804,0.000029211535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082157145,0.00027782362,0.0007660555,0.00019406229,0.0009940572,0.016999783,0.000020395211,0.0000033790461,6.70184e-7,0.000007660091,0.9272452,0.052669343],"study_design_scores_gemma":[0.003342974,0.0005498197,0.0001564502,0.00040910134,0.0029823391,0.3031033,0.0022168898,0.000032134856,0.0000018897028,0.00028002894,0.6867456,0.00017951605],"about_ca_topic_score_codex":0.00013896689,"about_ca_topic_score_gemma":0.000114445305,"teacher_disagreement_score":0.28610352,"about_ca_system_score_codex":0.00011900376,"about_ca_system_score_gemma":0.0015290284,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W4225383400","doi":"10.1111/bjd.21601","title":"Systemic treatments for psoriasis: not another network meta‐analysis!","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Department of Medicine, University of Toronto; University of Toronto; Women's College Hospital","keywords":"Psoriasis; Meta-analysis; Medicine; MEDLINE; Dermatology; Intensive care medicine; Internal medicine; Biology","score_opus":0.04115178157844975,"score_gpt":0.2568427037830461,"score_spread":0.21569092220459632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225383400","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058883615,0.81278723,0.0018916754,0.15344658,0.016972525,0.0026002394,0.0054343604,0.00018655017,0.00079247385],"genre_scores_gemma":[0.17407429,0.033721656,0.003362884,0.68826777,0.011980475,0.0036834576,0.016354553,0.0011042136,0.067450695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499464,0.001772744,0.0015614344,0.00057371386,0.00015565855,0.00094179093],"domain_scores_gemma":[0.9962666,0.0009538802,0.0020364027,0.00044278003,0.00026252648,0.000037807982],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038400275,0.0006135229,0.0040380736,0.0005955893,0.00048667876,0.00006364306,0.00081034546,0.0015593567,0.0033882845],"category_scores_gemma":[0.000052127987,0.0006028533,0.004309103,0.00043354701,0.0001411542,0.00011730984,0.000100313344,0.0014069476,0.000078641926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033030112,0.0001018953,0.00013802601,0.00006222192,0.38164583,0.0063082883,0.00004284454,0.000031836178,0.000043423977,0.000009327953,0.60964215,0.0016438597],"study_design_scores_gemma":[0.0029890288,0.00022266996,0.00006873437,0.000037472168,0.35955352,0.09746815,0.00003186716,5.873831e-7,0.00028243545,0.000070604794,0.5389016,0.00037332298],"about_ca_topic_score_codex":0.0000918289,"about_ca_topic_score_gemma":0.00004481712,"teacher_disagreement_score":0.77906555,"about_ca_system_score_codex":0.00015151095,"about_ca_system_score_gemma":0.0002700953,"threshold_uncertainty_score":0.99973685},"labels":[],"label_agreement":null},{"id":"W4230277598","doi":"10.1111/bjd.20033","title":"P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate‐to‐severe AD","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.0043051286011207765,"score_gpt":0.21272131542208195,"score_spread":0.20841618682096116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230277598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925745,0.0050204294,0.000065329856,0.0017758426,0.000050926697,0.00042995156,0.000012931641,0.000013380512,0.000056684665],"genre_scores_gemma":[0.99651474,0.0006517637,0.0008226059,0.0018968929,0.000016250191,0.000019282172,0.000015927455,0.000026983374,0.000035528356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829143,0.00017599213,0.00059173343,0.0002882912,0.00025801768,0.00039453153],"domain_scores_gemma":[0.99919575,0.000030827334,0.00020031966,0.00016130731,0.00016074811,0.00025103174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007113541,0.00019338488,0.00072473404,0.00023896624,0.000059574577,0.000054490316,0.000117796306,0.0001535432,0.000034936096],"category_scores_gemma":[0.00008204344,0.00019344587,0.00005568662,0.0002630334,0.0001249076,0.00024133272,0.00006603738,0.00052298396,0.0000042770434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058369426,0.00043284945,0.92822933,0.0002296867,0.00014247002,0.056068618,0.00027601796,0.000032377266,0.000043673594,0.000002564787,0.0012357427,0.012723002],"study_design_scores_gemma":[0.008547795,0.000120489894,0.6927288,0.001877631,0.000071854105,0.29584906,0.00021644571,0.000025802925,0.00029740727,0.00006503518,0.000043384884,0.00015629349],"about_ca_topic_score_codex":0.00005893449,"about_ca_topic_score_gemma":0.0012511038,"teacher_disagreement_score":0.23978043,"about_ca_system_score_codex":0.00006644802,"about_ca_system_score_gemma":0.00034897713,"threshold_uncertainty_score":0.78884935},"labels":[],"label_agreement":null},{"id":"W4233501085","doi":"10.1111/j.1365-2133.2008.08935.x","title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","year":2008,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Isotretinoin; Family medicine; Incidence (geometry); Dermatology; Acne; Library science","score_opus":0.01278395999922658,"score_gpt":0.25340339318543864,"score_spread":0.24061943318621207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233501085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7877211,0.04080944,0.000029582961,0.17010473,0.00027326946,0.000959976,0.000021986936,0.0000086982955,0.00007119796],"genre_scores_gemma":[0.9062205,0.010298642,0.00006623979,0.0825579,0.00060653436,0.000014698969,0.0000054100483,0.000032990756,0.00019708175],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99764115,0.00076629076,0.0008245696,0.0001879156,0.00031627825,0.0002637897],"domain_scores_gemma":[0.9978599,0.0007194316,0.0008587793,0.00021397538,0.00027338025,0.00007453179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002678037,0.00023959855,0.0015130528,0.00014486535,0.00016120217,0.000024169389,0.00014651944,0.0004540583,0.00003966934],"category_scores_gemma":[0.0001745495,0.00015202769,0.00026638652,0.00011190559,0.00044024247,0.00007307331,0.000032981145,0.0015012532,0.0000019693784],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009133446,0.000244154,0.016634649,0.000079064426,0.0011379704,0.64512,0.00070960465,2.8803447e-7,0.0000064782457,9.877033e-7,0.32594022,0.009213185],"study_design_scores_gemma":[0.023737045,0.00090759306,0.01580666,0.00046334,0.00079340336,0.9458055,0.00021941261,0.000013063244,0.000019480896,0.000020019083,0.012095595,0.00011888902],"about_ca_topic_score_codex":0.0003122928,"about_ca_topic_score_gemma":0.000028317812,"teacher_disagreement_score":0.31384462,"about_ca_system_score_codex":0.000020304391,"about_ca_system_score_gemma":0.000167473,"threshold_uncertainty_score":0.6522282},"labels":[],"label_agreement":null},{"id":"W4233991869","doi":"10.1111/bjd.17055","title":"Applying the phenotype approach for rosacea to practice and research","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosacea; Telangiectases; Flexibility (engineering); Disease; Medicine; Nose; Argument (complex analysis); Dermatology; Rhinophyma; Telangiectasia; Intensive care medicine; Surgery; Pathology; Internal medicine","score_opus":0.040899040880977025,"score_gpt":0.37523142141444144,"score_spread":0.3343323805334644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233991869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.852457,0.025549643,0.04571937,0.051942147,0.001134681,0.006273153,0.000016536665,0.00003717248,0.0168703],"genre_scores_gemma":[0.9785623,0.00026185843,0.01864027,0.0017335288,0.00047298698,0.00008751427,0.0000020982802,0.000013409638,0.00022602658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991471,0.00013817995,0.00019581047,0.00010519708,0.00017940158,0.00023429404],"domain_scores_gemma":[0.9987722,0.00038181953,0.00008325401,0.00008507067,0.00055006304,0.00012759716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005863404,0.000057060977,0.00022448463,0.000071735885,0.00034013862,0.00004970425,0.00007668809,0.000067892404,0.0000073477945],"category_scores_gemma":[0.000749867,0.000039116945,0.00004421145,0.000128633,0.00015712637,0.000088875015,0.00004251018,0.00023685378,0.000005884824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033458103,0.00095636677,0.004325143,0.00028116943,0.00077840325,0.0037072103,0.002618925,0.00000426262,0.0022818008,0.0007793393,0.32220912,0.65871245],"study_design_scores_gemma":[0.005233661,0.0024108635,0.004394663,0.0002851732,0.00037503047,0.30969205,0.003648471,0.00046051596,0.0021413807,0.00040457322,0.67080486,0.00014874576],"about_ca_topic_score_codex":0.00002989156,"about_ca_topic_score_gemma":0.000005132057,"teacher_disagreement_score":0.6585637,"about_ca_system_score_codex":0.000017220103,"about_ca_system_score_gemma":0.00007795384,"threshold_uncertainty_score":0.26161057},"labels":[],"label_agreement":null},{"id":"W4235461058","doi":"10.1111/bjd.16744","title":"Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosus","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discoid lupus erythematosus; Syk; Dermatology; Lupus erythematosus; Scars; Autoimmune disease; Placebo; Systemic lupus erythematosus; Janus kinase; Disease; Surgery; Internal medicine; Immunology; Pathology; Tyrosine kinase; Antibody","score_opus":0.07007353733330347,"score_gpt":0.4229872516184881,"score_spread":0.35291371428518464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235461058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97171646,0.00045286457,0.021642024,0.0014608819,0.00215026,0.0024227127,0.00002286076,0.000012972562,0.00011897553],"genre_scores_gemma":[0.9900956,0.00013607497,0.008502458,0.00019581603,0.00082655647,0.00007071502,0.0000073260194,0.000034325025,0.00013109451],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99384207,0.0017645054,0.003078079,0.00030306657,0.00053925323,0.00047300648],"domain_scores_gemma":[0.9937653,0.003882823,0.0008421234,0.00029708722,0.00084914576,0.0003635481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033416345,0.00019188855,0.0031949873,0.00053340755,0.00008187685,0.000030081144,0.0003926016,0.00032031882,0.000045370645],"category_scores_gemma":[0.007522922,0.00017282863,0.0006355915,0.00032551624,0.000568508,0.00009766397,0.00017215854,0.00046534036,0.000004992607],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97484267,0.0021369124,0.0073794997,0.00037072474,0.00037156086,0.0048360173,0.0005497005,2.8715587e-7,0.0017109385,0.00023217767,0.0036531282,0.0039163567],"study_design_scores_gemma":[0.65349567,0.00377056,0.00016856332,0.001339149,0.00011050494,0.33768046,0.0002544096,0.00020053632,0.0019678376,0.00023752943,0.00066715124,0.00010760804],"about_ca_topic_score_codex":0.000020736356,"about_ca_topic_score_gemma":0.000037889746,"teacher_disagreement_score":0.33284447,"about_ca_system_score_codex":0.00007987973,"about_ca_system_score_gemma":0.0006658159,"threshold_uncertainty_score":0.9006184},"labels":[],"label_agreement":null},{"id":"W4236993097","doi":"10.1111/bjd.12981","title":"Historical Archives","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; History","score_opus":0.01117811099174698,"score_gpt":0.2371114572556818,"score_spread":0.22593334626393483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236993097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49549198,0.09440056,0.029610101,0.048868053,0.0052629774,0.00030445989,0.0000013526056,0.00011401169,0.32594648],"genre_scores_gemma":[0.9822049,0.0013975165,0.0034069081,0.011240037,0.0005772015,0.0000025838672,0.0000012549101,0.000020831983,0.0011487491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998772,0.00013781754,0.0005949811,0.00010603451,0.00017425716,0.0002148623],"domain_scores_gemma":[0.99909663,0.00021219697,0.00026893493,0.000113298265,0.00010448203,0.00020442808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001068694,0.00009003013,0.0007211344,0.0001842569,0.0000833277,0.000003897567,0.00010306967,0.000093197166,0.000026825748],"category_scores_gemma":[0.00044765306,0.000089173314,0.00017435986,0.00006905705,0.00020096631,0.000043681775,0.000026073676,0.0004222684,0.00001610008],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025512834,0.0002777452,0.039566047,0.00014813188,0.00021298471,0.02239811,0.00022756659,3.4777548e-7,0.00044553692,0.0005438578,0.8597141,0.07621047],"study_design_scores_gemma":[0.001993381,0.00018263393,0.009510516,0.00013398883,0.000109343666,0.3972719,0.000056003326,0.000015450156,0.00014534974,0.0003601559,0.5901537,0.00006754983],"about_ca_topic_score_codex":0.0000064714286,"about_ca_topic_score_gemma":0.0000026935343,"teacher_disagreement_score":0.48671293,"about_ca_system_score_codex":0.000060284525,"about_ca_system_score_gemma":0.00009436723,"threshold_uncertainty_score":0.36363822},"labels":[],"label_agreement":null},{"id":"W4237473484","doi":"10.1111/bjd.15597","title":"News and Notices","year":2017,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Human auditory perception and evaluation","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.021396689857333197,"score_gpt":0.2669231712785827,"score_spread":0.24552648142124953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237473484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399835,0.0007812522,0.0005743226,0.0004078995,0.0007871873,0.00001786116,7.725974e-7,0.000014431849,0.003417917],"genre_scores_gemma":[0.99873686,0.0006571742,0.00030541042,0.000045384157,0.00019558477,3.2233075e-7,2.9432368e-7,0.0000058301525,0.000053169526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99966496,0.000019137973,0.00015952287,0.00002962805,0.000059154845,0.00006760332],"domain_scores_gemma":[0.99975973,0.000011339312,0.00008798544,0.00005683254,0.000039007213,0.000045128196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000054849486,0.000033661305,0.00010942267,0.00003246076,0.00011417288,0.00011347563,0.000092606824,0.00004145702,0.00074861944],"category_scores_gemma":[0.000059393296,0.000040521478,0.000022132708,0.00000540315,0.000050711504,0.0002399066,0.000010299001,0.00010274659,0.00010470018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019988525,0.00004171309,0.03501497,0.00014489013,0.00012930682,0.002773995,0.00089177134,0.00086672377,0.0031540364,0.000057673133,0.35835353,0.5985514],"study_design_scores_gemma":[0.0020657915,0.000037783015,0.82303905,0.00019896892,0.000059626298,0.07070774,0.00030005616,0.0070059462,0.0005940987,0.00083722256,0.09489919,0.0002545127],"about_ca_topic_score_codex":0.0000015761404,"about_ca_topic_score_gemma":0.00007828885,"teacher_disagreement_score":0.7880241,"about_ca_system_score_codex":0.0000072582393,"about_ca_system_score_gemma":0.000006815236,"threshold_uncertainty_score":0.81968576},"labels":[],"label_agreement":null},{"id":"W4238105007","doi":"10.1111/bjd.19067","title":"Quality of reporting in systematic reviews published in dermatology journals","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systematic review; Protocol (science); Transparency (behavior); Guideline; Medicine; MEDLINE; Family medicine; Alternative medicine; Health care; Medical literature; Quality (philosophy); Computer science; Pathology; Political science","score_opus":0.7758984387384652,"score_gpt":0.5525483587738867,"score_spread":0.22335007996457845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238105007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.887856,0.087874286,0.008276251,0.012407712,0.000494101,0.0015412046,0.0000058542287,0.0000035497521,0.0015410093],"genre_scores_gemma":[0.99533427,0.0012091438,0.0025653206,0.0007812839,0.000047379854,0.000016955957,0.0000010019991,0.000012149467,0.000032511838],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.79884934,0.06962863,0.12556827,0.00084295607,0.004505305,0.00060548016],"domain_scores_gemma":[0.8697238,0.008482696,0.11760548,0.0013529623,0.002473942,0.00036115068],"candidate_categories":["metaresearch","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.18158248,0.00028677232,0.017028207,0.0010541473,0.000050459803,0.00052765856,0.002317477,0.00023747214,0.002116642],"category_scores_gemma":[0.5686078,0.00018542903,0.0025853717,0.0027375817,0.00010681213,0.000831712,0.00017218113,0.000842141,0.00012500858],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041025785,0.00021958258,0.9247651,0.016071588,0.0002683637,0.011128999,0.0017210031,0.000053763102,0.00050232804,0.0004677825,0.03889363,0.005866797],"study_design_scores_gemma":[0.0054975445,0.00013897521,0.37274766,0.033949435,0.00061556086,0.5433387,0.008749098,0.003633424,0.0006041953,0.018059168,0.01152239,0.0011438279],"about_ca_topic_score_codex":0.000045509718,"about_ca_topic_score_gemma":0.00035996063,"teacher_disagreement_score":0.55201745,"about_ca_system_score_codex":0.000046052723,"about_ca_system_score_gemma":0.00022928331,"threshold_uncertainty_score":0.99879557},"labels":[],"label_agreement":null},{"id":"W4239053007","doi":"10.1111/bjd.16195","title":"Efficacy and adverse events of oral isotretinoin for acne: a systematic review","year":2018,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Isotretinoin; Acne; Medicine; Adverse effect; Placebo; Dermatology; Randomized controlled trial; Clinical trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.030212448862144258,"score_gpt":0.3555140972082674,"score_spread":0.32530164834612313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239053007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014625817,0.99703157,0.000044051045,0.00010087435,0.00018912052,0.002418582,0.00003445056,0.0000050037397,0.00003006948],"genre_scores_gemma":[0.0001030054,0.9988729,0.00055522955,0.00014650277,0.00007395776,0.000045358258,0.000035776346,0.00003372867,0.00013358639],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99753314,0.00030984223,0.0015873915,0.00017168872,0.00017366301,0.00022425257],"domain_scores_gemma":[0.99735814,0.0002853198,0.0017677696,0.00017534963,0.0002552054,0.00015823274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033781986,0.0002586013,0.0051914896,0.00013641764,0.000053503143,0.000004560191,0.00013507095,0.00026269146,0.000023117644],"category_scores_gemma":[0.00063102675,0.00018413368,0.00078934856,0.00011498104,0.000092444025,0.000053139174,0.000041156054,0.00023152216,0.0000088008255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000421829,0.00017953315,0.0000116531355,0.93846726,0.001248785,0.0016337552,0.00001161473,2.4233968e-9,7.193947e-8,0.0000037035425,0.008760061,0.04964139],"study_design_scores_gemma":[0.002034386,0.0003737028,0.000008408818,0.6800568,0.013226977,0.22268671,0.000005528144,5.399375e-7,7.658282e-7,0.0000059552226,0.081500165,0.0001000818],"about_ca_topic_score_codex":0.0000041344956,"about_ca_topic_score_gemma":0.0000014633009,"teacher_disagreement_score":0.25841045,"about_ca_system_score_codex":0.00003310239,"about_ca_system_score_gemma":0.00023674607,"threshold_uncertainty_score":0.75087535},"labels":[],"label_agreement":null},{"id":"W4239586427","doi":"10.1046/j.1365-2133.2000.03724.x","title":"Cutaneous Cryptococcus infection due to C. albidus associated with Sezary syndrome","year":2000,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Dermatology; Medicine; Mycosis fungoides; Library science; Pathology; Lymphoma; Computer science","score_opus":0.008117500037824634,"score_gpt":0.23689983504497591,"score_spread":0.22878233500715128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239586427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938869,0.0006313328,0.00014580906,0.0011821705,0.00020336716,0.00019726942,0.000006642086,0.000037919526,0.0037086247],"genre_scores_gemma":[0.99824864,0.00038964883,0.00015899341,0.00059366284,0.000062943436,0.000008494145,0.0000038741055,0.000018182203,0.00051557535],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989983,0.00007813326,0.0003971611,0.00010266504,0.00017962219,0.00024412716],"domain_scores_gemma":[0.9992606,0.00008543751,0.0001326671,0.000077851495,0.00027849752,0.00016496678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000070741014,0.00011323464,0.0005434171,0.00015549125,0.00015197559,0.000029026627,0.000045120367,0.00011508041,0.0006166122],"category_scores_gemma":[0.00016023032,0.00010837352,0.00010344808,0.0002815856,0.00006886597,0.000094165305,0.000012448061,0.00036713906,0.00006957713],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010606141,0.001649207,0.30366823,0.000116138355,0.0021991918,0.49732062,0.00053908187,0.00034452035,0.00046545203,0.00004091117,0.067362025,0.125234],"study_design_scores_gemma":[0.0010878422,0.00073522597,0.21617183,0.000397924,0.00012761125,0.775058,0.000025799245,0.000014379468,0.000106344705,0.000043730866,0.0061354325,0.00009591934],"about_ca_topic_score_codex":0.0001599935,"about_ca_topic_score_gemma":0.00026292462,"teacher_disagreement_score":0.27773732,"about_ca_system_score_codex":0.0000816831,"about_ca_system_score_gemma":0.000080971404,"threshold_uncertainty_score":0.6751471},"labels":[],"label_agreement":null},{"id":"W4241667302","doi":"10.1111/bjd.16627","title":"Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epidermolysis bullosa; Medicine; Context (archaeology); Disease; Dermatology; Perspective (graphical); Severity of illness; Pathology; Internal medicine","score_opus":0.09219870509020982,"score_gpt":0.40402842750019236,"score_spread":0.3118297224099825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241667302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960951,0.00076855795,0.0016579772,0.00076931424,0.00030666968,0.00033151504,0.000035415025,9.668936e-7,0.000034454886],"genre_scores_gemma":[0.9969456,0.0006743804,0.0021065352,0.000031861404,0.00017125746,0.000012491119,0.0000054633597,0.000009347012,0.000043043507],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789363,0.0006771462,0.000780418,0.00021340798,0.0001701313,0.00026527292],"domain_scores_gemma":[0.99764097,0.00065068924,0.00034687936,0.00026129163,0.0010254482,0.000074725926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002811164,0.000077401106,0.00043733962,0.000056661636,0.00013512731,0.000009573391,0.00036100886,0.00022557582,0.00000616359],"category_scores_gemma":[0.0049190857,0.000061583494,0.00032501886,0.00008050538,0.0014277108,0.0000047282133,0.00022828091,0.00020781034,1.9592969e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009071647,0.00039586864,0.9094047,0.00023679362,0.00042014298,0.00005935743,0.000043611122,8.414598e-7,0.0681364,0.00020488036,0.0042742323,0.015916003],"study_design_scores_gemma":[0.004417041,0.0023635603,0.26478875,0.00018266874,0.00012291825,0.019676415,0.0002496659,0.00006519315,0.6983442,0.0045340247,0.005074312,0.00018126964],"about_ca_topic_score_codex":0.00002440181,"about_ca_topic_score_gemma":0.000033210446,"teacher_disagreement_score":0.64461595,"about_ca_system_score_codex":0.000008035108,"about_ca_system_score_gemma":0.0001871125,"threshold_uncertainty_score":0.58889604},"labels":[],"label_agreement":null},{"id":"W4245510738","doi":"10.1111/bjd.12753","title":"Plain Language Summaries","year":2014,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Natural Language Processing Techniques","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.004832617028212291,"score_gpt":0.23732686511124645,"score_spread":0.23249424808303415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245510738","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032136742,0.017130978,0.9462168,0.0030530589,0.00042179026,0.000044513134,0.0000016692899,0.00018890125,0.0008055438],"genre_scores_gemma":[0.7552301,0.000052711493,0.24405798,0.00054947764,0.000070559334,7.228377e-7,6.7133965e-7,0.0000057701636,0.00003199957],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999052,0.00015584896,0.0003150244,0.00010947823,0.00017272218,0.00019496649],"domain_scores_gemma":[0.9992492,0.00013648551,0.00025415485,0.00015288357,0.0001365416,0.00007072565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024911278,0.000073343224,0.00023725082,0.00011532258,0.00007643726,0.00018515383,0.00090206624,0.00008353498,0.000010207398],"category_scores_gemma":[0.0004154948,0.00007593802,0.00006472988,0.00014242996,0.00006971695,0.00048415648,0.00013477665,0.00029363576,0.0000068964528],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016190983,0.00008041006,0.0013905556,0.000060584804,0.00004128218,0.011443407,0.0009863443,0.0000016909959,0.0027157806,0.08678149,0.032024205,0.8644581],"study_design_scores_gemma":[0.0016840829,0.00020569986,0.0011731968,0.0005523069,0.000029438017,0.6914023,0.00015977818,0.0025741532,0.115131915,0.14932524,0.03714993,0.0006119704],"about_ca_topic_score_codex":0.000025922107,"about_ca_topic_score_gemma":0.00002627409,"teacher_disagreement_score":0.8638461,"about_ca_system_score_codex":0.00001455515,"about_ca_system_score_gemma":0.000047356665,"threshold_uncertainty_score":0.30966628},"labels":[],"label_agreement":null},{"id":"W4247068466","doi":"10.1111/bjd.20279","title":"PA03: Understanding phenotypic variations of pseudohypoparathyroidism and loss‐of‐function <i>GNAS</i> variants","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"GNAS complex locus; Pseudohypoparathyroidism; Phenotype; Medicine; Genetics; Internal medicine; Biology; Parathyroid hormone","score_opus":0.017472123474787944,"score_gpt":0.2562795952215628,"score_spread":0.23880747174677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247068466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95786875,0.015980812,0.025102895,0.0002241773,0.00019424091,0.00006525376,0.00002380171,0.0000020002353,0.0005380394],"genre_scores_gemma":[0.9976797,0.0015814865,0.0005656106,0.000042705135,0.000057669466,0.0000010748178,0.000012319897,0.000010745194,0.0000486722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896246,0.0001837101,0.00041030502,0.000135866,0.00014721268,0.00016043916],"domain_scores_gemma":[0.9992062,0.000063723346,0.0002023318,0.00011622913,0.00033394553,0.00007759819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014498293,0.00007172046,0.0002570211,0.000070959,0.00006414633,0.000019552119,0.00008590152,0.00013038173,0.00002360396],"category_scores_gemma":[0.00025014416,0.00008823922,0.000087322325,0.0001380999,0.00013110516,0.000012769938,0.000086720116,0.000149903,9.037296e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003660798,0.0003398935,0.018044628,0.0001771388,0.0005642981,0.0018085139,0.00011586872,0.000021510641,0.96537614,0.0043296376,0.0030611735,0.005795112],"study_design_scores_gemma":[0.00933039,0.001447226,0.10502683,0.0004518232,0.0005743203,0.3540212,0.0012493177,0.0003151937,0.49497962,0.02792002,0.00399439,0.0006896777],"about_ca_topic_score_codex":0.000013106747,"about_ca_topic_score_gemma":0.00007435202,"teacher_disagreement_score":0.47039655,"about_ca_system_score_codex":0.000012581742,"about_ca_system_score_gemma":0.00023681817,"threshold_uncertainty_score":0.3598291},"labels":[],"label_agreement":null},{"id":"W4249995199","doi":"10.1111/bjd.19509","title":"A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research; Dermatrials Research; Dalhousie University; Guenther Dermatology Research Centre","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Double blinded; Randomized controlled trial; Dermatology; Plaque psoriasis; Head (geology); Physical therapy; Internal medicine; Alternative medicine; Placebo; Psoriatic arthritis; Secukinumab; Pathology","score_opus":0.031101962779269417,"score_gpt":0.2690927002085634,"score_spread":0.237990737429294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249995199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916859,0.0029757489,0.0002556892,0.0023813143,0.0006110336,0.0016176885,0.00037671713,0.000023601751,0.00007225347],"genre_scores_gemma":[0.99811965,0.00028651624,0.0009519668,0.00032168854,0.0000621168,0.000034712226,0.00017421882,0.000032623433,0.000016528222],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99577886,0.0010997977,0.002024868,0.00048121923,0.00014716764,0.00046809195],"domain_scores_gemma":[0.99747133,0.0009117014,0.00091661606,0.00021511281,0.00030003628,0.00018519774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003230731,0.00035007027,0.002623731,0.00029626006,0.00013722504,0.000042930125,0.00034754322,0.00042873345,0.000043481756],"category_scores_gemma":[0.0005213563,0.0003234338,0.0001992221,0.00034732922,0.00017709825,0.00017636931,0.00010288288,0.00052570447,0.000031306296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9697051,0.001367308,0.0035589936,0.00002430175,0.0011443313,0.00038380254,0.0030806023,0.000160422,0.00010657016,0.000019538089,0.0020406037,0.018408438],"study_design_scores_gemma":[0.9677833,0.002403043,0.023372179,0.0005491926,0.0004887262,0.0013664743,0.00024377649,0.00001589586,0.0025072696,0.000038192673,0.0008807631,0.0003512344],"about_ca_topic_score_codex":0.00051341555,"about_ca_topic_score_gemma":0.00067761604,"teacher_disagreement_score":0.019813186,"about_ca_system_score_codex":0.00005771284,"about_ca_system_score_gemma":0.00024182656,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W4253956332","doi":"10.1111/bjd.19673","title":"Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Dermatology Life Quality Index; Atopic dermatitis; Medicine; Quality of life (healthcare); Eczema Area and Severity Index; Pediatrics; Family medicine; Physical therapy; Dermatology; Disease; Nursing; Pathology","score_opus":0.13085183247409027,"score_gpt":0.38162369681757974,"score_spread":0.25077186434348947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253956332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585468,0.004474591,0.00001890604,0.035862412,0.00032459912,0.0005876141,0.00014564158,0.0000076613205,0.00003175542],"genre_scores_gemma":[0.9962116,0.00031413033,0.00014547603,0.0032728594,0.000027527352,0.0000037876005,0.000010462708,0.000010673356,0.0000034888658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948958,0.0009932397,0.003503352,0.00017691251,0.00018329712,0.0002474039],"domain_scores_gemma":[0.99530077,0.0013095507,0.0026712257,0.00013914877,0.00034391962,0.00023536939],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014029394,0.00013763682,0.0023150782,0.00009885592,0.00006823532,0.0000072295607,0.00015700301,0.00020471869,0.000007178404],"category_scores_gemma":[0.009786371,0.000118316944,0.0002991611,0.00014932742,0.00027433198,0.0000454088,0.000059679733,0.00041768476,2.9826836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074166087,0.00020357837,0.98403156,0.0007734186,0.00036201865,0.0004292314,0.00039280197,0.0000011234913,0.00010485016,0.000020224237,0.0030763529,0.0031882129],"study_design_scores_gemma":[0.034595236,0.00015158363,0.94998777,0.00079586485,0.00016984608,0.013058371,0.00035632923,0.000094125266,0.0003152737,0.00033663615,0.000046552293,0.00009239329],"about_ca_topic_score_codex":0.00011249846,"about_ca_topic_score_gemma":0.00012242053,"teacher_disagreement_score":0.03766478,"about_ca_system_score_codex":0.00002737495,"about_ca_system_score_gemma":0.00029173793,"threshold_uncertainty_score":0.99855465},"labels":[],"label_agreement":null},{"id":"W4255499790","doi":"10.1111/bjd.16749","title":"Systematic review of atopic dermatitis disease definition in studies using routinely collected health data","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Medical diagnosis; Medical record; Disease; Diagnosis code; MEDLINE; Family medicine; Health care; Dermatology; Pathology; Surgery; Environmental health; Population","score_opus":0.08715602629951488,"score_gpt":0.37006225061013576,"score_spread":0.28290622431062085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255499790","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.246257,0.74708444,0.00034563753,0.0049724914,0.0003226445,0.0007819734,0.000094080104,0.00001712423,0.00012461991],"genre_scores_gemma":[0.9258225,0.06859804,0.0011864981,0.00426454,0.000050062434,0.000006652301,0.000051287523,0.0000138195,0.000006623133],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99664664,0.0007081642,0.0019775918,0.00016397494,0.0002534105,0.00025022164],"domain_scores_gemma":[0.9973421,0.00023455443,0.0012510678,0.0003462995,0.0006321103,0.00019384672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042324947,0.00012964745,0.0017419962,0.00022612435,0.000093538365,0.000009686306,0.0002502642,0.00006631131,0.000041733852],"category_scores_gemma":[0.0039700065,0.0001292617,0.000121918405,0.00036566277,0.00030397245,0.00021150828,0.00009754465,0.00019731723,0.0000055588553],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014800743,0.0006960229,0.07693273,0.829848,0.0009287185,0.019272046,0.00032566825,4.20866e-7,0.000009368109,0.00014924347,0.07137849,0.0003112938],"study_design_scores_gemma":[0.0027187846,0.00009291889,0.082804725,0.63081455,0.0012286175,0.2808393,0.00034501796,0.00022146346,0.000039166203,0.0006648374,0.00006973806,0.00016089856],"about_ca_topic_score_codex":0.000030213934,"about_ca_topic_score_gemma":0.00008146225,"teacher_disagreement_score":0.6795655,"about_ca_system_score_codex":0.00007389267,"about_ca_system_score_gemma":0.0007528732,"threshold_uncertainty_score":0.5271139},"labels":[],"label_agreement":null},{"id":"W4256582461","doi":"10.1111/bjd.20280","title":"PA04 (P16): An assessment of the experiences of general practitioners and general practitioner trainees of referrals to paediatric dermatology services","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Family medicine; Dermatology; Medical education","score_opus":0.017734771065999914,"score_gpt":0.32692870187651013,"score_spread":0.3091939308105102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256582461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846055,0.008070581,0.00019996711,0.0048607397,0.0005719332,0.00016968926,0.000011753428,0.000005889188,0.0015039763],"genre_scores_gemma":[0.9883662,0.0018903806,0.006305417,0.0032206026,0.00012223565,0.0000142314275,0.000012210086,0.000013535621,0.00005520723],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.997447,0.0005004766,0.0012283358,0.00020289798,0.00038984764,0.00023142362],"domain_scores_gemma":[0.9973802,0.00019050538,0.0011911761,0.00022668492,0.0008379323,0.00017353128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020957272,0.00015162153,0.0010722094,0.00023458301,0.000102000165,0.0000065510535,0.0001711265,0.00017245121,0.00006117948],"category_scores_gemma":[0.00022728578,0.00012837749,0.00015841484,0.0003189308,0.0004732111,0.0002294686,0.00008961282,0.00031754776,3.4086537e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015550175,0.0061431746,0.5212063,0.0075066322,0.0043329457,0.033279534,0.08611512,0.00019968428,0.14728498,0.0051373173,0.17636955,0.010869754],"study_design_scores_gemma":[0.00764312,0.0010405321,0.22043453,0.0010365779,0.0013160169,0.6077545,0.08706288,0.00025972506,0.058753688,0.00033478663,0.013917031,0.0004465965],"about_ca_topic_score_codex":0.00006457269,"about_ca_topic_score_gemma":0.00009640072,"teacher_disagreement_score":0.574475,"about_ca_system_score_codex":0.0000312117,"about_ca_system_score_gemma":0.0005783963,"threshold_uncertainty_score":0.5235082},"labels":[],"label_agreement":null},{"id":"W4281287539","doi":"10.1111/bjd.21673","title":"The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"H. Lundbeck A/S; Lundbeckfonden","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Drug; MEDLINE; Internal medicine; Pharmacology; Disease","score_opus":0.013532170588659397,"score_gpt":0.2619211913445645,"score_spread":0.24838902075590508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281287539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872407,0.00037857646,0.00003340221,0.011172963,0.00019967555,0.0007839396,0.00002244464,0.000010619856,0.00015772133],"genre_scores_gemma":[0.9995529,0.00004276918,0.00011956998,0.000044193333,0.000022819931,0.00005507285,0.000033454668,0.000015713274,0.00011351033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811554,0.00050604827,0.0005589761,0.00015413965,0.00042862218,0.00023669541],"domain_scores_gemma":[0.9991433,0.00012445102,0.00025061902,0.00011370551,0.00026468554,0.00010322515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000022630975,0.00011689626,0.00035695898,0.00020490166,0.0003955744,0.00004386673,0.0001676582,0.000030407095,0.0000833425],"category_scores_gemma":[0.0002039564,0.00009011398,0.00005167325,0.00044901637,0.000057731442,0.0001463315,0.000071752795,0.0003581918,0.000005303996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057896855,0.0013500993,0.8990718,0.000004033562,0.000108498585,0.07893099,0.0011288145,0.0000030176514,0.0000039281695,0.000022251852,0.00098578,0.0178118],"study_design_scores_gemma":[0.006326357,0.0013455413,0.65389377,0.000043018066,0.00005497297,0.33420417,0.002891692,0.000009463191,0.00003435954,0.000056240446,0.00105004,0.00009036247],"about_ca_topic_score_codex":0.000077740646,"about_ca_topic_score_gemma":0.00044710244,"teacher_disagreement_score":0.2552732,"about_ca_system_score_codex":0.00012905024,"about_ca_system_score_gemma":0.000152235,"threshold_uncertainty_score":0.36747414},"labels":[],"label_agreement":null},{"id":"W4281382713","doi":"10.1111/bjd.21677","title":"Biomarkers of systemic treatment response in people with psoriasis: a scoping review","year":2022,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; Innovative Medicines Initiative; Astellas Pharma; Novo Nordisk; National Institute for Health and Care Research; Department of Medicine, University of Toronto; Psoriasis Association; Department of Health and Social Care; European Commission; Sanofi; Kidney Foundation of Canada; Merck Canada; University of Toronto; European Federation of Pharmaceutical Industries and Associations; AstraZeneca; Eli Lilly and Company; King's College London; Gilead Sciences; Vifor Pharma; Heart and Stroke Foundation of Canada; Amgen","keywords":"Psoriasis; Medicine; Intensive care medicine; Dermatology","score_opus":0.031994865585863876,"score_gpt":0.29623763703079387,"score_spread":0.26424277144492997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281382713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002541265,0.9951535,0.000004604295,0.00004252883,0.0007178668,0.0013446921,0.00013097694,0.000013085628,0.000051518997],"genre_scores_gemma":[0.00077353214,0.99863774,0.000051451745,0.000020742591,0.000019876228,0.0002615003,0.000117632495,0.000051257783,0.00006629602],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99251324,0.0044034985,0.0022030394,0.00035328997,0.00009752526,0.00042943313],"domain_scores_gemma":[0.99580026,0.001261641,0.0024719883,0.00032743972,0.00009211403,0.00004656032],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074871624,0.00046004582,0.0049335305,0.0006686396,0.00010796437,0.000011818192,0.00045871676,0.0004213636,0.00049233524],"category_scores_gemma":[0.00022726081,0.00039112204,0.0008269672,0.0006473108,0.00012759615,0.00008564324,0.000073239215,0.0004216133,0.00002292865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013983414,0.00041577747,0.00019366333,0.050010968,0.0034604222,0.008052425,0.00015629389,3.9661626e-7,0.000009625703,0.0000032521518,0.0005317992,0.93576705],"study_design_scores_gemma":[0.0029894125,0.0006886319,0.000045237084,0.43930846,0.0036172916,0.42835593,0.00012978225,1.4969567e-8,0.000021075339,9.5019305e-7,0.124559455,0.00028376732],"about_ca_topic_score_codex":0.00011915221,"about_ca_topic_score_gemma":0.00019663872,"teacher_disagreement_score":0.9354833,"about_ca_system_score_codex":0.0003801759,"about_ca_system_score_gemma":0.0022869857,"threshold_uncertainty_score":0.9998541},"labels":[],"label_agreement":null},{"id":"W4283835003","doi":"10.1111/bjd.21222","title":"P100: Efficacy of current treatments under study in patients with alopecia areata","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Current (fluid); Hair disease","score_opus":0.014126487937245262,"score_gpt":0.2733089600141399,"score_spread":0.25918247207689465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283835003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975212,0.0015761752,0.000024112762,0.00012231666,0.00014909383,0.0003891835,0.000013965128,0.0000043689893,0.00019957771],"genre_scores_gemma":[0.99976563,0.000050052873,0.000032793232,0.000083973726,0.0000132720015,0.000008278416,0.000021323545,0.000013348621,0.000011338932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986133,0.0001707284,0.0005171814,0.00012448477,0.00037899762,0.00019528337],"domain_scores_gemma":[0.99937624,0.000048773956,0.00023999676,0.00011155454,0.00011653845,0.0001068696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007559352,0.00009618468,0.0004842457,0.00022614074,0.000056677327,0.0000060156513,0.000121795245,0.000024781304,0.00014360175],"category_scores_gemma":[0.00005081395,0.00009247203,0.00007000171,0.00023801929,0.000050157938,0.000064071406,0.000054132655,0.00030198903,0.0000018934759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010507132,0.0069813402,0.9734754,0.000018636654,0.00014631618,0.0020872378,0.00031424096,0.000029049766,0.0000012403799,0.000007357495,0.0007620754,0.015126369],"study_design_scores_gemma":[0.026555182,0.0015535818,0.96463853,0.00009560996,0.00014311458,0.0054130424,0.0010795351,0.0000023204293,0.000010642355,0.000027800854,0.00040764268,0.00007302434],"about_ca_topic_score_codex":0.00005320876,"about_ca_topic_score_gemma":0.00009370263,"teacher_disagreement_score":0.02550447,"about_ca_system_score_codex":0.00007681032,"about_ca_system_score_gemma":0.00018710145,"threshold_uncertainty_score":0.37708998},"labels":[],"label_agreement":null},{"id":"W4285085766","doi":"10.1111/bjd.21774","title":"Heterozygous variants in the integrin subunit beta 4 gene (ITGB4) cause autosomal dominant nail dystrophy","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Israel Science Foundation","keywords":"BETA (programming language); Gene; Genetics; Integrin; Dystrophy; Protein subunit; Nail (fastener); Biology; Medicine; Molecular biology; Receptor","score_opus":0.02450000851162791,"score_gpt":0.280548452866202,"score_spread":0.2560484443545741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285085766","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43327412,0.0084645385,0.00013977393,0.5545035,0.0014325215,0.0010472955,0.0001300267,0.000025146586,0.0009830684],"genre_scores_gemma":[0.527671,0.0066654305,0.001191108,0.4562554,0.0040743067,0.00015033122,0.0005888137,0.00038532272,0.0030182763],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99337035,0.0019843346,0.0016075962,0.0004662782,0.001594587,0.0009768767],"domain_scores_gemma":[0.99746984,0.00058774365,0.0007822406,0.00061876356,0.0003486076,0.0001927742],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00065097486,0.00041461532,0.0015570644,0.00095251866,0.00019852836,0.00014718015,0.0013466246,0.00081719767,0.0017045577],"category_scores_gemma":[0.00039378658,0.00036350783,0.00052373484,0.0005195592,0.000325665,0.00010922342,0.00039229897,0.010359705,0.00006752298],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002575418,0.00019010369,0.0005159117,0.00016076792,0.00021366734,0.56217754,0.0001344219,0.0000014380165,0.00075096305,0.000003133704,0.4330343,0.002560243],"study_design_scores_gemma":[0.0028582544,0.00048626793,0.004045812,0.00035531414,0.00020869751,0.67107964,0.00011689329,0.000020296962,0.0005307084,0.00004249716,0.3200264,0.00022925943],"about_ca_topic_score_codex":0.00036627258,"about_ca_topic_score_gemma":0.00008762548,"teacher_disagreement_score":0.11300791,"about_ca_system_score_codex":0.00034547874,"about_ca_system_score_gemma":0.0008346917,"threshold_uncertainty_score":0.9998817},"labels":[],"label_agreement":null},{"id":"W4288855303","doi":"10.1111/bjd.21798","title":"Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Eli Lilly and Company","keywords":"Hidradenitis suppurativa; Medicine; Patient satisfaction; MEDLINE; Dermatology; Internal medicine; Surgery; Biology; Disease","score_opus":0.024259246157149444,"score_gpt":0.25464233170054423,"score_spread":0.2303830855433948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288855303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932455,0.00021968257,0.0000071712857,0.0043542064,0.00013964839,0.0005942267,0.001255599,0.000017674914,0.0001663376],"genre_scores_gemma":[0.99919564,0.000029323262,0.000053913194,0.000018982866,0.000028893468,0.000026086595,0.0005957986,0.000020681533,0.00003066748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978027,0.0005473062,0.0005763758,0.00022987534,0.0005442007,0.00029954786],"domain_scores_gemma":[0.99875253,0.00031645398,0.0005312634,0.00014141099,0.00016528192,0.00009304545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000009505534,0.00021607945,0.00058212626,0.00008734604,0.00028011244,0.00004419843,0.000109325236,0.00007378582,0.00006775249],"category_scores_gemma":[0.0001540532,0.00013917785,0.0000918313,0.00041467603,0.00010333864,0.0002272554,0.000029662606,0.0003848427,0.0000016818068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016856802,0.00078418746,0.9284306,0.0000019038783,0.00054220046,0.06407159,0.0008566998,0.0000017893025,0.0000016072963,0.0000028607708,0.00046243996,0.0031584217],"study_design_scores_gemma":[0.019278172,0.0020873284,0.8428699,0.00015108264,0.00025420924,0.13380115,0.0011483982,0.0000041204585,0.00003491923,0.000021580925,0.0002306221,0.000118530246],"about_ca_topic_score_codex":0.00289323,"about_ca_topic_score_gemma":0.0067150975,"teacher_disagreement_score":0.08556073,"about_ca_system_score_codex":0.0009511348,"about_ca_system_score_gemma":0.0004250017,"threshold_uncertainty_score":0.5675508},"labels":[],"label_agreement":null},{"id":"W4289711506","doi":"10.1111/bjd.21793","title":"Where’s the colour? Advocating for morphological and antioppressive fluencies in dermatology","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; Women's College Hospital; Queen's University; University of Toronto; University Health Network; Hotel Dieu Hospital; Public Health Ontario","funders":"","keywords":"Dermatology; Medicine","score_opus":0.020930577054448476,"score_gpt":0.2837741085101155,"score_spread":0.262843531455667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289711506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966488,0.0084406445,0.00017554463,0.02335713,0.00047662357,0.00018753606,0.000011699146,0.000007987433,0.00085481955],"genre_scores_gemma":[0.99725837,0.001067705,0.00024770468,0.0013013531,0.00005895359,0.000013841036,0.0000013239702,0.0000033774957,0.000047351492],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9983213,0.00073532865,0.00029330296,0.00009743513,0.00029191206,0.0002607],"domain_scores_gemma":[0.9988961,0.0006302663,0.00023491746,0.000043033513,0.000132196,0.00006345578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093312317,0.000053123822,0.000262516,0.00007216232,0.0008792725,0.000048647395,0.00046428095,0.00007180335,0.00011419386],"category_scores_gemma":[0.0006473761,0.000051384166,0.000056200992,0.00014868444,0.00065328827,0.00010919177,0.00015278505,0.00038912919,5.6746654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006161774,0.00057678454,0.5095264,0.00019747179,0.00025097895,0.06093174,0.06861588,0.00020411494,0.0005310153,0.040584322,0.25278842,0.06517671],"study_design_scores_gemma":[0.004901089,0.0003358958,0.03875019,0.00018666689,0.00012863448,0.29196668,0.4316143,0.00013681388,0.000111205765,0.011882167,0.2196729,0.00031345745],"about_ca_topic_score_codex":0.00033917977,"about_ca_topic_score_gemma":0.0009789414,"teacher_disagreement_score":0.4707762,"about_ca_system_score_codex":0.00004278184,"about_ca_system_score_gemma":0.0001652734,"threshold_uncertainty_score":0.67627424},"labels":[],"label_agreement":null},{"id":"W4292063299","doi":"10.1111/bjd.21822","title":"The sound of silence: where are the voices of patients in eczema guideline development?","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"","keywords":"Guideline; Silence; Sound (geography); Medicine; Audiology; Acoustics; Pathology; Physics","score_opus":0.061049813637790565,"score_gpt":0.3929239920716602,"score_spread":0.3318741784338696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292063299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864457,0.0030852908,0.000119292774,0.009728747,0.00031610718,0.00021462403,0.00001779027,0.0000022948955,0.000070103044],"genre_scores_gemma":[0.99745315,0.00083935296,0.00088408525,0.00072927953,0.000042467393,0.0000067609044,0.0000130550425,0.000009716256,0.000022119697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630183,0.0004117338,0.0025136208,0.000089159614,0.00052214105,0.00016152133],"domain_scores_gemma":[0.9957048,0.0012600032,0.0021479374,0.00013175416,0.000712679,0.000042807627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013725813,0.0000716023,0.00037932093,0.000080829486,0.0001555911,0.000011344215,0.00028467923,0.00004044414,0.00022830229],"category_scores_gemma":[0.0027960902,0.000054408592,0.000088074776,0.00021494544,0.00013664235,0.000111405236,0.00014432851,0.00045969163,0.0000012043066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006126115,0.00052437116,0.8879625,0.00008346184,0.00015199388,0.00051331817,0.0006195049,0.000081578095,0.00005291837,0.000030044692,0.043001834,0.06636587],"study_design_scores_gemma":[0.009750182,0.00052812335,0.7974844,0.00043834007,0.000238739,0.023177173,0.032157265,0.00020582347,0.0006548103,0.0015494771,0.13363598,0.00017967513],"about_ca_topic_score_codex":0.00015703357,"about_ca_topic_score_gemma":0.0009828067,"teacher_disagreement_score":0.090634145,"about_ca_system_score_codex":0.000055961693,"about_ca_system_score_gemma":0.00033890305,"threshold_uncertainty_score":0.3347383},"labels":[],"label_agreement":null},{"id":"W4295083464","doi":"10.1111/bjd.21867","title":"Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Manchester Biomedical Research Centre; LEO Pharma; LEO Pharma Research Foundation; National Institute for Health and Care Research","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Adverse effect; Upper respiratory tract infection; Confidence interval; Randomized controlled trial; Gastroenterology; Immunology; Pathology","score_opus":0.012012766408466076,"score_gpt":0.2885681162650966,"score_spread":0.2765553498566305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295083464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930134,0.0025871021,0.00088604813,0.00085560785,0.00010938683,0.0021196224,0.00028154821,0.0000087883955,0.0001385112],"genre_scores_gemma":[0.998497,0.00033378022,0.00028965907,0.0005349205,0.000015567712,0.00014190414,0.0001403247,0.000018631274,0.000028202921],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9941711,0.0016975437,0.0030411778,0.0002621514,0.00050759275,0.00032044045],"domain_scores_gemma":[0.9959438,0.0010584377,0.0019095233,0.0001946646,0.00064386777,0.00024973493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096396374,0.0002493924,0.0055221003,0.0012173842,0.00018098825,0.00001597078,0.00020183691,0.00014407118,0.0004390828],"category_scores_gemma":[0.0009253863,0.00022388724,0.0006866874,0.0007354581,0.0002609834,0.00018987601,0.000084335115,0.0004376598,3.0157818e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9689614,0.003939632,0.0069616484,0.00012065727,0.0097098425,0.0032391103,0.0010173288,0.0032511228,0.000010470967,0.00005223871,0.00077063276,0.0019658718],"study_design_scores_gemma":[0.97011095,0.0006457554,0.0017574008,0.0002890135,0.0113931475,0.010662329,0.0005339184,0.004131262,0.00019571577,0.00006877164,0.000020010324,0.00019174947],"about_ca_topic_score_codex":0.000105407766,"about_ca_topic_score_gemma":0.000114617,"teacher_disagreement_score":0.007423219,"about_ca_system_score_codex":0.000055340726,"about_ca_system_score_gemma":0.00033918308,"threshold_uncertainty_score":0.9129857},"labels":[],"label_agreement":null},{"id":"W4301765318","doi":"10.1111/bjd.14560","title":"BSID Annual Meeting, Dalhousie Building, University of Dundee, 4-6 April 2016","year":2016,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urbanization and City Planning","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Library science; Computer science","score_opus":0.009236799012500721,"score_gpt":0.23653421177914846,"score_spread":0.22729741276664775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301765318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9165049,0.002471755,0.014987142,0.007856437,0.0009364461,0.00011508357,0.000052520652,0.00006319111,0.05701249],"genre_scores_gemma":[0.9956996,0.0012036682,0.00081299344,0.00009698363,0.00010146038,3.5488586e-8,3.2233632e-7,0.0000062080167,0.0020787446],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893385,0.00026736586,0.0002638154,0.000086220374,0.00023793096,0.00021084245],"domain_scores_gemma":[0.9988456,0.00015018941,0.000430237,0.00005125346,0.0003977136,0.00012505111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030973644,0.000052836458,0.00022296276,0.00008791492,0.00024510222,0.000018583869,0.0003109494,0.00011886816,0.0005056359],"category_scores_gemma":[0.00041334474,0.000055642235,0.00007775103,0.00013963351,0.00034396618,0.00031479713,0.000041374056,0.000102869686,0.000011803315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017633331,0.00035278266,0.3306174,0.00004379654,0.00028139036,0.0065054456,0.015328634,0.000018444362,0.0021880579,0.01952223,0.53925055,0.085714914],"study_design_scores_gemma":[0.0028593957,0.000080206555,0.04154428,0.0008154138,0.000080477635,0.007855938,0.008703903,0.0000066981697,0.0011841891,0.0015932879,0.93495786,0.0003183766],"about_ca_topic_score_codex":0.0007296009,"about_ca_topic_score_gemma":0.0011155151,"teacher_disagreement_score":0.39570728,"about_ca_system_score_codex":0.000033422857,"about_ca_system_score_gemma":0.00028042862,"threshold_uncertainty_score":0.55363584},"labels":[],"label_agreement":null},{"id":"W4302283101","doi":"10.1111/bjd.21880","title":"How will brepocitinib cream compare with established treatments for mild-to-moderate eczema?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Medicine; Dermatology","score_opus":0.019419140307171286,"score_gpt":0.2663980559441169,"score_spread":0.24697891563694563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302283101","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05627607,0.011173456,0.0011585949,0.9249774,0.0014954503,0.0021630328,0.001329366,0.000104158666,0.0013224487],"genre_scores_gemma":[0.20773621,0.00088412745,0.0054154587,0.7724707,0.0025366775,0.00052807893,0.0033844628,0.00037427412,0.0066700177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965578,0.000384982,0.0010050788,0.0005649606,0.00063917023,0.0008480165],"domain_scores_gemma":[0.9968519,0.0004908654,0.0010836071,0.0004102852,0.0007668934,0.00039640034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011091698,0.00054064085,0.0024335189,0.00055626174,0.00036655765,0.00022636366,0.000466075,0.0005816937,0.00039056968],"category_scores_gemma":[0.00031587764,0.00053183734,0.0006110013,0.00025060406,0.00026075818,0.0003418604,0.00009103033,0.0019690506,0.0000066913717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001944754,0.00040725546,0.004162437,0.00041199996,0.0017539111,0.16950053,0.000060732415,0.0000048476913,0.0000027677956,0.000003425673,0.82097936,0.0007680025],"study_design_scores_gemma":[0.0062721563,0.000585393,0.0012878042,0.00066083355,0.0017177461,0.4632069,0.00012283349,0.000010035301,0.000098190634,0.00015644544,0.52554303,0.0003386278],"about_ca_topic_score_codex":0.000025969784,"about_ca_topic_score_gemma":0.00002860707,"teacher_disagreement_score":0.2954363,"about_ca_system_score_codex":0.00015691578,"about_ca_system_score_gemma":0.0007457639,"threshold_uncertainty_score":0.9997133},"labels":[],"label_agreement":null},{"id":"W4313728090","doi":"10.1093/bjd/ljac040","title":"Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Placebo; Randomized controlled trial; Psoriasis; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis","score_opus":0.022812531839389194,"score_gpt":0.28525301356138516,"score_spread":0.26244048172199597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313728090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97608745,0.022021398,0.000020730608,0.00038244718,0.00040307947,0.00065697986,0.00037503228,0.0000030011327,0.000049864302],"genre_scores_gemma":[0.9952868,0.0044683884,0.00009227094,0.000030506208,0.000017136666,0.000014335373,0.000028793813,0.00000980446,0.000051968902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956059,0.0024367347,0.001527741,0.00018578203,0.000070570495,0.00017330235],"domain_scores_gemma":[0.99720377,0.0012484104,0.0012358265,0.00017223474,0.0001156213,0.000024119949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006505,0.00015308303,0.0019389876,0.00015339482,0.00010849666,0.000004731567,0.00015790558,0.00016371068,0.00007441736],"category_scores_gemma":[0.0007014187,0.00011485769,0.00030320341,0.00018990386,0.00023915019,0.000054759803,0.00009869594,0.00018448314,3.4143446e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73625684,0.0031100318,0.008951915,0.00014493238,0.004313329,0.0011074679,0.010785902,0.00004683848,0.09250187,0.0002301674,0.0016531043,0.14089762],"study_design_scores_gemma":[0.8651841,0.0015209354,0.034579195,0.00050758524,0.0015215119,0.021816265,0.0006040492,0.0000012596981,0.07290551,0.00019060019,0.0009758615,0.00019308462],"about_ca_topic_score_codex":0.0001736459,"about_ca_topic_score_gemma":0.000083681385,"teacher_disagreement_score":0.14070454,"about_ca_system_score_codex":0.000035909678,"about_ca_system_score_gemma":0.00012338796,"threshold_uncertainty_score":0.46837607},"labels":[],"label_agreement":null},{"id":"W4313729039","doi":"10.1093/bjd/ljac021","title":"Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Cilag; LEO Pharma; Novo Nordisk; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Sanofi Genzyme; Incyte; Dermira; UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Samsung; Valeant Pharmaceuticals International; Sanofi; Amgen; Meiji Seika Pharma; Pfizer","keywords":"Open label; Randomized controlled trial; Plaque psoriasis; Medicine; Term (time); Psoriasis; Extension (predicate logic); Surgery; Dermatology; Computer science","score_opus":0.018578486234398846,"score_gpt":0.2485509443510118,"score_spread":0.22997245811661296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313729039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98412544,0.0065347976,0.000014809999,0.0034776828,0.0011327779,0.0040799,0.0005874691,0.000011145158,0.00003595768],"genre_scores_gemma":[0.9956694,0.003361646,0.00005366881,0.000401384,0.00011426043,0.000077401324,0.00024759234,0.00002236804,0.00005224432],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936463,0.0041116965,0.0014326357,0.00035208263,0.00014415597,0.00031313222],"domain_scores_gemma":[0.98848915,0.010033341,0.00096003094,0.00031366583,0.000167648,0.000036191323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014326578,0.0002622871,0.0022261825,0.00007063031,0.000330044,0.00011345688,0.00052548,0.0003239291,0.00003002436],"category_scores_gemma":[0.0014013036,0.00013286364,0.00019782802,0.00020448577,0.00059823773,0.00017234372,0.00020236212,0.0004329348,0.0000039973315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859824,0.00039965517,0.00028858244,0.0000018652851,0.0019273557,0.00023391529,0.0022246584,0.000007688957,0.000028516424,0.000061623876,0.0027926671,0.0060510584],"study_design_scores_gemma":[0.976956,0.00040305976,0.019760678,0.00021820245,0.00096634234,0.0005529902,0.0002625092,0.000010281208,0.00008295648,0.00027620807,0.00035507852,0.00015566763],"about_ca_topic_score_codex":0.0011154249,"about_ca_topic_score_gemma":0.00050139247,"teacher_disagreement_score":0.019472096,"about_ca_system_score_codex":0.000019502388,"about_ca_system_score_gemma":0.00016561116,"threshold_uncertainty_score":0.5418022},"labels":[],"label_agreement":null},{"id":"W4317360689","doi":"10.1093/bjd/ljac017","title":"Granzyme K contributes to endothelial microvascular damage and leakage during skin inflammation","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University; International Collaboration On Repair Discoveries; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Inflammation; Angiogenesis; Granzyme A; Immunology; Medicine; Pathogenesis; Granzyme; Vascular permeability; Erythema; Immune system; Pathology; Granzyme B; T cell; CD8; Cancer research","score_opus":0.004902850591071911,"score_gpt":0.2159892521330893,"score_spread":0.2110864015420174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317360689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98862255,0.0064020804,0.0003609308,0.004051761,0.00026476465,0.00020386642,0.000015874659,0.000017781575,0.00006040242],"genre_scores_gemma":[0.9985541,0.0002806148,0.00027154596,0.0005113349,0.00018935147,0.0000082288425,0.000013951278,0.000018307279,0.00015254828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875623,0.00013331584,0.0005301123,0.00013649138,0.00021896033,0.00022489889],"domain_scores_gemma":[0.99935913,0.00007316147,0.00021216564,0.000092865135,0.00013210399,0.00013059791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021559471,0.00010035413,0.00043456745,0.00023087101,0.00026927743,0.00004401221,0.00009712082,0.00005366558,0.0001310567],"category_scores_gemma":[0.00014653278,0.00012217699,0.00013844747,0.00015815935,0.00006141029,0.00012183464,0.00008821866,0.00025238458,0.0000039682386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003057666,0.0007472622,0.42357442,0.00076876814,0.0018291852,0.05852989,0.004755899,0.000363409,0.38374728,0.002839626,0.021081941,0.09870465],"study_design_scores_gemma":[0.010448054,0.00021803059,0.5090307,0.0002539888,0.00024597906,0.31638506,0.0006058728,0.00010051543,0.1151914,0.0006149974,0.04665769,0.00024770608],"about_ca_topic_score_codex":0.000069874906,"about_ca_topic_score_gemma":0.000043710563,"teacher_disagreement_score":0.26855588,"about_ca_system_score_codex":0.000057479974,"about_ca_system_score_gemma":0.00007796241,"threshold_uncertainty_score":0.49822333},"labels":[],"label_agreement":null},{"id":"W4317646215","doi":"10.1093/bjd/ljac080","title":"Safety of baricitinib in patients with alopecia areata","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Alopecia areata; Dermatology; Medicine","score_opus":0.005759247926343786,"score_gpt":0.20826884686696745,"score_spread":0.20250959894062368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55114794,0.00866554,0.00020600327,0.41575778,0.0014002171,0.0014593529,0.0007094139,0.000033584372,0.02062014],"genre_scores_gemma":[0.640983,0.00095439976,0.0006192181,0.35503402,0.0006404124,0.000014413807,0.0013228193,0.00013704874,0.0002946675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764365,0.00020460163,0.0010351229,0.00018988398,0.00057065935,0.0003561073],"domain_scores_gemma":[0.9986663,0.00012692812,0.0006526676,0.00018044068,0.00028109242,0.00009259719],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000102193764,0.00019180305,0.0011865372,0.0004515196,0.000041737305,0.000009878437,0.00025134665,0.00037922693,0.0010303021],"category_scores_gemma":[0.0001846569,0.00019698337,0.00017301165,0.0002615346,0.0001393165,0.00008110757,0.00006108002,0.0022343548,0.0000035014123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010774608,0.00026009965,0.28254715,0.00027838335,0.00019830503,0.043946996,0.000069024514,0.0000023180646,2.6119375e-7,0.0000035891576,0.66675806,0.0048583513],"study_design_scores_gemma":[0.013781468,0.0008046143,0.24989653,0.0010886317,0.00025064408,0.07058143,0.00012365344,0.0000014228045,0.0000075919165,0.000054454897,0.6631468,0.0002627941],"about_ca_topic_score_codex":0.00008785559,"about_ca_topic_score_gemma":0.000062648716,"teacher_disagreement_score":0.089835025,"about_ca_system_score_codex":0.00007847308,"about_ca_system_score_gemma":0.00043308196,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W4317646773","doi":"10.1093/bjd/ljac052","title":"Does bimekizumab stand the test of time for psoriasis?","year":2022,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Psoriasis; Test (biology); Medicine; Dermatology; Biology","score_opus":0.010099609438465305,"score_gpt":0.21994090026958446,"score_spread":0.20984129083111916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646773","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057675354,0.21538626,0.00020570646,0.68916875,0.023200836,0.002498554,0.010264949,0.000103637816,0.0014959367],"genre_scores_gemma":[0.3123258,0.10515415,0.0032910306,0.4312062,0.020479588,0.0015129865,0.009461122,0.0015862385,0.11498287],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739015,0.0006862313,0.001061548,0.00026474308,0.00010907921,0.00048825747],"domain_scores_gemma":[0.9952234,0.0027229956,0.0014447521,0.00029843784,0.0002905197,0.000019914049],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000299511,0.00030659794,0.0012098267,0.00022775993,0.00034647054,0.000036136676,0.00080786255,0.00089483825,0.0020321952],"category_scores_gemma":[0.00040588016,0.00020336224,0.00064850884,0.00013254328,0.0003536557,0.00009513949,0.00011139941,0.0013313324,0.0000406251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034622833,0.00014664132,0.0002298559,0.000121121324,0.0015608644,0.00259731,0.00009900882,5.1271184e-7,0.0010044186,0.0000056079966,0.9731721,0.020716306],"study_design_scores_gemma":[0.0037600484,0.00042196014,0.00019125079,0.00021124959,0.0010388392,0.074703194,0.000099349345,3.0490682e-7,0.0060022287,0.00039273466,0.9129374,0.00024142029],"about_ca_topic_score_codex":0.00003681874,"about_ca_topic_score_gemma":0.0000131632705,"teacher_disagreement_score":0.25796255,"about_ca_system_score_codex":0.00006427039,"about_ca_system_score_gemma":0.0003939959,"threshold_uncertainty_score":0.9988801},"labels":[],"label_agreement":null},{"id":"W4317646803","doi":"10.1093/bjd/ljac038","title":"Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Vitiligo; Medicine; Meta-analysis; Dermatology; Lupus erythematosus; MEDLINE; Immunology; Pathology; Antibody; Biology","score_opus":0.04082151094400545,"score_gpt":0.3156295654674686,"score_spread":0.2748080545234632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317646803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028172066,0.998562,0.000041539446,0.00002801686,0.00009618818,0.00084761286,0.00011553366,0.0000017411171,0.000025639813],"genre_scores_gemma":[0.002060791,0.99725354,0.00006740348,0.00010302147,0.000012616173,0.0003064696,0.00012016217,0.000026473066,0.000049551345],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99527526,0.0016727719,0.0023591004,0.00027024467,0.00024055086,0.00018205661],"domain_scores_gemma":[0.9968255,0.00021104902,0.0024868066,0.00029809185,0.00010209755,0.00007644962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007123577,0.000271487,0.0071155895,0.00033748563,0.00003681401,0.00002210276,0.00037118953,0.00022369184,0.00016876768],"category_scores_gemma":[0.00032379106,0.00024466982,0.0018658199,0.00040067857,0.00006137072,0.0000063469683,0.00012421755,0.00027986776,0.0000010575719],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056193676,0.000111404595,0.000103742874,0.9236395,0.071657054,0.0017043868,0.000028290888,0.0000012120229,0.0000022677498,0.000015123098,0.0011344143,0.0015969898],"study_design_scores_gemma":[0.00031416377,0.00007100121,9.684622e-7,0.038052488,0.57007694,0.3791089,0.000100542515,6.1346617e-7,0.0000148844965,0.000007587125,0.012006139,0.00024574454],"about_ca_topic_score_codex":0.000022140537,"about_ca_topic_score_gemma":0.00004651119,"teacher_disagreement_score":0.88558704,"about_ca_system_score_codex":0.00003085663,"about_ca_system_score_gemma":0.00012626295,"threshold_uncertainty_score":0.99773455},"labels":[],"label_agreement":null},{"id":"W4317952699","doi":"10.1093/bjd/ljac140.009","title":"309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SKiN Health; Queen's University; Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adverse effect; Atopic dermatitis; Placebo; Dosing; Interim analysis; Internal medicine; Clinical trial; Pediatrics; Dermatology; Alternative medicine","score_opus":0.027450819459691467,"score_gpt":0.28470093458630624,"score_spread":0.2572501151266148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656,0.00034005012,0.000082559454,0.0014883248,0.0002405101,0.00064827665,0.00009797526,0.000018525669,0.00052377203],"genre_scores_gemma":[0.9988921,0.00020216499,0.0004908306,0.00020451397,0.00005018989,0.000025660538,0.000029492398,0.00002066017,0.000084354935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780947,0.00022120899,0.0011836239,0.0002078393,0.00021687453,0.00036100528],"domain_scores_gemma":[0.99876285,0.000117889096,0.00040100957,0.0001562001,0.00028614784,0.00027592605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010039508,0.00020004749,0.0011030883,0.00050821336,0.00006245672,0.0000056705317,0.00015690719,0.00015232818,0.00012195392],"category_scores_gemma":[0.00017575665,0.00019331269,0.00017731213,0.0005056961,0.00013345068,0.00013118665,0.000058826623,0.00021341983,0.00001914478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008853147,0.0015998528,0.8856864,0.00093144877,0.0015578667,0.06184658,0.0040974696,0.0012132379,0.00072222215,0.00020216755,0.017365623,0.015923994],"study_design_scores_gemma":[0.0181986,0.0010244951,0.8153137,0.0046369,0.0004013026,0.14691982,0.0031575896,0.00040138405,0.008567543,0.00023021945,0.0008049535,0.00034349327],"about_ca_topic_score_codex":0.000094075695,"about_ca_topic_score_gemma":0.00091820443,"teacher_disagreement_score":0.08507323,"about_ca_system_score_codex":0.00016031596,"about_ca_system_score_gemma":0.000574667,"threshold_uncertainty_score":0.7883063},"labels":[],"label_agreement":null},{"id":"W4317952701","doi":"10.1093/bjd/ljac140.005","title":"301 Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Adverse effect; Psoriasis; Body surface area; Clinical trial; Randomized controlled trial; Clinical endpoint; Pediatrics; Dermatology; Internal medicine","score_opus":0.025587148880056212,"score_gpt":0.2834103890511923,"score_spread":0.2578232401711361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837386,0.013211073,0.000069854796,0.0018584052,0.00031680372,0.00073454896,0.00004569427,0.000013087481,0.000011920733],"genre_scores_gemma":[0.99164474,0.0076055326,0.00011799991,0.00043266898,0.00009990928,0.000030058774,0.000016803748,0.000015913996,0.00003635003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998553,0.00015153123,0.00069662486,0.00015549157,0.00015460055,0.00028879367],"domain_scores_gemma":[0.99885356,0.0003825129,0.00032680866,0.00013995916,0.00018054813,0.000116581265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008316606,0.00013937012,0.0007066503,0.00018802317,0.00009768364,0.000024251765,0.00010989531,0.0001376899,0.000010972559],"category_scores_gemma":[0.0003646173,0.00011885028,0.00020217041,0.00016416515,0.00027132095,0.00014580222,0.000025693906,0.00015464312,0.0000032866521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010280673,0.0028329832,0.9005481,0.00021376897,0.0005053797,0.016798252,0.0006503992,0.000010381985,0.000038855887,0.000048950475,0.020650132,0.047422115],"study_design_scores_gemma":[0.04699182,0.0008282456,0.8631499,0.00056656444,0.0002553108,0.08635582,0.00023757161,0.000080962796,0.00030211473,0.00018660047,0.0009557879,0.00008933718],"about_ca_topic_score_codex":0.00007448479,"about_ca_topic_score_gemma":0.000063419015,"teacher_disagreement_score":0.06955757,"about_ca_system_score_codex":0.000029602312,"about_ca_system_score_gemma":0.0001331667,"threshold_uncertainty_score":0.48465738},"labels":[],"label_agreement":null},{"id":"W4317952709","doi":"10.1093/bjd/ljac140.031","title":"337 Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Placebo; Atopic dermatitis; Medicine; Concomitant; Incidence (geometry); Internal medicine; Eczema Area and Severity Index; Randomized controlled trial; Adverse effect; Dermatology; Pathology; Alternative medicine","score_opus":0.008691247916455452,"score_gpt":0.2401094852616762,"score_spread":0.23141823734522074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985943,0.00008334885,0.000028555582,0.00046318938,0.00006242898,0.00044786365,0.00016531326,0.00003655066,0.00011845329],"genre_scores_gemma":[0.99851286,0.00014350591,0.00020644502,0.00095200667,0.000013992246,0.000028067574,0.00007392935,0.00002845519,0.00004075322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982393,0.0003347748,0.0005886001,0.00020694376,0.00029439974,0.00033597808],"domain_scores_gemma":[0.998689,0.00016025628,0.00033705166,0.00018171615,0.00029553563,0.00033644028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085095766,0.00017709711,0.000779837,0.00046805738,0.00009452376,0.000024283776,0.00009493616,0.00014975038,0.00005197702],"category_scores_gemma":[0.00028288196,0.00016866946,0.000099101875,0.00048385453,0.00007660604,0.00019289299,0.000027044158,0.00025067668,0.000016025455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012427488,0.0012238347,0.9802055,0.000028095452,0.00047184704,0.008972384,0.0006444832,0.000343067,0.0000055086766,0.00000340209,0.005352274,0.0015068565],"study_design_scores_gemma":[0.013560652,0.0013381942,0.9729652,0.00053296896,0.0002727777,0.010548533,0.000095359086,0.00014055788,0.00023602338,0.000050819748,0.00009579655,0.00016310837],"about_ca_topic_score_codex":0.0008000622,"about_ca_topic_score_gemma":0.00219047,"teacher_disagreement_score":0.012317903,"about_ca_system_score_codex":0.00012708518,"about_ca_system_score_gemma":0.00026812693,"threshold_uncertainty_score":0.6878141},"labels":[],"label_agreement":null},{"id":"W4317952713","doi":"10.1093/bjd/ljac140.023","title":"328 Understanding the impact of atopic dermatitis on patients: a large international, ethnically diverse survey-based qualitative study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ethnically diverse; Atopic dermatitis; Population; Disease; Qualitative research; Telephone interview; Family medicine; Environmental health; Pathology","score_opus":0.07348607169088718,"score_gpt":0.39905004627109814,"score_spread":0.32556397458021097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702394,0.00019341496,0.00055085507,0.0011609087,0.00032175443,0.00027499007,0.00018428106,0.000020206779,0.00026965473],"genre_scores_gemma":[0.99924654,0.00012673055,0.000016472502,0.00047731033,0.000024258028,0.000005646352,0.00007442733,0.000014103947,0.000014512918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997185,0.0012955504,0.00072297186,0.00013413114,0.00041016794,0.00025216036],"domain_scores_gemma":[0.9973038,0.0014383976,0.000509442,0.00015491738,0.00047358972,0.00011988419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063147664,0.00013070073,0.0005377197,0.0002829849,0.00013538299,0.000023804727,0.00026210703,0.00010093538,0.00016219121],"category_scores_gemma":[0.0016695736,0.0001031072,0.00029284722,0.00033668758,0.00020201686,0.00011747875,0.000060898652,0.00036180866,0.000021575826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000409491,0.0016773103,0.9303975,0.00003980933,0.0007861527,0.0046030516,0.0047727968,0.000035861267,0.0000017886641,0.00007778269,0.0568836,0.00031483034],"study_design_scores_gemma":[0.006291075,0.00041246702,0.97712743,0.00024065425,0.00011266714,0.0026029474,0.012422948,0.0001338932,0.000015269872,0.000503884,0.000048519287,0.00008824867],"about_ca_topic_score_codex":0.00011048364,"about_ca_topic_score_gemma":0.0001526984,"teacher_disagreement_score":0.056835078,"about_ca_system_score_codex":0.00011151946,"about_ca_system_score_gemma":0.00022462614,"threshold_uncertainty_score":0.42045897},"labels":[],"label_agreement":null},{"id":"W4317952733","doi":"10.1093/bjd/ljac140.004","title":"288 Once-daily crisaborole as a long-term maintenance treatment in patients with mild-to-moderate atopic dermatitis: A 52-week clinical trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Atopic dermatitis; Maintenance therapy; Adverse effect; Randomized controlled trial; Internal medicine; Surgery; Dermatology; Chemotherapy","score_opus":0.02956280420410868,"score_gpt":0.32864235440599526,"score_spread":0.2990795502018866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99312496,0.0011539069,0.00008445862,0.003740957,0.00063837116,0.00084994576,0.000026112526,0.000050889994,0.000330416],"genre_scores_gemma":[0.9957305,0.0009620172,0.00019752228,0.0026076098,0.00014983641,0.000060851457,0.000046459434,0.000031803804,0.0002133525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675524,0.00046357105,0.001439111,0.00035485358,0.00036725678,0.0006199532],"domain_scores_gemma":[0.9982011,0.0002921499,0.0004406263,0.00026030885,0.00032697094,0.00047885522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019412622,0.00026203264,0.0012999285,0.00035867858,0.00011027237,0.000053106825,0.00022608413,0.00026105705,0.000074078474],"category_scores_gemma":[0.0004933144,0.00023656218,0.0002840427,0.00041768493,0.00023335178,0.00021197365,0.00004458255,0.00046058567,0.00016184546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018915497,0.0024202736,0.8831975,0.00007627378,0.00035381608,0.058016136,0.0002169688,0.000008812203,6.386096e-7,0.000015042872,0.021126552,0.015652504],"study_design_scores_gemma":[0.09889009,0.0018047071,0.86893797,0.00083010824,0.00020856752,0.02818113,0.00007612194,0.000022998971,0.000037973743,0.0001615142,0.00065144146,0.0001973655],"about_ca_topic_score_codex":0.000048517973,"about_ca_topic_score_gemma":0.00023316582,"teacher_disagreement_score":0.07997459,"about_ca_system_score_codex":0.000117364,"about_ca_system_score_gemma":0.00058587536,"threshold_uncertainty_score":0.96467257},"labels":[],"label_agreement":null},{"id":"W4317952754","doi":"10.1093/bjd/ljac140.016","title":"320 Study design and interim recruitment into the post-authorization safety study to monitor pregnancy and infant outcomes following administration of dupilumab during planned or unexpected pregnancy in North America","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Medicine; Pregnancy; Atopic dermatitis; Asthma; Prospective cohort study; Obstetrics; Pediatrics; Immunology; Internal medicine","score_opus":0.03629529792572218,"score_gpt":0.3312989481729265,"score_spread":0.2950036502472043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941624,0.0018275322,0.00016855758,0.0008616681,0.00017711754,0.0027680825,0.000006321375,0.000025132233,0.0000031875938],"genre_scores_gemma":[0.9987892,0.00048133466,0.00053224334,0.000030240884,0.000016471244,0.00010061473,0.000008537321,0.00002332735,0.000018037228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976799,0.00050703005,0.0010448215,0.00024498944,0.00030110936,0.00022214219],"domain_scores_gemma":[0.9988803,0.00028491198,0.00038892584,0.00015861506,0.0001679516,0.00011929183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018465387,0.0001670971,0.0007086462,0.00033677474,0.00012732379,0.000039651095,0.00012772364,0.000054138272,0.000004371518],"category_scores_gemma":[0.00069940195,0.00013834269,0.000053384367,0.0005722708,0.000054092583,0.00018047632,0.00011201216,0.00024100365,7.896575e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001512969,0.00095538783,0.93115354,0.00010337682,0.00032345753,0.016570875,0.026822055,0.000018742749,0.0004822043,7.823293e-7,0.0000071350264,0.0220495],"study_design_scores_gemma":[0.0053047864,0.004649583,0.96689636,0.0019425943,0.00016414002,0.0053357678,0.015074795,0.000040303883,0.0004711725,0.0000061280616,0.0000017995651,0.000112562884],"about_ca_topic_score_codex":0.00017337286,"about_ca_topic_score_gemma":0.0016254757,"teacher_disagreement_score":0.03574285,"about_ca_system_score_codex":0.00006483768,"about_ca_system_score_gemma":0.000102731436,"threshold_uncertainty_score":0.5641451},"labels":[],"label_agreement":null},{"id":"W4317952775","doi":"10.1093/bjd/ljac140.017","title":"321 Cancer risk with topical pimecrolimus and tacrolimus for atopic dermatitis: systematic review and Bayesian meta-analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina; University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Pimecrolimus; Medicine; Calcineurin; Atopic dermatitis; Randomized controlled trial; Dermatology; Tacrolimus; Relative risk; Odds ratio; Skin cancer; Population; Meta-analysis; Absolute risk reduction; Cancer; Confidence interval; Internal medicine; Environmental health; Transplantation","score_opus":0.020288888898497507,"score_gpt":0.29775498489498087,"score_spread":0.27746609599648336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952775","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11201633,0.86394095,0.0020753408,0.020281265,0.00008463436,0.0013414457,0.00014005111,0.000053461634,0.000066501154],"genre_scores_gemma":[0.9368362,0.05846067,0.00041659322,0.003976538,0.000028668312,0.00015443085,0.00001274656,0.000018645693,0.00009550412],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9981973,0.00031085,0.0008209359,0.00020804424,0.00017963888,0.0002832072],"domain_scores_gemma":[0.9983437,0.00049753825,0.0005178307,0.00017234971,0.00022135982,0.00024723948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023530926,0.0001741577,0.002682704,0.00023537799,0.00015135283,0.00003958233,0.00010136413,0.0001251136,0.000093182476],"category_scores_gemma":[0.000434176,0.00013504046,0.00051003014,0.00032119424,0.00017699022,0.00011758527,0.000033188633,0.00023420843,0.0000025299262],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021686568,0.00030688144,0.26074946,0.30619052,0.33110753,0.038248084,0.0003882585,0.000015697948,0.0000030136143,0.00031879634,0.06111052,0.0013443724],"study_design_scores_gemma":[0.0025539917,0.000109898065,0.062263113,0.005101418,0.66219735,0.26594442,0.00013604657,0.00026337802,0.000029566705,0.00064394623,0.0005093312,0.00024754932],"about_ca_topic_score_codex":0.00004176371,"about_ca_topic_score_gemma":0.0001749,"teacher_disagreement_score":0.82481986,"about_ca_system_score_codex":0.000013997353,"about_ca_system_score_gemma":0.000092383125,"threshold_uncertainty_score":0.550679},"labels":[],"label_agreement":null},{"id":"W4317952776","doi":"10.1093/bjd/ljac140.033","title":"339 Dupilumab 16-week efficacy and safety are robust and consistent in adults over 60 years of age with moderate-to-severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Dupilumab; Atopic dermatitis; Dermatology Life Quality Index; Placebo; Quality of life (healthcare); Population; Internal medicine; Randomized controlled trial; Dermatology; Disease; Alternative medicine; Pathology","score_opus":0.012251911398168747,"score_gpt":0.2342836336024542,"score_spread":0.22203172220428544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453837,0.0033837475,0.00004186903,0.0014496143,0.00007179718,0.00023834736,0.000030609794,0.000016844784,0.00022879468],"genre_scores_gemma":[0.9971123,0.0018521433,0.00024566054,0.000690352,0.000018323126,0.0000047304898,0.000014032464,0.000017950928,0.00004455025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860114,0.00013540116,0.0006123059,0.00018841217,0.00019378428,0.0002689852],"domain_scores_gemma":[0.9990466,0.00022093525,0.00025793613,0.00011483787,0.00012863529,0.00023100968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086208136,0.00013362251,0.0007647691,0.00028419652,0.00005583271,0.00002224507,0.00007952723,0.00013985952,0.000040665855],"category_scores_gemma":[0.00022016586,0.00014291558,0.00005962323,0.00023482688,0.00025883818,0.00011635774,0.00006095597,0.00028546678,0.000004544096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003084168,0.00057451305,0.7066352,0.0011032778,0.0003910893,0.25031945,0.0009976939,0.00024368607,0.000014989713,0.00006928095,0.022732588,0.013834084],"study_design_scores_gemma":[0.009109101,0.00011531205,0.8333535,0.0021158701,0.00008630692,0.15413125,0.0003565176,0.00011068498,0.000032687145,0.00009348786,0.00037822837,0.000117047406],"about_ca_topic_score_codex":0.00005297797,"about_ca_topic_score_gemma":0.00037772697,"teacher_disagreement_score":0.12671831,"about_ca_system_score_codex":0.000026170976,"about_ca_system_score_gemma":0.0001092487,"threshold_uncertainty_score":0.5827928},"labels":[],"label_agreement":null},{"id":"W4317952779","doi":"10.1093/bjd/ljac140.008","title":"308 Tralokinumab provides other clinically meaningful improvements in adolescents with moderate-to-severe atopic dermatitis who did not achieve IGA 0/1 at week 16","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Placebo; Medicine; Atopic dermatitis; Clinical endpoint; Post-hoc analysis; Eczema Area and Severity Index; Internal medicine; Randomized controlled trial; Imputation (statistics); Gastroenterology; Dermatology; Missing data; Pathology","score_opus":0.016824153032463204,"score_gpt":0.2719084973916451,"score_spread":0.25508434435918187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927173,0.0006268677,0.00021050061,0.0049006785,0.00027363468,0.0005671245,0.000037134836,0.000067524415,0.0005991917],"genre_scores_gemma":[0.9911318,0.00031714645,0.00021785864,0.0077641895,0.00008630068,0.000034202258,0.000016598608,0.00006314299,0.00036876553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667436,0.00031848124,0.0014063515,0.0003943495,0.00048213103,0.0007243442],"domain_scores_gemma":[0.9983969,0.000117105184,0.0005078138,0.0002596525,0.000263895,0.00045465495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024214713,0.0002978805,0.0011574093,0.00038846518,0.00015991356,0.000061018087,0.0003318248,0.00029056892,0.000097669414],"category_scores_gemma":[0.0003434791,0.0002905622,0.00022074356,0.00040319032,0.00021132124,0.00030127235,0.00013518163,0.00065480854,0.00012802206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033503957,0.000824032,0.9083865,0.0005984965,0.00031255872,0.040338837,0.00055176916,0.00005186618,0.00013585712,0.00001943394,0.033949602,0.011480652],"study_design_scores_gemma":[0.015499193,0.0006149811,0.8144151,0.005030507,0.00020829668,0.15953338,0.00031196928,0.0002501476,0.0013815783,0.00053568167,0.0017658903,0.00045326565],"about_ca_topic_score_codex":0.00007826455,"about_ca_topic_score_gemma":0.0006593151,"teacher_disagreement_score":0.11919454,"about_ca_system_score_codex":0.00014701314,"about_ca_system_score_gemma":0.00032042988,"threshold_uncertainty_score":0.99995464},"labels":[],"label_agreement":null},{"id":"W4317952794","doi":"10.1093/bjd/ljac140.022","title":"327 Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Systemic therapy; Medicine; Atopic dermatitis; Disease; Family medicine; Intensive care medicine; Breast cancer; Immunology; Internal medicine; Cancer","score_opus":0.0601214467038856,"score_gpt":0.34576311969541956,"score_spread":0.285641672991534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94366676,0.006824765,0.0012854205,0.04761666,0.00009497544,0.0004614493,0.000029110224,0.000011779689,0.000009106025],"genre_scores_gemma":[0.99372584,0.0022078566,0.0031924732,0.0007805115,0.00003777377,0.0000151431495,0.000008761856,0.000010412907,0.000021244925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99926007,0.00010286552,0.0002926335,0.00010688446,0.00009376885,0.0001437798],"domain_scores_gemma":[0.99920213,0.00025927232,0.00018990517,0.0000883048,0.00012408869,0.0001363178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011752042,0.000073884294,0.00028497376,0.00006571135,0.00010607704,0.000021567284,0.000046765843,0.00003867448,0.0000109628345],"category_scores_gemma":[0.000021459447,0.000060539496,0.00004273041,0.00008774042,0.000117750686,0.000036641635,0.000013198396,0.00009969362,1.5697817e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041489853,0.0004030163,0.11468087,0.009332659,0.0025040228,0.0155065,0.0069765514,0.000057751626,0.0005947885,0.000658574,0.096376225,0.74876004],"study_design_scores_gemma":[0.029190645,0.0012459634,0.68817866,0.00722564,0.0007918991,0.2452867,0.012295309,0.0030911898,0.0019291735,0.0007336947,0.0096456045,0.00038552808],"about_ca_topic_score_codex":0.00003537852,"about_ca_topic_score_gemma":0.000009359057,"teacher_disagreement_score":0.7483745,"about_ca_system_score_codex":0.000012237383,"about_ca_system_score_gemma":0.00013548211,"threshold_uncertainty_score":0.2468729},"labels":[],"label_agreement":null},{"id":"W4317952800","doi":"10.1093/bjd/ljac140.019","title":"323 Onset of atopic comorbidities relative to atopic dermatitis diagnosis in a real-world setting using an Israeli claims database","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Atopic dermatitis; Interquartile range; Asthma; Diagnosis code; Pediatrics; Epidemiology; Cohort; Population; Retrospective cohort study; Database; Internal medicine; Dermatology","score_opus":0.044431792324268346,"score_gpt":0.33796408556239177,"score_spread":0.2935322932381234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317952800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945476,0.0014359916,0.00012057013,0.0028643843,0.00030945527,0.0002508241,0.00013454197,0.00003996909,0.00029663913],"genre_scores_gemma":[0.99580526,0.0013229629,0.0015031408,0.0011232587,0.00007233845,0.000017030738,0.00008046749,0.000027502996,0.00004802798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745274,0.0004928134,0.0011251223,0.00022256648,0.00028289843,0.00042387124],"domain_scores_gemma":[0.9982261,0.0005812783,0.00044258783,0.00024274972,0.00022661319,0.0002806372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002373934,0.00017624816,0.000896929,0.0008426736,0.000121870115,0.000024221927,0.00021714857,0.000152797,0.00011897377],"category_scores_gemma":[0.00053798256,0.00020801743,0.00015757928,0.00074478844,0.00023061062,0.00046498887,0.00011120437,0.0004783301,0.000019876434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054689604,0.00027713427,0.92179114,0.0003134849,0.00013359664,0.04420058,0.00084739126,0.000036660218,0.00005164489,0.00020071097,0.029580425,0.0025125144],"study_design_scores_gemma":[0.0022910172,0.000082798426,0.9021616,0.0025075336,0.00018851565,0.086212076,0.0014846247,0.00038385857,0.0019894852,0.0013235385,0.0011639543,0.00021097672],"about_ca_topic_score_codex":0.00061700895,"about_ca_topic_score_gemma":0.0017513786,"teacher_disagreement_score":0.042011492,"about_ca_system_score_codex":0.00007559367,"about_ca_system_score_gemma":0.00028846718,"threshold_uncertainty_score":0.8482704},"labels":[],"label_agreement":null},{"id":"W4318183967","doi":"10.1093/bjd/ljac145","title":"Core outcome domains for lichen sclerosus: a CORALS initiative consensus statement","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Nottingham; British Association of Dermatologists; National Institute for Health and Care Research","keywords":"Lichen sclerosus; Statement (logic); Outcome (game theory); Medicine; Core (optical fiber); Dermatology; Political science; Computer science; Mathematics","score_opus":0.24404855591048868,"score_gpt":0.4286747833372107,"score_spread":0.18462622742672202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318183967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896004,0.0016356929,0.00015937757,0.0069346526,0.00041468284,0.000565914,0.000225929,0.00003934198,0.00042400055],"genre_scores_gemma":[0.9952511,0.00011376005,0.0010225931,0.003251937,0.00011316782,0.000024060118,0.000049107137,0.000021017717,0.00015325086],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982259,0.00007410087,0.0009404508,0.00012591973,0.00021353619,0.00042007348],"domain_scores_gemma":[0.9982119,0.0003261378,0.00039904582,0.00009042405,0.00047174047,0.00050071336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025634668,0.000108438784,0.00054246484,0.00018356233,0.000112707035,0.000018728386,0.00008168125,0.00009248381,0.000054022614],"category_scores_gemma":[0.000819681,0.00011421612,0.0001825463,0.00018679471,0.000113283815,0.00004750262,0.00002896497,0.00020700097,0.00005368462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043190955,0.00085096987,0.3601043,0.0023628457,0.00039941783,0.07725976,0.0010698473,0.00001269657,0.0005314653,0.0008601526,0.5375052,0.014724258],"study_design_scores_gemma":[0.043601934,0.0023522615,0.6456802,0.0008902964,0.0008287963,0.26068407,0.005987237,0.00045112838,0.0008720197,0.012061476,0.026020149,0.00057042215],"about_ca_topic_score_codex":0.000016132091,"about_ca_topic_score_gemma":0.00002380431,"teacher_disagreement_score":0.51148504,"about_ca_system_score_codex":0.00005860051,"about_ca_system_score_gemma":0.00048158207,"threshold_uncertainty_score":0.4657598},"labels":[],"label_agreement":null},{"id":"W4319460830","doi":"10.1093/bjd/ljac089","title":"Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma; Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Ustekinumab; Medicine; Secukinumab; Adalimumab; Psoriasis Area and Severity Index; Discontinuation; Adverse effect; Psoriasis; Dermatology; Dermatology Life Quality Index; Clinical trial; Internal medicine; Psoriatic arthritis; Disease","score_opus":0.019078634734313493,"score_gpt":0.25183596524701773,"score_spread":0.23275733051270425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319460830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889496,0.0033874938,0.0001216379,0.00052391837,0.0010104503,0.00078152184,0.0051268814,0.000032166143,0.00006635954],"genre_scores_gemma":[0.9972557,0.0005021853,0.00036479428,0.0002615778,0.00008698929,0.000044585504,0.0013025344,0.000050763243,0.00013086536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99418026,0.0023227888,0.0020685438,0.0006380536,0.00019915616,0.0005911719],"domain_scores_gemma":[0.99625635,0.0018667041,0.0012123516,0.00033434428,0.00019346077,0.00013676759],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006100926,0.00042244562,0.0020889712,0.00040026542,0.00047935455,0.00007088016,0.00046657783,0.00036794503,0.0010075581],"category_scores_gemma":[0.0005185634,0.0003835199,0.00018562627,0.0003765441,0.000120316305,0.00025328062,0.00022479659,0.0007498106,0.000020038662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7160042,0.004843947,0.011493927,0.000021876645,0.005081038,0.010483064,0.0058141933,0.00044317413,0.0015682941,0.000029696348,0.013954379,0.23026225],"study_design_scores_gemma":[0.8077281,0.0046679457,0.12984252,0.0008290449,0.0018435708,0.020853547,0.002244698,0.00003648723,0.008158283,0.00034883426,0.021852076,0.0015948748],"about_ca_topic_score_codex":0.0015843275,"about_ca_topic_score_gemma":0.0009816628,"teacher_disagreement_score":0.22866736,"about_ca_system_score_codex":0.00021120696,"about_ca_system_score_gemma":0.00041408415,"threshold_uncertainty_score":0.99990565},"labels":[],"label_agreement":null},{"id":"W4319978914","doi":"10.1093/bjd/ljac057","title":"Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Dosing; Medicine; Placebo; Atopic dermatitis; Cohort; Internal medicine; Anesthesia; Dermatology","score_opus":0.009185506710510306,"score_gpt":0.24559622675844336,"score_spread":0.23641072004793307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319978914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509495,0.0011834496,0.00009422113,0.0003637438,0.000060024195,0.0031320672,0.00004371326,0.000012485652,0.000015352607],"genre_scores_gemma":[0.99907243,0.000060401002,0.00016047996,0.00027184587,0.000015499538,0.0003024616,0.00007708646,0.000029533014,0.000010236487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664444,0.0011572508,0.0010539921,0.00033501573,0.0004848905,0.00032441624],"domain_scores_gemma":[0.99822026,0.0005564688,0.00057832326,0.00025882464,0.0002539247,0.00013220926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001474756,0.00030831914,0.0018865307,0.00025812295,0.00016972369,0.00005137009,0.00015580817,0.000062925465,0.00011948625],"category_scores_gemma":[0.00004822436,0.00018182334,0.0001163169,0.00036847527,0.00020464473,0.0001802657,0.000041488267,0.00027568126,9.748476e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20666094,0.0061851246,0.75562125,0.000019298699,0.0006365704,0.026391895,0.002635301,0.0003028585,0.0000011855749,4.598166e-7,0.000025637584,0.0015194848],"study_design_scores_gemma":[0.27545917,0.00278512,0.7035925,0.000539568,0.0006599146,0.01572269,0.0009889174,0.000059441663,0.000039129696,0.00000349586,0.000002803447,0.00014726412],"about_ca_topic_score_codex":0.0012168692,"about_ca_topic_score_gemma":0.010831278,"teacher_disagreement_score":0.068798214,"about_ca_system_score_codex":0.0002095663,"about_ca_system_score_gemma":0.00037232775,"threshold_uncertainty_score":0.74145406},"labels":[],"label_agreement":null},{"id":"W4323035929","doi":"10.1093/bjd/ljad053","title":"Atopic dermatitis in 2023 and beyond","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Epidemiology; Atopic dermatitis; Medicine; Dermatology; Pathogenesis; Family medicine; Immunology; Pathology","score_opus":0.010257209674156343,"score_gpt":0.2631347770804324,"score_spread":0.2528775674062761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323035929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808424,0.009271718,0.000018723324,0.007148131,0.00025665038,0.00008036566,0.000006576821,0.000022885999,0.002352525],"genre_scores_gemma":[0.9949991,0.0032842553,0.00014045594,0.0013359498,0.00004361579,0.000003605178,0.0000084950625,0.000010211229,0.00017427301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895674,0.00010046111,0.00047153558,0.00010289164,0.00012693545,0.00024144232],"domain_scores_gemma":[0.99943906,0.00014068109,0.00012367389,0.00007400422,0.00007510598,0.00014747298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009860311,0.00008025335,0.00044047568,0.00031794122,0.000049348524,0.000018172248,0.00007644881,0.00013075882,0.00010348524],"category_scores_gemma":[0.00025026887,0.000090974405,0.00007393892,0.00027825186,0.00014888961,0.00012912808,0.000040737465,0.00028124877,0.000056534456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032995882,0.00009705955,0.69457155,0.00016252176,0.00007471629,0.13181289,0.00014357509,0.0000011911817,0.000040021667,0.00016707493,0.15396674,0.018929634],"study_design_scores_gemma":[0.001751945,0.000016544021,0.6481287,0.00017093781,0.00003405903,0.34348655,0.00017741363,0.000044156073,0.00012486392,0.001550646,0.0044555585,0.000058621532],"about_ca_topic_score_codex":0.0000138599935,"about_ca_topic_score_gemma":0.000047738085,"teacher_disagreement_score":0.21167368,"about_ca_system_score_codex":0.000012700947,"about_ca_system_score_gemma":0.00009328648,"threshold_uncertainty_score":0.37098286},"labels":[],"label_agreement":null},{"id":"W4323652381","doi":"10.1093/bjd/ljad060","title":"Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research; Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Intertriginous; Medicine; Roflumilast; Psoriasis; Dermatology; Post-hoc analysis; Randomized controlled trial; Discontinuation; Reactogenicity; Internal medicine; Immunology; Disease; COPD","score_opus":0.009377737268086021,"score_gpt":0.226653947008203,"score_spread":0.21727620974011697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323652381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769274,0.019637702,0.00043591592,0.00029118374,0.000409109,0.0017632712,0.0004838376,0.000024367564,0.000027212216],"genre_scores_gemma":[0.9899084,0.0092165405,0.00015038459,0.00003981876,0.00007043253,0.00014494744,0.0003789447,0.000019619416,0.00007090322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99735737,0.0006859538,0.0012450778,0.00029186686,0.00007264089,0.00034710963],"domain_scores_gemma":[0.99613243,0.0024243305,0.0009853963,0.00013818029,0.00025568446,0.000063977895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004770982,0.00026233215,0.0031717448,0.0005446352,0.00017766374,0.00003682597,0.00016640621,0.00029880868,0.00008066116],"category_scores_gemma":[0.00038454094,0.00021161296,0.0005968026,0.00031304837,0.00039163098,0.00010596251,0.00005356547,0.00018687667,0.000002913018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9598912,0.00035753628,0.00078096637,0.000034511428,0.020119967,0.0003478444,0.0005138738,0.0000085866495,0.0016596533,0.00003518505,0.00038912566,0.015861556],"study_design_scores_gemma":[0.9815028,0.001880874,0.0021340498,0.00020107513,0.008552678,0.0026803485,0.00026937772,0.000039225295,0.0016717449,0.00007666669,0.0007849786,0.00020618708],"about_ca_topic_score_codex":0.00027185472,"about_ca_topic_score_gemma":0.00084481057,"teacher_disagreement_score":0.021611601,"about_ca_system_score_codex":0.000037272624,"about_ca_system_score_gemma":0.00020994089,"threshold_uncertainty_score":0.8629326},"labels":[],"label_agreement":null},{"id":"W4323653032","doi":"10.1093/bjd/ljad069","title":"Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Cilag; Sanofi Genzyme; InflaRx; Regeneron Pharmaceuticals; Sanofi; LEO Pharma; Galderma; Bayer HealthCare; Incyte; Amgen","keywords":"Hidradenitis suppurativa; Medicine; Comorbidity; Depression (economics); Anxiety; Disease; Quality of life (healthcare); Dermatology; Psychiatry; Internal medicine","score_opus":0.0380878632547377,"score_gpt":0.27690628934001854,"score_spread":0.23881842608528084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323653032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901165,0.00045141706,0.000006687822,0.0067348927,0.00012455537,0.0005359855,0.0018809095,0.00004369404,0.00010537851],"genre_scores_gemma":[0.9986228,0.00010890906,0.000020954118,0.000020689404,0.00006548721,0.000008695587,0.0010965683,0.00003280596,0.000023129434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750394,0.00039706388,0.00070543116,0.0002776983,0.0006323116,0.0004835512],"domain_scores_gemma":[0.99812317,0.00054446666,0.00048979104,0.00020232362,0.0003122328,0.00032802077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001415136,0.00027548955,0.00071934646,0.00014243499,0.00015386446,0.0000939048,0.00020220074,0.00012565832,0.000039274433],"category_scores_gemma":[0.0007560825,0.00016642368,0.00015146415,0.0009300506,0.00019495297,0.00034231768,0.00003561957,0.00044856334,0.00001541447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020915584,0.00042505527,0.8560014,0.0000048683823,0.00049173884,0.13453811,0.00042037264,0.0000012068723,8.469208e-7,0.0000023546947,0.0055107153,0.0005118145],"study_design_scores_gemma":[0.014916144,0.0005568168,0.9492251,0.00074417994,0.00018809558,0.033500846,0.0004914152,0.000009332117,0.000008518185,0.00003919421,0.00015267334,0.00016765321],"about_ca_topic_score_codex":0.00038711992,"about_ca_topic_score_gemma":0.00073742226,"teacher_disagreement_score":0.101037264,"about_ca_system_score_codex":0.00029007197,"about_ca_system_score_gemma":0.0006480352,"threshold_uncertainty_score":0.6786561},"labels":[],"label_agreement":null},{"id":"W4324130045","doi":"10.1093/bjd/ljad073","title":"We are not ‘Other’ populations: building research, education and clinical capacity around gender variance in dermatology","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"LGBTQ Health, Identity, and Policy","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; University Health Network; Women's College Hospital; University of Toronto","funders":"University of Toronto","keywords":"Transgender; Dignity; Curriculum; Equity (law); Gender equity; Health equity; Medicine; Capacity building; Medical education; Psychology; Public relations; Political science; Sociology; Nursing; Pedagogy; Public health; Gender studies; Law","score_opus":0.294102398181579,"score_gpt":0.509031748550382,"score_spread":0.214929350368803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324130045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97430825,0.005758165,0.00022043179,0.015467979,0.0028033948,0.0002002963,0.00001742437,0.000029444267,0.0011946236],"genre_scores_gemma":[0.9922762,0.0049927076,0.00076517934,0.0009768066,0.0006376913,0.000016383987,0.000003876375,0.000029495315,0.0003016674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522966,0.002254823,0.0012878997,0.0003199069,0.00025763368,0.0006501032],"domain_scores_gemma":[0.9978867,0.0007961602,0.000541014,0.00022879498,0.00030752283,0.00023976652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013565778,0.00013220626,0.00056613405,0.0008284628,0.00028943535,0.0000870667,0.0003192208,0.00044548747,0.00007854887],"category_scores_gemma":[0.001015308,0.00016633593,0.000103227176,0.00065000314,0.00039304368,0.0002810072,0.000081024664,0.0012273609,0.00012182857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007244462,0.00045032555,0.9072702,0.00027003835,0.000064349784,0.0024488212,0.0008229705,0.0000031415611,0.00001721284,0.017734656,0.055355515,0.015490317],"study_design_scores_gemma":[0.0012309657,0.000033611053,0.8582034,0.0001388569,0.000031754033,0.09130974,0.0010607408,0.000044811244,0.000004015096,0.041222867,0.006574405,0.00014481384],"about_ca_topic_score_codex":0.0036765246,"about_ca_topic_score_gemma":0.0031796067,"teacher_disagreement_score":0.088860914,"about_ca_system_score_codex":0.00009154087,"about_ca_system_score_gemma":0.0003612407,"threshold_uncertainty_score":0.67829823},"labels":[],"label_agreement":null},{"id":"W4328052704","doi":"10.1093/bjd/ljad081","title":"Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Janssen Research and Development; St Vincent's Hospital Melbourne; Pusan National University Hospital; Humboldt-Universität zu Berlin; Janssen Scientific Affairs; Freie Universität Berlin; Pusan National University; Berlin Institute of Health; University of Melbourne","keywords":"Medicine; Malignancy; Psoriasis; Dermatology; Skin cancer; Breast cancer; Cancer; Population; Family history; Internal medicine","score_opus":0.01635308347776333,"score_gpt":0.21098835684000225,"score_spread":0.19463527336223893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328052704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974866,0.00855692,0.000010328577,0.00019727647,0.00039871718,0.00023054148,0.0005579671,0.0000094771285,0.00029013932],"genre_scores_gemma":[0.9978854,0.0015834128,0.000133821,0.000029655646,0.000021595837,0.0000050770054,0.00011465371,0.000014852755,0.00021154743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997519,0.00090158416,0.0010764534,0.00018529005,0.000087075576,0.00023057483],"domain_scores_gemma":[0.9974671,0.0010602578,0.0010895994,0.00018679924,0.00017146154,0.00002481038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060474005,0.0001514668,0.000972881,0.00017217975,0.00004783683,0.0000051308793,0.00021165035,0.0002005797,0.00006517692],"category_scores_gemma":[0.00037478234,0.000106264546,0.00010573939,0.00019110288,0.00030703098,0.00009388399,0.000044412718,0.0002035966,0.0000065877402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055308487,0.0012180706,0.80585873,0.00011822281,0.0047059576,0.0026009197,0.0058128964,0.000020566109,0.0036457747,0.00023519715,0.046579536,0.073895626],"study_design_scores_gemma":[0.03968105,0.0006944353,0.9462624,0.00068958034,0.0005848186,0.0017124888,0.00047426642,5.202773e-7,0.0033029427,0.00008251835,0.0063225594,0.00019240048],"about_ca_topic_score_codex":0.000381581,"about_ca_topic_score_gemma":0.00037107745,"teacher_disagreement_score":0.14040367,"about_ca_system_score_codex":0.000052291667,"about_ca_system_score_gemma":0.0002165365,"threshold_uncertainty_score":0.43333423},"labels":[],"label_agreement":null},{"id":"W4361009497","doi":"10.1093/bjd/ljad035","title":"Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Plaque psoriasis; Body surface area; Open label; Imputation (statistics); Randomized controlled trial; Internal medicine; Surgery; Dermatology; Missing data","score_opus":0.028912431949101897,"score_gpt":0.2601819524444339,"score_spread":0.23126952049533198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361009497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484813,0.0009713498,0.00002186893,0.0019240984,0.0009808064,0.00058300165,0.00060055614,0.000015840487,0.000054331238],"genre_scores_gemma":[0.99851,0.0003925722,0.00032071274,0.00032901435,0.000035695153,0.000019067891,0.00015484648,0.000025181804,0.00021293308],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970341,0.0012130509,0.0009257738,0.0003204939,0.00011201498,0.00039457463],"domain_scores_gemma":[0.99786544,0.0009656269,0.0005755977,0.0003099726,0.0002466234,0.00003672792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005243446,0.00018793825,0.00073094555,0.00014930339,0.00014185849,0.000038762293,0.0006212646,0.0002825158,0.000036132467],"category_scores_gemma":[0.00057894184,0.00014635769,0.00007969567,0.0004348013,0.0001564488,0.0002430975,0.00016821972,0.0003357624,0.000054935055],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8900876,0.0013032513,0.0042441096,0.0000072098355,0.0007780871,0.0038497704,0.00205404,0.0000700324,0.0013135364,0.000064973196,0.07505962,0.021167796],"study_design_scores_gemma":[0.466191,0.0021468608,0.50600815,0.0010580417,0.00026203803,0.0055407956,0.00066037686,0.0000060845696,0.0057756975,0.0006539559,0.011235071,0.00046195998],"about_ca_topic_score_codex":0.0006237868,"about_ca_topic_score_gemma":0.00037268948,"teacher_disagreement_score":0.501764,"about_ca_system_score_codex":0.00005150484,"about_ca_system_score_gemma":0.0002610268,"threshold_uncertainty_score":0.59682935},"labels":[],"label_agreement":null},{"id":"W4362657980","doi":"10.1093/bjd/ljad115","title":"Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Medicine; Psoriasis; Clinical trial; Dermatology; Internal medicine","score_opus":0.0560023929324294,"score_gpt":0.35370666446939775,"score_spread":0.2977042715369683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996666,0.00083778036,0.00007545071,0.00011580554,0.0004659432,0.0008784732,0.00093973696,0.000014829689,0.0000059631357],"genre_scores_gemma":[0.9988566,0.0002737995,0.0004641092,0.00005206581,0.000026629707,0.000054275035,0.00016951996,0.000032860647,0.00007011528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632037,0.000974725,0.0017990925,0.00032051935,0.00012621935,0.0004590945],"domain_scores_gemma":[0.9974864,0.00078851776,0.0010114881,0.00023732547,0.0003826651,0.0000936098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006138986,0.00023774162,0.0018688795,0.0003230761,0.00007240776,0.000014776957,0.00024914273,0.00032130737,0.00002735899],"category_scores_gemma":[0.0004081234,0.00020206529,0.00036195177,0.0004656867,0.00012477068,0.000107207175,0.00005505898,0.00015474147,0.000010263936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08998701,0.0021265137,0.5822415,0.00007866248,0.0079804985,0.0010697893,0.008770766,0.0016703788,0.00095963385,0.000009411811,0.0020457937,0.30306005],"study_design_scores_gemma":[0.046584565,0.006411454,0.9325779,0.0005650073,0.0009552148,0.001314613,0.0026950345,0.0000023692453,0.007981755,0.000021156653,0.0005692982,0.00032160996],"about_ca_topic_score_codex":0.00013239283,"about_ca_topic_score_gemma":0.0004300286,"teacher_disagreement_score":0.35033643,"about_ca_system_score_codex":0.00006143352,"about_ca_system_score_gemma":0.00023688834,"threshold_uncertainty_score":0.8239984},"labels":[],"label_agreement":null},{"id":"W4366452142","doi":"10.1093/bjd/ljad071","title":"The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Boehringer Ingelheim","keywords":"Medicine; Psoriasis; Generalized pustular psoriasis; Erythema; Dermatology; Disease; Severity of illness; Pustular psoriasis; Internal medicine","score_opus":0.030948719773450945,"score_gpt":0.3016663221667482,"score_spread":0.2707176023932973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366452142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931168,0.004838798,0.00014076778,0.0004697426,0.0008233376,0.00036208448,0.00019328295,0.000016381488,0.000038793372],"genre_scores_gemma":[0.9969871,0.0027094798,0.00012098642,0.000014909359,0.000056144014,0.000015533566,0.00006309439,0.000012895029,0.000019857862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974504,0.0011946317,0.00068100926,0.00021940973,0.0001767108,0.00027785316],"domain_scores_gemma":[0.998406,0.00021769853,0.0007955933,0.00023190008,0.00029356655,0.000055265897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042432407,0.0001819844,0.0006722267,0.00010563045,0.00025357696,0.000029519431,0.0002530403,0.00012602548,0.000015401292],"category_scores_gemma":[0.00004844812,0.00015778896,0.00018633423,0.00033222855,0.00019294402,0.00013329001,0.000098236844,0.00021197248,0.0000023565085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027188093,0.008753519,0.4756864,0.00013208622,0.0049611907,0.0020074379,0.0004325633,0.000091515685,0.04995671,0.0008148741,0.004669835,0.44977504],"study_design_scores_gemma":[0.007682906,0.0005596889,0.9829962,0.00011890616,0.0006828308,0.0016279455,0.0010438432,0.000017234563,0.0042280974,0.00034983153,0.000531306,0.00016116252],"about_ca_topic_score_codex":0.00007680304,"about_ca_topic_score_gemma":0.00010906326,"teacher_disagreement_score":0.50730985,"about_ca_system_score_codex":0.00007296692,"about_ca_system_score_gemma":0.00024413392,"threshold_uncertainty_score":0.6434447},"labels":[],"label_agreement":null},{"id":"W4377134024","doi":"10.1093/bjd/ljad166","title":"Patient-reported influences on COVID-19 vaccine acceptance and hesitancy in people with hidradenitis suppurativa","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Hidradenitis suppurativa; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cross-sectional study; Vaccination; MEDLINE; Disease; Family medicine; Internal medicine; Immunology; Virology; Infectious disease (medical specialty); Pathology; Outbreak","score_opus":0.015301931450041842,"score_gpt":0.285011617472612,"score_spread":0.26970968602257017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377134024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711346,0.0010319984,0.000020547986,0.027123513,0.0001018898,0.0002844748,0.000014637779,0.000037603953,0.0002507407],"genre_scores_gemma":[0.9985217,0.00098026,0.00019932551,0.00013827709,0.000032833967,0.000017184857,0.000021937274,0.000021886415,0.00006662741],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9982772,0.00015094987,0.0006876999,0.00023160686,0.00032280997,0.00032976482],"domain_scores_gemma":[0.998816,0.0002440059,0.00035777938,0.0001226575,0.0001303594,0.00032919538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00001054335,0.0001758153,0.0006598426,0.00039119236,0.000116395975,0.000043029773,0.00007738261,0.00011196336,0.00014800356],"category_scores_gemma":[0.0004205657,0.0001561875,0.00006021277,0.0006118518,0.00007875565,0.00030631435,0.000025797512,0.0003386489,0.000015706799],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032132966,0.000120513025,0.54028493,0.00004262978,0.00008503258,0.45360702,0.0005992365,8.81868e-7,0.00006336806,0.000016951184,0.0011236526,0.0037344382],"study_design_scores_gemma":[0.004003218,0.00048519758,0.37864065,0.00029592353,0.000050703544,0.6151553,0.0006211552,0.000008222479,0.00026390515,0.00013343846,0.00025024475,0.00009206101],"about_ca_topic_score_codex":0.00012774007,"about_ca_topic_score_gemma":0.0009791,"teacher_disagreement_score":0.16164428,"about_ca_system_score_codex":0.00009002554,"about_ca_system_score_gemma":0.00031068028,"threshold_uncertainty_score":0.63691413},"labels":[],"label_agreement":null},{"id":"W4378781272","doi":"10.1093/bjd/ljad070","title":"Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Dermatophyte; Discontinuation; Internal medicine; Adverse effect; Odds ratio; Itraconazole; Fluconazole; Regimen; Dermatology; Surgery; Antifungal","score_opus":0.1208888193358796,"score_gpt":0.369089752367413,"score_spread":0.2482009330315334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378781272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100167,0.006242041,0.00046558277,0.0008843858,0.00016392076,0.0006978714,0.00043858157,0.000024830497,0.00008109522],"genre_scores_gemma":[0.998502,0.00023697363,0.00073930854,0.00015113612,0.000102521626,0.000047064314,0.000100270394,0.000025477648,0.00009525415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775326,0.00026837556,0.0010003882,0.00021762203,0.00039295678,0.0003674077],"domain_scores_gemma":[0.9979405,0.0004208561,0.0006897578,0.00017678927,0.0005174644,0.00025464973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002322651,0.00020096035,0.002146218,0.00039954227,0.00011524194,0.000030276366,0.00013115582,0.00009890113,0.00033258382],"category_scores_gemma":[0.00017615568,0.00016981008,0.0033077507,0.0009931948,0.000076282035,0.0002252149,0.000025407458,0.00020281409,0.000010298038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001561643,0.0026451529,0.4833515,0.00006818952,0.4470091,0.011206752,0.00017887107,0.00067541027,0.00001519587,0.00009085408,0.052544326,0.0006530334],"study_design_scores_gemma":[0.0062883426,0.001114648,0.77700347,0.00004543553,0.20044753,0.013038479,0.00014001562,0.0002345626,0.00002901786,0.0014169911,0.000105489504,0.00013602147],"about_ca_topic_score_codex":0.000079623445,"about_ca_topic_score_gemma":0.00005242489,"teacher_disagreement_score":0.29365197,"about_ca_system_score_codex":0.00005629512,"about_ca_system_score_gemma":0.00023345063,"threshold_uncertainty_score":0.69246536},"labels":[],"label_agreement":null},{"id":"W4379600190","doi":"10.1093/bjd/ljad182","title":"Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; Calgary Laboratory Services; SKiN Health","funders":"","keywords":"Scalp; Tolerability; Roflumilast; Medicine; Psoriasis; Randomized controlled trial; Clinical endpoint; Adverse effect; Randomization; Dermatology; Surgery; Internal medicine","score_opus":0.02527273897059209,"score_gpt":0.2932965594720684,"score_spread":0.26802382050147633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379600190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764458,0.017938333,0.00021908102,0.0007492943,0.0019507038,0.0024100794,0.000071478826,0.0000795418,0.00013567026],"genre_scores_gemma":[0.996322,0.0020648027,0.00007780895,0.00009947475,0.00019221926,0.00047262976,0.00006996711,0.000042564385,0.0006585739],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99645513,0.0010301411,0.0013978911,0.0003830449,0.00010005412,0.0006337468],"domain_scores_gemma":[0.99718523,0.0014426088,0.00074664946,0.00019853415,0.0003251462,0.00010183689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011973458,0.0003311599,0.0022660946,0.00045952434,0.0004295536,0.0000862042,0.00032651037,0.0003866617,0.00008558742],"category_scores_gemma":[0.00043900064,0.00030667827,0.0006218095,0.00028714605,0.00030169953,0.00022648508,0.00008677015,0.00035131586,0.0000882437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.905835,0.0025448222,0.0030397784,0.00005924967,0.0071022604,0.0035954127,0.0010946394,0.000003340398,0.0052274354,0.00017828727,0.013629221,0.057690606],"study_design_scores_gemma":[0.9659086,0.000859902,0.0009105184,0.00010138603,0.0020883007,0.022641495,0.0011753787,0.000030279252,0.0032089923,0.000267186,0.0025126848,0.00029526715],"about_ca_topic_score_codex":0.000059396156,"about_ca_topic_score_gemma":0.0000853771,"teacher_disagreement_score":0.060073663,"about_ca_system_score_codex":0.00003109815,"about_ca_system_score_gemma":0.00016860053,"threshold_uncertainty_score":0.99993855},"labels":[],"label_agreement":null},{"id":"W4379601097","doi":"10.1093/bjd/ljad192","title":"Gender disparity in Canadian Institutes of Health Research grant funding decisions among recipients from dermatology departments: a retrospective study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of Calgary; University of Toronto; University of British Columbia","funders":"University of British Columbia","keywords":"Family medicine; Gender disparity; Medicine; Grant funding; Medical education; Political science; Demography; Sociology; Public administration","score_opus":0.17155686528485584,"score_gpt":0.40606068931544204,"score_spread":0.2345038240305862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379601097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420816,0.0009665935,0.000033118435,0.0022736616,0.001109155,0.0003322815,0.000045593206,0.000011766775,0.0010196771],"genre_scores_gemma":[0.9983375,0.0013722704,0.000064272346,0.0001252004,0.00006037954,0.0000056075637,0.000012915556,0.0000069561943,0.000014881187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948764,0.002141295,0.00076338515,0.00022421085,0.0011277336,0.00086697045],"domain_scores_gemma":[0.99800634,0.00053981354,0.0003029183,0.00012948054,0.00051513064,0.0005063079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041909423,0.0000882237,0.00062071154,0.0009757022,0.00085854664,0.000066716144,0.00069626287,0.00015719388,0.00006469071],"category_scores_gemma":[0.0036418114,0.00010537394,0.00007612985,0.0014007434,0.00075351406,0.00032468513,0.00015084843,0.0006964284,0.000012964647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002158281,0.00018256289,0.96901935,0.0000052133787,0.000071993825,0.0071733226,0.012269835,0.0000034663299,8.8303574e-7,0.00044563928,0.008642821,0.002163313],"study_design_scores_gemma":[0.0011725764,0.00006606792,0.94228894,0.00019541047,0.000015180784,0.0005408869,0.050649997,0.00000796273,0.0000032361622,0.0034614059,0.0015249708,0.00007340059],"about_ca_topic_score_codex":0.6336883,"about_ca_topic_score_gemma":0.93416137,"teacher_disagreement_score":0.3004731,"about_ca_system_score_codex":0.0006613724,"about_ca_system_score_gemma":0.0016530111,"threshold_uncertainty_score":0.66033334},"labels":[],"label_agreement":null},{"id":"W4381336619","doi":"10.1093/bjd/ljad162.036","title":"416 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Regimen; Concomitant; Adverse effect; Dermatology; Internal medicine; Clinical endpoint; Clinical trial","score_opus":0.0289953219994888,"score_gpt":0.31603454749335846,"score_spread":0.2870392254938697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545425,0.0006723725,0.000063239386,0.002182702,0.00047412797,0.00091839465,0.00010484488,0.000034842895,0.000095195195],"genre_scores_gemma":[0.9976435,0.0002458217,0.000538932,0.001216287,0.00009708585,0.000020061849,0.00013920276,0.000036075246,0.00006307279],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99725974,0.00033352512,0.00123567,0.00038916685,0.00036455042,0.000417357],"domain_scores_gemma":[0.99815804,0.000297618,0.00040301343,0.0003695123,0.00031730902,0.00045450826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020279801,0.00019823489,0.0010941732,0.00045632033,0.00007250006,0.000059145994,0.0004687931,0.00023098836,0.0000483235],"category_scores_gemma":[0.0007470545,0.0002071599,0.000070974624,0.0005240045,0.00010737001,0.00034512806,0.00016885613,0.00038873067,0.000058824615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43970436,0.0047441116,0.124085,0.00038797184,0.0006582303,0.27133954,0.0050893035,0.00042336676,0.00026023434,0.00003624242,0.10359738,0.049674246],"study_design_scores_gemma":[0.18079722,0.0008804903,0.77193457,0.003346067,0.00011383272,0.041785777,0.00022744572,0.00013844378,0.00035526804,0.0001087209,0.000090757356,0.00022138076],"about_ca_topic_score_codex":0.00023311262,"about_ca_topic_score_gemma":0.0006834568,"teacher_disagreement_score":0.64784956,"about_ca_system_score_codex":0.000042298092,"about_ca_system_score_gemma":0.00035298106,"threshold_uncertainty_score":0.8447736},"labels":[],"label_agreement":null},{"id":"W4381336722","doi":"10.1093/bjd/ljad162.013","title":"386 Complete/near-complete itch response observed in adult and adolescent patients with moderate-to-severe atopic dermatitis initiating dupilumab treatment in real-world practice","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Concomitant; Interim analysis; Quality of life (healthcare); Internal medicine; Young adult; Dosing; Rating scale; Dermatology; Interim; Eczema Area and Severity Index; Severity of illness; Pediatrics; Randomized controlled trial; Psychology","score_opus":0.0333704723240458,"score_gpt":0.2890839369807879,"score_spread":0.25571346465674205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917544,0.00043329966,0.000016814203,0.0067721796,0.00010335318,0.0005810742,0.00005519597,0.000034939072,0.00024875012],"genre_scores_gemma":[0.9952236,0.0006310886,0.0010215446,0.0029440343,0.000022106973,0.000035525558,0.000056440775,0.000032931835,0.000032749045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969842,0.0008978327,0.0010021017,0.0002956055,0.0003136857,0.0005066169],"domain_scores_gemma":[0.9979599,0.00079871825,0.00039273206,0.00018295941,0.00037657717,0.00028911865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021949904,0.0002380412,0.00091188843,0.00051189965,0.00014899837,0.00007106587,0.00012667861,0.00013048429,0.00002472254],"category_scores_gemma":[0.0009324955,0.00024243201,0.00007874692,0.0006178442,0.00013607786,0.00034200473,0.00006804792,0.00044163142,0.000021350648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040464625,0.00072841084,0.94200367,0.00018070234,0.00011782459,0.04594773,0.00069625024,0.00008342982,0.000010265055,0.000018267241,0.003022215,0.0031447618],"study_design_scores_gemma":[0.014065397,0.00023094201,0.9458961,0.0016519104,0.000095972515,0.03545912,0.00047509794,0.00064438354,0.00003294474,0.00006978054,0.0011675543,0.00021079555],"about_ca_topic_score_codex":0.00038994517,"about_ca_topic_score_gemma":0.0022377828,"teacher_disagreement_score":0.010488612,"about_ca_system_score_codex":0.00020216215,"about_ca_system_score_gemma":0.00034728867,"threshold_uncertainty_score":0.988609},"labels":[],"label_agreement":null},{"id":"W4381336753","doi":"10.1093/bjd/ljad162.043","title":"423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Medicine; JADE (particle detector); Post-hoc analysis; Atopic dermatitis; Placebo; Blinding; Clinical trial; Eczema Area and Severity Index; Randomized controlled trial; Internal medicine; Pediatrics; Dermatology","score_opus":0.03138261134272837,"score_gpt":0.35866921129217444,"score_spread":0.3272865999494461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161017,0.0012818277,0.00010456038,0.0059691896,0.00017301783,0.0005735825,0.00013293183,0.000009019847,0.00014568254],"genre_scores_gemma":[0.9977732,0.0010194787,0.00008209076,0.0009638533,0.0000529139,0.000012976364,0.000029153915,0.000014915578,0.000051434206],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977361,0.0002806166,0.0010287067,0.00020040383,0.0004180237,0.00033615794],"domain_scores_gemma":[0.9982815,0.0005018988,0.00053783134,0.00016994808,0.00027442892,0.0002344149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021270954,0.00015922493,0.0010584852,0.00030206356,0.00008523218,0.000032519958,0.00024388518,0.00010967272,0.00012534179],"category_scores_gemma":[0.00048653322,0.00012815875,0.00024032738,0.0012487335,0.0001265132,0.00013362274,0.00008160337,0.000438958,0.000003761224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38407528,0.007414848,0.119634725,0.0030102248,0.018508539,0.06012392,0.016533181,0.0009100241,0.00757624,0.00013313569,0.043713477,0.3383664],"study_design_scores_gemma":[0.23425245,0.0039640805,0.7203749,0.0033241021,0.004047881,0.022297505,0.002146865,0.00056147156,0.00689393,0.000049087463,0.0015600757,0.0005276531],"about_ca_topic_score_codex":0.00016627456,"about_ca_topic_score_gemma":0.0009964466,"teacher_disagreement_score":0.6007402,"about_ca_system_score_codex":0.000033376356,"about_ca_system_score_gemma":0.00012861262,"threshold_uncertainty_score":0.5226162},"labels":[],"label_agreement":null},{"id":"W4381336787","doi":"10.1093/bjd/ljad162.045","title":"425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Medicine; SCORAD; Placebo; Erythema; Atopic dermatitis; Edema; Post-hoc analysis; Internal medicine; Randomized controlled trial; Dermatology; Anesthesia; Gastroenterology; Dermatology Life Quality Index; Pathology; Disease","score_opus":0.030158721334944506,"score_gpt":0.3072472176860344,"score_spread":0.2770884963510899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632046,0.030838393,0.00002777275,0.004922783,0.0006473996,0.00017869378,0.00005741252,0.000030048395,0.00009287863],"genre_scores_gemma":[0.9966515,0.0024422451,0.000016280046,0.00070503965,0.00009462345,0.000005481707,0.000023077459,0.000014936386,0.00004686359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997649,0.00071301305,0.0007116435,0.00022427105,0.00043069475,0.0002713537],"domain_scores_gemma":[0.99687994,0.0016471288,0.00045487165,0.00024087595,0.000622808,0.00015436902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005832477,0.0001962985,0.0015529186,0.00031024416,0.00017238458,0.000022854192,0.00019248702,0.00018735095,0.000029189698],"category_scores_gemma":[0.003157712,0.00014400555,0.00042659693,0.0006361037,0.00054485764,0.000090945556,0.00007776573,0.00052632706,0.000013516243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023379354,0.00009252853,0.8385441,0.00019236935,0.008026498,0.011225791,0.00067094935,0.000005954992,0.00018386041,0.000015154947,0.13013761,0.008567301],"study_design_scores_gemma":[0.0060491026,0.00031333868,0.91839963,0.0016912803,0.007166433,0.0581019,0.002095813,0.000083917235,0.004525718,0.0004559455,0.0008989128,0.00021797908],"about_ca_topic_score_codex":0.00005624648,"about_ca_topic_score_gemma":0.000110103916,"teacher_disagreement_score":0.1292387,"about_ca_system_score_codex":0.000020958376,"about_ca_system_score_gemma":0.00008889666,"threshold_uncertainty_score":0.5872376},"labels":[],"label_agreement":null},{"id":"W4381336812","doi":"10.1093/bjd/ljad162.037","title":"417 Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Concomitant; Adverse effect; Internal medicine; Clinical trial; Open label; Dermatology; Randomized controlled trial; Population","score_opus":0.028853905519966125,"score_gpt":0.31236463918444207,"score_spread":0.28351073366447593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950128,0.0006940784,0.00006262486,0.002399344,0.00039674138,0.0010841546,0.0002045122,0.000029240475,0.00011647735],"genre_scores_gemma":[0.99759394,0.00059429713,0.0005235687,0.0008344282,0.00007996021,0.000033120996,0.00020644223,0.000031927742,0.000102344326],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974043,0.00032798675,0.0011997431,0.00037481624,0.000303887,0.00038930844],"domain_scores_gemma":[0.9983757,0.00021021729,0.00037510353,0.00035427362,0.0002581604,0.0004265093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015276567,0.00021001819,0.0011355875,0.00037570688,0.00008052744,0.00004693308,0.0003377091,0.00020578293,0.000050106504],"category_scores_gemma":[0.0002893909,0.00020610461,0.000074658456,0.0003974409,0.000090488065,0.00030179168,0.00011471119,0.00024329938,0.000042584186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4678394,0.0045906473,0.1294207,0.00023474357,0.0008375461,0.27461824,0.005276585,0.00040127733,0.0001249567,0.00002602098,0.035412237,0.08121765],"study_design_scores_gemma":[0.19975276,0.0017920731,0.7451787,0.002706047,0.00016701053,0.048894506,0.00035490625,0.00016120914,0.00047969614,0.00010383396,0.00017570908,0.0002335492],"about_ca_topic_score_codex":0.00048024207,"about_ca_topic_score_gemma":0.0017661359,"teacher_disagreement_score":0.615758,"about_ca_system_score_codex":0.00009168305,"about_ca_system_score_gemma":0.00040782976,"threshold_uncertainty_score":0.84047025},"labels":[],"label_agreement":null},{"id":"W4381336836","doi":"10.1093/bjd/ljad162.016","title":"390 Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis in two phase 3 trials (INTEGUMENT-1 and INTEGUMENT-2)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Probity Medical Research; Queen's University","funders":"","keywords":"Integument; Atopic dermatitis; Roflumilast; Medicine; Eczema Area and Severity Index; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology; Anatomy","score_opus":0.012896441509989458,"score_gpt":0.3020527063558678,"score_spread":0.2891562648458783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926294,0.005146388,0.00003902993,0.0014824974,0.000057638117,0.0005525047,0.000043134496,0.000012953742,0.000036449754],"genre_scores_gemma":[0.9957867,0.0034571846,0.00024346569,0.0004230529,0.000023168424,0.000011608181,0.000023385233,0.000017657216,0.000013748714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784285,0.00041009558,0.0010513489,0.00023206927,0.0001692994,0.00029433533],"domain_scores_gemma":[0.99889654,0.00037521968,0.00030301418,0.00010503019,0.00007540675,0.00024478318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040609913,0.00016771485,0.0011737831,0.0005138353,0.000046408193,0.000029115097,0.000084846615,0.00010529529,0.000028258792],"category_scores_gemma":[0.0005061731,0.00016614648,0.00005566972,0.00027956048,0.00023303716,0.00016375906,0.00007233806,0.00033252433,0.0000021198705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006855457,0.00089798943,0.9255493,0.00035876792,0.0003844708,0.016876014,0.0022748143,0.000018866785,0.00018920792,0.000034197834,0.006287585,0.040273283],"study_design_scores_gemma":[0.039206367,0.0002789839,0.9002199,0.0025376352,0.00011811664,0.056144483,0.00041574653,0.000088312336,0.00067156396,0.00012567313,0.0000517254,0.00014145723],"about_ca_topic_score_codex":0.00015353375,"about_ca_topic_score_gemma":0.0005534213,"teacher_disagreement_score":0.040131822,"about_ca_system_score_codex":0.000021890832,"about_ca_system_score_gemma":0.00009082262,"threshold_uncertainty_score":0.6775257},"labels":[],"label_agreement":null},{"id":"W4381336840","doi":"10.1093/bjd/ljad162.027","title":"405 Understanding patient experience and factors influencing patient preference in the treatment of moderate-to-severe atopic dermatitis through in-depth qualitative patient interviews","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Atopic dermatitis; Affect (linguistics); Systemic therapy; Preference; Patient experience; Adverse effect; Qualitative research; Physical therapy; Family medicine; Dermatology; Internal medicine; Psychology; Health care","score_opus":0.102094130900106,"score_gpt":0.34169060742493335,"score_spread":0.23959647652482735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563694,0.0027266175,0.00013065695,0.0006799657,0.00013709317,0.0004655738,0.000018011026,0.000009940807,0.00019520425],"genre_scores_gemma":[0.997452,0.0017738164,0.00013589335,0.0005684925,0.0000055370647,0.000043223252,0.0000083234,0.000011018145,0.0000016862949],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99755275,0.0006060696,0.0010506094,0.00020154624,0.00027523775,0.0003138093],"domain_scores_gemma":[0.99884975,0.00041906937,0.00038260486,0.0001432929,0.00009888483,0.00010636869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080336686,0.00018273425,0.00069286424,0.00026839328,0.000083768886,0.000026361988,0.00011890832,0.00010314368,0.000016951142],"category_scores_gemma":[0.00019110607,0.0001444836,0.00010438583,0.00038370726,0.0001743921,0.00023897266,0.000048534323,0.00020057723,0.0000023645694],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023354511,0.0007261597,0.2815913,0.0001982944,0.000106791,0.0072088377,0.6955018,0.00012651387,0.000031102474,0.00019932751,0.0010410892,0.013035244],"study_design_scores_gemma":[0.004329333,0.0017097483,0.47272274,0.0027111536,0.00009039414,0.027072359,0.48287278,0.0002102147,0.0030246072,0.004181678,0.00071757694,0.0003574184],"about_ca_topic_score_codex":0.00021582261,"about_ca_topic_score_gemma":0.0004121512,"teacher_disagreement_score":0.212629,"about_ca_system_score_codex":0.00017718574,"about_ca_system_score_gemma":0.00010163248,"threshold_uncertainty_score":0.589187},"labels":[],"label_agreement":null},{"id":"W4381336871","doi":"10.1093/bjd/ljad162.030","title":"409 Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Discontinuation; Dermatology Life Quality Index; Adverse effect; Placebo; Randomized controlled trial; Internal medicine; Concomitant; Clinical trial; Quality of life (healthcare); Pediatrics; Dermatology; Disease","score_opus":0.037969130427281804,"score_gpt":0.3412072024070543,"score_spread":0.30323807197977254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906183,0.008264334,0.00006821615,0.001631257,0.00024035224,0.0005699418,0.00012319443,0.000013266352,0.00002760272],"genre_scores_gemma":[0.9960185,0.0033779906,0.000050288167,0.0004463757,0.000027028009,0.0000071059508,0.000019907236,0.000020202697,0.00003258586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527186,0.0015474973,0.002060393,0.00033659663,0.0004473751,0.00033628632],"domain_scores_gemma":[0.99729323,0.00071831455,0.0009602191,0.00024976037,0.00041447332,0.00036400842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012412732,0.00023775402,0.0022987002,0.00046030554,0.00012976947,0.000023151324,0.00017710034,0.00033148524,0.000027099675],"category_scores_gemma":[0.0023903593,0.00018938941,0.00028043604,0.0007348336,0.0005413339,0.00014419708,0.00012628004,0.0005071196,0.0000012839137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012780214,0.00045440762,0.9535482,0.0006911599,0.0018083965,0.00257305,0.0008445528,0.000019065139,0.00006144567,0.000009755514,0.0038473692,0.023362378],"study_design_scores_gemma":[0.036278326,0.00018905319,0.9289279,0.0039836424,0.0021865494,0.026933903,0.00044916163,0.00044024157,0.0002700273,0.000039865987,0.0001256164,0.00017574044],"about_ca_topic_score_codex":0.00002926724,"about_ca_topic_score_gemma":0.0004373045,"teacher_disagreement_score":0.024620334,"about_ca_system_score_codex":0.000023569768,"about_ca_system_score_gemma":0.00020795646,"threshold_uncertainty_score":0.7723076},"labels":[],"label_agreement":null},{"id":"W4381336888","doi":"10.1093/bjd/ljad162.014","title":"388 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: assessment of pruritus","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Tolerability; Medicine; Clinical endpoint; Randomized controlled trial; Internal medicine; Randomization; Scalp; Adverse effect; Gastroenterology; Dermatology","score_opus":0.009345976654062928,"score_gpt":0.3023906144160007,"score_spread":0.29304463776193773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979817,0.00095275545,0.000020073014,0.00024349107,0.000074144664,0.0005828683,0.000061900435,0.000005705905,0.00007731629],"genre_scores_gemma":[0.9983506,0.0012594372,0.0002716557,0.000040242878,0.000011356484,0.00000853162,0.000038394624,0.000014677816,0.0000051081815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982881,0.00013310439,0.0009793488,0.000121385674,0.00027017074,0.00020791938],"domain_scores_gemma":[0.99899733,0.00014872171,0.0004758225,0.00009593035,0.00015688855,0.00012528057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012209706,0.000108737106,0.00077545684,0.00036614612,0.00001902498,0.000007279877,0.00006282908,0.00007236157,0.00002085745],"category_scores_gemma":[0.00014104907,0.000104008526,0.000072232615,0.0003587298,0.00009141435,0.00010385354,0.000031171196,0.00017678448,7.350108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009196376,0.003839235,0.9501482,0.00023138152,0.00021140676,0.0067209606,0.000102,0.00000680891,0.000017065286,0.000013860457,0.00034968313,0.029163025],"study_design_scores_gemma":[0.19770443,0.0011959649,0.79701203,0.0010427644,0.00012161358,0.0025905457,0.00005889227,0.00004114123,0.00006921815,0.000025986374,0.00007739897,0.000060020095],"about_ca_topic_score_codex":0.00007919735,"about_ca_topic_score_gemma":0.00008458216,"teacher_disagreement_score":0.18850805,"about_ca_system_score_codex":0.000049498107,"about_ca_system_score_gemma":0.00022138724,"threshold_uncertainty_score":0.42413446},"labels":[],"label_agreement":null},{"id":"W4381336927","doi":"10.1093/bjd/ljad162.039","title":"419 Patient satisfaction with treatments for moderate-to-severe atopic dermatitis according to degree and speed of skin and itch improvements: results from a patient survey in the United States","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dry skin; Dermatology; Patient satisfaction; Disease; Internal medicine; Surgery","score_opus":0.02916834198608426,"score_gpt":0.2715352545625309,"score_spread":0.24236691257644666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381336927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712795,0.00032158574,0.00010977116,0.0012507591,0.0000688492,0.00064902863,0.0004542043,0.000007925604,0.000009922165],"genre_scores_gemma":[0.9980853,0.00037528347,0.00037912355,0.0009140303,0.000008431326,0.000020747446,0.00020121974,0.0000127524245,0.0000031019622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856895,0.00023770143,0.00061955024,0.00017572286,0.00017848008,0.00021956435],"domain_scores_gemma":[0.99870676,0.0005654225,0.00026693588,0.00010585354,0.00022484748,0.00013019965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001275276,0.000127885,0.00045332007,0.0002894896,0.00008324722,0.00003288381,0.00005632884,0.00007559121,0.0000027431215],"category_scores_gemma":[0.00032852063,0.000103237006,0.00003555688,0.00031384098,0.000053025917,0.00011000205,0.00003935328,0.00012025824,9.993793e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002247035,0.00015779208,0.9475112,0.00006651082,0.00027831979,0.0018443998,0.002547871,0.00013905707,0.00004435302,0.000002209499,0.00451908,0.040642206],"study_design_scores_gemma":[0.006489097,0.00043265912,0.98101336,0.0004495029,0.000115113704,0.0075906077,0.0026053058,0.00036771956,0.0005836291,0.00018953944,0.00006382805,0.00009962652],"about_ca_topic_score_codex":0.0034544305,"about_ca_topic_score_gemma":0.0026880847,"teacher_disagreement_score":0.04054258,"about_ca_system_score_codex":0.000030198804,"about_ca_system_score_gemma":0.000057747984,"threshold_uncertainty_score":0.52220887},"labels":[],"label_agreement":null},{"id":"W4381383503","doi":"10.1093/bjd/ljad162.010","title":"382 Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Discontinuation; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Dermatology; Adverse effect; Internal medicine; Pathology","score_opus":0.010076684446063744,"score_gpt":0.2611501223975873,"score_spread":0.25107343795152354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703467,0.0008049716,0.0000109185,0.00092799484,0.0001327597,0.0005392289,0.000008640874,0.000046818954,0.0004939756],"genre_scores_gemma":[0.9982064,0.00059327146,0.00018916279,0.0008000327,0.000027918664,0.000028391953,0.000046330504,0.00003164694,0.000076841105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970818,0.00029265007,0.001459428,0.00026508546,0.0003383378,0.0005626735],"domain_scores_gemma":[0.99864686,0.0001816667,0.0005105164,0.00018110858,0.00026459093,0.0002152367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022659438,0.00020121898,0.0009466397,0.0005185533,0.000060522358,0.000034813456,0.00021585403,0.00022448425,0.000055089055],"category_scores_gemma":[0.00061245274,0.0001988109,0.00013538734,0.00055575895,0.00017543668,0.00029093836,0.0000634016,0.0005487168,0.000035965004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005172499,0.0006527564,0.9422182,0.00019713168,0.00011617201,0.033207264,0.00017819693,0.0000042444526,0.000004831599,0.0000069641696,0.0058595194,0.017037487],"study_design_scores_gemma":[0.015467916,0.00044903366,0.9528615,0.0013685209,0.00009618919,0.0286122,0.00013997988,0.00007298999,0.00011147543,0.00017836576,0.00046829792,0.00017352604],"about_ca_topic_score_codex":0.0001039137,"about_ca_topic_score_gemma":0.00033521434,"teacher_disagreement_score":0.016863959,"about_ca_system_score_codex":0.00009586045,"about_ca_system_score_gemma":0.0003290374,"threshold_uncertainty_score":0.81072736},"labels":[],"label_agreement":null},{"id":"W4381383517","doi":"10.1093/bjd/ljad162.025","title":"402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Placebo; Eczema Area and Severity Index; Randomized controlled trial; Clinical endpoint; Internal medicine; Clinical trial; Population; Clinical efficacy; Gastroenterology; Dermatology; Pathology","score_opus":0.06020217488123019,"score_gpt":0.36108435542954853,"score_spread":0.30088218054831833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929685,0.0018679873,0.0007610621,0.0023260321,0.00048690772,0.0011542891,0.00024234618,0.00003615603,0.0001566952],"genre_scores_gemma":[0.99743503,0.00074850995,0.00042494826,0.0009919589,0.00011910845,0.000018622319,0.00021511133,0.00003106693,0.00001563475],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9922167,0.0023440619,0.004166292,0.00034772782,0.0004955444,0.00042966858],"domain_scores_gemma":[0.9931787,0.0040730373,0.0015388997,0.00029864663,0.0005021212,0.000408574],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017023017,0.0002525741,0.0035823158,0.0004527287,0.000068501635,0.000032163724,0.00027484432,0.00031509824,0.00009074918],"category_scores_gemma":[0.010941511,0.00022074,0.0005977261,0.00041023854,0.00035327167,0.00017422359,0.00007591185,0.00066687685,0.00003968403],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49315935,0.0076045874,0.33774808,0.00025203358,0.0017490024,0.027886579,0.00036321054,0.00011429929,0.0000054602297,0.000029142826,0.07486785,0.056220394],"study_design_scores_gemma":[0.4882936,0.00023746338,0.5012726,0.0019360312,0.0005218419,0.006408394,0.000053330867,0.00023877216,0.00012851392,0.00049997197,0.0002356088,0.0001738824],"about_ca_topic_score_codex":0.000090750626,"about_ca_topic_score_gemma":0.00020418243,"teacher_disagreement_score":0.16352452,"about_ca_system_score_codex":0.000048840808,"about_ca_system_score_gemma":0.00042891028,"threshold_uncertainty_score":0.99738973},"labels":[],"label_agreement":null},{"id":"W4381383525","doi":"10.1093/bjd/ljad162.041","title":"421 The role of itch resolution and skin clearance in patient-reported atopic dermatitis severity and quality of life: real-world insights from TARGET-DERM AD","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Eczema Area and Severity Index; Observational study; Severity of illness; Logistic regression; Telephone interview; Dermatology; Disease; Internal medicine","score_opus":0.014471423984876634,"score_gpt":0.2671026630371674,"score_spread":0.2526312390522908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744864,0.02081526,0.000010133758,0.0011424577,0.00010332994,0.00016618146,0.000028211329,0.000012513539,0.00027327772],"genre_scores_gemma":[0.99509305,0.0044254973,0.00015701402,0.00026543147,0.000019153762,0.000004490113,0.000017545783,0.000009752886,0.000008065033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977704,0.00047878106,0.0011730645,0.00015925292,0.00023094473,0.00018754414],"domain_scores_gemma":[0.9984328,0.0003552962,0.0007344282,0.00016341599,0.00018829145,0.00012574566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015937848,0.00011135953,0.0007479069,0.00019528058,0.000073454816,0.000010133482,0.000093423645,0.0001470441,0.00002112412],"category_scores_gemma":[0.00052468793,0.00010438486,0.00008656271,0.00030846542,0.0003767773,0.00015253412,0.000069367336,0.0003102806,0.0000011555521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033190422,0.0001804167,0.98458725,0.00021403296,0.00017301473,0.0022853357,0.0009973429,0.0000034143923,0.00033540648,0.00011606383,0.0020531283,0.008722667],"study_design_scores_gemma":[0.0019234222,0.000023753712,0.98278713,0.00037881735,0.00006414104,0.0073703276,0.0007141548,0.0002215592,0.0019435165,0.0038039242,0.0006862177,0.00008304573],"about_ca_topic_score_codex":0.0011938033,"about_ca_topic_score_gemma":0.0018062606,"teacher_disagreement_score":0.017644417,"about_ca_system_score_codex":0.00001596698,"about_ca_system_score_gemma":0.00014480573,"threshold_uncertainty_score":0.4256691},"labels":[],"label_agreement":null},{"id":"W4381383527","doi":"10.1093/bjd/ljad162.033","title":"413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Post-hoc analysis; Internal medicine; Quality of life (healthcare); Dermatology","score_opus":0.03351757199696836,"score_gpt":0.3050932978455515,"score_spread":0.27157572584858314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96641374,0.030811163,0.000028696573,0.0019448976,0.00017041125,0.00041966117,0.00016318502,0.00002013191,0.000028121096],"genre_scores_gemma":[0.9917895,0.0074057705,0.000081783,0.00061030313,0.000027648062,0.000016828386,0.00003325329,0.00002131547,0.000013586808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972253,0.00036436834,0.0012625573,0.0003685991,0.00040557564,0.000373589],"domain_scores_gemma":[0.99836236,0.00025309576,0.0006305615,0.00017299548,0.00034706283,0.00023392371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031498374,0.00025826387,0.0013003208,0.0002195086,0.000088466404,0.000025920981,0.00010294547,0.00019417098,0.0000045624997],"category_scores_gemma":[0.0007365863,0.00022641133,0.00005266645,0.00027277294,0.000579776,0.0003070792,0.00007723106,0.00046338016,7.4095345e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008077985,0.0005625328,0.95973074,0.0017952203,0.0005976552,0.0065058824,0.004858195,0.0000010515055,0.00006535778,0.000012271602,0.002964509,0.014828592],"study_design_scores_gemma":[0.065419085,0.00043514898,0.89773244,0.011884699,0.00020368808,0.014180942,0.009038616,0.000023548495,0.0004524713,0.00026743018,0.000096912256,0.00026501337],"about_ca_topic_score_codex":0.0003829833,"about_ca_topic_score_gemma":0.003030246,"teacher_disagreement_score":0.061998308,"about_ca_system_score_codex":0.000038465856,"about_ca_system_score_gemma":0.00021782971,"threshold_uncertainty_score":0.92327857},"labels":[],"label_agreement":null},{"id":"W4381383531","doi":"10.1093/bjd/ljad162.004","title":"373 Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; MedDRA; Adverse effect; Clinical trial; Incidence (geometry); Dermatology; Internal medicine; Pharmacovigilance","score_opus":0.026858656466248947,"score_gpt":0.2885990372914035,"score_spread":0.26174038082515455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905871,0.0059605087,0.00020657945,0.0022505738,0.0001750616,0.00033689843,0.0003318595,0.00001921465,0.0001321828],"genre_scores_gemma":[0.9961282,0.002524166,0.0004282069,0.0006639377,0.000059567512,0.0000046977734,0.00015468916,0.00002050661,0.000016019909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974344,0.0004484878,0.0012669278,0.0002739294,0.00027474572,0.0003015442],"domain_scores_gemma":[0.99850965,0.0002809692,0.00046827953,0.00031905397,0.0001791925,0.00024288545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003054537,0.0001634678,0.0013596305,0.00031269406,0.000059233433,0.000022857488,0.00030426792,0.0001830513,0.00006544219],"category_scores_gemma":[0.0008144025,0.00015492109,0.00007787702,0.00029989274,0.00015422366,0.0002796002,0.00015806337,0.00033407396,0.000018526032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069270534,0.00044293253,0.87210524,0.0008534541,0.0004392394,0.05041844,0.00043426058,0.0000258205,0.00003273931,0.000019586534,0.055162303,0.013138931],"study_design_scores_gemma":[0.01491669,0.000074001204,0.8852402,0.0061635226,0.00021552789,0.09116544,0.00029032247,0.00042327636,0.00030979078,0.00034975086,0.0006852107,0.00016624508],"about_ca_topic_score_codex":0.000117153744,"about_ca_topic_score_gemma":0.0003929152,"teacher_disagreement_score":0.054477092,"about_ca_system_score_codex":0.000021226666,"about_ca_system_score_gemma":0.000249362,"threshold_uncertainty_score":0.63174987},"labels":[],"label_agreement":null},{"id":"W4381383538","doi":"10.1093/bjd/ljad162.018","title":"393 Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Internal medicine; Randomized controlled trial; Clinical endpoint; Discontinuation; Physical therapy; Dermatology; Alternative medicine","score_opus":0.061003503598004674,"score_gpt":0.3326872160313547,"score_spread":0.27168371243335004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983788,0.009286217,0.004264422,0.001621321,0.00020605285,0.0006315715,0.00009300573,0.00005921399,0.00005019329],"genre_scores_gemma":[0.9970385,0.00016866483,0.0013942732,0.0009711008,0.00007809642,0.00004055144,0.00020965002,0.000022274442,0.00007690699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712676,0.0005660494,0.0013324523,0.0002649612,0.00028279502,0.00042699472],"domain_scores_gemma":[0.9977974,0.0003643098,0.0006079404,0.0002729903,0.0006497237,0.00030758002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019735839,0.00022818572,0.00277404,0.00036497906,0.00014983244,0.000041984073,0.0002556596,0.0002092941,0.0002155664],"category_scores_gemma":[0.0001319997,0.00020988507,0.00095570984,0.0007228269,0.00016749132,0.00021554476,0.000044156077,0.00026080073,0.00001426069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044486537,0.0017780068,0.4324863,0.00084687356,0.3579234,0.013856977,0.004955526,0.0124323,0.00065824034,0.00073847943,0.16787106,0.0020041922],"study_design_scores_gemma":[0.013265841,0.0007119735,0.6665003,0.00029713797,0.15772662,0.14566056,0.0018216838,0.007969311,0.0020713878,0.0012856663,0.0019381122,0.000751466],"about_ca_topic_score_codex":0.000016442807,"about_ca_topic_score_gemma":0.00006983385,"teacher_disagreement_score":0.23401394,"about_ca_system_score_codex":0.000023626455,"about_ca_system_score_gemma":0.0001516538,"threshold_uncertainty_score":0.85588646},"labels":[],"label_agreement":null},{"id":"W4381383541","doi":"10.1093/bjd/ljad162.026","title":"403 Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Quality of life (healthcare); Dermatology Life Quality Index; Rating scale; Physical therapy; Minimal clinically important difference; Severity of illness; Anxiety; Disease; Pediatrics; Internal medicine; Dermatology; Randomized controlled trial; Psychology; Psychiatry","score_opus":0.012430668346969126,"score_gpt":0.2620752754936429,"score_spread":0.24964460714667377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859554,0.00036011016,0.000007178523,0.00056743604,0.000037190086,0.00032071787,0.000092242175,0.0000070857664,0.000012523661],"genre_scores_gemma":[0.9995345,0.00023585453,0.000025115714,0.00014335751,0.0000046152004,0.000012087506,0.000027752027,0.0000103876855,0.0000063605585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984196,0.0002513476,0.00068466505,0.00014782211,0.0002864784,0.00021009223],"domain_scores_gemma":[0.99882615,0.00014306424,0.0006148732,0.000100182864,0.00015228358,0.00016342854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010861189,0.0001301996,0.00074772595,0.0002550313,0.000029038194,0.0000061415644,0.00004601802,0.000090323214,0.000016356586],"category_scores_gemma":[0.00016939409,0.00011681829,0.00006127869,0.00023981491,0.00015296687,0.00015966604,0.000023637436,0.0001409158,4.8801604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014212552,0.0011844139,0.9876379,0.0001943521,0.0003257582,0.0010432249,0.00016103563,0.0000028130326,0.000019928008,0.000003613714,0.00016595458,0.007839794],"study_design_scores_gemma":[0.014763498,0.0005046077,0.9833166,0.0005736369,0.000114907176,0.0002699542,0.00008636029,0.000028695053,0.0002152682,0.00003129248,0.00000506606,0.00009008832],"about_ca_topic_score_codex":0.00032910687,"about_ca_topic_score_gemma":0.0008542557,"teacher_disagreement_score":0.013342243,"about_ca_system_score_codex":0.00008701915,"about_ca_system_score_gemma":0.00023902024,"threshold_uncertainty_score":0.47637117},"labels":[],"label_agreement":null},{"id":"W4381383603","doi":"10.1093/bjd/ljad162.021","title":"396 Rapid, substantial and sustained reduction of itch in adults with atopic dermatitis applying ruxolitinib cream 1.5% (SCRATCH-AD)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Atopic dermatitis; Dermatology; Clinical endpoint; Eczema Area and Severity Index; Janus kinase inhibitor; Clinical trial; Medical prescription; Internal medicine; Janus kinase; Pharmacology; Cytokine","score_opus":0.008613113508923725,"score_gpt":0.24791926878416548,"score_spread":0.23930615527524177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381383603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914747,0.0052015684,0.000069947106,0.0022470525,0.00017070251,0.0003128448,0.000011534375,0.00003234274,0.00047933],"genre_scores_gemma":[0.99600065,0.003398132,0.00027492805,0.00016223418,0.000057386766,0.000016629858,0.000025245463,0.0000211694,0.00004361333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982415,0.00017788673,0.00080549193,0.0001827875,0.00023554811,0.00035680563],"domain_scores_gemma":[0.9989026,0.00013612889,0.0003845199,0.000120687415,0.00028641926,0.00016960556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015625793,0.00014596501,0.0007244118,0.0004247033,0.00008014911,0.000018593435,0.00009892318,0.00018486462,0.000059130074],"category_scores_gemma":[0.00020944487,0.00015189809,0.00009231434,0.00044830682,0.00031996478,0.00022038099,0.000034006807,0.00035570347,0.0000040484024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031592944,0.0011420846,0.7547846,0.003674919,0.0006134315,0.13177268,0.0033120753,0.000017246126,0.00079043885,0.0005388133,0.034492996,0.06570141],"study_design_scores_gemma":[0.011672223,0.00022714361,0.55999035,0.0024714544,0.00019295985,0.413488,0.0067778328,0.00014950796,0.0028775744,0.0011632561,0.0007611166,0.00022855286],"about_ca_topic_score_codex":0.000054083765,"about_ca_topic_score_gemma":0.000075446165,"teacher_disagreement_score":0.28171533,"about_ca_system_score_codex":0.000025650883,"about_ca_system_score_gemma":0.00022672818,"threshold_uncertainty_score":0.61942244},"labels":[],"label_agreement":null},{"id":"W4382025202","doi":"10.1093/bjd/ljad113.088","title":"P60 Intralesional steroids vs. liquid nitrogen cryotherapy vs. 595 nm pulsed dye laser in the management of chest keloids: a comparative study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cryotherapy; Triamcinolone acetonide; Keloid; Surgery; Acne; Dermatology","score_opus":0.0418323033147149,"score_gpt":0.34603540771581104,"score_spread":0.30420310440109616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920224,0.0012093736,0.000017341947,0.0053049857,0.00011737987,0.0007815266,0.000013979128,0.000015954567,0.0005170916],"genre_scores_gemma":[0.9974791,0.0016916292,0.00016143797,0.00041930692,0.00004348936,0.0000465378,0.000016173897,0.000016546794,0.00012579274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736047,0.0005454548,0.00086005416,0.00020294657,0.0006186872,0.00041241065],"domain_scores_gemma":[0.99902767,0.00018862358,0.0002714818,0.00020001334,0.00019587309,0.00011635079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048601435,0.00017480267,0.0008347914,0.0003329876,0.00009745777,0.00003644615,0.00037089956,0.00010355404,0.00013055009],"category_scores_gemma":[0.000020004438,0.00012423244,0.0001666751,0.00045271614,0.00022828618,0.0001004301,0.000085908105,0.00046504443,0.000032174506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01264431,0.013906631,0.58594626,0.00081303477,0.0057497257,0.30192703,0.01131646,0.000049677932,0.00053467165,0.00022406563,0.04649698,0.020391129],"study_design_scores_gemma":[0.023801971,0.0033082587,0.8712972,0.00083933654,0.00029000634,0.0764873,0.017145753,0.00009050495,0.0019610259,0.00048774626,0.0040519456,0.00023896853],"about_ca_topic_score_codex":0.0000463104,"about_ca_topic_score_gemma":0.00006644666,"teacher_disagreement_score":0.28535092,"about_ca_system_score_codex":0.000054139757,"about_ca_system_score_gemma":0.000109923676,"threshold_uncertainty_score":0.50660515},"labels":[],"label_agreement":null},{"id":"W4382025342","doi":"10.1093/bjd/ljad113.278","title":"GD04 Patient education for all! Skin of colour under-represented again","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatology; Medicine; Acne; Atopic dermatitis; Rosacea; Hidradenitis suppurativa; Skin cancer; Psoriasis; Skin type; Disease; Family medicine; Pathology; Cancer","score_opus":0.021256719263957197,"score_gpt":0.3089806242613739,"score_spread":0.28772390499741674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96310514,0.008381191,0.0011666619,0.020680062,0.0017236992,0.0005634124,0.0000154743,0.000037772275,0.0043265573],"genre_scores_gemma":[0.9899571,0.0011735562,0.000813667,0.0075120837,0.00014810232,0.000028804332,0.0000437009,0.000023283244,0.0002997323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984038,0.00011444203,0.0008540368,0.0001404226,0.0002275933,0.00025972852],"domain_scores_gemma":[0.99829286,0.00028298213,0.00055191165,0.00014076033,0.00058603834,0.00014546119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017054334,0.000105941384,0.0006983243,0.00033742812,0.000070800816,0.0000037066432,0.00010446835,0.00014292543,0.000019468427],"category_scores_gemma":[0.0005010491,0.00011202638,0.00019798044,0.00022409917,0.00019649282,0.00005347275,0.000038620714,0.00022530058,0.000012499622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022183366,0.00038943914,0.0027679612,0.00026995922,0.00037102832,0.0017666805,0.00044812978,0.000007026675,0.0010934905,0.00016602063,0.9652341,0.027264342],"study_design_scores_gemma":[0.013451152,0.0019888894,0.038090955,0.0021085115,0.0012846473,0.33758542,0.015501608,0.0003755809,0.016135983,0.0031090195,0.5698475,0.00052069384],"about_ca_topic_score_codex":0.000024380406,"about_ca_topic_score_gemma":0.000018582039,"teacher_disagreement_score":0.39538655,"about_ca_system_score_codex":0.000056731034,"about_ca_system_score_gemma":0.0004722445,"threshold_uncertainty_score":0.4568303},"labels":[],"label_agreement":null},{"id":"W4382025359","doi":"10.1093/bjd/ljad113.105","title":"P77 Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, vs. placebo and apremilast in moderate-to-severe plaque psoriasis: achievement of absolute Psoriasis Area and Severity Index thresholds in two phase III trials","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"European League Against Rheumatism; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Apremilast; Internal medicine; Plaque psoriasis; Randomized controlled trial; Gastroenterology; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.029527391441481896,"score_gpt":0.29683082332800753,"score_spread":0.2673034318865256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949221,0.0030261434,0.00007820351,0.00039879367,0.0005742065,0.0006513421,0.00028361377,0.00002836386,0.00003721201],"genre_scores_gemma":[0.9973935,0.0019899302,0.00017927239,0.00014059889,0.00005911747,0.000058743713,0.00010899053,0.000033158547,0.0000367045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99568075,0.0014607066,0.0016338758,0.00048605577,0.00011687484,0.00062171434],"domain_scores_gemma":[0.99837047,0.00046549394,0.00065435946,0.00018239078,0.00018707862,0.00014023356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012953022,0.00037457788,0.0017950424,0.00081129797,0.00014410015,0.00005230555,0.00023564734,0.00040940492,0.000043904383],"category_scores_gemma":[0.00028650876,0.0004004954,0.00013606338,0.0005955687,0.00019825833,0.00038777798,0.00016778025,0.00050208886,0.000005303395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15089643,0.0070605422,0.41232836,0.00044250244,0.0036877575,0.01587239,0.010305249,0.00070634374,0.12437156,0.00018676482,0.008929032,0.26521307],"study_design_scores_gemma":[0.29571462,0.003853408,0.5072001,0.0020073443,0.0010391196,0.07129917,0.003502309,0.0005837455,0.110123925,0.0015954422,0.0012094142,0.0018713946],"about_ca_topic_score_codex":0.0006189841,"about_ca_topic_score_gemma":0.003910419,"teacher_disagreement_score":0.2633417,"about_ca_system_score_codex":0.000094334886,"about_ca_system_score_gemma":0.00021275171,"threshold_uncertainty_score":0.9998447},"labels":[],"label_agreement":null},{"id":"W4382025379","doi":"10.1093/bjd/ljad113.366","title":"PS14 Bimekizumab response up to 3 years in patients with moderate-to-severe plaque psoriasis who responded at week 16: post hoc results from the BE BRIGHT open-label extension trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Plaque psoriasis; Psoriasis Area and Severity Index; Psoriasis; Quality of life (healthcare); Open label; Randomized controlled trial; Internal medicine; Dermatology","score_opus":0.027861972868238737,"score_gpt":0.25728290783648694,"score_spread":0.2294209349682482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900678,0.0007508584,0.000006826651,0.005173248,0.0017071211,0.0010014849,0.0012140779,0.000032938347,0.000045663273],"genre_scores_gemma":[0.99565136,0.00022652044,0.00014235344,0.0011975731,0.00006969892,0.00004184443,0.00047655244,0.000051505074,0.0021425688],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99540055,0.0022206528,0.0010366733,0.000544807,0.00017609709,0.0006211946],"domain_scores_gemma":[0.997123,0.0014987387,0.00045700234,0.00045353486,0.00034276262,0.000124966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079669914,0.00029954268,0.0009051706,0.0004386207,0.00037334356,0.00011217786,0.00082372525,0.00042894942,0.00011934749],"category_scores_gemma":[0.0009648376,0.00025009352,0.000110653906,0.00068057707,0.00011697214,0.00025608175,0.00040145576,0.00043130683,0.00036881355],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87014914,0.00052727613,0.0012367696,0.0000027214392,0.0004338971,0.0033860053,0.0015968601,0.000022677965,0.0018632424,0.000009951071,0.103190914,0.017580573],"study_design_scores_gemma":[0.43861538,0.0053937845,0.49762166,0.00073079474,0.00029923953,0.008273533,0.00065310515,0.00000346915,0.0065062353,0.00013486364,0.041016184,0.0007517516],"about_ca_topic_score_codex":0.0006615148,"about_ca_topic_score_gemma":0.0019102189,"teacher_disagreement_score":0.4963849,"about_ca_system_score_codex":0.00020846687,"about_ca_system_score_gemma":0.00036365906,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W4382025478","doi":"10.1093/bjd/ljad113.068","title":"P40 Dupilumab treatment restores skin barrier function in lesional and nonlesional skin of patients with atopic dermatitis and improves patient-reported outcomes","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Atopic dermatitis; Dupilumab; Eczema Area and Severity Index; Medicine; Transepidermal water loss; Dermatology Life Quality Index; Dermatology; Internal medicine; Severity of illness; Quality of life (healthcare); Gastroenterology; Psoriasis; Pathology","score_opus":0.007596004494175723,"score_gpt":0.23629260642762745,"score_spread":0.22869660193345173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382025478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971541,0.0018497795,0.0000099999115,0.00053961505,0.00014295301,0.00021890063,0.000031474276,0.000012595812,0.0000405378],"genre_scores_gemma":[0.99898314,0.0005064176,0.00016407021,0.00022043036,0.000015407682,0.000011235084,0.000050010163,0.0000144672185,0.000034802888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985056,0.00011934791,0.0007075423,0.0001781529,0.000275344,0.00021400857],"domain_scores_gemma":[0.9989832,0.00019758976,0.00037736562,0.000095940064,0.0001871427,0.00015878078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057584777,0.0001529489,0.00062214525,0.00033622453,0.0000774457,0.000013647841,0.000042915588,0.00013423586,0.000033985274],"category_scores_gemma":[0.00015725191,0.00012845728,0.0000826103,0.00015240897,0.0002402736,0.00017134334,0.000037555452,0.00015147208,0.0000015279192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037185033,0.0003489127,0.9708932,0.000090627844,0.00022315187,0.0043982733,0.00017562511,0.0000014072206,0.000022538034,0.00001847624,0.0015268589,0.021929089],"study_design_scores_gemma":[0.007193884,0.00037488985,0.9711124,0.00026037675,0.00016055488,0.019583344,0.00019228882,0.000022943621,0.00025901105,0.00023278096,0.00050350797,0.000104023144],"about_ca_topic_score_codex":0.000058491034,"about_ca_topic_score_gemma":0.00013069189,"teacher_disagreement_score":0.021825066,"about_ca_system_score_codex":0.000031390635,"about_ca_system_score_gemma":0.00017042582,"threshold_uncertainty_score":0.5238336},"labels":[],"label_agreement":null},{"id":"W4382058417","doi":"10.1093/bjd/ljad113.250","title":"DS11 A double-blinded randomized control study to compare the effectiveness and safety of intralesional vitamin D3 with intralesional triamcinolone and its correlation with tissue expression of vitamin D receptors in patients with keloid","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Triamcinolone acetonide; Keloid; Vitamin D and neurology; Calcitriol receptor; Internal medicine; Vitamin; Randomized controlled trial; Surgery; Urology; Gastroenterology","score_opus":0.013200268053003682,"score_gpt":0.28314024974648505,"score_spread":0.2699399816934814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382058417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610496,0.00032855265,0.00021642045,0.00046765417,0.000049722035,0.0027950243,0.000020241938,0.0000070430247,0.0000103564535],"genre_scores_gemma":[0.9995773,0.0001331542,0.00017158975,0.000016774226,0.000010041829,0.000049381062,0.00001506889,0.00001510733,0.000011580003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973357,0.0010105211,0.0006940678,0.00020639566,0.00052430184,0.00022901325],"domain_scores_gemma":[0.9976255,0.0012720051,0.00041861506,0.000095865726,0.0004556954,0.00013228957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007500737,0.0001687497,0.001280172,0.00033317847,0.00008577284,0.000014229914,0.00009370269,0.00006832625,0.000013970523],"category_scores_gemma":[0.00016991005,0.000090798894,0.000038098824,0.00029266896,0.00030643088,0.000117367854,0.00004774888,0.00030493495,6.368772e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42266116,0.0010636966,0.5716496,0.00014977095,0.0003113868,0.0009784376,0.0005908089,0.00010823239,0.00025853445,0.000014289421,0.00005869078,0.002155348],"study_design_scores_gemma":[0.32564834,0.0016163484,0.6655354,0.0012946472,0.00014766947,0.0037217506,0.00044489387,0.00004742012,0.0014622144,0.000005606552,0.0000036790839,0.0000720414],"about_ca_topic_score_codex":0.0000340841,"about_ca_topic_score_gemma":0.00007997448,"teacher_disagreement_score":0.09701282,"about_ca_system_score_codex":0.00003253421,"about_ca_system_score_gemma":0.00013016409,"threshold_uncertainty_score":0.37026715},"labels":[],"label_agreement":null},{"id":"W4382058787","doi":"10.1093/bjd/ljad113.335","title":"PA31 Congenital alopecia areata: a systematic review","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Alopecia areata; Medicine; Alopecia universalis; Minoxidil; Dermatology; Hair loss; Scalp; Family history; Placebo; Internal medicine; Pathology","score_opus":0.04401743594222972,"score_gpt":0.34399788179182567,"score_spread":0.29998044584959593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382058787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025510917,0.99635786,0.000015027144,0.00018096504,0.0005647152,0.002398561,0.00010539806,0.000076170356,0.00029874046],"genre_scores_gemma":[0.000014472642,0.9980705,0.000058206486,0.00041433278,0.00022009027,0.00013802707,0.00013252953,0.00016306544,0.00078877684],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938098,0.0008476869,0.003933326,0.00031702188,0.00059661985,0.0004955017],"domain_scores_gemma":[0.99502224,0.00063607644,0.0029061674,0.00054975285,0.0005481847,0.00033759233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045704635,0.0005092998,0.01055632,0.00040846207,0.00008622785,0.000064809676,0.00061879115,0.0004356924,0.00022095071],"category_scores_gemma":[0.0039916574,0.00045294277,0.0022049595,0.0005316686,0.00016842612,0.00010465043,0.00016166225,0.0010666379,0.00078724505],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005665594,0.000098987344,0.0000039496636,0.80864805,0.0020997033,0.108752444,0.0000054979632,5.058238e-9,1.1026586e-8,0.0000070289784,0.041110165,0.03926848],"study_design_scores_gemma":[0.00028120558,0.000029266032,0.0000051592865,0.43324763,0.014161759,0.39165315,0.0000100120305,1.16651805e-7,4.2368956e-8,0.000007249927,0.16045682,0.00014760306],"about_ca_topic_score_codex":0.000014465315,"about_ca_topic_score_gemma":0.000010816982,"teacher_disagreement_score":0.37540042,"about_ca_system_score_codex":0.00018207183,"about_ca_system_score_gemma":0.001467908,"threshold_uncertainty_score":0.99999076},"labels":[],"label_agreement":null},{"id":"W4382059161","doi":"10.1093/bjd/ljad113.214","title":"DP01 Survey on the management of dysplastic naevus","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atypia; Cohort; Dermatology; Excise; General surgery; Surgery; Pathology","score_opus":0.012276107501609223,"score_gpt":0.24145163007853793,"score_spread":0.2291755225769287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382059161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969821,0.0012987558,0.00022575444,0.0003888871,0.00030941475,0.00007235823,0.000034178018,0.000003397624,0.00068514014],"genre_scores_gemma":[0.9976142,0.0018808297,0.00006676592,0.00014884397,0.000045038385,0.000002533002,0.000027992957,0.000010859748,0.00020293676],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9991332,0.00015887171,0.00029543755,0.000103461454,0.00014155908,0.00016746706],"domain_scores_gemma":[0.9994642,0.000056056717,0.00016991899,0.00014113306,0.00011236856,0.000056306795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019126567,0.000072416595,0.00015653028,0.000044783654,0.000051420568,0.000011150384,0.00026128837,0.0000697231,0.000035163852],"category_scores_gemma":[0.00008888566,0.00006159796,0.00009700367,0.00012616314,0.00009884901,0.0000013051762,0.000082566716,0.00008412802,0.000019507337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010296343,0.0007466136,0.08866659,0.00036162074,0.0024938888,0.013420874,0.00008852206,0.000891041,0.010225219,0.0009230763,0.82774454,0.0534084],"study_design_scores_gemma":[0.001109371,0.00020828097,0.97265756,0.00017058816,0.000070149734,0.007607902,0.00015839297,0.000019244813,0.01077954,0.00029326577,0.006784303,0.00014140946],"about_ca_topic_score_codex":0.000011722045,"about_ca_topic_score_gemma":0.000018139152,"teacher_disagreement_score":0.88399094,"about_ca_system_score_codex":0.0000033681895,"about_ca_system_score_gemma":0.000040894854,"threshold_uncertainty_score":0.25118917},"labels":[],"label_agreement":null},{"id":"W4383293155","doi":"10.1093/bjd/ljad220","title":"Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"European Academy of Dermatology and Venereology; Sun Pharma; EMBO; National Institutes of Health; Helsinn; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Universität Zürich; Narodowe Centrum Nauki; Swiss Cancer Research Foundation; European Commission; National Science Foundation; Les Laboratories Pierre Fabre; Promedica Stiftung; Cancer Research Foundation; Bristol-Myers Squibb","keywords":"Medicine; Extracorporeal Photopheresis; Cutaneous T-cell lymphoma; Immunology; Photopheresis; Peripheral blood mononuclear cell; Cytokine; Tumor necrosis factor alpha; Immune system; Lymphoma; Internal medicine; Mycosis fungoides; Graft-versus-host disease; Transplantation; Biology","score_opus":0.008715627945288308,"score_gpt":0.2617786532048653,"score_spread":0.253063025259577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383293155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807084,0.00040876702,0.0000065840823,0.0004026453,0.000060345265,0.0004911002,0.00006439342,0.000013551891,0.00048178024],"genre_scores_gemma":[0.9991978,0.0003001369,0.00022116194,0.00009769505,0.00000892958,0.000007675525,0.000020837824,0.000040904997,0.00010485876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971366,0.0005313996,0.0010495582,0.00020421838,0.000649806,0.0004284356],"domain_scores_gemma":[0.9976444,0.0005105671,0.0005158033,0.00024493903,0.0008680971,0.00021615734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039116226,0.00018406604,0.0008826352,0.0009975336,0.000053175372,0.000014266997,0.00029617906,0.00016046643,0.00008834404],"category_scores_gemma":[0.0011108563,0.00018812667,0.00013883917,0.0011441562,0.00031533377,0.00008570522,0.0001047949,0.00023944883,0.000013549799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07629167,0.0019313272,0.78659064,0.00039170394,0.00036571716,0.044144064,0.00081494974,0.000038295508,0.074010335,0.000002945168,0.0024125152,0.013005824],"study_design_scores_gemma":[0.019396117,0.0031230238,0.73503894,0.0011832461,0.00009022856,0.1702094,0.0012713335,0.000056088687,0.06908525,0.00008333905,0.0002013649,0.00026165074],"about_ca_topic_score_codex":0.000956027,"about_ca_topic_score_gemma":0.00031278777,"teacher_disagreement_score":0.12606533,"about_ca_system_score_codex":0.00016340925,"about_ca_system_score_gemma":0.0008494728,"threshold_uncertainty_score":0.76715827},"labels":[],"label_agreement":null},{"id":"W4383499400","doi":"10.1093/bjd/ljad174.020","title":"O20 Advanced melanoma is associated with distinct circulating B-cell profiles enriched with immunoregulatory and autoreactive features","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Immunology; Antibody; B cell; Isotype; Melanoma; Autoantibody; Immune system; Population; Biology; Medicine; Cancer research; Monoclonal antibody","score_opus":0.009355883340755076,"score_gpt":0.254630042186687,"score_spread":0.24527415884593193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383499400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942426,0.0031955945,0.000014838449,0.0012877246,0.00004362767,0.00019236923,0.00002556759,0.000033477732,0.0009641757],"genre_scores_gemma":[0.99829715,0.00027571572,0.0003681675,0.0001445227,0.0000557097,0.0000072548137,0.000039915783,0.000029409275,0.00078214414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985532,0.00011867895,0.00033571053,0.00019441675,0.0004259266,0.0003720639],"domain_scores_gemma":[0.9987598,0.0002855516,0.00032696736,0.000087618144,0.00035807941,0.00018194871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014933701,0.00016195017,0.00057662185,0.00016315396,0.0001776282,0.000039533592,0.000099149154,0.00011521811,0.000035078214],"category_scores_gemma":[0.00014881259,0.00012549367,0.000077253884,0.00029886607,0.0002785599,0.00013088455,0.000051377832,0.00054294465,0.0000042603297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040277317,0.00051165145,0.81644523,0.0005182958,0.0017700733,0.09923261,0.0017621946,0.000010747065,0.026077699,0.00011302476,0.007741328,0.041789435],"study_design_scores_gemma":[0.0034698762,0.000509001,0.8601405,0.00057131023,0.00010762427,0.13046974,0.00049081363,0.00009553164,0.0034733582,0.00008344455,0.0004322605,0.00015655682],"about_ca_topic_score_codex":0.00007213898,"about_ca_topic_score_gemma":0.000049639282,"teacher_disagreement_score":0.043695264,"about_ca_system_score_codex":0.000046997113,"about_ca_system_score_gemma":0.00021616991,"threshold_uncertainty_score":0.5117483},"labels":[],"label_agreement":null},{"id":"W4383980227","doi":"10.1093/bjd/ljad237","title":"Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Medicine; Randomized controlled trial; Clinical trial; Outcome (game theory); Meta-analysis; Set (abstract data type); Core (optical fiber); Physical therapy; MEDLINE; Systematic review; Intensive care medicine; Pediatrics; Surgery; Dermatology; Internal medicine; Computer science","score_opus":0.33727410059929286,"score_gpt":0.4874199634092887,"score_spread":0.15014586280999587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383980227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224526,0.0026560666,0.000672545,0.0014348542,0.0008062661,0.0020777618,0.000057150584,0.000025213089,0.000024876887],"genre_scores_gemma":[0.9975974,0.00079054513,0.0009035088,0.0003463384,0.000069576614,0.00015581383,0.0000645474,0.000030645922,0.000041627918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98506683,0.0016284627,0.012308318,0.00026165156,0.00028420737,0.00045055128],"domain_scores_gemma":[0.9874428,0.005265396,0.0066001266,0.00018049827,0.0003431762,0.00016799908],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010227677,0.000218277,0.005667576,0.0006519138,0.000071887356,0.000024574343,0.00017920493,0.0003613761,0.000010048293],"category_scores_gemma":[0.04465473,0.00020312685,0.0012772735,0.00027075954,0.00020021165,0.0001577751,0.000036345304,0.00032875928,0.0000026959535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071022534,0.00025347283,0.9691057,0.0010747648,0.0006295928,0.009816816,0.00015745188,0.000007642143,0.000031938842,0.000028911852,0.001834443,0.009956995],"study_design_scores_gemma":[0.31755283,0.00012191588,0.50181127,0.003284297,0.0011401686,0.17163384,0.00058043347,0.00088639127,0.00036422082,0.0022721344,0.00011738214,0.00023510457],"about_ca_topic_score_codex":0.000040250834,"about_ca_topic_score_gemma":0.000040077095,"teacher_disagreement_score":0.46729442,"about_ca_system_score_codex":0.00008667521,"about_ca_system_score_gemma":0.00030146854,"threshold_uncertainty_score":0.96339256},"labels":[],"label_agreement":null},{"id":"W4385230266","doi":"10.1093/bjd/ljad252","title":"Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dermatrials Research; Probity Medical Research; University of British Columbia","funders":"National Institutes of Health; AbbVie; Boehringer Ingelheim","keywords":"Apremilast; Medicine; Psoriasis Area and Severity Index; Psoriasis; Randomized controlled trial; Internal medicine; Secukinumab; Clinical endpoint; Dermatology; Psoriatic arthritis","score_opus":0.06904877460295726,"score_gpt":0.35285259864049323,"score_spread":0.28380382403753596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96927977,0.024267368,0.0010034663,0.00031077358,0.00040682126,0.003762066,0.00094100874,0.000017672859,0.000011059456],"genre_scores_gemma":[0.99068564,0.00802209,0.00044821197,0.000014849969,0.00004546489,0.00049384456,0.00021125114,0.000032041673,0.000046602992],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99686503,0.0007885367,0.0015820501,0.00034142847,0.00008523093,0.0003377014],"domain_scores_gemma":[0.99373186,0.0039842455,0.0015619892,0.00026269004,0.00041946265,0.000039739596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005673844,0.00028723874,0.0023049111,0.00018553736,0.0002824727,0.00005284523,0.00039047396,0.00024157901,0.0000073081865],"category_scores_gemma":[0.00014142256,0.0001953368,0.00020768405,0.00018883415,0.00023150991,0.00013281449,0.000038445134,0.00012404396,0.0000016793181],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.870071,0.00830485,0.001868859,0.000085477535,0.010946317,0.00021765077,0.009775544,0.00010791708,0.005703421,0.0000325407,0.002604377,0.090282075],"study_design_scores_gemma":[0.92168427,0.0074672275,0.0004825285,0.00047635558,0.0020608762,0.003945193,0.007111386,0.00077917124,0.055087186,0.00012745759,0.00053282664,0.00024551878],"about_ca_topic_score_codex":0.0004941481,"about_ca_topic_score_gemma":0.00031285782,"teacher_disagreement_score":0.090036556,"about_ca_system_score_codex":0.00003586645,"about_ca_system_score_gemma":0.00018867424,"threshold_uncertainty_score":0.79656035},"labels":[],"label_agreement":null},{"id":"W4385751891","doi":"10.1093/bjd/ljad275","title":"Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; Melanoma Institute Australia","keywords":"Meta-analysis; Melanoma; Medicine; Primary (astronomy); Oncology; Dermatology; MEDLINE; Internal medicine; Cancer research; Biology","score_opus":0.038073957090055434,"score_gpt":0.2915269607715725,"score_spread":0.253453003681517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385751891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002696968,0.99364346,0.00009782706,0.00007623621,0.00007671565,0.0056024124,0.0001824647,0.000023885792,0.000027272452],"genre_scores_gemma":[0.00038426658,0.9984736,0.00015520728,0.00016057178,0.000015330286,0.0003191467,0.00015004844,0.00007255778,0.00026927106],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955454,0.0007508004,0.0025606228,0.00039356263,0.00041388272,0.0003357392],"domain_scores_gemma":[0.99573624,0.00053423515,0.0028839523,0.00034551404,0.00029713465,0.00020294961],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005888659,0.00046203763,0.0127054835,0.0009568975,0.000067965666,0.000053323787,0.00021704474,0.00024251553,0.000049361224],"category_scores_gemma":[0.00039552728,0.00032150283,0.002372811,0.00077346904,0.00006091291,0.00007022535,0.0000696911,0.0005545615,0.000006182193],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033509034,0.00018011457,0.00038098102,0.8066188,0.18592335,0.0034526945,0.000020049023,3.6389298e-7,1.5590573e-9,0.000004386735,0.0004460818,0.0029396468],"study_design_scores_gemma":[0.0010285934,0.0003391842,0.00034575537,0.050908178,0.90133935,0.03580982,0.000017191283,7.450134e-7,5.6253608e-8,0.0000047747253,0.009929502,0.00027687397],"about_ca_topic_score_codex":0.00004795471,"about_ca_topic_score_gemma":0.00013743681,"teacher_disagreement_score":0.75571066,"about_ca_system_score_codex":0.00020944684,"about_ca_system_score_gemma":0.0001639919,"threshold_uncertainty_score":0.9999237},"labels":[],"label_agreement":null},{"id":"W4385752045","doi":"10.1093/bjd/ljad284","title":"Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Atopic dermatitis; Placebo; Medicine; Dupilumab; Randomized controlled trial; Young adult; Double blinded; Anesthesia; Internal medicine; Dermatology","score_opus":0.01621801280966888,"score_gpt":0.26303766098546305,"score_spread":0.24681964817579416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385752045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98010087,0.003574019,0.00005817064,0.00747183,0.0006994796,0.007410731,0.00011161529,0.00006666431,0.0005066089],"genre_scores_gemma":[0.9980247,0.00041130095,0.00006186783,0.0005658361,0.00014017303,0.00052375847,0.00004720156,0.000055776913,0.00016938237],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99146944,0.002964518,0.0034338518,0.00052164355,0.0008747428,0.0007357825],"domain_scores_gemma":[0.9917246,0.004503299,0.002282576,0.0006768921,0.0005429405,0.00026965537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001607425,0.0005073874,0.004231868,0.00041662372,0.00036041983,0.000115879186,0.00081349304,0.00032545312,0.00008190997],"category_scores_gemma":[0.0032879768,0.00031457367,0.00092527026,0.0006269968,0.000959486,0.0002782118,0.00013652559,0.0011645778,0.000016530545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9517817,0.0036776226,0.0106698945,0.000118694654,0.0029372063,0.018934619,0.0047031385,0.000050504623,0.00007896602,0.000027498076,0.006118774,0.0009013649],"study_design_scores_gemma":[0.93026906,0.00056227134,0.036993954,0.0011750697,0.0019965088,0.018548576,0.008155236,0.0014108457,0.0002627841,0.00026584635,0.00006424606,0.00029562745],"about_ca_topic_score_codex":0.00047225025,"about_ca_topic_score_gemma":0.0018340234,"teacher_disagreement_score":0.026324058,"about_ca_system_score_codex":0.00006622675,"about_ca_system_score_gemma":0.000762831,"threshold_uncertainty_score":0.9999306},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4386154925","doi":"10.1093/bjd/ljad308","title":"Failure of scabies treatment: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact","funders":"Robert Koch Institut","keywords":"Medicine; Ivermectin; Meta-analysis; Internal medicine; Scabies; Confidence interval; Permethrin; Observational study; Randomized controlled trial; Pediatrics; Dermatology; Veterinary medicine","score_opus":0.11766982122767836,"score_gpt":0.3879529429545716,"score_spread":0.2702831217268933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386154925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028470738,0.9977135,0.000026351654,0.00074235164,0.000019600506,0.0011204777,0.00029477774,0.000015191559,0.000064889275],"genre_scores_gemma":[0.000060835664,0.99902517,0.00017847391,0.00022652738,0.000010026915,0.000111424226,0.00007794982,0.000027002798,0.0002826003],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99614525,0.00060430914,0.0026087798,0.000201339,0.00024256702,0.00019778614],"domain_scores_gemma":[0.99636275,0.00052486395,0.0022742844,0.0002665299,0.00035586063,0.00021569312],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00016850399,0.0003098035,0.015750013,0.00050500885,0.00004897167,0.00003153043,0.00015923088,0.0002196613,0.00024572082],"category_scores_gemma":[0.00068326166,0.00020130453,0.005200913,0.0008299051,0.00015106336,0.00007928774,0.000039556195,0.00024277308,0.000026049336],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014935341,0.00010400117,0.000003834371,0.7740411,0.21822764,0.004514104,0.0000070995443,5.4752476e-8,5.6745497e-9,0.000061672275,0.0012563145,0.0017826348],"study_design_scores_gemma":[0.000179735,0.000059972666,0.000005065783,0.070301734,0.76367134,0.14969882,0.000021156597,7.491032e-7,5.3738457e-8,0.00003400922,0.015924282,0.000103077364],"about_ca_topic_score_codex":0.000013073898,"about_ca_topic_score_gemma":0.000017845223,"teacher_disagreement_score":0.7037394,"about_ca_system_score_codex":0.000031676904,"about_ca_system_score_gemma":0.00022840775,"threshold_uncertainty_score":0.9988622},"labels":[],"label_agreement":null},{"id":"W4386305920","doi":"10.1093/bjd/ljad305","title":"Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"National Institutes of Health; LEO Pharma; British Skin Foundation; UCB Pharma; Wellcome Trust; Celgene; Irish Research Council; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Hidradenitis suppurativa; Medicine; Metformin; Reprogramming; Dermatology; Dandruff; Disease; Internal medicine; Diabetes mellitus; Biology; Pathology; Endocrinology","score_opus":0.014738504729396354,"score_gpt":0.2523786805294522,"score_spread":0.23764017580005586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386305920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097776,0.004934566,0.00028291336,0.0029213852,0.00034234778,0.00042989993,0.000007268414,0.00005773857,0.00004609951],"genre_scores_gemma":[0.99682504,0.0013568216,0.0016079934,0.000012252683,0.00006363885,0.000029412922,0.000026116964,0.00004002742,0.000038693142],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997862,0.00024948595,0.0008375235,0.00026317014,0.00029506956,0.0004927826],"domain_scores_gemma":[0.9988422,0.0003337965,0.0003328566,0.00015420557,0.00011695582,0.00022001144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003595537,0.00022468311,0.00094433775,0.00066012045,0.00017281612,0.000096565316,0.00013013081,0.00021501117,0.000028047763],"category_scores_gemma":[0.00042275072,0.00023262804,0.00015288104,0.00052597886,0.00019025909,0.00048147482,0.00007513265,0.00049886736,0.000031717645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008600264,0.0002159574,0.08237728,0.0002024031,0.0002642665,0.7819937,0.0008609825,1.3410157e-7,0.030703632,0.00007286412,0.00011324023,0.103109516],"study_design_scores_gemma":[0.005095183,0.00019484042,0.12036051,0.00050094706,0.00011668287,0.8436802,0.0004529564,0.00005569892,0.028412811,0.0006870484,0.00027336122,0.0001697631],"about_ca_topic_score_codex":0.0001148757,"about_ca_topic_score_gemma":0.00008333456,"teacher_disagreement_score":0.102939755,"about_ca_system_score_codex":0.00005096562,"about_ca_system_score_gemma":0.00014132174,"threshold_uncertainty_score":0.9486296},"labels":[],"label_agreement":null},{"id":"W4386390585","doi":"10.1093/bjd/ljad320","title":"A detailed evaluation of the effect of dupilumab on sleep in adults with atopic dermatitis","year":2023,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atopic dermatitis; Conceptualization; Medicine; Family medicine; Library science; Dermatology","score_opus":0.009283254884598417,"score_gpt":0.2560187303331278,"score_spread":0.24673547544852936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386390585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314135,0.003382628,0.000004827616,0.06345722,0.00050890003,0.00078456214,0.00003416973,0.000010937444,0.0004032699],"genre_scores_gemma":[0.9832199,0.00022619538,0.000018450904,0.016211294,0.00016855453,0.000037573893,0.000044472745,0.000041545547,0.000031971686],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99580944,0.0015704638,0.0011469374,0.00020524293,0.0009670305,0.0003008673],"domain_scores_gemma":[0.9970715,0.0007508093,0.0012787646,0.00032225664,0.0005185307,0.000058159516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004117599,0.00024622906,0.001471876,0.0004401363,0.00004324884,0.000008535128,0.00031991204,0.0006522351,0.0000888112],"category_scores_gemma":[0.0010279542,0.00018477037,0.00036156148,0.00034531354,0.00032887593,0.00007087867,0.000044740736,0.0015392009,0.000009913773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070512603,0.0001485675,0.4285569,0.0033799978,0.00071079336,0.03519109,0.0001564903,0.000040424442,0.0000049348814,0.0000026045777,0.52373046,0.007372647],"study_design_scores_gemma":[0.01891208,0.0007152668,0.74154013,0.017859263,0.0020075366,0.21430814,0.000047447124,0.00021866617,0.002010119,0.00016808622,0.001978696,0.00023455631],"about_ca_topic_score_codex":0.000035718018,"about_ca_topic_score_gemma":0.00021907686,"teacher_disagreement_score":0.52175176,"about_ca_system_score_codex":0.00007807408,"about_ca_system_score_gemma":0.00038986912,"threshold_uncertainty_score":0.7534717},"labels":[],"label_agreement":null},{"id":"W4386819540","doi":"10.1093/bjd/ljad281","title":"Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"British Association of Dermatologists; National Institute for Health and Care Research; National Institutes of Health; Medical Research Council; Barts Charity; Queen Mary University of London","keywords":"Medicine; Eczema Area and Severity Index; SCORAD; Atopic dermatitis; Randomized controlled trial; Ciclosporin; Methotrexate; Internal medicine; Quality of life (healthcare); Population; Adverse effect; Clinical trial; Dermatology Life Quality Index; Pediatrics; Dermatology; Transplantation; Disease","score_opus":0.03608489002482184,"score_gpt":0.3489702251065328,"score_spread":0.31288533508171096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386819540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355745,0.0045699966,0.0000067267633,0.00088673696,0.00019317945,0.00068394863,0.000022632057,0.000007769046,0.00007154746],"genre_scores_gemma":[0.98523444,0.014336639,0.00028432108,0.00004222801,0.000045781042,0.000011156065,0.000029026105,0.00001036502,0.000006064183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972676,0.00078795373,0.001322563,0.00018535933,0.00019043141,0.00024611608],"domain_scores_gemma":[0.9978499,0.0013399286,0.0004898901,0.00014753002,0.00006461681,0.00010816812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035990906,0.00014722951,0.0011050116,0.00022198101,0.000042712538,0.000012033968,0.00011883671,0.00020691268,0.000014989056],"category_scores_gemma":[0.0005222724,0.00012390762,0.00016146948,0.00029146817,0.00021426371,0.000097919146,0.000031998872,0.00026630322,0.0000011278437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018532254,0.0016013037,0.9583539,0.000072502444,0.00030115596,0.0033268083,0.0010493244,0.000005138581,0.0000022919592,0.000033979475,0.00038103305,0.016340343],"study_design_scores_gemma":[0.1594295,0.00051752105,0.81322753,0.00017885421,0.00028362437,0.025568502,0.0005395682,0.00004978753,0.00001579638,0.0000758007,0.00003912602,0.00007436765],"about_ca_topic_score_codex":0.00020034504,"about_ca_topic_score_gemma":0.0009113732,"teacher_disagreement_score":0.14512633,"about_ca_system_score_codex":0.000022812406,"about_ca_system_score_gemma":0.000100099795,"threshold_uncertainty_score":0.5052807},"labels":[],"label_agreement":null},{"id":"W4386979770","doi":"10.1093/bjd/ljad347","title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Institute for Health and Care Research; Psoriasis Association","keywords":"Psoriasis; Medicine; Dermatology; Association (psychology); Dermatologic agents; Plaque psoriasis; MEDLINE; Family medicine; Psychology; Psychotherapist; Political science","score_opus":0.03792392213837212,"score_gpt":0.3033003803270341,"score_spread":0.26537645818866196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386979770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530592,0.034376238,0.0020773255,0.0052646673,0.003126047,0.0010376986,0.00089922163,0.00009599133,0.00006361694],"genre_scores_gemma":[0.959185,0.03202527,0.0049352623,0.0008229795,0.00026818528,0.00032837965,0.0010723027,0.000064791806,0.0012978513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738264,0.0003984854,0.0013631277,0.00024459788,0.0000727332,0.0005384422],"domain_scores_gemma":[0.9959762,0.0011572847,0.0014125608,0.00013931189,0.0012775174,0.00003713223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080204045,0.00020068743,0.0010005188,0.00024433262,0.00018390623,0.000036501446,0.00035963967,0.0005535032,0.00015791872],"category_scores_gemma":[0.0022930067,0.00021719588,0.0005139455,0.0002954913,0.00011396718,0.00014559875,0.000041311545,0.00015352297,0.00003815176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086604455,0.0004071825,0.01953309,0.00021519925,0.002591044,0.00043884641,0.0001274757,0.000016237731,0.0126736965,0.00023208505,0.7197376,0.24316148],"study_design_scores_gemma":[0.066357,0.002151551,0.0736757,0.0013931585,0.0020060788,0.13758492,0.0012819279,0.00015134575,0.12214023,0.017329037,0.57422954,0.0016995326],"about_ca_topic_score_codex":0.00006249496,"about_ca_topic_score_gemma":0.00017282648,"teacher_disagreement_score":0.24146195,"about_ca_system_score_codex":0.000050266135,"about_ca_system_score_gemma":0.00016944451,"threshold_uncertainty_score":0.8856991},"labels":[],"label_agreement":null},{"id":"W4387331497","doi":"10.1093/bjd/ljad361","title":"Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Epidermolysis bullosa; Harmonization; Medicine; Outcome (game theory); Comparability; Pooling; Dermatology; Computer science","score_opus":0.14280767770682123,"score_gpt":0.43731526210306115,"score_spread":0.2945075843962399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387331497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97947574,0.0006244953,0.00083383516,0.017424436,0.0004666155,0.0006566536,0.000051786043,0.000044173463,0.0004222953],"genre_scores_gemma":[0.996734,0.0006285287,0.0022352007,0.00005471105,0.00004575024,0.00003156295,0.0000080925965,0.000028343022,0.00023375887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950757,0.0008777056,0.0023104486,0.00024681003,0.0009387,0.0005506389],"domain_scores_gemma":[0.99433357,0.0022592004,0.0019555362,0.0003012702,0.0010341424,0.00011629908],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045755277,0.00014941105,0.0010470061,0.00057708524,0.00027917651,0.000042958865,0.00089427707,0.0002781717,0.000043366297],"category_scores_gemma":[0.018647822,0.00014513546,0.0005216596,0.001522924,0.00056756707,0.00021559482,0.00019886112,0.00041069707,0.0000027180217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006231548,0.00026569443,0.94155395,0.00023715748,0.00028522746,0.02371246,0.001752255,0.00016005762,0.0012773767,0.0008953693,0.010866356,0.018931754],"study_design_scores_gemma":[0.006006819,0.0002480266,0.6480227,0.002647133,0.00075568096,0.23930626,0.018137062,0.0023192293,0.03260237,0.04170947,0.006945432,0.0012998227],"about_ca_topic_score_codex":0.001614382,"about_ca_topic_score_gemma":0.001577094,"teacher_disagreement_score":0.29353127,"about_ca_system_score_codex":0.0001233492,"about_ca_system_score_gemma":0.00039905758,"threshold_uncertainty_score":0.98961854},"labels":[],"label_agreement":null},{"id":"W4387564463","doi":"10.1093/bjd/ljad388","title":"Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS): a prospective cohort study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"UCB Pharma; University of Oxford; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK; Insmed; Pfizer","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Prospective cohort study; Cohort; Cohort study; Surgery; Disease; Pathology","score_opus":0.030725119389069133,"score_gpt":0.3402123620377406,"score_spread":0.30948724264867145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387564463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291897,0.0004498433,0.00000843201,0.002104109,0.00025528867,0.0034990257,0.000021448826,0.00003574041,0.0007071734],"genre_scores_gemma":[0.9991024,0.00022952772,0.000056949528,0.0000012143232,0.00008896819,0.00020193464,0.00003056081,0.000031279356,0.00025715338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969558,0.0006682556,0.00096805923,0.00027631648,0.00084068155,0.00029087125],"domain_scores_gemma":[0.9982057,0.00018449422,0.0004777045,0.00022401678,0.00075155986,0.00015650158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002972134,0.00021447171,0.0011044185,0.0003992401,0.00012564001,0.00003117366,0.00011126745,0.00008761628,0.00025547884],"category_scores_gemma":[0.0002556089,0.0001954875,0.00021072236,0.0005552932,0.00010386993,0.00021526612,0.000028314436,0.00016796369,0.000053747834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024351217,0.0055534053,0.6787962,0.000010395766,0.0012727364,0.29908913,0.0034421978,3.031354e-7,0.000084607505,0.000003470236,0.00012985436,0.011374208],"study_design_scores_gemma":[0.009795953,0.004600411,0.5106357,0.000051240826,0.00095840724,0.46816832,0.0051348703,0.00003573117,0.00044944548,0.0000732892,0.000022027667,0.00007461573],"about_ca_topic_score_codex":0.00020162968,"about_ca_topic_score_gemma":0.00018721564,"teacher_disagreement_score":0.16907918,"about_ca_system_score_codex":0.0002669434,"about_ca_system_score_gemma":0.00034067142,"threshold_uncertainty_score":0.79717493},"labels":[],"label_agreement":null},{"id":"W4387613843","doi":"10.1093/bjd/ljad393","title":"Comparing binary efficacy outcomes for systemic immunomodulatory treatments for atopic dermatitis in a living systematic review and network meta-analysis","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Ottawa; McMaster University; Women's College Hospital; University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Meta-analysis; Medicine; Dermatology; MEDLINE; Internal medicine; Biology","score_opus":0.10706416343727936,"score_gpt":0.37075712512574593,"score_spread":0.26369296168846657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387613843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024829397,0.993992,0.00013671175,0.00024301845,0.00015231928,0.005129342,0.000060721577,0.000032991265,0.000004605418],"genre_scores_gemma":[0.0043636383,0.993407,0.00027141577,0.00037623462,0.0000373468,0.001235155,0.00010488244,0.0000778979,0.00012642071],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99401134,0.001071009,0.0037971255,0.00038963446,0.00021116904,0.00051971985],"domain_scores_gemma":[0.9927246,0.0039352505,0.0025209072,0.0003931674,0.00023270052,0.00019334904],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00078388833,0.00053286,0.01974383,0.00073830405,0.00015940481,0.000054825683,0.00032875108,0.00039478095,0.0000131203515],"category_scores_gemma":[0.0012033915,0.00044066607,0.005131209,0.0006088849,0.000091863345,0.00012548309,0.000081790604,0.00040272303,0.000006823551],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000592026,0.00014325092,0.0017689132,0.77723455,0.21323252,0.0039739995,0.0000232755,0.000004323531,3.5805123e-9,0.000011604191,0.002870728,0.0007309087],"study_design_scores_gemma":[0.0008560922,0.00002935892,0.0011978047,0.27484247,0.58190405,0.13959725,0.000018562565,0.00002687092,1.0822422e-8,0.000018502997,0.0012964407,0.00021258653],"about_ca_topic_score_codex":0.000011302827,"about_ca_topic_score_gemma":0.000026581738,"teacher_disagreement_score":0.50239205,"about_ca_system_score_codex":0.0001446172,"about_ca_system_score_gemma":0.0002803417,"threshold_uncertainty_score":0.9998045},"labels":[],"label_agreement":null},{"id":"W4387847520","doi":"10.1093/bjd/ljad398","title":"Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Toronto; BC Children's Hospital; McGill University; Canadian Arthritis Patient Alliance; University of British Columbia; SKiN Health; Women's College Hospital; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Merkel cell carcinoma; Alliance; Skin cancer; Medicine; Dermatology; Merkel cell; Family medicine; Carcinoma; Political science; Pathology; Cancer; Internal medicine","score_opus":0.018688191998823836,"score_gpt":0.24677560154316544,"score_spread":0.2280874095443416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387847520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790182,0.013092909,0.00004118948,0.0068779355,0.00048782842,0.00026023452,0.000056491877,0.0000066672887,0.00015852712],"genre_scores_gemma":[0.99841374,0.00029939244,0.00011828784,0.00083568774,0.00018571044,0.0000067326187,0.000013690983,0.00001258262,0.000114200986],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99840224,0.00019757867,0.00059460494,0.00011149407,0.00036109856,0.0003329964],"domain_scores_gemma":[0.99777526,0.0009559192,0.0005182373,0.00010140894,0.0004795575,0.00016963217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029655715,0.000105467705,0.00039858482,0.00004330527,0.00021902725,0.000014418309,0.00015600015,0.00009359459,0.000025972018],"category_scores_gemma":[0.0009037559,0.00009045979,0.00009971484,0.00026061098,0.00014439342,0.00008613305,0.00003525888,0.00029751266,2.7581262e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006370144,0.000050715767,0.21519913,0.0007672867,0.00038335155,0.0051681497,0.0009247778,0.0011824359,0.00022556298,0.00011272844,0.76705015,0.008298709],"study_design_scores_gemma":[0.0038420944,0.00019254748,0.95683634,0.0021129434,0.0007214808,0.010683612,0.0031829886,0.0025096864,0.010209371,0.0010734185,0.008312261,0.0003232497],"about_ca_topic_score_codex":0.5972488,"about_ca_topic_score_gemma":0.7758157,"teacher_disagreement_score":0.75873786,"about_ca_system_score_codex":0.0001534809,"about_ca_system_score_gemma":0.0071272263,"threshold_uncertainty_score":0.9985014},"labels":[],"label_agreement":null},{"id":"W4387900889","doi":"10.1093/bjd/ljad404","title":"Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Ottawa Hospital; Women's College Hospital; Queen's University; Ontario Council of University Libraries; University of Toronto","funders":"C.R. Younger Foundation","keywords":"Medicine; Population; Merkel cell carcinoma; Incidence (geometry); Systematic review; Cochrane Library; Epidemiology; Demography; MEDLINE; Relative survival; Checklist; Mortality rate; Meta-analysis; Cancer registry; Internal medicine; Carcinoma; Environmental health; Biology","score_opus":0.08332795147480887,"score_gpt":0.3870284469297087,"score_spread":0.30370049545489985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387900889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039129765,0.99484926,0.000002703245,0.00003392035,0.00024428303,0.00081421755,0.000104888924,0.000008091169,0.000029659514],"genre_scores_gemma":[0.021642588,0.97814125,0.00003138646,0.00004373028,0.000035389483,0.00001712752,0.000037862577,0.00003117276,0.000019488692],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99542534,0.0007198197,0.0030560105,0.00017061763,0.0004452421,0.00018293755],"domain_scores_gemma":[0.99481887,0.00080711243,0.0034491115,0.00023297282,0.0005368501,0.00015507707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059133535,0.00024833696,0.0066977297,0.00029720395,0.00003862374,0.0000059730314,0.00016598863,0.00024293955,0.000010045129],"category_scores_gemma":[0.0017507852,0.00019657132,0.00082310475,0.0003556312,0.00017117459,0.000046960675,0.000056594436,0.0003725833,0.0000021943615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007081196,0.00010509939,0.003327618,0.99062437,0.0008761059,0.003517592,0.000007907124,1.2325228e-7,1.2694136e-7,0.0000072336566,0.0003756665,0.0011510999],"study_design_scores_gemma":[0.0006488294,0.00006881593,0.0022117966,0.9491406,0.022134665,0.025306039,0.00004310248,0.0000028611369,0.0000017997522,0.000021612224,0.00027482264,0.00014507216],"about_ca_topic_score_codex":0.00019169279,"about_ca_topic_score_gemma":0.00002329913,"teacher_disagreement_score":0.041483764,"about_ca_system_score_codex":0.000052070052,"about_ca_system_score_gemma":0.00064717804,"threshold_uncertainty_score":0.80159456},"labels":[],"label_agreement":null},{"id":"W4388486845","doi":"10.1093/bjd/ljad439","title":"Digital biobanks are underutilized in dermatology and create opportunities to reduce the burden of skin disease","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"U.S. National Library of Medicine; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; Data Science Institute, Columbia University","keywords":"Biobank; Repurposing; Disease; Medicine; Psychological intervention; Pharmacogenomics; Drug repositioning; Data science; Bioinformatics; Drug; Computer science; Biology; Pathology; Pharmacology","score_opus":0.03254179545910678,"score_gpt":0.2741890844147064,"score_spread":0.24164728895559962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97051114,0.0010600929,0.00003889247,0.026932545,0.00018700339,0.00021830545,0.000017786613,0.000020917862,0.0010132972],"genre_scores_gemma":[0.99763006,0.0011571605,0.000023127679,0.00040156321,0.000049445363,0.000006164727,0.0000050757453,0.000013013805,0.0007144103],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99891543,0.00009119416,0.0005075834,0.0001182299,0.0001590499,0.00020849476],"domain_scores_gemma":[0.9992494,0.000118410695,0.00021043226,0.00011885,0.00010488592,0.00019802057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089980334,0.0000937881,0.00042927224,0.00036262092,0.00004943045,0.00003801869,0.000107644904,0.000060818686,0.00003396071],"category_scores_gemma":[0.00025390924,0.00008492067,0.00008354416,0.0001959293,0.00017457294,0.00007037759,0.00009123206,0.00017686386,0.000007822533],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038414283,0.00048013555,0.036775973,0.0010149586,0.00068989507,0.48278284,0.002591828,0.00008570079,0.0012343667,0.0006392702,0.073182225,0.39668137],"study_design_scores_gemma":[0.006404438,0.00021191547,0.18301143,0.0012846424,0.00028196588,0.7142629,0.019258767,0.00040411987,0.0015810123,0.0010842724,0.071906574,0.00030794312],"about_ca_topic_score_codex":0.00004855047,"about_ca_topic_score_gemma":0.000042710126,"teacher_disagreement_score":0.39637342,"about_ca_system_score_codex":0.00002535878,"about_ca_system_score_gemma":0.000091406786,"threshold_uncertainty_score":0.34629643},"labels":[],"label_agreement":null},{"id":"W4388586208","doi":"10.1093/bjd/ljad429","title":"Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials","year":2023,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"UCB Pharma; LEO Pharma; Sun Pharma; Eisai; National Institute for Health and Care Research; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Discontinuation; Adverse effect; Psoriasis; Incidence (geometry); Internal medicine; Plaque psoriasis; Gastroenterology; Dermatology","score_opus":0.06127394202515896,"score_gpt":0.32844693045013756,"score_spread":0.2671729884249786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388586208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08987184,0.89904827,0.00006259134,0.000054225315,0.0015387584,0.0035196245,0.005866043,0.000020358433,0.000018300965],"genre_scores_gemma":[0.01254883,0.9824972,0.0002065107,0.000032396063,0.00006967348,0.00019964851,0.0042327964,0.00008630766,0.00012660984],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98963565,0.004982242,0.0040705306,0.00065117434,0.00012135911,0.00053905696],"domain_scores_gemma":[0.9939734,0.003041857,0.002111167,0.000615198,0.00015108772,0.000107317195],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001318874,0.00057345786,0.010787849,0.0011530956,0.000057467918,0.000031820633,0.0008786675,0.0008042734,0.00018011824],"category_scores_gemma":[0.0010573184,0.00048238755,0.0007013626,0.00061987515,0.00010555341,0.00016009579,0.0002082972,0.0004543422,0.00013233215],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17094977,0.0010319925,0.00007857908,0.00031918322,0.007886634,0.002170968,0.0003826898,0.000011961877,0.0000025437512,0.0000068668687,0.0014135026,0.8157453],"study_design_scores_gemma":[0.87315315,0.00096798845,0.00034901104,0.020308308,0.009179994,0.004074418,0.00013078026,0.0000020754226,0.00005211462,0.00006428121,0.09088277,0.0008351338],"about_ca_topic_score_codex":0.0013421678,"about_ca_topic_score_gemma":0.0015248241,"teacher_disagreement_score":0.8149102,"about_ca_system_score_codex":0.0003139139,"about_ca_system_score_gemma":0.0011266455,"threshold_uncertainty_score":0.9997628},"labels":[],"label_agreement":null},{"id":"W4389471935","doi":"10.1093/bjd/ljad487","title":"Further refinement of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure using classical test theory and item response theory","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Jikei University School of Medicine; Clalit Health Services; University of Leeds; Cardiff University; Yale University","keywords":"Rasch model; Patient-reported outcome; Item response theory; Classical test theory; Cronbach's alpha; Exploratory factor analysis; Confirmatory factor analysis; Differential item functioning; Clinical psychology; Psychometrics; Reliability (semiconductor); Medicine; Structural equation modeling; Psychology; Quality of life (healthcare); Statistics; Developmental psychology","score_opus":0.01913950425351802,"score_gpt":0.25884221246329886,"score_spread":0.23970270820978085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389471935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812157,0.010904002,0.000033954242,0.00026813635,0.0003001268,0.00015795523,0.00016494413,0.000018470419,0.000030814303],"genre_scores_gemma":[0.99954796,0.00029380812,0.000027394955,0.00004050542,0.000013456274,0.000004231031,0.000011083759,0.000016547398,0.00004499172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995849,0.0026957672,0.00087171985,0.00017420315,0.00010258064,0.00030670996],"domain_scores_gemma":[0.996178,0.002475739,0.00086064264,0.00021333389,0.00021857813,0.000053732972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062989694,0.00018511988,0.00067405024,0.00017302504,0.00014350175,0.000010281566,0.00022440289,0.0002664888,0.00013095285],"category_scores_gemma":[0.0022151577,0.00012770887,0.00039601154,0.0002635703,0.0006068486,0.00007094455,0.0001273681,0.00023978336,0.000004433328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010848855,0.0010776209,0.7575053,0.00006845542,0.0027448658,0.0041180844,0.00085102016,0.00001641626,0.1775792,0.00042631815,0.002792225,0.04197166],"study_design_scores_gemma":[0.0034200656,0.00037547812,0.88074654,0.0003238499,0.00072560535,0.087848105,0.0006572033,0.0000051443744,0.024223115,0.0012853048,0.00021435568,0.00017522072],"about_ca_topic_score_codex":0.000010770295,"about_ca_topic_score_gemma":0.00000540838,"teacher_disagreement_score":0.15335608,"about_ca_system_score_codex":0.000036311365,"about_ca_system_score_gemma":0.00027571214,"threshold_uncertainty_score":0.5207817},"labels":[],"label_agreement":null},{"id":"W4389975898","doi":"10.1093/bjd/ljad387","title":"Top 10 research priorities for cutaneous squamous cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Alliance; Medicine; Basal cell; Family medicine; Political science; Pathology","score_opus":0.0337852476999843,"score_gpt":0.2944195852117961,"score_spread":0.2606343375118118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389975898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114096,0.0025604286,0.00000896171,0.0041754637,0.0004898605,0.00043053043,0.00011446924,0.000005608652,0.0010737182],"genre_scores_gemma":[0.99869627,0.00012332182,0.0005242594,0.000101719415,0.00028939228,0.0000101560445,0.0000065970053,0.000018077368,0.00023020095],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99752027,0.0003909786,0.00093910145,0.00015423835,0.00056474167,0.00043067517],"domain_scores_gemma":[0.9955591,0.002050502,0.0007209838,0.00017042094,0.0014071042,0.00009187246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075918523,0.00010555086,0.00057660026,0.00010142574,0.00023726851,0.000010066809,0.00021869024,0.00010626027,0.000005675065],"category_scores_gemma":[0.002693139,0.00010059705,0.00011595624,0.00051529193,0.00039419677,0.000056092525,0.00013235096,0.000469276,3.6656246e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020095527,0.00010302975,0.4431743,0.0023434972,0.0002398076,0.0074390303,0.006267469,0.00024066571,0.00074586325,0.00014743967,0.5313614,0.0059279217],"study_design_scores_gemma":[0.008783791,0.00096296007,0.8390496,0.0014690661,0.00023608822,0.053032313,0.006316277,0.0002681,0.079246715,0.002942337,0.0074091074,0.00028366983],"about_ca_topic_score_codex":0.017032132,"about_ca_topic_score_gemma":0.058407944,"teacher_disagreement_score":0.5239523,"about_ca_system_score_codex":0.00022263176,"about_ca_system_score_gemma":0.003180422,"threshold_uncertainty_score":0.9895135},"labels":[],"label_agreement":null},{"id":"W4390015928","doi":"10.1093/bjd/ljad504","title":"Infectious disease among adults with allergic contact dermatitis: a propensity score-matched case–control study","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Impetigo; Atopic dermatitis; Cohort; Scabies; Dermatology; Immunology; Contact dermatitis; Disease; Staphylococcal Skin Infections; Allergic contact dermatitis; Allergy; Skin infection; Internal medicine; Staphylococcus aureus; Biology","score_opus":0.012275583859629046,"score_gpt":0.2351843151550525,"score_spread":0.22290873129542346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390015928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954995,0.0010895708,0.00014071773,0.0013602001,0.00025462455,0.0012574497,0.000033795786,0.0001440123,0.00022016614],"genre_scores_gemma":[0.99868894,0.00040906787,0.000025017525,0.0005976041,0.00012556158,0.0000491762,0.00001016053,0.00004738587,0.000047089456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747545,0.00033848707,0.00095026096,0.000276038,0.00046753438,0.0004922107],"domain_scores_gemma":[0.99787825,0.00017684653,0.0005724121,0.00026191244,0.0005889869,0.0005216042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022471156,0.00027541045,0.0011578713,0.00033692067,0.0002455302,0.00014165834,0.0001578852,0.000103188635,0.00012522737],"category_scores_gemma":[0.00027828108,0.0002491379,0.00022565157,0.00038906495,0.0001274869,0.00045881013,0.0000641238,0.0005645188,0.000035053577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045063935,0.00038630716,0.5211161,0.00014237728,0.0005493477,0.47182286,0.00059182197,0.000018281795,0.000012348749,0.000008413414,0.001675952,0.0032255608],"study_design_scores_gemma":[0.010154201,0.00046493634,0.594101,0.0008514696,0.00031963145,0.3925496,0.001062915,0.00019375944,0.000015388812,0.000024442807,0.00009879271,0.0001638346],"about_ca_topic_score_codex":0.000515327,"about_ca_topic_score_gemma":0.0036949622,"teacher_disagreement_score":0.079273276,"about_ca_system_score_codex":0.00006546471,"about_ca_system_score_gemma":0.00032175725,"threshold_uncertainty_score":0.99999607},"labels":[],"label_agreement":null},{"id":"W4390062445","doi":"10.1093/bjd/ljad497","title":"How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eli Lilly Japan; Mitsubishi Tanabe Pharma Corporation; Genentech; National Jewish Health; Torii Pharmaceutical; University of Oxford; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Boehringer Ingelheim Japan; LEO Pharma; Castle Biosciences; Sun Pharma; Dermira; Pfizer; Incyte; Regeneron Pharmaceuticals; Amgen; Celgene; Valeant Pharmaceuticals International; Sanofi; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Outcome (game theory); Clinical trial; Atopic dermatitis; Medicine; Set (abstract data type); Alternative medicine; Sample (material); MEDLINE; Sample size determination; Family medicine; Medical physics; Core (optical fiber); Medical education; Computer science; Dermatology; Statistics; Pathology","score_opus":0.26502457919956474,"score_gpt":0.4130602091502216,"score_spread":0.1480356299506569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390062445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85143024,0.004501201,0.024896033,0.11316126,0.0024122752,0.0028534646,0.0005416434,0.00015591968,0.00004797759],"genre_scores_gemma":[0.98622537,0.00040030867,0.003525624,0.008363125,0.00027645743,0.00014874882,0.000057474328,0.00005676837,0.0009461398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671555,0.000365131,0.0017287157,0.00025128093,0.0003415373,0.0005977757],"domain_scores_gemma":[0.9946205,0.0033540835,0.000738814,0.00029109904,0.0006719803,0.00032354536],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0011957132,0.00024402683,0.0015887326,0.00032757502,0.00039978386,0.00024324893,0.0003742171,0.00024556112,0.000013476739],"category_scores_gemma":[0.017371738,0.00019990538,0.00084551296,0.00027959648,0.00016329307,0.00030885352,0.00007064736,0.00031301824,0.000014797964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033958585,0.00007577978,0.32135788,0.0003703492,0.0005935667,0.0064096656,0.00028340306,0.000008039803,0.00010132538,0.00023389289,0.66107374,0.00915276],"study_design_scores_gemma":[0.010413069,0.00018607733,0.21417207,0.0005856158,0.001395104,0.2409926,0.0011949096,0.00024212622,0.0010625616,0.0018967909,0.52746654,0.0003925562],"about_ca_topic_score_codex":0.000023628074,"about_ca_topic_score_gemma":0.000088720786,"teacher_disagreement_score":0.23458295,"about_ca_system_score_codex":0.000063509804,"about_ca_system_score_gemma":0.00021152695,"threshold_uncertainty_score":0.99090534},"labels":[],"label_agreement":null},{"id":"W4390114814","doi":"10.1093/bjd/ljad527","title":"Skin photoageing following sun exposure is associated with decreased epigenetic and biologic age, and correlates with basal cell carcinoma phenotype","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Toronto; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Cancer Research Society; Canadian Dermatology Foundation","keywords":"Epigenetics; Skin cancer; DNA methylation; Basal cell carcinoma; Basal (medicine); Biology; Phenotype; Sun exposure; Ageing; Pathology; Cancer; Basal cell; Medicine; Genetics; Dermatology; Endocrinology; Gene","score_opus":0.007521355220395408,"score_gpt":0.21194446863509983,"score_spread":0.20442311341470443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390114814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859,0.013342049,0.0004009133,0.000074109645,0.00007106682,0.000105335865,0.000010228612,0.0000075948506,0.00008873993],"genre_scores_gemma":[0.9980589,0.0012049687,0.0004704117,0.000106501386,0.000034931396,0.0000035678925,0.00004890044,0.00002602887,0.000045792804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892956,0.000158265,0.00029445486,0.00023352161,0.00011942669,0.0002647851],"domain_scores_gemma":[0.9993502,0.00007993184,0.0002436356,0.00009150895,0.00011212737,0.0001226343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018537974,0.00014998083,0.0003070635,0.00008487714,0.00012974707,0.000055440752,0.00009208641,0.00019862904,0.0000044627973],"category_scores_gemma":[0.000107787404,0.00013821364,0.000056644207,0.00014909814,0.0001145328,0.000008371906,0.000050945233,0.00015631581,7.200304e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027112843,0.00009905023,0.829513,0.00005217852,0.0002891516,0.009948425,0.00030519668,0.00007322462,0.15229511,0.000002869212,0.00032472354,0.0068259146],"study_design_scores_gemma":[0.005066918,0.0016138287,0.77466786,0.00019800467,0.00022851407,0.004847122,0.0003917887,0.00020908804,0.21170424,0.00030169822,0.00030579735,0.0004651264],"about_ca_topic_score_codex":0.00003342629,"about_ca_topic_score_gemma":0.0001369922,"teacher_disagreement_score":0.05940913,"about_ca_system_score_codex":0.000007427542,"about_ca_system_score_gemma":0.00007289572,"threshold_uncertainty_score":0.5636189},"labels":[],"label_agreement":null},{"id":"W4390521397","doi":"10.1093/bjd/ljad483.039","title":"P31 Association of atopic dermatitis with thyroid diseases: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Odds ratio; Meta-analysis; Confidence interval; Internal medicine; Thyroid disease; Thyroid; Subgroup analysis; Graves' disease; Disease; Dermatology","score_opus":0.02266863664459263,"score_gpt":0.3119836416970684,"score_spread":0.28931500505247576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390521397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007234407,0.9972507,0.000038537244,0.0011131101,0.000057890382,0.0011243062,0.00029214137,0.00001943892,0.00009666498],"genre_scores_gemma":[0.00092900154,0.9976093,0.0000923992,0.00077407545,0.000022808716,0.000109812914,0.00008330141,0.000040367984,0.0003388981],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952131,0.0011469928,0.002597308,0.0002847944,0.0004875469,0.0002702887],"domain_scores_gemma":[0.99518937,0.00057615066,0.0031526124,0.00034102701,0.0004884194,0.00025244942],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00032504054,0.00041495074,0.015044642,0.000614739,0.00005511391,0.00005401874,0.00024447686,0.00036481777,0.00016300534],"category_scores_gemma":[0.0007476261,0.00028506113,0.0036428147,0.00081603037,0.0001406302,0.00014033818,0.00006404158,0.0006442933,0.00001842141],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024975943,0.00008694385,0.00014898939,0.72508657,0.24810225,0.008744181,0.000011640314,3.2492547e-8,2.1555078e-9,0.000015982128,0.017383669,0.00041727742],"study_design_scores_gemma":[0.0002433401,0.00002958376,0.000045313598,0.09537591,0.69926494,0.19481452,0.000011002734,6.162007e-7,9.528144e-8,0.00003333329,0.010032836,0.00014850408],"about_ca_topic_score_codex":0.0000065589556,"about_ca_topic_score_gemma":0.000018740444,"teacher_disagreement_score":0.6297106,"about_ca_system_score_codex":0.000085791944,"about_ca_system_score_gemma":0.0004938616,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W4390595023","doi":"10.1093/bjd/ljae006","title":"Neonatal epidermolysis bullosa: a clinical practice guideline","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Debra International; Dystrophic Epidermolysis Bullosa Research Association","keywords":"Medicine; Psychosocial; Guideline; Epidermolysis bullosa; Multidisciplinary approach; Nursing; Clinical Practice; Intervention (counseling); Presentation (obstetrics); Family medicine; Pathology; Psychiatry; Surgery","score_opus":0.04017778618231954,"score_gpt":0.41401753382030504,"score_spread":0.3738397476379855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390595023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034494915,0.9961198,0.000989476,0.0005728265,0.0014043698,0.00023587709,0.00006848913,0.000009625711,0.0005650638],"genre_scores_gemma":[0.000045150267,0.99394464,0.0029655849,0.00025951507,0.0017948317,0.000014559808,0.00039540447,0.00008589344,0.00049439084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993867,0.001845692,0.002889599,0.00058913004,0.00030683618,0.00050176773],"domain_scores_gemma":[0.9971364,0.00032379784,0.0012055193,0.00042174826,0.00063409534,0.00027843463],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017365307,0.00039757512,0.0022401046,0.00023217693,0.00008406925,0.00009721761,0.000881312,0.0014268702,0.000096082],"category_scores_gemma":[0.0038920795,0.00036339695,0.0018772335,0.00025129045,0.00037795733,0.000009189579,0.0004799318,0.0017448718,0.00017724614],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038675003,0.00009274069,0.0000023751763,0.00088960794,0.0015004576,0.09079936,0.0000025434254,5.739915e-8,0.000004792235,0.000015576494,0.1600278,0.746626],"study_design_scores_gemma":[0.00023585418,0.00011136898,1.4824977e-7,0.0011858785,0.0011343581,0.47265568,0.000016572667,9.3733377e-7,0.000011205784,0.00002147728,0.52445865,0.00016787891],"about_ca_topic_score_codex":0.000010840026,"about_ca_topic_score_gemma":0.000007719147,"teacher_disagreement_score":0.7464581,"about_ca_system_score_codex":0.000027903856,"about_ca_system_score_gemma":0.0012248923,"threshold_uncertainty_score":0.9998818},"labels":[],"label_agreement":null},{"id":"W4390652292","doi":"10.1093/bjd/ljad391","title":"Top 10 research priorities for basal cell carcinoma: results of the Skin Investigation Network of Canada Priority Setting Initiative","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Toronto; BC Children's Hospital; University of British Columbia; SKiN Health; Women's College Hospital; McGill University; Canadian Arthritis Patient Alliance; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Alliance; Basal cell carcinoma; Medicine; Basal cell; Family medicine; Political science; Pathology","score_opus":0.04074082435344616,"score_gpt":0.3031091863920118,"score_spread":0.2623683620385656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390652292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98936915,0.0020900602,0.000012708168,0.006490028,0.0005048135,0.00036998797,0.000104725405,0.0000039361175,0.0010545785],"genre_scores_gemma":[0.99849457,0.00013856654,0.0007000602,0.00012709074,0.00031696027,0.000010225573,0.0000063694615,0.000015141818,0.00019104079],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99768007,0.00039752029,0.00086693943,0.00013797247,0.0005295034,0.0003880098],"domain_scores_gemma":[0.9962383,0.0015188684,0.0006487382,0.00015023391,0.0013603995,0.00008349636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010632478,0.00009237464,0.0005258642,0.00009570507,0.00021097243,0.0000089320665,0.00019894484,0.00009360029,0.000005763295],"category_scores_gemma":[0.0021431732,0.000087319735,0.00010740289,0.0005127411,0.00037582172,0.00006854518,0.00013251978,0.00043398095,3.0073105e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089912023,0.000045566318,0.4848555,0.0011038472,0.00017725283,0.0012113058,0.0028843144,0.000057265188,0.00035873617,0.00011118396,0.5059937,0.0023021996],"study_design_scores_gemma":[0.0040144953,0.0002653436,0.94109803,0.0008357896,0.0000767166,0.0033464155,0.002526233,0.000086172025,0.042884495,0.0017008197,0.00306332,0.00010216722],"about_ca_topic_score_codex":0.014277383,"about_ca_topic_score_gemma":0.04868509,"teacher_disagreement_score":0.5029304,"about_ca_system_score_codex":0.00017971022,"about_ca_system_score_gemma":0.0033685616,"threshold_uncertainty_score":0.9922866},"labels":[],"label_agreement":null},{"id":"W4391134082","doi":"10.1093/bjd/ljae019","title":"Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Dystrophic Epidermolysis Bullosa Research Association of America","keywords":"Medicine; Patient-reported outcome; Epidermolysis bullosa; Varimax rotation; Convergent validity; Cronbach's alpha; Psychometrics; Physical therapy; Clinical psychology; Internal consistency; Quality of life (healthcare); Dermatology; Nursing","score_opus":0.13684400318416517,"score_gpt":0.37962887471434187,"score_spread":0.2427848715301767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391134082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810842,0.01561009,0.00075541466,0.00078688486,0.0009086349,0.0007823418,0.000042913245,0.0000040288237,0.000025434147],"genre_scores_gemma":[0.99842894,0.0007376435,0.00053787907,0.00004026125,0.00009630998,0.000069017624,0.000011297949,0.000027438582,0.000051234623],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966074,0.0004891571,0.001712118,0.0003299563,0.00045116755,0.0004101557],"domain_scores_gemma":[0.99763405,0.00027428157,0.0005353332,0.00033474696,0.0011189576,0.00010263585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015741057,0.00015039723,0.0006601392,0.00032545152,0.00012738051,0.000032474658,0.00044632432,0.0002929619,0.0000060975317],"category_scores_gemma":[0.004062901,0.00010874465,0.0008033981,0.00041600296,0.0005573041,0.000009889374,0.00020839996,0.00040808518,5.140776e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012637695,0.0008158722,0.7299894,0.0009562041,0.0024715913,0.00048424242,0.0001619383,0.00000927873,0.106290564,0.00010352396,0.003774251,0.15367939],"study_design_scores_gemma":[0.0057979873,0.004185402,0.060153656,0.0020322325,0.00049874495,0.06910643,0.0011286869,0.00013427882,0.84793705,0.0007705048,0.0077175247,0.0005374817],"about_ca_topic_score_codex":0.00002854417,"about_ca_topic_score_gemma":0.000017566954,"teacher_disagreement_score":0.7416465,"about_ca_system_score_codex":0.000023914523,"about_ca_system_score_gemma":0.00037054688,"threshold_uncertainty_score":0.4863965},"labels":[],"label_agreement":null},{"id":"W4391462927","doi":"10.1093/bjd/ljae037","title":"Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"Pfizer; National Eczema Association","keywords":"Flare; Atopic dermatitis; Perspective (graphical); Medicine; Focus group; Qualitative research; Psychology; Dermatology; Computer science; Physics","score_opus":0.02076233669328348,"score_gpt":0.2885976772240937,"score_spread":0.2678353405308102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391462927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726014,0.022804027,0.0009673648,0.0019566896,0.00038341395,0.0008317781,0.00011730911,0.000046884612,0.00029110184],"genre_scores_gemma":[0.99719894,0.0005077516,0.0015401761,0.0005167664,0.000056769164,0.00007405204,0.000060627066,0.00003271179,0.000012209029],"study_design_codex":"qualitative","study_design_gemma":"case_report","domain_scores_codex":[0.99755996,0.0003905446,0.0011003913,0.00024304181,0.00037356518,0.00033251964],"domain_scores_gemma":[0.99823356,0.0003724081,0.00042829738,0.0001620639,0.00061039557,0.00019326435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007114666,0.00021523077,0.0008988209,0.00029928947,0.00011368095,0.000048218924,0.00014267526,0.00016851306,0.00008471003],"category_scores_gemma":[0.00027307638,0.00020459981,0.00024310694,0.00027281747,0.0001934026,0.000298784,0.000034367054,0.0003208052,0.000008110195],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002113552,0.009857748,0.07034266,0.014529847,0.007952358,0.17960458,0.36957327,0.000009821619,0.00006932183,0.0035825127,0.15742214,0.18494219],"study_design_scores_gemma":[0.028648272,0.0039345087,0.10305585,0.010349672,0.0024888478,0.6478433,0.1886201,0.00026544958,0.0027571935,0.0060281516,0.005294055,0.0007146018],"about_ca_topic_score_codex":0.00007953206,"about_ca_topic_score_gemma":0.00018259871,"teacher_disagreement_score":0.4682387,"about_ca_system_score_codex":0.00005808972,"about_ca_system_score_gemma":0.00040659407,"threshold_uncertainty_score":0.83433384},"labels":[],"label_agreement":null},{"id":"W4391463518","doi":"10.1093/bjd/ljae042","title":"Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Secukinumab; Hidradenitis suppurativa; Infliximab; Dermatology; Cohort; Danish; Internal medicine; Cohort study; Psoriasis; Psoriatic arthritis; Disease","score_opus":0.010357359291368582,"score_gpt":0.28216271813481447,"score_spread":0.27180535884344587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391463518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98960406,0.005518883,0.00005591895,0.0029943981,0.0004933752,0.0007300778,0.000044262713,0.000029368832,0.0005296519],"genre_scores_gemma":[0.9986835,0.00078826986,0.00012082421,0.000008111078,0.000097122036,0.00002327812,0.000031345215,0.000044301058,0.00020322906],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9970383,0.00041649828,0.001283406,0.0003334545,0.000583782,0.00034453225],"domain_scores_gemma":[0.9987029,0.00034141494,0.00030044303,0.00017064133,0.00029162865,0.00019296932],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000046362627,0.00025588908,0.0011460942,0.0005431389,0.000076698256,0.00011554784,0.00015885326,0.00014801693,0.00016929007],"category_scores_gemma":[0.00018738386,0.00026522542,0.0001623981,0.00041959135,0.00021403638,0.0005463778,0.00007667804,0.00060640567,0.0000081697135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014524232,0.0005921162,0.6050744,0.00016821138,0.00042169442,0.38809863,0.0012988232,1.1871881e-7,0.000095832365,0.000050058574,0.00018906349,0.0038658166],"study_design_scores_gemma":[0.0048402455,0.0002620689,0.42599195,0.00077229826,0.00025262052,0.5665461,0.0007166549,0.000023634933,0.00034861412,0.0000873114,0.000035914076,0.00012257342],"about_ca_topic_score_codex":0.00023519245,"about_ca_topic_score_gemma":0.0015292213,"teacher_disagreement_score":0.17908244,"about_ca_system_score_codex":0.00013245457,"about_ca_system_score_gemma":0.00037837066,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W4391609148","doi":"10.1093/bjd/ljad498.030","title":"525 - Real-world effectiveness of upadacitinib in moderate-to-severe atopic dermatitis (AD): Results from cross-sectional analyses of the CorEvitas AD Registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Cross-sectional study; Pathology","score_opus":0.0290146320203819,"score_gpt":0.34344441457034375,"score_spread":0.31442978254996184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858654,0.010720196,0.00013802662,0.00077108986,0.00061503984,0.0002531047,0.000502394,0.000016773061,0.0011179646],"genre_scores_gemma":[0.9985059,0.00076042046,0.00024559276,0.00020184203,0.000048049482,0.000009162966,0.00006177783,0.000020467323,0.00014681343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969837,0.00063643686,0.0014755476,0.00028167377,0.00036710236,0.00025552438],"domain_scores_gemma":[0.99739367,0.0013016672,0.0004998635,0.00029370593,0.00036856387,0.00014253125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032556686,0.00018095925,0.0009827766,0.00035165699,0.00007516306,0.00004496699,0.0002983448,0.00021963546,0.00009404018],"category_scores_gemma":[0.0009452329,0.00016073411,0.00037906703,0.000567931,0.00039630182,0.00019778569,0.00008303373,0.00055727194,0.0000072810485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021921305,0.00036197086,0.9648732,0.0014802645,0.00079234573,0.015348439,0.00016713594,0.00034205208,0.0015522388,0.00013302435,0.011208095,0.0015491109],"study_design_scores_gemma":[0.0031537602,0.000038476028,0.9311789,0.003980633,0.00019259381,0.04680806,0.00004134488,0.0001517839,0.012202843,0.001605522,0.0005236145,0.00012243171],"about_ca_topic_score_codex":0.0005459329,"about_ca_topic_score_gemma":0.00037070384,"teacher_disagreement_score":0.033694256,"about_ca_system_score_codex":0.00007764391,"about_ca_system_score_gemma":0.0005147798,"threshold_uncertainty_score":0.6554547},"labels":[],"label_agreement":null},{"id":"W4391609152","doi":"10.1093/bjd/ljad498.017","title":"509 - Dupilumab improves disease severity in children less than 12 years of age with moderate-severe AD: interim results from PEDISTAD real-world registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Université de Montréal; University of Calgary","funders":"","keywords":"Dupilumab; Interim; Medicine; Disease; Pediatrics; Internal medicine; Dermatology; Geography; Atopic dermatitis","score_opus":0.0060213165000120635,"score_gpt":0.22587338896184234,"score_spread":0.21985207246183028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291945,0.005636442,0.000040747927,0.00025940055,0.00013000285,0.000095381874,0.0006046171,0.000008520499,0.00030542925],"genre_scores_gemma":[0.9963988,0.0027456607,0.00015031734,0.000067591034,0.000068648566,0.000003135385,0.00035931787,0.000026705027,0.00017984166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868625,0.00011013436,0.00052067,0.00028337268,0.00014632763,0.0002532627],"domain_scores_gemma":[0.9993207,0.000028640769,0.00027786876,0.0001840257,0.00006655324,0.00012220007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009929245,0.00014303198,0.00036211163,0.00008533499,0.000028614122,0.00007756432,0.00025122057,0.00013669785,0.0000059801946],"category_scores_gemma":[0.00009043452,0.00015846583,0.00013601127,0.00010580854,0.00013986148,0.00002165818,0.00008426298,0.00028131047,8.688773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015765179,0.0029711053,0.6006366,0.00078915694,0.0047082687,0.040594928,0.0014492779,0.00059801165,0.040522803,0.00014834273,0.05789965,0.23391667],"study_design_scores_gemma":[0.00679088,0.00031431988,0.977715,0.001991735,0.00023509683,0.0032140715,0.00053471036,0.00020080619,0.0047633457,0.00093663443,0.0026264782,0.000676918],"about_ca_topic_score_codex":0.0010814798,"about_ca_topic_score_gemma":0.0036419358,"teacher_disagreement_score":0.37707838,"about_ca_system_score_codex":0.000023439092,"about_ca_system_score_gemma":0.00022345243,"threshold_uncertainty_score":0.64620495},"labels":[],"label_agreement":null},{"id":"W4391609172","doi":"10.1093/bjd/ljad498.046","title":"546 - Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health and Medical Studies","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine","score_opus":0.06984277296128534,"score_gpt":0.41046835691850186,"score_spread":0.34062558395721654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.941632,0.036745545,0.0015308599,0.01660134,0.0016237008,0.0012740578,0.0001062261,0.000035688565,0.00045058195],"genre_scores_gemma":[0.9934626,0.0029577161,0.0006695897,0.0019567856,0.00023999705,0.00054891594,0.000011532916,0.00001581274,0.00013704669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975234,0.00037533147,0.0010829243,0.00019627722,0.00019385407,0.0006281812],"domain_scores_gemma":[0.9982677,0.0009755891,0.00017457615,0.000074927215,0.00014898948,0.0003581827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001712516,0.00014803976,0.0006197469,0.00013032214,0.00032164546,0.000026601987,0.000120868055,0.00016353156,0.000119738754],"category_scores_gemma":[0.00045753294,0.00012406177,0.00010300114,0.00013593695,0.000044439574,0.00013168697,0.000055843815,0.00031321068,0.00003338473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041507857,0.00078839564,0.1065824,0.0038838757,0.00062609,0.0064004636,0.036528677,0.00006330425,0.000058182184,0.0011689214,0.22429179,0.61919284],"study_design_scores_gemma":[0.006996509,0.0015422745,0.06560353,0.008781534,0.000111615795,0.006177604,0.008540602,0.0005088674,0.0006529401,0.0027492102,0.8978325,0.00050280936],"about_ca_topic_score_codex":0.00063889986,"about_ca_topic_score_gemma":0.0018981731,"teacher_disagreement_score":0.6735407,"about_ca_system_score_codex":0.0003034802,"about_ca_system_score_gemma":0.0006247028,"threshold_uncertainty_score":0.5059092},"labels":[],"label_agreement":null},{"id":"W4391609515","doi":"10.1093/bjd/ljad498.028","title":"523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Internal medicine; Antibody; Gastroenterology; Pediatrics; Immunology","score_opus":0.011121274891763164,"score_gpt":0.2772268404591704,"score_spread":0.2661055655674072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930562,0.0049397247,0.00013574683,0.0004910548,0.00028111172,0.0005258123,0.0004952617,0.000022035909,0.000053096173],"genre_scores_gemma":[0.99855214,0.0005318016,0.00031895435,0.00027371704,0.0001153679,0.0000031222391,0.00016326206,0.000030725798,0.000010932795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99773324,0.00019755498,0.0011383252,0.0003120194,0.00033022626,0.0002886234],"domain_scores_gemma":[0.9987791,0.00018524146,0.00028751622,0.00017733578,0.0002213572,0.0003494149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111549685,0.00020459562,0.00090342655,0.0003046705,0.00006841625,0.000076033684,0.00012193499,0.00016292403,0.000025294816],"category_scores_gemma":[0.00021295882,0.00018254764,0.000101512014,0.00025156644,0.00015505355,0.00032120786,0.000041431176,0.00037142832,0.0000038619996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3327192,0.017764378,0.18410674,0.0013612034,0.0015826926,0.096574605,0.0043949885,0.00016386584,0.0014816382,0.000035793102,0.0062413774,0.35357353],"study_design_scores_gemma":[0.33024472,0.0047413944,0.64015913,0.0058720317,0.0004611792,0.0132158585,0.00033873896,0.00028205026,0.0012618823,0.00007434411,0.0029460066,0.00040267236],"about_ca_topic_score_codex":0.000068459995,"about_ca_topic_score_gemma":0.0000484567,"teacher_disagreement_score":0.45605236,"about_ca_system_score_codex":0.00003267693,"about_ca_system_score_gemma":0.00033995206,"threshold_uncertainty_score":0.74440765},"labels":[],"label_agreement":null},{"id":"W4391609609","doi":"10.1093/bjd/ljad498.009","title":"498 - Real-world use and effectiveness of upadacitinib in adults and adolescents with atopic dermatitis: preliminary analysis of the real-world multicountry AD-VISE study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Ottawa Hospital; University of Ottawa; Lynde Centre for Dermatology; University of Toronto; Queen's University; McMaster University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.008681572346317041,"score_gpt":0.2729348112004093,"score_spread":0.26425323885409224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399114,0.005104356,0.00001337837,0.0001573069,0.000102907405,0.000524323,0.000039879993,0.000011764851,0.000054952547],"genre_scores_gemma":[0.9980708,0.0017423506,0.00005468017,0.00006748481,0.000010931597,0.000012487306,0.0000069433036,0.000018641274,0.000015724223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771065,0.0007089549,0.0008390651,0.00024753227,0.0002747076,0.00021908982],"domain_scores_gemma":[0.99852896,0.00056387024,0.00034924806,0.00021199026,0.00021988954,0.00012604064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024164267,0.00017868489,0.0010930984,0.000793853,0.000055752123,0.00003230192,0.0001306125,0.00009611519,0.00001063356],"category_scores_gemma":[0.00017297838,0.00014367446,0.0001456005,0.0009308743,0.00042183232,0.00026056822,0.000082623046,0.00038982855,3.0415637e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012401671,0.00070385827,0.9815803,0.0025442827,0.0011405967,0.011017688,0.00051630684,0.000013341395,0.000017017484,0.000016370654,0.00014097555,0.0010690693],"study_design_scores_gemma":[0.0043590507,0.0001953673,0.9664971,0.01167803,0.0025839505,0.013465295,0.00042606905,0.00039599583,0.00024081931,0.000031309042,0.000014151316,0.0001128526],"about_ca_topic_score_codex":0.00075712556,"about_ca_topic_score_gemma":0.004360821,"teacher_disagreement_score":0.015083216,"about_ca_system_score_codex":0.000034688343,"about_ca_system_score_gemma":0.00015810358,"threshold_uncertainty_score":0.5858875},"labels":[],"label_agreement":null},{"id":"W4391609642","doi":"10.1093/bjd/ljad498.044","title":"544 - Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Guenther Dermatology Research Centre","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.007080068110595989,"score_gpt":0.23802930912656284,"score_spread":0.23094924101596684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429584,0.0029339532,0.000032793185,0.0021401532,0.0001498916,0.0002294937,0.000056141995,0.0000043972223,0.00015734573],"genre_scores_gemma":[0.998708,0.00012423763,0.00005880422,0.0010434781,0.000010125765,0.000008896475,0.000024953863,0.0000106905645,0.000010795028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845475,0.00023521742,0.00058809656,0.00016095984,0.00031091168,0.0002500712],"domain_scores_gemma":[0.9992005,0.00030361325,0.00011302367,0.00012603165,0.0001375742,0.000119212695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000939646,0.0001287284,0.00067764736,0.0005264239,0.00004078861,0.00003462354,0.00014086538,0.000097417746,0.00007353917],"category_scores_gemma":[0.000113818154,0.000106029605,0.000083445295,0.0005771439,0.00010166613,0.0001403299,0.000020709735,0.00034586014,9.644147e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012882296,0.00019378541,0.9657167,0.00012927265,0.00081925077,0.02073966,0.00044856046,0.00026442617,8.9713916e-7,0.00004003432,0.0075236866,0.0028354677],"study_design_scores_gemma":[0.005531897,0.00008774329,0.97633064,0.00031627488,0.000653511,0.015406629,0.00024398816,0.00035280926,0.000018281042,0.000026395377,0.00092585816,0.00010598912],"about_ca_topic_score_codex":0.019897982,"about_ca_topic_score_gemma":0.34384435,"teacher_disagreement_score":0.3239464,"about_ca_system_score_codex":0.000088644454,"about_ca_system_score_gemma":0.0005741628,"threshold_uncertainty_score":0.9866286},"labels":[],"label_agreement":null},{"id":"W4391609649","doi":"10.1093/bjd/ljad498.058","title":"562 - Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Dermatology; Medicine; Pediatrics","score_opus":0.006500198555793528,"score_gpt":0.24331996491118812,"score_spread":0.2368197663553946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927909,0.0051669176,0.00004402454,0.0009512913,0.00025433625,0.00055907667,0.00002236797,0.000022882175,0.00018822485],"genre_scores_gemma":[0.99820906,0.00091452815,0.00014073943,0.00048618266,0.00007338352,0.000041762563,0.0000264799,0.000029608898,0.00007827958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825555,0.00010113731,0.00072762615,0.00026325672,0.00026186643,0.00039055082],"domain_scores_gemma":[0.9993288,0.00008259484,0.00013196746,0.00013718064,0.0001117509,0.00020768605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005628748,0.00020513783,0.00063457363,0.0005208617,0.00004108993,0.00006984084,0.00011572927,0.00015179116,0.00013523862],"category_scores_gemma":[0.000052303352,0.00018623409,0.00011181569,0.00031845385,0.000053066233,0.00028072664,0.000037607493,0.0003176867,0.0000312006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030365138,0.00075716426,0.9466007,0.00039244522,0.00010539274,0.03726357,0.00020755624,0.000016591759,0.0000022880117,0.000012817079,0.0028285289,0.011509318],"study_design_scores_gemma":[0.0076201675,0.00030148253,0.97100973,0.000825016,0.0001594885,0.019422498,0.000030207148,0.00005705426,0.00010049573,0.00009821206,0.00019594909,0.00017968731],"about_ca_topic_score_codex":0.000057120284,"about_ca_topic_score_gemma":0.00047912545,"teacher_disagreement_score":0.024409065,"about_ca_system_score_codex":0.00022568433,"about_ca_system_score_gemma":0.00040933368,"threshold_uncertainty_score":0.75944054},"labels":[],"label_agreement":null},{"id":"W4391609698","doi":"10.1093/bjd/ljad498.022","title":"515 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Pediatrics; Atopic dermatitis; Dermatology","score_opus":0.009066299799720973,"score_gpt":0.2946682499661268,"score_spread":0.2856019501664058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769971,0.021544568,0.000037286594,0.00080673426,0.000053921398,0.00039740393,0.00006128758,0.000009326392,0.0000924206],"genre_scores_gemma":[0.99732363,0.0016912734,0.000703448,0.00020588786,0.000028243492,0.000009497091,0.000010906022,0.000018592336,0.000008519185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978439,0.000381826,0.0010940273,0.00022128658,0.00021442106,0.00024451458],"domain_scores_gemma":[0.998831,0.00042300363,0.00033846818,0.00012504745,0.00009734085,0.00018517024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037576383,0.00015414714,0.0013099153,0.00042496767,0.000022459328,0.000027974702,0.000102813596,0.00009077897,0.000024688647],"category_scores_gemma":[0.00035995975,0.00014410526,0.00007587796,0.00031109285,0.00033719017,0.00020474038,0.00003947923,0.00036499082,9.651827e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027125082,0.0007612183,0.8898576,0.00050418876,0.0003222569,0.071951024,0.0015855482,0.0000050690473,0.00010029884,0.000047492817,0.0024841079,0.029668722],"study_design_scores_gemma":[0.017033529,0.0007145477,0.7561824,0.005872487,0.0001618191,0.21883325,0.00017717412,0.000013186529,0.0006980375,0.00010616232,0.00008430992,0.00012309547],"about_ca_topic_score_codex":0.0005269278,"about_ca_topic_score_gemma":0.0006883522,"teacher_disagreement_score":0.14688224,"about_ca_system_score_codex":0.000018105327,"about_ca_system_score_gemma":0.00021780634,"threshold_uncertainty_score":0.58764416},"labels":[],"label_agreement":null},{"id":"W4391609703","doi":"10.1093/bjd/ljad498.050","title":"551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Dalhousie University","funders":"","keywords":"Atopic dermatitis; Medicine; Term (time); Dermatology; Pediatrics; Disease; Internal medicine","score_opus":0.005581683353862343,"score_gpt":0.24207949996426323,"score_spread":0.2364978166104009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97536284,0.02054265,0.00028363185,0.002657409,0.00024553543,0.00063651445,0.00007664916,0.000051591986,0.00014318712],"genre_scores_gemma":[0.99749726,0.00081208826,0.00010314662,0.0012322346,0.00009744371,0.000055074717,0.000026611358,0.000038928145,0.00013722188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981768,0.00017219197,0.0006767357,0.00029342496,0.00025147642,0.0004293386],"domain_scores_gemma":[0.99895,0.00014724559,0.00013605566,0.00017015553,0.000118035874,0.00047848432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000050678536,0.00023767594,0.0008567164,0.00032183318,0.000054397853,0.00010345448,0.00013398699,0.000142492,0.00017485928],"category_scores_gemma":[0.00008019026,0.00021751798,0.00021356008,0.0001903989,0.0001491137,0.00029438245,0.000017507491,0.00031437064,0.000035341367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002217081,0.0005372499,0.60046136,0.0005155594,0.00040572233,0.36604255,0.00038592578,0.000031606054,0.000005089887,0.000043627166,0.0060755285,0.023278702],"study_design_scores_gemma":[0.01085768,0.00025367519,0.7719718,0.0034800894,0.0003565866,0.21166407,0.000053192656,0.00025351648,0.00005043305,0.00012935679,0.0007272034,0.00020236126],"about_ca_topic_score_codex":0.000055822256,"about_ca_topic_score_gemma":0.00027087142,"teacher_disagreement_score":0.17151049,"about_ca_system_score_codex":0.00013147092,"about_ca_system_score_gemma":0.0005570946,"threshold_uncertainty_score":0.8870126},"labels":[],"label_agreement":null},{"id":"W4391609714","doi":"10.1093/bjd/ljad498.012","title":"504 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Probity Medical Research; Queen's University","funders":"","keywords":"Tolerability; Medicine; Dermatology; Seborrheic dermatitis; Roflumilast; Atopic dermatitis; Psoriasis; Adverse effect; Internal medicine","score_opus":0.011133358368482414,"score_gpt":0.2689921600853896,"score_spread":0.2578588017169072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825214,0.015132142,0.000147397,0.0015148598,0.00019428706,0.00037061467,0.00005639485,0.000013792897,0.000049122787],"genre_scores_gemma":[0.99842066,0.000649012,0.00026633096,0.00059106946,0.00001977183,0.000010654852,0.000025732033,0.000015017082,0.0000017414171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691,0.0006727006,0.0016777756,0.00023585545,0.00023638392,0.00026728082],"domain_scores_gemma":[0.99866897,0.00042859986,0.00032664713,0.00011607894,0.00016407677,0.00029561488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002499096,0.00018523676,0.0013180865,0.0003321451,0.000037655875,0.000038170292,0.000076937344,0.00022566385,0.00005444194],"category_scores_gemma":[0.00096615654,0.00017130448,0.00008877217,0.00027465585,0.00057884125,0.00029629798,0.000044378816,0.00045408335,0.000001096308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002568549,0.00062504836,0.94654804,0.0006901353,0.000125702,0.00844508,0.0005192711,0.0000021469195,0.000014839047,0.00006139484,0.003222493,0.039488986],"study_design_scores_gemma":[0.0122177,0.00034977956,0.94565564,0.0021732547,0.00015882801,0.036313046,0.000292216,0.00019796677,0.0011757916,0.00066191994,0.0006406841,0.00016316454],"about_ca_topic_score_codex":0.00006536543,"about_ca_topic_score_gemma":0.00016776324,"teacher_disagreement_score":0.03932582,"about_ca_system_score_codex":0.00005156746,"about_ca_system_score_gemma":0.00035234168,"threshold_uncertainty_score":0.6985594},"labels":[],"label_agreement":null},{"id":"W4391609744","doi":"10.1093/bjd/ljad498.054","title":"555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Atopic dermatitis; Medicine; Clinical trial; Dermatology; Safety profile; Pediatrics; Adverse effect; Internal medicine","score_opus":0.034957255479298906,"score_gpt":0.3602132351540593,"score_spread":0.3252559796747604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943324,0.003544413,0.00034635427,0.00030200035,0.00018964328,0.0006181942,0.0006457696,0.0000049259456,0.000016306583],"genre_scores_gemma":[0.99794805,0.0014041716,0.00031299115,0.000048630827,0.000016714686,0.000012774612,0.00022634283,0.000013547523,0.000016757975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965224,0.0006481141,0.0023187725,0.00016422453,0.0001764228,0.00017004489],"domain_scores_gemma":[0.99740607,0.0011122528,0.00077778933,0.0002144223,0.00037139107,0.00011805575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035134793,0.00014381083,0.0022048755,0.00055222394,0.000019522537,0.000006679009,0.0001386779,0.00016265745,0.00012080976],"category_scores_gemma":[0.00027373657,0.00009856476,0.00066124013,0.00067259726,0.0002464703,0.000087118904,0.000008129644,0.000100127356,4.5939655e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005309745,0.0032870835,0.844459,0.00019064061,0.013046334,0.0009885737,0.0013674592,0.000084221625,0.00002787781,0.000077390876,0.0017106463,0.12945102],"study_design_scores_gemma":[0.014021966,0.0031128423,0.96787614,0.0005102291,0.007896387,0.0013323358,0.00032864106,0.00042663253,0.0018593622,0.000053917458,0.00248665,0.00009492414],"about_ca_topic_score_codex":0.00017466374,"about_ca_topic_score_gemma":0.00031780824,"teacher_disagreement_score":0.1293561,"about_ca_system_score_codex":0.00006609794,"about_ca_system_score_gemma":0.00035302728,"threshold_uncertainty_score":0.40193543},"labels":[],"label_agreement":null},{"id":"W4391609834","doi":"10.1093/bjd/ljad498.035","title":"530 - Treatment efficacy in patients with moderate-to-severe atopic dermatitis who switched from dupilumab to abrocitinib in JADE EXTEND, a phase 3 long-term extension study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; JADE (particle detector); Term (time)","score_opus":0.01331149872286157,"score_gpt":0.29755227670613027,"score_spread":0.2842407779832687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936311,0.003373438,0.00015339172,0.0012252505,0.0002488808,0.0012335773,0.000056597717,0.000036998008,0.000040750878],"genre_scores_gemma":[0.9984253,0.00017270523,0.00022119246,0.00092315854,0.000059957707,0.000055888882,0.00006234767,0.000045213812,0.00003422187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973344,0.00029690255,0.0010516777,0.0004706646,0.00036287715,0.00048343244],"domain_scores_gemma":[0.9987576,0.00021701337,0.00015578499,0.00026122987,0.000184681,0.000423666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007799951,0.00031268652,0.0011953269,0.0006276399,0.00007380345,0.00009418271,0.00017822352,0.00017500645,0.00014813522],"category_scores_gemma":[0.00015181948,0.00029035273,0.00013923037,0.00043371497,0.00006042171,0.00026635008,0.000060750222,0.00043507174,0.00005393242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002647306,0.0072412905,0.8100309,0.000089685294,0.00033366043,0.14367387,0.0015998231,0.00003906222,0.000021362317,0.0000031373818,0.0015042252,0.032815695],"study_design_scores_gemma":[0.032917235,0.0011861937,0.937526,0.0025774457,0.0002507601,0.024661086,0.00018642211,0.000076212025,0.00018787349,0.000044471533,0.00012722543,0.0002590708],"about_ca_topic_score_codex":0.00014117168,"about_ca_topic_score_gemma":0.00074811047,"teacher_disagreement_score":0.12749511,"about_ca_system_score_codex":0.00021269423,"about_ca_system_score_gemma":0.00026815975,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W4391609906","doi":"10.1093/bjd/ljad498.033","title":"528 - Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Clinical trial; Internal medicine","score_opus":0.028388796192635218,"score_gpt":0.34113680935194335,"score_spread":0.3127480131593081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839429,0.0061662835,0.00041085194,0.0068560163,0.0010250626,0.0010680561,0.00024509293,0.00005154175,0.00023418255],"genre_scores_gemma":[0.9948935,0.0012032761,0.0012941799,0.0020750593,0.00031915412,0.00005494714,0.00007382743,0.00004869245,0.000037343136],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961584,0.00039297566,0.0017684253,0.0006514892,0.0004461073,0.00058257696],"domain_scores_gemma":[0.9977998,0.0006699856,0.00031569434,0.00030171033,0.00024747106,0.00066530233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003341797,0.00033684296,0.0013433476,0.00033581004,0.00011646439,0.00013232036,0.0002177036,0.0003148129,0.00007754234],"category_scores_gemma":[0.00048409536,0.00030497476,0.00016840656,0.0003770607,0.0002642986,0.00032171642,0.00006897107,0.0009772314,0.000027456132],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.687669,0.0018074502,0.007859594,0.00044434506,0.000919338,0.0914453,0.0014327423,0.000028178169,0.000014889634,0.00003608191,0.02722687,0.18111621],"study_design_scores_gemma":[0.7327115,0.009714823,0.08956095,0.011657157,0.00072395883,0.14025792,0.0010398823,0.001370068,0.0005708809,0.00022632511,0.011303251,0.0008633071],"about_ca_topic_score_codex":0.00023452347,"about_ca_topic_score_gemma":0.0015162005,"teacher_disagreement_score":0.18025291,"about_ca_system_score_codex":0.000073729294,"about_ca_system_score_gemma":0.0006399962,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W4391609907","doi":"10.1093/bjd/ljad498.013","title":"505 - Once-daily roflumilast cream 0.15% for atopic dermatitis: pooled results from INTEGUMENT-1/2 phase 3 trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Atopic dermatitis; Medicine; Dermatology; Integument; Internal medicine","score_opus":0.030491434103701774,"score_gpt":0.33832378134111074,"score_spread":0.307832347237409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8491619,0.11148448,0.006582779,0.024124522,0.0040594623,0.0010740045,0.0017858542,0.00019173887,0.0015352255],"genre_scores_gemma":[0.9925218,0.0024434896,0.0013189691,0.0021984354,0.000718352,0.000039330287,0.00032527113,0.00004750007,0.00038682512],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9959691,0.00054682064,0.002331891,0.00036722867,0.00031772812,0.00046721447],"domain_scores_gemma":[0.99619895,0.002180505,0.00062882993,0.00024851877,0.0003580943,0.00038507435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006119394,0.00027332417,0.0016721743,0.0003300355,0.00015247158,0.00016392411,0.00027946194,0.0003581339,0.00042867678],"category_scores_gemma":[0.003821018,0.00026914114,0.0007451964,0.00019678974,0.00023824167,0.0003768131,0.00005304621,0.0005891243,0.000083990664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016109092,0.0011162603,0.0013799255,0.00039735384,0.0019613744,0.049670648,0.00042509811,0.0000014195679,0.0005709301,0.00016865021,0.87007004,0.07262742],"study_design_scores_gemma":[0.060773578,0.00084577396,0.009913064,0.0067013134,0.0045471615,0.47113347,0.0011517082,0.00084914244,0.01909676,0.0077868723,0.41651127,0.000689893],"about_ca_topic_score_codex":0.00005486652,"about_ca_topic_score_gemma":0.000040412226,"teacher_disagreement_score":0.45355874,"about_ca_system_score_codex":0.00008324952,"about_ca_system_score_gemma":0.0005939734,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W4391609911","doi":"10.1093/bjd/ljad498.064","title":"569 - Impact of therapeutic inertia on patient-reported outcomes in moderate-to-severe atopic dermatitis: a 12-month longitudinal study from the TARGET-DERM AD registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Longitudinal study; Dermatology; Patient registry; Pediatrics; Physical therapy; Physical medicine and rehabilitation; Pathology","score_opus":0.022876064237182733,"score_gpt":0.30679196578588536,"score_spread":0.2839159015487026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096156,0.014903062,0.00008832844,0.002840107,0.0003971875,0.00054609636,0.000060604136,0.00003203461,0.00017101652],"genre_scores_gemma":[0.99855685,0.0001808593,0.00009499277,0.0010165191,0.000042003416,0.00002353487,0.000019011404,0.00003332818,0.000032918815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717754,0.00040041475,0.0013302959,0.00030191764,0.00041256062,0.000377287],"domain_scores_gemma":[0.9983212,0.000514898,0.0004049145,0.00036851346,0.00018482874,0.00020568132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013720745,0.00027559363,0.00111578,0.00026673774,0.00008844844,0.00007241283,0.00028025798,0.00018740758,0.00018109012],"category_scores_gemma":[0.0003904122,0.00020325788,0.0004065785,0.00027273377,0.0001481231,0.00019557144,0.00006477631,0.00072200416,0.000013254376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006129263,0.0011827989,0.9260032,0.00006326252,0.001572932,0.055093005,0.0009151859,0.00008398382,0.00002518385,0.000007795618,0.010100277,0.004339421],"study_design_scores_gemma":[0.0031646518,0.00045344717,0.9215474,0.0008629091,0.00036612098,0.071686715,0.0005846064,0.00019990184,0.0001274143,0.0006928645,0.00014657599,0.0001674047],"about_ca_topic_score_codex":0.0005040779,"about_ca_topic_score_gemma":0.00043779757,"teacher_disagreement_score":0.017595269,"about_ca_system_score_codex":0.00009933154,"about_ca_system_score_gemma":0.0004747514,"threshold_uncertainty_score":0.8288616},"labels":[],"label_agreement":null},{"id":"W4391609915","doi":"10.1093/bjd/ljad498.067","title":"519 - Efficacy of prolonged ruxolitinib cream treatment for vitiligo among patients with limited or no initial response at 6 months","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; SKiN Health","funders":"","keywords":"Vitiligo; Ruxolitinib; Medicine; Dermatology; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.011547635017653334,"score_gpt":0.27608910092722333,"score_spread":0.26454146590957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981253,0.00066159974,0.00021296558,0.00008552058,0.00026535033,0.00040536062,0.00014338306,0.0000066492953,0.00009386908],"genre_scores_gemma":[0.9985717,0.00017506289,0.00055557146,0.00005300569,0.0001257753,0.0000289123,0.00020335862,0.000025084813,0.00026153776],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988396,0.0001905403,0.0004599295,0.00018371307,0.00012924711,0.0001969389],"domain_scores_gemma":[0.99914294,0.00016950404,0.00022744224,0.000104532184,0.00026808356,0.000087482375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011541636,0.00012775196,0.00028708208,0.00008157427,0.000060093196,0.000028736662,0.0000990922,0.00014787957,0.000041458763],"category_scores_gemma":[0.00027797924,0.000106906205,0.00013093163,0.000059488826,0.00009187231,0.000011594371,0.000025930423,0.00006768709,0.0000030326503],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37223747,0.0087099485,0.18734714,0.001206381,0.005499814,0.0141234845,0.0023070679,0.00011147026,0.22520034,0.00006920914,0.06761948,0.11556818],"study_design_scores_gemma":[0.035304148,0.026645675,0.26803422,0.0011100951,0.00063591416,0.025330177,0.00025508844,0.00023101321,0.60971755,0.000036925885,0.032009747,0.00068941835],"about_ca_topic_score_codex":0.000013501818,"about_ca_topic_score_gemma":0.00006281444,"teacher_disagreement_score":0.38451722,"about_ca_system_score_codex":0.000036512225,"about_ca_system_score_gemma":0.0001670621,"threshold_uncertainty_score":0.43595085},"labels":[],"label_agreement":null},{"id":"W4391609952","doi":"10.1093/bjd/ljad498.021","title":"514 - Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; Innovaderm (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.017326852808123214,"score_gpt":0.3330302427429552,"score_spread":0.31570338993483194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770949,0.020782677,0.000010786988,0.0013046712,0.00010438699,0.00056272425,0.000052325733,0.000005267364,0.00008224251],"genre_scores_gemma":[0.9959225,0.0036893697,0.00011954675,0.00017840197,0.0000411864,0.00001650621,0.000015964892,0.000010514815,0.0000059881936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736625,0.0006965275,0.0013565704,0.00017444747,0.00017976992,0.00022646178],"domain_scores_gemma":[0.99853855,0.0009339566,0.0002569436,0.00013254718,0.000039226008,0.000098759956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004207424,0.00013070372,0.0011874799,0.0004070577,0.000015706235,0.00001918159,0.00013771158,0.00009177194,0.000031441094],"category_scores_gemma":[0.00054817053,0.00011364876,0.00016964757,0.00032637172,0.00018271468,0.00009214804,0.000019291827,0.00022570163,0.000002138558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024400658,0.011689941,0.5336599,0.0006975938,0.00050919194,0.20151187,0.01206593,0.000036027217,0.0006229415,0.00024075864,0.006453044,0.23007272],"study_design_scores_gemma":[0.01913219,0.00071871234,0.91389126,0.0029724296,0.00014672842,0.060671836,0.00045928964,0.000035240333,0.001298002,0.00017835097,0.00038736573,0.00010858077],"about_ca_topic_score_codex":0.00043722265,"about_ca_topic_score_gemma":0.00043745083,"teacher_disagreement_score":0.38023138,"about_ca_system_score_codex":0.00004269356,"about_ca_system_score_gemma":0.00015458888,"threshold_uncertainty_score":0.4634462},"labels":[],"label_agreement":null},{"id":"W4391609975","doi":"10.1093/bjd/ljad498.031","title":"526 - Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.015528948431389281,"score_gpt":0.30415394753365244,"score_spread":0.28862499910226314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391609975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879998,0.0068108574,0.0005539996,0.003353525,0.00023091021,0.00067776017,0.000324292,0.000015658065,0.000033197142],"genre_scores_gemma":[0.9988261,0.0002364774,0.00016967913,0.0005565467,0.000032234824,0.000020838794,0.000035518384,0.000023581919,0.00009901742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968067,0.0008044746,0.0014847569,0.00025663056,0.00033697128,0.00031050533],"domain_scores_gemma":[0.99674904,0.0021509235,0.00035069615,0.0002835776,0.0003070169,0.00015876275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005361046,0.00018429493,0.0014186734,0.0006017564,0.00006561818,0.000042024614,0.000298531,0.00012449708,0.0002137992],"category_scores_gemma":[0.000804774,0.00016368796,0.00044396787,0.0007439086,0.00015449556,0.00013875488,0.00006834641,0.00034345852,0.00001077646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029972395,0.0039583426,0.8149634,0.0006255077,0.014244984,0.038008105,0.009151691,0.0019091205,0.00060259295,0.00006572794,0.072460465,0.014037686],"study_design_scores_gemma":[0.007882031,0.00030241263,0.96804315,0.0010184523,0.002726946,0.0141979745,0.00069783896,0.0026527294,0.0011392828,0.0004550711,0.00070569495,0.00017841262],"about_ca_topic_score_codex":0.00017506139,"about_ca_topic_score_gemma":0.00036112752,"teacher_disagreement_score":0.15307978,"about_ca_system_score_codex":0.00005052386,"about_ca_system_score_gemma":0.00040883626,"threshold_uncertainty_score":0.66750014},"labels":[],"label_agreement":null},{"id":"W4391610049","doi":"10.1093/bjd/ljad498.005","title":"494 - Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology","score_opus":0.005036598918240202,"score_gpt":0.24310895892761222,"score_spread":0.238072360009372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938304,0.0021640165,0.00030725717,0.0029493582,0.0001327565,0.0003132635,0.0000376627,0.000014968636,0.0002503492],"genre_scores_gemma":[0.99719065,0.00013738962,0.0007676912,0.0018103136,0.000024057097,0.0000042887027,0.000009488972,0.000021156617,0.000034942525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986242,0.00010127562,0.00060973753,0.0001878283,0.0002166766,0.000260282],"domain_scores_gemma":[0.9992548,0.000115916075,0.00009984437,0.000118517884,0.00015717317,0.00025375342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007014597,0.00013082332,0.00061849674,0.00034093374,0.000035689518,0.00003178935,0.00010596614,0.00009732882,0.00010316995],"category_scores_gemma":[0.000113543254,0.00013347378,0.00006644635,0.0002675351,0.000099500874,0.00014331366,0.00005351919,0.00027254754,0.000015537918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003294802,0.0005730603,0.8703944,0.00051281526,0.00047831165,0.035542015,0.0013849566,0.00008107036,0.000014011914,0.00028522732,0.038723037,0.048716277],"study_design_scores_gemma":[0.008092815,0.00020561632,0.93165904,0.0017101986,0.000110478155,0.05572048,0.000068008165,0.000058592228,0.00014539936,0.00024862753,0.0018405381,0.00014018847],"about_ca_topic_score_codex":0.000033203647,"about_ca_topic_score_gemma":0.000047660902,"teacher_disagreement_score":0.061264645,"about_ca_system_score_codex":0.00004437437,"about_ca_system_score_gemma":0.00018425185,"threshold_uncertainty_score":0.54429024},"labels":[],"label_agreement":null},{"id":"W4391610118","doi":"10.1093/bjd/ljad498.063","title":"568 - Persistent inadequate disease control and therapeutic inertia in moderate-to-severe atopic dermatitis: a 12-month longitudinal analysis of real-world outcomes from TARGET-DERM registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Disease; Pediatrics; Dermatology; Internal medicine","score_opus":0.017066640563585585,"score_gpt":0.2725842717194319,"score_spread":0.2555176311558463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95148456,0.039431643,0.00048217172,0.0077562802,0.00019057674,0.0002497288,0.00017706427,0.000027281741,0.00020067193],"genre_scores_gemma":[0.9974062,0.0008903332,0.00017162552,0.0013145426,0.000036977774,0.000017259645,0.000046388966,0.000024428842,0.0000922761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758226,0.00029198345,0.0011106924,0.00033737687,0.00030985227,0.00036783787],"domain_scores_gemma":[0.99846786,0.0003958314,0.00028808386,0.00024681826,0.00015918147,0.00044224676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013137607,0.00024825925,0.0015032827,0.0009112312,0.00007142363,0.00007417605,0.00018631041,0.00014818413,0.00015848654],"category_scores_gemma":[0.00019177844,0.00024119986,0.0005363179,0.0005431979,0.00022151809,0.00018204228,0.000050115184,0.00044204894,0.000004405186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006472314,0.00026170534,0.955786,0.00028963436,0.0042818272,0.033853404,0.00025622747,0.00029899017,0.000018380777,0.0001063467,0.0017118745,0.002488414],"study_design_scores_gemma":[0.0032733148,0.00005096123,0.971941,0.00081132964,0.0046015847,0.009270293,0.00016883334,0.008662267,0.000029394354,0.0007498045,0.00023556089,0.00020567761],"about_ca_topic_score_codex":0.00054577965,"about_ca_topic_score_gemma":0.0014085522,"teacher_disagreement_score":0.045921586,"about_ca_system_score_codex":0.00008094935,"about_ca_system_score_gemma":0.0003148969,"threshold_uncertainty_score":0.98358446},"labels":[],"label_agreement":null},{"id":"W4391610224","doi":"10.1093/bjd/ljad498.049","title":"549 - Laboratory parameters in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Pediatrics","score_opus":0.01779111773238026,"score_gpt":0.26270154198818757,"score_spread":0.2449104242558073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179465,0.0013732297,0.00017941398,0.0045722406,0.00041018156,0.0010019576,0.00051574677,0.000048378144,0.00010420254],"genre_scores_gemma":[0.9952519,0.00013049212,0.0003451447,0.003903027,0.00009518763,0.00004287514,0.00013240158,0.000043486878,0.000055517285],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9971767,0.00050066295,0.0010239623,0.00039749194,0.0004238629,0.00047731158],"domain_scores_gemma":[0.9984299,0.00038810907,0.00023584071,0.00027900585,0.00024128635,0.00042585176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014332475,0.00029772348,0.0008854762,0.0002728471,0.00012995367,0.00014338111,0.00026300037,0.00019804278,0.000045655677],"category_scores_gemma":[0.00028387594,0.00022192622,0.00013387839,0.00046319963,0.00017342814,0.00026711082,0.00003161471,0.00073949003,0.000024327697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2136912,0.003878386,0.14150794,0.00027752598,0.0015835195,0.16976754,0.0043843305,0.00038215335,0.000039504663,0.0000108827,0.44914687,0.0153301405],"study_design_scores_gemma":[0.35420668,0.0035899726,0.55265194,0.008934538,0.001189842,0.06629315,0.0010795727,0.00026461628,0.0022384608,0.00011044976,0.008548038,0.00089271396],"about_ca_topic_score_codex":0.00014263706,"about_ca_topic_score_gemma":0.0008909664,"teacher_disagreement_score":0.44059885,"about_ca_system_score_codex":0.00011247713,"about_ca_system_score_gemma":0.00051204546,"threshold_uncertainty_score":0.9049889},"labels":[],"label_agreement":null},{"id":"W4391610232","doi":"10.1093/bjd/ljad498.029","title":"524 - Efficacy of upadacitinib and dupilumab on achieving stringent and composite skin and itch outcomes: an indirect comparison of adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","score_opus":0.013450096456945896,"score_gpt":0.2888462188151257,"score_spread":0.2753961223581798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98661447,0.011928181,0.00012995956,0.00083936733,0.000078097546,0.0002446933,0.000037675545,0.00001724072,0.00011034778],"genre_scores_gemma":[0.99823403,0.0006720705,0.0007946029,0.00024038693,0.000018723245,0.000003157926,0.0000115866305,0.00001953137,0.0000058963615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847615,0.00016241646,0.0007111752,0.00022422597,0.00021968571,0.00020632827],"domain_scores_gemma":[0.998901,0.00035021675,0.00024899686,0.00011605015,0.00012540395,0.0002583323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000883152,0.00017960153,0.0010517947,0.00027724128,0.00008596552,0.00004746645,0.00008116458,0.00012924275,0.000013198046],"category_scores_gemma":[0.00008720604,0.00016297659,0.0000650502,0.0001204929,0.00023820264,0.00016941568,0.000050289447,0.00033686857,6.7260453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011451475,0.0004809682,0.9546333,0.0014698941,0.00052279717,0.004713238,0.002115902,0.000024053903,0.0000973267,0.0000822354,0.0006774378,0.034037706],"study_design_scores_gemma":[0.0049441527,0.0004336796,0.8890981,0.00380004,0.00031100973,0.0976838,0.0005371847,0.00049905106,0.0023898005,0.000044173114,0.00010605932,0.00015294069],"about_ca_topic_score_codex":0.00003178715,"about_ca_topic_score_gemma":0.000060455644,"teacher_disagreement_score":0.09297056,"about_ca_system_score_codex":0.000014152376,"about_ca_system_score_gemma":0.00008556088,"threshold_uncertainty_score":0.66459924},"labels":[],"label_agreement":null},{"id":"W4391610246","doi":"10.1093/bjd/ljad498.043","title":"542 - Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Rating scale; Psychology","score_opus":0.005299054279597985,"score_gpt":0.24960116038948596,"score_spread":0.24430210610988798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97829354,0.0031119285,0.013448437,0.0040078172,0.00019798185,0.0008548433,0.000056699886,0.000009294418,0.000019466659],"genre_scores_gemma":[0.99708587,0.00014036904,0.0019017016,0.0007487238,0.0000420135,0.00004430187,0.0000065703007,0.000017896627,0.000012572312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998524,0.00025793197,0.00065059855,0.0001611582,0.00020662762,0.00019967265],"domain_scores_gemma":[0.9989474,0.00026371167,0.00031276676,0.00012666092,0.00024786242,0.000101591824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018449097,0.00013191465,0.0004945741,0.00007285265,0.00015748675,0.000041594387,0.00012689008,0.00011349529,0.000004658588],"category_scores_gemma":[0.00021199457,0.00009393882,0.00013712549,0.00013095561,0.00018807812,0.00013938881,0.000054261614,0.0001949557,1.3428007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020766753,0.0002876555,0.93525,0.0073710345,0.000360343,0.00028369593,0.0010761024,0.000047533376,0.00007842595,0.00027719716,0.007572179,0.047188178],"study_design_scores_gemma":[0.00593759,0.00026977138,0.8945516,0.011196279,0.0005380057,0.071534865,0.00047854098,0.006828552,0.0065144324,0.00114641,0.00080916256,0.00019482986],"about_ca_topic_score_codex":0.000016463538,"about_ca_topic_score_gemma":0.000032707125,"teacher_disagreement_score":0.07125117,"about_ca_system_score_codex":0.000027353895,"about_ca_system_score_gemma":0.00021255275,"threshold_uncertainty_score":0.3830714},"labels":[],"label_agreement":null},{"id":"W4391610330","doi":"10.1093/bjd/ljad498.047","title":"547 - Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Atopic dermatitis; Work productivity; Medicine; Dermatology; Productivity; Economics","score_opus":0.014862991524857953,"score_gpt":0.29560359648252826,"score_spread":0.28074060495767034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778445,0.0045053,0.000033368444,0.016892044,0.00030094432,0.00034399057,0.000009993722,0.000013253333,0.000056603792],"genre_scores_gemma":[0.9965961,0.0013666234,0.00010748309,0.0017685527,0.00009189199,0.000012977771,0.000024991925,0.0000120959685,0.000019264284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793506,0.000604137,0.0007930895,0.00020221635,0.00019562623,0.00026985508],"domain_scores_gemma":[0.9991422,0.00038454193,0.00010171594,0.000121009296,0.000110331326,0.0001401777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036865455,0.00012361833,0.00050455343,0.00032594855,0.00005007698,0.00006798445,0.00013350158,0.0001361726,0.000023286027],"category_scores_gemma":[0.00037566797,0.00010372562,0.000083477564,0.0004609929,0.00015039637,0.00015973614,0.00005197346,0.0006356284,0.000009825347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020702808,0.0003672467,0.9321882,0.00017460503,0.00007381404,0.02146306,0.00097234367,0.000044791475,2.439522e-7,0.000020472127,0.029384723,0.015103465],"study_design_scores_gemma":[0.002228105,0.00010307437,0.93077445,0.0009963072,0.000058600443,0.058844272,0.00025189898,0.0002285428,0.000008555556,0.0008640052,0.0055401684,0.000102022714],"about_ca_topic_score_codex":0.00011384417,"about_ca_topic_score_gemma":0.00013290417,"teacher_disagreement_score":0.03738121,"about_ca_system_score_codex":0.000036052723,"about_ca_system_score_gemma":0.0001300387,"threshold_uncertainty_score":0.42298082},"labels":[],"label_agreement":null},{"id":"W4391610379","doi":"10.1093/bjd/ljad498.010","title":"502 - Efficacy and safety of upadacitinib through 140 weeks in adolescents and adults with moderate-to-severe atopic dermatitis: phase 3 randomized clinical trial results","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Atopic dermatitis; Medicine; Randomized controlled trial; Clinical trial; Dermatology; Pediatrics; Internal medicine","score_opus":0.019839577528294707,"score_gpt":0.3326478991868297,"score_spread":0.312808321658535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97960436,0.0151891,0.0006252349,0.0027948364,0.00037186895,0.0010573096,0.000060076345,0.000022173832,0.00027503792],"genre_scores_gemma":[0.99370754,0.004734989,0.0006683386,0.0007060946,0.000113391885,0.000013240546,0.000018224622,0.000022094797,0.000016074257],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961116,0.00092944497,0.0020775096,0.00033347931,0.00025013863,0.00029785561],"domain_scores_gemma":[0.9979405,0.0010582685,0.00039159626,0.00014833293,0.00018090186,0.00028042553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006396849,0.00020943448,0.001812921,0.00020885938,0.000066471264,0.000048205813,0.00011088194,0.00027355313,0.00001750299],"category_scores_gemma":[0.0016735881,0.00018203899,0.00018304904,0.00018759417,0.0005668068,0.00025310897,0.000055602788,0.0006393439,0.0000030167448],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9302046,0.001212887,0.0063384003,0.0009169547,0.0004699655,0.030625423,0.0007845223,0.0000040766413,0.000002568286,0.000093622744,0.004615503,0.024731502],"study_design_scores_gemma":[0.82063127,0.000603718,0.018292116,0.009301592,0.00042882486,0.14901708,0.0001801367,0.00036860933,0.00006485093,0.0003555905,0.0005772274,0.0001789696],"about_ca_topic_score_codex":0.00003404331,"about_ca_topic_score_gemma":0.000051898303,"teacher_disagreement_score":0.118391655,"about_ca_system_score_codex":0.000017704739,"about_ca_system_score_gemma":0.00029012206,"threshold_uncertainty_score":0.7423334},"labels":[],"label_agreement":null},{"id":"W4391610433","doi":"10.1093/bjd/ljad498.023","title":"516 - Comparative efficacy of targeted systemic therapies with topical corticosteroids for moderate-to-severe atopic dermatitis: an updated network meta-analysis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Internal medicine","score_opus":0.04241401709714,"score_gpt":0.31451518762114616,"score_spread":0.2721011705240062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93682444,0.044665042,0.015821172,0.0017027841,0.00019020279,0.00058924133,0.00008809422,0.000048953578,0.00007009651],"genre_scores_gemma":[0.99645615,0.0001217423,0.002341024,0.0007823655,0.0000764541,0.000033868084,0.00011543873,0.000022029288,0.00005094919],"study_design_codex":"meta_analysis","study_design_gemma":"case_report","domain_scores_codex":[0.9976995,0.0003976298,0.0010559353,0.00026393065,0.0002500327,0.0003329787],"domain_scores_gemma":[0.998427,0.00032486356,0.0003187669,0.00021743534,0.00045282356,0.00025911932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013189943,0.00022047103,0.0022607087,0.00027937547,0.000102099104,0.00007199978,0.00019312582,0.00017093145,0.00026959027],"category_scores_gemma":[0.000038149115,0.00017697377,0.00073761237,0.00045674716,0.00017408303,0.0002612683,0.000024531671,0.0002873547,0.000005838125],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074459873,0.0023115254,0.10446604,0.0021123944,0.69798034,0.040819753,0.0059295474,0.010990469,0.0004623726,0.0027155585,0.121012,0.0037540025],"study_design_scores_gemma":[0.011050732,0.0015274496,0.17797378,0.00089372415,0.30402,0.48467466,0.0015669871,0.0096843075,0.0021969746,0.0012316371,0.0043031876,0.0008765865],"about_ca_topic_score_codex":0.00001242661,"about_ca_topic_score_gemma":0.000066905435,"teacher_disagreement_score":0.4438549,"about_ca_system_score_codex":0.000026317286,"about_ca_system_score_gemma":0.00021796468,"threshold_uncertainty_score":0.7216781},"labels":[],"label_agreement":null},{"id":"W4391610449","doi":"10.1093/bjd/ljad498.059","title":"563 - Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (<i>FLG</i>) mutation status","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Filaggrin; Atopic dermatitis; Dupilumab; Dermatology; Medicine","score_opus":0.004815963464652381,"score_gpt":0.24678462230956394,"score_spread":0.24196865884491156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391610449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894067,0.017988177,0.0003959792,0.001168947,0.00064883166,0.00024111137,0.0000372976,0.000026852695,0.00055213255],"genre_scores_gemma":[0.99785703,0.0011911425,0.00047094715,0.0003254558,0.00007217549,0.000011326777,0.000040476512,0.000019209816,0.000012243043],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795914,0.00032707653,0.0009805781,0.00018254404,0.00025261668,0.00029803492],"domain_scores_gemma":[0.99893904,0.00025768531,0.00032557428,0.000106797976,0.0002258079,0.00014508422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009823661,0.00014526953,0.0006126691,0.00043380828,0.000048283397,0.000036926867,0.00008772421,0.00016773574,0.00010861584],"category_scores_gemma":[0.00015741376,0.00016045169,0.00019681435,0.00027087153,0.00018609653,0.00030580664,0.000033372828,0.0004357811,0.000014221083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011835633,0.0033740753,0.21151364,0.0041872063,0.0015080194,0.2727669,0.0082048355,0.00012334486,0.004776754,0.0017168712,0.074494384,0.41615042],"study_design_scores_gemma":[0.003689055,0.00030686893,0.62320596,0.0025235924,0.00023739194,0.346376,0.0009461586,0.0004924714,0.017555224,0.002126371,0.0023253392,0.00021555534],"about_ca_topic_score_codex":0.00008923266,"about_ca_topic_score_gemma":0.00008404119,"teacher_disagreement_score":0.41593486,"about_ca_system_score_codex":0.000105572886,"about_ca_system_score_gemma":0.00029737974,"threshold_uncertainty_score":0.654303},"labels":[],"label_agreement":null},{"id":"W4391886200","doi":"10.1093/bjd/ljae057","title":"Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"UCB Pharma; University of Oxford; National Institute for Health and Care Research; Department of Health and Social Care; Insmed; Pfizer","keywords":"Hidradenitis suppurativa; Observational study; Medicine; Clinical trial; Physical therapy; Intervention (counseling); Dermatology; Internal medicine; Psychiatry","score_opus":0.4187291487448562,"score_gpt":0.4764521067916969,"score_spread":0.05772295804684069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391886200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95807016,0.021054074,0.0006255201,0.01803321,0.00070343335,0.0011179184,0.0002742329,0.000018114395,0.000103316685],"genre_scores_gemma":[0.99852306,0.00059947034,0.00052199373,0.000023218045,0.00024987964,0.0000056088256,0.000034752655,0.000026320355,0.000015721575],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9870988,0.008690825,0.002758129,0.00040537378,0.0007714843,0.00027536735],"domain_scores_gemma":[0.9947915,0.0035962344,0.00059583684,0.00058317377,0.00028270346,0.00015054521],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014464192,0.0002057249,0.0016009925,0.00014017597,0.00007984822,0.000100436584,0.00052805245,0.00016824272,0.00024737485],"category_scores_gemma":[0.009308777,0.00014726006,0.0003019821,0.00028703207,0.00025801075,0.00036855307,0.00016243421,0.0008287275,0.0000073548595],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005672142,0.0021707776,0.6050861,0.000065104374,0.0012991041,0.32579696,0.0010850577,1.6699875e-7,0.00033756194,0.000007955242,0.0039476445,0.059636354],"study_design_scores_gemma":[0.0114445,0.00078972743,0.25907427,0.0028661203,0.0017157278,0.71462554,0.006879806,0.000813627,0.0002764408,0.00069435796,0.0005936317,0.00022627169],"about_ca_topic_score_codex":0.0008958359,"about_ca_topic_score_gemma":0.0015777164,"teacher_disagreement_score":0.38882858,"about_ca_system_score_codex":0.00013126245,"about_ca_system_score_gemma":0.00074948114,"threshold_uncertainty_score":0.99903625},"labels":[],"label_agreement":null},{"id":"W4392344528","doi":"10.1093/bjd/ljae088","title":"Review of global epidemiology data for alopecia areata highlights gaps and a call for action","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Epidemiology; Call to action; Library science; Family medicine; Pathology; Computer science","score_opus":0.09303245027282371,"score_gpt":0.38536783926222123,"score_spread":0.29233538898939754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392344528","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009255099,0.45975843,0.0005660878,0.5348477,0.0008911547,0.000677309,0.0030861911,0.000010769417,0.00006980793],"genre_scores_gemma":[0.00030834787,0.36004207,0.0067967004,0.62643194,0.003844014,0.00004227589,0.00224418,0.00007162135,0.00021882102],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661404,0.00027207274,0.0019113931,0.0005477428,0.00019953646,0.0004552447],"domain_scores_gemma":[0.9961572,0.0011894037,0.0012605322,0.0005883617,0.00065849244,0.00014596593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067469943,0.00029884774,0.0026669416,0.00012716184,0.000048992108,0.000016089647,0.0005042375,0.0009772152,0.000034862536],"category_scores_gemma":[0.0026698853,0.00029575636,0.00038404844,0.00012211765,0.00025755083,0.00014558765,0.00018194065,0.0010598297,0.000004395231],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008810793,0.000032398722,0.00029932702,0.042881243,0.0006291073,0.006470549,0.0000043069085,7.0060504e-9,0.0000036622978,0.000081551065,0.9397053,0.009804422],"study_design_scores_gemma":[0.0011096266,0.00019152736,0.0002903604,0.02846831,0.0015581473,0.33363461,0.0000017288019,0.000008886291,0.000017130747,0.0014911221,0.6331039,0.00012461365],"about_ca_topic_score_codex":0.00005373934,"about_ca_topic_score_gemma":0.000058393034,"teacher_disagreement_score":0.32716405,"about_ca_system_score_codex":0.000118632684,"about_ca_system_score_gemma":0.00048600265,"threshold_uncertainty_score":0.99994946},"labels":[],"label_agreement":null},{"id":"W4392703525","doi":"10.1093/bjd/ljae098","title":"Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"European Academy of Dermatology and Venereology; Novartis Pharma; Regeneron Pharmaceuticals; Incyte; Amgen","keywords":"Hidradenitis suppurativa; Medicine; Secukinumab; Dermatology; Sunrise; Internal medicine; Psoriasis; Disease","score_opus":0.018167058827639727,"score_gpt":0.2935851276832833,"score_spread":0.27541806885564357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392703525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637646,0.003092933,0.0003352931,0.008842904,0.00007803705,0.00073448056,0.0004927361,0.000021133337,0.000026016694],"genre_scores_gemma":[0.99871105,0.00032829362,0.0004465387,0.000093667106,0.000060691083,0.000018025845,0.00030538096,0.000025025716,0.000011345485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970975,0.00095445296,0.0009657707,0.00039398577,0.00030668135,0.00028163253],"domain_scores_gemma":[0.9979131,0.0012261468,0.00024276691,0.00019717964,0.00013880059,0.00028199874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006508348,0.00027747414,0.0015744641,0.00037733396,0.00015242,0.00017967455,0.000114464994,0.00015993924,0.0002715193],"category_scores_gemma":[0.0003400842,0.0001734333,0.00017808941,0.0005310037,0.00013928705,0.00026747477,0.000027502922,0.00044152833,0.000002185993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041972898,0.003535102,0.48300102,0.00007659567,0.010874136,0.35898948,0.0023240345,0.000047282036,0.00009110092,0.000047431342,0.0005046578,0.098536275],"study_design_scores_gemma":[0.12369905,0.0075799883,0.57172287,0.0011714059,0.013536915,0.2782865,0.00044665,0.0020656995,0.00028293655,0.00019444681,0.00039875787,0.00061478256],"about_ca_topic_score_codex":0.00017756516,"about_ca_topic_score_gemma":0.0005826678,"teacher_disagreement_score":0.09792149,"about_ca_system_score_codex":0.000061577906,"about_ca_system_score_gemma":0.00015074624,"threshold_uncertainty_score":0.70724046},"labels":[],"label_agreement":null},{"id":"W4392866757","doi":"10.1093/bjd/ljae065","title":"A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Observational study; Confounding; Medicine; Term (time); Intensive care medicine; Risk analysis (engineering); Pathology","score_opus":0.054797153083419786,"score_gpt":0.3413586370917474,"score_spread":0.2865614840083276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392866757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97474056,0.01096376,0.0056053763,0.008307683,0.00015511914,0.00015599618,0.000010616129,0.000004799381,0.000056068166],"genre_scores_gemma":[0.99796164,0.0005109289,0.00047607895,0.00096536335,0.000027528253,0.0000045560555,0.0000023229193,0.000005137388,0.000046443918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867177,0.00023190184,0.0007052533,0.000097560376,0.00018612492,0.000107395004],"domain_scores_gemma":[0.9979071,0.0014935463,0.00019177461,0.00011357743,0.00023655551,0.000057454017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030046905,0.00007388482,0.0005122636,0.00014844644,0.00006529362,0.000014796193,0.00011914754,0.000054069846,0.00002799931],"category_scores_gemma":[0.000990142,0.000045815133,0.00016938672,0.00027392793,0.00027414743,0.00004613547,0.000050501338,0.00017536854,7.7147047e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011159565,0.00026292697,0.9354177,0.00050063076,0.008959332,0.009153794,0.0014641692,0.00017095344,0.0019080194,0.0024446475,0.014919897,0.023681974],"study_design_scores_gemma":[0.00045296078,0.00013510586,0.9646396,0.000553776,0.0022074333,0.02862147,0.00034605333,0.000645496,0.0020638497,0.0001600394,0.00012222496,0.0000520019],"about_ca_topic_score_codex":0.000004302657,"about_ca_topic_score_gemma":0.000016376662,"teacher_disagreement_score":0.029221887,"about_ca_system_score_codex":0.000018124107,"about_ca_system_score_gemma":0.00011940834,"threshold_uncertainty_score":0.1868287},"labels":[],"label_agreement":null},{"id":"W4393192973","doi":"10.1093/bjd/ljae132","title":"Psychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ottawa Hospital; University of Ottawa","funders":"Faculty of Medicine, Chiang Mai University; Health Systems Research Institute; National Research Council of Thailand","keywords":"Medicine; Hemodialysis; Dialysis; Quality of life (healthcare); Peritoneal dialysis; Itching; Kidney disease; Physical therapy; Dermatology Life Quality Index; Internal medicine; Surgery; Disease; Nursing","score_opus":0.012456072155962741,"score_gpt":0.2871093384831004,"score_spread":0.27465326632713766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393192973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97523934,0.023331989,0.00003105496,0.00030932258,0.0005100618,0.00047070117,0.000056195986,0.000007900117,0.000043410215],"genre_scores_gemma":[0.9991413,0.00053298863,0.00014699776,0.000028495304,0.000047186237,0.000017690443,0.000056245448,0.000021283495,0.000007820482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996326,0.000575531,0.0014821404,0.00028417545,0.0010552442,0.00027687487],"domain_scores_gemma":[0.9975849,0.00027927436,0.0007653397,0.00022136472,0.0010070725,0.00014208189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042447555,0.00020029001,0.0011828353,0.0009565988,0.000086978565,0.00002157333,0.0001700806,0.00021198166,0.00006464293],"category_scores_gemma":[0.00067534,0.00016082864,0.0003053232,0.0013320615,0.00046128413,0.00020863018,0.000066782166,0.00043291462,0.0000016058774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040389367,0.0011171297,0.9491586,0.00027988985,0.0005547821,0.00006779851,0.0004009649,0.000090017485,0.00008162573,0.0000025810577,0.001173333,0.04666936],"study_design_scores_gemma":[0.008205428,0.00016419614,0.98213035,0.0010187898,0.0025382128,0.002224585,0.000073036266,0.0021644793,0.0011510382,0.00005203662,0.00013349575,0.00014433867],"about_ca_topic_score_codex":0.00010263273,"about_ca_topic_score_gemma":0.0004258537,"teacher_disagreement_score":0.04652502,"about_ca_system_score_codex":0.00014341003,"about_ca_system_score_gemma":0.0005200414,"threshold_uncertainty_score":0.65584016},"labels":[],"label_agreement":null},{"id":"W4394641975","doi":"10.1093/bjd/ljae150","title":"Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; University of Alberta","funders":"Promedica Stiftung; Université de Lausanne; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Lymphomatoid papulosis; Medicine; Retrospective cohort study; Cutaneous lymphoma; Dermatology; Lymphoma; Cohort; Internal medicine; Oncology; Mycosis fungoides","score_opus":0.009270253234477352,"score_gpt":0.27515249364312666,"score_spread":0.26588224040864933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394641975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895058,0.0064453282,0.000012637904,0.0011395887,0.0005306933,0.0013823933,0.0002722785,0.0000360271,0.0006752065],"genre_scores_gemma":[0.99818397,0.0013124781,0.00006451132,0.000110609035,0.00010993679,0.000023074655,0.0000136462495,0.00006370044,0.00011810064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950901,0.0007559156,0.001699465,0.00047138095,0.0014600325,0.0005230579],"domain_scores_gemma":[0.99687725,0.00069409126,0.0007556931,0.00047346824,0.0009713147,0.00022816309],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005789763,0.00030691636,0.0013460078,0.0004817987,0.00014052477,0.000059410566,0.00048427383,0.0002228126,0.000057837602],"category_scores_gemma":[0.0019958897,0.0002586208,0.0005460542,0.0008581802,0.00044101028,0.000111944246,0.00016258431,0.00053281663,0.000012715712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030128572,0.00318567,0.93208987,0.00025148955,0.001073009,0.04738348,0.0016716429,0.000009465093,0.00055638497,0.000034691835,0.00551978,0.0052116383],"study_design_scores_gemma":[0.006666861,0.0013604636,0.5707608,0.00096966827,0.0005559965,0.41381085,0.0028475635,0.00020811404,0.0024139036,0.000102860424,0.00012980957,0.00017312565],"about_ca_topic_score_codex":0.0004710257,"about_ca_topic_score_gemma":0.0003915985,"teacher_disagreement_score":0.36642736,"about_ca_system_score_codex":0.000472221,"about_ca_system_score_gemma":0.0008124422,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4394748593","doi":"10.1093/bjd/ljae069","title":"Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Newcastle upon Tyne Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Psoriasis Association; American Institute of Mathematics","keywords":"Methotrexate; Psoriasis; Medicine; Cumulative dose; Fibrosis; Internal medicine; Dermatology; Liver fibrosis; Gastroenterology","score_opus":0.015903414195897782,"score_gpt":0.22267481643709014,"score_spread":0.20677140224119236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394748593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020624,0.008342407,0.00008625172,0.0001353096,0.00047448298,0.00021041889,0.00017347024,0.000020174202,0.00035123416],"genre_scores_gemma":[0.99827003,0.00023088994,0.0003935691,0.00015421008,0.000012497682,0.000010822873,0.00004356935,0.000027982182,0.0008564245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982,0.00050591835,0.0005890499,0.00026797605,0.0001052543,0.00033179225],"domain_scores_gemma":[0.9988197,0.0003270784,0.00035549552,0.00012128944,0.00032570865,0.000050746396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016331542,0.00022220485,0.00076231273,0.00038457045,0.000047803092,0.000016524758,0.00017796183,0.0002789987,0.00028250433],"category_scores_gemma":[0.00008379233,0.00019319437,0.00013672744,0.00028954333,0.00015147273,0.0002338669,0.000037579364,0.00033398368,0.000029592216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056181222,0.0063066455,0.4775055,0.0007126938,0.023703076,0.023485448,0.030521138,0.00057898497,0.009136838,0.00042046636,0.09112843,0.28031954],"study_design_scores_gemma":[0.03084509,0.0027916871,0.91524583,0.0036360417,0.0019173626,0.01284004,0.00026866986,0.000081208986,0.022759797,0.00012379949,0.008452141,0.0010383306],"about_ca_topic_score_codex":0.0001952272,"about_ca_topic_score_gemma":0.0002220346,"teacher_disagreement_score":0.43774033,"about_ca_system_score_codex":0.00028121198,"about_ca_system_score_gemma":0.0003360806,"threshold_uncertainty_score":0.7878238},"labels":[],"label_agreement":null},{"id":"W4395674289","doi":"10.1093/bjd/ljae164","title":"Expanding global health dermatology leadership: launching the GLODERM international mentorship programme","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; University of Toronto","funders":"","keywords":"Mentorship; Medicine; Global health; Dermatology; Political science; Medical education; Family medicine; Nursing; Public health","score_opus":0.06971886026226405,"score_gpt":0.34543845984069715,"score_spread":0.2757195995784331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395674289","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095760915,0.018961936,0.00029124634,0.9646925,0.009648781,0.00023543605,0.00004557567,0.00006373292,0.005103211],"genre_scores_gemma":[0.120990366,0.004041433,0.00024319065,0.86313945,0.009958504,0.000010895399,0.00010887916,0.000042099386,0.001465195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99480766,0.0013779723,0.0008621378,0.00030527372,0.0015992543,0.001047728],"domain_scores_gemma":[0.9981083,0.0003571676,0.0008142735,0.00014726473,0.00034684708,0.00022614136],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015180124,0.00024582297,0.0007478813,0.00019874606,0.0007289604,0.0007838699,0.0020250604,0.0007785199,0.00021694115],"category_scores_gemma":[0.0005957915,0.00023454371,0.00037459642,0.00032313552,0.0010115069,0.00031295058,0.00021700283,0.0031357459,0.000050777366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011888124,0.00002566295,0.0012163635,0.00014552784,0.00032275292,0.026214141,0.0038279442,3.4233034e-7,1.1356418e-7,0.0011485242,0.93846315,0.028623605],"study_design_scores_gemma":[0.00045046443,0.000030283814,0.000060730858,0.00088200724,0.00013246643,0.083853185,0.019112565,0.0000024557485,0.0000017384251,0.0033550973,0.8919412,0.00017779018],"about_ca_topic_score_codex":0.0014303443,"about_ca_topic_score_gemma":0.0023305407,"teacher_disagreement_score":0.12003276,"about_ca_system_score_codex":0.00076003984,"about_ca_system_score_gemma":0.0014746406,"threshold_uncertainty_score":0.99916404},"labels":[],"label_agreement":null},{"id":"W4396846587","doi":"10.1093/bjd/ljae173","title":"Impact of pruritus on patient fatigue: a cross-sectional study","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ethnic group; Medicine; Race (biology); Cross-sectional study; Physical therapy; Gerontology; Pathology","score_opus":0.025500199275782336,"score_gpt":0.3427987053360124,"score_spread":0.3172985060602301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396846587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961011,0.008311807,0.0000075768166,0.027203016,0.001800616,0.00052277034,0.00023988633,0.000030411096,0.00087290176],"genre_scores_gemma":[0.96598047,0.00018547343,0.000030058094,0.032571852,0.0008650972,0.00001565084,0.00009803726,0.00006108128,0.00019228135],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9963676,0.0003517674,0.0017984419,0.00033536745,0.00073434744,0.00041252913],"domain_scores_gemma":[0.9976598,0.00029897274,0.0009892333,0.0002712258,0.00061396806,0.0001668197],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00012683503,0.00033796218,0.001426533,0.0006368751,0.000077094366,0.00007446341,0.00025747108,0.0008910216,0.00046755563],"category_scores_gemma":[0.0003847517,0.00031182583,0.0010564997,0.00018934088,0.00031663486,0.00009339501,0.00006836589,0.0030506318,0.00005273228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031674033,0.0007108868,0.32279325,0.00024286425,0.0011990404,0.16404282,0.000057913105,0.000003693864,0.000001623966,8.260939e-7,0.5102004,0.0004299998],"study_design_scores_gemma":[0.002231178,0.0012029232,0.4968866,0.0008231465,0.00046298257,0.47841457,0.000025267536,0.0000036230253,0.000026813213,0.00016777575,0.019575052,0.000180057],"about_ca_topic_score_codex":0.000053690568,"about_ca_topic_score_gemma":0.0000042293827,"teacher_disagreement_score":0.49062532,"about_ca_system_score_codex":0.0001353558,"about_ca_system_score_gemma":0.00078095676,"threshold_uncertainty_score":0.99993336},"labels":[],"label_agreement":null},{"id":"W4399202770","doi":"10.1093/bjd/ljae225","title":"Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Debra International; Université de Fribourg; Ministry of Health, British Columbia","keywords":"Histone deacetylase; Cancer research; Fibrosis; Fibroblast; Acetylation; Biology; Histone; Pathology; Medicine; Gene; Cell culture; Biochemistry; Genetics","score_opus":0.007677624783542499,"score_gpt":0.2851203799187281,"score_spread":0.27744275513518557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399202770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93788683,0.05950985,0.00038965495,0.0017432661,0.00023927136,0.00013346534,0.000026194712,0.000010305368,0.00006117916],"genre_scores_gemma":[0.9941291,0.004898174,0.00041848107,0.000054979664,0.00019930332,0.0000213117,0.00015442845,0.000024630892,0.00009959893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982304,0.00041008246,0.0005262978,0.00031569073,0.00017813931,0.0003394024],"domain_scores_gemma":[0.99929523,0.000049900867,0.0001549188,0.00014088395,0.00014949571,0.00020959285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021363566,0.00014940993,0.00030391628,0.00021032256,0.00007940293,0.00006389266,0.00017828103,0.00024516083,0.000054362517],"category_scores_gemma":[0.00029238357,0.000153859,0.000203077,0.00019473015,0.00026584626,0.000017197754,0.000100097765,0.00039003018,0.000014752856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007797058,0.0004106934,0.008808173,0.00035704396,0.0002510561,0.19135022,0.00008039207,0.000045789573,0.7427143,0.0000944204,0.011851696,0.043256547],"study_design_scores_gemma":[0.002853976,0.0005732008,0.007029319,0.0028010202,0.00015378768,0.4188541,0.00017642546,0.00057906535,0.557885,0.0011561222,0.007343958,0.00059403],"about_ca_topic_score_codex":0.000012745346,"about_ca_topic_score_gemma":0.000021391901,"teacher_disagreement_score":0.22750387,"about_ca_system_score_codex":0.00004040925,"about_ca_system_score_gemma":0.00024508566,"threshold_uncertainty_score":0.6274188},"labels":[],"label_agreement":null},{"id":"W4399509792","doi":"10.1093/bjd/ljae243","title":"Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Immune privilege; Hair follicle; Immune system; Mitogen-activated protein kinase; Medicine; Immunology; Cancer research; Kinase; Biology; Internal medicine; Cell biology","score_opus":0.0172735129031925,"score_gpt":0.2651910212484439,"score_spread":0.2479175083452514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399509792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793783,0.01679818,0.00005544533,0.0020602546,0.000978984,0.00042515722,0.00011279712,0.00007944483,0.00011145685],"genre_scores_gemma":[0.9981089,0.0012023383,0.00019351354,0.00008700124,0.00018072677,0.000022494034,0.000023501048,0.000058811573,0.00012266186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699837,0.00055518,0.001245256,0.00029651306,0.000426811,0.00047787602],"domain_scores_gemma":[0.9979901,0.0006213148,0.00047447646,0.00020926808,0.0003160048,0.00038886885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003128165,0.00031732983,0.0010522249,0.00050334964,0.00013586748,0.00006696121,0.00019373084,0.0002969076,0.00023825969],"category_scores_gemma":[0.0009814084,0.00029937862,0.00047409002,0.00042590732,0.00031788502,0.00041255582,0.00008240444,0.00044337517,0.000021592876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013939881,0.0015472589,0.09031395,0.0013523247,0.0016927563,0.037514333,0.0036564337,0.0000017425532,0.80310905,0.00009503146,0.006724312,0.04005295],"study_design_scores_gemma":[0.007317389,0.0012496671,0.11339321,0.002315819,0.00024477055,0.050512366,0.0009903031,0.000019647947,0.8132447,0.00009173752,0.010257839,0.00036255288],"about_ca_topic_score_codex":0.000161281,"about_ca_topic_score_gemma":0.00006354016,"teacher_disagreement_score":0.039690398,"about_ca_system_score_codex":0.00023917088,"about_ca_system_score_gemma":0.0010486781,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4399963617","doi":"10.1093/bjd/ljae262","title":"Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"British Skin Foundation","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Pathology; Disease","score_opus":0.034768231747152205,"score_gpt":0.3544695209095369,"score_spread":0.31970128916238466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399963617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035260706,0.99474835,0.000022540658,0.0029221645,0.0008981344,0.00060223904,0.000047286463,0.000034520966,0.00068951474],"genre_scores_gemma":[0.026534472,0.9722506,0.0001770642,0.000011491237,0.00031453016,0.000042320014,0.00010750885,0.00012492933,0.00043708802],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9960069,0.00049374154,0.0021312756,0.0003747059,0.00041306918,0.0005803205],"domain_scores_gemma":[0.9984364,0.00021824826,0.0007231358,0.00021892134,0.00014569328,0.00025763846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000016238935,0.00055383734,0.0038220535,0.0010969683,0.00007135932,0.00011297959,0.00029131788,0.0005924884,0.0004000104],"category_scores_gemma":[0.00013266296,0.0004844102,0.0010399341,0.0006309559,0.00014933643,0.0002785397,0.000077031225,0.001885446,0.00022633694],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010792769,0.0001027306,0.00006765775,0.004551247,0.0006185064,0.5291151,0.00013810972,4.649336e-9,4.8707415e-7,0.000035607543,0.001112925,0.46424684],"study_design_scores_gemma":[0.0008204886,0.00008402243,0.000009917121,0.028238565,0.0018034816,0.5942752,0.00007343919,0.0000011964946,0.0000032693488,0.00016427935,0.37432787,0.00019827837],"about_ca_topic_score_codex":0.000019762841,"about_ca_topic_score_gemma":0.000056270208,"teacher_disagreement_score":0.46404856,"about_ca_system_score_codex":0.0002876248,"about_ca_system_score_gemma":0.0009958373,"threshold_uncertainty_score":0.99976075},"labels":[],"label_agreement":null},{"id":"W4400030395","doi":"10.1093/bjd/ljae267","title":"Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Arthritis Patient Alliance","funders":"Jikei University School of Medicine; Clalit Health Services; University of Leeds; Cardiff University; Yale University","keywords":"Patient-reported outcome; Intraclass correlation; Construct validity; Criterion validity; Physical therapy; Medicine; Interpretability; Ceiling effect; Reliability (semiconductor); Convergent validity; Content validity; Quality of life (healthcare); Psychology; Clinical psychology; Psychometrics; Internal consistency; Pathology; Alternative medicine; Nursing; Computer science","score_opus":0.035422669925068366,"score_gpt":0.23313437663996328,"score_spread":0.1977117067148949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400030395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84788674,0.15115474,0.00003285102,0.0001661823,0.00050532544,0.00015309862,0.000050026563,0.000012129279,0.00003890025],"genre_scores_gemma":[0.99944663,0.00049707195,0.000011809443,0.000013789742,0.0000091411075,0.0000058868654,0.000002334845,0.000008924059,0.000004393223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809825,0.00060162664,0.0008285163,0.0001581279,0.00011585375,0.00019762498],"domain_scores_gemma":[0.998963,0.00007640895,0.00040538068,0.00015702349,0.00036184106,0.000036333444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019181074,0.00015171892,0.00059496914,0.00008650727,0.00007342243,0.000016699862,0.00018550275,0.00017374502,0.000051775387],"category_scores_gemma":[0.0004189777,0.00009454056,0.00042046965,0.00012286226,0.00047079774,0.000107639586,0.00008305841,0.00021901079,0.0000018386412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011638217,0.0008690708,0.74018824,0.0005065392,0.004726626,0.0011321924,0.00095393707,0.0000060374414,0.12550282,0.000061107494,0.002099128,0.122790456],"study_design_scores_gemma":[0.002097942,0.00042965604,0.7008688,0.0022363556,0.0012498063,0.13175127,0.00028807373,0.000009050659,0.16017818,0.00031737535,0.00035318732,0.000220318],"about_ca_topic_score_codex":0.000062233004,"about_ca_topic_score_gemma":0.000022702117,"teacher_disagreement_score":0.1515599,"about_ca_system_score_codex":0.000048609036,"about_ca_system_score_gemma":0.00033092027,"threshold_uncertainty_score":0.38552523},"labels":[],"label_agreement":null},{"id":"W4400125399","doi":"10.1093/bjd/ljae090.150","title":"BH03 Do patients with afro-textured hair who are experiencing hair loss feel understood by their dermatologists? A cross-sectional study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Medicine; Hair loss; Dermatology; Family medicine","score_opus":0.012024287407721377,"score_gpt":0.2646408259889136,"score_spread":0.2526165385811922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619734,0.03153293,0.0017831074,0.001268765,0.0014882289,0.00057646236,0.000059034195,0.00012718163,0.001190876],"genre_scores_gemma":[0.9962767,0.00037837538,0.00013791709,0.0026680476,0.00021777427,0.000037822814,0.000033720124,0.00006838409,0.00018131181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637246,0.00028920345,0.0013697802,0.0005711024,0.0007498566,0.000647579],"domain_scores_gemma":[0.99773645,0.00029400317,0.00059936027,0.00030834394,0.00070056674,0.00036126512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025248266,0.0004311503,0.00148706,0.00033654986,0.00046244363,0.00013795354,0.0003062455,0.00035937148,0.0000842146],"category_scores_gemma":[0.00022105889,0.00036060263,0.00028481748,0.000389329,0.0009524622,0.00039872687,0.00010690262,0.0012246899,0.00002111662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049241394,0.0008134712,0.8252532,0.00024567946,0.0008913382,0.031643342,0.001957516,0.0000029901864,0.000009365069,0.00002009867,0.13788107,0.00078949623],"study_design_scores_gemma":[0.013870663,0.0011463737,0.6369877,0.0015573709,0.00039684013,0.30948558,0.0116832,0.000059158043,0.00017716357,0.00011413211,0.023921086,0.00060074095],"about_ca_topic_score_codex":0.000030371548,"about_ca_topic_score_gemma":0.00006507918,"teacher_disagreement_score":0.27784225,"about_ca_system_score_codex":0.00028408045,"about_ca_system_score_gemma":0.00040414187,"threshold_uncertainty_score":0.9998846},"labels":[],"label_agreement":null},{"id":"W4400125475","doi":"10.1093/bjd/ljae090.089","title":"P062 A multicentre retrospective observational study reviewing the management of severely dysplastic naevi","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Histopathology; Medical diagnosis; Retrospective cohort study; Multidisciplinary team; Margin (machine learning); Dermatology; Surgery; General surgery; Radiology; Pathology; Nursing","score_opus":0.03699043018520979,"score_gpt":0.29972084157905854,"score_spread":0.26273041139384873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97825885,0.012642891,0.0015311338,0.0031914348,0.0013874948,0.00097350066,0.0000066679695,0.000037117246,0.0019708886],"genre_scores_gemma":[0.99702984,0.0016507724,0.0005002186,0.00019650185,0.00008744224,0.000008595736,0.0000016097724,0.000013846431,0.0005111562],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9986141,0.000112087684,0.0006292182,0.00014115816,0.0003563698,0.00014708532],"domain_scores_gemma":[0.99931425,0.000102330894,0.00020728711,0.000116341005,0.00020206855,0.0000577083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025877022,0.00009519254,0.00037833885,0.000109914945,0.00007156319,0.00004116117,0.00011717925,0.00003624457,0.00016761433],"category_scores_gemma":[0.00007969951,0.000078054014,0.00015129827,0.00025759533,0.000049260925,0.00007520744,0.00006112562,0.00030520913,0.000017870623],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021565112,0.004534322,0.13431787,0.010109565,0.019756725,0.46135288,0.0064202794,0.00021573498,0.0005981019,0.006831063,0.0666381,0.28706884],"study_design_scores_gemma":[0.0038545234,0.00069234974,0.56102324,0.0056966245,0.002753691,0.37590036,0.0054157344,0.0013641166,0.0001764966,0.00033442324,0.04256717,0.00022126078],"about_ca_topic_score_codex":0.000014413035,"about_ca_topic_score_gemma":0.000020103926,"teacher_disagreement_score":0.42670536,"about_ca_system_score_codex":0.000094936884,"about_ca_system_score_gemma":0.00005008607,"threshold_uncertainty_score":0.31829503},"labels":[],"label_agreement":null},{"id":"W4400125530","doi":"10.1093/bjd/ljae090.151","title":"BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Alopecia areata; Medicine; Hair loss; Dermatology; Subspecialty; Disease; Alopecia universalis; Thyroid disease; Family medicine; Pediatrics; Internal medicine; Thyroid","score_opus":0.03234239558445554,"score_gpt":0.3361293212804224,"score_spread":0.3037869256959668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696435,0.017224558,0.001109427,0.003968223,0.00069097074,0.00022328443,0.0002943789,0.000029488918,0.006816224],"genre_scores_gemma":[0.9966612,0.00021526832,0.0018670826,0.0010870968,0.00011570408,0.0000022168904,0.000018025032,0.000016953785,0.000016474916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981212,0.00036753048,0.00074876536,0.0001776865,0.00030310827,0.00028170878],"domain_scores_gemma":[0.9981669,0.0006686968,0.0001852891,0.00010724768,0.0006333057,0.000238525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006329591,0.000116322,0.000544614,0.00015990956,0.00002610581,0.0000571986,0.00015445815,0.00012815514,0.000038806254],"category_scores_gemma":[0.007901846,0.00013340324,0.00006218932,0.0009839978,0.000074656265,0.0002895099,0.000043852644,0.00036039445,0.00001498963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054594124,0.000559178,0.7067881,0.00037973878,0.00018115243,0.056318007,0.00020412212,0.000009217381,0.0008061341,0.00017090049,0.2047686,0.029268885],"study_design_scores_gemma":[0.0037779792,0.00041895683,0.6811805,0.0027332348,0.00017389141,0.2175035,0.000912865,0.00008367922,0.0009385894,0.0001844196,0.09175481,0.0003375748],"about_ca_topic_score_codex":0.00090901897,"about_ca_topic_score_gemma":0.0017331508,"teacher_disagreement_score":0.16118549,"about_ca_system_score_codex":0.00010243735,"about_ca_system_score_gemma":0.0008134439,"threshold_uncertainty_score":0.9459819},"labels":[],"label_agreement":null},{"id":"W4400125623","doi":"10.1093/bjd/ljae090.057","title":"P030 Implementing the Edmonton Obesity Staging System: a cross-sectional study of the prevalence and management of obesity in a systemic therapies clinic","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Overweight; Obesity; Body mass index; Psoriasis; Cross-sectional study; Population; Hidradenitis suppurativa; Incidence (geometry); Internal medicine; Dermatology; Environmental health; Pathology; Disease","score_opus":0.018026244068118973,"score_gpt":0.2790227932212983,"score_spread":0.2609965491531793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521057,0.046649672,0.000014881569,0.0000314719,0.000677466,0.00042161372,0.000028753917,0.000009100192,0.00006134218],"genre_scores_gemma":[0.99755645,0.0022821561,0.000010469555,0.0000048341544,0.00001654411,0.00001537039,0.0000011741654,0.0000074346062,0.00010556279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780345,0.0008135819,0.00091478915,0.00017403,0.00008554192,0.00020861615],"domain_scores_gemma":[0.9990221,0.0002559118,0.00047240272,0.00014841449,0.0000906909,0.000010459016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009622531,0.00011300584,0.00038746142,0.000098440534,0.00019559277,0.00003514408,0.0002945149,0.00009506234,0.000026356245],"category_scores_gemma":[0.00001690327,0.00007945996,0.00012904,0.00016207348,0.00015854792,0.00011367588,0.00015215384,0.00023603582,0.0000022932488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008682973,0.00025085386,0.9928436,0.0014507961,0.0008964984,0.00035186636,0.0014054081,0.0000020763166,0.0008889858,0.00016929762,0.000032939133,0.0016208461],"study_design_scores_gemma":[0.0016585236,0.00008993559,0.9753069,0.0013370061,0.0002805397,0.016763361,0.00377989,0.000003439248,0.00064114266,0.000034191715,0.000042647112,0.00006241264],"about_ca_topic_score_codex":0.00022745828,"about_ca_topic_score_gemma":0.00021166027,"teacher_disagreement_score":0.045450754,"about_ca_system_score_codex":0.000047199326,"about_ca_system_score_gemma":0.000055842058,"threshold_uncertainty_score":0.3240283},"labels":[],"label_agreement":null},{"id":"W4400125754","doi":"10.1093/bjd/ljae090.072","title":"P045 An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Delphi method; Facilitator; Medicine; Psoriasis; Disease; Likert scale; Delphi; Family medicine; Intensive care medicine; Psychology; Pathology; Dermatology; Computer science; Artificial intelligence","score_opus":0.0435485983189179,"score_gpt":0.30582179960449596,"score_spread":0.2622732012855781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98287255,0.00423258,0.0070168907,0.0022716764,0.0024792838,0.00029337776,0.0006372086,0.000034915975,0.00016152672],"genre_scores_gemma":[0.9931054,0.00089673226,0.005347381,0.00012430608,0.00012139655,0.000040182018,0.00030827717,0.00001992633,0.000036374688],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9983569,0.0002396637,0.00091217895,0.00023033378,0.000058966412,0.00020197376],"domain_scores_gemma":[0.99867547,0.0004250523,0.00031834657,0.00013263934,0.00036820726,0.00008030513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003001954,0.00012892213,0.00038652026,0.00024206887,0.00007436179,0.00003381497,0.00023602803,0.00020286391,0.00007263527],"category_scores_gemma":[0.00042356816,0.00013649875,0.00023206252,0.000109301065,0.000100516234,0.00012335887,0.000027713968,0.00015692503,0.000039571052],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025718303,0.0044044782,0.013858626,0.00062757195,0.005855737,0.0039131427,0.001887603,0.00016938329,0.081432074,0.05454333,0.021544604,0.78604513],"study_design_scores_gemma":[0.07413397,0.009533729,0.21813196,0.0064132116,0.010335701,0.28482142,0.0027603763,0.0014213161,0.112050086,0.14275262,0.13369831,0.003947303],"about_ca_topic_score_codex":0.00002222096,"about_ca_topic_score_gemma":0.000023749868,"teacher_disagreement_score":0.7820978,"about_ca_system_score_codex":0.00003346185,"about_ca_system_score_gemma":0.0002339109,"threshold_uncertainty_score":0.5566258},"labels":[],"label_agreement":null},{"id":"W4400125898","doi":"10.1093/bjd/ljae090.149","title":"BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changi General Hospital; NYU Grossman School of Medicine; Uniwersytet Warszawski; Victoria University; Università di Bologna; Universidade de São Paulo; University of Pennsylvania; Inyuvesi Yakwazulu-Natali; York University; Warszawski Uniwersytet Medyczny; University of Minnesota; Yale University","keywords":"Alopecia areata; Dupilumab; Dermatology; Medicine; Clinical Practice; Family medicine; Atopic dermatitis","score_opus":0.03473036972189514,"score_gpt":0.4212446598299633,"score_spread":0.38651429010806815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400125898","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13239862,0.42229384,0.0013256884,0.4383635,0.00085664797,0.0026448655,0.00028015772,0.00005922802,0.0017774644],"genre_scores_gemma":[0.50953233,0.37403312,0.041402604,0.06942325,0.001033076,0.00043070482,0.00007960725,0.00012711425,0.0039381837],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980244,0.00022741043,0.0010612383,0.0002649315,0.00013728967,0.0002847477],"domain_scores_gemma":[0.9981899,0.00082451344,0.00008705761,0.00014738778,0.0003372397,0.00041385097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003200389,0.00016579221,0.00081815664,0.00014801996,0.00006826854,0.00010798918,0.0000634701,0.00015840656,0.000081223465],"category_scores_gemma":[0.006844391,0.00011575614,0.0002048958,0.00026501215,0.000081254904,0.0003091249,0.00003315777,0.00033790217,0.000004885805],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017443764,0.00042147012,0.0011088771,0.0026040527,0.00024148953,0.714237,0.0009715454,5.4377818e-8,0.0000042453134,0.00023596537,0.11296851,0.16546246],"study_design_scores_gemma":[0.002531475,0.00116065,0.00037210665,0.006089483,0.00045530967,0.6597082,0.0005099225,0.000010026185,0.000007643901,0.00004460347,0.32902065,0.00008993807],"about_ca_topic_score_codex":0.00002672311,"about_ca_topic_score_gemma":0.00066879747,"teacher_disagreement_score":0.37713373,"about_ca_system_score_codex":0.000049163962,"about_ca_system_score_gemma":0.0004169844,"threshold_uncertainty_score":0.81938696},"labels":[],"label_agreement":null},{"id":"W4400126202","doi":"10.1093/bjd/ljae090.360","title":"H12 A history of evidence-based medicine and dermatology as an early adopter","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Early adopter; Dermatology; Medicine; Business; Marketing","score_opus":0.086125059983983,"score_gpt":0.32258545766525754,"score_spread":0.23646039768127453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5703221,0.3960215,0.0006438628,0.024992635,0.0021742948,0.00022284739,0.0000027832698,0.000059974867,0.0055600475],"genre_scores_gemma":[0.97903687,0.0076173046,0.0006832674,0.011859117,0.00026968354,0.000007692593,0.0000045059924,0.000038050526,0.00048351733],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9973925,0.00032458786,0.0012312033,0.00030175838,0.00040349594,0.00034648052],"domain_scores_gemma":[0.997816,0.0006992194,0.00040041076,0.00023689355,0.00047657703,0.00037087165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032574372,0.00022887556,0.00138914,0.00068849017,0.00005681067,0.0000077019995,0.00017754873,0.0002955823,0.00021178005],"category_scores_gemma":[0.00070064573,0.00019133819,0.00017320742,0.00017513173,0.001661982,0.00033387056,0.00004316578,0.0007106601,0.000017568314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014681951,0.00037456633,0.038090356,0.0032813323,0.0009167045,0.21350744,0.0036214583,5.974637e-7,0.0025256432,0.0013066374,0.7021193,0.032787807],"study_design_scores_gemma":[0.0042732214,0.0016746458,0.009424863,0.0070228223,0.0010636451,0.7140667,0.0006739209,0.00018713334,0.000488621,0.00037321993,0.26049355,0.00025770118],"about_ca_topic_score_codex":0.00013687655,"about_ca_topic_score_gemma":0.000021685853,"teacher_disagreement_score":0.5005592,"about_ca_system_score_codex":0.0001704418,"about_ca_system_score_gemma":0.0010163811,"threshold_uncertainty_score":0.7802544},"labels":[],"label_agreement":null},{"id":"W4400126522","doi":"10.1093/bjd/ljae090.282","title":"PA27 Expanding the phenotype of congenital erosive and vesicular dermatosis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Neonatal skin health care","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Phenotype; Biology; Dermatology; Medicine; Genetics; Gene","score_opus":0.023230449203279078,"score_gpt":0.3603552881156795,"score_spread":0.3371248389124004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9213837,0.072241716,0.0002795958,0.0036544336,0.0015925899,0.00030461513,0.000044237368,0.000022388624,0.00047673858],"genre_scores_gemma":[0.9964202,0.0024130961,0.00020847836,0.00068448373,0.0002010031,0.0000140160555,0.000003004207,0.00002447267,0.00003125547],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9978271,0.00057219027,0.0008896514,0.00013152568,0.00022529399,0.0003542496],"domain_scores_gemma":[0.9978081,0.0012935414,0.00035138405,0.000108381966,0.0003011602,0.0001374381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033808246,0.00010758444,0.0004165746,0.00011151955,0.00036304208,0.000024662671,0.00019585063,0.00018235193,0.0001345225],"category_scores_gemma":[0.0003138177,0.00009062378,0.00009984586,0.00018033438,0.00019638849,0.0001958709,0.00011308974,0.0009028382,0.000023976678],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008086106,0.00030859464,0.24965937,0.015594617,0.002484644,0.0650902,0.051000237,0.00001719984,0.014878017,0.013553035,0.24387845,0.34272704],"study_design_scores_gemma":[0.008702844,0.0005714623,0.2522878,0.019368257,0.001266878,0.5137333,0.047487095,0.000587934,0.010899411,0.0155549515,0.12825929,0.0012807664],"about_ca_topic_score_codex":0.00014728603,"about_ca_topic_score_gemma":0.00009179805,"teacher_disagreement_score":0.44864312,"about_ca_system_score_codex":0.00005794333,"about_ca_system_score_gemma":0.00032577929,"threshold_uncertainty_score":0.39224327},"labels":[],"label_agreement":null},{"id":"W4400126687","doi":"10.1093/bjd/ljae090.229","title":"DP07 Diagnostic implication of skin biopsy for a rare neurodegenerative disorder","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Skin biopsy; Medicine; Dermatology; Biopsy; Pathology","score_opus":0.01592835470188757,"score_gpt":0.28068188734154764,"score_spread":0.26475353263966006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400126687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97907436,0.004752841,0.013465553,0.0014298212,0.0006462943,0.0003322923,0.00022314541,0.00002171696,0.00005399376],"genre_scores_gemma":[0.99817044,0.00071261975,0.0006385482,0.00025267026,0.000108092085,0.000044126107,0.000005975502,0.000031934003,0.000035621604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998307,0.000285486,0.0006587041,0.00030814146,0.00020093369,0.00023976098],"domain_scores_gemma":[0.9978724,0.0013673083,0.00028188495,0.00013602032,0.00023914762,0.00010321336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073638876,0.00013894055,0.00034059238,0.00018042017,0.00009460171,0.000086787695,0.0002926055,0.00006202595,0.000037993483],"category_scores_gemma":[0.0026740844,0.00014873684,0.00020677486,0.00028912825,0.00018540716,0.00018206336,0.000047885518,0.00016694429,0.000007889645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001263471,0.0005400482,0.0029004696,0.000422294,0.00006537103,0.0035232254,0.00043417074,0.00039831575,0.9230134,0.0068792608,0.014607973,0.04708916],"study_design_scores_gemma":[0.0006972406,0.00016477791,0.006977489,0.00015644889,0.000076040844,0.04292443,0.00005385145,0.0006004857,0.94365686,0.0021218986,0.0024096735,0.00016079636],"about_ca_topic_score_codex":0.000007225007,"about_ca_topic_score_gemma":0.000009305389,"teacher_disagreement_score":0.046928365,"about_ca_system_score_codex":0.000014500851,"about_ca_system_score_gemma":0.00017246362,"threshold_uncertainty_score":0.6065312},"labels":[],"label_agreement":null},{"id":"W4400639687","doi":"10.1093/bjd/ljae289","title":"Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"LEO Pharma; Galderma; ZonMw; Sanofi; Novartis; Pfizer","keywords":"Dupilumab; Eosinophilia; Medicine; Atopic dermatitis; Hypereosinophilia; Eosinophil; Cohort; Incidence (geometry); Dermatology; Eczema Area and Severity Index; SCORAD; Single Center; Internal medicine; Immunology; Dermatology Life Quality Index; Asthma","score_opus":0.007402441772108903,"score_gpt":0.22091670103209543,"score_spread":0.21351425925998652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400639687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99127394,0.006308051,0.000002061697,0.0011618352,0.00023861935,0.0007262547,0.000022840388,0.000012838374,0.0002535879],"genre_scores_gemma":[0.9994926,0.00019075368,0.000008732621,0.00011168873,0.000026101734,0.000012467786,0.000010955172,0.000019229115,0.00012747927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980123,0.000418273,0.0008036468,0.00017593444,0.00034946657,0.00024037331],"domain_scores_gemma":[0.99877256,0.00021386378,0.00043498294,0.0002811591,0.00022251239,0.000074944866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079068544,0.00017603964,0.0007879386,0.00011392622,0.000079057325,0.000023371244,0.00020611552,0.00014586932,0.000040656178],"category_scores_gemma":[0.00011768876,0.00010914504,0.00017708023,0.00029923886,0.0002555203,0.000086000866,0.000033287968,0.0002542447,0.0000019792476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010454943,0.003266286,0.9865523,0.0001311609,0.0006415105,0.003144634,0.00096420007,0.0000043413174,0.0000031345303,0.000007850861,0.0027506151,0.0024294232],"study_design_scores_gemma":[0.006597598,0.0005085473,0.9808278,0.0011266513,0.0007231138,0.008883666,0.00066379807,0.000017817289,0.00014821645,0.000058591606,0.00035729774,0.00008690632],"about_ca_topic_score_codex":0.00013107125,"about_ca_topic_score_gemma":0.0005565334,"teacher_disagreement_score":0.0082186805,"about_ca_system_score_codex":0.00011714101,"about_ca_system_score_gemma":0.00021175788,"threshold_uncertainty_score":0.44508055},"labels":[],"label_agreement":null},{"id":"W4401322385","doi":"10.1093/bjd/ljae316","title":"Addressing the unmet care needs of people with hidradenitis suppurativa","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; University of Calgary","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Quality of life (healthcare); Perspective (graphical); Health professionals; Health care; MEDLINE; Family medicine; Nursing; Disease; Pathology","score_opus":0.025502725536028482,"score_gpt":0.2946934402149817,"score_spread":0.26919071467895317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401322385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93036413,0.03788247,0.0005136722,0.027744636,0.0004459296,0.00030282055,0.00006307479,0.00003543216,0.002647814],"genre_scores_gemma":[0.99873286,0.0005096546,0.0004229904,0.000015341506,0.00012208153,0.000005774091,0.000020006748,0.000029839623,0.00014145655],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99871784,0.00014766614,0.000495714,0.000097171025,0.00031074585,0.00023085951],"domain_scores_gemma":[0.99910295,0.00019796625,0.00017946876,0.00012867992,0.00027619294,0.000114741306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000063564094,0.00014106256,0.0005442852,0.00022244862,0.000113122,0.000080372476,0.00013262403,0.00009758747,0.00022072904],"category_scores_gemma":[0.000058448953,0.00009704647,0.00016585474,0.00042446758,0.00020820156,0.000242511,0.000025806614,0.0004224378,0.000010390057],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003098498,0.00021196812,0.06018161,0.0007466768,0.0010765799,0.8631946,0.018665325,7.2968504e-7,0.0009986563,0.00048526865,0.006098265,0.048030496],"study_design_scores_gemma":[0.0014753707,0.00033114327,0.0053684367,0.0017878799,0.00041799093,0.97523904,0.009016406,0.000014038149,0.004654357,0.00006831077,0.0015362491,0.00009080237],"about_ca_topic_score_codex":0.00007551566,"about_ca_topic_score_gemma":0.00009928344,"teacher_disagreement_score":0.11204444,"about_ca_system_score_codex":0.000049644445,"about_ca_system_score_gemma":0.00035237824,"threshold_uncertainty_score":0.395744},"labels":[],"label_agreement":null},{"id":"W4401435844","doi":"10.1093/bjd/ljae266.035","title":"656 - Systemic exposure and safety profile of delgocitinib cream in adults with moderate to severe chronic hand eczema in the phase 3 DELTA-2 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Cmax; Pharmacokinetics; Randomized controlled trial; Janus kinase inhibitor; Oral administration; Double blind; Internal medicine; Gastroenterology; Placebo; Pathology","score_opus":0.007961776991061527,"score_gpt":0.2664089137337084,"score_spread":0.25844713674264685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98224425,0.015445514,0.00014421383,0.00095348473,0.000114784496,0.00083103613,0.000054817254,0.0000058893093,0.00020598651],"genre_scores_gemma":[0.9988962,0.00063442945,0.00012942986,0.00014553519,0.000101341284,0.000030142064,0.000020432228,0.000015838576,0.00002664686],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9985285,0.00017960422,0.0006894222,0.00017519122,0.0001993087,0.00022798912],"domain_scores_gemma":[0.99937,0.00017411575,0.00016075403,0.000102442944,0.00010136328,0.00009134155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002107636,0.00013801534,0.0006558829,0.00019223701,0.00003747515,0.00005020639,0.000086019834,0.00011822187,0.000025669264],"category_scores_gemma":[0.00006426016,0.00009645734,0.000069108624,0.00019558733,0.00006871868,0.00013933764,0.000014903227,0.00034832428,0.0000019223153],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30847663,0.005749452,0.018840933,0.004312057,0.0017969968,0.3008684,0.013734023,0.00018843162,0.000819159,0.00021187079,0.0042509106,0.34075117],"study_design_scores_gemma":[0.27037317,0.008276044,0.009238607,0.017055478,0.000500293,0.6899311,0.0012754772,0.0005639384,0.0017042997,0.00011954023,0.0007050495,0.00025700426],"about_ca_topic_score_codex":0.0001103302,"about_ca_topic_score_gemma":0.0007676778,"teacher_disagreement_score":0.3890627,"about_ca_system_score_codex":0.000068773305,"about_ca_system_score_gemma":0.00031258666,"threshold_uncertainty_score":0.39334163},"labels":[],"label_agreement":null},{"id":"W4401435845","doi":"10.1093/bjd/ljae266.024","title":"644 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an interim analysis of week 20-32 data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Toronto; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Adverse effect; Body surface area; Dermatology Life Quality Index; Incidence (geometry); Interim analysis; Internal medicine; Clinical endpoint; Retrospective cohort study; Dermatology; Clinical trial; Disease","score_opus":0.016441301462157786,"score_gpt":0.30373617075410314,"score_spread":0.28729486929194537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96098703,0.03749936,0.00013118556,0.00031702133,0.000066970104,0.00033903192,0.0005811335,0.000008012199,0.000070255905],"genre_scores_gemma":[0.9811222,0.0180394,0.00023276055,0.00028588396,0.00001327152,0.0000044019544,0.00028595468,0.000013780403,0.0000023342568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796575,0.0004621642,0.00090237753,0.0002963909,0.00020882736,0.00016447263],"domain_scores_gemma":[0.99865776,0.00023968148,0.0003773955,0.0002624269,0.0003265568,0.00013619055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001775245,0.00015276013,0.0013215948,0.00039434028,0.000026114914,0.000017186354,0.0001588722,0.000084008396,0.000062614374],"category_scores_gemma":[0.00022302914,0.00013875756,0.00009252127,0.00043098204,0.000289473,0.00033389675,0.00010244619,0.00030922337,5.263729e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055264856,0.000566497,0.98470044,0.003052481,0.0014282656,0.0027145818,0.00013496401,5.0722775e-7,0.000011824391,0.000016718022,0.0009446703,0.0058763907],"study_design_scores_gemma":[0.0034985072,0.00014516416,0.96866226,0.021557191,0.0025927157,0.0027276292,0.000083279585,0.00037777904,0.000092919625,0.000040338986,0.0001154346,0.00010675774],"about_ca_topic_score_codex":0.00031441156,"about_ca_topic_score_gemma":0.0016568059,"teacher_disagreement_score":0.020135185,"about_ca_system_score_codex":0.00003882096,"about_ca_system_score_gemma":0.00008716828,"threshold_uncertainty_score":0.56583697},"labels":[],"label_agreement":null},{"id":"W4401435846","doi":"10.1093/bjd/ljae266.014","title":"630 - Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Internal medicine; Placebo; Randomized controlled trial; Psoriasis Area and Severity Index; SCORAD; Confidence interval; Clinical endpoint; Clinical trial; Dermatology Life Quality Index; Dermatology; Disease; Psoriasis","score_opus":0.0637753858043968,"score_gpt":0.3434577313322313,"score_spread":0.2796823455278345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6110065,0.34513414,0.03863609,0.0035908981,0.00053974614,0.00076114753,0.000104338505,0.000085880245,0.00014126553],"genre_scores_gemma":[0.9955817,0.00044991993,0.0029833775,0.00067752175,0.00012215826,0.00004470351,0.0000359304,0.000038181286,0.000066510096],"study_design_codex":"meta_analysis","study_design_gemma":"case_report","domain_scores_codex":[0.99700546,0.00033432592,0.0016461585,0.00028582063,0.00030235262,0.000425908],"domain_scores_gemma":[0.99788046,0.0007243363,0.0005125548,0.00022609008,0.0004252397,0.00023131554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025729396,0.0002510909,0.0030111377,0.0005469298,0.0001672573,0.000084052466,0.000251664,0.0002399841,0.00018006348],"category_scores_gemma":[0.00024202449,0.00024158982,0.001705947,0.0006993505,0.00012198933,0.0001950674,0.000054840824,0.0003657637,0.000010295251],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021346412,0.0013654551,0.07472012,0.005531682,0.554994,0.018654753,0.0039502396,0.025019921,0.00033805688,0.0016607892,0.29977638,0.011853964],"study_design_scores_gemma":[0.0107772555,0.0005375613,0.042121533,0.0027811565,0.43372726,0.45137548,0.0016026823,0.03613695,0.0047561754,0.0039564027,0.011004297,0.0012232361],"about_ca_topic_score_codex":0.000021606444,"about_ca_topic_score_gemma":0.000038479364,"teacher_disagreement_score":0.43272072,"about_ca_system_score_codex":0.00005199682,"about_ca_system_score_gemma":0.00024398537,"threshold_uncertainty_score":0.98517466},"labels":[],"label_agreement":null},{"id":"W4401435862","doi":"10.1093/bjd/ljae266.060","title":"686 - Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; Disease; Internal medicine","score_opus":0.00808920633286845,"score_gpt":0.26858783542475456,"score_spread":0.2604986290918861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894694,0.007356239,0.00006921098,0.002086218,0.00013888901,0.00030079513,0.00014436516,0.000025068375,0.00040978548],"genre_scores_gemma":[0.9985284,0.00072480267,0.00016030867,0.00039989036,0.000055538152,0.000016931863,0.000030976753,0.00002539952,0.00005773016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983881,0.0001683039,0.0005938228,0.00023659803,0.00027782167,0.00033536422],"domain_scores_gemma":[0.9988956,0.00015159813,0.00013985157,0.00016707326,0.0001637034,0.00048216045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005064641,0.00022105267,0.0007790612,0.00031798912,0.00004960932,0.000035320347,0.00011532591,0.00012103492,0.0002185032],"category_scores_gemma":[0.000101677244,0.00018490282,0.00030745586,0.0002563833,0.00012879238,0.00019431366,0.000022237138,0.00030896574,0.000023987115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074469685,0.0017727346,0.7046339,0.0009539043,0.00090772053,0.23902403,0.00056715484,0.00042218415,0.000008661928,0.000120268385,0.020649167,0.023493292],"study_design_scores_gemma":[0.0054290113,0.0005848399,0.8035589,0.0040994533,0.00020389428,0.18415818,0.000059020404,0.00096785,0.00015895447,0.0002848571,0.00032380805,0.00017123799],"about_ca_topic_score_codex":0.00011557721,"about_ca_topic_score_gemma":0.00012977996,"teacher_disagreement_score":0.09892498,"about_ca_system_score_codex":0.00020301972,"about_ca_system_score_gemma":0.0009445116,"threshold_uncertainty_score":0.75401187},"labels":[],"label_agreement":null},{"id":"W4401435864","doi":"10.1093/bjd/ljae266.021","title":"640 - Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Probity Medical Research; Queen's University","funders":"","keywords":"Tolerability; Medicine; Dermatology; Roflumilast; Dermis; Atopic dermatitis; Erythema; Psoriasis; Adverse effect; Transepidermal water loss; Stratum corneum; Pharmacology; Pathology; Internal medicine","score_opus":0.01592771776821899,"score_gpt":0.2840045594220336,"score_spread":0.2680768416538146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900395,0.008373173,0.00009927262,0.0009448308,0.0001318194,0.00031969068,0.000073674135,0.00000800033,0.0000100187035],"genre_scores_gemma":[0.99843186,0.00065745186,0.00013798723,0.00069106295,0.000031590625,0.000007916232,0.000027661967,0.00001326624,0.0000012096436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975838,0.0005134618,0.0013087816,0.00020637765,0.0002033392,0.00018424152],"domain_scores_gemma":[0.99898815,0.00027600018,0.00023818426,0.00008667191,0.00016978245,0.00024121118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015224349,0.00015258446,0.00097034423,0.00024221012,0.000026571164,0.000040423016,0.00004708147,0.000107789856,0.000026289485],"category_scores_gemma":[0.0006653217,0.0001373975,0.00007014902,0.00022993512,0.00027642617,0.00024819028,0.000030862768,0.00030525352,4.184597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002638351,0.0007007034,0.9428482,0.00055720913,0.000083998195,0.006044594,0.0006441639,0.000003816596,0.00020548125,0.00003403381,0.0010433749,0.04757059],"study_design_scores_gemma":[0.0122311935,0.00056632794,0.96334696,0.0019987505,0.00012827496,0.01370428,0.00020309453,0.00023435129,0.006946918,0.00012771112,0.00036467318,0.00014745932],"about_ca_topic_score_codex":0.000070969414,"about_ca_topic_score_gemma":0.00019257766,"teacher_disagreement_score":0.04742313,"about_ca_system_score_codex":0.000039703686,"about_ca_system_score_gemma":0.00024996596,"threshold_uncertainty_score":0.5602907},"labels":[],"label_agreement":null},{"id":"W4401435875","doi":"10.1093/bjd/ljae266.045","title":"671 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); Dermatology Life Quality Index; Clinical trial; Young adult; Severity of illness; Dermatology; Internal medicine; Disease","score_opus":0.008924834989019722,"score_gpt":0.29425078418172296,"score_spread":0.2853259491927032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97785246,0.020690221,0.000038915317,0.0007992191,0.00005425506,0.00039956748,0.00006136773,0.000009236918,0.000094764655],"genre_scores_gemma":[0.99727577,0.0017272483,0.00071580755,0.00020549416,0.00002825399,0.000009200539,0.000010946933,0.000018631912,0.000008663387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978402,0.00038161926,0.0010962201,0.00022190309,0.00021464024,0.00024539308],"domain_scores_gemma":[0.9988195,0.00043564348,0.00033929755,0.00012549925,0.000096023665,0.0001840453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037390253,0.0001544477,0.0013099889,0.00042598604,0.000022734544,0.000028058954,0.00010312692,0.000090917245,0.00002590307],"category_scores_gemma":[0.0003615794,0.00014435404,0.00007651273,0.00031022154,0.00034123787,0.00020491131,0.00003950032,0.00036593614,9.729996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026443773,0.0007543015,0.89091724,0.00050292676,0.00031457742,0.07108413,0.0015341077,0.0000049611313,0.00010441918,0.000049020233,0.0023690446,0.02972087],"study_design_scores_gemma":[0.016905565,0.00070919166,0.7603245,0.0058192206,0.00015823088,0.21485454,0.00017072666,0.000013101831,0.000729576,0.000106649575,0.00008568522,0.00012304065],"about_ca_topic_score_codex":0.00053727825,"about_ca_topic_score_gemma":0.0006902899,"teacher_disagreement_score":0.14377043,"about_ca_system_score_codex":0.00001826189,"about_ca_system_score_gemma":0.00021568195,"threshold_uncertainty_score":0.5886587},"labels":[],"label_agreement":null},{"id":"W4401435878","doi":"10.1093/bjd/ljae266.097","title":"724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Alopecia areata; Medicine; Hair loss; Placebo; Atopic dermatitis; Internal medicine; Dermatology; Psoriasis; Gastroenterology; Immunology; Pathology","score_opus":0.014839006785408579,"score_gpt":0.30632501857114464,"score_spread":0.2914860117857361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779154,0.010409153,0.00029790416,0.0052711456,0.00025248347,0.0051340563,0.000028667331,0.000027015643,0.00066416565],"genre_scores_gemma":[0.9981197,0.0005804514,0.0003044584,0.0006114646,0.000086797205,0.0001737298,0.000010962695,0.000037159225,0.00007526621],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99597967,0.0010546674,0.0015707869,0.0004196422,0.0005329159,0.0004423449],"domain_scores_gemma":[0.9972989,0.0014361654,0.0002584153,0.00032329521,0.00031468988,0.00036851724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013014447,0.00032363093,0.0023670418,0.000497566,0.00011574031,0.000085226915,0.0003242881,0.00014887618,0.00012057867],"category_scores_gemma":[0.00085176213,0.00022351963,0.00026074375,0.0005100297,0.00025867106,0.00020890466,0.00011873142,0.00065624324,0.000015605787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93473446,0.0018189115,0.006302026,0.00022986355,0.0015927629,0.039352626,0.0021620877,0.000144439,0.000008082685,0.00007963413,0.008749402,0.0048256824],"study_design_scores_gemma":[0.77422976,0.00089991285,0.007438912,0.0030621286,0.0013251936,0.21060388,0.0013430848,0.00020355041,0.000019225286,0.0000943301,0.0005489015,0.00023115118],"about_ca_topic_score_codex":0.00008670428,"about_ca_topic_score_gemma":0.0006591697,"teacher_disagreement_score":0.17125125,"about_ca_system_score_codex":0.000060212096,"about_ca_system_score_gemma":0.0003949089,"threshold_uncertainty_score":0.91148657},"labels":[],"label_agreement":null},{"id":"W4401435885","doi":"10.1093/bjd/ljae266.036","title":"657 - Impact of pruritus on patient fatigue: a case-control study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Internal medicine; Odds ratio; Depression (economics); Cohort; Itching; Disease; Dermatology","score_opus":0.014405252670214572,"score_gpt":0.3146136763410321,"score_spread":0.3002084236708175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760589,0.022027446,0.000085550804,0.00048484807,0.00041477205,0.00035999753,0.000069038244,0.00002528485,0.00047414046],"genre_scores_gemma":[0.99941504,0.00024407443,0.000042347154,0.00018593778,0.00006639798,0.0000075880716,0.0000024165977,0.000020610434,0.000015580998],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981532,0.0002977189,0.0008837105,0.00016201104,0.0002494401,0.00025391128],"domain_scores_gemma":[0.99883085,0.00033258586,0.00025733947,0.0001543473,0.00021448535,0.00021040642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013244999,0.00015201453,0.0007593574,0.00030792403,0.000056642282,0.000029936768,0.000094189774,0.00012681868,0.00027991095],"category_scores_gemma":[0.00033275984,0.0001329407,0.00042280686,0.00017064593,0.00012468989,0.00011537871,0.000019197167,0.00045397054,0.000014659385],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086247124,0.0017517993,0.1618804,0.00016097796,0.0015115314,0.7547412,0.00056667713,0.000018908375,0.000040896783,0.000021000722,0.050305076,0.028139062],"study_design_scores_gemma":[0.003597057,0.0013090557,0.12853505,0.0006064128,0.0005552543,0.8641524,0.00044835894,0.00011859575,0.00015612939,0.00011638024,0.00030835316,0.00009697969],"about_ca_topic_score_codex":0.000050167462,"about_ca_topic_score_gemma":0.000012809788,"teacher_disagreement_score":0.10941119,"about_ca_system_score_codex":0.000049032587,"about_ca_system_score_gemma":0.00032256285,"threshold_uncertainty_score":0.5421164},"labels":[],"label_agreement":null},{"id":"W4401435911","doi":"10.1093/bjd/ljae266.034","title":"655 - Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Clinical endpoint; Open label; Clinical trial; Delta; Internal medicine; Pediatrics","score_opus":0.022100597746292694,"score_gpt":0.33353116274289446,"score_spread":0.31143056499660177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884937,0.007222916,0.00033011084,0.0018169042,0.0004329736,0.001483798,0.00013481211,0.0000048833763,0.0000798937],"genre_scores_gemma":[0.99868405,0.0006119377,0.00027627425,0.00012366325,0.00011228377,0.000013363359,0.00003532797,0.000022607099,0.000120473494],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982159,0.00010329738,0.0009891123,0.0002443434,0.00020364423,0.00024370992],"domain_scores_gemma":[0.9986102,0.0004300839,0.00038661936,0.00018085811,0.00025497822,0.00013726941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024371609,0.00015801871,0.0008428289,0.00015647862,0.000065018925,0.000045112574,0.00017470254,0.00013869557,0.000011337133],"category_scores_gemma":[0.00037217126,0.00011095588,0.00010096463,0.0001862453,0.00015531873,0.00014845074,0.000066901186,0.00026771412,6.007436e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60050046,0.0045175073,0.0017479082,0.0008820143,0.0010417443,0.012990465,0.00116745,0.000010459426,0.001149154,0.00004469006,0.004981288,0.37096688],"study_design_scores_gemma":[0.82660973,0.013131594,0.049993925,0.015880097,0.0011454424,0.08000255,0.00008495264,0.00014453675,0.010563031,0.00006563292,0.0021473493,0.00023116166],"about_ca_topic_score_codex":0.00011500147,"about_ca_topic_score_gemma":0.00082773773,"teacher_disagreement_score":0.3707357,"about_ca_system_score_codex":0.000058623766,"about_ca_system_score_gemma":0.000371265,"threshold_uncertainty_score":0.45246494},"labels":[],"label_agreement":null},{"id":"W4401435914","doi":"10.1093/bjd/ljae266.039","title":"661 - Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Atopic dermatitis; Internal medicine; Clinical trial; Randomized controlled trial; Eczema Area and Severity Index; Double blind; Gastroenterology; Immunology; Pathology","score_opus":0.008430683096162642,"score_gpt":0.28471864149805526,"score_spread":0.27628795840189263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903294,0.0072978344,0.00018863323,0.0010416803,0.00028925657,0.00061903644,0.00009531963,0.000027778817,0.00011108078],"genre_scores_gemma":[0.9979307,0.0010990449,0.00038975032,0.00039853255,0.000045549663,0.000005744096,0.000083192564,0.000032529057,0.000014934725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772835,0.00022858383,0.0010672755,0.0003063299,0.00030095392,0.00036851273],"domain_scores_gemma":[0.9987714,0.00019183663,0.000248294,0.00019153029,0.00024603834,0.0003508902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013112409,0.0002330914,0.0011068522,0.00043435034,0.00008509745,0.00007223499,0.00015153796,0.00021925967,0.000055519147],"category_scores_gemma":[0.00018624932,0.0002212767,0.000116112045,0.00031637007,0.00025141146,0.00042322295,0.000050361425,0.00044542225,0.0000054915713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10353748,0.010934965,0.658515,0.0023206233,0.0015674455,0.100010514,0.0022292603,0.000052085365,0.00043227928,0.000110762776,0.009693599,0.110596],"study_design_scores_gemma":[0.17573245,0.0018661845,0.70703715,0.003473216,0.0004908582,0.10815898,0.00014705095,0.0002700785,0.0008497786,0.00018874597,0.0014171414,0.00036833397],"about_ca_topic_score_codex":0.000020145206,"about_ca_topic_score_gemma":0.000035428315,"teacher_disagreement_score":0.11022767,"about_ca_system_score_codex":0.000031229,"about_ca_system_score_gemma":0.00031033801,"threshold_uncertainty_score":0.90234023},"labels":[],"label_agreement":null},{"id":"W4401435925","doi":"10.1093/bjd/ljae266.068","title":"694 - Dupilumab improves itch and skin lesions in North American patients with prurigo nodularis: a subset analysis of the pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Dupilumab; Prurigo nodularis; Dermatology Life Quality Index; Eczema Area and Severity Index; Atopic dermatitis; Placebo; Internal medicine; Subgroup analysis; Quality of life (healthcare); Clinical trial; Dermatology; Clinical endpoint; Disease; Confidence interval; Pathology","score_opus":0.009748969031384842,"score_gpt":0.2840902866512158,"score_spread":0.27434131761983094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905901,0.007086731,0.000039105566,0.0012878914,0.000095619536,0.00035627844,0.0005120926,0.000011671839,0.000020499774],"genre_scores_gemma":[0.9986415,0.00066009397,0.00028155817,0.00023082094,0.00003175831,0.0000057378707,0.000119287746,0.00001751978,0.000011718723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972703,0.0006299541,0.001283542,0.00029978444,0.00027315086,0.00024326317],"domain_scores_gemma":[0.99784,0.00081461604,0.0007533412,0.00022696632,0.00018647837,0.0001786244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028970395,0.00018165784,0.0015038368,0.00046990748,0.00007301257,0.00004919517,0.00014785018,0.00008936085,0.000013117596],"category_scores_gemma":[0.0009849956,0.00012939086,0.00023057415,0.0009074996,0.00049520447,0.00016071742,0.00006907004,0.0004140131,5.849602e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003830061,0.00088753836,0.9208294,0.000076966106,0.0040618093,0.004295789,0.00080712495,0.0000046564205,0.00014402991,0.0000054164916,0.0015397167,0.06351749],"study_design_scores_gemma":[0.013679012,0.00015057625,0.974817,0.0004137015,0.004707393,0.0047671366,0.00014392746,0.00036622834,0.0005764275,0.000050727955,0.00019617304,0.00013172117],"about_ca_topic_score_codex":0.00068546325,"about_ca_topic_score_gemma":0.0025240486,"teacher_disagreement_score":0.06338576,"about_ca_system_score_codex":0.000023361921,"about_ca_system_score_gemma":0.00026466715,"threshold_uncertainty_score":0.5276406},"labels":[],"label_agreement":null},{"id":"W4401435930","doi":"10.1093/bjd/ljae266.003","title":"603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Tolerability; Discontinuation; Ruxolitinib; Adverse effect; Atopic dermatitis; Clinical trial; Janus kinase inhibitor; Internal medicine; Surgery; Pediatrics; Dermatology; Janus kinase; Myelofibrosis; Cytokine","score_opus":0.02266750183778903,"score_gpt":0.2817145184424843,"score_spread":0.25904701660469526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716367,0.023240393,0.00012810301,0.002681998,0.0006736462,0.00092492707,0.0006288567,0.000025829664,0.000059541348],"genre_scores_gemma":[0.99405336,0.00426312,0.00044585275,0.00059966097,0.0003306797,0.000046556193,0.00014789506,0.000029459541,0.000083436695],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976831,0.00028415144,0.0012129752,0.00026268748,0.00021954456,0.0003375342],"domain_scores_gemma":[0.9970119,0.0020407913,0.00036429797,0.0002576261,0.00017809034,0.00014727336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013727721,0.00019314111,0.0009053816,0.0002244149,0.00007041062,0.000070667265,0.00019237275,0.00022414836,0.000057902194],"category_scores_gemma":[0.0007693495,0.00016567971,0.0004333081,0.0001729224,0.0002565816,0.00020716828,0.00002416681,0.00027005258,0.000009654487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06980379,0.012051924,0.21097359,0.00047918552,0.008242135,0.16711214,0.0097876815,0.000032452022,0.00017777747,0.000547927,0.36277252,0.15801887],"study_design_scores_gemma":[0.085388765,0.0010621225,0.78281194,0.0010576367,0.001133027,0.108848795,0.00044587706,0.000089916204,0.0005667299,0.001863538,0.01653094,0.0002006953],"about_ca_topic_score_codex":0.0008229895,"about_ca_topic_score_gemma":0.00028222066,"teacher_disagreement_score":0.5718384,"about_ca_system_score_codex":0.000060567403,"about_ca_system_score_gemma":0.00031157333,"threshold_uncertainty_score":0.6756223},"labels":[],"label_agreement":null},{"id":"W4401435949","doi":"10.1093/bjd/ljae266.023","title":"643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Toronto; University of Calgary","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Dermatology Life Quality Index; Body surface area; Adverse effect; Internal medicine; Clinical endpoint; Quality of life (healthcare); Dermatology; Clinical trial; Pediatrics; Disease","score_opus":0.015502671122553865,"score_gpt":0.2991949706967398,"score_spread":0.2836922995741859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646879,0.03385196,0.00011169215,0.00021039491,0.000057328874,0.0003813176,0.0006423712,0.000008434024,0.000048638165],"genre_scores_gemma":[0.9795767,0.019628992,0.00018452235,0.00020109731,0.000014630084,0.0000050212284,0.00037246884,0.000014879384,0.0000016907042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978985,0.00043283953,0.00092594593,0.00032034385,0.00024323608,0.00017910107],"domain_scores_gemma":[0.99869215,0.00024944585,0.00029499558,0.0002857183,0.00032539322,0.00015230701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017831539,0.00016280019,0.0013661262,0.00038756023,0.00003042238,0.00001831772,0.00016156735,0.00009126015,0.000046635254],"category_scores_gemma":[0.00017355137,0.00014791725,0.00009873493,0.00041880735,0.00029433056,0.0003552979,0.000092226335,0.00030863204,3.648103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042580653,0.00054672454,0.98516345,0.0030192423,0.0013024706,0.0035569144,0.0001095084,6.207889e-7,0.00001107834,0.000016659786,0.0003684602,0.005479051],"study_design_scores_gemma":[0.0028544294,0.000118134165,0.97140205,0.018800575,0.003157328,0.0029670324,0.000059193255,0.0003734255,0.000077833654,0.000029946084,0.000043938384,0.000116142604],"about_ca_topic_score_codex":0.00020699912,"about_ca_topic_score_gemma":0.0017806853,"teacher_disagreement_score":0.015781332,"about_ca_system_score_codex":0.000041555006,"about_ca_system_score_gemma":0.00009263596,"threshold_uncertainty_score":0.60318905},"labels":[],"label_agreement":null},{"id":"W4401435959","doi":"10.1093/bjd/ljae266.067","title":"693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Internal medicine; Tolerability; Apremilast; Population; Clinical endpoint; Psoriasis; Randomized controlled trial; Gastroenterology; Clinical trial; Adverse effect; Immunology; Disease; Psoriatic arthritis; Pathology","score_opus":0.018068436978460722,"score_gpt":0.3136291326597535,"score_spread":0.2955606956812928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816228,0.0076856543,0.0017271641,0.0047640833,0.0007166047,0.003041941,0.000020575619,0.000028912698,0.00039226105],"genre_scores_gemma":[0.99572194,0.0029525931,0.0005373145,0.0002810671,0.0003031388,0.00009349379,0.000017304092,0.000031549047,0.000061614934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99589187,0.0006023321,0.0025030356,0.00030813416,0.00034975004,0.00034488653],"domain_scores_gemma":[0.99763423,0.00113005,0.0004324097,0.0001496751,0.00027774976,0.00037585828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068470876,0.00023553272,0.0022884163,0.00048167334,0.00007872928,0.00007199712,0.00011713516,0.00039542798,0.00007052517],"category_scores_gemma":[0.0004607241,0.00018809576,0.00040495265,0.00033382655,0.00032364615,0.00018738667,0.000043089283,0.0011252452,0.000008692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9733914,0.0011638153,0.00013705753,0.00013618966,0.0021780785,0.01536091,0.00049557624,0.000058735117,0.000014701227,0.0002531417,0.0010523928,0.005757974],"study_design_scores_gemma":[0.8943296,0.00132206,0.0001958765,0.0039802277,0.0021044733,0.09567204,0.00015342842,0.0016366073,0.00008068878,0.00015141025,0.00020624489,0.00016735037],"about_ca_topic_score_codex":0.00004650299,"about_ca_topic_score_gemma":0.000053912216,"teacher_disagreement_score":0.080311134,"about_ca_system_score_codex":0.000049941107,"about_ca_system_score_gemma":0.0006693738,"threshold_uncertainty_score":0.76703227},"labels":[],"label_agreement":null},{"id":"W4401435984","doi":"10.1093/bjd/ljae266.026","title":"647 - Upadacitinib dose alterations in adolescent and adult patients with atopic dermatitis: a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Dosing; Atopic dermatitis; Adverse effect; Dermatology Life Quality Index; Context (archaeology); Body surface area; Incidence (geometry); Retrospective cohort study; Internal medicine; Dermatology; Disease","score_opus":0.0215756722092803,"score_gpt":0.3361874794010688,"score_spread":0.3146118071917885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401435984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8388076,0.12762351,0.00009376174,0.029537873,0.00031407308,0.0008091382,0.000040801944,0.000028796081,0.0027444798],"genre_scores_gemma":[0.9029855,0.09246576,0.00028897641,0.004134449,0.000063158346,0.000009401217,0.000008147666,0.0000112918915,0.000033277087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880326,0.00013031499,0.0005242958,0.00014791208,0.00019754915,0.00019666093],"domain_scores_gemma":[0.99927604,0.00010939853,0.00015351076,0.00005921917,0.00026807585,0.00013372613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098309145,0.0001075545,0.00045230638,0.00010022238,0.000062871644,0.000054921187,0.000047478185,0.000038443446,0.000087906345],"category_scores_gemma":[0.00019182956,0.00009076956,0.000058367736,0.00020282438,0.00008782732,0.00027868946,0.00003186387,0.00052265514,0.000005735051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019464368,0.000545782,0.8992202,0.0036602283,0.0003595267,0.013166276,0.00033350152,2.419508e-7,0.0000054398806,0.00037251157,0.025419474,0.056722168],"study_design_scores_gemma":[0.0033854085,0.00014254809,0.9374405,0.016133754,0.00031857798,0.015840746,0.000056564244,0.000096985685,0.000026512309,0.000058003938,0.026386334,0.00011404027],"about_ca_topic_score_codex":0.000101877915,"about_ca_topic_score_gemma":0.0007031449,"teacher_disagreement_score":0.064177975,"about_ca_system_score_codex":0.00007668249,"about_ca_system_score_gemma":0.000056708734,"threshold_uncertainty_score":0.37014753},"labels":[],"label_agreement":null},{"id":"W4401436000","doi":"10.1093/bjd/ljae266.066","title":"692 - Dupilumab reduces atopic dermatitis lesion severity and extent in children &amp;lt;12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Université de Montréal; University of Calgary","funders":"","keywords":"Dupilumab; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Methotrexate; Adverse effect; Observational study; Internal medicine; Dermatology; Pediatrics","score_opus":0.01726805268602429,"score_gpt":0.27635244748895926,"score_spread":0.259084394802935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827166,0.012441366,0.000055796903,0.0038097007,0.00016879359,0.00023285755,0.00017767135,0.000022397217,0.0003748087],"genre_scores_gemma":[0.9945499,0.004067358,0.0006173931,0.00043876006,0.00006891612,0.0000059178874,0.000081684084,0.000021360473,0.0001487518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818003,0.00024633564,0.00080302515,0.00027546825,0.00024909232,0.0002460653],"domain_scores_gemma":[0.99897444,0.0002682382,0.0002582949,0.0002387713,0.00008822537,0.00017205578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015160191,0.00016276028,0.0006377751,0.00018090205,0.00006880326,0.00007256346,0.00020520024,0.00013911059,0.000036934467],"category_scores_gemma":[0.0002268146,0.00014116598,0.00009937646,0.00019614461,0.00030984072,0.00018014465,0.000089901805,0.00052208407,0.000005221716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053972886,0.0009128209,0.5635744,0.0007015365,0.0014591153,0.10585381,0.005196269,0.000042487263,0.00048832974,0.000119473974,0.23190512,0.08434939],"study_design_scores_gemma":[0.0024512894,0.000054706597,0.8746579,0.0035200333,0.00017913044,0.11604765,0.0001654764,0.000029463097,0.00026825131,0.0004295137,0.0020554198,0.00014111164],"about_ca_topic_score_codex":0.00073286163,"about_ca_topic_score_gemma":0.0027385557,"teacher_disagreement_score":0.31108359,"about_ca_system_score_codex":0.000043754397,"about_ca_system_score_gemma":0.00022306705,"threshold_uncertainty_score":0.57565814},"labels":[],"label_agreement":null},{"id":"W4401436011","doi":"10.1093/bjd/ljae266.022","title":"641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Calgary","funders":"","keywords":"Atopic dermatitis; Medicine; Roflumilast; SCORAD; Dermatology Life Quality Index; Eczema Area and Severity Index; Tolerability; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Adverse effect; Dermatology; Disease","score_opus":0.00957381112976554,"score_gpt":0.27291981456588693,"score_spread":0.2633460034361214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95538753,0.04134437,0.0001481543,0.002236829,0.00015289559,0.00047219786,0.00020408962,0.000014696756,0.000039235852],"genre_scores_gemma":[0.9954803,0.0037818782,0.0002382844,0.00037713948,0.00003234619,0.000005829139,0.000058948524,0.000018387738,0.0000068893605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973315,0.0004029366,0.0016011456,0.00022509339,0.00024378274,0.00019551846],"domain_scores_gemma":[0.99763095,0.0010483298,0.0007887065,0.00016615496,0.00018105902,0.00018478505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027828643,0.00020350338,0.0013660877,0.0001502607,0.000075995325,0.0000420551,0.00010129334,0.00014817585,0.00009239702],"category_scores_gemma":[0.00088044093,0.00014153073,0.00015693596,0.000117080686,0.0005830199,0.00016970072,0.00008015629,0.0003416272,6.086633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017432417,0.0008334906,0.8667038,0.00032103693,0.0040506334,0.0049553877,0.0013558639,2.6701034e-7,0.0001576629,0.00005888031,0.008100426,0.11171931],"study_design_scores_gemma":[0.017838094,0.00044730882,0.8323643,0.0029754962,0.0018750867,0.14076565,0.0006941707,0.00003193619,0.0021916644,0.00020275512,0.00047094963,0.00014255346],"about_ca_topic_score_codex":0.00018029957,"about_ca_topic_score_gemma":0.00006709093,"teacher_disagreement_score":0.13581026,"about_ca_system_score_codex":0.000013223727,"about_ca_system_score_gemma":0.00015405154,"threshold_uncertainty_score":0.5771456},"labels":[],"label_agreement":null},{"id":"W4401436015","doi":"10.1093/bjd/ljae266.070","title":"696 - Sustained improvements over 140 weeks in signs, symptoms, and quality of life with upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis: integrated results from the phase 3 Measure Up 1 and Measure Up 2 studies","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Calgary","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Randomized controlled trial; Severity of illness; Internal medicine; Dermatology; Disease","score_opus":0.02017044620747292,"score_gpt":0.2930086273057454,"score_spread":0.27283818109827246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95442426,0.042571556,0.000071384624,0.0020383901,0.00011041587,0.0005499688,0.00020148444,0.000015722027,0.000016798198],"genre_scores_gemma":[0.99734366,0.0015817361,0.0000658662,0.000901418,0.000026704305,0.000016242082,0.000027649261,0.000022381519,0.000014351757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973546,0.00055065495,0.0010591014,0.00036005586,0.0003600702,0.0003155117],"domain_scores_gemma":[0.9985107,0.00035102665,0.00031613687,0.00015565928,0.0004311382,0.00023530558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038514467,0.00026341548,0.0010363545,0.00021290939,0.00008205137,0.00006733662,0.00011242838,0.00018365642,0.0000052090313],"category_scores_gemma":[0.00092264067,0.0001884604,0.000044573328,0.00027807074,0.00039970403,0.0002837675,0.00006802128,0.00060640386,3.630203e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024880646,0.00057062897,0.9303037,0.0022460602,0.0014168461,0.011955799,0.0073816334,0.0000052219184,0.00015963898,0.000041436695,0.005061146,0.01597725],"study_design_scores_gemma":[0.07006982,0.00070129207,0.862692,0.026009588,0.00044053592,0.022509716,0.015966887,0.0003719102,0.0003651496,0.0003009456,0.00012767121,0.00044450964],"about_ca_topic_score_codex":0.0005503971,"about_ca_topic_score_gemma":0.002743221,"teacher_disagreement_score":0.06761172,"about_ca_system_score_codex":0.000050162467,"about_ca_system_score_gemma":0.00039022407,"threshold_uncertainty_score":0.7685192},"labels":[],"label_agreement":null},{"id":"W4401436017","doi":"10.1093/bjd/ljae266.107","title":"734 - Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Gastroenterology","score_opus":0.040689143248115046,"score_gpt":0.35857249122525336,"score_spread":0.3178833479771383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352473,0.0026959684,0.00018294294,0.0015271733,0.00018531276,0.0015744584,0.00020517895,0.000024344718,0.00007991246],"genre_scores_gemma":[0.9981782,0.00028580168,0.0009186616,0.00047097937,0.000035819554,0.000018331486,0.00003109393,0.000043285097,0.000017855617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962673,0.00050369627,0.0018271737,0.00053403364,0.00042470463,0.0004431],"domain_scores_gemma":[0.9979612,0.00029933653,0.000436737,0.00032392683,0.0004257859,0.0005529762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036908765,0.00032077957,0.001626265,0.00057429355,0.00011039188,0.00010616179,0.00036702774,0.0002270858,0.000013033891],"category_scores_gemma":[0.0005726185,0.00031294953,0.000050951432,0.00051396125,0.0002431543,0.0004981149,0.00020378211,0.0006085814,0.0000029271462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2852092,0.048614003,0.335082,0.007451517,0.0021597615,0.11656049,0.013862576,0.00018478822,0.0007675559,0.00012249476,0.008339681,0.18164591],"study_design_scores_gemma":[0.15035608,0.0034914124,0.73916996,0.013474346,0.00038115648,0.09032962,0.0009348086,0.00047784223,0.00084567873,0.00005848706,0.0001374797,0.00034310907],"about_ca_topic_score_codex":0.00016458167,"about_ca_topic_score_gemma":0.0007972535,"teacher_disagreement_score":0.40408796,"about_ca_system_score_codex":0.000040506722,"about_ca_system_score_gemma":0.00047887204,"threshold_uncertainty_score":0.9999322},"labels":[],"label_agreement":null},{"id":"W4401436023","doi":"10.1093/bjd/ljae266.091","title":"718 - Dupilumab reduces the number of lesions in adult patients with prurigo nodularis presenting with multiple lesion morphologies: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Dupilumab; Medicine; Prurigo nodularis; Placebo; Adverse effect; Lesion; Eczema Area and Severity Index; Clinical trial; Internal medicine; Atopic dermatitis; Dermatology; Dermatology Life Quality Index; Surgery; Pathology; Disease","score_opus":0.01998264709892643,"score_gpt":0.3112154386162995,"score_spread":0.2912327915173731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224114,0.0051029283,0.000103123944,0.0013894103,0.00014348942,0.0007280991,0.0001873863,0.000035260353,0.00006915604],"genre_scores_gemma":[0.9968566,0.00056322204,0.0022330352,0.000079580874,0.00007321004,0.00001266934,0.00008689534,0.000043665143,0.000051151284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668175,0.000640065,0.001536887,0.00034652973,0.00047017646,0.000324583],"domain_scores_gemma":[0.99649715,0.0016617901,0.0009899501,0.0002788202,0.00045115527,0.00012113766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047729592,0.00022785604,0.0011120165,0.00017753798,0.00011077594,0.00007846915,0.00022491952,0.00014053719,0.000044833552],"category_scores_gemma":[0.003755353,0.00014898852,0.00014616334,0.00027270673,0.00037584812,0.0002526276,0.00011153279,0.0005444302,0.0000034547809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035124376,0.005722245,0.7874185,0.0005869884,0.003339476,0.04350302,0.0053302846,0.00008548702,0.0092376685,0.00003198321,0.01060844,0.09901152],"study_design_scores_gemma":[0.094569474,0.0008610211,0.7961155,0.011253822,0.002231939,0.05545516,0.0015632517,0.00094022846,0.035502426,0.0003150545,0.0006531636,0.0005389188],"about_ca_topic_score_codex":0.0011494005,"about_ca_topic_score_gemma":0.00009260634,"teacher_disagreement_score":0.0984726,"about_ca_system_score_codex":0.00004647919,"about_ca_system_score_gemma":0.00040599413,"threshold_uncertainty_score":0.60755754},"labels":[],"label_agreement":null},{"id":"W4401436033","doi":"10.1093/bjd/ljae266.020","title":"639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Roflumilast; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Tolerability; Adverse effect; Vomiting; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology Life Quality Index; Fluticasone propionate; Gastroenterology; Asthma; Dermatology","score_opus":0.00699859495050022,"score_gpt":0.2653204882726066,"score_spread":0.2583218933221064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908008,0.0051154755,0.00034872757,0.0008436607,0.000362049,0.0022973686,0.000038928887,0.000013388112,0.00017962471],"genre_scores_gemma":[0.997792,0.0011920573,0.00039952563,0.0004043716,0.00007029737,0.00006168011,0.000013419156,0.000023272565,0.000043361353],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99692464,0.0005066681,0.0017143937,0.00022647237,0.00033859027,0.0002892202],"domain_scores_gemma":[0.9979831,0.00092283107,0.0004182526,0.00013128773,0.00024881208,0.00029574247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033311208,0.00019535617,0.002538529,0.0006160011,0.00003404971,0.00003168969,0.00012018669,0.00014743791,0.00005122023],"category_scores_gemma":[0.0010818818,0.00017641719,0.00028882863,0.0003364673,0.0001867415,0.00013662202,0.000047663278,0.00031349636,0.0000043883756],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9556544,0.0022712382,0.0062911445,0.000505732,0.0007662824,0.017656136,0.001072774,0.0000344347,0.000024196625,0.000041208546,0.009041351,0.006641106],"study_design_scores_gemma":[0.96771777,0.001100394,0.017694363,0.0013776819,0.0009680146,0.010215457,0.00007441055,0.00015841171,0.00020307445,0.00007056271,0.0002579929,0.00016185954],"about_ca_topic_score_codex":0.000035386387,"about_ca_topic_score_gemma":0.000044597517,"teacher_disagreement_score":0.012063382,"about_ca_system_score_codex":0.000034526176,"about_ca_system_score_gemma":0.0002985681,"threshold_uncertainty_score":0.71940845},"labels":[],"label_agreement":null},{"id":"W4401436035","doi":"10.1093/bjd/ljae266.029","title":"650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Clinical trial; Post-hoc analysis; Quality of life (healthcare); Clinical endpoint; Dupilumab; Pediatrics; Internal medicine; Dermatology","score_opus":0.01436139911004404,"score_gpt":0.27611169599113256,"score_spread":0.26175029688108853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838714,0.010336702,0.0006278961,0.0042815567,0.00019401089,0.00040432773,0.000037710208,0.000028759183,0.00021763389],"genre_scores_gemma":[0.99802256,0.0003356204,0.00031930325,0.0012063418,0.00003487852,0.000018111366,0.000007248832,0.000026359874,0.000029605892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979438,0.00032024828,0.00085289613,0.0002540284,0.0002778369,0.0003511737],"domain_scores_gemma":[0.99883413,0.00029840227,0.00013192408,0.00020776215,0.00024743448,0.00028032882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015114322,0.0001824055,0.00081152533,0.00042244387,0.00004575268,0.000040125782,0.00019222428,0.00016175369,0.00021223146],"category_scores_gemma":[0.00018077096,0.0001716597,0.00014806444,0.00039332904,0.00016351779,0.00021379621,0.000035868463,0.00041160904,0.000018109085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004827018,0.0005420319,0.8755444,0.0016333065,0.00031743603,0.086814724,0.0016982382,0.000020999394,0.000119598844,0.00007346683,0.0028842255,0.025524534],"study_design_scores_gemma":[0.0025601694,0.00024903883,0.7344421,0.0035326227,0.0001120966,0.25556076,0.00017492293,0.00004959041,0.0028348914,0.00018872255,0.00014572337,0.00014936023],"about_ca_topic_score_codex":0.000033587137,"about_ca_topic_score_gemma":0.00034606335,"teacher_disagreement_score":0.16874601,"about_ca_system_score_codex":0.00006837519,"about_ca_system_score_gemma":0.0004933801,"threshold_uncertainty_score":0.700008},"labels":[],"label_agreement":null},{"id":"W4401436060","doi":"10.1093/bjd/ljae266.078","title":"704 - Effectiveness of atopic dermatitis patient education programs – a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Atopic dermatitis; Meta-analysis; Psychological intervention; Systematic review; SCORAD; Dermatology Life Quality Index; MEDLINE; Cochrane Library; Quality of life (healthcare); Modalities; Physical therapy; Disease; Pediatrics; Family medicine; Dermatology; Internal medicine; Psychiatry; Nursing","score_opus":0.03127070906240224,"score_gpt":0.34294951743209773,"score_spread":0.31167880836969547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051483956,0.99700236,0.000024101619,0.00018145095,0.00015882701,0.0024319955,0.000046696478,0.000015756246,0.00008732645],"genre_scores_gemma":[0.004530019,0.9945028,0.000101185535,0.0002621231,0.000014061613,0.00040452013,0.00010648492,0.00003504913,0.0000437457],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945669,0.0020674362,0.002547128,0.00029022864,0.00030877834,0.00021951097],"domain_scores_gemma":[0.99662066,0.0003830386,0.0019623353,0.00033676723,0.00048932113,0.00020787794],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040775718,0.0003887686,0.013111066,0.0006236547,0.000044174434,0.000043667904,0.00020326744,0.00033437522,0.00006478856],"category_scores_gemma":[0.0004540348,0.0002887396,0.0038219492,0.0007669902,0.00018705947,0.000104092745,0.000071063296,0.00053327094,0.000013439248],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024440667,0.00025039047,0.00003544016,0.83807635,0.14066981,0.0030129962,0.000014235274,1.3465429e-8,5.345773e-9,0.00002973494,0.0015527485,0.016355839],"study_design_scores_gemma":[0.000075799355,0.00003169462,0.000014571195,0.20745489,0.55022764,0.23538983,0.0000111186555,2.6583962e-7,4.9952865e-7,0.00005856063,0.0066259042,0.00010926497],"about_ca_topic_score_codex":0.000012757758,"about_ca_topic_score_gemma":0.000005618886,"teacher_disagreement_score":0.63062143,"about_ca_system_score_codex":0.000054383392,"about_ca_system_score_gemma":0.0007543207,"threshold_uncertainty_score":0.9999565},"labels":[],"label_agreement":null},{"id":"W4401436063","doi":"10.1093/bjd/ljae266.025","title":"645 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of long-term (week 52) data from a real-world multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; Women's College Hospital; University of Toronto","funders":"","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Dermatology Life Quality Index; Body surface area; Adverse effect; Incidence (geometry); Internal medicine; Dermatology; Disease","score_opus":0.01451922208765543,"score_gpt":0.30003038764977336,"score_spread":0.2855111655621179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604061,0.03828618,0.0001418095,0.00021011327,0.000058364538,0.00037770296,0.00047805897,0.000008055786,0.00003361145],"genre_scores_gemma":[0.9761782,0.023071388,0.00014925945,0.00022596118,0.000014464273,0.0000045016836,0.00033991228,0.000014455678,0.0000018344144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792606,0.0004515174,0.0008952943,0.00031352785,0.00023707937,0.00017652698],"domain_scores_gemma":[0.9985866,0.00025832813,0.00038856897,0.00028290442,0.000334063,0.00014951515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017251789,0.00015994118,0.0013361948,0.00038434195,0.0000302574,0.000018564657,0.00016070723,0.00008950012,0.000057633053],"category_scores_gemma":[0.00019701246,0.00014454052,0.000096244774,0.00042738803,0.00029547996,0.00035825704,0.00009117612,0.00030373235,4.876528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046138692,0.00058072933,0.98254204,0.003727455,0.0013489756,0.0049958676,0.00010405535,4.517861e-7,0.000004713836,0.00001377479,0.00027228481,0.0059482874],"study_design_scores_gemma":[0.0038414055,0.00011571423,0.968093,0.02074129,0.003198346,0.0035307924,0.000037290527,0.00021086057,0.00008060596,0.000021763248,0.000015867536,0.00011311129],"about_ca_topic_score_codex":0.00024282496,"about_ca_topic_score_gemma":0.0018375282,"teacher_disagreement_score":0.017013835,"about_ca_system_score_codex":0.00004179808,"about_ca_system_score_gemma":0.000092982504,"threshold_uncertainty_score":0.5894191},"labels":[],"label_agreement":null},{"id":"W4401436065","doi":"10.1093/bjd/ljae266.083","title":"709 - Greater levels of itch relief and skin clearance correlate with improved patient outcomes in atopic dermatitis – real-world insights from TARGET-DERM AD","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology Life Quality Index; Quality of life (healthcare); Eczema Area and Severity Index; Observational study; Severity of illness; Patient-reported outcome; Physical therapy; Disease; Dermatology; Internal medicine","score_opus":0.007798387773227206,"score_gpt":0.23865282969070606,"score_spread":0.23085444191747886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97580326,0.020881938,0.00007160641,0.0021328698,0.00040719626,0.00022831577,0.0000605281,0.000025837724,0.00038844612],"genre_scores_gemma":[0.99666613,0.0016598179,0.00081958435,0.0006718122,0.000022799946,0.000008472063,0.000011931481,0.000030213823,0.00010923346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981089,0.00017745988,0.00096609077,0.00025638446,0.0002133835,0.00027774705],"domain_scores_gemma":[0.9989924,0.00021999812,0.00030457674,0.00016651307,0.00014378846,0.00017274023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048116377,0.00020905652,0.0010119356,0.00034487815,0.00005237491,0.00003755217,0.00011547149,0.00018764018,0.000091995455],"category_scores_gemma":[0.00006705997,0.00018089566,0.00013591093,0.00022095142,0.00026414433,0.00027182617,0.000048632086,0.00052378594,0.000007453786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047576582,0.00041093826,0.89887995,0.00058899936,0.0008335884,0.0647369,0.0020190782,0.0000047446288,0.0002781392,0.00013075155,0.006351221,0.025289899],"study_design_scores_gemma":[0.002601453,0.0001176857,0.95602465,0.0019308703,0.00018448375,0.03387801,0.00017241681,0.00023583682,0.0022753458,0.0010236703,0.0013736946,0.00018188031],"about_ca_topic_score_codex":0.00024172415,"about_ca_topic_score_gemma":0.0005205624,"teacher_disagreement_score":0.057144683,"about_ca_system_score_codex":0.000038989016,"about_ca_system_score_gemma":0.00018399423,"threshold_uncertainty_score":0.7376711},"labels":[],"label_agreement":null},{"id":"W4401436072","doi":"10.1093/bjd/ljae266.076","title":"702 - IMG-007, a nondepleting OX40 monoclonal antibody with an extended half-life, improves skin lesions in adults with moderate-to-severe atopic dermatitis: interim results from a phase 2a trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eczema Area and Severity Index; SCORAD; Atopic dermatitis; Body surface area; Internal medicine; Clinical trial; Antibody; Gastroenterology; Immunology; Dermatology Life Quality Index; Disease","score_opus":0.015276068778094258,"score_gpt":0.3079531878510824,"score_spread":0.29267711907298816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841745,0.0040203063,0.0016707021,0.004191231,0.00038664276,0.00073054456,0.00025415432,0.00008674968,0.00024220494],"genre_scores_gemma":[0.9941083,0.0003157245,0.0035382942,0.0013301282,0.00028806934,0.000043458225,0.0002835108,0.00006402916,0.000028473149],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9964673,0.00041995896,0.0014797307,0.0006052745,0.00042674845,0.00060097186],"domain_scores_gemma":[0.9979858,0.00038264517,0.00038372254,0.0003139247,0.00028939452,0.00064451597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002122681,0.0003739715,0.001207498,0.0005227343,0.00015993981,0.000190583,0.00030359763,0.00029664708,0.00009367679],"category_scores_gemma":[0.00046080936,0.00033086305,0.00018764299,0.00039904282,0.00024831854,0.00065387157,0.000074458854,0.00096896745,0.000017578346],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40558523,0.0068660923,0.009086051,0.0010862176,0.0019695815,0.48191002,0.0055948975,0.00010885579,0.0006713449,0.00018854204,0.019245246,0.06768792],"study_design_scores_gemma":[0.30040225,0.0047194967,0.094191626,0.017764043,0.0008654425,0.5636627,0.0033711728,0.009889296,0.0014596106,0.0007720229,0.0017846348,0.0011176777],"about_ca_topic_score_codex":0.00055230025,"about_ca_topic_score_gemma":0.0010057421,"teacher_disagreement_score":0.105182946,"about_ca_system_score_codex":0.000069712194,"about_ca_system_score_gemma":0.0009905879,"threshold_uncertainty_score":0.99991435},"labels":[],"label_agreement":null},{"id":"W4401436075","doi":"10.1093/bjd/ljae266.019","title":"638 - Long-term safety and efficacy of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis: a 52-week, phase 3, open-label extension trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Queen's University; Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Roflumilast; Clinical endpoint; Dosing; Internal medicine; Randomized controlled trial; Dermatology","score_opus":0.016784349340504354,"score_gpt":0.30022435900811295,"score_spread":0.2834400096676086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97655123,0.021055797,0.00020031449,0.0010788317,0.00015548742,0.00085013045,0.000042863514,0.000017481505,0.00004788722],"genre_scores_gemma":[0.9965969,0.0023232051,0.00036302794,0.00056094094,0.000062385996,0.000010165404,0.000030347965,0.000027692531,0.000025339577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811393,0.00022784504,0.00085662823,0.00031264266,0.0002002515,0.0002887293],"domain_scores_gemma":[0.9990396,0.00018926637,0.00020409391,0.00015673076,0.00011162818,0.00029866592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016996004,0.00018994008,0.0009595251,0.000319582,0.00007444616,0.00008965246,0.00016219083,0.00017402752,0.00003255315],"category_scores_gemma":[0.00018983366,0.0001867879,0.000059075417,0.0002214796,0.00023591939,0.00030527855,0.00011672953,0.0004294815,0.0000033838433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24128133,0.013214586,0.3098803,0.0020793136,0.0018089699,0.20974761,0.0028211188,0.000020847277,0.0003248578,0.00009976547,0.028625531,0.19009578],"study_design_scores_gemma":[0.12806444,0.0010629438,0.68162537,0.004945856,0.00024306303,0.18343897,0.000039903,0.00011120581,0.00022323037,0.00003997481,0.000038371138,0.00016665744],"about_ca_topic_score_codex":0.00006174651,"about_ca_topic_score_gemma":0.00017241678,"teacher_disagreement_score":0.37174508,"about_ca_system_score_codex":0.000023178463,"about_ca_system_score_gemma":0.00020910149,"threshold_uncertainty_score":0.76169896},"labels":[],"label_agreement":null},{"id":"W4401436077","doi":"10.1093/bjd/ljae266.005","title":"619 - Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Adverse effect; Placebo; Clinical endpoint; Concomitant; Randomized controlled trial; Randomization; Body surface area; Internal medicine; Potency; Dermatology","score_opus":0.014506074665990314,"score_gpt":0.33507238343301954,"score_spread":0.32056630876702924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674756,0.00444174,0.0012321689,0.0008127585,0.0006865478,0.005871269,0.000083888386,0.000029463936,0.00009462958],"genre_scores_gemma":[0.9976927,0.0006556059,0.00041361823,0.0006861148,0.00010005384,0.00024859907,0.00002109245,0.000043875094,0.0001383416],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99484,0.00074306916,0.0031879966,0.00041192214,0.00034915702,0.0004678487],"domain_scores_gemma":[0.9950443,0.0032292183,0.0007075261,0.00019373062,0.00047044898,0.0003547732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009523934,0.00033904202,0.004592313,0.0005336488,0.00009124301,0.0000833985,0.00020732654,0.00028263245,0.00004806476],"category_scores_gemma":[0.0027271074,0.0002747814,0.0006572364,0.00022834208,0.00026387867,0.00030881504,0.00007237578,0.0005156832,0.0000050340254],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9061822,0.004531778,0.03579692,0.0007957783,0.0031555928,0.014776096,0.00058653054,0.00001465708,0.00003929368,0.000047792655,0.003672045,0.030401299],"study_design_scores_gemma":[0.95840913,0.003062353,0.010868627,0.0010601426,0.0019629525,0.018955879,0.00034734377,0.0044729584,0.00015560279,0.00026694936,0.00014135736,0.00029668456],"about_ca_topic_score_codex":0.00003016159,"about_ca_topic_score_gemma":0.000044073095,"teacher_disagreement_score":0.052226935,"about_ca_system_score_codex":0.00004242607,"about_ca_system_score_gemma":0.0005572744,"threshold_uncertainty_score":0.99997044},"labels":[],"label_agreement":null},{"id":"W4401436082","doi":"10.1093/bjd/ljae266.051","title":"677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Flare; Atopic dermatitis; Perspective (graphical); Anxiety; Rating scale; Delphi method; Focus group; Patient-reported outcome; Disease; Family medicine; Clinical psychology; Psychology; Quality of life (healthcare); Psychiatry; Nursing; Dermatology; Internal medicine; Developmental psychology","score_opus":0.023235446533182085,"score_gpt":0.26004902039709454,"score_spread":0.23681357386391247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694697,0.027093992,0.0006718256,0.0007287318,0.00086618564,0.00028565465,0.000060978036,0.000046536225,0.0007763673],"genre_scores_gemma":[0.9981805,0.0005721091,0.0006007481,0.00044692264,0.0000953954,0.000011229646,0.00006197385,0.000025481475,0.0000056109075],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99771386,0.0003144367,0.0011443954,0.00022667734,0.00036070935,0.00023994588],"domain_scores_gemma":[0.99870425,0.00028581414,0.00035202331,0.00018407089,0.00028577814,0.0001880303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006059319,0.00017451146,0.00079569395,0.00034656728,0.000090093585,0.000096333635,0.0001761676,0.0001896304,0.00012274808],"category_scores_gemma":[0.00032927105,0.00018139355,0.00025013054,0.00025127703,0.00013133463,0.000486475,0.00006573728,0.0004827478,0.000015102729],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001022068,0.0073508983,0.29605362,0.0019457072,0.004609286,0.47012934,0.015290985,0.000016015294,0.0012290402,0.0015858348,0.12611382,0.0746534],"study_design_scores_gemma":[0.014935874,0.0009059376,0.4407664,0.0078027635,0.0024611265,0.4930651,0.00779449,0.0006946046,0.004293728,0.02204512,0.004540126,0.00069475616],"about_ca_topic_score_codex":0.00013605566,"about_ca_topic_score_gemma":0.000097364675,"teacher_disagreement_score":0.14471278,"about_ca_system_score_codex":0.00004111078,"about_ca_system_score_gemma":0.0002551654,"threshold_uncertainty_score":0.7397014},"labels":[],"label_agreement":null},{"id":"W4401436098","doi":"10.1093/bjd/ljae266.008","title":"624 - Vitiligo biomarker CXCL10 correlates with clinical response in the phase 2 randomized, double-blind, vehicle-controlled TRuE-V mechanism of action study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Lynde Centre for Dermatology","funders":"Astellas Pharma; LEO Pharma; Galderma; Incyte; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Vitiligo; Medicine; Ruxolitinib; Tolerability; Biomarker; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Gastroenterology; Oncology; Adverse effect; Myelofibrosis","score_opus":0.036421545958138866,"score_gpt":0.36755087238286055,"score_spread":0.3311293264247217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933766,0.0024162435,0.0022764024,0.00050837395,0.00054568687,0.00080544734,0.000005482998,0.000004414283,0.000061342376],"genre_scores_gemma":[0.9989647,0.0006638457,0.00008083142,0.00009939042,0.000087984605,0.00004322373,0.000014250637,0.0000151042395,0.000030650306],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962558,0.0021118536,0.0010661599,0.00019436097,0.00021702425,0.00015476884],"domain_scores_gemma":[0.9987188,0.0005844182,0.0003816699,0.0001381067,0.00012746034,0.00004954562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002784613,0.00012513313,0.00065617217,0.00014806044,0.00004775482,0.000060251823,0.00019099303,0.00018156515,0.000022462502],"category_scores_gemma":[0.00029922772,0.00008954381,0.0002526251,0.00014191639,0.0001441844,0.000016688204,0.0000241899,0.00029217894,0.000002126453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9604597,0.001131089,0.00088150776,0.000027933294,0.0008087891,0.003335949,0.0003571465,0.000008119677,0.027701251,0.00012246227,0.00082295964,0.0043430924],"study_design_scores_gemma":[0.933799,0.002380051,0.001025759,0.0002126307,0.00058117055,0.03944971,0.0025645397,0.001070602,0.01808429,0.0003511315,0.00028454402,0.0001965447],"about_ca_topic_score_codex":0.000020840962,"about_ca_topic_score_gemma":0.00006728678,"teacher_disagreement_score":0.03611376,"about_ca_system_score_codex":0.000009641046,"about_ca_system_score_gemma":0.00014472663,"threshold_uncertainty_score":0.36514908},"labels":[],"label_agreement":null},{"id":"W4401436102","doi":"10.1093/bjd/ljae266.106","title":"733 - Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Placebo; Arcadia; Randomized controlled trial; Internal medicine; Post-hoc analysis; Clinical endpoint; Anesthesia; Dermatology","score_opus":0.01626430918366514,"score_gpt":0.2993289737933812,"score_spread":0.2830646646097161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566698,0.037919506,0.00012473231,0.0045504794,0.00021005461,0.0001225862,0.00023163484,0.000019120927,0.00015204815],"genre_scores_gemma":[0.9964279,0.0021515368,0.0004222208,0.00080030435,0.00003444377,0.000002886748,0.00010278843,0.000019006462,0.00003893672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758244,0.00047253238,0.0011123602,0.0002949591,0.00025408468,0.00028365446],"domain_scores_gemma":[0.9983833,0.00056314137,0.00028373642,0.00036453997,0.000188674,0.00021660523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039433874,0.00016315747,0.001058784,0.001201566,0.000050878003,0.000057957084,0.0003259759,0.0002098915,0.00012978504],"category_scores_gemma":[0.0008363458,0.00017163937,0.00016908615,0.00087169936,0.00030110966,0.000365904,0.00014831522,0.0004905899,0.0000069767557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041481443,0.0007104247,0.60821563,0.0014751471,0.0060698446,0.29937294,0.0032038216,0.00004363457,0.0006594288,0.00045389982,0.038013186,0.03763388],"study_design_scores_gemma":[0.002029907,0.00010800895,0.6737878,0.0011450965,0.0017941854,0.31535476,0.0005079102,0.002954489,0.00019756953,0.00018816048,0.0017824795,0.00014966613],"about_ca_topic_score_codex":0.00010592318,"about_ca_topic_score_gemma":0.0005377767,"teacher_disagreement_score":0.06557212,"about_ca_system_score_codex":0.00003436513,"about_ca_system_score_gemma":0.0004852137,"threshold_uncertainty_score":0.69992507},"labels":[],"label_agreement":null},{"id":"W4401436130","doi":"10.1093/bjd/ljae266.102","title":"729 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group; Lynde Centre for Dermatology; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Atopic dermatitis; Placebo; Internal medicine; Randomized controlled trial; Body surface area; Adverse effect; Dosing; Gastroenterology; Immunology; Pathology","score_opus":0.014972394820659766,"score_gpt":0.3125974713425097,"score_spread":0.29762507652184994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401436130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791871,0.007370097,0.001421722,0.0074116057,0.00037305537,0.003865584,0.000019304121,0.000023556333,0.00032803317],"genre_scores_gemma":[0.99727094,0.0009776179,0.00051881303,0.0009034133,0.00006643295,0.00018081065,0.000010079226,0.000028385539,0.000043517106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99661833,0.00077954034,0.0014794415,0.00032553557,0.0004720602,0.00032510227],"domain_scores_gemma":[0.99784774,0.0010712594,0.0002625368,0.00021208212,0.00034874026,0.0002576458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007954134,0.0002574241,0.0016000195,0.00048107372,0.000095959105,0.00010413895,0.00029331952,0.000107799104,0.00008969945],"category_scores_gemma":[0.0005708174,0.00018525247,0.0002085753,0.00028109757,0.00021780451,0.00024286631,0.00009928998,0.00051626994,0.000010975619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94761646,0.002531353,0.011172116,0.000277375,0.0019722774,0.023322783,0.003577144,0.0004170684,0.0000080728505,0.00015852654,0.0035693496,0.0053774863],"study_design_scores_gemma":[0.9064306,0.00045673066,0.010131499,0.0031764146,0.000843888,0.07306853,0.0012234359,0.0038965791,0.00004419649,0.000100279925,0.00042033783,0.00020752303],"about_ca_topic_score_codex":0.00011143601,"about_ca_topic_score_gemma":0.00046160744,"teacher_disagreement_score":0.049745742,"about_ca_system_score_codex":0.000058772905,"about_ca_system_score_gemma":0.00021057867,"threshold_uncertainty_score":0.7554376},"labels":[],"label_agreement":null},{"id":"W4401506767","doi":"10.1093/bjd/ljae312","title":"Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Mycosis fungoides; Pathological; Internal medicine; Gastroenterology; Stage (stratigraphy); Cumulative incidence; Cohort; Incidence (geometry); Multivariate analysis; Peripheral T-cell lymphoma; Dermatology; Lymphoma; Immunology; T cell","score_opus":0.03614740506937778,"score_gpt":0.34180196940525753,"score_spread":0.30565456433587973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401506767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9288592,0.06028687,0.0006749587,0.009581787,0.00017720733,0.00027531805,0.000017129836,0.000036801786,0.000090777845],"genre_scores_gemma":[0.9943564,0.00301488,0.0016293831,0.0007801706,0.0000644954,0.000009851631,0.0000036809952,0.00003075079,0.0001104067],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99791753,0.00031855502,0.00079930335,0.0002703667,0.00031162013,0.0003826158],"domain_scores_gemma":[0.99883986,0.0003038335,0.00011672155,0.000114912255,0.00033296034,0.00029172612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033289372,0.00016627084,0.00069557334,0.0003182179,0.000140472,0.00023090579,0.000097084296,0.00019675613,0.00014990344],"category_scores_gemma":[0.001679804,0.0001569333,0.00022539316,0.0002900634,0.00043614034,0.0001614213,0.00009671003,0.00064602826,0.000020921274],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029509957,0.00019564606,0.07610941,0.0003366752,0.0001635982,0.89535993,0.0002010052,0.0000011230328,0.0018183036,0.00008387854,0.0017485132,0.023686787],"study_design_scores_gemma":[0.0016697068,0.0003857565,0.0022873136,0.000277049,0.00023331268,0.9886994,0.00065161346,0.0005361962,0.0011523989,0.00020388879,0.0037711302,0.00013225229],"about_ca_topic_score_codex":0.000037006408,"about_ca_topic_score_gemma":0.000039753377,"teacher_disagreement_score":0.09333942,"about_ca_system_score_codex":0.000060988634,"about_ca_system_score_gemma":0.00025819795,"threshold_uncertainty_score":0.6399554},"labels":[],"label_agreement":null},{"id":"W4401566375","doi":"10.1093/bjd/ljae321","title":"Recent progress in Stevens–Johnson syndrome/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development","keywords":"Toxic epidermal necrolysis; Medicine; Mucocutaneous zone; Disease; Immunology; Drug development; Drug; Intensive care medicine; Dermatology; Pathology; Pharmacology","score_opus":0.04020037571583161,"score_gpt":0.34639283790205094,"score_spread":0.3061924621862193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401566375","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056503867,0.99147254,0.0000034423201,0.0007751139,0.00093894504,0.00091161043,0.00011028005,0.000034592522,0.00010307332],"genre_scores_gemma":[0.0052460553,0.99386585,0.00024239902,0.00004994556,0.0001976412,0.00015391558,0.00005923526,0.00011466361,0.00007029118],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99612635,0.0006251415,0.0018959632,0.00049351127,0.0003018189,0.00055719377],"domain_scores_gemma":[0.9977969,0.0005950166,0.00078445097,0.00027104677,0.00015949247,0.0003930834],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002465471,0.0005414745,0.003965603,0.0010378683,0.0000710542,0.00010292618,0.00015988018,0.0005646769,0.000029539537],"category_scores_gemma":[0.00043764673,0.00049473945,0.0007130305,0.0005769431,0.00019826285,0.0001565099,0.000085618274,0.0009162182,0.00006385566],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055989053,0.00038926993,0.00013953095,0.004457834,0.0007392761,0.21930592,0.000031644773,7.982482e-8,6.003778e-7,0.000002415747,0.00029133615,0.7746365],"study_design_scores_gemma":[0.0007689411,0.00008213727,0.0011446769,0.029568842,0.004628075,0.52464664,0.000039780098,0.0000022060567,0.0000013682009,0.000008072702,0.4389161,0.00019315879],"about_ca_topic_score_codex":0.0000211747,"about_ca_topic_score_gemma":0.00006737385,"teacher_disagreement_score":0.7744433,"about_ca_system_score_codex":0.0006364123,"about_ca_system_score_gemma":0.00094060303,"threshold_uncertainty_score":0.99975044},"labels":[],"label_agreement":null},{"id":"W4402217252","doi":"10.1093/bjd/ljae350","title":"Management of dupilumab-related ocular surface disorders","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"NF-κB Signaling Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Dermatology; Atopic dermatitis","score_opus":0.004848859978758261,"score_gpt":0.21373847114722366,"score_spread":0.2088896111684654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402217252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43081668,0.23834892,0.002584218,0.31202212,0.0075995736,0.0010557737,0.00045041446,0.00007400224,0.0070483116],"genre_scores_gemma":[0.89398056,0.03172213,0.0041393675,0.061110225,0.0016593393,0.00001511398,0.0010876177,0.00047554704,0.005810116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975615,0.00023709616,0.0010554758,0.00038090715,0.0003566705,0.0004083568],"domain_scores_gemma":[0.9986728,0.000025110834,0.0007151551,0.0003282191,0.00019127337,0.00006748585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019590132,0.00030163434,0.0006979145,0.00013140545,0.000046434652,0.000044003107,0.0006131939,0.0010555163,0.00006736996],"category_scores_gemma":[0.000028854502,0.000362458,0.0005329061,0.00014581859,0.0002228131,0.0000053974168,0.00021458686,0.0012947667,0.000027382088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031761985,0.000063536245,0.0001323204,0.0008594154,0.0018070203,0.035735544,0.0000209119,0.0000860118,0.00469698,0.000027761977,0.95388365,0.0026550828],"study_design_scores_gemma":[0.0012417579,0.00018258906,0.00007460032,0.0014024943,0.0005534177,0.06991892,0.000045341614,0.000013605137,0.015316478,0.0009776711,0.90979254,0.0004806039],"about_ca_topic_score_codex":0.00002192701,"about_ca_topic_score_gemma":0.000009747378,"teacher_disagreement_score":0.46316388,"about_ca_system_score_codex":0.00002498054,"about_ca_system_score_gemma":0.00013154937,"threshold_uncertainty_score":0.99988276},"labels":[],"label_agreement":null},{"id":"W4402348974","doi":"10.1093/bjd/ljae342","title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"Eli Lilly Japan; Sanofi Genzyme; Otsuka Pharmaceutical; Genentech; National Jewish Health; Torii Pharmaceutical; Kiniksa Pharmaceuticals; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Castle Biosciences; Celgene; BioCryst; Sun Pharma; Dermira; Valeant Pharmaceuticals International; Pfizer; Incyte; Regeneron Pharmaceuticals; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; LEO Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen","keywords":"Medicine; Atopic dermatitis; Dosing; Pharmacovigilance; Omalizumab; Adverse effect; MEDLINE; Expert opinion; Clinical trial; Intensive care medicine; Internal medicine; Dermatology; Immunology","score_opus":0.05098543487854836,"score_gpt":0.34486040565998033,"score_spread":0.293874970781432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402348974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89300156,0.015896678,0.01445989,0.07188018,0.003513993,0.00043859257,0.00018546179,0.000048332782,0.0005753023],"genre_scores_gemma":[0.98367083,0.00022700544,0.009673726,0.005620278,0.00064412656,0.000014296015,0.000023156721,0.00002488294,0.000101698904],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9983265,0.00011735465,0.00068549666,0.0001834844,0.00043270172,0.00025450345],"domain_scores_gemma":[0.99815995,0.00072574563,0.0001494281,0.0001262798,0.0006328871,0.00020572997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002523079,0.00013558891,0.00042082125,0.00009210297,0.00011955746,0.00014576531,0.00019563016,0.00014594433,0.0002080248],"category_scores_gemma":[0.0019487761,0.00011331957,0.00030105005,0.00012636476,0.00012996577,0.00024838178,0.00006872899,0.00035090325,0.000032701133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015760775,0.00013631946,0.020950204,0.000059978338,0.00055172644,0.040884536,0.00017846025,0.000008369851,0.00019047405,0.00019122369,0.9281422,0.008548931],"study_design_scores_gemma":[0.00196428,0.00006506708,0.015543747,0.0010016947,0.00047859168,0.50242126,0.00024556392,0.0017261561,0.001188479,0.0010749269,0.47413874,0.00015146742],"about_ca_topic_score_codex":0.00018856913,"about_ca_topic_score_gemma":0.00016989127,"teacher_disagreement_score":0.46153674,"about_ca_system_score_codex":0.00027131304,"about_ca_system_score_gemma":0.0014649325,"threshold_uncertainty_score":0.4621038},"labels":[],"label_agreement":null},{"id":"W4402580517","doi":"10.1093/bjd/ljae361","title":"Sexual dysfunction following retinoid treatment: a systematic review","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Ottawa","funders":"","keywords":"Medicine; Sexual dysfunction; Systematic review; MEDLINE; Dermatology; Internal medicine; Biology","score_opus":0.02778182518277294,"score_gpt":0.33667438710238196,"score_spread":0.308892561919609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402580517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020313695,0.996932,0.000016573424,0.00018757624,0.0009951624,0.0015391104,0.000016153695,0.000032043066,0.00026102274],"genre_scores_gemma":[0.00006475762,0.9976723,0.00004675836,0.00018514378,0.00027100326,0.00008609501,0.00008338733,0.00006896485,0.0015215692],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970563,0.0004278738,0.0016867145,0.0002645489,0.00027005264,0.00029449057],"domain_scores_gemma":[0.99842435,0.0001453126,0.00092631136,0.00022098164,0.0000887367,0.00019428463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002356219,0.00042410666,0.006174112,0.00024152746,0.000089794135,0.0000580816,0.00011446341,0.00036504463,0.000036458303],"category_scores_gemma":[0.00021060822,0.0002724042,0.0018670055,0.00026814704,0.00003207976,0.000083813655,0.000029832267,0.0005247668,0.00018797992],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056361623,0.00011682315,0.00000199059,0.76113325,0.0033597471,0.071147546,0.000013923477,3.3550793e-9,7.2657215e-8,0.0000039639626,0.010355996,0.15386102],"study_design_scores_gemma":[0.0004004522,0.0002574708,1.6557019e-7,0.45521733,0.044899907,0.3512432,0.000010019639,4.6226617e-7,1.4826766e-7,0.0000023663986,0.14787416,0.00009432696],"about_ca_topic_score_codex":0.000012573252,"about_ca_topic_score_gemma":0.0000031141326,"teacher_disagreement_score":0.30591595,"about_ca_system_score_codex":0.0002580329,"about_ca_system_score_gemma":0.00045610307,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W4403129964","doi":"10.1093/bjd/ljae377","title":"Do large language model chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Les Laboratories Pierre Fabre; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Readability; Medicine; Computer science","score_opus":0.047603648428009106,"score_gpt":0.3650601324547645,"score_spread":0.31745648402675536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403129964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594134,0.001332409,0.0002466446,0.0012828014,0.00040287094,0.00038301776,0.000010998847,0.000020470363,0.0003794349],"genre_scores_gemma":[0.99920875,0.00007210923,0.00017083561,0.0004219961,0.0000759972,0.000023402767,0.0000138735595,0.000008707586,0.0000043416303],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9984292,0.00012413708,0.0008318622,0.000117032614,0.0002673731,0.00023043485],"domain_scores_gemma":[0.9993147,0.00010049155,0.00018295365,0.00010069686,0.00019973422,0.00010137727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021723539,0.000105326006,0.00031695183,0.00042456063,0.00008668495,0.00011603503,0.00006586676,0.00008727081,0.000030540938],"category_scores_gemma":[0.0001147125,0.00010221962,0.00006231015,0.00021703633,0.000028624208,0.000545,0.000022969629,0.0004938072,0.000022012668],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065837573,0.001691475,0.14696135,0.00027919392,0.00013839974,0.004480331,0.5049231,0.0007726604,0.00009110998,0.00013392884,0.0037541625,0.3361159],"study_design_scores_gemma":[0.0017257166,0.0069777225,0.18170908,0.008180175,0.00024149234,0.051335957,0.64517766,0.08856003,0.00940572,0.0010310337,0.0048501124,0.000805276],"about_ca_topic_score_codex":0.00027103833,"about_ca_topic_score_gemma":0.00030441533,"teacher_disagreement_score":0.3353106,"about_ca_system_score_codex":0.00014060002,"about_ca_system_score_gemma":0.00014134552,"threshold_uncertainty_score":0.41683954},"labels":[],"label_agreement":null},{"id":"W4403202892","doi":"10.1093/bjd/ljae381","title":"Dr James Alastair Carruthers, 1945–2024","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Obituary; Philosophy; Medicine; Theology","score_opus":0.008943873608809808,"score_gpt":0.3311130863782508,"score_spread":0.322169212769441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403202892","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41309607,0.48180425,0.016099162,0.054638676,0.017431676,0.00037256698,0.00002921956,0.00019386837,0.016334508],"genre_scores_gemma":[0.97291434,0.014841322,0.0038648727,0.0023487604,0.0014297852,0.0000039340416,0.000003719362,0.00004492688,0.0045483187],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9989445,0.000087669294,0.00044181032,0.00013843275,0.00015078622,0.00023675709],"domain_scores_gemma":[0.99935937,0.00021513611,0.00010686437,0.000089188565,0.00010147202,0.00012798997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012491048,0.00010592458,0.0004624714,0.00016342652,0.00006438935,0.0000287543,0.00011684739,0.00018636606,0.0005980798],"category_scores_gemma":[0.00010095528,0.0000994955,0.00019206287,0.00015703116,0.00026226003,0.0001469809,0.000016635258,0.000654867,0.00004176308],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031507455,0.00017902614,0.008650783,0.00026630616,0.000840393,0.16095094,0.00065572973,0.000012098658,0.0006195522,0.00076691544,0.5668054,0.25993776],"study_design_scores_gemma":[0.0008760481,0.00016381285,0.0009084445,0.00042379272,0.00009050772,0.5155818,0.00022331928,0.000053415984,0.00039345145,0.00102697,0.48018703,0.000071422975],"about_ca_topic_score_codex":0.0000071788245,"about_ca_topic_score_gemma":0.000010149097,"teacher_disagreement_score":0.55981827,"about_ca_system_score_codex":0.000075063756,"about_ca_system_score_gemma":0.0002912576,"threshold_uncertainty_score":0.65485543},"labels":[],"label_agreement":null},{"id":"W4403329069","doi":"10.1093/bjd/ljae386","title":"Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Office of the Director; National Heart, Lung, and Blood Institute; National Institute of Mental Health; Medical Research Council; National Cancer Institute; National Institutes of Health; Medical Research Council Canada; Common Fund; Wellcome Trust","keywords":"Copy number analysis; Biology; Copy-number variation; PTEN; Gene duplication; Comparative genomic hybridization; Exome sequencing; Chromosomal translocation; Genetics; Chromosome; Cancer research; Gene; Mutation; Genome","score_opus":0.019732912421197842,"score_gpt":0.29447862983088224,"score_spread":0.2747457174096844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403329069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656456,0.030039633,0.00009890807,0.0034236943,0.0005047618,0.00015810994,0.000005949692,0.000017034485,0.00010627109],"genre_scores_gemma":[0.9976314,0.00071674905,0.0010887192,0.00025668167,0.00013436194,0.0000046123027,0.000015099981,0.000016523829,0.00013585523],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988497,0.00006774964,0.0005080552,0.00014382905,0.00024048837,0.00019020711],"domain_scores_gemma":[0.9993892,0.00020599991,0.00009714854,0.000057743633,0.00013236384,0.000117586824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000034959543,0.000102559396,0.00038331316,0.00026177138,0.000033776116,0.00003120948,0.00007082211,0.00007791679,0.000112275],"category_scores_gemma":[0.000044152745,0.00010566825,0.00015609663,0.00016099542,0.000046282425,0.00013241431,0.000025290788,0.0002759285,0.00004596739],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016651438,0.00058979844,0.3331561,0.00030528515,0.00062310894,0.58734196,0.0004622632,0.00002852701,0.0011286031,0.00045957553,0.0072824564,0.06845577],"study_design_scores_gemma":[0.0019968066,0.000073791234,0.17016652,0.0011521075,0.00013092966,0.8183057,0.00020291432,0.00014730643,0.0026612016,0.002551879,0.0025178886,0.00009298194],"about_ca_topic_score_codex":0.00014460325,"about_ca_topic_score_gemma":0.000057769696,"teacher_disagreement_score":0.23096368,"about_ca_system_score_codex":0.00008276536,"about_ca_system_score_gemma":0.00026508808,"threshold_uncertainty_score":0.43090263},"labels":[],"label_agreement":null},{"id":"W4403501334","doi":"10.1093/bjd/ljae382","title":"Overtreatment of dysplastic naevi: results of a multiregional UK questionnaire study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Plant Pathogens and Fungal Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Family medicine","score_opus":0.007731717279609807,"score_gpt":0.24565735486320597,"score_spread":0.23792563758359617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403501334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809492,0.017673662,0.0003441963,0.00006962308,0.00023941408,0.000095690346,0.00052605337,0.0000032411635,0.00009888659],"genre_scores_gemma":[0.9987742,0.0009189352,0.00013807291,0.000016599817,0.00006567268,0.000002730385,0.000039560702,0.0000085133815,0.00003572304],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989709,0.0001017204,0.0005261022,0.0001415294,0.0001450818,0.00011464731],"domain_scores_gemma":[0.99943626,0.000037526228,0.00020381255,0.00009045311,0.00016382686,0.000068099784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008459249,0.00009013425,0.00026277913,0.00007290836,0.000024051722,0.000011435712,0.000110185865,0.000078361016,0.0000058773167],"category_scores_gemma":[0.00019101486,0.00008837702,0.00014857885,0.00006456287,0.000067270696,0.00000499208,0.000038248527,0.00007627337,0.0000012605956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044384026,0.0052206516,0.1887014,0.00085969764,0.003354086,0.042081665,0.00042209149,0.0004304826,0.68175846,0.00031937097,0.039272808,0.033140898],"study_design_scores_gemma":[0.010754628,0.0053161327,0.691905,0.0037078615,0.0010918574,0.21305166,0.00077484327,0.0006800622,0.06661673,0.00025750973,0.0052036787,0.0006399985],"about_ca_topic_score_codex":0.000035543446,"about_ca_topic_score_gemma":0.00005237157,"teacher_disagreement_score":0.6151417,"about_ca_system_score_codex":0.000008501004,"about_ca_system_score_gemma":0.00015641237,"threshold_uncertainty_score":0.36039102},"labels":[],"label_agreement":null},{"id":"W4403623250","doi":"10.1093/bjd/ljae406","title":"Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Discontinuation; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Psoriasis; Placebo; Plaque psoriasis; Randomized controlled trial; Clinical trial; Gastroenterology; Dermatology; Pathology","score_opus":0.014479805038292212,"score_gpt":0.2706572667441224,"score_spread":0.25617746170583017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403623250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925267,0.0039530345,0.0004364172,0.00023841218,0.0014788721,0.0009516961,0.0003384069,0.00003591494,0.000040553972],"genre_scores_gemma":[0.9984708,0.00028704345,0.00047747485,0.00011797019,0.00019502318,0.000058093185,0.00031523223,0.000041442385,0.000036940837],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995158,0.0023525148,0.0014044729,0.0005200458,0.00009757444,0.00046737873],"domain_scores_gemma":[0.99874884,0.0003846774,0.0003970419,0.00015239566,0.00016107966,0.00015594276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00068944256,0.00035145538,0.0017975338,0.0003385094,0.0001445918,0.00012467732,0.00019812214,0.00048041387,0.00007498942],"category_scores_gemma":[0.0002491788,0.00029909637,0.00023415907,0.00025019347,0.00027066018,0.0003292178,0.00006464767,0.0006546783,0.000018197226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9169119,0.0017882456,0.011289996,0.000020899752,0.001543663,0.0043658344,0.0022076291,0.0000047721282,0.00021074276,0.00002691051,0.0008840832,0.060745347],"study_design_scores_gemma":[0.9738365,0.0033965618,0.009358883,0.00048694556,0.0008506554,0.009617456,0.00032002278,0.00005196771,0.0010696725,0.00027062267,0.0002993515,0.0004413536],"about_ca_topic_score_codex":0.00022132875,"about_ca_topic_score_gemma":0.00037609518,"teacher_disagreement_score":0.060303994,"about_ca_system_score_codex":0.000054261196,"about_ca_system_score_gemma":0.0003228049,"threshold_uncertainty_score":0.9999461},"labels":[],"label_agreement":null},{"id":"W4403665664","doi":"10.1093/bjd/ljae402","title":"Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized double-blinded active-controlled comparative clinical study over 52 weeks","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Amgen","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Clinical endpoint; Adverse effect; Internal medicine; Psoriasis; Randomization; Gastroenterology; Dermatology; Adalimumab; Disease","score_opus":0.027337013886964728,"score_gpt":0.3263798375749371,"score_spread":0.29904282368797236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403665664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291545,0.002411777,0.00021733443,0.0011452644,0.0007384775,0.002379774,0.000047706835,0.000011068727,0.00013312495],"genre_scores_gemma":[0.99917424,0.00018002467,0.00026445385,0.00026606556,0.000028454147,0.000027092714,0.0000030510457,0.000016482438,0.000040145005],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99413824,0.0032786825,0.0017503025,0.0003629157,0.00012959311,0.00034026112],"domain_scores_gemma":[0.996721,0.0021768096,0.0005488913,0.00018909574,0.00028958434,0.00007458192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012690085,0.0002661756,0.0025164296,0.00022797054,0.00012059744,0.00005494701,0.00032645022,0.000413294,0.000095221854],"category_scores_gemma":[0.00036024678,0.00016655702,0.00032355133,0.0003622419,0.00063410477,0.00013785674,0.00013199434,0.0011622717,0.0000028631434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9659307,0.0023596499,0.019484194,0.000039523096,0.0044837873,0.00033719544,0.0009152445,0.000025174597,0.00008481951,0.00022023208,0.0012725182,0.0048469664],"study_design_scores_gemma":[0.8218519,0.00102928,0.17091896,0.0006421021,0.0010153087,0.0024956022,0.00037850082,0.00008345824,0.00076952047,0.00016485379,0.00037536293,0.0002751803],"about_ca_topic_score_codex":0.00003987394,"about_ca_topic_score_gemma":0.00015429157,"teacher_disagreement_score":0.15143475,"about_ca_system_score_codex":0.000039351336,"about_ca_system_score_gemma":0.000208081,"threshold_uncertainty_score":0.6791998},"labels":[],"label_agreement":null},{"id":"W4403667407","doi":"10.1093/bjd/ljae404","title":"Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Clinical endpoint; Randomized controlled trial; Dupilumab; Adverse effect; Internal medicine; Dermatology; Clinical trial; Dermatology Life Quality Index; Severity of illness; Disease","score_opus":0.04700225101236575,"score_gpt":0.359323760572684,"score_spread":0.31232150956031823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403667407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919589,0.003348368,0.00029851246,0.0012659974,0.00030146597,0.0024986826,0.00016848787,0.000025665297,0.00013391106],"genre_scores_gemma":[0.9983728,0.0004176646,0.00076636375,0.0002731084,0.00003563313,0.000034229637,0.000037568218,0.000043895358,0.000018724115],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954237,0.0009850624,0.0021539049,0.00053732377,0.0004552817,0.0004447447],"domain_scores_gemma":[0.9972997,0.00083976716,0.0005481756,0.00031274042,0.00045325342,0.00054640445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006294827,0.00034942766,0.0024479062,0.0005973127,0.00011251737,0.00010517426,0.000355456,0.00022905399,0.000015280852],"category_scores_gemma":[0.0013574607,0.00032666433,0.0000871746,0.00047924236,0.00036063467,0.0004762437,0.00018450277,0.0006051126,0.0000025801376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92072195,0.011452329,0.009046418,0.0011756907,0.0009687594,0.017155558,0.002753105,0.000031970598,0.00005272964,0.00003896057,0.0012385079,0.035364028],"study_design_scores_gemma":[0.81135964,0.0028296073,0.13608347,0.00994702,0.00065353053,0.03674666,0.000995404,0.0006270634,0.00032123458,0.000060456172,0.00006231459,0.00031359904],"about_ca_topic_score_codex":0.0002117584,"about_ca_topic_score_gemma":0.0009335455,"teacher_disagreement_score":0.12703705,"about_ca_system_score_codex":0.000054160904,"about_ca_system_score_gemma":0.00048095605,"threshold_uncertainty_score":0.9999185},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4403976052","doi":"10.1093/bjd/ljae428","title":"The future of patient-reported outcome measurement in hyperhidrosis lies in thoughtful, evidence-based implementation","year":2024,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute for Health and Care Research","keywords":"Hyperhidrosis; Medicine; Patient-reported outcome; Outcome (game theory); MEDLINE; Intensive care medicine; Medical physics; Family medicine; Dermatology; Quality of life (healthcare); Nursing; Political science","score_opus":0.05520966782668938,"score_gpt":0.3184707973099928,"score_spread":0.2632611294833034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403976052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44794044,0.12477066,0.000005662414,0.42478412,0.0016465102,0.00077089394,0.000028698661,0.000015083752,0.000037937534],"genre_scores_gemma":[0.9478451,0.007242675,0.00019935826,0.043891724,0.0006418883,0.000067261775,0.00004072364,0.000053772386,0.00001748925],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955817,0.00045654405,0.0022729174,0.00027263336,0.0010051739,0.00041103715],"domain_scores_gemma":[0.9977659,0.0003026149,0.0011534228,0.00025740516,0.00045966424,0.000061018465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005397048,0.00028994647,0.0011890049,0.0005702348,0.00006343577,0.00006234795,0.00022161586,0.0005114397,0.000045186767],"category_scores_gemma":[0.00023653304,0.00022721472,0.00040749557,0.00037629792,0.000117171156,0.00013084758,0.00003957094,0.0015984225,0.0000051500133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047109454,0.00039262223,0.5743092,0.0011972093,0.0009594278,0.08898058,0.00056326285,0.000003245929,0.00020520469,0.000008219058,0.26633704,0.066572905],"study_design_scores_gemma":[0.018902654,0.0018101418,0.3009526,0.03360626,0.0039000588,0.21084112,0.0036475167,0.000030575964,0.008941167,0.0007952202,0.4155344,0.001038262],"about_ca_topic_score_codex":0.0002389753,"about_ca_topic_score_gemma":0.0009835088,"teacher_disagreement_score":0.49990466,"about_ca_system_score_codex":0.00042358504,"about_ca_system_score_gemma":0.00062515825,"threshold_uncertainty_score":0.92655474},"labels":[],"label_agreement":null},{"id":"W4404149846","doi":"10.1093/bjd/ljae432","title":"Exploration of the mutational landscape of cutaneous leiomyoma confirms <i>FH</i> as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Wellcome Trust","keywords":"Purine; Leiomyoma; Gene; Biology; Purine analogue; Computational biology; Cancer research; Bioinformatics; Medicine; Genetics; Pathology; Biochemistry; Enzyme","score_opus":0.012709794551547308,"score_gpt":0.2679911303786871,"score_spread":0.2552813358271398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404149846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9451943,0.051296905,0.00016355881,0.0024992598,0.00041226207,0.00012732853,0.000012990543,0.0000074998475,0.0002858744],"genre_scores_gemma":[0.9975541,0.0018371929,0.00012825002,0.00013854116,0.00011822801,0.0000034424731,0.0000066196512,0.000010088568,0.0002034862],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99887544,0.00012126001,0.00054378394,0.00011297007,0.0002183275,0.00012824348],"domain_scores_gemma":[0.9992587,0.000110301895,0.00026582897,0.000053014246,0.0002681047,0.00004406241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095784046,0.000096994205,0.0004244728,0.00010348515,0.000084316154,0.000024227958,0.000077926605,0.000084416904,0.00008381494],"category_scores_gemma":[0.00006778921,0.00007777954,0.0001369099,0.00011836955,0.00030637914,0.00021916276,0.00004741981,0.000226239,0.00000334928],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060489806,0.002607037,0.028978257,0.0030254377,0.014845029,0.23975284,0.014809357,0.0007743426,0.5639521,0.011849607,0.014047318,0.099309705],"study_design_scores_gemma":[0.002507427,0.00069979427,0.024850447,0.00032320395,0.0012121986,0.90325373,0.002897507,0.0001996138,0.050864,0.011202216,0.001841455,0.00014840797],"about_ca_topic_score_codex":0.000027252621,"about_ca_topic_score_gemma":0.000015162166,"teacher_disagreement_score":0.6635009,"about_ca_system_score_codex":0.000006915551,"about_ca_system_score_gemma":0.00017527066,"threshold_uncertainty_score":0.31717578},"labels":[],"label_agreement":null},{"id":"W4404200238","doi":"10.1093/bjd/ljae443","title":"Disabling pansclerotic morphoea: a century of discovery","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Department of Paediatrics, University of Melbourne; National Institute of Allergy and Infectious Diseases; American Academy of Allergy, Asthma and Immunology Foundation","keywords":"Morphea; Medicine; Dermatology","score_opus":0.038371095859378236,"score_gpt":0.3223701915766471,"score_spread":0.28399909571726883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404200238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096130464,0.9965959,0.000023028932,0.00007653233,0.0017008522,0.00036184533,0.00009143592,0.000016670227,0.00017243801],"genre_scores_gemma":[0.009012995,0.9902934,0.000051995605,0.00003711368,0.00038241455,0.000008533411,0.00003538977,0.00007205701,0.00010612206],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99671215,0.00023380244,0.002153491,0.00024040003,0.00036591894,0.00029423245],"domain_scores_gemma":[0.9979234,0.00019848447,0.0012650941,0.00021604565,0.00017921647,0.00021777379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016165402,0.00030335496,0.0035034372,0.0004083074,0.000035322675,0.00006865209,0.00024150706,0.0005129781,0.00005727724],"category_scores_gemma":[0.0002619885,0.00023486564,0.0017739374,0.00037139366,0.00016474263,0.00012544957,0.00007640143,0.0009469471,0.00003528834],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042409658,0.00038998004,0.00010438803,0.085128166,0.0032700151,0.022006284,0.00005787681,5.137244e-7,0.000012306061,0.000070191454,0.01888351,0.87003434],"study_design_scores_gemma":[0.0006896965,0.000060275303,0.00004352114,0.35707435,0.0101113515,0.4241062,0.00012410873,0.0000017346998,0.000004177825,0.000019506653,0.2075932,0.00017185723],"about_ca_topic_score_codex":0.00001762304,"about_ca_topic_score_gemma":0.0000012925086,"teacher_disagreement_score":0.8698625,"about_ca_system_score_codex":0.00009377412,"about_ca_system_score_gemma":0.0007722656,"threshold_uncertainty_score":0.95775425},"labels":[],"label_agreement":null},{"id":"W4404403485","doi":"10.1093/bjd/ljae441","title":"Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Kyowa Kirin International; Université de Lausanne; Canadian Dermatology Foundation; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Mycosis fungoides; Pathogenesis; Erythroderma; Pathology; Cutaneous T-cell lymphoma; Disease; Medicine; Bone marrow; Epidermis (zoology); Biology; Lymphoma; Immunology","score_opus":0.17278817015948203,"score_gpt":0.4877713858132075,"score_spread":0.31498321565372545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404403485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013506595,0.9843137,0.000018258103,0.0011461345,0.0002240204,0.000723615,0.000030813124,0.0000135083765,0.000023321056],"genre_scores_gemma":[0.016309103,0.9832938,0.00014038348,0.000050636856,0.00008848819,0.000036521193,0.000009889621,0.000050695602,0.000020521342],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99654293,0.00049512606,0.0018785256,0.00042856636,0.0002764309,0.00037839075],"domain_scores_gemma":[0.9975805,0.0011847425,0.00046946367,0.00017737375,0.00025634296,0.0003315275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064770906,0.00028570252,0.0028036698,0.0006810868,0.000088208864,0.0001331616,0.00020740092,0.0003613391,0.000018292345],"category_scores_gemma":[0.0015450171,0.00026928575,0.00040193126,0.0004335074,0.00036734622,0.0001343319,0.00024043454,0.0017110913,0.000016364625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017429236,0.00018454996,0.019812668,0.02294392,0.00038222002,0.032436695,0.000046918125,1.2359648e-8,4.5143042e-7,0.00003550504,0.0019088751,0.9222308],"study_design_scores_gemma":[0.00039869724,0.00015105866,0.0027572007,0.081753306,0.0013580518,0.8506321,0.000037380134,0.000007894028,1.5793398e-7,0.00018569133,0.06255285,0.00016562919],"about_ca_topic_score_codex":0.00002459579,"about_ca_topic_score_gemma":0.000067322406,"teacher_disagreement_score":0.92206514,"about_ca_system_score_codex":0.00015141442,"about_ca_system_score_gemma":0.0010819276,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W4404410709","doi":"10.1093/bjd/ljae447","title":"Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 cases","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Wellcome Trust","keywords":"Carcinogenesis; Somatic cell; Fusion gene; YAP1; Gene; Biology; Mutation; Cancer research; Genetics; Somatic fusion; Transcription factor","score_opus":0.046430757716539456,"score_gpt":0.3075137331645374,"score_spread":0.26108297544799797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404410709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892895,0.009703188,0.00006200532,0.0003086167,0.00037443428,0.00015314824,0.000016530188,0.0000060059097,0.000086545995],"genre_scores_gemma":[0.99871415,0.0010144478,0.00010093307,0.000030959185,0.000102350736,0.000005702981,0.0000010800227,0.0000095863525,0.00002077752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989096,0.000058657224,0.0005279598,0.0001207235,0.00026125892,0.00012179881],"domain_scores_gemma":[0.9993846,0.00010027667,0.00013849002,0.00009581314,0.00021146491,0.000069386195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009512792,0.00007865556,0.00038448768,0.0001364515,0.00008059526,0.000014340525,0.00008196686,0.000029830626,0.00004370958],"category_scores_gemma":[0.00012114949,0.00006571338,0.000098531615,0.00015493271,0.00021248082,0.00013563213,0.000054137523,0.00023478504,6.4362507e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001910928,0.00043262338,0.95279384,0.0002003289,0.0003633114,0.038897373,0.0013196765,0.000019300272,0.0007791793,0.00020468542,0.00051337876,0.0042851926],"study_design_scores_gemma":[0.0011947236,0.0003120205,0.70233375,0.0003568721,0.00014205121,0.29451707,0.00035537634,0.00001562854,0.00046677602,0.00014416708,0.00012521594,0.000036324225],"about_ca_topic_score_codex":0.00025768552,"about_ca_topic_score_gemma":0.00013819765,"teacher_disagreement_score":0.2556197,"about_ca_system_score_codex":0.00004291264,"about_ca_system_score_gemma":0.00018010417,"threshold_uncertainty_score":0.26797137},"labels":[],"label_agreement":null},{"id":"W4404532483","doi":"10.1093/bjd/ljae454","title":"Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Portugal; Janssen Australia; Caisse nationale de l'Assurance Maladie; Bristol-Myers Squibb Canada; AbbVie Canada; Psoriasis Association; LEO Pharma; Assistance publique-Hôpitaux de Paris; Cilag; University of Manchester; British Association of Dermatologists; Almirall; Boehringer Ingelheim España; Assistance Publique - Hôpitaux de Paris; Manchester Biomedical Research Centre","keywords":"Biosimilar; Adalimumab; Medicine; Psoriasis; Multinational corporation; Cohort; Internal medicine; Cohort study; Oncology; Family medicine; Dermatology; Business; Disease","score_opus":0.013596104107275651,"score_gpt":0.2890731079822312,"score_spread":0.27547700387495555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404532483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98360956,0.010094313,0.00279118,0.0016243928,0.0008753392,0.0005693349,0.00020392935,0.00002543594,0.00020651775],"genre_scores_gemma":[0.9956036,0.00024505542,0.003923827,0.000049803628,0.00003688082,0.0000105343215,0.0000110918745,0.000016567605,0.0001026057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983423,0.00041294182,0.00070341036,0.00022689927,0.00008083282,0.00023361342],"domain_scores_gemma":[0.9982743,0.0010171181,0.00026170525,0.00007950086,0.00032555708,0.000041786236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681839,0.0001487503,0.0007223734,0.00015754347,0.00012928768,0.00003458748,0.00014917382,0.0001412618,0.00008582582],"category_scores_gemma":[0.00019307822,0.00012516101,0.00012589178,0.00016552402,0.0003159332,0.000099369136,0.000038879458,0.0002977845,8.64652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066608037,0.0026331886,0.85012037,0.0008373484,0.011210697,0.0029786306,0.0014716414,0.0000148118725,0.009880121,0.00459328,0.021253806,0.0883453],"study_design_scores_gemma":[0.046459675,0.003556345,0.6526658,0.0028474499,0.0052373977,0.16000037,0.009492441,0.0011384295,0.050346393,0.0018906733,0.06476641,0.0015985995],"about_ca_topic_score_codex":0.000039549308,"about_ca_topic_score_gemma":0.000120661505,"teacher_disagreement_score":0.19745456,"about_ca_system_score_codex":0.000027949753,"about_ca_system_score_gemma":0.000117864896,"threshold_uncertainty_score":0.5103918},"labels":[],"label_agreement":null},{"id":"W4404568156","doi":"10.1093/bjd/ljae457","title":"Tailored bioengineering and nanomedicine strategies for sex-specific healing of chronic wounds","year":2024,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Wound healing; Modalities; Clinical trial; Health care; Healthcare system; Intensive care medicine; Chronic wound; Surgery; Pathology","score_opus":0.04389997851501952,"score_gpt":0.3444212572089619,"score_spread":0.30052127869394235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404568156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034827305,0.9973887,0.00068145606,0.00027434694,0.000835456,0.00036710638,0.000038205384,0.000019963907,0.000046452704],"genre_scores_gemma":[0.007285599,0.99092495,0.0010617132,0.000011430642,0.0005322756,0.000018436227,0.00004768731,0.000062107494,0.00005581739],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980033,0.00005095652,0.0012667312,0.00021518458,0.00016819086,0.00029563133],"domain_scores_gemma":[0.99880165,0.00023509416,0.00049283105,0.00016320242,0.00015329178,0.00015394237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018917215,0.00027168344,0.0026110467,0.00043427185,0.000058081012,0.000052091957,0.00012580706,0.0003066659,0.0000106003545],"category_scores_gemma":[0.00006211526,0.00023528817,0.00039798595,0.0001764201,0.00015689095,0.0000662278,0.00003605981,0.00054801453,0.0000020811274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036969326,0.00012253675,0.000013947237,0.102667294,0.0014594318,0.006538355,0.00013654734,0.0000018898153,0.000008047841,0.0002959175,0.0035271759,0.8851919],"study_design_scores_gemma":[0.0013939658,0.0005403009,0.0000045372954,0.070492,0.002555717,0.28935903,0.00015052535,0.000025259442,0.0000051247544,0.00032350436,0.6350015,0.00014856752],"about_ca_topic_score_codex":0.00001570355,"about_ca_topic_score_gemma":0.0000056117324,"teacher_disagreement_score":0.8850433,"about_ca_system_score_codex":0.0001565119,"about_ca_system_score_gemma":0.0008561529,"threshold_uncertainty_score":0.9594773},"labels":[],"label_agreement":null},{"id":"W4404646375","doi":"10.1093/bjd/ljae462","title":"Genome sequencing reveals novel <i>IKBKG</i> structural variants associated with incontinentia pigmenti","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Genome Canada","funders":"Paul Foundation","keywords":"Incontinentia pigmenti; Genetics; Genome; Biology; DNA sequencing; Gene; Whole genome sequencing; Computational biology","score_opus":0.006453289211267948,"score_gpt":0.21746943278972014,"score_spread":0.2110161435784522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404646375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147666,0.013772728,0.0035990444,0.00019134005,0.00043678767,0.000092219096,0.000068171335,0.000012610236,0.00035045424],"genre_scores_gemma":[0.9981093,0.00033272017,0.00079783326,0.00021328221,0.00021265261,0.000002493388,0.000078753954,0.000030822688,0.00022218353],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9987534,0.000087650384,0.0004417337,0.0002334451,0.00017888285,0.00030483076],"domain_scores_gemma":[0.9992978,0.000019448553,0.0002164957,0.00012219492,0.00020815228,0.00013592467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012991397,0.00015044402,0.000285075,0.000072840456,0.00008722137,0.00011061937,0.00023281148,0.00016237507,0.00004846531],"category_scores_gemma":[0.00010098111,0.00014505627,0.00013940061,0.00012306287,0.000108749,0.000014291748,0.00007210889,0.00020059673,0.0000035089652],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015047495,0.00011422941,0.015863936,0.0001444648,0.0016694163,0.012498193,0.00013114822,0.00016357127,0.95879394,0.000087679204,0.008021336,0.002361609],"study_design_scores_gemma":[0.0072149024,0.0007961186,0.37540612,0.0019660476,0.0010273821,0.55807745,0.00037996945,0.0004147817,0.039357137,0.0012964963,0.012648416,0.0014151912],"about_ca_topic_score_codex":0.0000127344765,"about_ca_topic_score_gemma":0.000029008,"teacher_disagreement_score":0.9194368,"about_ca_system_score_codex":0.00002996804,"about_ca_system_score_gemma":0.00030896242,"threshold_uncertainty_score":0.59152234},"labels":[],"label_agreement":null},{"id":"W4405227144","doi":"10.1093/bjd/ljae439","title":"Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"LEO Pharma","keywords":"Medicine; Dosing; Eczema Area and Severity Index; Atopic dermatitis; Post-hoc analysis; Population; Internal medicine; Adverse effect; Dermatology; Environmental health","score_opus":0.006344643202463898,"score_gpt":0.2356969828714622,"score_spread":0.22935233966899832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405227144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948358,0.002953691,0.000287502,0.00092049874,0.00018132603,0.00026603107,0.000022782708,0.000028021817,0.0005043398],"genre_scores_gemma":[0.9985235,0.00006070473,0.0010543182,0.00026194358,0.00003583877,0.000007503878,0.000014908125,0.000029721203,0.000011617031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982699,0.00013183635,0.0007600939,0.000205663,0.00031410507,0.0003184015],"domain_scores_gemma":[0.99905497,0.00010909331,0.00022155639,0.00012701299,0.0003011964,0.00018618625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000075357035,0.00016584643,0.0006994474,0.00037046766,0.00006142332,0.000048139336,0.00014464291,0.00013862066,0.000055716802],"category_scores_gemma":[0.000097868055,0.0001471043,0.000082835206,0.00038166982,0.00014207925,0.00039004773,0.000021819367,0.00044997138,0.0000030208325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041069888,0.00025439812,0.9750013,0.000532695,0.00022938447,0.01866352,0.00039383012,0.000056001198,0.000026728518,0.00004421098,0.0009225446,0.0034647237],"study_design_scores_gemma":[0.0048440658,0.00021997646,0.8656747,0.0051997867,0.00019242782,0.12217953,0.0001089083,0.00013345153,0.0010461081,0.00020871653,0.000032100477,0.00016023127],"about_ca_topic_score_codex":0.00007569449,"about_ca_topic_score_gemma":0.00013778795,"teacher_disagreement_score":0.10932657,"about_ca_system_score_codex":0.00005827503,"about_ca_system_score_gemma":0.00038935445,"threshold_uncertainty_score":0.59987396},"labels":[],"label_agreement":null},{"id":"W4405229307","doi":"10.1093/bjd/ljae360.126","title":"P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interim analysis; Plaque psoriasis; Interim; Psoriasis; Retrospective cohort study; Dermatology; Internal medicine; Clinical trial; History","score_opus":0.01386349948587046,"score_gpt":0.27420053712202475,"score_spread":0.2603370376361543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305177,0.0023938054,0.00039874436,0.000022420252,0.00044821727,0.0005222213,0.0031251782,0.000014430957,0.000023221293],"genre_scores_gemma":[0.9983161,0.0005509021,0.00037866837,0.0000069548373,0.000023078921,0.000013586404,0.0006812627,0.000021821157,0.000007633333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785775,0.00070196966,0.0007415136,0.0004036474,0.00008133429,0.00021380163],"domain_scores_gemma":[0.9979684,0.00058392447,0.0004935092,0.0003285865,0.0005843555,0.000041260242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025737743,0.00019507886,0.0011552927,0.00047814412,0.0000843642,0.000023636821,0.0003349898,0.0001552579,0.000056531513],"category_scores_gemma":[0.00015883567,0.00017326004,0.00015047516,0.00045169925,0.00018286784,0.00028952534,0.000105868516,0.0001869571,0.0000016046685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013156164,0.0021140159,0.92769676,0.0001281598,0.026641782,0.0003555784,0.0013888124,0.0000052705486,0.0009608797,0.00010731208,0.00019361451,0.027251625],"study_design_scores_gemma":[0.012907446,0.0012208816,0.9732274,0.00045047284,0.007778647,0.00033991996,0.0012001911,0.000052394527,0.00253578,0.00005588597,0.0000575681,0.00017342063],"about_ca_topic_score_codex":0.0011732093,"about_ca_topic_score_gemma":0.004724821,"teacher_disagreement_score":0.04553061,"about_ca_system_score_codex":0.000054423304,"about_ca_system_score_gemma":0.00009962228,"threshold_uncertainty_score":0.7065339},"labels":[],"label_agreement":null},{"id":"W4405229310","doi":"10.1093/bjd/ljae360.051","title":"P21 Development of a novel multidisciplinary care model for screening and managing patients with psoriatic arthritis: consensus guidance for primary care providers in Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriatic arthritis; Multidisciplinary approach; Medicine; Primary care; Arthritis; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.012021041866497151,"score_gpt":0.24146255019775067,"score_spread":0.2294415083312535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92753804,0.065307826,0.005757697,0.00023773816,0.0001261071,0.0008236246,0.00018491186,0.0000054756947,0.000018570816],"genre_scores_gemma":[0.9174863,0.0002438335,0.08207481,0.00004257695,0.000013448479,0.00006332337,0.000049332164,0.000022826636,0.0000035170053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880713,0.000011789274,0.00057494076,0.00018387783,0.0001738466,0.0002484374],"domain_scores_gemma":[0.99922234,0.00010622489,0.00017553529,0.000052780575,0.0003664986,0.00007663369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000040298313,0.00012932913,0.0005174786,0.000108069384,0.00010497092,0.000015487181,0.00004296488,0.000041596933,4.0602245e-7],"category_scores_gemma":[0.000037881247,0.00013049316,0.000053341846,0.000070332055,0.00005365037,0.00006537174,0.000035324247,0.000106688945,1.9102888e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022965046,0.00028874268,0.31134045,0.0094031235,0.0010003136,0.0057774913,0.009640952,0.00070626586,0.000034516004,0.00002748853,0.000470312,0.6590138],"study_design_scores_gemma":[0.13672249,0.0016637316,0.663186,0.06881949,0.0010232431,0.04134753,0.052686166,0.03201524,0.0005730215,0.00011626181,0.00076504005,0.0010817379],"about_ca_topic_score_codex":0.006445142,"about_ca_topic_score_gemma":0.28747186,"teacher_disagreement_score":0.6579321,"about_ca_system_score_codex":0.0002977823,"about_ca_system_score_gemma":0.0014443441,"threshold_uncertainty_score":0.97431695},"labels":[],"label_agreement":null},{"id":"W4405229326","doi":"10.1093/bjd/ljae360.064","title":"P34 The incidence and prevalence of psoriasis in Newfoundland and Labrador, Canada","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psoriasis; Incidence (geometry); Medicine; Geography; Demography; Epidemiology; Dermatology; Pathology; Sociology","score_opus":0.007111329557458947,"score_gpt":0.2156186800416515,"score_spread":0.20850735048419256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8410278,0.15758987,0.000009794875,0.0007100993,0.00051316613,0.000054545406,0.000026678588,0.0000031217019,0.00006492942],"genre_scores_gemma":[0.9878476,0.011882232,0.000033215536,0.00006130035,0.000019342693,0.0000024214987,0.0000015670608,0.0000055140194,0.00014680627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991242,0.0002184529,0.00034777663,0.000115795076,0.000037381687,0.00015638469],"domain_scores_gemma":[0.99934345,0.00040913673,0.00011545313,0.00006543654,0.000046119876,0.000020424128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016438006,0.00008379091,0.00026841988,0.00007515038,0.000060292125,0.000019941748,0.00012755895,0.00009948201,0.00004785578],"category_scores_gemma":[0.0000853438,0.00006808936,0.00003176775,0.00010300014,0.00019017483,0.00010144493,0.000042445852,0.0002002461,0.0000013193686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002180859,0.00008159159,0.69982326,0.0005206279,0.00052760006,0.006661995,0.0011458411,0.000002165883,0.004453349,0.00078881474,0.005996759,0.27977988],"study_design_scores_gemma":[0.0016164238,0.000097573306,0.796236,0.00066966197,0.00022075945,0.18938744,0.00027080777,0.0000072278553,0.0025565552,0.0003867039,0.00841337,0.0001374796],"about_ca_topic_score_codex":0.097167745,"about_ca_topic_score_gemma":0.36104456,"teacher_disagreement_score":0.2796424,"about_ca_system_score_codex":0.00003319489,"about_ca_system_score_gemma":0.0002959665,"threshold_uncertainty_score":0.9088443},"labels":[],"label_agreement":null},{"id":"W4405229705","doi":"10.1093/bjd/ljae360.145","title":"P115 Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-23 inhibitors: a 52-week multicentre retrospective review","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Women's College Hospital; McMaster University","keywords":"Medicine; Discontinuation; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Adverse effect; Plaque psoriasis; Body surface area; Gastroenterology; Interleukin 17; Retrospective cohort study; Dermatology; Cytokine","score_opus":0.008607231824469994,"score_gpt":0.24633820757110672,"score_spread":0.23773097574663674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717377,0.02525788,0.000068072055,0.0005525863,0.00121774,0.0008751581,0.0001817615,0.00002503485,0.00008409229],"genre_scores_gemma":[0.9928004,0.005998874,0.00064976054,0.00015404062,0.000055954657,0.00010326404,0.000056890247,0.0000325186,0.0001482873],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99782616,0.00027365316,0.0010525578,0.00035208176,0.00009707277,0.00039845658],"domain_scores_gemma":[0.998539,0.0002648499,0.00042690328,0.00017519378,0.0005305571,0.00006351178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014906169,0.00024659344,0.000944606,0.00038804047,0.00007308932,0.000025233185,0.00027339833,0.00019561817,0.0000767389],"category_scores_gemma":[0.00028741048,0.00022332784,0.00022190824,0.00048472808,0.00012350861,0.00023426795,0.000054913235,0.0003012405,0.000022416132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011117625,0.0042725164,0.41707426,0.004470915,0.0035442698,0.0067294524,0.01772723,0.0000073989427,0.0051117986,0.0005842921,0.05281428,0.47654596],"study_design_scores_gemma":[0.06399168,0.010573634,0.58232427,0.10569769,0.002996426,0.039601758,0.005240607,0.000010874935,0.15132253,0.00031757928,0.035334524,0.002588414],"about_ca_topic_score_codex":0.00018949537,"about_ca_topic_score_gemma":0.0015909777,"teacher_disagreement_score":0.47395754,"about_ca_system_score_codex":0.00017057887,"about_ca_system_score_gemma":0.00018944948,"threshold_uncertainty_score":0.91070443},"labels":[],"label_agreement":null},{"id":"W4405229751","doi":"10.1093/bjd/ljae360.045","title":"P15 Evaluating risankizumab for moderate-to-severe plaque psoriasis: real-world outcomes from an international study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Ustekinumab; Psoriasis; Plaque psoriasis; Adalimumab; Adverse effect; Internal medicine; Randomized controlled trial; Severity of illness; Dermatology; Disease","score_opus":0.04039434091804939,"score_gpt":0.33980244830136674,"score_spread":0.29940810738331736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405229751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888813,0.0027573337,0.00058274704,0.00096753467,0.005498978,0.00046784448,0.00038449027,0.00007000358,0.0003898007],"genre_scores_gemma":[0.9973105,0.00024590088,0.0011591329,0.0001879632,0.0002585477,0.00007496193,0.00018012177,0.000039532082,0.00054332556],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977729,0.000522522,0.0008600894,0.00038331875,0.00010945903,0.0003517262],"domain_scores_gemma":[0.9986203,0.0006298276,0.00024537474,0.00018741624,0.00024702464,0.0000700649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003716369,0.00023675148,0.00069114845,0.00036749087,0.00021295254,0.00015409039,0.00046169353,0.00020412322,0.0004936963],"category_scores_gemma":[0.00017354141,0.0002359018,0.00025090514,0.00014533017,0.000046411977,0.00039933948,0.000072223665,0.00031508028,0.000089330635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007374597,0.002990557,0.26951528,0.00007085938,0.014763283,0.008996738,0.005760507,0.00030664625,0.006014719,0.0010235669,0.028824156,0.6543591],"study_design_scores_gemma":[0.064556405,0.0048659625,0.7603733,0.001644708,0.0057386816,0.08844484,0.008270427,0.0010756153,0.020014318,0.0082149925,0.034283172,0.002517596],"about_ca_topic_score_codex":0.00061153714,"about_ca_topic_score_gemma":0.001456037,"teacher_disagreement_score":0.65184146,"about_ca_system_score_codex":0.00010443038,"about_ca_system_score_gemma":0.000225521,"threshold_uncertainty_score":0.9619796},"labels":[],"label_agreement":null},{"id":"W4405665962","doi":"10.1093/bjd/ljae502","title":"Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Calgary Laboratory Services; SKiN Health; University of Calgary","funders":"Janssen Research and Development; LEO Pharma; Janssen Scientific Affairs; Celgene; Amgen; Pfizer; Eli Lilly and Company; Language Literacy and Culture, University of Maryland, Baltimore County","keywords":"Medicine; Placebo; Psoriasis; Internal medicine; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology; Pathology","score_opus":0.011350609452663618,"score_gpt":0.2568854939495789,"score_spread":0.24553488449691527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405665962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972839,0.016987275,0.000101195015,0.00051955745,0.0013484195,0.007804542,0.0003492036,0.000010347327,0.00004045425],"genre_scores_gemma":[0.9970031,0.0017297118,0.000045985114,0.000023125282,0.00005152813,0.00095667614,0.000023616163,0.00002030418,0.00014596125],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99618775,0.0014645389,0.0017163033,0.00023793938,0.000093895156,0.0002995907],"domain_scores_gemma":[0.9958518,0.002906668,0.0007119016,0.00023014199,0.00027088256,0.000028619672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007275687,0.00023677971,0.0016902979,0.00028150636,0.00014236518,0.000023808863,0.0003282375,0.00019819486,0.000027251823],"category_scores_gemma":[0.000516744,0.00013734208,0.0006744296,0.0002998494,0.00014097826,0.00008537607,0.00003581031,0.00017517475,0.000003769848],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91143763,0.0065521523,0.0010766318,0.00006312195,0.0056106327,0.0002700163,0.0057560885,0.00017135951,0.0004102891,0.00005264576,0.0023363526,0.06626306],"study_design_scores_gemma":[0.9813832,0.0020924387,0.00063821144,0.00018606255,0.0021431244,0.0015287435,0.00077079,0.000086134496,0.009401518,0.00012264367,0.0014882276,0.00015892608],"about_ca_topic_score_codex":0.00019492154,"about_ca_topic_score_gemma":0.0002840683,"teacher_disagreement_score":0.06994552,"about_ca_system_score_codex":0.000079329,"about_ca_system_score_gemma":0.0002598148,"threshold_uncertainty_score":0.56006473},"labels":[],"label_agreement":null},{"id":"W4405962344","doi":"10.1093/bjd/ljae433","title":"Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Deutsche Forschungsgemeinschaft","keywords":"Melanoma; Immune system; Cancer research; Sirtuin; Infiltration (HVAC); Proteome; Sirtuin 1; Immune checkpoint; Proteomics; Biology; Immunology; Medicine; Computational biology; Immunotherapy; Bioinformatics; Genetics; Gene; Downregulation and upregulation","score_opus":0.013698859260636203,"score_gpt":0.28508294349239865,"score_spread":0.27138408423176247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405962344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927289,0.0021339164,0.0014059017,0.0026388448,0.00035882916,0.00034391382,0.000008575482,0.0000083828,0.00037276975],"genre_scores_gemma":[0.99717665,0.0002466933,0.00171368,0.0004723581,0.00025072368,0.000007670068,0.000007951486,0.000019089179,0.00010519527],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9983593,0.00010183157,0.00094776513,0.00013792678,0.00024935845,0.00020376797],"domain_scores_gemma":[0.99932873,0.00007292179,0.00019780718,0.00010357621,0.00015584665,0.0001411236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030373607,0.00010580223,0.0005994593,0.00038665836,0.000027839067,0.000021957294,0.000105595835,0.0001483447,0.00007191299],"category_scores_gemma":[0.0001728984,0.00009854299,0.00011486665,0.00020326846,0.00007424039,0.0000774248,0.000025221661,0.00042583008,0.0000026220714],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003914116,0.00040073146,0.031368084,0.0008963076,0.00009843013,0.05095333,0.0009970517,0.000011568509,0.8874427,0.00013314719,0.008345114,0.018962122],"study_design_scores_gemma":[0.009246821,0.0040540933,0.101441,0.00843436,0.00038736846,0.50693065,0.0007140864,0.00096275035,0.36139712,0.0006362041,0.005387944,0.00040761905],"about_ca_topic_score_codex":0.00019368803,"about_ca_topic_score_gemma":0.00029606096,"teacher_disagreement_score":0.52604556,"about_ca_system_score_codex":0.000050581177,"about_ca_system_score_gemma":0.00018872457,"threshold_uncertainty_score":0.40184662},"labels":[],"label_agreement":null},{"id":"W4406207363","doi":"10.1093/bjd/ljaf019","title":"Mechanistic insights into ruxolitinib cream for mild hidradenitis suppurativa","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Ruxolitinib; Medicine; Dermatology; Family medicine; Internal medicine; Disease","score_opus":0.01721475976789652,"score_gpt":0.2843255510579181,"score_spread":0.2671107912900216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406207363","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010922954,0.008451044,0.0027401268,0.9810121,0.0022466292,0.0013191245,0.00032116272,0.00006462407,0.0027529092],"genre_scores_gemma":[0.8910988,0.0035442773,0.008372073,0.07575201,0.006691005,0.00025848497,0.0029060661,0.00027455966,0.011102714],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9962081,0.00035107214,0.0016432547,0.00050375296,0.0005683806,0.0007254702],"domain_scores_gemma":[0.99667937,0.0008834852,0.00091422495,0.0003426361,0.0009163852,0.00026389866],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.000008792939,0.00057111337,0.002238625,0.0007289757,0.0003009,0.00013373706,0.00042119774,0.00150189,0.00032765762],"category_scores_gemma":[0.0006404987,0.00059670006,0.00082026556,0.00024367217,0.000244217,0.00023825513,0.00007727535,0.0023954038,0.00003946984],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001172328,0.00018477575,0.000048993945,0.00067456544,0.00063169753,0.46813762,0.000120710516,7.7030515e-9,0.000033346943,0.00014551161,0.52711576,0.0027897612],"study_design_scores_gemma":[0.0037852041,0.0004976252,0.000027561426,0.001956434,0.001002601,0.6164136,0.000065111766,0.000007039886,0.00085918064,0.0051161023,0.36999768,0.00027185824],"about_ca_topic_score_codex":0.000103211896,"about_ca_topic_score_gemma":0.000057028366,"teacher_disagreement_score":0.9052601,"about_ca_system_score_codex":0.00025994075,"about_ca_system_score_gemma":0.0011260678,"threshold_uncertainty_score":0.9999061},"labels":[],"label_agreement":null},{"id":"W4406249011","doi":"10.1093/bjd/ljaf015","title":"Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; Epidermolysis Bullosa Medical Research Foundation; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Academy of Nutrition and Dietetics; Georgia Clinical and Translational Science Alliance","keywords":"Missense mutation; splice; Splice site mutation; Genotype; Genetics; Disease; Exon; Medicine; Biology; Internal medicine; Mutation; Gene; Alternative splicing","score_opus":0.013163642067973907,"score_gpt":0.2655083367997697,"score_spread":0.25234469473179577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406249011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857406,0.0078167,0.0038143052,0.0016823484,0.0003831185,0.00010037504,0.0000153097,0.000004523132,0.00044272517],"genre_scores_gemma":[0.9977767,0.0013408896,0.000171688,0.00014019752,0.00015830893,0.000011252564,0.00013149218,0.000009066243,0.0002604416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984729,0.00040910227,0.000480255,0.00025414332,0.0001286588,0.0002549358],"domain_scores_gemma":[0.9991552,0.0000559547,0.00020994735,0.0001660831,0.00030144904,0.000111322945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027558857,0.00010915211,0.0002585772,0.00014784491,0.00010505287,0.00003008952,0.00024050538,0.00020495096,0.0000489195],"category_scores_gemma":[0.0010144487,0.00012483289,0.00013534093,0.00020733931,0.00019875512,0.0000071462337,0.00009338529,0.00031641207,0.000005914531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003501036,0.0013374907,0.63910407,0.00028919155,0.000878971,0.041447476,0.000056878165,0.00008165873,0.19206606,0.0016671459,0.040437046,0.079133004],"study_design_scores_gemma":[0.002823955,0.000102878446,0.9093727,0.00021678625,0.000103525796,0.064370476,0.00016312113,0.0002471532,0.011416023,0.003222134,0.007627398,0.00033388668],"about_ca_topic_score_codex":0.000019051575,"about_ca_topic_score_gemma":0.000051631567,"teacher_disagreement_score":0.27026862,"about_ca_system_score_codex":0.000033830966,"about_ca_system_score_gemma":0.00029670104,"threshold_uncertainty_score":0.50905377},"labels":[],"label_agreement":null},{"id":"W4406283031","doi":"10.1093/bjd/ljaf020","title":"Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"Incyte; Sanofi; LEO Pharma; Pfizer","keywords":"Medicine; Epidemiology; Demography; Population; Cross-sectional study; Observational study; Confidence interval; Ethnic group; Gerontology; Environmental health","score_opus":0.0063731671370814685,"score_gpt":0.2589601847066724,"score_spread":0.25258701756959095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406283031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338866,0.015678996,0.000027394579,0.0003010946,0.00019948394,0.00015894415,0.00020062536,8.7043964e-7,0.0000439246],"genre_scores_gemma":[0.9984118,0.0012449684,0.000016877351,0.00014722756,0.00003469916,0.0000025042707,0.000011450052,0.0000047115905,0.00012580634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982781,0.00033527406,0.00088396465,0.00009719079,0.00027992312,0.00012558975],"domain_scores_gemma":[0.9985043,0.0005385378,0.0005295054,0.00011922592,0.00027979608,0.000028659688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042668913,0.0000786399,0.00045528606,0.00008588856,0.00005655587,0.000017591465,0.0001511889,0.00007485879,0.000090279085],"category_scores_gemma":[0.00034436528,0.00006032351,0.00006862484,0.00014456184,0.00026701184,0.00007908738,0.000047085225,0.00020516601,4.7260066e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090220023,0.000041718456,0.99694484,0.00021961295,0.00012426863,0.00018138664,0.00009971974,0.000033225922,0.00019307072,0.000052918433,0.0005254746,0.0006815749],"study_design_scores_gemma":[0.005257125,0.00004003846,0.99061495,0.0011903334,0.000029538318,0.0018574649,0.000018894618,0.00050919206,0.00027338177,0.00012921398,0.00003753716,0.000042300773],"about_ca_topic_score_codex":0.29685423,"about_ca_topic_score_gemma":0.400047,"teacher_disagreement_score":0.103192784,"about_ca_system_score_codex":0.00005283669,"about_ca_system_score_gemma":0.00043319023,"threshold_uncertainty_score":0.70782804},"labels":[],"label_agreement":null},{"id":"W4406733220","doi":"10.1093/bjd/ljae491","title":"Global Delphi consensus on treatment goals for generalized pustular psoriasis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"Boehringer Ingelheim España; Biogen; Amgen","keywords":"Medicine; Delphi method; Disease; Intensive care medicine; Delphi; Psoriasis; Physical therapy; Dermatology; Internal medicine","score_opus":0.039593174392979484,"score_gpt":0.3227014374868438,"score_spread":0.28310826309386433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406733220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005150548,0.9913554,0.000083923485,0.00019326844,0.004236395,0.001129469,0.0020520876,0.000037410286,0.00039695753],"genre_scores_gemma":[0.00016477736,0.9969308,0.00053370936,0.0001016157,0.00020976143,0.00020355123,0.0005547516,0.00004242805,0.0012586194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576956,0.0012347755,0.0017627627,0.00049690995,0.00007000178,0.0006659852],"domain_scores_gemma":[0.99666715,0.0012231112,0.0014028805,0.0003455483,0.00027926295,0.0000820607],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002035427,0.0007114918,0.00439646,0.00035861132,0.00027982597,0.000049590464,0.0005068948,0.0013409512,0.00013050578],"category_scores_gemma":[0.00033231912,0.00061710645,0.0022399807,0.00028355667,0.00017639436,0.00003576395,0.000057039044,0.00027549165,0.00008712186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036656237,0.0004487516,0.000019325225,0.0016805058,0.005679861,0.0027343507,0.000013999,9.888595e-7,0.0000019267873,0.00040547617,0.037110873,0.9515374],"study_design_scores_gemma":[0.006813791,0.0004691196,0.0000113436245,0.0058970526,0.008636708,0.10318701,0.00001929901,1.0169534e-7,0.00007115078,0.00017728706,0.87433064,0.00038647052],"about_ca_topic_score_codex":0.00006626426,"about_ca_topic_score_gemma":0.00008577221,"teacher_disagreement_score":0.9511509,"about_ca_system_score_codex":0.0004446349,"about_ca_system_score_gemma":0.0012829531,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W4406785134","doi":"10.1093/bjd/ljae507","title":"Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Manchester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Atopic dermatitis; Placebo; Medicine; Dose-ranging study; Multicenter study; Dermatology; Internal medicine; Randomized controlled trial; Double blind; Alternative medicine; Pathology","score_opus":0.006689492097948261,"score_gpt":0.2768975909451721,"score_spread":0.2702080988472238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406785134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733023,0.019293733,0.0009098571,0.0028520813,0.0004857203,0.0028885151,0.000028393613,0.000039680282,0.00019971606],"genre_scores_gemma":[0.9962206,0.00086027227,0.0005577151,0.0020655934,0.000071839066,0.00010423677,0.000016118487,0.000025443474,0.00007821285],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99570537,0.0012313166,0.0018956261,0.00039204917,0.00027828943,0.00049736904],"domain_scores_gemma":[0.99702454,0.0017208409,0.0004435299,0.00022520687,0.00024211347,0.0003437922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045575746,0.00034799532,0.0029061995,0.00055612973,0.00020558281,0.00010677463,0.00019576552,0.0002442112,0.00008953106],"category_scores_gemma":[0.0018693466,0.00034373984,0.00030076015,0.0003113142,0.00019663412,0.0002544692,0.000115127325,0.000683449,0.000009482632],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78431815,0.0077382084,0.072207265,0.00034806243,0.0031957966,0.09319248,0.0053711077,0.00016415345,0.0000893265,0.000037675676,0.0100569,0.023280846],"study_design_scores_gemma":[0.9327739,0.000115223134,0.03601961,0.0021866623,0.0013109414,0.022519033,0.0017604653,0.002284165,0.00027086897,0.00021167041,0.00025785933,0.00028962124],"about_ca_topic_score_codex":0.00016360322,"about_ca_topic_score_gemma":0.00024289404,"teacher_disagreement_score":0.14845571,"about_ca_system_score_codex":0.00008473143,"about_ca_system_score_gemma":0.0003686755,"threshold_uncertainty_score":0.9999015},"labels":[],"label_agreement":null},{"id":"W4406822184","doi":"10.1093/bjd/ljaf032","title":"Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Cilag; Manchester Biomedical Research Centre; Sanofi Genzyme; Genentech; Medac; L'Oreal USA; Bausch Health; Celltrion; Astellas Pharma; National Institute for Health and Care Research; Pfizer; Biogen; Incyte; Castle Biosciences; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Sanofi; Amgen; Meiji Seika Pharma; Les Laboratories Pierre Fabre; Galderma; LEO Pharma; Ortho Dermatologics; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Secukinumab; Medicine; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Interleukin 17; Plaque psoriasis; Open label; Dosing; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis; Cytokine","score_opus":0.02186603706440261,"score_gpt":0.27622659060136234,"score_spread":0.25436055353695974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406822184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98954844,0.006127162,0.00007712068,0.0018172706,0.0009961581,0.0009231199,0.000425403,0.000011308958,0.00007401007],"genre_scores_gemma":[0.9978005,0.000987124,0.00025375362,0.0005472451,0.000043877928,0.000018141249,0.00025116798,0.000018416198,0.00007975055],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99766314,0.000663816,0.00084987155,0.0003896879,0.000072921575,0.00036057644],"domain_scores_gemma":[0.9987246,0.00045332106,0.00035888245,0.00027449793,0.00013876236,0.00004995686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021315247,0.00023090362,0.0007662705,0.0001252965,0.0002893479,0.00010666617,0.00045996738,0.0003102206,0.000038927068],"category_scores_gemma":[0.00022592969,0.0001871634,0.000059739476,0.00022589412,0.00016958712,0.00026410192,0.0001686972,0.0004043309,0.000011172732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7341068,0.004965193,0.013096737,0.000015710573,0.0018016805,0.0049267067,0.0024345051,0.000020486013,0.00043624124,0.00009214018,0.012178216,0.2259256],"study_design_scores_gemma":[0.66255796,0.0014302832,0.32590988,0.0008297872,0.00041821031,0.0050712726,0.00018516435,0.000002577448,0.00069738936,0.00008527817,0.0024896788,0.00032249372],"about_ca_topic_score_codex":0.0003013693,"about_ca_topic_score_gemma":0.0004647188,"teacher_disagreement_score":0.31281316,"about_ca_system_score_codex":0.000063908854,"about_ca_system_score_gemma":0.00027652367,"threshold_uncertainty_score":0.7632302},"labels":[],"label_agreement":null},{"id":"W4406933768","doi":"10.1093/bjd/ljaf039","title":"The UK-Irish Atopic eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council","keywords":"Register (sociolinguistics); Medicine; Baseline (sea); Systemic therapy; Cohort; Prospective cohort study; Cohort study; Irish; Pediatrics; Internal medicine","score_opus":0.00918654019646863,"score_gpt":0.26044836561917856,"score_spread":0.2512618254227099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406933768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613079,0.027511194,0.00019853798,0.00816298,0.0012392926,0.00033974045,0.000019215478,0.000011557883,0.0012095881],"genre_scores_gemma":[0.9902974,0.006543535,0.000039214727,0.0022057747,0.00009506246,0.000008762503,0.0000053854856,0.000011718622,0.0007931807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978532,0.00046152805,0.0010671115,0.00013214897,0.0002381577,0.00024785163],"domain_scores_gemma":[0.99784887,0.00047951197,0.00066860963,0.00037662534,0.00054566155,0.00008074187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037457174,0.00013503635,0.0007012103,0.00008267047,0.00021205102,0.000034098273,0.00040426923,0.00017518095,0.00005027584],"category_scores_gemma":[0.00077286694,0.00008983604,0.00030440034,0.00018519693,0.00046363336,0.000053642743,0.00006333282,0.00044211955,0.0000039249394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033289104,0.00013538935,0.8408759,0.0001704118,0.00046316627,0.0022479012,0.000040019066,2.606944e-7,0.00010911336,0.00014954519,0.14618482,0.009290577],"study_design_scores_gemma":[0.0022439994,0.000031170195,0.805234,0.0012408424,0.00029084072,0.16142845,0.0001237206,0.000026942005,0.0010327009,0.00028093148,0.027980937,0.00008543875],"about_ca_topic_score_codex":0.000014436599,"about_ca_topic_score_gemma":0.000012311713,"teacher_disagreement_score":0.15918054,"about_ca_system_score_codex":0.0000310691,"about_ca_system_score_gemma":0.0003776826,"threshold_uncertainty_score":0.36634073},"labels":[],"label_agreement":null},{"id":"W4407108020","doi":"10.1093/bjd/ljae455","title":"Hidradenitis suppurativa<i>: BJD</i> state-of-the-art review series","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hidradenitis suppurativa; Series (stratigraphy); Dermatology; Medicine; Internal medicine; Biology; Paleontology","score_opus":0.006343718646888987,"score_gpt":0.26077806615088006,"score_spread":0.2544343475039911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407108020","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16795138,0.25838587,0.00067705294,0.54240143,0.0029371332,0.0019840668,0.00017946945,0.000070812304,0.02541276],"genre_scores_gemma":[0.97391057,0.021042867,0.00050283823,0.00027583932,0.000030101852,0.000009005399,0.000010665216,0.000014922043,0.0042032083],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981502,0.00025382944,0.0009445928,0.0001317468,0.0002771671,0.00024245944],"domain_scores_gemma":[0.9987837,0.00010044905,0.00042740666,0.00020519142,0.00037891287,0.00010433966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000011258624,0.00015209454,0.00086167234,0.000112549606,0.00010731717,0.000020611675,0.0002102063,0.0000790634,0.00023024455],"category_scores_gemma":[0.00032827875,0.00012666897,0.00031015568,0.0003604662,0.00026218707,0.00025074207,0.00006038969,0.00037305284,0.00002155834],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003606008,0.00079400616,0.08068028,0.0037580444,0.0012418623,0.4714931,0.00025367236,1.2015359e-7,0.0013960298,0.0006565702,0.33964476,0.09972098],"study_design_scores_gemma":[0.0017449695,0.00012052196,0.006092332,0.008091292,0.00036436875,0.93114096,0.000038032045,7.2846245e-7,0.008963691,0.0007778463,0.042581487,0.000083795814],"about_ca_topic_score_codex":0.000013789109,"about_ca_topic_score_gemma":0.000051502288,"teacher_disagreement_score":0.80595917,"about_ca_system_score_codex":0.000046639758,"about_ca_system_score_gemma":0.00044424506,"threshold_uncertainty_score":0.51654106},"labels":[],"label_agreement":null},{"id":"W4407853068","doi":"10.1093/bjd/ljaf066","title":"High prevalence of chronic hand eczema in Europe and Canada","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Family medicine; Medicine; Allergy; Dermatology; Library science","score_opus":0.005345158504312348,"score_gpt":0.21109936650581454,"score_spread":0.20575420800150218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407853068","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3603445,0.07190636,0.00003248275,0.56552136,0.0012211235,0.0003074436,0.0001531508,0.0000060346574,0.0005075387],"genre_scores_gemma":[0.7867571,0.042689644,0.00013049738,0.16748306,0.0009214479,0.0000049669466,0.00003878481,0.000039172937,0.0019352892],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983209,0.00013483295,0.0008768466,0.00015220043,0.00026697086,0.00024824834],"domain_scores_gemma":[0.9987759,0.00017426845,0.00051372964,0.00013036498,0.0003500123,0.000055735738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006200811,0.00016035,0.0009988747,0.00021627695,0.00003124864,0.000027395798,0.00017125541,0.00026083304,0.00010947531],"category_scores_gemma":[0.0002046687,0.00017487553,0.00006544822,0.00011756602,0.00013750244,0.000065740234,0.000063867454,0.0012552985,4.0689153e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021574775,0.000024576304,0.006628392,0.0038216773,0.0001267279,0.11115163,0.000018782324,9.085542e-7,0.000048115766,0.000006918798,0.87283057,0.0053201113],"study_design_scores_gemma":[0.0029416566,0.00014036802,0.12074223,0.010905555,0.00023264629,0.28985515,0.00001308804,0.0000102781105,0.00047210054,0.00003667002,0.5744473,0.0002029841],"about_ca_topic_score_codex":0.10106966,"about_ca_topic_score_gemma":0.22537674,"teacher_disagreement_score":0.4264126,"about_ca_system_score_codex":0.00010720181,"about_ca_system_score_gemma":0.0021686559,"threshold_uncertainty_score":0.9049164},"labels":[],"label_agreement":null},{"id":"W4407853073","doi":"10.1093/bjd/ljaf068","title":"Dermatological care in Muslim patients: a perspective on gender and cultural considerations","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Islamic Studies and History","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto; St Joseph's Health Centre; Queen's University","funders":"","keywords":"Ethnic group; Limiting; Medicine; Islam; Perspective (graphical); Diversity (politics); Population; Family medicine; Alternative medicine; Culturally sensitive; Cultural diversity; Dermatology; Psychology; Sociology; Environmental health; Geography; Pathology; Social psychology","score_opus":0.015981294863556518,"score_gpt":0.3032407317707475,"score_spread":0.28725943690719097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407853073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015141,0.0098554995,0.000014832774,0.0054138214,0.0005270176,0.00014164463,0.000005420719,0.000010002833,0.082517676],"genre_scores_gemma":[0.99769807,0.0010765771,0.00009162174,0.0010701088,0.0000284682,0.0000030535828,5.5676543e-7,0.000002115084,0.00002941296],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.99911606,0.0002523576,0.00025123046,0.0000990853,0.000112290996,0.00016896446],"domain_scores_gemma":[0.9992504,0.00017830594,0.000093956194,0.000028497825,0.00041440036,0.00003440727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000066587076,0.00005746932,0.00022914865,0.00011243006,0.00044020632,0.00004092001,0.00006375416,0.00009332419,0.000028531691],"category_scores_gemma":[0.000612,0.000060210677,0.00004954687,0.0000924644,0.0003838568,0.00009648053,0.000025318808,0.00022373842,0.0000015179064],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007806271,0.0003313435,0.12519257,0.000039317467,0.0001334361,0.003777446,0.22656718,0.0000055753612,0.0000032226383,0.5798289,0.057532266,0.0065106396],"study_design_scores_gemma":[0.003518578,0.00007605721,0.2947269,0.00022197633,0.00005606452,0.003424642,0.65086854,0.0000042926317,0.000010335489,0.015907157,0.03095069,0.00023476225],"about_ca_topic_score_codex":0.00043039708,"about_ca_topic_score_gemma":0.004147952,"teacher_disagreement_score":0.5639218,"about_ca_system_score_codex":0.00024377051,"about_ca_system_score_gemma":0.0001711218,"threshold_uncertainty_score":0.33857557},"labels":[],"label_agreement":null},{"id":"W4408142413","doi":"10.1093/bjd/ljaf061","title":"Congenital melanocytic naevi initiated by <i>BRAF</i> fusion oncogene with firmness, pruritus and desmoplastic stroma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; Fonds de Recherche du Québec - Santé; Melanoma Research Alliance","keywords":"Stroma; Medicine; Dermatology; Nevus; Pathology; Melanoma; Cancer research; Immunohistochemistry","score_opus":0.006758010627951715,"score_gpt":0.2305361639152335,"score_spread":0.22377815328728176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408142413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894479,0.0060142935,0.0014223364,0.0010336107,0.00030059865,0.00021823628,0.00001057137,0.000029351273,0.0015231243],"genre_scores_gemma":[0.99741346,0.0010824554,0.00031363446,0.0007154737,0.000033314183,0.0000048042616,0.000011174102,0.000014600722,0.0004110713],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99889797,0.000080967,0.00046974834,0.00015714315,0.00017647308,0.0002177271],"domain_scores_gemma":[0.9992954,0.00009440913,0.00020324187,0.00008591558,0.00017711258,0.00014391374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007118166,0.00013190495,0.00045165388,0.00017725334,0.00010791899,0.000049485614,0.000070430906,0.00010709885,0.00007885289],"category_scores_gemma":[0.00009142033,0.00012927753,0.000055952845,0.00017905238,0.00013433167,0.00007914692,0.000047924357,0.0002807621,0.000004985553],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009730752,0.002885577,0.18892968,0.0020209986,0.005779202,0.42077312,0.00043284023,0.000021303764,0.04998812,0.0007021456,0.15314908,0.1655872],"study_design_scores_gemma":[0.0105839195,0.0009788829,0.017677933,0.0008558768,0.0008377055,0.9267984,0.0003138976,0.00015817603,0.006185331,0.00010548775,0.03527846,0.00022591934],"about_ca_topic_score_codex":0.000038757185,"about_ca_topic_score_gemma":0.00011991655,"teacher_disagreement_score":0.5060253,"about_ca_system_score_codex":0.000055089557,"about_ca_system_score_gemma":0.00014867284,"threshold_uncertainty_score":0.52717847},"labels":[],"label_agreement":null},{"id":"W4408725089","doi":"10.1093/bjd/ljaf046","title":"A qualitative interview study exploring patients’ views and experiences of treatment for hidradenitis suppurativa in the UK","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Health Technology Assessment Programme; Department of Health and Social Care; National Institute for Health and Care Research","keywords":"Hidradenitis suppurativa; Qualitative research; Medicine; Nonprobability sampling; Patient satisfaction; Health care; Grounded theory; Family medicine; Psychology; Nursing; Disease; Population","score_opus":0.1390809064629161,"score_gpt":0.40525111564292193,"score_spread":0.26617020918000583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408725089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922202,0.0035540601,0.0001052349,0.0028630446,0.00016282329,0.000953764,0.000012579161,0.0000025905838,0.00012569752],"genre_scores_gemma":[0.99872535,0.00061398046,0.00025399786,0.000018145973,0.000014673331,0.0003276903,0.000006554694,0.000006202186,0.00003341031],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9981589,0.00064258976,0.0007737654,0.0001350414,0.00012996027,0.0001597781],"domain_scores_gemma":[0.9989552,0.00049562095,0.00025407257,0.00008992313,0.00016083711,0.00004437207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003031831,0.00012799633,0.0006832987,0.00018108959,0.000072037095,0.00002461038,0.00010432691,0.00004050363,0.00002336472],"category_scores_gemma":[0.00018949671,0.000091089576,0.00012033662,0.00017738943,0.00012527002,0.00016583085,0.000020900632,0.00010778794,4.0409716e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045505067,0.0032843621,0.14553936,0.00020963587,0.00059529516,0.031038186,0.74067926,2.617765e-8,0.000023636387,0.0001668465,0.000469653,0.077538714],"study_design_scores_gemma":[0.014345151,0.004879236,0.02871541,0.0012959371,0.00034099084,0.19744906,0.7513259,0.0000040404325,0.0007714058,0.0003140353,0.00043804498,0.00012075275],"about_ca_topic_score_codex":0.00007219977,"about_ca_topic_score_gemma":0.00024487023,"teacher_disagreement_score":0.16641088,"about_ca_system_score_codex":0.000064317835,"about_ca_system_score_gemma":0.00009646453,"threshold_uncertainty_score":0.3714525},"labels":[],"label_agreement":null},{"id":"W4409088865","doi":"10.1093/bjd/ljaf092","title":"Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Women's College Hospital; University of Toronto","funders":"Strategy for Patient-Oriented Research; Leslie Dan Faculty of Pharmacy, University of Toronto; Canadian Institutes of Health Research; Mitacs; Institute of Chemical and Engineering Sciences; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Minor (academic); Pharmacy; Medicine; Healthcare system; Service (business); Population; Cross-sectional study; Health care; Family medicine; Health services; Business; Environmental health; Marketing; Economic growth; Political science; Pathology","score_opus":0.07400207882187795,"score_gpt":0.359630796639295,"score_spread":0.28562871781741705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409088865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967225,0.00039166032,0.00007409964,0.0009364816,0.0012461542,0.00036217738,0.000135315,0.000003866015,0.00012771059],"genre_scores_gemma":[0.99833655,0.000010940602,0.00011582987,0.0013549066,0.000026664518,0.000012017011,0.00006899335,0.000010040051,0.00006405334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935719,0.00027159273,0.0055809305,0.00021898389,0.00012580883,0.0002308053],"domain_scores_gemma":[0.99574643,0.0003656828,0.003457312,0.000120072924,0.00023367254,0.00007683269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019971104,0.00011756436,0.0009167517,0.00041931798,0.000108293265,0.00005786174,0.00023795055,0.00008546944,0.00028073374],"category_scores_gemma":[0.00039604455,0.0001803068,0.00008706741,0.00016371431,0.000025558598,0.0002389804,0.00003213467,0.0002958661,0.0000064255782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041052976,0.00038260303,0.9981707,0.00016929548,0.00009933351,0.000045602315,0.00027319693,0.00018998397,1.7980513e-7,0.00012939931,0.00038771555,0.00011095806],"study_design_scores_gemma":[0.0032780836,0.000027556405,0.9939019,0.00015063996,0.000010583935,0.00009269263,0.00011596807,0.0009748672,0.0000018050592,0.00023822689,0.0010924498,0.000115216746],"about_ca_topic_score_codex":0.89353937,"about_ca_topic_score_gemma":0.9129801,"teacher_disagreement_score":0.01944075,"about_ca_system_score_codex":0.0013290487,"about_ca_system_score_gemma":0.0013097258,"threshold_uncertainty_score":0.7352698},"labels":[],"label_agreement":null},{"id":"W4409118828","doi":"10.1093/bjd/ljaf119","title":"Transcriptomic skin niches in systemic sclerosis underpin a role for mitochondrial dysfunction","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Arthritis Society; Canadian Institutes of Health Research; National Scleroderma Foundation; Institute of Musculoskeletal Health and Arthritis; Natural Sciences and Engineering Research Council of Canada; Canadian Dermatology Foundation","keywords":"Transcriptome; Niche; Biology; Medicine; Genetics; Ecology; Gene","score_opus":0.013128727620917423,"score_gpt":0.2446767411643741,"score_spread":0.23154801354345667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409118828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171051,0.07557131,0.003287671,0.0013241483,0.001857449,0.0005656071,0.000014980332,0.000021827665,0.00025194942],"genre_scores_gemma":[0.99495155,0.004066317,0.00026769808,0.00034364857,0.0001828161,0.000037847713,0.0000081563385,0.00001776555,0.000124181],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9982434,0.00015442261,0.000992265,0.00018845013,0.00015791297,0.0002635809],"domain_scores_gemma":[0.9991533,0.0001598954,0.00027493582,0.0001119842,0.00019293072,0.00010692391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001451128,0.00012997443,0.0007011501,0.00037965813,0.00006981727,0.00003888271,0.00012489986,0.00028793068,0.000020431517],"category_scores_gemma":[0.0002104892,0.00013393862,0.00033496015,0.00025321826,0.00006439759,0.000103381375,0.00001134217,0.00028090342,0.0000039927886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008116244,0.0020521437,0.047407214,0.002830714,0.0021222648,0.0020367901,0.0010238616,0.0001693168,0.6908229,0.0006916204,0.094411895,0.14831506],"study_design_scores_gemma":[0.12117302,0.0011520871,0.26282436,0.13375904,0.004125396,0.36010757,0.013187091,0.0026456744,0.09215802,0.0031071648,0.0046462095,0.0011143986],"about_ca_topic_score_codex":0.00009320354,"about_ca_topic_score_gemma":0.0000886471,"teacher_disagreement_score":0.5986649,"about_ca_system_score_codex":0.00014988688,"about_ca_system_score_gemma":0.00033663065,"threshold_uncertainty_score":0.54618585},"labels":[],"label_agreement":null},{"id":"W4409146806","doi":"10.1093/bjd/ljaf127","title":"Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Clinical Research; Brock University; Western University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Australian College of Perioperative Nurses","keywords":"Construct validity; Cronbach's alpha; Medicine; Quality of life (healthcare); Cohort; Cohort study; Differential item functioning; Clinical psychology; Confirmatory factor analysis; Criterion validity; Acne; Convergent validity; Psychometrics; Item response theory; Internal consistency; Structural equation modeling; Internal medicine; Statistics","score_opus":0.10567993091205796,"score_gpt":0.3221930553069158,"score_spread":0.21651312439485781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409146806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98666143,0.009634573,0.00025619962,0.0021116508,0.00037923502,0.000813642,0.000009681976,0.0000040435543,0.0001295253],"genre_scores_gemma":[0.99950415,0.00009020067,0.000060399358,0.00023624473,0.000039199156,0.000017587456,0.0000018163734,0.000006683239,0.000043749584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984809,0.00015703721,0.0006924942,0.00010495688,0.00044505936,0.000119531505],"domain_scores_gemma":[0.9981162,0.000058658672,0.00045137704,0.00012544991,0.001201031,0.000047283098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029659836,0.00009778984,0.00067627855,0.00007535911,0.00010164419,0.000008863038,0.00016161923,0.000060902974,0.000009756912],"category_scores_gemma":[0.0003991106,0.00006469756,0.00023104402,0.00007854344,0.00011747552,0.00004311818,0.00007529884,0.00012538358,4.6573868e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010696101,0.0009414313,0.9826446,0.0003294334,0.0023559358,0.00006929553,0.00020585094,0.0000060449,0.0075270636,0.00003432448,0.0034912121,0.0013251803],"study_design_scores_gemma":[0.006683609,0.0002483353,0.98110795,0.0014157438,0.00045514028,0.0019389889,0.0003670152,0.000026569105,0.0072132675,0.00006172502,0.0004220405,0.00005960236],"about_ca_topic_score_codex":0.0001189238,"about_ca_topic_score_gemma":0.0004917994,"teacher_disagreement_score":0.012842671,"about_ca_system_score_codex":0.000069412716,"about_ca_system_score_gemma":0.00021103998,"threshold_uncertainty_score":0.26382902},"labels":[],"label_agreement":null},{"id":"W4409522276","doi":"10.1093/bjd/ljaf144","title":"Monoclonal gammopathy of thrombotic significance","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Monoclonal gammopathy; Medicine; Monoclonal gammopathy of undetermined significance; Differential diagnosis; Monoclonal; Dermatology; Pathology; Monoclonal antibody; Immunology; Antibody","score_opus":0.01133759398230168,"score_gpt":0.30098992309151007,"score_spread":0.2896523291092084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409522276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981944,0.009976131,0.0018711267,0.0018009482,0.00033611883,0.00017743978,0.000004993337,0.000010260268,0.0038789518],"genre_scores_gemma":[0.99704945,0.00092201075,0.0013465536,0.00027898813,0.00006680286,0.0000026757516,0.0000017069927,0.000010731456,0.0003210647],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99842197,0.00011232982,0.00073328725,0.00012735894,0.00032975894,0.00027529048],"domain_scores_gemma":[0.99874914,0.00025432758,0.00025985928,0.00016370593,0.00045385218,0.00011911161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021079437,0.000087956396,0.0006468662,0.00021596212,0.00003721043,0.000013278097,0.00021785965,0.00012304055,0.00012277094],"category_scores_gemma":[0.0005037879,0.00009420563,0.00017426732,0.00028629228,0.0003031175,0.00007301408,0.00005853094,0.0003791405,0.000009306604],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006304479,0.0044524497,0.10943663,0.0076476107,0.004483156,0.27024734,0.0012190136,0.0003072534,0.08040454,0.012814406,0.24914543,0.25353768],"study_design_scores_gemma":[0.039570734,0.0005135229,0.052198913,0.0034817574,0.00046182456,0.79557824,0.000480803,0.002459967,0.09398131,0.0036549468,0.0073557342,0.00026223433],"about_ca_topic_score_codex":0.00013488127,"about_ca_topic_score_gemma":0.000019858915,"teacher_disagreement_score":0.5253309,"about_ca_system_score_codex":0.0009957743,"about_ca_system_score_gemma":0.0061999443,"threshold_uncertainty_score":0.999434},"labels":[],"label_agreement":null},{"id":"W4409591467","doi":"10.1093/bjd/ljaf151","title":"The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hidradenitis suppurativa; Meta-analysis; Medicine; Association (psychology); Psychiatry; Psychiatric Disease; Disease; Dermatology; MEDLINE; Psychology; Psychotherapist; Pathology; Biology","score_opus":0.030247697519285657,"score_gpt":0.3377231107443181,"score_spread":0.30747541322503247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409591467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.4577704e-7,0.98153025,0.000021492315,0.0162063,0.00006241594,0.0017554655,0.00033816206,0.000010575017,0.00007451201],"genre_scores_gemma":[0.0012360936,0.9969883,0.00006913181,0.000038492075,0.000048346967,0.00014612867,0.00011041237,0.00002449579,0.0013385857],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99489677,0.0018224765,0.0022284703,0.00029831563,0.00045179852,0.0003021682],"domain_scores_gemma":[0.9945534,0.0021239088,0.002413497,0.0002878403,0.00031641696,0.00030497444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006882645,0.00040760988,0.010307927,0.0004457016,0.0002980968,0.00017462287,0.00020965267,0.00027441749,0.00004872097],"category_scores_gemma":[0.001364285,0.00025903014,0.0025072303,0.0008780828,0.00009114255,0.00014066223,0.000067259505,0.000651115,0.000006075688],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003655097,0.000047848815,0.00052459777,0.6601215,0.29374656,0.03611811,0.000009961707,5.1251553e-10,8.159648e-10,0.000030179075,0.0016872346,0.0077103428],"study_design_scores_gemma":[0.00023215513,0.000022782262,0.000055853903,0.035424653,0.62083286,0.33301663,0.0000057674642,8.113174e-8,9.6520285e-9,0.00003475958,0.01026562,0.000108810615],"about_ca_topic_score_codex":0.000007897068,"about_ca_topic_score_gemma":0.000019587562,"teacher_disagreement_score":0.62469685,"about_ca_system_score_codex":0.00012809275,"about_ca_system_score_gemma":0.00044847582,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null},{"id":"W4409839579","doi":"10.1093/bjd/ljaf158","title":"Atopic dermatitis starting in childhood has a stronger impact on adults: results from the ‘Scars of Life’ international project in 27 countries","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Universidade Tiradentes; Roche","keywords":"Atopic dermatitis; Scars; Medicine; Dermatology; Pediatrics; Surgery","score_opus":0.009297849098293946,"score_gpt":0.2745553851064156,"score_spread":0.26525753600812163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409839579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815971,0.005353914,0.000015256851,0.011587962,0.0003644914,0.00023990247,0.00019221945,0.000007641846,0.00064147124],"genre_scores_gemma":[0.99768233,0.00061535067,0.00009159677,0.001488954,0.000055577326,0.00000574188,0.000040877814,0.000008187105,0.000011410809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979243,0.00027548324,0.0011716955,0.00015644508,0.00023554663,0.00023648473],"domain_scores_gemma":[0.99841493,0.000727143,0.00047098688,0.00014881439,0.00018063227,0.000057485075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019273313,0.00013321334,0.00060587935,0.00033385455,0.00004897098,0.00003696958,0.0002541196,0.00014139275,0.000046457633],"category_scores_gemma":[0.0014223682,0.00011050104,0.00016005777,0.00022400502,0.0002143733,0.00015719268,0.00004862714,0.0005116475,0.000003118043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00134177,0.0004414178,0.94668293,0.000053093114,0.00026566966,0.003960326,0.0012991425,0.00003712262,0.000002920673,0.000046243746,0.04270197,0.0031673955],"study_design_scores_gemma":[0.009444451,0.0000560531,0.9779667,0.0027169604,0.000056516736,0.0070897066,0.0011117803,0.0001101956,0.000184887,0.00043223964,0.0007525108,0.00007798904],"about_ca_topic_score_codex":0.0008492238,"about_ca_topic_score_gemma":0.0010056846,"teacher_disagreement_score":0.04194946,"about_ca_system_score_codex":0.00007570967,"about_ca_system_score_gemma":0.00082489545,"threshold_uncertainty_score":0.45061016},"labels":[],"label_agreement":null},{"id":"W4410050643","doi":"10.1093/bjd/ljaf156","title":"Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Sanofi","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Clinical endpoint; Adverse effect; Internal medicine; Regimen; Dermatology Life Quality Index; Clinical trial; Randomized controlled trial; Dermatology; Disease","score_opus":0.01982358497355226,"score_gpt":0.3147354051382038,"score_spread":0.29491182016465156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945018,0.0020954076,0.00041435476,0.0013123837,0.0003047933,0.0008228695,0.00016003799,0.000007881064,0.0003804559],"genre_scores_gemma":[0.99846125,0.0000988282,0.0006572836,0.000626999,0.00004531011,0.0000063139128,0.00006615782,0.000011382758,0.000026498106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966075,0.00043398072,0.0022065137,0.00026259554,0.00023978735,0.00024965988],"domain_scores_gemma":[0.997758,0.00070427125,0.0007596032,0.0002050072,0.00037081796,0.00020231838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021733152,0.00016767396,0.0013645904,0.00024638866,0.00007371167,0.000011798363,0.00017252732,0.00025407472,0.00003315642],"category_scores_gemma":[0.0014768591,0.00016100028,0.00013997368,0.00024013355,0.000374234,0.00013584386,0.00008718751,0.0004576111,6.053137e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49817768,0.018025214,0.31352928,0.00030888675,0.0013186184,0.005287377,0.0009032621,0.000046548303,0.0000030495785,0.00008149183,0.027052963,0.13526562],"study_design_scores_gemma":[0.5076739,0.0027958343,0.4799979,0.0028880662,0.00042687764,0.0037662536,0.00010649825,0.000052630334,0.00078008365,0.00044305224,0.0008878428,0.00018107549],"about_ca_topic_score_codex":0.000041742638,"about_ca_topic_score_gemma":0.00004852596,"teacher_disagreement_score":0.16646862,"about_ca_system_score_codex":0.000025754181,"about_ca_system_score_gemma":0.00046247637,"threshold_uncertainty_score":0.6565401},"labels":[],"label_agreement":null},{"id":"W4410050705","doi":"10.1093/bjd/ljaf173","title":"Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Psoriasis Association; Medical Research Council Canada; Wellcome Trust","keywords":"Ultraviolet b; Dermatology; Medicine; Skin cancer; Ultraviolet radiation; Ultraviolet B radiation; Cancer; Human skin; Internal medicine; Genetics; Biology; Chemistry","score_opus":0.0062283563374657125,"score_gpt":0.2928336131970718,"score_spread":0.2866052568596061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862282,0.008457994,0.00065036654,0.003944583,0.00022117628,0.00027332612,0.000007007511,0.000010436249,0.00020685491],"genre_scores_gemma":[0.9967361,0.0016634992,0.00038331983,0.00092084956,0.00009501324,0.000015961456,0.0000023119092,0.000014011362,0.00016890005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986303,0.00016004802,0.00067122426,0.00017532168,0.00016878282,0.00019436497],"domain_scores_gemma":[0.99919647,0.00012268359,0.00028798397,0.00009308403,0.00021569803,0.00008406026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024178352,0.00011280497,0.0005399123,0.00030681217,0.0000648297,0.00002319742,0.00009425026,0.00011127719,0.000071875016],"category_scores_gemma":[0.00020188991,0.00012626397,0.000067581095,0.00027799295,0.000096100026,0.0000945203,0.000014892947,0.00030523742,7.578635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002279987,0.0005064291,0.37676743,0.0010036016,0.0005578741,0.008005149,0.005495508,0.0005892151,0.24027824,0.00018220444,0.014713726,0.34962064],"study_design_scores_gemma":[0.014567149,0.0004660944,0.6830304,0.0057192454,0.00006728727,0.061539017,0.0012254809,0.00018588084,0.22200605,0.0008926045,0.009910693,0.00039005838],"about_ca_topic_score_codex":0.0009709163,"about_ca_topic_score_gemma":0.0005313705,"teacher_disagreement_score":0.3492306,"about_ca_system_score_codex":0.000050141676,"about_ca_system_score_gemma":0.00010804018,"threshold_uncertainty_score":0.51488954},"labels":[],"label_agreement":null},{"id":"W4410149816","doi":"10.1093/bjd/ljaf166","title":"Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Women's College Hospital; University of Toronto","funders":"Medical Research Council; National Institutes of Health; Canadian Institutes of Health Research; National Institute for Health and Care Research; Eczema Society of Canada; Canadian Dermatology Foundation; 100,000 Strong in the Americas Innovation Fund; National Eczema Association","keywords":"Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Systemic therapy; Perspective (graphical); Internal medicine; Computer science","score_opus":0.033701468053319895,"score_gpt":0.29721364000184375,"score_spread":0.26351217194852383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410149816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63545823,0.31673205,0.027033405,0.008511846,0.0014894498,0.0025106748,0.00031114815,0.00017024149,0.0077829254],"genre_scores_gemma":[0.98948306,0.00038522546,0.0021304826,0.005950199,0.00007083175,0.00007968767,0.000031803887,0.00002331266,0.0018453975],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99763185,0.00033628955,0.0010977958,0.00026699092,0.00019170862,0.00047536107],"domain_scores_gemma":[0.9981668,0.00045347365,0.0004285401,0.00027773532,0.0004260352,0.00024739918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016815843,0.0002320708,0.0022744883,0.00045433445,0.00023977745,0.000058059395,0.0002407833,0.00013668842,0.0005352243],"category_scores_gemma":[0.0002351843,0.00022790585,0.0013520259,0.0006603708,0.00007455891,0.000121474244,0.000055975517,0.00020295144,0.00004329446],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015522784,0.00045726183,0.20381917,0.00041472827,0.23102877,0.0062772203,0.00015155268,0.00063113327,0.000029349294,0.00015179362,0.55558634,0.0012974296],"study_design_scores_gemma":[0.0092387805,0.00016933765,0.1275538,0.0017819612,0.6193379,0.17272663,0.0006311456,0.0017088125,0.0008429911,0.0006862004,0.064455576,0.00086687057],"about_ca_topic_score_codex":0.000059138998,"about_ca_topic_score_gemma":0.00017083585,"teacher_disagreement_score":0.4911308,"about_ca_system_score_codex":0.00009342091,"about_ca_system_score_gemma":0.00024860364,"threshold_uncertainty_score":0.92937315},"labels":[],"label_agreement":null},{"id":"W4410458691","doi":"10.1093/bjd/ljaf189","title":"Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; King's Health Partners; Times Higher Education; Pfizer","keywords":"Psychosocial; Anxiety; Quality of life (healthcare); Hospital Anxiety and Depression Scale; Medicine; Psychiatry; Stigma (botany); Depression (economics); Dermatology Life Quality Index; Alopecia areata; Clinical psychology; Severity of illness; Disease; Internal medicine","score_opus":0.014269740545942357,"score_gpt":0.3243911310333227,"score_spread":0.3101213904873803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410458691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922122,0.004321934,0.00002479914,0.0022257825,0.000064332,0.00033106166,0.00008210787,0.000003545868,0.0007342364],"genre_scores_gemma":[0.9970089,0.002741144,0.000028009634,0.00012148376,0.00007326251,0.0000034868763,0.000005472035,0.000007191528,0.000011007283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837273,0.0005320214,0.0006661464,0.00014564936,0.000161155,0.00012231345],"domain_scores_gemma":[0.99881876,0.0005682452,0.00028124126,0.00013854599,0.00011195639,0.00008128181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000428694,0.00009866272,0.00060306786,0.00009099963,0.00010342934,0.000018664643,0.00010058959,0.00009716808,0.000010047193],"category_scores_gemma":[0.0011775033,0.000062775776,0.00007687447,0.00015318376,0.00038768997,0.000059384172,0.000055381508,0.00027761536,1.0392842e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003929411,0.00023382466,0.96798176,0.000026948044,0.00020142432,0.000056875804,0.005749297,0.0000035590201,0.00006574029,0.000027679032,0.005606827,0.016116673],"study_design_scores_gemma":[0.016799502,0.000085799715,0.96836174,0.00034736434,0.000085791435,0.0006315603,0.013202877,0.000021007709,0.000008865939,0.0003367195,0.000065619184,0.000053157233],"about_ca_topic_score_codex":0.0064594797,"about_ca_topic_score_gemma":0.0029694957,"teacher_disagreement_score":0.016063517,"about_ca_system_score_codex":0.000011320372,"about_ca_system_score_gemma":0.00011240694,"threshold_uncertainty_score":0.9764844},"labels":[],"label_agreement":null},{"id":"W4410531072","doi":"10.1093/bjd/ljaf191","title":"Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Debra International; Ministero della Salute; Ospedale Pediatrico Bambino Gesù","keywords":"Medicine; Epidermolysis bullosa; Guideline; Dysphagia; Intensive care medicine; Quality of life (healthcare); Population; Intervention (counseling); Disease; Pediatrics; Dermatology; Surgery; Internal medicine; Nursing; Pathology","score_opus":0.01360680705887383,"score_gpt":0.3546153173724265,"score_spread":0.34100851031355267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410531072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85428596,0.10702214,0.005793127,0.024448592,0.00086969975,0.00073000614,0.000020025418,0.000043911157,0.006786548],"genre_scores_gemma":[0.973049,0.0050691897,0.020001108,0.0016726835,0.00005380528,0.000005131648,0.0000119005235,0.000016330667,0.0001208741],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99600714,0.00047600284,0.002724622,0.00020192865,0.00032570574,0.0002645979],"domain_scores_gemma":[0.9975118,0.0005543397,0.00096865644,0.0002452875,0.0006105613,0.00010932219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007125051,0.00014336783,0.0010741949,0.0004175585,0.000035947785,0.000015678368,0.00025139068,0.00018968503,0.00013544415],"category_scores_gemma":[0.0025804518,0.00015584816,0.00032208886,0.00055992097,0.0001772596,0.00011439255,0.00013278557,0.00053955114,0.0000040431783],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002245848,0.0040439623,0.08591016,0.0006981293,0.0027295048,0.54566973,0.00007475622,0.000059891794,0.00006366875,0.0006743257,0.11740411,0.24042591],"study_design_scores_gemma":[0.012626215,0.00026932385,0.6264508,0.0026233331,0.0019928652,0.31997365,0.0010871073,0.000176861,0.00033753068,0.0009758244,0.033284914,0.00020162338],"about_ca_topic_score_codex":0.000106273605,"about_ca_topic_score_gemma":0.000007672515,"teacher_disagreement_score":0.5405406,"about_ca_system_score_codex":0.00006013819,"about_ca_system_score_gemma":0.00030469452,"threshold_uncertainty_score":0.63553035},"labels":[],"label_agreement":null},{"id":"W4410841064","doi":"10.1093/bjd/ljaf205","title":"Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Digital Technology Supercluster; DEBRA Austria; Debra International; Cure EB; Dystrophic Epidermolysis Bullosa Research Association of America","keywords":"Medicine; Epidermolysis bullosa; Dermatology; Basal cell; Epidermolysis bullosa dystrophica; Pathology; Oncology; Cancer research","score_opus":0.003818697452522538,"score_gpt":0.22600070437693148,"score_spread":0.22218200692440895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410841064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935117,0.005791994,0.00015343793,0.00011529712,0.00006337052,0.0001959555,0.00002161604,0.0000019355598,0.0001447244],"genre_scores_gemma":[0.9991232,0.00045426434,0.00023564004,0.000037900383,0.000008104102,0.000003568004,0.000052187133,0.00001265608,0.000072485615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836344,0.00039037646,0.0005901899,0.00023024718,0.00013389929,0.0002918669],"domain_scores_gemma":[0.9989688,0.00012291018,0.00037467698,0.00014155272,0.00031525487,0.000076808166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013705129,0.0001388485,0.0004922056,0.0001594361,0.000062536776,0.000011681744,0.00021039743,0.00016835591,0.0000103398825],"category_scores_gemma":[0.00040068844,0.0001365215,0.000073930525,0.00020646804,0.00023557806,0.0000064822075,0.000084395986,0.00026657918,5.108453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009869117,0.0024501032,0.88220644,0.00035092194,0.0005953171,0.023480581,0.000117798154,0.00017664977,0.049091063,0.000023393859,0.00067637645,0.030962264],"study_design_scores_gemma":[0.038748577,0.0034802062,0.77401286,0.0005436213,0.00034706283,0.0632054,0.00030644677,0.000048292954,0.11819687,0.00024264016,0.00028315576,0.00058488717],"about_ca_topic_score_codex":0.00002511385,"about_ca_topic_score_gemma":0.000042134034,"teacher_disagreement_score":0.10819357,"about_ca_system_score_codex":0.00002366592,"about_ca_system_score_gemma":0.00016135233,"threshold_uncertainty_score":0.55671847},"labels":[],"label_agreement":null},{"id":"W4411162776","doi":"10.1093/bjd/ljaf222","title":"Menopausal age, hormone therapy and risk of psoriasis: a prospective cohort study applying inverse probability of treatment weighting analysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Hunan Provincial Innovation Foundation for Postgraduate; Central South University; National Natural Science Foundation of China","keywords":"Medicine; Psoriasis; Prospective cohort study; Hormone therapy; Cohort; Cohort study; Marginal structural model; Inverse probability weighting; Internal medicine; Oncology; Dermatology; Observational study; Cancer; Breast cancer","score_opus":0.10988797068105641,"score_gpt":0.3655859878935787,"score_spread":0.2556980172125223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411162776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885754,0.00823065,0.0009477223,0.00041510913,0.0001200483,0.0012812553,0.000084461826,0.00000676949,0.00033856588],"genre_scores_gemma":[0.99368906,0.0039611473,0.0021052172,0.00008316927,0.000031568346,0.000097526936,0.000003295515,0.0000089340465,0.000020082542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99444604,0.00078620756,0.004169079,0.00031906797,0.00007958463,0.00020003706],"domain_scores_gemma":[0.99443835,0.0006563851,0.0043724203,0.00023734859,0.00021633752,0.000079167876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058905673,0.00014187119,0.0020611081,0.00060620956,0.00012551024,0.000032316835,0.00016206759,0.00010458469,0.000024680765],"category_scores_gemma":[0.0012699548,0.00017143362,0.00016708237,0.00046461704,0.00014730908,0.00020838101,0.0000374801,0.00017098278,0.0000021662286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000837158,0.0005642383,0.9909069,0.00007431113,0.0044988324,0.000025943044,0.0016275786,0.0000868256,0.000006381803,0.0009008565,0.00018479272,0.0010396488],"study_design_scores_gemma":[0.0033356065,0.0005046188,0.98542446,0.000057227,0.00047708585,0.00019326131,0.001918961,0.00057609944,0.000037294012,0.0071737636,0.00017787213,0.000123723],"about_ca_topic_score_codex":0.0033882067,"about_ca_topic_score_gemma":0.0013326481,"teacher_disagreement_score":0.0062729074,"about_ca_system_score_codex":0.0003387008,"about_ca_system_score_gemma":0.00018511536,"threshold_uncertainty_score":0.69908607},"labels":[],"label_agreement":null},{"id":"W4411687990","doi":"10.1093/bjd/ljaf250","title":"Assessing the performance of artificial intelligence models in evaluating inflammatory skin disease severity: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); McGill University Health Centre; Université de Montréal","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Mental Health; National Institutes of Health","keywords":"Medicine; Meta-analysis; Contingency table; Bivariate analysis; Atopic dermatitis; Internal medicine; Systematic review; MEDLINE; Disease; Dermatology; Machine learning; Computer science","score_opus":0.0970255586441627,"score_gpt":0.3885096566984381,"score_spread":0.29148409805427544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411687990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023237352,0.9972528,0.0008093262,0.00022667432,0.00005679667,0.0013775863,0.0000068550758,0.0000051620304,0.00003242136],"genre_scores_gemma":[0.0068392265,0.99260163,0.00019131407,0.00020576947,0.000013670813,0.00008132537,0.000004367061,0.000012384632,0.000050299877],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954073,0.001197034,0.002652947,0.00020354238,0.00037231605,0.00016685901],"domain_scores_gemma":[0.9969801,0.00046709526,0.001914244,0.00028905825,0.0002595874,0.00008996463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015380039,0.00022686174,0.0059057684,0.0005881437,0.00006728957,0.000066866814,0.00021939611,0.000105377796,0.000042227417],"category_scores_gemma":[0.0006996845,0.0001623566,0.0013784033,0.0007502289,0.00009072341,0.00014240861,0.00010126128,0.0005351271,0.0000010839523],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075154876,0.000050435683,0.0000034274976,0.88042074,0.023916334,0.0015107685,0.000024468773,0.000048123056,3.5511484e-8,0.000023345397,0.00001479254,0.09398],"study_design_scores_gemma":[0.000058446385,0.000023837527,0.0000073809206,0.17740399,0.7829886,0.036514483,0.00008131735,0.002445986,7.7874415e-7,0.000065256325,0.00027380048,0.00013609165],"about_ca_topic_score_codex":0.000008809251,"about_ca_topic_score_gemma":0.00002193099,"teacher_disagreement_score":0.7590723,"about_ca_system_score_codex":0.00007029246,"about_ca_system_score_gemma":0.00043289165,"threshold_uncertainty_score":0.66207105},"labels":[],"label_agreement":null},{"id":"W4411696664","doi":"10.1093/bjd/ljaf245","title":"Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Culprit; Medicine; Dermatology; Allergic contact dermatitis; Diabetes mellitus; Immunology; Contact dermatitis; Allergy; Internal medicine","score_opus":0.007997982548241429,"score_gpt":0.2371688922132767,"score_spread":0.22917090966503526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411696664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569041,0.0141549595,0.00013163922,0.026689136,0.00036383644,0.00024613252,0.000005597655,0.00007183759,0.0014327568],"genre_scores_gemma":[0.9928443,0.0049262997,0.000331722,0.00171136,0.00003880849,0.000015514586,0.00001667761,0.0000218433,0.000093463954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769795,0.0001676289,0.00121321,0.00020685885,0.00023899914,0.0004753268],"domain_scores_gemma":[0.9987074,0.00015226223,0.00047166526,0.0001706331,0.00037132716,0.00012667658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024700936,0.00020504769,0.0009465382,0.0010178748,0.00012852404,0.000054176675,0.00022333616,0.0003559113,0.00006483858],"category_scores_gemma":[0.00075443136,0.00024121469,0.00019198947,0.000669481,0.00012559703,0.00026841482,0.0000757176,0.0007617404,0.000007957573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051168496,0.00059097947,0.928483,0.00048055264,0.0012289109,0.019094711,0.0007250986,0.000029304701,0.0068456465,0.0045986422,0.019478843,0.01839312],"study_design_scores_gemma":[0.008360352,0.00016019981,0.93688273,0.0076099173,0.00016866572,0.025406025,0.001685917,0.0009769362,0.005780106,0.006025627,0.0065678614,0.00037565624],"about_ca_topic_score_codex":0.000037494297,"about_ca_topic_score_gemma":0.0009476978,"teacher_disagreement_score":0.035940208,"about_ca_system_score_codex":0.00018333446,"about_ca_system_score_gemma":0.0002953264,"threshold_uncertainty_score":0.98364496},"labels":[],"label_agreement":null},{"id":"W4411712121","doi":"10.1093/bjd/ljaf085.526","title":"BT01 The effectiveness of telemedicine in dermatology services: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telemedicine; Dermatology; Medicine; Teledermatology; MEDLINE; Health care; Political science","score_opus":0.019737523510117715,"score_gpt":0.3709661474405102,"score_spread":0.3512286239303925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008925139,0.9938863,0.00007531953,0.00076456065,0.0003993147,0.004598402,0.000022330812,0.0000106703865,0.00015387483],"genre_scores_gemma":[0.0009021557,0.9971998,0.000068595546,0.001366739,0.00007587636,0.00022751304,0.00011371785,0.000032362237,0.000013286313],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9902252,0.0039072065,0.004736496,0.0002530724,0.00045544017,0.00042260517],"domain_scores_gemma":[0.9920119,0.0037618228,0.0031436943,0.0004202925,0.00052080775,0.00014147618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022815594,0.00037288514,0.0087942025,0.0007330912,0.000052959862,0.000008926326,0.00051593775,0.00033636965,0.00004153497],"category_scores_gemma":[0.0015096002,0.00025542206,0.00063013786,0.0010511702,0.00015958065,0.000079281424,0.000084104744,0.0011286654,0.0000055346404],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043527114,0.00011253458,0.0002463937,0.9394222,0.00047603174,0.0060051014,0.00003295848,1.858343e-8,1.9285501e-7,0.00005402306,0.000853102,0.052753914],"study_design_scores_gemma":[0.0015418403,0.000108527354,0.00011685219,0.6586818,0.005844377,0.30524048,0.00009154053,4.9282954e-7,0.0000023710302,0.000035949935,0.028241992,0.000093733135],"about_ca_topic_score_codex":0.0001233802,"about_ca_topic_score_gemma":0.0001018443,"teacher_disagreement_score":0.29923537,"about_ca_system_score_codex":0.00014048668,"about_ca_system_score_gemma":0.0013436398,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W4411712151","doi":"10.1093/bjd/ljaf085.415","title":"BI06 Global perspective on skin cancer in organ transplant recipients with skin of colour: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Organ transplantation; Skin cancer; Perspective (graphical); Cancer; Dermatology; Intensive care medicine; Transplantation; Internal medicine; Computer science","score_opus":0.014940730729723193,"score_gpt":0.34710926926582997,"score_spread":0.3321685385361068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011846113,0.9956352,0.000014948463,0.0005405158,0.00035339457,0.0022218362,0.00029970848,0.000006604436,0.00080934307],"genre_scores_gemma":[0.0019675542,0.99733835,0.00009284535,0.00026422206,0.00006182097,0.00016905014,0.000008813056,0.00003501468,0.00006231096],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956822,0.00073655625,0.0023003533,0.00036734054,0.0005381247,0.0003754701],"domain_scores_gemma":[0.9965471,0.00038289506,0.0020841046,0.00028444102,0.0005752125,0.00012625751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003209462,0.00045104933,0.008204942,0.00038445788,0.00004209114,0.000012609444,0.00038392158,0.0002953756,0.000050986502],"category_scores_gemma":[0.00038218804,0.00035869368,0.00063716376,0.0009946717,0.00018301138,0.000050602095,0.00004532806,0.0008369557,0.000004591543],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018000357,0.00032218097,0.0011992343,0.94102705,0.0024883924,0.017384157,0.00014783119,2.6823497e-7,1.6983149e-8,0.00007905765,0.0018390233,0.035332803],"study_design_scores_gemma":[0.001559093,0.00026376988,0.00067312975,0.82262486,0.0072740945,0.16341856,0.00010112225,1.1296559e-7,0.0000016531518,0.000012303188,0.0038658483,0.00020544526],"about_ca_topic_score_codex":0.00031088793,"about_ca_topic_score_gemma":0.0013574769,"teacher_disagreement_score":0.1460344,"about_ca_system_score_codex":0.0016289445,"about_ca_system_score_gemma":0.0019661551,"threshold_uncertainty_score":0.9998865},"labels":[],"label_agreement":null},{"id":"W4411712184","doi":"10.1093/bjd/ljaf085.094","title":"P066 Core outcome set implementation in vitiligo clinical trials: barriers and facilitators from a survey of lead researchers","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Outcome (game theory); Core (optical fiber); Set (abstract data type); Medicine; Clinical trial; Medical physics; Dermatology; Computer science; Pathology","score_opus":0.5967871668851944,"score_gpt":0.6481919008067792,"score_spread":0.051404733921584844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453545,0.0013861513,0.00026953686,0.0027203301,0.0002572152,0.00033979394,0.00023475815,0.000009092812,0.00024765055],"genre_scores_gemma":[0.99768525,0.0016283704,0.00052083767,0.000096686046,0.000020975205,0.000007711533,0.00001001814,0.0000057693255,0.000024405175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9867507,0.010066799,0.0021150436,0.00018849886,0.00052675145,0.00035218452],"domain_scores_gemma":[0.99037725,0.008296133,0.0005182426,0.00010747124,0.00050837593,0.00019252692],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025987672,0.00007799143,0.000830766,0.00039159914,0.000121960176,0.00006731415,0.00043781163,0.00025722172,0.00015953388],"category_scores_gemma":[0.04722902,0.00009052529,0.00013166292,0.0005472537,0.0009898852,0.00020551866,0.00010455669,0.00068517716,0.0000012380377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018348217,0.000025245368,0.93256253,0.000016892564,0.000062601255,0.0004718861,0.00076842,2.0204209e-7,0.000047364945,0.00016767016,0.010335914,0.055357784],"study_design_scores_gemma":[0.0027414572,0.00008933334,0.95755094,0.00018377198,0.000024586237,0.00023149127,0.030828847,0.000029120978,0.000270029,0.0063550025,0.001582244,0.00011320068],"about_ca_topic_score_codex":0.046951063,"about_ca_topic_score_gemma":0.07168332,"teacher_disagreement_score":0.055244584,"about_ca_system_score_codex":0.00011148029,"about_ca_system_score_gemma":0.0010922679,"threshold_uncertainty_score":0.9607966},"labels":[],"label_agreement":null},{"id":"W4411722122","doi":"10.1093/bjd/ljaf229","title":"Impact of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: a mixed-methods systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Health Research Board","keywords":"PsycINFO; CINAHL; Toxic epidermal necrolysis; MEDLINE; Medicine; Quality of life (healthcare); Cochrane Library; Systematic review; Gerontology; Alternative medicine; Psychological intervention; Psychiatry; Dermatology; Nursing; Pathology","score_opus":0.0354337495392775,"score_gpt":0.3926762546159824,"score_spread":0.35724250507670485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411722122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03063386,0.9661486,0.00007408882,0.00042006528,0.00020955333,0.0023061757,0.00009090294,0.000012415588,0.000104348735],"genre_scores_gemma":[0.07667762,0.92241627,0.00059436104,0.00012973252,0.000014756382,0.00009106513,0.000016555243,0.000040202976,0.00001944678],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98560053,0.006609836,0.0062931976,0.00038805764,0.00067178154,0.00043660635],"domain_scores_gemma":[0.983776,0.0041755415,0.010294876,0.00067468797,0.0007176439,0.00036129428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030441238,0.0005297952,0.0123412805,0.00065203774,0.00010310107,0.000015344409,0.00044667537,0.00042008897,0.000029105468],"category_scores_gemma":[0.006484972,0.00034274344,0.001706428,0.0011474408,0.00046167907,0.00015084978,0.000087642795,0.0011699026,0.0000017267505],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086988315,0.00046209726,0.000037414837,0.87421054,0.0039137434,0.0010388078,0.0006509124,0.0000010819839,0.0000017794217,0.000027592168,0.00021436736,0.11935465],"study_design_scores_gemma":[0.001122664,0.00051252585,0.00075534894,0.7703977,0.0044594356,0.22000183,0.0023247788,0.0000039113393,0.000005499284,0.0000068433606,0.00019369017,0.00021576928],"about_ca_topic_score_codex":0.00040313636,"about_ca_topic_score_gemma":0.000030096235,"teacher_disagreement_score":0.21896303,"about_ca_system_score_codex":0.0002030883,"about_ca_system_score_gemma":0.0026217988,"threshold_uncertainty_score":0.9999025},"labels":[],"label_agreement":null},{"id":"W4411732496","doi":"10.1093/bjd/ljaf085.161","title":"P133 Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic urticaria; Medicine; Dermatology; Perception; Family medicine; Psychology","score_opus":0.005063736603835319,"score_gpt":0.23587782810495864,"score_spread":0.2308140915011233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888752,0.0020896597,0.00004090628,0.0075850654,0.00035361937,0.00038392982,0.00041837656,0.0000040558243,0.0002491962],"genre_scores_gemma":[0.999161,0.0004593365,0.00004118503,0.00015098003,0.00012296454,0.0000036116105,0.0000199247,0.000008540759,0.0000324485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981453,0.00036018022,0.0009180166,0.0001410376,0.000278855,0.00015665714],"domain_scores_gemma":[0.99766034,0.0010528445,0.00053952466,0.00033064416,0.00037666986,0.00003999197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010534782,0.00010848409,0.0005136859,0.000046055873,0.00016996523,0.000015647878,0.00034314636,0.00012572529,0.000056675766],"category_scores_gemma":[0.00045285877,0.00006505858,0.00018118254,0.00021823175,0.00059466437,0.000042401112,0.000109640045,0.0004952022,0.0000011464991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031942646,0.0067868493,0.8120329,0.00006983503,0.036034565,0.0031131422,0.05662397,0.0003515033,0.02462944,0.0012452711,0.03630706,0.019611211],"study_design_scores_gemma":[0.005215883,0.00029895655,0.9729015,0.0007303676,0.008430235,0.0019566496,0.008655178,0.00017283109,0.0005048191,0.0009453289,0.00012204808,0.00006617817],"about_ca_topic_score_codex":0.0024467467,"about_ca_topic_score_gemma":0.0008646371,"teacher_disagreement_score":0.16086864,"about_ca_system_score_codex":0.000026534284,"about_ca_system_score_gemma":0.00021996637,"threshold_uncertainty_score":0.36987653},"labels":[],"label_agreement":null},{"id":"W4411732515","doi":"10.1093/bjd/ljaf085.133","title":"P105 Lebrikizumab improves quality of life and wellbeing of patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin: German extension results (week 76) of the ADvantage study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; German; Quality of life (healthcare); Dermatology; Internal medicine; Transplantation","score_opus":0.014146575069906981,"score_gpt":0.2923844091531926,"score_spread":0.2782378340832856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582803,0.001154061,0.00034990738,0.0009281681,0.000100877725,0.0014725296,0.00007834986,0.000007176191,0.00008091946],"genre_scores_gemma":[0.99887115,0.00011017409,0.00048364466,0.00041909897,0.000011212078,0.000021581685,0.0000090740605,0.00001540847,0.000058657457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733895,0.00030754186,0.0015764536,0.00021931608,0.00032459918,0.00023313457],"domain_scores_gemma":[0.9968081,0.00055621733,0.0012485535,0.00026439992,0.00098958,0.00013315704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025047158,0.0001875482,0.0016119062,0.00020197555,0.00011019348,0.000013212791,0.00018846155,0.00011198271,0.000004103087],"category_scores_gemma":[0.0010014338,0.00012372513,0.00013219667,0.00024571895,0.00026622863,0.00016234953,0.00008144226,0.0002135393,1.089182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07426564,0.0024202606,0.9144825,0.0017198037,0.0011113842,0.00063552416,0.0007533178,0.000035111778,0.00019010372,0.00010991134,0.0017759306,0.0025005657],"study_design_scores_gemma":[0.06004599,0.001049977,0.9314348,0.0012755614,0.00047814834,0.002475095,0.0009597327,0.00008479601,0.0018263656,0.00018839123,0.000048791007,0.00013234145],"about_ca_topic_score_codex":0.000073846044,"about_ca_topic_score_gemma":0.00019712557,"teacher_disagreement_score":0.016952362,"about_ca_system_score_codex":0.00001914309,"about_ca_system_score_gemma":0.00046402705,"threshold_uncertainty_score":0.50453645},"labels":[],"label_agreement":null},{"id":"W4411732595","doi":"10.1093/bjd/ljaf085.410","title":"British Society for Skin Care in Immunosuppressed IndividualsOral presentationsBI01 Persistent nonpruritic scabies in a patient on nemolizumab for the treatment of prurigo nodularis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Prurigo nodularis; Scabies; Dermatology; Medicine; Prurigo; Dermatologic agents; Biology","score_opus":0.012596032333014184,"score_gpt":0.2938436234916678,"score_spread":0.2812475911586536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744293,0.02026347,0.00032070483,0.0028226026,0.00019031325,0.0015914079,0.0002618864,0.000006178449,0.000114106035],"genre_scores_gemma":[0.995702,0.0023940234,0.0010126845,0.00043387976,0.000019475481,0.00030902668,0.00008453898,0.000011251963,0.000033075463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985002,0.00008678555,0.00083150016,0.00015668766,0.00016107145,0.00026372407],"domain_scores_gemma":[0.99864024,0.0005788881,0.00023809908,0.00012110775,0.00036424075,0.000057441473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000052083185,0.000120991586,0.00055191846,0.00014650472,0.00010624981,0.000048771817,0.0001239238,0.000100821715,0.000028597695],"category_scores_gemma":[0.00020344941,0.00011282776,0.00067660154,0.00019398845,0.00016046273,0.00008799604,0.000018580866,0.00013172055,3.2593863e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007700639,0.028787969,0.2779743,0.0051540895,0.00471026,0.005602278,0.02251868,0.0028012872,0.0003098963,0.001719028,0.0582014,0.58452016],"study_design_scores_gemma":[0.053112615,0.007279222,0.85543585,0.003926187,0.0017473263,0.020694507,0.033292957,0.0034914392,0.0021277666,0.0015406476,0.016922446,0.00042900917],"about_ca_topic_score_codex":0.00031142513,"about_ca_topic_score_gemma":0.00043053497,"teacher_disagreement_score":0.5840911,"about_ca_system_score_codex":0.00014392937,"about_ca_system_score_gemma":0.00024686466,"threshold_uncertainty_score":0.46009827},"labels":[],"label_agreement":null},{"id":"W4411732624","doi":"10.1093/bjd/ljaf085.132","title":"P104 Lebrikizumab improves quality of life in patients with moderate-to-severe atopic dermatitis inadequately controlled or ineligible for ciclosporin (ADvantage study)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ciclosporin; Atopic dermatitis; Medicine; Dermatology; Quality of life (healthcare); Pediatrics; Surgery; Transplantation","score_opus":0.014271004617189564,"score_gpt":0.30194686396652193,"score_spread":0.2876758593493324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943099,0.0013612254,0.00080144324,0.001252141,0.00020792078,0.001796095,0.000040489573,0.000016133505,0.00021464717],"genre_scores_gemma":[0.997627,0.000081690276,0.00061719236,0.0014099432,0.000020950254,0.0000793833,0.0000153795,0.000019652382,0.00012880623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969698,0.00031995215,0.0017963026,0.00024841298,0.00029347575,0.0003720466],"domain_scores_gemma":[0.9977004,0.0004921433,0.00066914345,0.00021440652,0.0007110659,0.0002128738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000255603,0.00022047419,0.002002689,0.00045504005,0.000086305394,0.000028615757,0.00023139016,0.00016936605,0.000029729603],"category_scores_gemma":[0.0014929991,0.00018955319,0.00018572295,0.00035734923,0.00012001746,0.00022475849,0.00006061144,0.0003070348,0.0000017290406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02914237,0.002362973,0.9581556,0.0006620939,0.00062388106,0.001697082,0.00019429959,0.000022485827,0.000013133017,0.00010582346,0.0041817203,0.002838574],"study_design_scores_gemma":[0.08784702,0.00063208124,0.9066603,0.00065093173,0.0002520978,0.002223704,0.0007083862,0.00005007767,0.00026455347,0.00038100762,0.00014283626,0.00018700946],"about_ca_topic_score_codex":0.000110946225,"about_ca_topic_score_gemma":0.00044643172,"teacher_disagreement_score":0.05870465,"about_ca_system_score_codex":0.00006131816,"about_ca_system_score_gemma":0.0007698783,"threshold_uncertainty_score":0.7729755},"labels":[],"label_agreement":null},{"id":"W4411732719","doi":"10.1093/bjd/ljaf085.156","title":"P128 the risk of atopic eczema in breastfed offspring whose mothers were supplemented with vitamin D during pregnancy","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Offspring; Pregnancy; Medicine; Vitamin; Obstetrics; Pediatrics; Endocrinology; Biology","score_opus":0.005900744541400474,"score_gpt":0.2482169902473604,"score_spread":0.24231624570595994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696065,0.0032441316,0.000086443164,0.0087837465,0.00011038846,0.00017708166,0.000006304273,0.0000072273115,0.0006240343],"genre_scores_gemma":[0.9978848,0.0014756246,0.0004043789,0.00009586344,0.000025475027,0.0000047314124,8.533544e-7,0.000010161873,0.000098077995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986659,0.00015679628,0.00063477457,0.00012337374,0.00018940018,0.0002297144],"domain_scores_gemma":[0.99892104,0.00014949203,0.00058068393,0.00013573779,0.0001591255,0.00005391809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016706146,0.00010615975,0.00045518568,0.00018044283,0.00008112895,0.000027209513,0.00018389136,0.0000772578,0.0000648348],"category_scores_gemma":[0.00014149075,0.000081405546,0.00009252924,0.00024411165,0.000149322,0.00022209098,0.000043578035,0.00048433902,8.832108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037916852,0.00018934027,0.9584381,0.0003240581,0.00038778022,0.0025239992,0.0003914711,0.00002656188,0.0006072131,0.00010577176,0.0001974291,0.036429107],"study_design_scores_gemma":[0.0046525165,0.000103673476,0.9200659,0.005074026,0.00022252923,0.065202124,0.0009234033,0.000058081576,0.0030611136,0.00006404612,0.0004987481,0.00007385049],"about_ca_topic_score_codex":0.00052141835,"about_ca_topic_score_gemma":0.00043043113,"teacher_disagreement_score":0.06267813,"about_ca_system_score_codex":0.000035567144,"about_ca_system_score_gemma":0.00014243339,"threshold_uncertainty_score":0.3319622},"labels":[],"label_agreement":null},{"id":"W4411732750","doi":"10.1093/bjd/ljaf085.499","title":"PS01 Dermatitis artefacta in a paediatric population: clinical insights from a retrospective review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Child Abuse and Related Trauma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Dermatology; Retrospective cohort study; Population; Environmental health; Surgery","score_opus":0.022670182386521,"score_gpt":0.3467218910526485,"score_spread":0.3240517086661275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004042719,0.9959878,0.000009484336,0.0008809315,0.001118581,0.00084305287,0.000045919092,0.000021322194,0.00068869157],"genre_scores_gemma":[0.0011718654,0.9964732,0.00019161905,0.0012164084,0.0006023864,0.000013821078,0.0002485497,0.0000379365,0.000044190736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940218,0.0010074836,0.003915358,0.00040390083,0.0003591945,0.0002922929],"domain_scores_gemma":[0.9966535,0.0007054487,0.0018321334,0.00031511032,0.00026214976,0.00023168523],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00022999411,0.0003781066,0.005986435,0.00065026816,0.00006197914,0.000032881868,0.00029570595,0.0010486942,0.00016182502],"category_scores_gemma":[0.0010723281,0.0003419195,0.0015465142,0.0009514596,0.00008494521,0.0001412872,0.00007969547,0.0031323165,0.000043817996],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012664396,0.00032952463,0.00447693,0.024247816,0.0008650954,0.039806418,0.000021264936,4.2064205e-8,4.405946e-9,0.000026682994,0.028306194,0.9019074],"study_design_scores_gemma":[0.0018738051,0.000061079125,0.021514146,0.3520951,0.0041354024,0.15737896,0.000004942277,8.0114717e-7,5.3749886e-8,0.00031493348,0.46238294,0.0002378545],"about_ca_topic_score_codex":0.000095315714,"about_ca_topic_score_gemma":0.00017382459,"teacher_disagreement_score":0.9016695,"about_ca_system_score_codex":0.00020228614,"about_ca_system_score_gemma":0.0008808673,"threshold_uncertainty_score":0.99990326},"labels":[],"label_agreement":null},{"id":"W4411732774","doi":"10.1093/bjd/ljaf085.270","title":"CD01 Contact allergy to alkyl glucosides: a multicentre audit in the UK and Ireland","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Contact allergy; Audit; Allergy; Medicine; Alkyl; Contact dermatitis; Immunology; Chemistry; Organic chemistry; Business; Accounting","score_opus":0.006691761065815924,"score_gpt":0.2542137386438112,"score_spread":0.24752197757799527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96032584,0.012103018,0.00013040943,0.025149096,0.00022503817,0.00023406289,0.000004166033,0.0000068913764,0.0018215048],"genre_scores_gemma":[0.99067247,0.0031641345,0.00020710407,0.005763222,0.000049432765,0.000006181443,0.0000022335698,0.000006742353,0.00012847077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988652,0.00011833792,0.0005233681,0.00011627657,0.00015049816,0.0002263029],"domain_scores_gemma":[0.9992854,0.00026688832,0.0001299529,0.000108256776,0.0001145199,0.00009500488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013338629,0.00010542339,0.00046337617,0.000186613,0.00006716768,0.00006867402,0.00014199955,0.00008667739,0.000078267476],"category_scores_gemma":[0.00029325226,0.000088147506,0.000083382874,0.00015614227,0.000041233077,0.00007789047,0.00004542357,0.00032631957,0.000004958011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013898648,0.00087718957,0.41804463,0.00048285548,0.0011981727,0.10737369,0.0064316336,0.000015765716,0.0037332748,0.002834243,0.2731836,0.18443505],"study_design_scores_gemma":[0.005995788,0.00013108802,0.77154106,0.0015562945,0.000073243435,0.13122004,0.002342846,0.000063203865,0.00026012587,0.00024604955,0.08644907,0.00012116167],"about_ca_topic_score_codex":0.0002757016,"about_ca_topic_score_gemma":0.0031864417,"teacher_disagreement_score":0.35349643,"about_ca_system_score_codex":0.000030632047,"about_ca_system_score_gemma":0.00012404413,"threshold_uncertainty_score":0.3594551},"labels":[],"label_agreement":null},{"id":"W4411732797","doi":"10.1093/bjd/ljaf085.372","title":"PA13 Comparison of oral minipulse dexamethasone and tofacitinib in progressive nonsegmental childhood vitiligo","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Victoria University; King's College London; Nottingham University Hospitals NHS Trust; University of Nottingham; University of Southampton; University of Sussex","keywords":"Vitiligo; Medicine; Tofacitinib; Dermatology; Dexamethasone; Pediatrics; Internal medicine","score_opus":0.008643234890038003,"score_gpt":0.2681140334908631,"score_spread":0.2594707986008251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9030126,0.09619447,0.0001160857,0.00014781374,0.0002245204,0.00013949086,0.0000417432,0.000005910666,0.000117407595],"genre_scores_gemma":[0.99878037,0.0008508399,0.00021839577,0.0001000847,0.0000055483633,0.000007382284,0.000014297077,0.000007838277,0.000015229104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847746,0.00040615466,0.0006735004,0.00015864245,0.00004911647,0.00023514907],"domain_scores_gemma":[0.9993437,0.000114457805,0.00031199038,0.00010317848,0.00009694966,0.000029755132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016174623,0.00012323874,0.0007977659,0.00015330219,0.00006674956,0.00001649822,0.00016258532,0.00019668267,0.00008787919],"category_scores_gemma":[0.00012105211,0.0001330918,0.00021975105,0.00013410547,0.00038953405,0.00008731457,0.0000797933,0.00030669797,0.0000029436894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038327006,0.001618386,0.71183723,0.00010523313,0.0014559232,0.0008711935,0.0007201378,0.0000043308128,0.019421045,0.0001579033,0.0034187832,0.26000655],"study_design_scores_gemma":[0.008894324,0.0002103962,0.88399035,0.00096009707,0.0003295844,0.027145186,0.0034144605,0.0000035610246,0.072809555,0.00020930219,0.0018151924,0.00021797634],"about_ca_topic_score_codex":0.000049717757,"about_ca_topic_score_gemma":0.00004362208,"teacher_disagreement_score":0.25978857,"about_ca_system_score_codex":0.000016829685,"about_ca_system_score_gemma":0.00009939275,"threshold_uncertainty_score":0.5427326},"labels":[],"label_agreement":null},{"id":"W4411732817","doi":"10.1093/bjd/ljaf085.505","title":"PS07 (P113) Perceptions of patients and physicians from the UK of the burden of chronic spontaneous urticaria: results from the Urticaria Voices study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic urticaria; Medicine; Dermatology; Perception; Family medicine; Psychology","score_opus":0.005122337496385051,"score_gpt":0.23687961043041514,"score_spread":0.2317572729340301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886182,0.0021871394,0.00004692583,0.0076745027,0.00037577274,0.00040684192,0.00043022336,0.0000044304,0.00025599395],"genre_scores_gemma":[0.9990991,0.00049404835,0.00004415164,0.0001617559,0.00013048499,0.0000039278984,0.000021099333,0.00000927018,0.000036203488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804854,0.00037256832,0.00096600567,0.00015019404,0.00029535402,0.00016734876],"domain_scores_gemma":[0.99756545,0.001078013,0.0005674096,0.0003490803,0.00039699615,0.000043060292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114400624,0.000115833645,0.0005394022,0.00004994992,0.00018110948,0.000017263734,0.0003619117,0.00013432541,0.000059713107],"category_scores_gemma":[0.00047323445,0.00006987963,0.00019010545,0.00023341348,0.00061831233,0.00004545245,0.00011705912,0.0005233934,0.0000012785474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034517285,0.0072506946,0.8038991,0.0000763423,0.037170216,0.003237113,0.05963989,0.00037020486,0.025223434,0.001214174,0.03796158,0.020505534],"study_design_scores_gemma":[0.005615779,0.00032612184,0.9714392,0.0007858869,0.008900903,0.0021792145,0.008833455,0.00019356144,0.00054512214,0.0009699205,0.00013763107,0.00007320446],"about_ca_topic_score_codex":0.0027346015,"about_ca_topic_score_gemma":0.0009772672,"teacher_disagreement_score":0.16754012,"about_ca_system_score_codex":0.000028765582,"about_ca_system_score_gemma":0.0002372633,"threshold_uncertainty_score":0.41339177},"labels":[],"label_agreement":null},{"id":"W4411732819","doi":"10.1093/bjd/ljaf085.213","title":"AI16 Performance of a deep neural network in diagnosing lesions referred on the suspected skin cancer pathway: a prospective observational study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MetaOptima Technology (Canada)","funders":"","keywords":"Observational study; Medicine; Skin cancer; Cancer; Prospective cohort study; Dermatology; Internal medicine","score_opus":0.03225364000346986,"score_gpt":0.2923897812691514,"score_spread":0.2601361412656815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428064,0.00086416706,0.00004284995,0.003310488,0.0003883778,0.0005565292,0.000001580007,0.000009837023,0.00054554146],"genre_scores_gemma":[0.998839,0.00022900422,0.000056250028,0.0006593994,0.00007828131,0.000042527696,0.0000012659937,0.000007878687,0.0000863911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880445,0.00016788056,0.0005347834,0.000120765035,0.00019726246,0.0001748367],"domain_scores_gemma":[0.9991701,0.00022888611,0.00024691827,0.000101076475,0.00021764265,0.000035344918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001676168,0.00008779062,0.00035670263,0.00016044937,0.000109079505,0.000016712931,0.00010340068,0.000048642458,0.00006170406],"category_scores_gemma":[0.00019897234,0.00007519433,0.00007215946,0.0004569335,0.000057477246,0.00004995966,0.00004191154,0.00038898317,8.026216e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00129833,0.0011212968,0.94606996,0.000067200155,0.00030969648,0.0043687145,0.0005584846,0.0017069035,0.00013355781,0.0006535621,0.002780202,0.040932093],"study_design_scores_gemma":[0.002328061,0.00038576577,0.98449486,0.0005681084,0.00007157259,0.00778964,0.0007973043,0.0026334014,0.00036026453,0.00012977203,0.0003787847,0.0000624559],"about_ca_topic_score_codex":0.00011930096,"about_ca_topic_score_gemma":0.0016174732,"teacher_disagreement_score":0.04086964,"about_ca_system_score_codex":0.00012646864,"about_ca_system_score_gemma":0.00011716257,"threshold_uncertainty_score":0.3066336},"labels":[],"label_agreement":null},{"id":"W4411732835","doi":"10.1093/bjd/ljaf085.148","title":"P120 Climate change: impact on cutaneous carcinogenesis and dermatological practice","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatological diseases; Medicine; Dermatology","score_opus":0.02557687890981433,"score_gpt":0.369522982113814,"score_spread":0.3439461032039997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963882,0.013778748,0.00006180706,0.01693396,0.00032154383,0.00024590833,0.0000059673894,0.000017463572,0.0047525894],"genre_scores_gemma":[0.9794747,0.014188422,0.00031292278,0.0058265887,0.00013714383,0.000005791746,0.0000022034883,0.000009332808,0.000042853528],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9981723,0.00022492849,0.0004945139,0.0002071319,0.00041025324,0.00049088814],"domain_scores_gemma":[0.9982736,0.0005761608,0.00021354535,0.00014301758,0.0004202088,0.0003734571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036606344,0.00014362956,0.0006619872,0.0003669287,0.00014864508,0.0000427005,0.00015736767,0.00016438136,0.00006440042],"category_scores_gemma":[0.0016015806,0.00011336875,0.000131028,0.00033483023,0.00033209234,0.00016012763,0.000070595874,0.00053671404,0.000011197303],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042411573,0.0008176081,0.3828089,0.00052744616,0.00046315696,0.33094245,0.00068134465,0.0000031299537,0.001990749,0.0009575018,0.022383625,0.25418293],"study_design_scores_gemma":[0.0024282855,0.0006320609,0.13288115,0.00067295326,0.00021643827,0.8567518,0.0006824767,0.000110402034,0.0011702678,0.00011782296,0.0042419555,0.00009436987],"about_ca_topic_score_codex":0.00009528229,"about_ca_topic_score_gemma":0.000010845192,"teacher_disagreement_score":0.52580935,"about_ca_system_score_codex":0.00008492582,"about_ca_system_score_gemma":0.00030534432,"threshold_uncertainty_score":0.46230435},"labels":[],"label_agreement":null},{"id":"W4411732855","doi":"10.1093/bjd/ljaf085.373","title":"PA14 Spironolactone for the treatment of acne vulgaris affecting female patients aged 18 years and under: results from a UK and Irish survey","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University Hospital Foundation","funders":"Queen's University; Victoria University; King's College London; Nottingham University Hospitals NHS Trust; University of Nottingham; University of Southampton; University of Sussex","keywords":"Spironolactone; Irish; Acne; Medicine; Dermatology; Family medicine; Internal medicine","score_opus":0.024131853723676665,"score_gpt":0.295327146444146,"score_spread":0.2711952927204693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907708,0.007992148,0.00017991912,0.00037933124,0.00015504229,0.00035016966,0.00011342433,0.0000035272599,0.000055601686],"genre_scores_gemma":[0.99524146,0.00423022,0.00023388866,0.000110797984,0.0000337183,0.000004261905,0.000041736315,0.000008297235,0.00009558773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913937,0.00012186842,0.00037480931,0.00013628979,0.00007832416,0.00014933097],"domain_scores_gemma":[0.9984054,0.0010963187,0.0002500142,0.00009268223,0.00009046593,0.000065094035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015237789,0.00010035412,0.00048321922,0.00006205167,0.000117179196,0.000024397486,0.00003941333,0.00009852142,0.0000071291834],"category_scores_gemma":[0.00020752651,0.00007320626,0.00008215412,0.00005652311,0.000093136805,0.00003771448,0.000020224234,0.00009419044,2.0610572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017554068,0.0006052915,0.8875987,0.00005038179,0.00091333507,0.00041405446,0.0006470819,0.0000018013858,0.00012262548,0.000001189925,0.0061694733,0.10172068],"study_design_scores_gemma":[0.014542811,0.00085979345,0.9811787,0.00027319565,0.00040809865,0.0009473007,0.0003069644,0.000023758694,0.00084037666,0.00003511149,0.00052856945,0.000055345048],"about_ca_topic_score_codex":0.0013136395,"about_ca_topic_score_gemma":0.00057723,"teacher_disagreement_score":0.10166533,"about_ca_system_score_codex":0.000030069981,"about_ca_system_score_gemma":0.0000493773,"threshold_uncertainty_score":0.2985265},"labels":[],"label_agreement":null},{"id":"W4411732876","doi":"10.1093/bjd/ljaf085.430","title":"BI21 Intermittent and progressive pustular psoriasis during chemotherapy cycles in a toddler","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Toddler; Pustular psoriasis; Medicine; Psoriasis; Chemotherapy; Pediatrics; Dermatology; Surgery; Psychology; Developmental psychology","score_opus":0.009912229357831513,"score_gpt":0.29934590807549233,"score_spread":0.2894336787176608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96649855,0.017343618,0.00007547139,0.015369945,0.0002872422,0.00019665851,0.0000020993039,0.000013727884,0.00021267979],"genre_scores_gemma":[0.99529445,0.002082224,0.00064850925,0.0017786315,0.00011544773,0.0000075402395,0.0000010947781,0.000014801949,0.00005730331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853057,0.00014571653,0.00072464003,0.0001749333,0.00018597973,0.00023817175],"domain_scores_gemma":[0.9992894,0.00008246216,0.00027195155,0.00011627402,0.00013301594,0.00010690745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019016783,0.000120797726,0.00064074015,0.00031123587,0.000048398313,0.000038979288,0.00011767796,0.00012313823,0.000044649467],"category_scores_gemma":[0.00022850819,0.00013546177,0.00011342148,0.00019285077,0.00013579066,0.00011527674,0.00005737868,0.00040432235,0.0000012722501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014891651,0.00095115753,0.7737357,0.0012608715,0.0009140634,0.032501146,0.0033590116,0.0000022553158,0.0013202536,0.00014198058,0.0063847187,0.17793967],"study_design_scores_gemma":[0.008667584,0.00008631927,0.8519709,0.0034806153,0.00007994741,0.1269209,0.0010976144,0.000011318153,0.005621514,0.00047476747,0.0014504913,0.00013800384],"about_ca_topic_score_codex":0.000087492335,"about_ca_topic_score_gemma":0.00012737591,"teacher_disagreement_score":0.17780167,"about_ca_system_score_codex":0.000066170396,"about_ca_system_score_gemma":0.000144212,"threshold_uncertainty_score":0.5523971},"labels":[],"label_agreement":null},{"id":"W4411732890","doi":"10.1093/bjd/ljaf085.486","title":"HX23 Illuminating the skin: the enduring legacy of the wood lamp in dermatology","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Dermatology; Medicine","score_opus":0.008337448967818453,"score_gpt":0.25406756541529746,"score_spread":0.245730116447479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8854721,0.02673959,0.00015110815,0.06572654,0.0015348041,0.0003652526,0.0000016557133,0.000011366264,0.019997573],"genre_scores_gemma":[0.9888149,0.00086462795,0.000087094755,0.009893077,0.00009210896,0.00001246094,6.6879903e-7,0.000012954033,0.00022212],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9974015,0.00058093714,0.0011966971,0.00016045598,0.0002788627,0.00038156295],"domain_scores_gemma":[0.9978092,0.0008626168,0.00064591726,0.00036057376,0.00027010552,0.00005161203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004306559,0.0001637354,0.00085888384,0.00022439483,0.00033043028,0.000013268703,0.00056908495,0.00018497051,0.000019349922],"category_scores_gemma":[0.0010375858,0.00009710096,0.00025872563,0.0004955108,0.0011411919,0.0000992214,0.0002088856,0.0011816657,0.000003097997],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007052566,0.0011730065,0.3654856,0.0018304505,0.0022705293,0.03427334,0.010749031,0.00003137474,0.001987805,0.009261347,0.51066536,0.0615669],"study_design_scores_gemma":[0.009070767,0.000099980665,0.20838314,0.0029336896,0.0007281584,0.62560666,0.019346489,0.00014761258,0.012420768,0.0011452407,0.11984932,0.00026818042],"about_ca_topic_score_codex":0.000064542575,"about_ca_topic_score_gemma":0.00019990404,"teacher_disagreement_score":0.5913333,"about_ca_system_score_codex":0.000066469125,"about_ca_system_score_gemma":0.00038759553,"threshold_uncertainty_score":0.51338154},"labels":[],"label_agreement":null},{"id":"W4411732967","doi":"10.1093/bjd/ljaf085.126","title":"P098 Asthma control in patients receiving systemic therapy for atopic eczema: results from the UK Atopic eczema Systemic TherApy Register (A-STAR)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"NIHR Newcastle Biomedical Research Centre; Directorate for Biological Sciences; Newcastle University; University of Manchester; University of Oxford; King's College London; University of Southampton; National Institute for Health and Care Research","keywords":"Systemic therapy; Medicine; Register (sociolinguistics); Asthma; Dermatology; Pediatrics; Immunology; Internal medicine","score_opus":0.010892786146812597,"score_gpt":0.25556748180046335,"score_spread":0.24467469565365074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411732967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9446005,0.046227783,0.0003309238,0.0059896703,0.0011981305,0.0012767318,0.000102590886,0.00002737662,0.00024624926],"genre_scores_gemma":[0.99158597,0.0039363955,0.0000821436,0.0038957945,0.00017937964,0.00006713029,0.000050746978,0.000028487368,0.00017394999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964079,0.0007587299,0.0017080363,0.00036742078,0.00027898443,0.0004788892],"domain_scores_gemma":[0.9966613,0.0014440803,0.0008274351,0.0004437645,0.0004966464,0.0001267462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004411333,0.0002754927,0.0012566086,0.00022005448,0.00019812709,0.000068639376,0.000456387,0.00037610772,0.000022986947],"category_scores_gemma":[0.0007658108,0.0002237698,0.00037086447,0.00022333642,0.00018671482,0.00014317503,0.000036186142,0.00055668544,0.0000073301694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044557806,0.00040704713,0.9234351,0.00021619692,0.000715251,0.0023315223,0.00051143277,0.0000055918067,0.00006672254,0.000087518914,0.047222544,0.020545287],"study_design_scores_gemma":[0.052838422,0.00022147919,0.9033516,0.0054047816,0.00015106649,0.027575793,0.00051736727,0.000085345775,0.00020838442,0.0007777334,0.008610634,0.00025738438],"about_ca_topic_score_codex":0.000110929985,"about_ca_topic_score_gemma":0.000111353875,"teacher_disagreement_score":0.048382644,"about_ca_system_score_codex":0.0001326543,"about_ca_system_score_gemma":0.00034895047,"threshold_uncertainty_score":0.91250676},"labels":[],"label_agreement":null},{"id":"W4411733095","doi":"10.1093/bjd/ljaf085.130","title":"P102 Raising the bar of efficacy in atopic dermatitis: lebrikizumab provides deep clinical and itch responses up to 16 weeks (ADvantage study)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Bar (unit); Raising (metalworking); Materials science","score_opus":0.02221577409191623,"score_gpt":0.3558559011643451,"score_spread":0.3336401270724289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97918427,0.01189445,0.00035405415,0.0071577285,0.0004249609,0.00058136287,0.0000045259667,0.000013757797,0.00038491838],"genre_scores_gemma":[0.9968931,0.00076190516,0.00017206096,0.0020060039,0.000043280947,0.000010643613,0.0000014484751,0.000013103565,0.00009841812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967049,0.0010538553,0.0015024018,0.00022762817,0.0002149356,0.00029631885],"domain_scores_gemma":[0.99748415,0.0015679465,0.00032934756,0.00024107985,0.00021747498,0.0001600319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005767949,0.0001594059,0.0010005806,0.00035121167,0.00012591523,0.000039275234,0.00026469826,0.00017248285,0.000036670674],"category_scores_gemma":[0.003071126,0.00014029056,0.00016992888,0.0002804738,0.00044558384,0.0001466345,0.00013831204,0.0005777498,0.000004382684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000982614,0.00079159456,0.937428,0.00018477325,0.0002521272,0.010159198,0.00062343484,0.0000016426446,0.000021820852,0.00010976136,0.0077584884,0.04168652],"study_design_scores_gemma":[0.0072452375,0.00016001011,0.92383677,0.0010301936,0.00025393543,0.061897308,0.0023501003,0.000015857362,0.00033936775,0.00050854986,0.0022549736,0.00010772612],"about_ca_topic_score_codex":0.000038618502,"about_ca_topic_score_gemma":0.00021125245,"teacher_disagreement_score":0.05173811,"about_ca_system_score_codex":0.000029689734,"about_ca_system_score_gemma":0.00035299754,"threshold_uncertainty_score":0.5720883},"labels":[],"label_agreement":null},{"id":"W4411733096","doi":"10.1093/bjd/ljaf085.153","title":"P125 International incidence trends for melanoma in children, teenagers and young adults: a systematic review","year":2025,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incidence (geometry); Medicine; Pediatrics; Demography; Sociology","score_opus":0.008673762937583023,"score_gpt":0.2931664391241949,"score_spread":0.28449267618661184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001690498,0.99688405,0.00013326929,0.00038741913,0.0005582318,0.0016027426,0.000032394546,0.000012553759,0.0003724451],"genre_scores_gemma":[0.00022581602,0.9981705,0.0002324196,0.00036750737,0.00007749209,0.00014844604,0.00004924196,0.000021070477,0.00070752366],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99736476,0.00021392322,0.0017544243,0.00024432884,0.00022428716,0.00019829317],"domain_scores_gemma":[0.998301,0.00018774852,0.001100463,0.00015691482,0.0001584978,0.000095321295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032982943,0.00023821977,0.0030294205,0.0008369182,0.00003825684,0.000043051783,0.0002524009,0.0001948314,0.000036078585],"category_scores_gemma":[0.0008860163,0.00022151263,0.0005079204,0.00030580134,0.00004746518,0.00007002446,0.00007704969,0.00043491364,0.00000256312],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025285011,0.000055806442,0.00010044584,0.62801003,0.0006124509,0.003580208,0.000010319783,1.6173008e-8,1.5389544e-8,0.000020652884,0.0038977247,0.36368704],"study_design_scores_gemma":[0.00073656987,0.000052633193,0.00004591794,0.5408405,0.00228791,0.4219487,0.000015329397,0.0000031715376,7.777232e-8,0.0000048802985,0.033962984,0.00010133426],"about_ca_topic_score_codex":0.000024523148,"about_ca_topic_score_gemma":0.00006170236,"teacher_disagreement_score":0.4183685,"about_ca_system_score_codex":0.00015262442,"about_ca_system_score_gemma":0.00016979354,"threshold_uncertainty_score":0.90330225},"labels":[],"label_agreement":null},{"id":"W4411733197","doi":"10.1093/bjd/ljaf085.421","title":"BI12 Systematic review of checkpoint inhibitor-induced epidermal necrolysis: a clinical entity distinct from ‘classic’ Stevens–Johnson syndrome/toxic epidermal necrolysis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Toxic epidermal necrolysis; Dermatology; Medicine; Erythroderma","score_opus":0.02318165474011521,"score_gpt":0.31872012790244386,"score_spread":0.2955384731623287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9333464,0.055284794,0.0009280814,0.005915568,0.0018515817,0.0013704502,0.00009401007,0.00007728439,0.0011318292],"genre_scores_gemma":[0.98645306,0.011011931,0.0007377877,0.0013272668,0.00020495783,0.000042801683,0.000042613356,0.00005451007,0.0001250925],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9899352,0.0019621719,0.0060267113,0.00058947894,0.00081365916,0.0006727514],"domain_scores_gemma":[0.99267054,0.0015414347,0.00344641,0.00083160395,0.0009748725,0.0005351561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018475483,0.0004739694,0.005277051,0.0006578769,0.00019203051,0.00006247222,0.00052517286,0.00055187265,0.00009105815],"category_scores_gemma":[0.008122943,0.00048135285,0.0020076626,0.0010122886,0.00031233573,0.0004470444,0.00022134365,0.0017199435,0.00006526342],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000572207,0.0106489835,0.061632767,0.6498105,0.02667693,0.14712933,0.00029309516,0.000011038418,0.017553868,0.00026760137,0.01537972,0.070024],"study_design_scores_gemma":[0.007894082,0.00021863736,0.19179636,0.4770171,0.016105538,0.29913172,0.00050981715,0.00021508784,0.0052422555,0.00023188358,0.00094215764,0.0006953472],"about_ca_topic_score_codex":0.00034110263,"about_ca_topic_score_gemma":0.00013838329,"teacher_disagreement_score":0.17279334,"about_ca_system_score_codex":0.0003083928,"about_ca_system_score_gemma":0.0010867977,"threshold_uncertainty_score":0.9997638},"labels":[],"label_agreement":null},{"id":"W4411733218","doi":"10.1093/bjd/ljaf085.500","title":"PS02 (P135) Patient satisfaction in virtual support group meetings for vitiligo: a service evaluation","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Patient satisfaction; Medicine; Service (business); Psychology; Dermatology; Nursing; Business","score_opus":0.007747618350989182,"score_gpt":0.2739550690753969,"score_spread":0.2662074507244077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332964,0.00062191323,0.0043746596,0.0005718362,0.000515799,0.00027257096,0.00000999855,0.0000025649165,0.00030102447],"genre_scores_gemma":[0.99829364,0.00017238663,0.0005417086,0.00079942844,0.000053587613,0.000034021665,0.00007947257,0.0000077042605,0.000018074774],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989212,0.0001639529,0.00048477924,0.00014403222,0.00013873918,0.00014725709],"domain_scores_gemma":[0.99930334,0.000032304168,0.00024305264,0.00006767002,0.00031859538,0.00003501784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003105972,0.00007680083,0.00017453598,0.000098025776,0.000051677078,0.00002438821,0.00007236597,0.00013903598,0.000023321278],"category_scores_gemma":[0.00019664173,0.00009539626,0.00006749351,0.000090754605,0.000019441917,0.000012796303,0.00002552202,0.000086702035,0.0000012186324],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013810728,0.0004085456,0.055142816,0.00020157036,0.00027027703,0.00028977502,0.00056595844,0.00045645045,0.4200092,0.00046679215,0.052098867,0.46870866],"study_design_scores_gemma":[0.03138522,0.0032765116,0.3413608,0.0011481644,0.0005514852,0.045941707,0.0060905945,0.005341012,0.5165722,0.00544632,0.04176484,0.00112118],"about_ca_topic_score_codex":0.00008134465,"about_ca_topic_score_gemma":0.0013641056,"teacher_disagreement_score":0.46758747,"about_ca_system_score_codex":0.00003938488,"about_ca_system_score_gemma":0.00013337337,"threshold_uncertainty_score":0.38901463},"labels":[],"label_agreement":null},{"id":"W4411733287","doi":"10.1093/bjd/ljaf085.016","title":"O01 The UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR): a pilot descriptive analysis of healthcare resource use, costs and health-related quality of life in patients on systemic treatments for atopic eczema","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Systemic therapy; Register (sociolinguistics); Irish; Quality of life (healthcare); Health care; Family medicine; Nursing; Internal medicine","score_opus":0.05956655509467911,"score_gpt":0.33198797557917215,"score_spread":0.272421420484493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96364224,0.031781435,0.00003404571,0.0030680653,0.00015665793,0.0011526865,0.00011659976,0.000009049034,0.00003925034],"genre_scores_gemma":[0.9964966,0.0018981536,0.0000319576,0.001400809,0.000009973484,0.00003676298,0.000050662,0.000014655157,0.000060425722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995498,0.001352452,0.0022794432,0.00027808952,0.00027052956,0.00032148501],"domain_scores_gemma":[0.99658525,0.00073610625,0.0016760749,0.00032996488,0.0005024419,0.00017016854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051630806,0.00020763163,0.0020357897,0.0005887863,0.00012135353,0.000017867782,0.00019142053,0.00021682713,0.0000055615733],"category_scores_gemma":[0.00048845966,0.00017381426,0.0003187103,0.0005736479,0.0002371711,0.00008262454,0.000034598226,0.00031457463,3.2165562e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025195202,0.0006350294,0.986436,0.0009445149,0.002818681,0.00018630808,0.0006448406,0.0000065074582,0.0000059829936,0.00017732837,0.0034359563,0.0021893405],"study_design_scores_gemma":[0.011370657,0.0006487569,0.9800354,0.003473766,0.000666276,0.0024185146,0.0010681977,0.000033422213,0.000039094557,0.00008448171,0.000060430808,0.00010097281],"about_ca_topic_score_codex":0.0019029444,"about_ca_topic_score_gemma":0.0007328611,"teacher_disagreement_score":0.03285439,"about_ca_system_score_codex":0.00026494794,"about_ca_system_score_gemma":0.00040083186,"threshold_uncertainty_score":0.70879394},"labels":[],"label_agreement":null},{"id":"W4411733297","doi":"10.1093/bjd/ljaf085.021","title":"O06 Association between novel systemic immunomodulatory medications and achievement of super response in patients with moderate-to-severe atopic eczema: results from the UK–Irish Atopic Eczema Systemic Therapy Register (A-STAR)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Systemic therapy; Register (sociolinguistics); Dermatology; Internal medicine; Cancer","score_opus":0.010022716704644241,"score_gpt":0.24366606009335456,"score_spread":0.23364334338871032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772234,0.0055857333,0.00019706256,0.0054605734,0.00018207017,0.0006123845,0.00018136235,0.000010422998,0.000048053673],"genre_scores_gemma":[0.9984875,0.00038619546,0.00011641088,0.0007883185,0.0000374647,0.000019988514,0.00006204067,0.000014414994,0.000087693814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972477,0.0006304594,0.0012545735,0.0002498504,0.0003628902,0.0002545316],"domain_scores_gemma":[0.99741036,0.0009978488,0.00068497093,0.00032952437,0.00046880508,0.000108516884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000564132,0.00017250967,0.0008254486,0.00022208592,0.00012292669,0.000030290592,0.00023831331,0.00025488602,0.0000077000395],"category_scores_gemma":[0.00056113285,0.00014120531,0.00009350184,0.00022826884,0.00012563713,0.00012270674,0.00005807306,0.00040447662,0.000001947287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003958429,0.00023371249,0.98932815,0.000090625625,0.0007243333,0.00017996004,0.00061616715,0.000011871336,0.000067911205,0.000011966524,0.0042913146,0.00048555474],"study_design_scores_gemma":[0.0134422835,0.00012169902,0.9807532,0.0025712638,0.0002563511,0.0019456549,0.00035503134,0.000013625393,0.00011486269,0.000057556997,0.0002555917,0.000112878646],"about_ca_topic_score_codex":0.00013183664,"about_ca_topic_score_gemma":0.00004594131,"teacher_disagreement_score":0.010765135,"about_ca_system_score_codex":0.00019709076,"about_ca_system_score_gemma":0.0004054497,"threshold_uncertainty_score":0.57581854},"labels":[],"label_agreement":null},{"id":"W4411733317","doi":"10.1093/bjd/ljaf085.151","title":"P123 A novel self-referral enrolment pathway in a UK multicentre atopic dermatitis trial (BEACON trial): a single-site prospective observational study to assess feasibility and effectiveness","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Observational study; Medicine; Atopic dermatitis; Referral; Physical therapy; Pediatrics; Dermatology; Family medicine; Internal medicine","score_opus":0.06952446655235316,"score_gpt":0.34016026675537003,"score_spread":0.27063580020301686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921585,0.0013048853,0.00039522274,0.00094742427,0.0006831986,0.0043339697,0.000023014674,0.00002959067,0.00012419822],"genre_scores_gemma":[0.99841577,0.00003041305,0.00059307186,0.0006788659,0.000075706324,0.0001649583,0.00001170869,0.000013943775,0.000015558511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688447,0.0008787049,0.0011453553,0.00040128359,0.0003300486,0.00036014445],"domain_scores_gemma":[0.9981103,0.00078816636,0.00033641298,0.0001928739,0.00035217303,0.00022010706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005565378,0.00023886927,0.0011729905,0.00035476798,0.00012875117,0.000073680545,0.000151945,0.00018521337,0.000019764031],"category_scores_gemma":[0.0013681313,0.0002538169,0.00017560174,0.00038028051,0.000099348166,0.0002113212,0.00010916722,0.00048934424,0.000002682157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06899135,0.009832508,0.91281635,0.00023557947,0.00044065312,0.0052525676,0.00082333386,0.0000035587725,0.0001481884,0.000062517545,0.00036072225,0.0010326699],"study_design_scores_gemma":[0.26479095,0.000797199,0.72335225,0.00056425546,0.00019994978,0.008930372,0.00044490682,0.00003262277,0.00042429208,0.00022612706,0.00009854598,0.00013849593],"about_ca_topic_score_codex":0.000069322494,"about_ca_topic_score_gemma":0.0005568971,"teacher_disagreement_score":0.1957996,"about_ca_system_score_codex":0.0003318714,"about_ca_system_score_gemma":0.0005998372,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W4411733382","doi":"10.1093/bjd/ljaf085.322","title":"DS28 Left-handedness in dermatological surgery","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hemispheric Asymmetry in Neuroscience","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Dermatology; Surgery","score_opus":0.02318190960145816,"score_gpt":0.2812025967525991,"score_spread":0.25802068715114096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890362,0.00067626237,0.0023395082,0.0027246918,0.0016142323,0.00009641156,0.000002924511,0.000033531516,0.003476235],"genre_scores_gemma":[0.9959754,0.00063679495,0.00021425346,0.003017669,0.000023237713,0.0000028319935,1.8955978e-7,0.000009714711,0.00011991827],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9971777,0.0006157776,0.0010274444,0.00033309343,0.00032220222,0.0005237696],"domain_scores_gemma":[0.9974647,0.0018048998,0.00034508336,0.00016937048,0.00008569737,0.00013024852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032548237,0.00015032051,0.00065175607,0.00031563587,0.00013142939,0.000099475525,0.00068699074,0.00017386155,0.00007317879],"category_scores_gemma":[0.006243078,0.00016563926,0.00015648763,0.0009346386,0.00045854197,0.00035707513,0.00014356972,0.000639297,0.000015070418],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000263384,0.0014079838,0.5127677,0.00027471638,0.000022209035,0.2145355,0.00022031587,0.00010643495,0.11509819,0.0037889339,0.05846272,0.09305194],"study_design_scores_gemma":[0.0013533935,0.00002646483,0.045511562,0.0005388979,0.0000168509,0.5841284,0.00013793155,0.0004589192,0.35120216,0.003747119,0.012505536,0.00037280103],"about_ca_topic_score_codex":0.000010642132,"about_ca_topic_score_gemma":0.000017521688,"teacher_disagreement_score":0.4672561,"about_ca_system_score_codex":0.00005721129,"about_ca_system_score_gemma":0.0003525093,"threshold_uncertainty_score":0.7473998},"labels":[],"label_agreement":null},{"id":"W4411733394","doi":"10.1093/bjd/ljaf085.157","title":"P129 A prospective comparative audit of outcomes in patients with basal cell carcinoma receiving 10 600-nm carbon dioxide laser-assisted photodynamic therapy with either methyl aminolaevulinate or 5-aminolaevulinic acid as a photosensitizer","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Photodynamic therapy; Carbon dioxide laser; Medicine; Basal cell carcinoma; Audit; Laser therapy; Basal (medicine); Basal cell; Dermatology; Laser; Internal medicine; Chemistry; Optics; Organic chemistry","score_opus":0.012569728245028314,"score_gpt":0.28725467866350896,"score_spread":0.2746849504184806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956276,0.0012064651,0.000014988189,0.0003680155,0.00010977329,0.0015474897,0.000046375248,0.0000256534,0.0010536461],"genre_scores_gemma":[0.9981805,0.00026790495,0.00048054702,0.00024313759,0.000015561733,0.0000746421,0.000011304583,0.000056266716,0.0006701129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996321,0.0006017119,0.0011919473,0.00049208757,0.0007142784,0.0006789562],"domain_scores_gemma":[0.99667436,0.00059965707,0.00091733393,0.000347681,0.001280003,0.0001809679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033479245,0.00046501242,0.00228704,0.0007476155,0.00010686442,0.000033485383,0.0002888419,0.00021179869,0.00006780503],"category_scores_gemma":[0.00027172363,0.0003441742,0.00020934951,0.00083240005,0.0005561694,0.00019469483,0.00009942065,0.0010400091,0.000002236833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03329691,0.0028317238,0.9243687,0.000250856,0.0021908886,0.008596725,0.0016459549,0.000007662702,0.02544097,0.0000022996674,0.00009750642,0.0012698388],"study_design_scores_gemma":[0.027228199,0.0036603964,0.8381699,0.0010190929,0.00018575207,0.0032023673,0.0010359786,0.00005369725,0.12510532,0.000035811318,0.000020036317,0.00028349736],"about_ca_topic_score_codex":0.0005788902,"about_ca_topic_score_gemma":0.002423789,"teacher_disagreement_score":0.09966435,"about_ca_system_score_codex":0.0004021292,"about_ca_system_score_gemma":0.0010018236,"threshold_uncertainty_score":0.99990106},"labels":[],"label_agreement":null},{"id":"W4411733402","doi":"10.1093/bjd/ljaf085.080","title":"P052 Nemolizumab elicits rapid itch-free state and sleep improvement in prurigo nodularis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Prurigo nodularis; Medicine; Prurigo; Dermatology; Sleep (system call); Computer science","score_opus":0.0049594348416102715,"score_gpt":0.24401873215008715,"score_spread":0.2390592973084769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95479256,0.03315369,0.00035080058,0.008162699,0.00040439348,0.0002643782,0.000014743791,0.0000149099415,0.0028418484],"genre_scores_gemma":[0.993864,0.003015157,0.00039508202,0.0024371198,0.00003182,0.000008403092,0.0000048959682,0.000013344616,0.0002301959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982698,0.00013970501,0.00084645627,0.00020181783,0.00017920579,0.00036300204],"domain_scores_gemma":[0.99903685,0.00012680248,0.00024849086,0.00021441448,0.0001954711,0.00017796524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015099991,0.00015647602,0.00071804447,0.00039558852,0.000077392644,0.00003574158,0.00020796117,0.00017015645,0.0001008107],"category_scores_gemma":[0.0004283125,0.00017038116,0.00011954683,0.00021663765,0.00019316442,0.00015007447,0.00012596963,0.00048169648,0.0000070216397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018060773,0.0013278872,0.3661761,0.0009212954,0.0009708722,0.12567978,0.00031140348,0.000009174831,0.0011197942,0.0004033283,0.14940654,0.35186777],"study_design_scores_gemma":[0.020985324,0.00020364362,0.5888169,0.0013840656,0.00043295062,0.3556255,0.000265924,0.00026476802,0.00684124,0.010090513,0.014766663,0.00032252347],"about_ca_topic_score_codex":0.000058935664,"about_ca_topic_score_gemma":0.00011523664,"teacher_disagreement_score":0.35154524,"about_ca_system_score_codex":0.000046749534,"about_ca_system_score_gemma":0.0002370389,"threshold_uncertainty_score":0.6947942},"labels":[],"label_agreement":null},{"id":"W4411733547","doi":"10.1093/bjd/ljaf085.163","title":"P135 Patient satisfaction in virtual support group meetings for vitiligo: a service evaluation","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Vitiligo; Patient satisfaction; Service (business); Medicine; Nursing; Dermatology; Business","score_opus":0.007636084267282979,"score_gpt":0.2738188487619751,"score_spread":0.26618276449469214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411733547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937921,0.000537837,0.004121551,0.00052660384,0.0004851893,0.00024917707,0.00000934883,0.0000022749289,0.00027590973],"genre_scores_gemma":[0.9983745,0.0001555451,0.00051404955,0.0007752982,0.000049660597,0.000030366358,0.000078076446,0.000006977208,0.000015512083],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900115,0.00015208776,0.00045078754,0.00013281133,0.00012841653,0.00013473116],"domain_scores_gemma":[0.99935246,0.000030342231,0.0002241041,0.00006196626,0.00029953453,0.000031576463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002893024,0.00007005728,0.00015995785,0.000093058574,0.000047358943,0.000022039872,0.000066452776,0.00012846992,0.000021049054],"category_scores_gemma":[0.00018500771,0.0000873278,0.00006154734,0.00008773711,0.000018172028,0.00001139626,0.000023468623,0.00007968442,0.0000010688256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012478813,0.00036604697,0.055062793,0.00018466066,0.00024370222,0.0002657037,0.0004997777,0.00045519843,0.4383593,0.00048500925,0.04513263,0.4576973],"study_design_scores_gemma":[0.027389098,0.0028493856,0.33119965,0.0009990184,0.00046983446,0.041508064,0.0054739313,0.0045397715,0.5407839,0.0053819437,0.038432132,0.00097329187],"about_ca_topic_score_codex":0.00006190706,"about_ca_topic_score_gemma":0.00096008263,"teacher_disagreement_score":0.456724,"about_ca_system_score_codex":0.000034448716,"about_ca_system_score_gemma":0.00012436333,"threshold_uncertainty_score":0.35611242},"labels":[],"label_agreement":null},{"id":"W4411750799","doi":"10.1093/bjd/ljaf257","title":"Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the phosphoinositide 3-kinase/AKT pathway","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Wellcome Trust","keywords":"PI3K/AKT/mTOR pathway; Hidradenoma; Biology; Pathogenesis; Gene; Cancer research; Genetics; Protein kinase B; Computational biology; Bioinformatics; Signal transduction; Immunology","score_opus":0.009017301433216949,"score_gpt":0.25755170083050477,"score_spread":0.24853439939728783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411750799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869763,0.008954701,0.00012437748,0.0028111741,0.00013119593,0.00021097205,0.000065073786,0.0000020211853,0.0007241681],"genre_scores_gemma":[0.99903584,0.00018707094,0.0004317072,0.000281246,0.00002914256,0.0000057321613,0.000012725831,0.0000051162992,0.000011397977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867284,0.00018993391,0.0007266643,0.00007595491,0.00021932661,0.00011528806],"domain_scores_gemma":[0.9986833,0.00040391178,0.00037130268,0.00012569356,0.00039047012,0.000025357136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009723468,0.00007106218,0.00042086927,0.00012759693,0.000060370927,0.000008470682,0.00017950183,0.00006188294,0.000031616546],"category_scores_gemma":[0.00015262351,0.000053378135,0.0001589124,0.00026647912,0.0001593493,0.000054604745,0.000035437653,0.00025022696,2.932726e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008875493,0.0015626281,0.8444519,0.0010360042,0.0006534588,0.0031052318,0.0063126455,0.00060653454,0.10986775,0.016287247,0.006097797,0.009131234],"study_design_scores_gemma":[0.0034521567,0.00013488495,0.49289072,0.0019047357,0.00019505972,0.04875366,0.0053109145,0.00030538687,0.443154,0.0031386185,0.0006690205,0.00009083714],"about_ca_topic_score_codex":0.00009920553,"about_ca_topic_score_gemma":0.000055772573,"teacher_disagreement_score":0.35156122,"about_ca_system_score_codex":0.000015840798,"about_ca_system_score_gemma":0.0003817571,"threshold_uncertainty_score":0.21766973},"labels":[],"label_agreement":null},{"id":"W4411928345","doi":"10.1093/bjd/ljaf236","title":"Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; Probity Medical Research; SKiN Health; Queen's University","funders":"AbbVie","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Clinical endpoint; Randomized controlled trial; Adverse effect; Internal medicine; Dermatology","score_opus":0.009325407154275793,"score_gpt":0.28987825642968496,"score_spread":0.2805528492754092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411928345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935038,0.002178336,0.00038369006,0.001716789,0.00009610098,0.0018280207,0.000040123155,0.000011405954,0.00024173706],"genre_scores_gemma":[0.9982719,0.00045820637,0.0010194187,0.0001367631,0.00001687081,0.000022777345,0.00002234471,0.0000115775,0.0000401373],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972066,0.00058108714,0.0015188676,0.0002618746,0.00021341437,0.00021811864],"domain_scores_gemma":[0.9982607,0.00043803678,0.00054390734,0.00015228344,0.00041116672,0.00019390545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031755064,0.00018330682,0.0015113148,0.0005357922,0.00007017563,0.00001769058,0.000081165774,0.00014980295,0.000010551601],"category_scores_gemma":[0.0010360383,0.00017151894,0.00008729035,0.0003389393,0.00021687738,0.00017303086,0.000040531457,0.00025158946,4.7581707e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9005954,0.004386876,0.05277542,0.0009100271,0.0009220275,0.0054794652,0.007406519,0.0002492763,0.00014583749,0.00005448134,0.0015610664,0.025513576],"study_design_scores_gemma":[0.7182464,0.00048450465,0.23506069,0.0035690193,0.0006625068,0.037034072,0.0023365472,0.00093829655,0.0012906101,0.00017525096,0.000033200307,0.0001688924],"about_ca_topic_score_codex":0.000083122264,"about_ca_topic_score_gemma":0.00011234087,"teacher_disagreement_score":0.18234903,"about_ca_system_score_codex":0.000027642593,"about_ca_system_score_gemma":0.00018096133,"threshold_uncertainty_score":0.6994339},"labels":[],"label_agreement":null},{"id":"W4412492661","doi":"10.1093/bjd/ljaf280","title":"Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Norwegian Institute of Public Health; Faculty of Medicine and Health, University of Sydney; Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet; Sun Pharma; Astellas Pharma; Helse Midt-Norge; National Institute for Health and Care Research; Norges Teknisk-Naturvitenskapelige Universitet; Medical Research Council; Celgene; Biogen; China Scholarship Council; Leading Edge Endowment Fund; Sanofi; Amgen; Pfizer; King's College London; Galderma; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Mendelian randomization; Palmoplantar pustulosis; Mediator; Medicine; Randomization; Cigarette smoking; Dermatology; Internal medicine; Clinical trial; Immunology; Psoriasis; Genetics; Biology; Gene","score_opus":0.003880486165490858,"score_gpt":0.24154747806358992,"score_spread":0.23766699189809906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398583,0.0015181645,0.00054402265,0.001608223,0.0017877603,0.00019455717,0.0000109226075,0.0000058253813,0.000344667],"genre_scores_gemma":[0.9989464,0.0005357389,0.000024406876,0.0003467069,0.00007710949,0.000003590925,0.0000045098977,0.000008518284,0.00005296827],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986753,0.00016946354,0.0006764567,0.000090198235,0.00026986742,0.00011875041],"domain_scores_gemma":[0.99868244,0.00029768134,0.00054830156,0.00011471276,0.0003129803,0.0000439069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014900083,0.00008521141,0.00050333515,0.00023794433,0.00007731198,0.000014721003,0.00012749992,0.00009828849,0.000057066016],"category_scores_gemma":[0.0009929277,0.00007118172,0.0002815096,0.00019041225,0.00009119503,0.00006595063,0.000033036544,0.0003070121,6.145875e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066789715,0.0015607171,0.05074884,0.0029453686,0.0048822486,0.006283246,0.0014398587,0.00024926115,0.83670133,0.00088360836,0.06902738,0.018599141],"study_design_scores_gemma":[0.009469998,0.00020523218,0.016773805,0.004654663,0.0008290467,0.023840422,0.00028363086,0.000082299266,0.9429737,0.00035179,0.00046130188,0.00007416453],"about_ca_topic_score_codex":0.0000659955,"about_ca_topic_score_gemma":0.00001656782,"teacher_disagreement_score":0.10627229,"about_ca_system_score_codex":0.000027559123,"about_ca_system_score_gemma":0.0001466404,"threshold_uncertainty_score":0.29027063},"labels":[],"label_agreement":null},{"id":"W4412658675","doi":"10.1093/bjd/ljaf291","title":"A call to integrate specialized dermatology clinics into care of patients with inflammatory bowel disease","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Pyoderma gangrenosum; Inflammatory bowel disease; Dermatology; Psoriasis; Disease; Multidisciplinary approach; Population; Inflammatory Bowel Diseases; Intensive care medicine; Internal medicine","score_opus":0.005000307232274269,"score_gpt":0.26617756740490806,"score_spread":0.26117726017263376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412658675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928009,0.0021435565,0.00048082735,0.003216064,0.00037038556,0.0004553359,0.000045440403,0.000015610534,0.0004718656],"genre_scores_gemma":[0.9979246,0.00019675403,0.0014204794,0.00025615975,0.000038965405,0.000012811818,0.000048712398,0.000021889795,0.00007960549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803376,0.00020311237,0.0010076228,0.00020503657,0.0002689023,0.00028159222],"domain_scores_gemma":[0.99794924,0.00011027042,0.00040015703,0.00020379185,0.00096729695,0.00036922423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000014597124,0.00019631039,0.000864406,0.00036717494,0.00008184503,0.000019858622,0.00018546937,0.00015140459,0.000048637266],"category_scores_gemma":[0.00034565126,0.00017917257,0.00018719728,0.00022882708,0.00020835378,0.0001288221,0.000063957996,0.00034027922,0.000012240525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002502921,0.00044736077,0.91852164,0.00034750387,0.00038303636,0.066375084,0.0006713006,7.866106e-7,0.000015549404,0.000148854,0.0024059373,0.008180042],"study_design_scores_gemma":[0.0188881,0.00056789257,0.8956391,0.0024450526,0.00088962837,0.071540184,0.0007828912,0.000008780908,0.0010278226,0.0003941357,0.007537474,0.00027893102],"about_ca_topic_score_codex":0.000027148939,"about_ca_topic_score_gemma":0.00019984394,"teacher_disagreement_score":0.022882521,"about_ca_system_score_codex":0.000107702464,"about_ca_system_score_gemma":0.0007540421,"threshold_uncertainty_score":0.7306445},"labels":[],"label_agreement":null},{"id":"W4412743752","doi":"10.1093/bjd/ljaf305","title":"Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"Amgen","keywords":"Apremilast; Medicine; Placebo; Psoriasis; Randomized controlled trial; Internal medicine; Dermatology; Psoriatic arthritis; Alternative medicine; Pathology","score_opus":0.006006601279841326,"score_gpt":0.2054851770162141,"score_spread":0.1994785757363728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412743752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866888,0.008817162,0.00012773614,0.0007507276,0.00097449136,0.0021712095,0.00019558758,0.000008889904,0.0002653987],"genre_scores_gemma":[0.9980593,0.0014061959,0.00013239031,0.00013306974,0.000052136165,0.000061523104,0.00006915708,0.000011545463,0.0000747229],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99593127,0.0018618448,0.0015873294,0.00025540162,0.00007941156,0.00028474745],"domain_scores_gemma":[0.9945497,0.0042088637,0.00080665265,0.00017027113,0.00022756391,0.000036964742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067268725,0.00022342303,0.002063409,0.00023399353,0.0001339327,0.00002629021,0.00026274833,0.00029998485,0.000022472159],"category_scores_gemma":[0.0014014553,0.00015152912,0.00023642926,0.00023946729,0.00020772885,0.00008919036,0.000066654306,0.00035276628,0.0000046709893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98308605,0.0006334491,0.004045205,0.000008013524,0.0015406578,0.0001285719,0.0003845514,0.000043844637,0.000043080865,0.00004675671,0.0011096109,0.008930192],"study_design_scores_gemma":[0.97601646,0.00029259623,0.021044966,0.00031051852,0.00082353555,0.0005366318,0.00010684225,0.0000047017493,0.0003466994,0.000137616,0.00024227239,0.00013715861],"about_ca_topic_score_codex":0.00018586572,"about_ca_topic_score_gemma":0.00022891643,"teacher_disagreement_score":0.01699976,"about_ca_system_score_codex":0.000031290645,"about_ca_system_score_gemma":0.00023756016,"threshold_uncertainty_score":0.61791784},"labels":[],"label_agreement":null},{"id":"W4412785444","doi":"10.1093/bjd/ljaf290","title":"Under the Arctic sun: assessment of skin cancer risk and sun-protection behaviours in Indigenous communities in Nunavik, an emerging at-risk population for skin cancers","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Makivik Corporation; Université de Montréal; McGill University Health Centre; St Mary's Hospital Centre; University of Ottawa","funders":"LEO Fondet; Canadian Institutes of Health Research; Réseau de cancérologie Rossy","keywords":"Skin cancer; Indigenous; Sun exposure; Sun protection; The arctic; Population; Environmental health; Medicine; Arctic; Cancer; Dermatology; Ecology; Biology; Internal medicine","score_opus":0.02053269997960226,"score_gpt":0.33587277365148693,"score_spread":0.31534007367188466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412785444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374974,0.0022709987,0.002420517,0.0007617051,0.0002546281,0.0005102635,0.000013874736,0.0000058164665,0.000012467349],"genre_scores_gemma":[0.99748594,0.0019839285,0.00027989352,0.00013255546,0.000028292226,0.000056566958,0.00000899313,0.000011668938,0.00001218969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985986,0.00041556824,0.000568474,0.00009795808,0.00012924641,0.00019016024],"domain_scores_gemma":[0.9991387,0.00012321655,0.00046868226,0.00009819306,0.00013261332,0.00003860355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005277412,0.00009122492,0.00035588848,0.00037187917,0.00021969793,0.000021813074,0.00007921831,0.00009974089,0.000020112246],"category_scores_gemma":[0.000053486918,0.00009008971,0.00006473542,0.00023935986,0.0000886179,0.000119051474,0.00002801,0.00060842076,2.937994e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014976798,0.00008588848,0.9155394,0.00009774906,0.00006061152,0.000053728938,0.00159952,0.0018150789,0.000054285007,0.000028381648,0.000013530282,0.080502056],"study_design_scores_gemma":[0.002678025,0.00009804609,0.9837126,0.0008976049,0.00012765607,0.00393707,0.00499615,0.0024014225,0.00032761745,0.00070339395,0.000045920013,0.00007446933],"about_ca_topic_score_codex":0.22535585,"about_ca_topic_score_gemma":0.21285675,"teacher_disagreement_score":0.08042759,"about_ca_system_score_codex":0.00057132257,"about_ca_system_score_gemma":0.00021433142,"threshold_uncertainty_score":0.8015066},"labels":[],"label_agreement":null},{"id":"W4413104618","doi":"10.1093/bjd/ljaf307","title":"The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Novartis Pharmaceuticals UK Limited; Novartis Pharma","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine; Disease","score_opus":0.03256686548980241,"score_gpt":0.3450716910055878,"score_spread":0.3125048255157854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413104618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97926223,0.006320351,0.0005774429,0.012259461,0.00026416124,0.0010494771,0.00012294303,0.000008833935,0.00013510302],"genre_scores_gemma":[0.99758947,0.0006522363,0.0015561907,0.0000065833565,0.00002025549,0.000052461666,0.00005276874,0.000020678028,0.00004935079],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99703836,0.0002819485,0.0015321241,0.0002340546,0.00059561897,0.00031786086],"domain_scores_gemma":[0.99651766,0.0010500648,0.0010038617,0.000176921,0.0010898025,0.0001616978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046156903,0.00025023404,0.0010179515,0.0005870099,0.00022332948,0.00005589369,0.00012189085,0.00016871483,0.000026574206],"category_scores_gemma":[0.001513102,0.00019239381,0.00020518742,0.0005074811,0.00030932267,0.00027207463,0.00005339971,0.00022220882,2.7645152e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078188477,0.00085273373,0.65249395,0.0003392331,0.0035742233,0.011797012,0.0021331508,4.238134e-7,0.0012225262,0.00026607327,0.001258928,0.3252799],"study_design_scores_gemma":[0.011870752,0.00047043356,0.22438471,0.00062887685,0.00092078676,0.7546469,0.00096958113,0.00016533602,0.0050244574,0.00040621607,0.0003554078,0.00015654333],"about_ca_topic_score_codex":0.00006449561,"about_ca_topic_score_gemma":0.00006658052,"teacher_disagreement_score":0.7428499,"about_ca_system_score_codex":0.000117508935,"about_ca_system_score_gemma":0.000775132,"threshold_uncertainty_score":0.7845592},"labels":[],"label_agreement":null},{"id":"W4413105160","doi":"10.1093/bjd/ljaf312","title":"European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lymphoproliferative disorders; Medicine; Dermatology; Intensive care medicine; Lymphoma; Pathology","score_opus":0.046720807417611206,"score_gpt":0.37185825501058295,"score_spread":0.32513744759297175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413105160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722137,0.006950863,0.0011444769,0.0100005595,0.00016907087,0.003228885,0.0011036757,0.000014921744,0.00016617695],"genre_scores_gemma":[0.9152134,0.07622513,0.006697045,0.00015621311,0.000054567896,0.00025832123,0.0003428774,0.00004961974,0.0010028018],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99795854,0.00016562312,0.0008923035,0.00037378134,0.0002211305,0.00038859886],"domain_scores_gemma":[0.9962537,0.0017460721,0.00039950898,0.0001341597,0.0013169233,0.00014958324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017180579,0.00024163249,0.00077947474,0.00049169967,0.0003277841,0.00006386326,0.00010067159,0.00011462525,0.000013412202],"category_scores_gemma":[0.00019165286,0.00024153921,0.00018981795,0.00019937052,0.00074968045,0.000044078322,0.00005180826,0.000050325496,1.4273412e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023365919,0.0056372103,0.059483916,0.0018941271,0.011871367,0.0023338147,0.009253614,0.00010580956,0.0025204117,0.0024118386,0.010486956,0.87063503],"study_design_scores_gemma":[0.1293974,0.03166248,0.003954775,0.0021587743,0.0038894895,0.5303774,0.045002222,0.038591266,0.022038558,0.017884117,0.17384839,0.0011951559],"about_ca_topic_score_codex":0.00038244601,"about_ca_topic_score_gemma":0.000546926,"teacher_disagreement_score":0.86943984,"about_ca_system_score_codex":0.0006248323,"about_ca_system_score_gemma":0.00048487578,"threshold_uncertainty_score":0.9849683},"labels":[],"label_agreement":null},{"id":"W4413111259","doi":"10.1093/bjd/ljaf293","title":"Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Deutsche Forschungsgemeinschaft","keywords":"Cutaneous Lupus Erythematosus; Systemic lupus erythematosus; Medicine; Lupus erythematosus; Computational biology; Biology; Dermatology; Immunology; Disease; Pathology; Antibody","score_opus":0.010804504747582726,"score_gpt":0.309357202867814,"score_spread":0.2985526981202313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809029,0.015943304,0.00021048909,0.0018300554,0.00030673415,0.00021094312,0.0000031068425,0.000005986035,0.00058645033],"genre_scores_gemma":[0.99642956,0.0027032525,0.0004994833,0.00021820457,0.000032312513,0.0000027225124,0.0000027331364,0.000011604354,0.000100144694],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99799865,0.00027779536,0.0011341533,0.00015772112,0.00021853017,0.00021317422],"domain_scores_gemma":[0.99888045,0.0002700748,0.00027757898,0.00012846939,0.00033178984,0.000111667985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040256945,0.00009319877,0.0007517501,0.0003508029,0.00002121329,0.00001663607,0.000083494466,0.00021377132,0.000014259585],"category_scores_gemma":[0.0010502059,0.00009736499,0.00011798716,0.00021768917,0.0003046412,0.00006371544,0.00006771156,0.00046716936,0.000001332223],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010386715,0.00047495868,0.85806894,0.0014220368,0.00019191271,0.072147325,0.00011443402,9.801711e-7,0.039650623,0.0004287127,0.0041184467,0.022342974],"study_design_scores_gemma":[0.005483486,0.00023633333,0.016631892,0.0033464849,0.00007992347,0.9571773,0.00025658973,0.000105049585,0.015368898,0.0008933781,0.00034287834,0.00007781111],"about_ca_topic_score_codex":0.000063575,"about_ca_topic_score_gemma":0.00006995276,"teacher_disagreement_score":0.88503,"about_ca_system_score_codex":0.000036195466,"about_ca_system_score_gemma":0.00027811519,"threshold_uncertainty_score":0.3970429},"labels":[],"label_agreement":null},{"id":"W4413786495","doi":"10.1093/bjd/ljaf327","title":"SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; Dalhousie University; Innovaderm (Canada)","funders":"Johnson and Johnson; Dermira; Celgene; Teva Pharmaceutical Industries; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Intertriginous; Body surface area; Placebo; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Randomized controlled trial; Internal medicine; Dermatology; Disease; Pathology","score_opus":0.038585348085449125,"score_gpt":0.3233213397615486,"score_spread":0.2847359916760995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413786495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756859,0.018622195,0.0015298007,0.0010521426,0.0012805123,0.001126593,0.000611803,0.000017351927,0.0000737334],"genre_scores_gemma":[0.9820467,0.016822016,0.00044400012,0.00007827738,0.00010859604,0.0000223782,0.0001770371,0.000019927453,0.00028102662],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969809,0.00064036873,0.0015073619,0.00036718338,0.00007514114,0.00042903287],"domain_scores_gemma":[0.99633884,0.0021488632,0.0008956937,0.00031091267,0.00025156865,0.000054131186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042101,0.0003218705,0.0013182627,0.00009245239,0.00034264755,0.000042570904,0.00022786815,0.00032461312,0.000044606702],"category_scores_gemma":[0.00015638726,0.0002193325,0.000420885,0.00016825572,0.00037341643,0.00013286967,0.000034242097,0.0002227764,0.0000036431384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81356645,0.015529911,0.0027912196,0.00007474444,0.015761744,0.0010042788,0.0012682211,0.00024217175,0.0022289308,0.00032844575,0.013639462,0.13356441],"study_design_scores_gemma":[0.87088746,0.025153572,0.011526672,0.0005875594,0.004609667,0.008014377,0.000474519,0.00005573629,0.060897112,0.0005066585,0.016774762,0.0005119217],"about_ca_topic_score_codex":0.00028050793,"about_ca_topic_score_gemma":0.0003423722,"teacher_disagreement_score":0.1330525,"about_ca_system_score_codex":0.00012784563,"about_ca_system_score_gemma":0.0003718281,"threshold_uncertainty_score":0.894412},"labels":[],"label_agreement":null},{"id":"W4413811220","doi":"10.1093/bjd/ljaf309","title":"Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Dalhousie University","funders":"Cilag; LEO Pharma; Galderma; National Institute for Health and Care Research; Celgene; Gilead Sciences; Amgen; Pfizer; Manchester Biomedical Research Centre; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Placebo; Medicine; Adverse effect; Incidence (geometry); Atopic dermatitis; Clinical trial; Safety profile; Pediatrics; Internal medicine; Dermatology; Alternative medicine","score_opus":0.025778084014918944,"score_gpt":0.35354159469447594,"score_spread":0.327763510679557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413811220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177533,0.0004308498,0.00590525,0.00066650263,0.00025311133,0.0006652377,0.00022990897,0.000006753648,0.00006706103],"genre_scores_gemma":[0.99681634,0.00007467509,0.0019825674,0.0009335632,0.000014243434,0.000014373262,0.00011101095,0.000012239717,0.000040977407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597764,0.00084770424,0.0024965627,0.00021944575,0.00021436634,0.00024426577],"domain_scores_gemma":[0.99742967,0.00074302236,0.00066943915,0.00021576493,0.000717395,0.00022469014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006970838,0.00014856787,0.0024966323,0.0009571709,0.000032132455,0.00001335937,0.00021896731,0.0002424495,0.000083745006],"category_scores_gemma":[0.0019447687,0.00013874183,0.00048713112,0.0009690003,0.00011165126,0.0001334321,0.000028112549,0.00024976415,9.062995e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00877625,0.0010021863,0.9546037,0.00015814751,0.0032207572,0.00069654366,0.0002544097,0.00017339618,0.000006409471,0.00006633398,0.008995386,0.022046516],"study_design_scores_gemma":[0.016908143,0.00040712525,0.9770478,0.00078469596,0.0022551185,0.0007702321,0.00016951012,0.00024541665,0.00025871964,0.00011630714,0.00091371674,0.00012319766],"about_ca_topic_score_codex":0.000045803525,"about_ca_topic_score_gemma":0.00032486423,"teacher_disagreement_score":0.022444153,"about_ca_system_score_codex":0.000040448995,"about_ca_system_score_gemma":0.00042972303,"threshold_uncertainty_score":0.5657727},"labels":[],"label_agreement":null},{"id":"W4413978744","doi":"10.1093/bjd/ljaf345","title":"Multiharmonic imaging-based automated recognition of cutaneous T-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Horizon 2020 Framework Programme; Swiss Cancer Research Foundation; Centre Hospitalier Universitaire Vaudois; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Mallinckrodt Pharmaceuticals; H2020 LEIT Information and Communication Technologies; Université de Lausanne; Université de Genève; Helsinn; H2020 Leadership in Enabling and Industrial Technologies; National Science Foundation","keywords":"Mycosis fungoides; Biopsy; Pathology; Medicine; Convolutional neural network; Skin biopsy; Lymphoma; Atypical Lymphocyte; Cutaneous T-cell lymphoma; Haematoxylin; Staining; Artificial intelligence; Computer science","score_opus":0.010961421461604802,"score_gpt":0.29063409823356623,"score_spread":0.27967267677196145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413978744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640573,0.0073797978,0.0010553881,0.002116253,0.00021477575,0.00033866288,0.000029373683,0.00007759638,0.002382401],"genre_scores_gemma":[0.9974421,0.00039818903,0.0012973365,0.00065145025,0.000020935284,0.0000059765275,0.00002551979,0.000023205801,0.00013523805],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9980753,0.00023287958,0.00084433274,0.00018127795,0.00033418398,0.0003319999],"domain_scores_gemma":[0.99790794,0.00026715448,0.00037099645,0.00015186406,0.001171119,0.00013094301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001369174,0.00014478594,0.0006560566,0.00053276995,0.0000841644,0.00002934967,0.00017765061,0.00013171391,0.00015330057],"category_scores_gemma":[0.0005940071,0.00016745491,0.00023019496,0.0003911512,0.00028017402,0.000069847454,0.000036186768,0.0002404384,0.000019593987],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006229257,0.0073028347,0.16779703,0.0025334323,0.0009041694,0.19642338,0.00032716306,0.00009921081,0.08864565,0.000020707765,0.058799572,0.47091758],"study_design_scores_gemma":[0.01774885,0.0003279787,0.0069629857,0.0015282178,0.00028951338,0.79513663,0.0003640963,0.027840745,0.14805515,0.00030841425,0.0012127125,0.00022470538],"about_ca_topic_score_codex":0.00009789799,"about_ca_topic_score_gemma":0.000029182707,"teacher_disagreement_score":0.5987133,"about_ca_system_score_codex":0.00015266624,"about_ca_system_score_gemma":0.0011521691,"threshold_uncertainty_score":0.68286127},"labels":[],"label_agreement":null},{"id":"W4414068914","doi":"10.1093/bjd/ljaf334","title":"Striking improvement with targeted therapy in an anaplastic lymphoma kinase-positive atypical giant congenital melanocytic naevus of the right lower limb: a case report","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Targeted therapy; Debulking; Anaplastic lymphoma kinase; Surgical excision; Congenital melanocytic nevus; Nevus","score_opus":0.006884219687841592,"score_gpt":0.25563872780463415,"score_spread":0.24875450811679256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414068914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996324,0.0018058135,0.0003423389,0.00067294785,0.00035554572,0.00029631623,0.000018037179,0.00000617407,0.00017881322],"genre_scores_gemma":[0.9993102,0.000093252536,0.0001905764,0.00031277366,0.000041836767,0.000007226404,0.000004864223,0.000012134589,0.00002713911],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985524,0.00013116519,0.00070181873,0.00016981104,0.00021463548,0.00023020217],"domain_scores_gemma":[0.99893624,0.00014305915,0.0003195002,0.00018368172,0.00031299968,0.00010455038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011884768,0.00012497912,0.00051801075,0.00017675187,0.00008793218,0.000020896607,0.00011541685,0.000108974404,0.000044528017],"category_scores_gemma":[0.0001255334,0.00009232101,0.00013339761,0.00028876177,0.00020556596,0.00008007061,0.000033631746,0.0002852548,1.7317844e-7],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052067693,0.0008853658,0.024918253,0.00004540935,0.00040798142,0.94790685,0.00020572495,0.000013112934,0.003204694,0.000101851874,0.0003030784,0.016800879],"study_design_scores_gemma":[0.006143012,0.0013995183,0.19169107,0.00058723276,0.0001540572,0.78979826,0.00022097328,0.00015783664,0.009587954,0.000058695525,0.00011567729,0.00008573317],"about_ca_topic_score_codex":0.00019552647,"about_ca_topic_score_gemma":0.0018846748,"teacher_disagreement_score":0.16677281,"about_ca_system_score_codex":0.000163802,"about_ca_system_score_gemma":0.0007373235,"threshold_uncertainty_score":0.37647417},"labels":[],"label_agreement":null},{"id":"W4414319101","doi":"10.1093/bjd/ljaf370","title":"Metformin in necrobiotic xanthogranuloma","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Infectious Disease Case Reports and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Institute of Nano Science and Technology; Medizinische Fakultät, Universität zu Köln; Deutsche Forschungsgemeinschaft; Mazak Foundation; Faraday Institution; Health Research","keywords":"Metformin; Macrophage; Disease; Repurposing; Granulomatous disease; Drug repositioning","score_opus":0.004630283056386433,"score_gpt":0.26956898308600125,"score_spread":0.26493870002961484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414319101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545605,0.006832788,0.00016673718,0.00053686113,0.00031277695,0.00012387829,0.0000021739143,0.00000924073,0.006559476],"genre_scores_gemma":[0.9987102,0.000559275,0.00022934063,0.00031279505,0.00001966165,0.000002118298,0.0000035629732,0.000006183182,0.00015683782],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99914336,0.000042406708,0.000483158,0.00008205027,0.00008085539,0.00016818702],"domain_scores_gemma":[0.99953717,0.000037153757,0.00014631815,0.000073135445,0.00012845473,0.00007778629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007846975,0.00007095279,0.0003964875,0.00029243378,0.00003722607,0.000016503625,0.000034155564,0.00007788643,0.000067304645],"category_scores_gemma":[0.00011694875,0.00007109449,0.0001443477,0.00020303781,0.000052773103,0.00006666367,0.0000136767785,0.00018482661,0.0000046272307],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018544066,0.0009697469,0.5071802,0.00016328807,0.000375254,0.40625182,0.00003282924,0.000002016677,0.00018691171,0.0003532439,0.0035414842,0.080757745],"study_design_scores_gemma":[0.004198373,0.0000753401,0.21903343,0.00073616003,0.00025003427,0.7693362,0.000052013627,0.000014285918,0.001413309,0.00058102317,0.0042473953,0.000062384],"about_ca_topic_score_codex":0.000063263025,"about_ca_topic_score_gemma":0.000057739006,"teacher_disagreement_score":0.36308444,"about_ca_system_score_codex":0.00006240495,"about_ca_system_score_gemma":0.0002486827,"threshold_uncertainty_score":0.2899149},"labels":[],"label_agreement":null},{"id":"W4414351583","doi":"10.1093/bjd/ljaf366","title":"Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European Academy of Dermatology and Venereology; Universität zu Lübeck","keywords":"Clinical trial; Bullous pemphigoid; Pemphigoid; Alternative medicine; Clinical endpoint; Clinical research; Pemphigus","score_opus":0.26692924240803867,"score_gpt":0.5114426244138189,"score_spread":0.24451338200578027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414351583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436782,0.042641636,0.00014776178,0.011457451,0.0014256433,0.0005736992,0.00003813211,0.000013918075,0.000023537967],"genre_scores_gemma":[0.9621525,0.03517521,0.0007980526,0.0009851649,0.00079699775,0.000020163687,0.00004105707,0.000019850691,0.000011016251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925268,0.0038370509,0.002840366,0.00035015322,0.00021672825,0.00022885184],"domain_scores_gemma":[0.9857473,0.012530579,0.0010478189,0.00018432982,0.00033229592,0.00015771079],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008792634,0.00015643965,0.0014868922,0.000062951476,0.00010930742,0.00008846169,0.0002785301,0.0003048688,0.000023029388],"category_scores_gemma":[0.042124376,0.0001342196,0.00029967068,0.00006481638,0.0004060514,0.00012975435,0.000120735094,0.00093745044,6.272071e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026795536,0.00060935784,0.49431482,0.000026374255,0.00047201687,0.0009822134,0.00038361852,3.7545257e-7,0.00000975255,0.00005744345,0.0025914197,0.4737571],"study_design_scores_gemma":[0.06712121,0.00072156865,0.9166206,0.0010056531,0.0001861522,0.0068901596,0.0011292527,0.00012702434,0.0000108333315,0.00081646367,0.0052417046,0.00012937155],"about_ca_topic_score_codex":0.00045325203,"about_ca_topic_score_gemma":0.0005441005,"teacher_disagreement_score":0.47362772,"about_ca_system_score_codex":0.000023317381,"about_ca_system_score_gemma":0.00031616449,"threshold_uncertainty_score":0.96594423},"labels":[],"label_agreement":null},{"id":"W4414438945","doi":"10.1093/bjd/ljaf285","title":"Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage)","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Manchester Biomedical Research Centre","keywords":"Ciclosporin; Atopic dermatitis; Clinical study; Randomized controlled trial; Clinical trial; Signs and symptoms; Safety profile","score_opus":0.010542506242325422,"score_gpt":0.3139650421391255,"score_spread":0.30342253589680007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414438945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875685,0.0021587394,0.0019370919,0.0012497576,0.00010226021,0.006874184,0.000028665023,0.000012495071,0.00006828458],"genre_scores_gemma":[0.9970556,0.0009395964,0.0006868228,0.0010272446,0.000019806255,0.0001883035,0.0000116725505,0.000020644757,0.00005030135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99621916,0.0007443919,0.0021304924,0.00032238982,0.00024765736,0.0003359208],"domain_scores_gemma":[0.99623686,0.001883819,0.00074981735,0.00015932019,0.00071839034,0.00025180526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256496,0.00027792127,0.0038995338,0.00037942274,0.0001050927,0.000033761702,0.00012337735,0.00017044292,0.000010310777],"category_scores_gemma":[0.0020643156,0.00019645144,0.0001639509,0.00022998959,0.00033819687,0.00015729338,0.000051703155,0.0003949437,3.2181202e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71460724,0.0035538678,0.27136397,0.0003181794,0.00113526,0.0030093088,0.00014090126,0.000012853616,5.7268244e-7,0.00003112186,0.00074053224,0.005086234],"study_design_scores_gemma":[0.8607005,0.0013671502,0.12443213,0.0019543013,0.001382126,0.009000096,0.00038322405,0.0004812824,0.000021820819,0.00006232806,0.00004356789,0.00017148987],"about_ca_topic_score_codex":0.000020310243,"about_ca_topic_score_gemma":0.0001522203,"teacher_disagreement_score":0.14693183,"about_ca_system_score_codex":0.00003310407,"about_ca_system_score_gemma":0.00048298138,"threshold_uncertainty_score":0.8011057},"labels":[],"label_agreement":null},{"id":"W4414439665","doi":"10.1093/bjd/ljaf316","title":"Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Ciclosporin; Atopic dermatitis; Cyclosporins; Immunopathology; MEDLINE","score_opus":0.011718045001764259,"score_gpt":0.3049830816555852,"score_spread":0.2932650366538209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414439665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119014,0.0034864966,0.00016142371,0.0042030513,0.00019254026,0.00060460187,0.000040616975,0.000015687561,0.00010543539],"genre_scores_gemma":[0.9968987,0.0011778955,0.0010180168,0.0006956547,0.000027802793,0.00003242673,0.000009446755,0.000010201651,0.00012983475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803454,0.00015449048,0.0011853145,0.00020561604,0.00013702002,0.00028303138],"domain_scores_gemma":[0.9984167,0.00053798076,0.00039122964,0.00022146407,0.00032099598,0.00011161336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111348,0.00016801826,0.0010496961,0.00026435417,0.000056565386,0.000015365858,0.00018444983,0.00020606935,0.000044045693],"category_scores_gemma":[0.0010166875,0.0001347771,0.00025333476,0.00022798253,0.00023064775,0.00014649674,0.000035650322,0.00020863673,0.0000017591002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020120996,0.0026853231,0.9156149,0.0018137231,0.0005990368,0.014393225,0.00037070102,0.000026244123,0.00034398556,0.00032230178,0.008894338,0.052924097],"study_design_scores_gemma":[0.013476087,0.00026003053,0.89872444,0.0016288866,0.00036431814,0.05892797,0.0001548507,0.00003331687,0.02043627,0.0008876638,0.0049552256,0.000150938],"about_ca_topic_score_codex":0.00008685474,"about_ca_topic_score_gemma":0.00060430536,"teacher_disagreement_score":0.05277316,"about_ca_system_score_codex":0.00009628807,"about_ca_system_score_gemma":0.0006052354,"threshold_uncertainty_score":0.5496051},"labels":[],"label_agreement":null},{"id":"W4414557178","doi":"10.1093/bjd/ljaf380","title":"Long-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institutes of Health; InflaRx; Norges Idrettshøgskole; British Microcirculation Society; Medical Research Council; Biogen; Boehringer Ingelheim España; Novocure; Vanderbilt University; Canadian Dermatology Foundation; Physicians' Services Incorporated Foundation; Eli Lilly and Company; National Health and Medical Research Council; National Eczema Association; Vanderbilt University Medical Center; National Psoriasis Foundation; Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Quality of life (healthcare); Population; MEDLINE; Complication; Chronic condition","score_opus":0.026644246104899547,"score_gpt":0.30812070967203503,"score_spread":0.28147646356713546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414557178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940108,0.002887202,0.0002465791,0.0016444101,0.00029823315,0.00016142376,0.000022253193,0.000008485534,0.0007205785],"genre_scores_gemma":[0.9980528,0.0015895892,0.00016007881,0.00011007551,0.000022170118,0.0000018255084,0.0000043793757,0.000012473458,0.000046613746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973722,0.00040561066,0.0015049049,0.00018288396,0.00025955762,0.00027483338],"domain_scores_gemma":[0.9982382,0.00039157842,0.00081159826,0.00020271486,0.00018220463,0.00017366845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005267348,0.00014027033,0.0013795898,0.00059136905,0.000038132217,0.000009616787,0.0001338869,0.00019579414,0.000023819914],"category_scores_gemma":[0.0008862392,0.00016457362,0.00022628339,0.00045542786,0.00023808319,0.00018045072,0.000067766756,0.0005396057,0.0000014844491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009964252,0.0005876747,0.9823925,0.00074649864,0.00039009348,0.0044575436,0.00006738977,0.000012125239,0.0034201303,0.00012924819,0.000074522046,0.0076226215],"study_design_scores_gemma":[0.0027372008,0.0000359632,0.9415419,0.00083894766,0.0001625472,0.05032623,0.00019040103,0.000016683254,0.0038961223,0.00012176228,0.000039172108,0.00009305196],"about_ca_topic_score_codex":0.0021228867,"about_ca_topic_score_gemma":0.0034627477,"teacher_disagreement_score":0.045868684,"about_ca_system_score_codex":0.00007842747,"about_ca_system_score_gemma":0.00038437409,"threshold_uncertainty_score":0.67111176},"labels":[],"label_agreement":null},{"id":"W4414619922","doi":"10.1093/bjd/ljaf358","title":"Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlases","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Zoonotic diseases and public health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Fondet; Universidade Católica de Brasília; Boehringer Ingelheim; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Milestone; League; Public health; Global health; Health care; Disease; International health; Burden of disease","score_opus":0.026645296389563283,"score_gpt":0.3254258597116132,"score_spread":0.29878056332204994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414619922","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25477883,0.18853773,0.0035590115,0.5481382,0.001154607,0.0009840254,0.00027172355,0.000031777272,0.0025440888],"genre_scores_gemma":[0.9669387,0.025286317,0.000469714,0.006955221,0.00017650411,0.0000148059535,0.000034190834,0.000009953161,0.00011461738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982217,0.00020096933,0.0008865019,0.00015043207,0.00026577985,0.00027461647],"domain_scores_gemma":[0.99817073,0.00052797433,0.00047762346,0.00014239633,0.0004277119,0.00025353106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044961783,0.00011323301,0.00065930607,0.00012740232,0.00013259503,0.00003409401,0.00027448832,0.00008782599,0.00007163887],"category_scores_gemma":[0.00086593564,0.000088465604,0.0003722131,0.00010538584,0.00022776461,0.00008506152,0.00005392498,0.0002495471,0.0000010029243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020096735,0.0015960732,0.024769181,0.0047808257,0.0010446222,0.0014966482,0.00058735325,0.000010716074,0.000007785776,0.024838608,0.5382344,0.40062413],"study_design_scores_gemma":[0.015204076,0.0006162149,0.36631802,0.0059866216,0.0007129103,0.057797514,0.00553025,0.0004498573,0.0003476863,0.020124346,0.52653265,0.00037986605],"about_ca_topic_score_codex":0.000021054128,"about_ca_topic_score_gemma":0.000019895024,"teacher_disagreement_score":0.7121599,"about_ca_system_score_codex":0.000047995054,"about_ca_system_score_gemma":0.0010051223,"threshold_uncertainty_score":0.36075228},"labels":[],"label_agreement":null},{"id":"W4415095336","doi":"10.1093/bjd/ljaf394","title":"Real-world evidence on palmoplantar pustulosis: patient characteristics, diagnostic challenges and predictive factors for treatment survival – a retrospective registry study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; UCB Pharma; Merck Sharp and Dohme; Sandoz Canada; UCB Pharma France; LEO Pharma; Boehringer Ingelheim España; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Concomitant; Ustekinumab; Comorbidity; Psoriatic arthritis; Psoriasis; Retrospective cohort study; Risk factor; Disease","score_opus":0.027414595998122626,"score_gpt":0.2692421529409907,"score_spread":0.24182755694286806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415095336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735015,0.023233028,0.000019205538,0.0003698053,0.0015821819,0.000733704,0.00035770625,0.000020639785,0.00018220747],"genre_scores_gemma":[0.96627766,0.033322908,0.00001437208,0.000022049546,0.000048575042,0.00010054572,0.000045911052,0.000014651411,0.00015330916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981487,0.0005181673,0.0006004553,0.00035664265,0.00006148977,0.00031459183],"domain_scores_gemma":[0.9965353,0.0025289648,0.00048702743,0.00018676609,0.000214274,0.000047673428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014089646,0.00026223864,0.00089638325,0.00022653583,0.00023359864,0.000026388805,0.00015935538,0.00018435408,0.000013540753],"category_scores_gemma":[0.0009039033,0.00023849784,0.00015623568,0.00008351834,0.00014668083,0.00009931866,0.000045335943,0.00017123054,0.0000032389862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003410607,0.0028134924,0.9074303,0.000097117896,0.004027122,0.0024712891,0.0043788524,5.950938e-7,0.00035663237,0.00026895685,0.001242421,0.07350264],"study_design_scores_gemma":[0.0036866094,0.0034577579,0.9812649,0.00078082544,0.0008012797,0.0020239083,0.004010206,4.515563e-7,0.0030730302,0.0001404723,0.00057992904,0.00018066427],"about_ca_topic_score_codex":0.00014602674,"about_ca_topic_score_gemma":0.0005922568,"teacher_disagreement_score":0.07383459,"about_ca_system_score_codex":0.00020530098,"about_ca_system_score_gemma":0.00013458388,"threshold_uncertainty_score":0.972566},"labels":[],"label_agreement":null},{"id":"W4415105330","doi":"10.1093/bjd/ljaf398","title":"Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Hotel Dieu Hospital","funders":"Sanofi Genzyme; European Academy of Dermatology and Venereology; Idorsia Pharmaceuticals; Swedish Orphan Biovitrum; LEO Pharma; Servier; Genesis Pharma; UCB Pharma; Argenx; Galderma; XBiotech; InflaRx; Symphogen; Pfizer; Biogen; Incyte; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Novartis Pharma; European Commission; Springworks Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Bundesministerium für Bildung und Forschung; Cilag; Insmed; L'Oreal USA; Sanofi; AstraZeneca; Novocure; Celldex Therapeutics; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Hidradenitis suppurativa; Randomized controlled trial; Post-hoc analysis; Post hoc; Clinical trial; Randomization","score_opus":0.03081501622689424,"score_gpt":0.3624890151933463,"score_spread":0.33167399896645205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415105330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959564,0.00023101385,0.00021499667,0.029386956,0.0016283422,0.0067900848,0.000081042686,0.00002025645,0.002083361],"genre_scores_gemma":[0.9983743,0.00006343572,0.0004563366,0.0002818281,0.00017106246,0.0002575428,0.000022869268,0.00003415801,0.00033850153],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99232256,0.0030091805,0.0031256636,0.0005026635,0.00054606574,0.0004938428],"domain_scores_gemma":[0.9931847,0.0048750187,0.0009360018,0.00040442558,0.00033597008,0.0002638747],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030083532,0.00041449082,0.0043997513,0.000416024,0.00015813275,0.000079826124,0.00038287052,0.00037805684,0.000027241009],"category_scores_gemma":[0.006901952,0.00028362885,0.0009948185,0.00048467616,0.0002473566,0.00039176323,0.00010904384,0.0010514676,0.000008070064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9642535,0.0013402523,0.0021925364,0.000029968052,0.0013963408,0.02575264,0.00091068767,0.0000132569285,0.00008185859,0.00011680454,0.0003269221,0.0035852662],"study_design_scores_gemma":[0.9266258,0.0042164815,0.0009257447,0.0010817262,0.0007385863,0.0637838,0.00021526164,0.00010940128,0.0016293449,0.0004433448,0.000033533885,0.00019698459],"about_ca_topic_score_codex":0.00027429007,"about_ca_topic_score_gemma":0.00036426858,"teacher_disagreement_score":0.03881032,"about_ca_system_score_codex":0.00016346302,"about_ca_system_score_gemma":0.0005829293,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W4415286230","doi":"10.1093/bjd/ljaf411","title":"Clinical severity and parent–child discrepancies in paediatric atopic dermatitis across the USA","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Atopic dermatitis; Psychosocial; Psychological intervention; Quality of life (healthcare); MEDLINE; Severity of illness","score_opus":0.014064043312604217,"score_gpt":0.3269075968946484,"score_spread":0.3128435535820442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415286230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95671564,0.02597431,0.00008591349,0.015760567,0.0005052012,0.00014319025,0.000012237164,0.000009677531,0.000793271],"genre_scores_gemma":[0.98909193,0.0071303863,0.000102985665,0.0035094665,0.00008297102,0.0000057795414,0.0000035638084,0.0000060866614,0.00006683264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980663,0.0004100153,0.00093234103,0.0001581257,0.00013552402,0.00029767927],"domain_scores_gemma":[0.9988811,0.0004883117,0.00024176836,0.00015352592,0.000113753136,0.00012151448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032040337,0.0001157493,0.00064275065,0.000100972036,0.00018887976,0.000044369186,0.00017912294,0.00019423326,0.000035063356],"category_scores_gemma":[0.0008189074,0.000097032134,0.0001814104,0.00023521317,0.0005376249,0.0001419681,0.000119178956,0.0006989794,0.0000057195193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004793271,0.0001774555,0.9576921,0.00010781054,0.00009242935,0.007007339,0.00010031119,3.854348e-7,3.803657e-7,0.00014919696,0.015091515,0.019533185],"study_design_scores_gemma":[0.002044916,0.000016291244,0.8499269,0.00029355157,0.0001015883,0.13231552,0.0002717483,0.000019709447,0.000020363428,0.0007083513,0.014213774,0.00006730091],"about_ca_topic_score_codex":0.00009186703,"about_ca_topic_score_gemma":0.0012120792,"teacher_disagreement_score":0.12530817,"about_ca_system_score_codex":0.000018207107,"about_ca_system_score_gemma":0.00016276092,"threshold_uncertainty_score":0.39568555},"labels":[],"label_agreement":null},{"id":"W4415854073","doi":"10.1093/bjd/ljaf404","title":"Psoriasis at high-impact sites: shifting the paradigm","year":2025,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Psoriasis; MEDLINE; Immunopathology; Disease","score_opus":0.014956436982895206,"score_gpt":0.24276929069415865,"score_spread":0.22781285371126345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415854073","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.217944,0.13426457,0.0000919833,0.63282055,0.011346344,0.00062766275,0.00096155546,0.0001058575,0.0018374962],"genre_scores_gemma":[0.58584374,0.014215027,0.00023560695,0.3724448,0.005611905,0.000082066974,0.0028763649,0.00022366317,0.018466832],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960496,0.0014176472,0.0011822801,0.0003859026,0.00012209374,0.0008424975],"domain_scores_gemma":[0.9966212,0.0014441097,0.0012790859,0.00043448506,0.00018233206,0.00003880624],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002799644,0.00051059504,0.0014878564,0.00034485833,0.0006017137,0.00009138874,0.0009927691,0.0019604617,0.0012476415],"category_scores_gemma":[0.0002587567,0.00040498757,0.0009383728,0.00025365583,0.00034608154,0.00012545989,0.00020124692,0.0024935328,0.00032401487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015784353,0.000060144237,0.0020287908,0.00006150838,0.0029189116,0.013631436,0.00011034939,0.0000018274975,0.00015994466,0.000024237177,0.9648589,0.015986132],"study_design_scores_gemma":[0.0027224822,0.000116574214,0.00403168,0.00041982523,0.0014382947,0.20570658,0.00003173707,2.8712373e-7,0.0016416763,0.00041497502,0.7830909,0.00038499074],"about_ca_topic_score_codex":0.00023116035,"about_ca_topic_score_gemma":0.00011347525,"teacher_disagreement_score":0.36789972,"about_ca_system_score_codex":0.00022392257,"about_ca_system_score_gemma":0.00041496762,"threshold_uncertainty_score":0.9998402},"labels":[],"label_agreement":null},{"id":"W4416059453","doi":"10.1093/bjd/ljaf446","title":"Comment on ‘A call to integrate specialized dermatology clinics into care of patients with inflammatory bowel disease’: reply from authors","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multidisciplinary approach; Multidisciplinary team; Perspective (graphical); Mainstream; Health care; Inflammatory Bowel Diseases; Alternative medicine; Quality (philosophy)","score_opus":0.003994896320341049,"score_gpt":0.2416780378920913,"score_spread":0.23768314157175024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416059453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944419,0.0009994487,0.0007986435,0.0023563085,0.0006721912,0.00038576243,0.00018163904,0.000010800469,0.00015330307],"genre_scores_gemma":[0.9924383,0.00015585299,0.0009346931,0.006085475,0.000095636446,0.000019130754,0.00021122755,0.000034434466,0.000025219013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973916,0.00047989984,0.0011413945,0.00037754234,0.00027707568,0.00033251566],"domain_scores_gemma":[0.9976296,0.000069554844,0.0006283805,0.00045616846,0.00085026276,0.00036604787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011619056,0.00026768603,0.0005607499,0.00021308352,0.000111436995,0.00003225771,0.00051726046,0.00023657334,0.0000226957],"category_scores_gemma":[0.0005070901,0.0002800199,0.00023373759,0.00010821297,0.00027498972,0.0000142643,0.00019195107,0.00033404745,0.0000076392635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0101330625,0.00052200654,0.91917837,0.00026757517,0.0006042236,0.006191295,0.00044611475,0.000116493364,0.0003004765,0.00038238324,0.058100305,0.0037576954],"study_design_scores_gemma":[0.007336733,0.00034354083,0.90369725,0.00083546224,0.0002889378,0.0003029792,0.00049374445,0.000016419886,0.0056682597,0.0004925743,0.08003544,0.0004886806],"about_ca_topic_score_codex":0.000030475006,"about_ca_topic_score_gemma":0.00022280368,"teacher_disagreement_score":0.021935135,"about_ca_system_score_codex":0.00007331725,"about_ca_system_score_gemma":0.0005853485,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W4416243543","doi":"10.1093/bjd/ljaf463","title":"Sleep patterns and the risk of psoriatic disease: genetic predisposition and metabonomics","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Sleep and related disorders","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Fundamental Research Funds for Central Universities of the Central South University; Huxiang Youth Talent Support Program; National Natural Science Foundation of China","keywords":"Genetic predisposition; Sleep (system call); Sleep patterns; Risk factor; Association (psychology); Psoriasis; Genetic association","score_opus":0.002697167001372717,"score_gpt":0.22287482733779543,"score_spread":0.22017766033642272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416243543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91752154,0.07698253,0.0032585934,0.0011197932,0.00070006255,0.00013005793,0.000020797068,0.000004218956,0.00026243075],"genre_scores_gemma":[0.98720735,0.012457163,0.00010153276,0.00017255172,0.00002758189,0.000005156781,0.0000016246253,0.00000669464,0.000020365638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886435,0.00039988584,0.00044757503,0.00010372045,0.00005888741,0.00012556667],"domain_scores_gemma":[0.9991908,0.000262727,0.00032940245,0.00009873671,0.000059374528,0.000058954553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013922212,0.00007531303,0.00030100293,0.00010038065,0.00007718578,0.000022470498,0.000107834196,0.000096553464,0.00003676521],"category_scores_gemma":[0.00008912572,0.000062831714,0.00008394144,0.00007020662,0.0002640021,0.00004390423,0.000032587872,0.000231961,0.0000011462841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014200663,0.00035248647,0.73476475,0.00014065614,0.0043955646,0.0011225392,0.0013406059,0.00008431885,0.000008505958,0.007102548,0.002338747,0.24692918],"study_design_scores_gemma":[0.008268154,0.000030423733,0.96882004,0.000119030214,0.0020354793,0.011089909,0.00056702754,0.0005385456,0.00001402151,0.008130815,0.0003024692,0.00008407887],"about_ca_topic_score_codex":0.00011454693,"about_ca_topic_score_gemma":0.00003147362,"teacher_disagreement_score":0.2468451,"about_ca_system_score_codex":0.0000041616236,"about_ca_system_score_gemma":0.000020149328,"threshold_uncertainty_score":0.2562203},"labels":[],"label_agreement":null},{"id":"W4416538556","doi":"10.1093/bjd/ljaf468","title":"Darier disease is a syndromic epidermal differentiation disorder","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Darier's disease; Dyskeratosis; Darier Disease; Disease; Congenital disease","score_opus":0.0029644984604342084,"score_gpt":0.22480267157468375,"score_spread":0.22183817311424955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416538556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691879,0.018187484,0.009779205,0.0019358794,0.00044467524,0.0000895329,0.000032052474,0.0000046038244,0.00033862272],"genre_scores_gemma":[0.9967477,0.0011662932,0.0001810429,0.0013299312,0.00007827243,0.000005009282,0.000041778672,0.0000115678495,0.00043844213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990155,0.000105982945,0.00038996962,0.00017727537,0.000105888015,0.00020539283],"domain_scores_gemma":[0.9993688,0.00001325447,0.00016932828,0.00016022642,0.00014807652,0.00014034312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004608571,0.00011122279,0.00021831621,0.000076381184,0.00009886279,0.00004028195,0.00021325592,0.000118503944,0.00009448769],"category_scores_gemma":[0.00011616938,0.00012302636,0.00019232451,0.00007315073,0.000106541615,0.0000064541555,0.000088635774,0.00011719645,0.000005698771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095829956,0.0012881825,0.48513165,0.0003587508,0.0012688187,0.0044708145,0.00008370283,0.00013164995,0.01378222,0.0006442589,0.4193986,0.07248305],"study_design_scores_gemma":[0.0044407602,0.00010952581,0.88200897,0.00030783383,0.00043792662,0.019489268,0.00015303795,0.000198431,0.011147003,0.0030046918,0.078230135,0.0004724406],"about_ca_topic_score_codex":0.000010305436,"about_ca_topic_score_gemma":0.000011797189,"teacher_disagreement_score":0.3968773,"about_ca_system_score_codex":0.000008668314,"about_ca_system_score_gemma":0.00024399179,"threshold_uncertainty_score":0.50168693},"labels":[],"label_agreement":null},{"id":"W4416661874","doi":"10.1093/bjd/ljaf479","title":"Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: development, validation and severity strata of the cNF-PUSH-D","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Neurofibromatosis; Prom; Stigma (botany); Disease; Clinical trial; MEDLINE","score_opus":0.008603104957457055,"score_gpt":0.24877802312726,"score_spread":0.24017491816980294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416661874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641424,0.0005658356,0.000090704765,0.0020607763,0.00025104525,0.00028166367,0.0000069185467,0.000012468147,0.00031634702],"genre_scores_gemma":[0.9986113,0.00015306855,0.0008666026,0.00028573396,0.0000061805986,0.000002789651,0.0000046638684,0.000013069923,0.00005662958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981588,0.0002530438,0.0010085588,0.00017943155,0.00022139278,0.00017878451],"domain_scores_gemma":[0.99905336,0.0001487677,0.00036723365,0.00015960478,0.00018008488,0.00009095122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012266163,0.0001243872,0.00048603056,0.00028357445,0.00008922685,0.000038562852,0.00015399307,0.00011048797,0.000014583475],"category_scores_gemma":[0.0004689807,0.00011834046,0.0000728893,0.0005859091,0.00008345967,0.00014308037,0.00010074995,0.00026398196,0.0000012926117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045725808,0.00040660915,0.9068634,0.0009642175,0.00015253467,0.0054160394,0.000494056,0.00007745705,0.06453199,0.000751379,0.0041699964,0.015715055],"study_design_scores_gemma":[0.0014744857,0.00010199144,0.736268,0.0016591748,0.000077474186,0.16600542,0.00010128335,0.000093854695,0.0932252,0.00028932543,0.0005937975,0.000110032575],"about_ca_topic_score_codex":0.000021776792,"about_ca_topic_score_gemma":0.000024945963,"teacher_disagreement_score":0.17059545,"about_ca_system_score_codex":0.000028488163,"about_ca_system_score_gemma":0.0002548501,"threshold_uncertainty_score":0.4825784},"labels":[],"label_agreement":null},{"id":"W4416737953","doi":"10.1093/bjd/ljaf471","title":"Bullous pemphigoid outcome measurement: a scoping review of outcome heterogeneity and trends in clinical research of treatments","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cilag; UCB Pharma; Novartis Pharma; Celgene","keywords":"Outcome (game theory); Clinical research; Clinical trial; Bullous pemphigoid; MEDLINE; Relevance (law); Patient-reported outcome; Clinical significance","score_opus":0.1804567931965548,"score_gpt":0.4927175499689474,"score_spread":0.3122607567723926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416737953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7251309,0.2725169,0.000019437062,0.0015289418,0.00012845016,0.00033666843,0.000008114028,0.0000053703884,0.0003251859],"genre_scores_gemma":[0.9611456,0.03818856,0.0002591444,0.00032931723,0.000015872141,0.000008449926,0.0000032721593,0.000013107125,0.000036719575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490523,0.00086273014,0.0030763813,0.00021631048,0.00063029816,0.00030901717],"domain_scores_gemma":[0.99773633,0.0003129603,0.0007655333,0.00027331198,0.00077906006,0.00013280916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022938035,0.00013820219,0.0018483925,0.0006432716,0.000045585,0.0000085701795,0.00020815524,0.00014631565,0.000050265542],"category_scores_gemma":[0.0032485486,0.00013892501,0.000361711,0.00049047876,0.00038528765,0.000063278676,0.00013151787,0.00048081775,0.00000130247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025838273,0.00084293325,0.9548355,0.010236428,0.0002891507,0.0028590488,0.0000165183,1.9622195e-7,0.00006318852,0.000014856846,0.0006490653,0.02993474],"study_design_scores_gemma":[0.0052571646,0.00028282564,0.8851119,0.09260048,0.0003670384,0.015701734,0.00003089318,0.0000028122006,0.0004375672,0.000047100002,0.00008169834,0.000078743906],"about_ca_topic_score_codex":0.00012529372,"about_ca_topic_score_gemma":0.0001505293,"teacher_disagreement_score":0.23601462,"about_ca_system_score_codex":0.00010530578,"about_ca_system_score_gemma":0.00035640816,"threshold_uncertainty_score":0.56651974},"labels":[],"label_agreement":null},{"id":"W4416987386","doi":"10.1093/bjd/ljaf491","title":"The Inflammatory Skin Disease map: an interactive computational resource focused on molecular mechanisms in psoriasis and atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; UCB Pharma; University of Bristol; European Commission; King's College London; Medical Research Council; European Federation of Pharmaceutical Industries and Associations; Université du Luxembourg","keywords":"Atopic dermatitis; Psoriasis; Testbed; Disease; Representation (politics); Resource (disambiguation)","score_opus":0.0027973224414473983,"score_gpt":0.21390617384664806,"score_spread":0.21110885140520066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416987386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688962,0.0036330593,0.024257693,0.0024673087,0.00029097867,0.00016872186,0.00001298312,0.000004237972,0.0002688217],"genre_scores_gemma":[0.99758464,0.00024628307,0.00084123376,0.0012337506,0.000036695317,0.0000062085396,0.00002047453,0.000008328842,0.000022410824],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99902034,0.0001780709,0.00042509762,0.00011712373,0.000094281255,0.0001651146],"domain_scores_gemma":[0.99945337,0.00006593193,0.00019510047,0.000118175325,0.00008011029,0.00008728749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015359544,0.0000980841,0.00016353879,0.00007590432,0.00011139591,0.00007533871,0.00019080892,0.00010309695,0.0000024440276],"category_scores_gemma":[0.00006103752,0.0000965396,0.00006344813,0.00005105549,0.00009381473,0.000012338515,0.00007775181,0.00020913646,9.137469e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020085813,0.00097249023,0.010503909,0.00041707355,0.001412113,0.007017094,0.001259108,0.012361135,0.0034191913,0.062389284,0.040866062,0.85737395],"study_design_scores_gemma":[0.026526498,0.001339751,0.3072155,0.0025611152,0.00036944033,0.027490534,0.0034277136,0.025315067,0.040019,0.37883088,0.18487796,0.0020265416],"about_ca_topic_score_codex":0.000005221353,"about_ca_topic_score_gemma":0.00006699715,"teacher_disagreement_score":0.8553474,"about_ca_system_score_codex":0.000017795952,"about_ca_system_score_gemma":0.00010302326,"threshold_uncertainty_score":0.3936771},"labels":[],"label_agreement":null},{"id":"W4417200615","doi":"10.1093/bjd/ljaf508","title":"Distinct bacterial facial cutaneous microbiota composition in adolescents with acne vulgaris: a population-based cross-sectional observational study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Erasmus Universiteit Rotterdam; Health Services Research and Development","keywords":"Acne; Microbiome; Observational study; Streptococcus; Staphylococcus epidermidis","score_opus":0.017367194349638147,"score_gpt":0.29862449021004045,"score_spread":0.2812572958604023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417200615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985971,0.000120823344,0.0002179738,0.00026213203,0.00038939583,0.00035342664,0.000021980708,0.000010191734,0.000026971178],"genre_scores_gemma":[0.9993375,0.0000044202893,0.00015634815,0.00021760695,0.00010542017,0.0000066975117,0.00013463083,0.000009135133,0.00002824889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882764,0.00011177388,0.0005442829,0.0001604217,0.00018121705,0.00017468027],"domain_scores_gemma":[0.9994227,0.000038087554,0.00021414386,0.00006615679,0.0001963282,0.00006256798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006851146,0.00012275064,0.00039611282,0.00017272633,0.00015378866,0.00006620688,0.00006700007,0.000115120085,0.00003326989],"category_scores_gemma":[0.00003824696,0.0001121386,0.000080573955,0.0001626144,0.000051747375,0.00009716934,0.000016598986,0.00025466617,0.0000022099678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025392913,0.0016652644,0.98756236,0.00007226214,0.0001170762,0.0065946174,0.000022960998,0.000050918818,0.00058590743,0.0000028826487,0.00013919442,0.0006472856],"study_design_scores_gemma":[0.010276878,0.00037490638,0.95789945,0.0007416476,0.000092935355,0.030249126,0.000018554712,0.00008315339,0.00011950286,0.000013509421,0.000046160683,0.00008418883],"about_ca_topic_score_codex":0.00025593434,"about_ca_topic_score_gemma":0.0003147634,"teacher_disagreement_score":0.029662903,"about_ca_system_score_codex":0.00013254551,"about_ca_system_score_gemma":0.00028234022,"threshold_uncertainty_score":0.45728794},"labels":[],"label_agreement":null},{"id":"W4417419178","doi":"10.1093/bjd/ljaf485","title":"Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Barrie Urology Group; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Vitiligo; Clinical trial; Duration (music); Cohort","score_opus":0.04065782231475665,"score_gpt":0.3763890620810534,"score_spread":0.3357312397662967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417419178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560744,0.0024651461,0.0001679427,0.0003964617,0.00032043882,0.0008359542,0.000022598842,0.0000023019072,0.00018171968],"genre_scores_gemma":[0.9984513,0.0007476979,0.00015557444,0.00034846642,0.000064768705,0.00004153444,0.00014304185,0.000011019898,0.000036625916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974597,0.0007055456,0.0010075523,0.00033813267,0.00024874433,0.00024032236],"domain_scores_gemma":[0.9989478,0.00015347257,0.00031619152,0.0002757296,0.0002470361,0.000059774993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060632994,0.00016340164,0.000512499,0.00012756353,0.00007868198,0.000056563393,0.00035630545,0.0001852612,0.00004471145],"category_scores_gemma":[0.00032662784,0.00014930719,0.00007672532,0.00014951102,0.00008696222,0.000025619984,0.00016200067,0.00018198688,0.0000011241864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059555783,0.023158096,0.43913177,0.00006373778,0.00043760685,0.0039438605,0.0013786397,0.000026835283,0.30157578,0.00019110877,0.0022643225,0.22187267],"study_design_scores_gemma":[0.057370696,0.0023391475,0.81961125,0.00069716235,0.00021673892,0.0029211056,0.002268412,0.00030229232,0.11317154,0.00067015464,0.00018402965,0.00024749024],"about_ca_topic_score_codex":0.0005605582,"about_ca_topic_score_gemma":0.0014833132,"teacher_disagreement_score":0.38047948,"about_ca_system_score_codex":0.00007739944,"about_ca_system_score_gemma":0.00023307344,"threshold_uncertainty_score":0.60885704},"labels":[],"label_agreement":null},{"id":"W7117359154","doi":"10.1093/bjd/ljaf519","title":"Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Barrie Urology Group; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Continuation; Extension (predicate logic); Phase (matter); Phases of clinical research","score_opus":0.028534105601267228,"score_gpt":0.34988140367867215,"score_spread":0.3213472980774049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117359154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995465,0.0011890886,0.00076753506,0.00045642714,0.00023639567,0.0017011561,0.000010597824,0.000004095032,0.00016973895],"genre_scores_gemma":[0.9986789,0.0003925076,0.000112333,0.00025585524,0.00011255082,0.00015980157,0.00020575343,0.000012485653,0.00006978498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972477,0.0009071258,0.0009687801,0.00032664984,0.0002966409,0.00025308272],"domain_scores_gemma":[0.99888366,0.0002659753,0.0003368494,0.00019810055,0.00025381008,0.0000615983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080597645,0.00019352019,0.0006502829,0.00014399344,0.00009429016,0.00008500373,0.00017700571,0.00017975265,0.000056191744],"category_scores_gemma":[0.00024063519,0.0001430943,0.000110187226,0.0001609513,0.00013548255,0.000027353399,0.00004074427,0.00020098039,0.0000011117085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72064275,0.0073571876,0.20636953,0.00003637539,0.0007664103,0.0037054997,0.0019183431,0.00006833145,0.008279975,0.00013218296,0.00048310202,0.05024029],"study_design_scores_gemma":[0.86182934,0.0014649747,0.10550084,0.00044095897,0.00038505986,0.003740172,0.002207927,0.00026235436,0.023693625,0.00017457175,0.00007134223,0.00022883093],"about_ca_topic_score_codex":0.00048927445,"about_ca_topic_score_gemma":0.0053677396,"teacher_disagreement_score":0.14118658,"about_ca_system_score_codex":0.00008716461,"about_ca_system_score_gemma":0.00031731708,"threshold_uncertainty_score":0.5835216},"labels":[],"label_agreement":null}]}